data_2ky9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ky9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mmt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.952 -0.388 . . . . 63.13 109.952 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -100.8 154.24 18.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.38 0.672 . . . . 72.43 111.219 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.24 122.74 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 121.084 0.468 . . . . 62.0 110.397 173.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.7 -7.77 42.55 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 115.53 -0.759 . . . . 75.14 112.689 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -80.9 151.22 28.71 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.412 0.685 . . . . 71.23 112.349 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -93.06 136.96 32.84 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.163 0.985 . . . . 74.31 109.136 170.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.95 153.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.7 0.8 . . . . 74.15 110.308 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.8 mm -104.95 121.53 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.889 0.876 . . . . 74.24 109.828 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.464 HD13 ' HB1' ' A' ' 22' ' ' ALA . 35.3 mt -82.01 120.41 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 122.938 0.495 . . . . 74.23 109.886 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -96.86 -56.08 2.68 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.865 0.466 . . . . 70.35 110.833 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.482 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 84.3 m -95.3 140.03 30.77 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.85 -1.167 . . . . 75.54 107.85 174.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 17' ' ' MET . 79.6 p -154.71 141.28 18.86 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.976 0.732 . . . . 75.43 112.976 -164.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -75.18 -43.63 51.07 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.157 0.983 . . . . 75.34 109.6 174.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.474 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 25.3 mmt -96.34 140.42 31.03 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.377 -0.829 . . . . 74.44 110.535 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -60.96 -35.19 76.11 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.763 0.825 . . . . 71.13 111.468 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.46 -4.54 24.91 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 115.118 0.807 . . . . 73.13 115.118 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.509 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 48.6 mtm -99.52 -25.38 14.45 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 117.401 0.6 . . . . 72.14 111.678 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HZ1' ' HB2' ' A' ' 18' ' ' LYS . 4.3 ttmp? -68.34 116.93 9.48 Favored 'General case' 0 CA--C 1.556 1.178 0 CA-C-N 118.475 0.579 . . . . 74.51 110.375 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.81 2.0 89.81 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 115.383 -0.826 . . . . 44.13 113.689 -174.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.9 148.29 27.03 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.205 0.602 . . . . 73.42 111.797 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -95.18 104.26 16.14 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.643 0.777 . . . . 71.02 109.635 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.533 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -90.61 161.12 15.56 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.828 0.851 . . . . 74.3 112.189 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.4 m -124.11 121.77 36.05 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.363 -0.976 . . . . 63.32 108.363 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.07 100.4 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 122.8 0.44 . . . . 63.34 109.906 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.5 p -91.98 -8.1 47.11 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.167 0.587 . . . . 74.15 111.32 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.26 148.96 15.42 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.369 -0.378 . . . . 72.22 112.386 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.78 114.53 14.22 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.821 0.848 . . . . 52.31 109.915 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.44 ' HB2' HG21 ' A' ' 96' ' ' VAL . 5.9 m-85 -116.06 130.54 56.86 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.173 0.989 . . . . 73.31 111.155 -171.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -103.83 81.65 1.9 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.938 0.895 . . . . 75.24 110.319 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -133.88 166.15 23.34 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.088 0.555 . . . . 75.43 111.307 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.402 ' HB ' ' HG2' ' A' ' 54' ' ' GLN . 4.0 m -76.83 121.93 24.07 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.372 -0.603 . . . . 64.41 109.372 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.89 151.62 26.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.452 0.701 . . . . 74.24 109.635 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -136.42 149.18 48.14 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.934 0.873 . . . . 64.34 112.25 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.52 111.58 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 113.892 -1.503 . . . . 73.04 107.149 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.525 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 26.7 m -119.92 149.49 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.321 0.648 . . . . 75.12 112.165 -176.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.1 t -117.41 132.21 56.61 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.655 0.782 . . . . 71.4 109.908 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -150.71 156.1 40.64 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.09 0.472 . . . . 74.43 111.968 -173.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 m -109.3 111.66 59.79 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.332 -0.988 . . . . 74.21 108.332 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.79 117.2 3.11 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.376 2.718 . . . . 72.11 114.125 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.467 HG22 ' HA ' ' A' ' 84' ' ' ALA . 25.6 p -59.49 -24.4 63.57 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.741 1.216 . . . . 70.04 113.892 -173.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -79.38 14.69 1.47 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.483 0.713 . . . . 74.24 112.858 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.95 43.7 6.63 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 113.774 0.27 . . . . 64.34 113.774 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.93 163.61 12.94 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 122.708 0.194 . . . . 71.14 113.024 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -66.28 135.12 53.98 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.372 0.669 . . . . 74.55 111.099 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -58.19 116.83 3.82 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.584 0.754 . . . . 72.13 112.376 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' A' ' 49' ' ' HIS . 30.7 t -84.82 104.94 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.202 -0.908 . . . . 73.33 109.198 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -99.41 135.5 40.72 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.414 0.686 . . . . 75.52 110.668 -172.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.8 m170 57.45 39.06 28.36 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.233 1.013 . . . . 71.55 112.446 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.528 ' HB2' HG11 ' A' ' 46' ' ' VAL . 46.0 t60 -66.25 135.29 54.25 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.908 0.883 . . . . 70.51 110.701 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -150.81 153.61 35.75 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.889 -0.596 . . . . 74.23 110.46 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 98.0 m95 -106.43 139.61 40.63 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.39 1.476 . . . . 75.21 111.824 -2.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.5 137.43 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.333 1.053 . . . . 75.01 108.377 169.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.2 pt -113.74 174.1 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.965 0.506 . . . . 75.41 111.722 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.402 ' HG2' ' HB ' ' A' ' 31' ' ' THR . 14.1 mm100 -48.85 -49.16 40.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.57 1.322 . . . . 73.42 114.57 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.46 -1.22 40.66 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 122.856 0.462 . . . . 75.33 112.163 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.421 ' HG3' ' HB1' ' A' ' 75' ' ' ALA . 0.9 OUTLIER -83.81 -22.06 31.92 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.826 0.85 . . . . 71.52 110.27 175.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.4 mt -117.34 136.14 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 124.715 1.206 . . . . 72.35 111.079 -168.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.457 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 38.4 ttpt -72.01 -57.41 4.31 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.489 0.716 . . . . 64.1 111.539 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.09 -4.61 14.12 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.581 1.152 . . . . 74.21 113.685 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.705 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -54.55 -55.74 26.12 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.45 0.7 . . . . 75.22 112.006 171.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.91 19.79 65.93 Favored Glycine 0 N--CA 1.479 1.565 0 N-CA-C 114.676 0.63 . . . . 54.33 114.676 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 62.79 20.14 11.93 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.06 1.344 . . . . 73.15 113.813 -172.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.574 ' HZ2' HD22 ' A' ' 65' ' ' LEU . 16.6 pttp -98.32 160.18 14.46 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 122.914 0.486 . . . . 74.23 109.91 173.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.8 m -76.46 110.81 11.31 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.891 -0.411 . . . . 75.01 109.891 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.705 HD21 ' HA ' ' A' ' 60' ' ' ALA . 61.1 mt -74.68 114.07 12.68 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.267 0.627 . . . . 74.44 110.458 177.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -81.23 147.81 61.73 Favored Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 123.561 0.744 . . . . 73.05 111.731 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.42 114.63 1.65 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.836 2.358 . . . . 75.15 113.339 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.81 -14.21 24.39 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-N 115.826 -0.625 . . . . 61.23 113.96 -174.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -75.24 141.84 43.47 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.423 0.689 . . . . 75.34 111.03 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -111.38 133.22 53.84 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.536 0.684 . . . . 74.35 110.975 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.9 m -140.09 156.39 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 125.389 1.476 . . . . 73.33 110.634 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -103.46 136.13 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 122.853 0.461 . . . . 74.42 109.769 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.3 mt -87.44 120.88 29.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.167 0.987 . . . . 74.43 111.44 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 8.2 mm-40 -81.73 -36.97 28.01 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.317 0.647 . . . . 75.22 112.43 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HB1' ' HG3' ' A' ' 56' ' ' GLU . . . -83.73 164.99 19.26 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.058 0.456 . . . . 71.5 111.214 176.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 96.5 p -143.74 124.81 14.44 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.737 -0.468 . . . . 74.05 109.737 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -91.66 -4.28 55.37 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.777 0.831 . . . . 71.45 110.602 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -164.33 175.78 9.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.304 1.042 . . . . 74.14 111.141 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -80.4 116.38 20.43 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.352 0.661 . . . . 74.31 111.387 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.31 27.34 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 123.019 0.342 . . . . 75.33 113.821 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.9 ttt -82.53 -50.52 8.73 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.587 0.755 . . . . 73.34 112.906 -173.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -63.31 128.78 37.39 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.834 0.453 . . . . 73.32 111.893 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.2 -10.3 67.58 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.562 -0.29 . . . . 51.52 113.227 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.63 145.9 38.55 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.018 0.527 . . . . 73.34 111.775 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.0 m -84.17 117.25 23.37 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.693 -0.685 . . . . 72.54 109.554 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -110.95 149.27 30.9 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.758 1.223 . . . . 71.31 109.94 -175.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.47 132.24 52.71 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 109.483 -0.562 . . . . 73.32 109.483 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.507 HD11 HG11 ' A' ' 35' ' ' VAL . 30.4 mm -67.42 109.4 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.607 0.763 . . . . 73.1 110.354 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -78.06 -38.36 44.61 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.217 0.607 . . . . 74.12 109.743 172.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.2 t -154.92 141.15 18.55 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.458 -0.792 . . . . 75.43 111.301 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.16 131.89 52.07 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.907 0.883 . . . . 75.13 108.955 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -132.5 139.29 47.87 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.788 0.662 . . . . 74.52 112.788 -168.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -111.22 95.39 5.5 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.06 0.944 . . . . 73.0 109.414 169.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -137.56 157.25 46.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.116 0.966 . . . . 72.31 110.841 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.6 m -85.38 119.37 25.66 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.307 -0.997 . . . . 72.13 108.307 171.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.44 HG21 ' HB2' ' A' ' 28' ' ' TYR . 13.7 m -106.51 132.76 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.398 0.618 . . . . 63.14 109.624 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.406 ' HB2' HG21 ' A' ' 116' ' ' VAL . 89.7 m-85 -111.97 140.43 46.65 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.935 0.894 . . . . 70.34 111.231 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.8 ttp -94.21 119.88 33.65 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.268 -1.382 . . . . 72.51 107.268 167.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 23.5 m -128.03 156.56 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 113.789 1.033 . . . . 72.34 113.789 -171.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -110.29 118.28 35.91 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.124 1.37 . . . . 63.23 109.087 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -133.72 166.86 21.64 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.174 0.511 . . . . 71.21 110.947 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.4 m -105.61 119.14 38.37 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 108.791 -0.818 . . . . 75.55 108.791 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.8 m -56.84 95.98 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.754 0.821 . . . . 73.54 110.834 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.4 p -58.3 -26.0 62.51 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.351 1.06 . . . . 71.23 113.709 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 m -62.6 -38.3 89.63 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 123.734 0.813 . . . . 73.21 112.421 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.9 p -113.94 -50.76 2.81 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 123.357 0.663 . . . . 71.32 112.068 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.21 15.85 7.52 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.158 0.885 . . . . 71.35 111.945 -172.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -86.49 141.54 29.02 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.727 0.811 . . . . 52.14 111.547 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -85.01 117.71 24.15 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.752 1.221 . . . . 73.5 111.093 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -120.53 132.6 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 124.03 0.932 . . . . 73.32 110.591 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.8 168.7 9.82 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.263 0.625 . . . . 74.43 111.365 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.79 37.58 2.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 126.516 1.926 . . . . 74.42 115.221 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -61.53 133.0 55.2 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.483 0.713 . . . . 71.25 111.642 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 90.5 mttt -137.11 132.61 34.31 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.025 0.93 . . . . 74.23 110.951 -175.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.7 m95 -116.37 154.35 30.4 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.824 1.65 . . . . 74.15 111.564 -11.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.406 HG21 ' HB2' ' A' ' 97' ' ' TYR . 15.4 m -124.51 142.47 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.865 0.866 . . . . 61.03 109.637 172.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.1 p -109.98 168.26 9.56 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.52 0.563 . . . . 72.14 112.52 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -57.2 -35.23 69.37 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.678 0.791 . . . . 71.31 111.686 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.49 -43.01 93.4 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.34 1.056 . . . . 64.44 111.799 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.482 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 52.2 mt-10 -85.73 -2.79 58.56 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.903 0.881 . . . . 73.32 112.892 -172.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.07 150.49 40.49 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.636 0.731 . . . . 74.51 111.578 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 m -122.77 147.7 46.2 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.312 -1.366 . . . . 74.15 107.312 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.17 151.85 33.03 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.95 0.795 . . . . 72.33 111.692 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.7 tptt . . . . . 0 N--CA 1.484 1.228 0 C-N-CA 123.075 0.55 . . . . 73.04 110.766 175.406 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.505 ' HG2' HG11 ' A' ' 7' ' ' VAL . 1.8 mpt? . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.431 0.158 . . . . 72.24 110.95 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -109.13 164.13 12.71 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.613 0.765 . . . . 74.54 110.392 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.2 123.06 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-O 121.132 0.492 . . . . 75.41 110.532 172.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.57 -4.37 50.61 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 115.797 -0.638 . . . . 64.2 113.572 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -83.41 142.86 30.68 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.222 0.609 . . . . 64.5 111.455 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -109.13 135.73 49.79 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.42 0.629 . . . . 75.53 111.005 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.544 HG13 ' HA ' ' A' ' 123' ' ' ALA . 23.7 m -139.81 155.29 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.967 1.307 . . . . 64.55 110.475 -170.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.1 mm -98.56 132.53 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.173 0.589 . . . . 73.13 109.714 170.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.673 HG21 ' HG2' ' A' ' 17' ' ' MET . 39.8 mt -81.71 123.34 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 122.387 0.275 . . . . 72.52 110.357 -175.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -95.11 -60.06 1.76 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.433 0.693 . . . . 75.14 110.247 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.633 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 79.7 m -98.24 140.03 33.14 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.073 -1.084 . . . . 74.41 108.073 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' A' ' 17' ' ' MET . 74.1 m -140.16 139.88 35.82 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.991 1.108 . . . . 64.3 113.991 -167.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -91.31 -15.92 28.34 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 113.994 -1.457 . . . . 75.41 110.417 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 26.5 mmt -126.56 155.43 42.44 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.646 1.179 . . . . 73.33 110.226 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -67.05 -36.9 83.06 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.095 0.558 . . . . 73.22 112.193 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.43 -9.98 86.58 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 114.046 0.379 . . . . 75.12 114.046 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.673 ' HG2' HG21 ' A' ' 9' ' ' ILE . 44.0 ttm -80.69 -32.1 36.01 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 122.69 0.396 . . . . 74.23 111.718 -172.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -68.87 122.34 18.42 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.13 0.572 . . . . 64.45 112.201 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.61 -8.48 79.05 Favored Glycine 0 CA--C 1.537 1.469 0 CA-C-N 115.729 -0.669 . . . . 71.12 114.147 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.18 149.68 42.73 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.169 0.588 . . . . 75.34 112.131 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -87.94 101.93 14.23 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.623 0.369 . . . . 73.55 110.04 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . . . -86.56 156.96 19.85 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.604 0.762 . . . . 73.12 111.374 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.0 m -131.25 127.51 37.95 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.454 -0.943 . . . . 73.4 108.454 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.95 113.83 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 123.207 0.603 . . . . 73.14 111.017 -173.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.4 p -89.9 -21.04 22.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.102 0.561 . . . . 74.34 110.53 173.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.6 142.57 8.52 Favored Glycine 0 C--N 1.354 1.547 0 C-N-CA 122.741 0.21 . . . . 65.32 112.612 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.98 107.55 9.7 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.66 0.784 . . . . 61.04 110.067 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -111.58 132.91 54.21 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.801 0.84 . . . . 75.44 110.674 -175.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.4 82.71 1.77 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.77 0.795 . . . . 75.33 109.97 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -134.96 -179.51 5.66 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.816 0.846 . . . . 75.53 111.321 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 m -83.91 128.26 34.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.918 -0.489 . . . . 74.45 110.383 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.11 140.18 48.1 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.141 0.976 . . . . 74.14 109.895 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -113.72 152.51 30.41 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 122.081 0.943 . . . . 74.32 112.6 -174.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.54 111.41 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.069 -1.423 . . . . 74.13 107.753 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 88' ' ' ILE . 19.3 m -112.39 150.85 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.386 0.612 . . . . 75.2 112.444 -176.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -122.0 125.57 46.59 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.298 1.039 . . . . 72.25 109.263 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -152.27 159.03 43.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.564 0.745 . . . . 74.55 111.294 -174.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.9 m -105.52 116.73 59.64 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.724 -1.213 . . . . 74.53 107.724 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -58.96 133.32 52.79 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.096 1.864 . . . . 74.13 110.873 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.1 p -68.83 2.06 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.109 0.781 . . . . 64.11 113.109 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.14 -21.2 66.04 Favored 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 123.663 0.785 . . . . 72.31 111.317 165.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.19 15.13 56.46 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 115.066 0.786 . . . . 64.34 115.066 171.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.62 -131.43 7.38 Favored Glycine 0 N--CA 1.476 1.357 0 CA-C-N 117.655 0.728 . . . . 25.55 113.688 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -71.21 128.27 35.36 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.919 0.888 . . . . 73.32 111.974 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -62.24 122.3 15.28 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.587 0.755 . . . . 72.3 111.938 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.574 HG22 ' SD ' ' A' ' 78' ' ' MET . 68.0 t -84.47 110.77 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.396 0.679 . . . . 71.13 110.256 176.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -101.44 148.33 25.31 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.903 0.481 . . . . 73.22 109.958 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 34.3 m80 54.59 38.95 30.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.732 0.813 . . . . 75.03 112.779 173.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -60.46 128.35 36.21 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.857 0.863 . . . . 71.41 111.198 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 66.1 mttm -126.3 132.68 51.6 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 123.504 0.722 . . . . 72.34 110.594 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 94.4 m95 -117.86 156.14 28.92 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.154 1.382 . . . . 71.23 111.53 -11.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.55 160.4 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.96 1.304 . . . . 75.43 108.169 169.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.435 HG23 HG23 ' A' ' 96' ' ' VAL . 37.4 pt -126.7 163.65 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 118.983 0.81 . . . . 65.41 112.546 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -44.14 -51.59 7.96 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.499 1.519 . . . . 64.43 112.538 174.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -82.15 -5.92 58.81 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.787 0.835 . . . . 74.55 112.97 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -88.32 -33.67 17.92 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.686 0.795 . . . . 62.31 110.234 173.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.8 mt -78.93 130.25 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 115.754 -0.657 . . . . 74.41 110.468 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -69.34 -35.45 75.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.492 0.717 . . . . 71.23 112.351 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.24 -8.9 58.35 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.971 0.73 . . . . 73.1 112.971 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -34.17 -59.43 0.43 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 114.945 1.461 . . . . 73.0 114.945 -173.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.51 21.01 68.4 Favored Glycine 0 N--CA 1.479 1.519 0 N-CA-C 115.352 0.901 . . . . 75.54 115.352 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 68.84 -2.94 1.57 Allowed 'General case' 0 CA--C 1.573 1.85 0 C-N-CA 124.862 1.265 . . . . 64.44 112.472 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -95.68 152.78 18.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.628 -0.67 . . . . 75.51 111.022 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.6 m -84.08 112.36 20.15 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.006 -0.739 . . . . 74.32 109.006 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.52 ' HB3' HG13 ' A' ' 88' ' ' ILE . 42.3 mt -71.31 120.5 16.98 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.817 0.847 . . . . 71.51 110.763 -174.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -91.19 157.48 42.7 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 123.682 0.793 . . . . 75.54 111.292 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -50.99 112.25 0.74 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.644 2.229 . . . . 72.04 113.163 172.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.64 -9.93 16.52 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 115.975 -0.557 . . . . 73.2 114.031 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.6 122.73 19.12 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 117.772 0.786 . . . . 74.5 109.495 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -100.91 118.35 36.78 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.471 -0.937 . . . . 75.15 108.471 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.417 HG12 HD12 ' A' ' 65' ' ' LEU . 33.3 m -125.29 171.92 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.607 1.163 . . . . 63.42 110.877 -166.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.3 mm -116.17 135.95 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 122.863 0.465 . . . . 64.51 110.033 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.9 mt -90.93 134.73 34.24 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.74 0.816 . . . . 75.24 110.996 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.16 -5.62 27.49 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 113.0 0.741 . . . . 75.55 113.0 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.6 156.27 16.89 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.139 0.575 . . . . 74.3 110.618 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.9 p -136.04 124.4 23.34 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.193 0.521 . . . . 65.31 110.319 171.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -100.35 -16.22 17.72 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.793 0.837 . . . . 75.14 108.991 162.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.574 ' SD ' HG22 ' A' ' 46' ' ' VAL . 43.3 mtt -128.57 173.42 10.28 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.39 1.076 . . . . 73.21 112.213 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.59 105.67 8.89 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.0 0.92 . . . . 73.4 110.836 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.1 33.58 17.34 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.23 -0.441 . . . . 72.11 113.207 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -89.59 -49.4 6.69 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.303 0.641 . . . . 73.43 109.97 173.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -69.04 120.57 15.1 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.34 0.656 . . . . 74.43 111.036 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.71 2.35 75.82 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 123.103 0.252 . . . . 71.35 113.263 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.44 158.09 19.06 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.4 0.68 . . . . 72.44 111.551 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 m -87.51 118.33 26.9 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.2 -0.909 . . . . 72.11 110.023 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -115.43 162.17 17.52 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.112 0.965 . . . . 72.13 110.114 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -130.75 130.28 43.57 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.051 0.54 . . . . 71.3 109.873 173.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.52 HG13 ' HB3' ' A' ' 65' ' ' LEU . 36.7 mm -64.78 104.61 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.503 0.721 . . . . 74.4 110.137 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.6 -37.59 65.38 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.696 0.798 . . . . 72.32 110.601 172.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.6 t -162.66 159.04 23.95 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.287 0.635 . . . . 62.22 111.829 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.42 150.52 39.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.518 1.127 . . . . 62.2 110.645 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -154.54 134.0 12.68 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 112.02 0.378 . . . . 71.42 112.02 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -93.59 96.57 9.94 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.105 -0.702 . . . . 73.33 109.105 172.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.8 t -137.09 154.4 50.32 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.621 0.768 . . . . 71.31 111.68 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.2 m -80.11 119.21 22.6 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.055 -0.72 . . . . 72.42 109.055 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.435 HG23 HG23 ' A' ' 53' ' ' ILE . 24.8 m -108.65 136.42 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.811 0.845 . . . . 71.14 110.728 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.07 146.62 36.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.358 1.075 . . . . 72.11 112.912 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.7 ttp -108.03 118.93 38.03 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 113.466 -1.697 . . . . 73.45 106.825 165.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.2 m -127.99 173.27 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 112.699 0.629 . . . . 74.31 112.699 -170.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.676 ' HB2' ' HD3' ' A' ' 111' ' ' LYS . 4.8 p-10 -138.16 133.48 33.38 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.127 0.571 . . . . 75.32 110.441 172.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.455 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 47.7 p90 -151.18 177.23 10.42 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.165 0.586 . . . . 75.42 111.571 -174.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.2 m -111.59 112.34 23.99 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.291 -1.003 . . . . 72.4 108.291 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.5 p -59.01 116.57 3.9 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.3 0.64 . . . . 54.43 111.281 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.4 p -58.07 -32.81 68.4 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.846 1.258 . . . . 75.32 113.876 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.4 p -87.82 -45.13 10.57 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.262 0.467 . . . . 73.2 112.262 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -89.04 -31.89 17.85 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.401 0.68 . . . . 74.52 112.548 -169.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.14 -6.1 83.82 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 116.228 -0.442 . . . . 52.32 113.592 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -77.26 132.76 38.84 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.161 0.984 . . . . 75.33 112.142 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -80.27 94.15 6.03 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.476 0.71 . . . . 73.13 109.395 174.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 113' ' ' HIS . 58.5 t -77.35 104.62 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.234 -0.893 . . . . 75.14 109.713 -176.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.676 ' HD3' ' HB2' ' A' ' 100' ' ' ASP . 74.9 mmtt -99.93 133.75 43.85 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.597 0.759 . . . . 73.23 111.697 -172.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 m120 61.58 35.66 17.19 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.299 1.04 . . . . 51.01 112.21 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.441 ' HB2' HG13 ' A' ' 110' ' ' VAL . 86.3 t60 -58.78 129.52 42.5 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.98 0.912 . . . . 71.22 112.23 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 19.2 ptpt -152.49 147.45 26.25 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.899 0.88 . . . . 73.43 110.787 -176.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 97.6 m95 -109.14 138.48 45.43 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.33 1.452 . . . . 73.42 111.77 -4.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.78 172.38 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.438 1.095 . . . . 73.33 108.895 170.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.41 ' OG1' ' HG2' ' A' ' 120' ' ' GLU . 30.3 p -118.58 178.22 4.54 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.362 0.665 . . . . 61.3 111.01 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -67.28 -28.18 67.8 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.455 0.302 . . . . 74.51 111.385 174.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.42 -15.27 53.25 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 122.939 0.496 . . . . 72.04 111.754 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.633 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 4.7 mm-40 -81.19 -18.82 44.89 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.199 0.523 . . . . 70.42 110.407 171.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.0 mt -115.05 159.18 21.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.024 0.93 . . . . 75.33 110.593 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.1 m -137.71 138.18 39.08 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.019 -1.104 . . . . 60.3 108.019 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.544 ' HA ' HG13 ' A' ' 7' ' ' VAL . . . -57.38 158.08 5.95 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.73 0.695 . . . . 63.44 111.454 176.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.3 tptm . . . . . 0 N--CA 1.491 1.605 0 C-N-CA 122.924 0.49 . . . . 71.13 112.026 -178.219 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.56 ' HE3' ' HB2' ' A' ' 123' ' ' ALA . 24.9 mmt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.535 0.207 . . . . 71.44 110.93 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -70.97 157.14 38.72 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.464 1.105 . . . . 74.24 111.212 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -62.23 127.57 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 C-N-CA 122.589 0.356 . . . . 75.24 110.868 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.44 -3.62 56.52 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.246 0.45 . . . . 70.22 113.412 -175.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.8 t -73.15 127.85 33.78 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.229 0.612 . . . . 71.02 111.82 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -87.58 109.92 19.99 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.341 0.656 . . . . 74.51 110.14 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.424 HG22 HD11 ' A' ' 121' ' ' LEU . 30.4 m -125.99 157.66 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 124.011 0.924 . . . . 74.1 111.074 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.2 mm -105.54 136.99 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.344 1.057 . . . . 71.32 109.241 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 17' ' ' MET . 54.0 mt -76.76 118.43 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 CA-C-O 120.759 0.314 . . . . 74.22 110.192 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -84.54 -59.27 2.42 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.04 0.936 . . . . 71.42 110.127 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 94.0 m -91.88 139.69 30.41 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.527 -0.76 . . . . 73.11 109.767 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 14' ' ' MET . 80.6 p -130.34 122.42 27.86 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.091 0.472 . . . . 60.43 111.707 -174.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -83.12 -44.86 14.64 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.565 -0.902 . . . . 74.24 108.565 171.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.452 ' O ' ' HB2' ' A' ' 12' ' ' SER . 1.8 mpt? -94.18 130.9 40.22 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 114.164 -1.38 . . . . 73.33 107.536 166.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -63.0 -24.2 67.81 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 119.363 0.983 . . . . 72.25 113.234 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.01 -4.61 68.01 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 114.694 0.638 . . . . 74.02 114.694 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.429 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 35.0 mtp -84.97 -29.73 24.84 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.308 0.643 . . . . 73.2 110.722 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -67.94 117.73 10.2 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.571 0.348 . . . . 74.12 111.075 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.2 1.09 90.48 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 116.087 -0.506 . . . . 61.3 113.645 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.92 135.46 43.28 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.239 0.616 . . . . 72.33 111.141 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -82.29 103.94 12.24 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.641 -0.709 . . . . 73.42 110.323 -176.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.33 160.48 14.25 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.059 0.943 . . . . 70.44 113.301 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.3 m -133.14 136.36 45.73 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.841 1.257 . . . . 74.41 108.611 171.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 1' ' ' MET . 61.1 t -82.66 111.19 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 122.888 0.475 . . . . 73.55 110.868 -177.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.5 p -86.32 -19.9 29.14 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.824 0.45 . . . . 72.52 111.571 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.34 166.45 39.23 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 113.843 0.297 . . . . 54.23 113.843 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.63 138.51 47.39 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.091 0.957 . . . . 73.25 110.935 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.437 ' HB2' HG21 ' A' ' 96' ' ' VAL . 42.8 m-85 -128.55 111.84 13.67 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.32 1.048 . . . . 75.42 109.756 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -97.91 79.24 2.62 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.874 0.845 . . . . 72.4 110.401 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -133.91 170.89 14.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.658 0.783 . . . . 74.22 111.624 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -73.74 121.26 20.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.977 0.511 . . . . 71.33 109.879 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.35 147.86 43.08 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.638 0.775 . . . . 74.03 110.383 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -131.96 154.56 49.17 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.163 0.982 . . . . 75.33 112.591 -167.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 90' ' ' SER . 64.6 t -105.14 133.66 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 113.729 -1.578 . . . . 74.13 107.62 167.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.5 m -131.18 166.03 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.8 0.809 . . . . 75.12 112.788 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.2 t -132.92 127.78 35.07 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 114.38 -1.282 . . . . 74.31 108.658 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.496 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 43.8 p90 -155.87 160.27 40.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.596 0.758 . . . . 74.23 111.062 -171.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.1 m -109.28 119.48 48.31 Favored Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 108.783 -0.821 . . . . 65.44 108.783 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.27 133.17 45.0 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.127 1.885 . . . . 60.4 111.902 172.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.8 p -65.19 -7.28 12.02 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.99 0.916 . . . . 72.05 113.081 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.33 -18.0 60.29 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 124.728 1.211 . . . . 71.04 113.046 171.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.69 57.46 3.54 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 111.624 -0.59 . . . . 75.52 111.624 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.47 -155.56 8.16 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 115.007 -0.597 . . . . 72.04 113.005 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -69.48 119.05 13.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.469 0.708 . . . . 71.1 110.808 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -56.95 116.28 3.11 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 109.317 -0.623 . . . . 73.55 109.317 168.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.477 HG12 ' HB2' ' A' ' 49' ' ' HIS . 40.7 t -88.67 115.51 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 123.311 0.645 . . . . 74.43 110.154 -176.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -109.35 155.69 20.91 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.376 0.671 . . . . 75.41 110.491 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.2 m170 57.82 26.4 13.15 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.902 0.881 . . . . 74.45 112.376 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.477 ' HB2' HG12 ' A' ' 46' ' ' VAL . 84.9 t60 -71.65 136.95 47.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.811 0.844 . . . . 74.33 110.908 -178.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -158.11 148.71 20.56 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-N 116.313 -0.403 . . . . 74.44 111.508 -176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -107.59 147.75 30.2 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.022 1.329 . . . . 72.05 111.471 -0.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.92 135.5 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.436 1.095 . . . . 74.23 108.272 172.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.5 pt -115.53 169.98 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.284 -0.885 . . . . 74.41 112.754 -168.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -50.85 -39.76 54.42 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.299 1.039 . . . . 73.31 113.791 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -72.61 -20.86 61.21 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.479 0.712 . . . . 75.14 111.882 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.465 ' HG3' ' HB2' ' A' ' 75' ' ' ALA . 27.3 tt0 -91.98 -24.76 19.14 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.59 0.756 . . . . 73.21 111.446 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.1 mt -101.22 129.36 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.867 0.867 . . . . 74.42 110.35 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -72.02 -57.09 4.58 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.581 0.705 . . . . 72.1 111.567 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.99 -2.99 6.02 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.687 1.195 . . . . 74.04 113.98 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.519 ' HA ' HD12 ' A' ' 65' ' ' LEU . . . -39.53 -58.34 1.29 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.126 1.37 . . . . 74.31 114.166 171.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.07 27.6 73.5 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 114.76 0.664 . . . . 73.33 114.76 174.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 63.17 16.56 9.48 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.686 1.194 . . . . 71.34 113.561 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 14.5 ptpt -105.6 167.94 9.43 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 122.882 0.473 . . . . 75.13 111.18 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.4 m -82.87 108.95 16.58 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.742 -0.836 . . . . 74.14 108.742 169.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.631 ' HB3' HG13 ' A' ' 88' ' ' ILE . 86.9 mt -75.91 138.37 40.99 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.47 -0.567 . . . . 72.43 109.47 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -118.19 161.39 35.1 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 123.713 0.805 . . . . 73.33 111.275 -169.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -44.71 106.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.082 2.521 . . . . 73.04 113.937 171.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.48 -12.8 15.86 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 114.901 0.72 . . . . 61.51 114.901 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.95 100.46 1.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.252 1.026 . . . . 71.14 111.305 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -79.93 122.58 26.87 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 115.996 -0.547 . . . . 70.3 110.726 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.98 173.14 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 125.115 1.366 . . . . 73.35 111.68 -170.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.0 mm -115.13 139.79 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 123.845 0.858 . . . . 74.41 110.41 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.28 123.31 35.52 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.758 0.823 . . . . 64.12 111.76 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -79.98 -44.87 19.45 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.827 0.851 . . . . 73.33 112.457 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.465 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . . . -83.56 174.17 10.8 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.27 0.557 . . . . 74.01 111.542 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 80.0 p -143.73 126.28 15.92 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.05 -0.523 . . . . 71.35 111.055 175.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.468 ' H ' ' HG2' ' A' ' 81' ' ' MET . 19.9 m-70 -91.5 -23.48 19.94 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.991 0.916 . . . . 65.34 110.868 171.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -155.96 -176.9 6.2 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.838 0.855 . . . . 74.53 110.839 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -65.74 131.63 46.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.411 0.684 . . . . 74.13 112.213 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.64 10.93 84.61 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 115.871 -0.604 . . . . 65.25 114.567 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.468 ' HG2' ' H ' ' A' ' 77' ' ' HIS . 11.6 tpt -84.97 -52.43 5.99 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.58 0.752 . . . . 75.43 110.644 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 86.9 tttt -66.54 129.0 38.38 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.387 0.675 . . . . 75.12 111.379 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.11 -9.25 73.34 Favored Glycine 0 N--CA 1.476 1.316 0 O-C-N 123.004 0.19 . . . . 70.51 113.186 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 152.84 30.58 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.386 0.675 . . . . 65.53 111.118 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.7 m -90.26 120.07 31.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.228 -0.897 . . . . 74.03 109.774 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.496 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -104.15 162.97 12.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.885 0.874 . . . . 44.41 109.428 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -137.71 126.95 24.56 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.055 -0.72 . . . . 70.22 109.055 168.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.631 HG13 ' HB3' ' A' ' 65' ' ' LEU . 26.1 mm -60.47 110.27 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.381 0.672 . . . . 75.11 110.357 -177.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -77.93 -36.37 49.41 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.167 0.987 . . . . 71.4 110.284 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.526 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 47.3 t -160.1 163.27 33.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.353 1.061 . . . . 75.32 110.277 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.64 148.12 51.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.493 0.717 . . . . 75.54 111.535 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -156.05 148.27 23.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.302 0.482 . . . . 73.43 112.302 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.51 95.44 7.0 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 107.757 -1.201 . . . . 73.14 107.757 163.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 t -136.26 154.55 50.87 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.302 0.641 . . . . 73.12 110.317 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.8 m -84.99 120.48 26.57 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.383 -0.599 . . . . 62.43 109.383 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.437 HG21 ' HB2' ' A' ' 28' ' ' TYR . 13.4 m -107.67 132.68 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.875 -0.787 . . . . 75.15 108.875 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.527 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 96.3 m-85 -109.62 166.7 10.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.489 1.138 . . . . 75.14 112.648 -171.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.2 ttp -120.96 111.09 17.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 112.832 -1.986 . . . . 74.35 107.199 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.26 147.11 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 112.921 0.711 . . . . 74.02 112.921 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 111' ' ' LYS . 4.6 p30 -105.51 138.03 42.38 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.612 0.765 . . . . 74.13 110.165 172.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -156.69 178.25 10.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.642 0.777 . . . . 73.4 111.126 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.0 m -118.11 114.57 23.29 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.438 0.695 . . . . 71.44 109.242 173.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -56.85 109.3 0.61 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.679 0.792 . . . . 75.41 111.02 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.8 p -54.47 -31.17 55.2 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.669 1.188 . . . . 73.03 113.293 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.6 m -64.54 -60.77 2.75 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.392 0.677 . . . . 61.24 112.313 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 36.2 m -101.92 -12.95 17.83 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.296 0.85 . . . . 64.4 113.296 -166.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.5 12.32 83.76 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 113.723 0.249 . . . . 63.24 113.723 -172.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -71.38 125.51 27.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.709 0.804 . . . . 72.45 112.314 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -75.98 96.8 3.85 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.786 0.435 . . . . 75.31 109.94 171.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.65 107.88 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 109.458 -0.571 . . . . 74.41 109.458 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 92.5 mttt -106.78 143.84 34.29 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.647 0.379 . . . . 75.1 110.948 -174.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 54.62 39.43 31.22 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.151 0.981 . . . . 73.13 113.151 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -61.79 131.74 50.84 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.646 0.778 . . . . 75.43 111.399 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 97.5 mttt -134.76 146.61 49.54 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.301 1.04 . . . . 74.41 110.492 -175.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 85.1 m95 -109.54 127.55 54.56 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.658 1.583 . . . . 73.44 110.513 -10.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.6 m -119.63 162.09 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 C-N-CA 124.452 1.101 . . . . 72.25 109.814 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 50.0 p -117.82 171.12 8.27 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.931 0.715 . . . . 74.43 112.931 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.527 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 38.0 tt0 -67.18 -32.17 73.08 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.715 0.806 . . . . 72.4 111.891 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -70.76 -20.12 62.65 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.245 0.618 . . . . 73.43 111.948 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -91.87 4.06 53.76 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.602 0.761 . . . . 74.13 111.666 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.424 HD11 HG22 ' A' ' 7' ' ' VAL . 81.8 mt -121.11 171.92 8.34 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.861 1.265 . . . . 75.24 109.612 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.8 m -147.22 122.54 10.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.681 0.792 . . . . 64.35 109.962 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.56 ' HB2' ' HE3' ' A' ' 1' ' ' MET . . . -68.08 111.11 4.27 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.885 0.474 . . . . 74.11 110.871 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp . . . . . 0 CA--C 1.553 1.063 0 CA-C-O 121.486 0.66 . . . . 75.45 110.899 -176.872 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mmt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.695 0.283 . . . . 75.41 111.037 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -105.92 157.99 17.09 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.576 0.75 . . . . 74.34 109.913 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.97 122.76 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 CA-C-O 121.193 0.521 . . . . 71.51 110.118 170.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.77 -6.52 48.43 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-N 115.323 -0.853 . . . . 72.32 112.966 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.7 m -75.15 128.15 34.83 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.019 0.527 . . . . 42.22 111.559 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -85.57 117.58 24.56 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.282 -1.007 . . . . 72.14 108.282 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.4 HG13 ' HA ' ' A' ' 123' ' ' ALA . 27.2 m -125.09 150.84 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.287 0.635 . . . . 74.14 111.777 -174.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.1 mm -98.77 128.55 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.364 1.065 . . . . 72.43 108.406 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.405 HG23 ' HG2' ' A' ' 17' ' ' MET . 24.3 mt -91.58 115.89 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.872 -0.418 . . . . 74.13 109.872 -173.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -93.36 -24.44 18.09 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.065 0.546 . . . . 72.31 112.306 -171.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 m -110.62 142.57 42.3 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.401 0.68 . . . . 71.51 109.594 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' MET . 78.0 p -123.62 120.26 32.27 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.827 0.677 . . . . 73.41 112.827 -173.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -84.81 -41.75 15.8 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.23 1.012 . . . . 73.23 108.503 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.455 ' O ' ' HB2' ' A' ' 12' ' ' SER . 24.1 mmt -100.65 137.26 39.29 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.057 0.943 . . . . 74.42 108.698 167.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.525 ' HG3' HG22 ' A' ' 105' ' ' THR . 17.6 ptpt -60.65 -31.23 70.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.22 0.822 . . . . 74.22 113.22 -175.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.04 0.59 72.42 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 114.062 0.385 . . . . 74.3 114.062 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.405 ' HG2' HG23 ' A' ' 9' ' ' ILE . 39.6 ttp -99.04 -15.44 19.04 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.053 0.541 . . . . 63.2 110.893 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -65.96 117.0 7.69 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.171 0.588 . . . . 75.55 110.16 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.71 2.51 70.12 Favored Glycine 0 CA--C 1.542 1.772 0 N-CA-C 114.358 0.503 . . . . 54.34 114.358 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.38 146.34 43.06 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 117.575 0.687 . . . . 65.41 112.76 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -85.21 131.2 34.46 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.672 0.789 . . . . 72.33 110.219 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 100' ' ' ASP . . . -141.6 172.1 13.15 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.314 0.857 . . . . 74.14 113.314 -170.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.7 m -140.72 138.2 34.04 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.02 0.928 . . . . 74.23 109.801 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -81.76 112.93 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.371 0.669 . . . . 74.44 109.974 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.9 p -99.55 -4.99 29.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.749 0.82 . . . . 64.14 112.297 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.85 149.6 17.07 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 120.09 -0.283 . . . . 55.31 112.56 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.75 114.46 10.52 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.525 0.73 . . . . 75.0 110.464 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -115.42 111.92 21.53 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.972 0.909 . . . . 74.22 111.233 -173.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.97 80.28 5.76 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 122.163 0.982 . . . . 62.01 109.856 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -133.61 174.63 10.22 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 115.69 -0.686 . . . . 71.34 111.987 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.1 m -82.5 119.53 24.34 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.894 0.478 . . . . 71.35 109.87 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.96 162.63 13.42 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.639 1.176 . . . . 63.41 109.286 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -139.54 149.02 43.4 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.683 0.754 . . . . 73.44 111.26 -173.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.9 121.13 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 106.677 -1.601 . . . . 72.14 106.677 168.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.0 m -124.3 151.35 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 118.881 0.764 . . . . 62.41 112.681 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.5 p -119.52 125.45 48.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.168 0.987 . . . . 74.5 109.132 171.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.46 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 49.4 p90 -147.46 152.6 38.35 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.702 0.401 . . . . 74.4 112.057 -172.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.9 m -99.17 106.61 39.62 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 108.122 -1.066 . . . . 74.34 108.122 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.11 146.1 23.81 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.55 2.833 . . . . 55.13 113.984 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.5 p -66.09 -16.57 64.05 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.79 0.836 . . . . 71.05 112.554 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.57 -20.82 65.96 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 123.224 0.609 . . . . 71.31 111.292 170.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.06 14.72 76.48 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.682 -0.69 . . . . 71.21 114.483 172.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.53 -112.55 0.37 Allowed Glycine 0 CA--C 1.539 1.583 0 CA-C-N 117.272 0.536 . . . . 74.12 113.536 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -106.53 142.75 35.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.355 0.662 . . . . 74.25 111.259 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -66.91 133.94 51.02 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.374 0.669 . . . . 74.52 111.687 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.545 HG21 ' HE2' ' A' ' 78' ' ' MET . 41.6 t -91.48 118.8 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 124.1 0.96 . . . . 71.22 110.099 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -102.1 138.28 39.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.324 0.65 . . . . 74.41 110.493 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 m170 57.28 41.92 25.97 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.191 0.996 . . . . 75.44 113.351 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -67.1 124.18 22.33 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 116.07 -0.514 . . . . 75.5 110.654 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 31.3 mtmm -131.49 144.59 51.25 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.86 0.864 . . . . 74.21 110.216 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 94.4 m95 -112.69 141.66 46.22 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.347 1.459 . . . . 75.51 110.624 -9.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.86 142.48 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.696 -0.853 . . . . 74.25 108.696 170.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.1 pt -110.55 167.34 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 O-C-N 121.934 -0.479 . . . . 74.31 110.862 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -53.65 -35.02 60.54 Favored 'General case' 0 CA--C 1.563 1.442 0 C-N-CA 123.976 0.91 . . . . 73.15 113.201 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -67.21 -24.95 65.89 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.415 0.686 . . . . 73.34 112.296 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -91.44 1.47 57.1 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.548 0.739 . . . . 75.31 112.096 -175.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.7 mt -108.78 131.65 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.904 0.882 . . . . 73.31 110.151 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -72.65 -42.42 64.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.056 0.942 . . . . 75.31 112.019 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -78.71 -10.4 59.75 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.701 0.8 . . . . 73.34 112.35 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.45 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -43.45 -58.33 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.872 1.064 . . . . 72.01 113.872 -173.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.94 31.31 78.03 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 116.502 1.361 . . . . 73.43 116.502 167.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.8 t70 73.76 -10.58 1.06 Allowed 'General case' 0 CA--C 1.578 2.027 0 C-N-CA 124.551 1.14 . . . . 62.35 113.06 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 24.2 pttm -90.53 153.68 20.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.497 -0.752 . . . . 70.15 110.865 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.7 m -85.87 129.82 34.72 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.183 0.593 . . . . 75.12 109.645 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.8 mt -88.79 146.21 25.13 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.508 0.723 . . . . 72.15 111.492 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.58 158.68 42.81 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 124.966 1.306 . . . . 71.32 109.523 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.65 114.04 1.51 Allowed 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.621 2.214 . . . . 73.32 112.991 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.02 -17.52 12.79 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 115.23 -0.895 . . . . 72.15 114.426 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.0 125.99 27.73 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 117.936 0.868 . . . . 75.4 111.131 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.55 124.95 50.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.286 0.635 . . . . 73.24 109.913 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.71 174.74 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.84 1.256 . . . . 75.54 111.307 -169.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.3 mm -111.7 142.31 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 123.364 0.666 . . . . 74.11 109.741 170.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.1 mt -89.41 126.99 35.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.469 0.708 . . . . 74.44 112.26 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -87.29 -22.89 24.88 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.833 0.853 . . . . 75.05 111.847 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.86 158.93 19.83 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.048 0.451 . . . . 75.22 111.831 174.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.652 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 25.4 t -137.86 122.86 19.05 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.278 -0.874 . . . . 73.3 108.707 169.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -107.26 -9.52 16.06 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.045 0.538 . . . . 75.24 111.048 173.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.545 ' HE2' HG21 ' A' ' 46' ' ' VAL . 58.7 mtm -138.15 -175.75 4.21 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.588 1.155 . . . . 74.51 110.31 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -72.84 131.72 42.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 122.017 -0.427 . . . . 75.24 110.898 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.22 20.28 60.49 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 114.574 0.59 . . . . 74.44 114.574 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.54 ' SD ' ' HA ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -77.89 -43.26 30.66 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.6 0.76 . . . . 73.55 110.954 -174.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.652 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 88.8 tttt -65.36 134.85 54.43 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.975 0.51 . . . . 74.54 111.55 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.66 65.11 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.178 -0.464 . . . . 60.05 112.8 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.91 143.18 56.99 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.571 0.748 . . . . 73.12 112.243 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.0 m -77.95 105.92 9.47 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.737 -0.665 . . . . 73.3 109.931 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -103.77 150.11 24.39 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.23 1.012 . . . . 63.34 110.946 -172.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.43 128.98 44.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.319 -0.623 . . . . 75.55 109.319 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.0 mm -64.77 106.47 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 122.891 0.477 . . . . 74.43 110.009 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.39 -36.25 58.19 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.911 0.885 . . . . 75.35 109.991 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.1 t -158.57 147.78 19.09 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.661 0.784 . . . . 72.43 110.563 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.14 133.3 56.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.467 0.707 . . . . 75.11 110.55 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -145.07 123.76 12.55 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.734 0.814 . . . . 73.52 111.139 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.581 ' HZ2' ' HB2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -91.26 97.19 10.97 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.238 -0.653 . . . . 63.01 109.238 175.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.5 t -135.54 154.71 51.29 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.756 0.822 . . . . 74.13 111.108 -173.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.2 m -81.98 120.72 25.6 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.62 -0.881 . . . . 75.32 108.62 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 11.4 m -110.48 133.33 56.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.892 0.877 . . . . 75.0 108.952 -176.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.07 145.26 38.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.192 0.997 . . . . 75.03 111.511 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.7 ttm -92.51 120.87 33.4 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.31 -1.367 . . . . 73.44 107.31 166.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.69 152.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.627 0.771 . . . . 73.14 111.814 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 5.7 t70 -117.81 114.4 23.22 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.298 1.039 . . . . 72.12 109.002 175.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -129.0 170.48 13.41 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.48 0.657 . . . . 75.41 112.203 -174.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.0 m -114.02 127.78 56.1 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.06 -0.719 . . . . 55.33 109.06 170.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.9 t -64.7 125.52 25.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.962 0.905 . . . . 73.54 112.548 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 70.5 p -71.23 -36.67 71.9 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.937 0.895 . . . . 74.41 112.424 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.525 HG22 ' HG3' ' A' ' 15' ' ' LYS . 11.0 t -80.12 -40.0 28.34 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.946 0.721 . . . . 70.22 112.946 -175.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.6 p -113.83 -24.84 8.91 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 112.332 0.493 . . . . 73.34 112.332 -172.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.15 7.56 80.0 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-O 119.89 -0.395 . . . . 70.35 113.877 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -78.99 133.34 36.85 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 117.288 0.544 . . . . 74.43 111.323 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -83.09 109.74 17.41 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 109.206 -0.665 . . . . 74.41 109.206 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.23 127.09 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.975 0.91 . . . . 62.32 110.704 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.84 157.36 27.75 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.503 0.721 . . . . 75.44 111.548 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 57.66 30.67 19.22 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.428 1.091 . . . . 71.23 111.616 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -73.76 135.84 43.59 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.053 0.541 . . . . 73.02 111.179 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -164.41 154.46 14.31 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 122.964 0.505 . . . . 70.13 111.903 -172.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.505 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 81.9 m95 -106.53 137.14 45.08 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.747 1.619 . . . . 72.03 112.039 1.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 m -120.23 144.44 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.279 1.032 . . . . 74.02 109.452 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.3 p -100.31 178.41 4.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.487 -0.758 . . . . 63.43 112.014 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -56.38 -50.81 70.48 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.338 1.055 . . . . 71.0 112.336 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -66.53 -17.9 65.07 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.591 0.756 . . . . 71.32 113.02 -178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -90.37 -6.2 55.29 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.062 0.545 . . . . 74.42 111.482 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 75.2 mt -115.23 160.7 19.42 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.376 1.07 . . . . 75.52 109.47 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -146.6 120.75 9.48 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.166 -0.679 . . . . 72.13 109.166 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HA ' HG13 ' A' ' 7' ' ' VAL . . . -62.99 139.87 58.81 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.029 0.531 . . . . 65.34 112.028 -174.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.5 tptt . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.865 0.84 . . . . 74.15 110.65 -178.681 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.668 0.271 . . . . 60.05 110.627 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -101.44 142.28 33.07 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.208 1.003 . . . . 53.45 110.195 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.85 132.51 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-O 121.038 0.446 . . . . 75.32 111.077 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.45 -3.57 68.96 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 115.776 -0.647 . . . . 72.04 112.948 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.0 m -85.1 151.6 24.02 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.773 0.657 . . . . 71.44 112.773 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -92.89 122.65 35.48 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.97 -1.014 . . . . 73.24 109.808 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.451 HG22 HD11 ' A' ' 121' ' ' LEU . 27.0 m -121.56 151.89 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.36 0.664 . . . . 74.12 109.72 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.7 mm -107.51 134.78 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.43 -0.952 . . . . 65.24 108.43 172.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.9 mt -75.29 105.57 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.327 0 CA-C-O 120.95 0.405 . . . . 74.1 109.927 -176.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -83.18 -34.25 26.0 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.931 0.892 . . . . 73.35 111.034 -172.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.7 m -131.47 141.13 49.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.578 1.151 . . . . 74.23 108.244 172.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' A' ' 17' ' ' MET . 95.7 p -143.5 159.3 42.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.855 0.836 . . . . 64.32 112.366 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.495 ' HE1' ' HG3' ' A' ' 50' ' ' LYS . 7.9 m-70 -91.29 -17.58 25.72 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 114.114 -1.403 . . . . 74.44 110.457 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.653 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 53.6 mtt -131.34 144.37 51.2 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.418 1.087 . . . . 71.33 109.788 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -54.07 -41.23 67.94 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.206 1.187 . . . . 75.03 114.206 -173.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.33 -11.98 83.63 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 114.339 0.496 . . . . 65.01 114.339 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.653 ' HG3' ' HB2' ' A' ' 14' ' ' MET . 20.6 mtm -81.24 -29.27 34.5 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.398 0.599 . . . . 73.24 109.921 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -64.11 122.81 17.48 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 122.739 0.415 . . . . 74.41 111.008 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.4 1.74 89.25 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 115.694 -0.684 . . . . 73.43 113.545 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 149.62 31.72 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.776 0.658 . . . . 54.51 112.776 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -84.66 105.64 15.61 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.17 0.588 . . . . 65.01 110.251 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.43 154.37 19.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.938 0.895 . . . . 71.31 111.532 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.5 m -120.84 122.3 39.99 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.362 0.665 . . . . 61.33 109.661 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -73.27 103.35 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.855 0.462 . . . . 74.42 109.906 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.4 p -113.94 -5.78 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.482 0.549 . . . . 74.51 112.482 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.17 123.39 1.75 Allowed Glycine 0 C--N 1.344 1.015 0 N-CA-C 111.834 -0.506 . . . . 71.25 111.834 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.98 116.59 32.22 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.384 0.674 . . . . 72.14 110.493 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.431 ' HB2' HG21 ' A' ' 96' ' ' VAL . 38.8 m-85 -127.12 119.44 26.53 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.392 0.677 . . . . 73.32 109.961 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -113.82 87.4 2.61 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.906 0.86 . . . . 74.53 109.721 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -135.95 179.93 6.05 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.792 0.837 . . . . 74.43 110.669 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -78.76 123.75 27.5 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 122.022 -0.424 . . . . 71.04 110.433 176.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.89 126.27 54.93 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.102 0.961 . . . . 74.11 110.17 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -103.34 150.32 23.9 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.971 0.891 . . . . 74.44 113.02 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.401 HG22 ' HB3' ' A' ' 50' ' ' LYS . 21.7 t -107.49 114.1 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 114.084 -1.416 . . . . 74.5 107.915 169.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.478 HG11 HD13 ' A' ' 88' ' ' ILE . 34.1 m -125.89 146.7 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 112.908 0.707 . . . . 75.24 112.908 -170.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.1 m -110.08 131.4 55.09 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.177 0.591 . . . . 75.14 110.491 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -157.04 159.78 38.3 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.36 0.6 . . . . 74.44 112.079 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.9 m -111.95 113.78 52.06 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 107.771 -1.196 . . . . 71.35 107.771 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.83 116.8 2.99 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.003 2.469 . . . . 74.04 112.108 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 p -68.94 -7.04 31.31 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.329 1.052 . . . . 71.31 113.745 -169.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -77.8 -3.06 39.52 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 123.433 0.693 . . . . 64.13 111.585 171.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.02 34.95 8.45 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 122.198 -0.313 . . . . 72.52 112.319 -173.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.42 -173.48 44.62 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 122.911 0.291 . . . . 72.33 113.444 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.08 117.47 15.92 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.443 0.697 . . . . 73.01 110.16 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.56 117.85 2.45 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.512 0.725 . . . . 74.22 110.969 169.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.96 115.38 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.371 -0.831 . . . . 74.04 109.609 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -100.38 140.78 34.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.145 0.578 . . . . 72.32 109.482 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.8 m170 57.92 39.58 26.55 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.423 0.689 . . . . 64.34 112.396 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -61.22 131.71 51.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.352 1.061 . . . . 72.54 111.455 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.495 ' HG3' ' HE1' ' A' ' 13' ' ' HIS . 25.2 pttm -149.13 148.49 29.73 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.288 -0.869 . . . . 74.51 109.665 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 92.1 m95 -109.95 135.88 50.1 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.456 -1.402 . . . . 74.04 111.502 0.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.01 147.15 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.782 1.233 . . . . 73.11 108.306 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.3 pt -111.47 167.17 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 122.046 -0.409 . . . . 73.32 111.669 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -53.96 -36.18 62.59 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.943 0.897 . . . . 75.51 113.265 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -70.24 -19.24 63.14 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 123.464 0.706 . . . . 62.14 112.092 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -94.54 8.28 42.77 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.589 0.756 . . . . 72.11 112.442 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.5 mt -124.23 136.64 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.692 0.797 . . . . 65.15 110.631 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -72.08 -53.72 11.96 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.796 0.839 . . . . 62.52 111.614 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.08 -3.96 11.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.705 1.202 . . . . 64.23 113.381 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.407 ' HA ' HD11 ' A' ' 65' ' ' LEU . . . -41.23 -46.75 3.22 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.534 1.309 . . . . 73.25 114.534 173.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.69 19.06 68.88 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.924 1.13 . . . . 71.21 115.924 165.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 66.19 11.17 7.68 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.051 1.341 . . . . 71.03 112.801 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -110.47 167.93 9.84 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.016 0.926 . . . . 71.25 110.817 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.3 m -82.93 118.17 23.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.487 -0.931 . . . . 72.3 108.487 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.599 HD12 HG12 ' A' ' 71' ' ' VAL . 76.4 mt -74.48 118.3 17.28 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.315 0.579 . . . . 73.41 110.24 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -110.91 155.25 42.72 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.426 1.091 . . . . 73.52 110.712 -169.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 76.1 Cg_exo -45.64 111.84 0.36 Allowed 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.702 2.935 . . . . 70.44 114.506 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.44 -11.54 16.43 Favored Glycine 0 N--CA 1.485 1.963 0 CA-C-N 116.182 -0.463 . . . . 73.31 113.938 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -79.88 124.04 28.3 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.386 0.593 . . . . 72.43 111.222 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -98.23 122.18 41.07 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.742 -0.836 . . . . 71.32 108.742 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.599 HG12 HD12 ' A' ' 65' ' ' LEU . 32.4 m -121.62 175.81 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.927 0.891 . . . . 74.52 112.115 -172.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mm -121.65 136.71 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.336 1.055 . . . . 73.3 109.079 170.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.5 mt -83.49 119.19 24.37 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.574 0.75 . . . . 73.35 111.411 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -81.92 -26.64 33.88 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.526 0.73 . . . . 74.11 111.473 171.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.51 153.99 25.29 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.029 0.442 . . . . 62.12 111.152 173.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 42.9 t -142.25 124.31 15.38 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.71 -0.677 . . . . 65.04 110.698 173.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -106.43 -24.86 12.11 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.331 1.053 . . . . 64.32 109.784 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.2 mtm -127.28 164.64 21.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.083 0.953 . . . . 74.15 110.867 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.519 ' HD2' ' H ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.37 127.92 33.63 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.877 0.471 . . . . 74.43 111.986 174.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.41 14.81 82.11 Favored Glycine 0 N--CA 1.476 1.315 0 N-CA-C 114.328 0.491 . . . . 64.34 114.328 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.4 ttt -84.71 -40.9 16.78 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 117.632 0.716 . . . . 63.51 110.739 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 21.0 tptm -66.53 119.57 11.91 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.209 -0.663 . . . . 72.23 109.209 166.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.55 74.66 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 116.063 -0.517 . . . . 74.44 112.914 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.31 137.63 46.81 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.753 0.776 . . . . 44.25 111.529 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 78.7 m -79.09 114.55 18.12 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.176 0.59 . . . . 73.2 109.531 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.67 157.24 21.49 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.785 0.834 . . . . 61.02 109.739 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -129.42 131.88 46.87 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.79 -0.819 . . . . 70.2 108.79 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' HB3' ' A' ' 65' ' ' LEU . 24.3 mm -74.27 107.5 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.28 0.632 . . . . 64.35 110.724 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -68.91 -39.72 79.53 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.926 0.394 . . . . 75.21 110.662 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.0 t -164.41 157.36 17.33 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.207 -0.906 . . . . 63.53 111.357 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -114.14 131.27 56.49 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.216 1.007 . . . . 72.34 109.131 171.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -126.7 135.51 51.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.007 0.523 . . . . 73.21 111.522 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -97.14 95.77 7.99 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.587 0.708 . . . . 71.14 109.657 168.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -135.85 148.3 48.6 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.929 -1.032 . . . . 74.42 109.4 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.4 m -84.24 123.61 30.32 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.221 -0.659 . . . . 74.13 109.221 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 28' ' ' TYR . 16.1 m -112.87 135.96 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.375 0.67 . . . . 73.32 109.553 -173.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.439 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 98.2 m-85 -120.03 141.54 49.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.43 0.692 . . . . 72.3 111.965 -175.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.415 ' SD ' ' HA ' ' A' ' 112' ' ' ASN . 19.4 tmm? -90.14 112.47 23.97 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.879 -1.055 . . . . 72.45 108.254 169.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.51 160.83 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 112.668 0.618 . . . . 74.55 112.668 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -119.57 116.98 27.16 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.87 0.868 . . . . 72.43 108.7 172.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -124.27 165.29 17.89 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 122.96 0.504 . . . . 75.32 111.918 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.8 m -109.21 111.67 23.41 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.3 0.64 . . . . 74.42 110.552 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.3 p -58.8 122.48 13.67 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.144 0.577 . . . . 73.14 111.87 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.7 p -70.91 -23.23 62.23 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.414 1.086 . . . . 73.33 112.767 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -87.86 -10.73 49.88 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.234 0.828 . . . . 73.54 113.234 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.4 m -134.74 -40.19 0.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.234 0.614 . . . . 74.43 111.833 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.81 -1.82 59.9 Favored Glycine 0 N--CA 1.48 1.582 0 CA-C-N 116.197 -0.456 . . . . 54.01 113.077 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -80.84 140.16 35.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.008 0.923 . . . . 71.22 111.124 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -96.37 132.81 41.51 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 121.156 0.503 . . . . 74.23 110.783 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.96 128.39 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.115 1.366 . . . . 75.22 109.723 -175.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 136.71 42.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.876 0.87 . . . . 74.03 111.105 -173.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.415 ' HA ' ' SD ' ' A' ' 98' ' ' MET . 11.8 m120 56.0 43.01 27.89 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.694 1.198 . . . . 74.44 113.84 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -62.3 132.8 53.87 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.672 0.789 . . . . 73.45 112.104 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 59.4 mttp -133.76 136.35 44.51 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.137 0.975 . . . . 74.42 111.491 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.7 m95 -114.44 146.11 41.03 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.511 1.524 . . . . 72.4 111.122 -15.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -119.67 148.23 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.022 0.929 . . . . 74.44 109.331 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.4 p -97.93 163.96 12.56 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.018 0.748 . . . . 75.11 113.018 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.439 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 44.0 tt0 -60.99 -33.91 73.98 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.489 1.116 . . . . 75.33 110.916 173.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.1 -36.84 85.56 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.701 1.2 . . . . 74.34 112.428 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.99 10.02 38.78 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.202 0.445 . . . . 62.02 112.202 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.451 HD11 HG22 ' A' ' 7' ' ' VAL . 91.2 mt -120.24 162.27 19.68 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.017 0.927 . . . . 73.4 109.215 175.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -138.83 120.67 15.4 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.074 0.549 . . . . 73.12 109.752 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.41 ' HA ' HG13 ' A' ' 7' ' ' VAL . . . -71.75 115.25 10.73 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.639 0.376 . . . . 64.33 110.676 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt . . . . . 0 N--CA 1.478 0.959 0 C-N-CA 122.905 0.482 . . . . 71.41 111.541 -177.348 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.7 mmt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 109.725 -0.472 . . . . 70.34 109.725 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.496 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -72.44 158.87 34.94 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 120.965 0.412 . . . . 74.42 111.824 -179.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.81 130.1 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 123.609 0.763 . . . . 72.33 112.262 -175.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.57 -13.03 47.1 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.268 -0.878 . . . . 55.31 113.343 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.9 m -82.67 152.9 25.64 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.387 0.675 . . . . 71.21 111.638 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -108.74 141.03 41.32 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.143 -0.688 . . . . 72.45 109.143 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 123' ' ' ALA . 33.4 m -135.9 157.63 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.047 0.939 . . . . 61.22 111.063 -172.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.1 mm -96.46 129.06 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.423 -0.954 . . . . 74.14 108.423 166.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.67 HD11 ' HB1' ' A' ' 22' ' ' ALA . 48.7 mt -82.65 127.0 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.186 0.594 . . . . 75.45 109.945 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.546 HD22 ' HB3' ' A' ' 122' ' ' SER . 62.6 m-20 -96.8 -63.05 1.17 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 120.951 0.405 . . . . 73.45 110.386 -177.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.8 m -91.79 140.97 29.17 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.13 -0.692 . . . . 73.14 109.13 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.9 p -132.04 140.42 48.88 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.569 0.7 . . . . 72.3 112.24 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -85.66 -37.97 18.87 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.02 1.328 . . . . 65.33 109.326 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 52.0 mtt -99.34 130.53 45.63 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.316 1.046 . . . . 74.22 109.219 169.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' H ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -55.92 -37.98 69.66 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 113.0 0.741 . . . . 75.23 113.0 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.62 0.8 60.03 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 114.439 0.536 . . . . 75.21 114.439 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.481 ' HG2' HG23 ' A' ' 9' ' ' ILE . 52.9 ttp -93.3 -25.21 17.85 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.324 0.65 . . . . 72.44 111.13 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -67.36 123.34 20.1 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.994 0.518 . . . . 74.33 111.39 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.99 -12.18 66.89 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.658 -0.701 . . . . 75.13 113.868 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.43 155.42 40.13 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.642 0.777 . . . . 63.03 112.212 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -91.07 100.28 13.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.302 0.641 . . . . 70.22 110.946 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 9' ' ' ILE . . . -89.65 158.14 17.72 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.78 -0.645 . . . . 72.4 111.137 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.4 m -131.7 126.01 33.49 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.865 -0.791 . . . . 65.21 108.865 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.3 t -76.57 102.0 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.346 0.658 . . . . 73.41 110.281 -170.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.2 p -96.25 -10.63 27.52 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.331 0.652 . . . . 72.23 111.561 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.49 149.09 19.5 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 112.125 -0.39 . . . . 75.01 112.125 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.06 119.47 15.81 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.645 0.778 . . . . 61.1 110.694 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -121.92 117.22 25.91 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.852 0.861 . . . . 63.21 110.445 -172.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -95.49 83.82 3.88 Favored 'General case' 0 CA--C 1.565 1.519 0 CA-C-O 122.236 1.017 . . . . 72.01 110.645 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -134.39 -178.61 5.13 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.473 0.709 . . . . 74.33 111.878 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 m -90.87 128.58 36.8 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.714 -0.476 . . . . 64.44 109.714 170.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.46 157.93 19.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.716 0.806 . . . . 74.53 110.43 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.485 ' HB2' HG22 ' A' ' 52' ' ' VAL . 97.2 m-85 -135.15 149.55 49.99 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.726 0.774 . . . . 74.11 111.383 -173.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.54 109.65 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.188 -1.369 . . . . 61.13 107.439 171.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 86' ' ' ALA . 29.6 m -121.82 148.01 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.525 0.679 . . . . 75.21 112.699 -173.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.1 t -112.3 139.24 48.02 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.915 0.886 . . . . 75.55 109.152 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -158.92 159.42 34.91 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.171 0.589 . . . . 74.21 111.777 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.5 m -107.91 108.78 61.78 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 107.29 -1.374 . . . . 61.14 107.29 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -47.59 152.82 2.47 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 123.949 3.099 . . . . 72.14 115.715 -175.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.8 p -64.92 -24.29 67.48 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.228 1.011 . . . . 61.31 112.393 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.513 HD21 ' HA3' ' A' ' 80' ' ' GLY . 10.9 p30 -67.55 -19.81 65.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.657 0.265 . . . . 75.24 111.213 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 19.21 71.18 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 114.812 0.685 . . . . 74.44 114.812 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.0 -130.18 2.89 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 117.62 0.71 . . . . 74.52 113.085 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -69.99 129.04 38.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.282 0.633 . . . . 75.42 111.493 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -58.5 133.16 55.56 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.296 0.638 . . . . 75.21 111.5 171.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.43 108.85 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.435 0.694 . . . . 72.43 110.128 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -102.57 148.78 25.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.736 0.814 . . . . 74.14 111.04 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.3 m80 55.63 33.97 22.29 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.25 1.02 . . . . 71.4 112.86 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -62.4 122.78 16.56 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.132 0.973 . . . . 73.52 111.036 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 41.3 mtmt -121.37 143.9 48.95 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.531 0.733 . . . . 74.03 110.933 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.537 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 92.8 m95 -110.55 144.44 39.41 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.295 1.438 . . . . 75.45 109.4 -14.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 33' ' ' TYR . 25.4 m -115.65 130.06 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 107.748 -1.205 . . . . 74.31 107.748 169.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.427 HG21 HG22 ' A' ' 96' ' ' VAL . 26.0 pt -104.9 163.69 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 121.794 -0.566 . . . . 74.23 111.696 -169.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -52.56 -39.19 61.22 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.852 1.261 . . . . 73.34 113.494 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -73.71 -28.91 61.96 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 120.885 0.374 . . . . 75.51 111.703 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.454 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 28.1 tt0 -80.38 -13.42 59.17 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.378 1.071 . . . . 74.51 110.956 -174.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.37 139.9 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 124.369 1.068 . . . . 75.21 109.84 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -75.58 -55.8 5.32 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.489 0.715 . . . . 72.21 111.477 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.22 -5.38 13.6 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.161 0.985 . . . . 74.15 113.285 -175.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.566 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -51.59 -50.24 60.55 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.569 0.951 . . . . 74.24 113.569 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.51 25.44 71.46 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 114.917 0.727 . . . . 73.25 114.917 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 64.78 16.3 10.34 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 124.831 1.253 . . . . 63.41 113.434 -175.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 64.1 pttt -115.26 179.65 3.9 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.0 0.52 . . . . 72.34 111.161 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.2 m -84.75 114.9 22.39 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.691 -0.686 . . . . 70.43 109.902 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.675 HD12 HG12 ' A' ' 71' ' ' VAL . 70.5 mt -76.29 115.69 16.26 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.624 -0.51 . . . . 72.12 109.624 170.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -89.6 147.91 38.94 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.474 0.71 . . . . 74.04 111.643 -168.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.24 116.23 2.15 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.408 2.739 . . . . 73.23 114.44 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.07 -22.92 11.04 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 115.053 0.781 . . . . 62.14 115.053 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -79.35 149.1 31.8 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.083 0.942 . . . . 73.23 112.04 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -107.17 132.82 52.62 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.179 0.592 . . . . 74.14 111.552 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.675 HG12 HD12 ' A' ' 65' ' ' LEU . 26.8 m -138.73 155.55 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.361 1.065 . . . . 74.5 111.063 -174.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.07 135.33 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 123.189 0.595 . . . . 73.42 109.785 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.2 mt -88.33 118.17 27.76 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.974 0.909 . . . . 74.32 110.837 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -84.12 -3.19 57.93 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 112.808 0.67 . . . . 64.33 112.808 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.454 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -128.81 173.15 10.61 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.272 0.629 . . . . 65.12 111.015 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 66.1 p -149.32 127.77 12.27 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.435 -0.802 . . . . 71.34 110.998 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -85.27 -14.75 45.66 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.813 0.845 . . . . 73.35 110.253 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -156.85 -179.04 7.82 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.253 1.021 . . . . 71.22 111.139 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -67.19 135.88 54.16 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.786 0.662 . . . . 74.05 112.786 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.513 ' HA3' HD21 ' A' ' 41' ' ' ASN . . . 71.33 17.67 76.23 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 115.103 0.801 . . . . 74.13 115.103 175.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.7 ttt -90.95 -42.8 10.36 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 117.625 0.713 . . . . 73.43 111.273 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 4.1 ttpm? -67.79 129.25 39.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.873 0.469 . . . . 74.51 111.156 175.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.38 -15.72 62.64 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 116.48 -0.327 . . . . 74.12 112.629 -178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.73 141.99 49.79 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.224 0.61 . . . . 71.33 111.665 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.7 m -90.36 110.33 21.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.474 -0.936 . . . . 71.32 108.474 176.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.469 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . . . -98.05 167.94 10.58 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.45 0.7 . . . . 62.22 110.972 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.22 138.34 52.41 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.969 0.908 . . . . 74.53 109.281 171.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.441 HD11 HG13 ' A' ' 35' ' ' VAL . 28.0 mm -72.14 120.58 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 123.106 0.562 . . . . 71.53 110.777 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -85.43 -42.13 14.78 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.925 0.49 . . . . 75.3 109.757 170.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.0 m -155.11 153.99 31.69 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.975 0.91 . . . . 71.33 110.841 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.29 146.99 49.79 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.681 0.792 . . . . 75.0 110.453 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -156.2 131.52 9.4 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.865 0.466 . . . . 73.52 111.493 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -88.93 96.33 10.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.482 -0.933 . . . . 74.05 108.482 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.6 t -136.63 153.74 50.84 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.534 0.734 . . . . 74.4 111.256 -171.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 48.7 m -84.52 123.94 30.83 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.81 -0.441 . . . . 71.14 109.81 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 18.0 m -113.2 138.8 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.727 0.811 . . . . 73.32 109.451 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -115.37 150.07 36.93 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.588 0.755 . . . . 61.02 112.126 -171.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 58.2 ttp -96.36 115.37 27.32 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.421 -1.326 . . . . 74.53 107.421 163.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 30.0 m -122.79 160.21 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.219 0.533 . . . . 74.23 112.413 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -121.94 116.84 25.08 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.369 1.068 . . . . 74.32 109.591 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -132.47 173.79 10.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.085 0.554 . . . . 73.43 110.508 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 31.8 m -119.28 116.76 26.91 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.588 -0.523 . . . . 75.42 109.588 173.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.8 t -54.71 121.88 9.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.456 1.102 . . . . 75.44 112.408 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p -66.62 -30.44 70.72 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.25 1.02 . . . . 74.2 112.584 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.7 t -83.17 -34.24 26.04 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.037 0.755 . . . . 74.3 113.037 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.0 p -106.78 -28.12 10.34 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.567 0.58 . . . . 75.34 112.567 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.93 9.33 85.5 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 116.611 -0.268 . . . . 64.32 113.177 -172.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -91.13 138.57 31.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.053 0.941 . . . . 73.25 110.659 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.538 ' HZ2' ' HB3' ' A' ' 109' ' ' LYS . 5.7 ttpm? -84.88 120.59 26.64 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 120.984 0.421 . . . . 75.21 110.513 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.67 114.29 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 109.369 -0.604 . . . . 72.54 109.369 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.25 150.37 29.69 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.008 0.923 . . . . 71.24 111.208 -171.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 57.28 31.9 20.87 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.382 1.073 . . . . 75.42 112.243 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -64.41 124.49 21.91 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.249 0.62 . . . . 73.14 111.649 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.541 ' HB2' ' HZ3' ' A' ' 114' ' ' LYS . 10.2 mtmp? -140.85 140.02 34.55 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 124.177 0.991 . . . . 73.33 110.681 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.537 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 87.8 m95 -112.51 148.53 34.26 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.875 1.67 . . . . 75.41 111.928 -4.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.8 m -131.47 142.36 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 124.347 1.059 . . . . 74.34 110.3 174.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 81.3 p -100.41 167.86 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 112.644 0.609 . . . . 63.41 112.644 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -56.12 -38.01 70.21 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.69 1.196 . . . . 74.54 111.701 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -58.39 -39.87 80.84 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.926 1.29 . . . . 75.43 112.111 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -88.39 -0.62 57.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.017 0.927 . . . . 75.34 113.367 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.53 163.86 17.32 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.438 0.695 . . . . 72.22 110.988 -177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.546 ' HB3' HD22 ' A' ' 10' ' ' ASN . 80.9 p -145.35 124.08 12.59 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.547 0.739 . . . . 74.34 110.447 174.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.563 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -66.11 133.47 50.78 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 113.268 0.84 . . . . 75.52 113.268 -172.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.591 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 C-N-CA 123.652 0.781 . . . . 72.42 111.077 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.644 ' HE2' ' HG3' ' A' ' 118' ' ' GLU . 14.5 mmt . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.415 -0.587 . . . . 73.12 109.415 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -113.59 159.32 19.74 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.131 0.572 . . . . 71.1 110.176 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.1 t -65.22 124.73 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 CA-C-O 121.376 0.608 . . . . 64.11 111.688 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.32 -2.99 43.37 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 115.559 -0.746 . . . . 62.55 113.094 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 p -81.56 145.34 30.71 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 117.343 0.571 . . . . 73.23 112.359 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -94.02 128.74 40.54 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.583 0.753 . . . . 73.44 110.276 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.523 HG23 HD11 ' A' ' 121' ' ' LEU . 29.5 m -131.35 152.88 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.639 0.776 . . . . 73.42 110.111 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.1 mm -102.76 132.6 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.521 0.728 . . . . 72.43 109.241 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.6 mt -78.85 113.02 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 C-N-CA 122.739 0.416 . . . . 75.5 109.915 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.441 HD21 ' HB2' ' A' ' 122' ' ' SER . 33.9 p30 -91.49 -31.07 16.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 122.002 -0.437 . . . . 74.23 111.672 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.2 m -125.88 141.16 52.11 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.256 1.022 . . . . 74.31 109.905 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 m -154.1 139.66 17.85 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.987 0.515 . . . . 73.34 111.198 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.404 ' CE1' ' HB2' ' A' ' 50' ' ' LYS . 73.0 m-70 -79.23 -25.61 42.6 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.345 0.658 . . . . 71.32 110.1 170.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.608 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 1.6 mpt? -97.55 125.23 42.14 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.171 0.988 . . . . 73.22 109.527 171.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.68 -28.46 68.63 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.23 0.826 . . . . 74.14 113.23 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.79 -12.8 84.1 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 114.597 0.599 . . . . 62.45 114.597 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.608 ' SD ' ' HB2' ' A' ' 14' ' ' MET . 39.3 mtp -91.47 -24.36 19.7 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.549 0.74 . . . . 73.42 111.761 -177.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.45 119.41 12.23 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.073 0.549 . . . . 72.44 111.659 -176.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.92 2.17 69.5 Favored Glycine 0 CA--C 1.541 1.677 0 CA-C-N 115.799 -0.637 . . . . 64.34 113.78 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.25 156.77 21.83 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.371 0.668 . . . . 74.24 112.792 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -83.83 114.31 21.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.352 0.661 . . . . 75.54 111.204 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . . . -107.03 150.63 26.31 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.861 0.864 . . . . 42.41 111.895 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -124.6 121.05 33.66 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.634 0.774 . . . . 71.24 108.968 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.2 t -72.75 106.29 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 122.823 0.449 . . . . 72.22 110.277 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.7 p -99.08 -11.33 21.54 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.352 0.661 . . . . 72.31 111.9 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.11 145.31 11.81 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 112.187 -0.365 . . . . 73.52 112.187 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.87 121.7 27.21 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.911 0.884 . . . . 73.13 110.503 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.479 ' HB2' HG21 ' A' ' 96' ' ' VAL . 26.3 m-85 -125.6 125.97 44.01 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.665 0.786 . . . . 71.24 111.249 -175.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.18 78.87 1.34 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.263 1.03 . . . . 75.3 110.35 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.534 HG22 HD12 ' A' ' 53' ' ' ILE . 10.2 t -134.79 174.86 10.11 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.726 -0.67 . . . . 65.32 111.867 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.5 m -78.98 125.03 28.84 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.97 0.508 . . . . 72.44 110.752 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . . . -100.27 163.54 12.35 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.478 1.111 . . . . 72.25 109.215 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -134.11 138.03 44.98 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.54 0.686 . . . . 74.34 111.208 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.0 t -99.15 107.75 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 107.711 -1.218 . . . . 74.35 107.711 172.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG13 HD11 ' A' ' 88' ' ' ILE . 34.3 m -119.88 145.16 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-O 121.314 0.578 . . . . 74.03 112.056 -173.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -115.16 132.88 56.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.817 0.847 . . . . 74.22 109.091 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -148.88 157.14 43.21 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.241 0.543 . . . . 74.42 112.361 -172.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.4 m -105.7 112.11 64.59 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 108.163 -1.051 . . . . 74.14 108.163 170.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.26 118.74 5.59 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.344 2.029 . . . . 74.33 111.399 174.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.0 t -60.8 -14.22 20.25 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 124.361 1.064 . . . . 74.34 113.552 -170.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -82.8 10.83 6.87 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 123.789 0.836 . . . . 75.43 111.92 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.94 46.97 7.4 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 113.672 0.229 . . . . 73.44 113.672 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.23 -177.91 21.4 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 113.542 0.177 . . . . 64.3 113.542 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -65.36 122.42 17.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.924 0.49 . . . . 71.31 110.984 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -58.81 115.35 3.03 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.988 0.423 . . . . 73.54 110.593 173.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -86.57 120.46 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.713 -0.676 . . . . 62.44 110.399 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -92.84 120.69 33.46 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.334 0.653 . . . . 74.31 109.683 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.6 m170 58.64 54.8 5.13 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.597 1.159 . . . . 75.41 113.147 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -65.04 132.07 48.24 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.063 0.945 . . . . 74.42 111.892 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HB2' ' CE1' ' A' ' 13' ' ' HIS . 99.5 mttt -136.94 150.13 48.0 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.743 0.817 . . . . 64.44 110.652 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -107.43 130.81 54.78 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.888 1.275 . . . . 73.21 111.908 -7.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.84 142.68 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.716 1.207 . . . . 75.42 108.088 168.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.612 HG23 HG23 ' A' ' 96' ' ' VAL . 27.8 pt -117.02 -175.37 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.075 0.55 . . . . 74.15 110.032 175.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -47.73 -33.18 6.7 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.623 1.169 . . . . 73.42 113.357 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.579 ' H ' HG13 ' A' ' 53' ' ' ILE . 7.0 tp10 -69.94 -28.86 65.92 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 113.924 1.083 . . . . 74.21 113.924 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -80.89 -10.98 59.66 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.487 -0.758 . . . . 73.15 112.589 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.9 mt -110.12 138.92 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 C-N-CA 123.543 0.737 . . . . 74.13 111.759 -172.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.58 ' HE3' ' HB ' ' A' ' 72' ' ' ILE . 27.8 ttpp -65.68 -53.22 44.13 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.312 1.045 . . . . 70.51 112.336 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.19 -3.33 39.04 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.014 -0.994 . . . . 75.43 113.138 -170.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -40.87 -58.76 1.6 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.444 1.276 . . . . 74.55 114.444 177.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.0 23.71 69.69 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 115.537 0.975 . . . . 53.14 115.537 170.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 61.53 17.35 8.43 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.621 1.168 . . . . 75.51 113.113 -173.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 12.3 ptpt -108.75 167.07 10.33 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.364 0.666 . . . . 73.44 110.54 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.5 m -87.02 112.5 21.91 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.293 -0.632 . . . . 75.14 109.293 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.545 HD11 HG13 ' A' ' 71' ' ' VAL . 54.5 mt -75.26 120.71 21.12 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.443 0.697 . . . . 73.14 109.353 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -96.77 154.1 38.47 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.913 0.885 . . . . 61.44 111.513 -167.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.486 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 84.8 Cg_exo -49.25 113.92 1.1 Allowed 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.995 2.463 . . . . 73.23 113.736 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.56 -17.91 18.01 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-N 115.975 -0.557 . . . . 74.52 114.135 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.8 133.14 47.09 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.327 0.564 . . . . 63.5 110.626 173.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -111.27 121.24 44.75 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.899 -0.778 . . . . 75.11 108.899 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.545 HG13 HD11 ' A' ' 65' ' ' LEU . 27.0 m -131.21 164.53 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.543 1.137 . . . . 74.34 111.027 -167.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.58 ' HB ' ' HE3' ' A' ' 58' ' ' LYS . 46.3 mm -110.51 141.47 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.01 0.524 . . . . 75.22 110.534 176.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.2 mt -88.71 123.64 33.34 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.806 0.843 . . . . 74.35 111.565 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -88.77 -28.74 20.28 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.239 0.615 . . . . 71.31 112.352 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.52 158.55 20.93 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.12 0.486 . . . . 75.52 110.572 171.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 21.1 t -143.58 125.02 14.74 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.728 -0.669 . . . . 75.4 109.703 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.7 m170 -95.34 -13.88 24.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.953 0.901 . . . . 72.33 111.272 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -156.3 177.35 11.54 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.617 0.767 . . . . 71.22 111.896 -173.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -63.95 104.96 0.77 Allowed 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.113 0.965 . . . . 72.52 112.566 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.56 12.94 56.46 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 115.182 0.833 . . . . 73.3 115.182 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -74.36 -42.23 59.71 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 117.481 0.641 . . . . 73.01 111.677 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 50.5 tttm -66.22 132.63 48.86 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 122.414 -0.179 . . . . 73.13 110.522 172.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.57 -9.52 75.7 Favored Glycine 0 N--CA 1.472 1.094 0 CA-C-O 120.337 -0.146 . . . . 72.31 112.89 -177.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.11 141.48 50.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.47 0.708 . . . . 74.22 111.903 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -81.83 113.44 19.78 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.965 -0.561 . . . . 75.01 109.945 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -110.1 150.68 28.25 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.5 1.12 . . . . 75.31 110.388 -175.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -125.06 130.34 52.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.12 0.568 . . . . 65.01 109.958 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.502 HD11 HG13 ' A' ' 35' ' ' VAL . 27.4 mm -69.86 101.64 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.442 0.697 . . . . 71.11 109.639 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.61 -32.97 70.52 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.319 0.581 . . . . 75.35 110.346 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.486 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . 40.0 t -168.89 150.31 4.61 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.669 -1.151 . . . . 74.01 109.849 -175.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.84 128.49 54.31 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.536 -0.913 . . . . 74.14 108.536 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -114.07 125.77 54.35 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.708 0.803 . . . . 72.13 111.551 -169.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -93.91 95.12 8.88 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.5 -0.555 . . . . 75.02 109.5 170.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.0 t -137.06 154.39 50.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.786 0.835 . . . . 74.13 110.592 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.3 m -86.37 125.47 33.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.509 -0.552 . . . . 74.04 109.509 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.612 HG23 HG23 ' A' ' 53' ' ' ILE . 14.9 m -114.42 134.83 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.361 0.664 . . . . 71.3 110.092 -172.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.21 143.03 46.04 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.434 0.694 . . . . 72.54 112.049 -174.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.5 ttp -89.57 115.86 27.29 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.109 -1.441 . . . . 75.44 107.109 164.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.4 m -118.16 152.95 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.866 0.841 . . . . 71.12 112.135 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -121.28 121.56 37.98 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.608 1.563 . . . . 74.11 107.4 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.541 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 51.2 p90 -152.45 178.85 9.12 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.143 0.497 . . . . 75.14 112.098 -171.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.2 m -118.49 117.49 29.15 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.761 0.824 . . . . 75.31 109.631 172.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.5 t -60.95 119.25 7.91 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.449 0.7 . . . . 75.32 110.378 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.1 p -59.4 -45.18 92.23 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.815 0.846 . . . . 72.52 113.139 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.4 m -64.06 -52.86 57.35 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.108 0.563 . . . . 71.53 111.793 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.1 m -79.06 -24.08 43.78 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.137 0.575 . . . . 73.11 112.319 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.41 17.27 74.26 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 116.35 -0.386 . . . . 75.25 113.566 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -108.6 144.09 36.79 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.876 0.87 . . . . 75.02 111.661 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -77.13 105.1 8.01 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.013 0.925 . . . . 75.25 111.304 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.2 t -90.46 110.55 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 108.297 -1.001 . . . . 75.52 108.297 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -112.94 145.96 39.85 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.692 0.797 . . . . 71.35 111.76 -166.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 17.8 m120 57.45 32.41 21.76 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 124.064 0.946 . . . . 64.4 113.225 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -64.59 133.42 52.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.675 0.79 . . . . 75.1 112.573 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 99.7 mttt -135.59 134.42 39.31 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.199 1.0 . . . . 75.13 110.72 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 97.7 m95 -115.15 155.61 26.81 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.321 1.448 . . . . 74.31 112.521 -10.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.22 160.98 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.774 1.23 . . . . 74.32 109.084 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.8 p -118.2 162.76 17.71 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.735 0.414 . . . . 74.32 111.557 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.644 ' HG3' ' HE2' ' A' ' 1' ' ' MET . 30.5 tt0 -61.36 -36.18 79.49 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.891 0.476 . . . . 73.43 111.671 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -66.28 -32.55 74.03 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.309 0.644 . . . . 74.32 110.885 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -83.33 -9.91 58.8 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.119 0.967 . . . . 73.41 111.376 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.523 HD11 HG23 ' A' ' 7' ' ' VAL . 82.6 mt -112.08 173.37 6.4 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.993 0.917 . . . . 71.01 109.857 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.441 ' HB2' HD21 ' A' ' 10' ' ' ASN . 47.8 t -137.28 136.68 38.25 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.657 0.783 . . . . 70.32 109.171 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.484 ' HB2' ' HE3' ' A' ' 1' ' ' MET . . . -70.63 138.09 50.46 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 120.863 0.364 . . . . 74.05 111.522 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.0 tttt . . . . . 0 CA--C 1.558 1.263 0 CA-C-O 121.727 0.775 . . . . 75.12 110.846 -176.455 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.524 ' SD ' HG11 ' A' ' 7' ' ' VAL . 24.2 ptp . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.629 0.252 . . . . 75.21 110.574 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -99.41 161.61 13.52 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.31 0.644 . . . . 74.21 111.575 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.56 132.29 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 123.592 0.757 . . . . 70.23 111.779 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.41 -7.21 39.67 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.508 -0.769 . . . . 74.25 113.566 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 m -75.4 134.85 40.82 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.01 0.524 . . . . 71.44 111.782 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -95.81 123.64 39.47 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.317 0.647 . . . . 62.04 109.636 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.524 HG11 ' SD ' ' A' ' 1' ' ' MET . 31.8 m -130.04 154.54 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.735 0.814 . . . . 70.14 111.818 -172.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.8 mm -98.05 128.76 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.93 0.892 . . . . 60.21 109.656 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.425 ' HB ' ' O ' ' A' ' 17' ' ' MET . 49.8 mt -78.01 109.96 13.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.38 0.672 . . . . 74.02 109.968 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -87.53 -53.22 4.92 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.79 0.436 . . . . 75.34 110.76 -173.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.811 ' HB ' ' HB2' ' A' ' 120' ' ' GLU . 72.0 m -91.42 140.36 29.84 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.694 -0.854 . . . . 74.23 108.694 170.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 14' ' ' MET . 86.0 p -133.06 124.83 28.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.502 0.321 . . . . 74.43 111.825 -173.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -71.36 -33.37 69.51 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.347 0.659 . . . . 75.52 110.088 171.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.686 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 1.8 mpt? -115.58 137.48 52.03 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.518 1.127 . . . . 73.51 108.938 172.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -30.87 69.79 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.591 1.33 . . . . 74.33 114.591 -169.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.82 -3.34 87.46 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 114.599 0.6 . . . . 74.25 114.599 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.686 ' SD ' ' HB2' ' A' ' 14' ' ' MET . 61.6 mtp -86.63 -26.99 24.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.622 0.769 . . . . 74.51 111.196 -178.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -67.46 121.96 16.94 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.587 0.355 . . . . 74.05 111.05 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.69 -3.84 86.03 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 116.134 -0.485 . . . . 73.11 113.606 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.78 150.69 32.31 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 117.503 0.651 . . . . 60.03 112.651 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -90.1 100.61 13.4 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.765 0.826 . . . . 72.42 111.464 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.97 163.56 13.44 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.804 0.842 . . . . 65.35 112.297 176.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.6 m -130.79 130.94 44.34 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.108 0.963 . . . . 64.03 108.958 172.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.4 t -74.01 103.36 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.085 0.554 . . . . 74.31 109.515 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.8 p -95.79 -12.19 25.73 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.09 0.556 . . . . 75.22 111.756 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.6 139.69 6.45 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.747 -0.541 . . . . 64.31 111.747 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.74 122.08 37.14 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.298 0.639 . . . . 74.5 111.184 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -128.88 122.44 30.34 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.277 1.031 . . . . 74.01 110.688 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -103.98 79.67 1.66 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.947 0.879 . . . . 74.15 110.085 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -133.63 175.75 9.16 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.588 -0.733 . . . . 73.21 112.467 -169.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 93' ' ' LYS . 54.9 m -77.93 118.95 20.73 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.851 0.86 . . . . 73.34 110.931 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.81 111.61 24.21 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.04 0.936 . . . . 72.24 110.373 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -87.86 149.9 23.85 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.868 0.842 . . . . 75.21 111.956 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 55.8 t -106.92 118.84 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 107.907 -1.146 . . . . 71.34 107.907 170.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.421 HG11 HD13 ' A' ' 88' ' ' ILE . 30.0 m -117.59 168.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 112.492 0.552 . . . . 73.13 112.492 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 91.1 p -137.33 134.87 36.52 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.568 0.747 . . . . 73.43 109.467 170.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.411 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 43.5 p90 -151.66 157.6 42.33 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.469 0.652 . . . . 73.13 111.96 -174.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 m -101.19 110.98 62.85 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.182 -1.044 . . . . 73.05 108.182 171.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.97 123.39 13.71 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.861 2.374 . . . . 74.32 112.846 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.3 p -58.02 -25.32 60.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.525 1.306 . . . . 73.41 114.525 -171.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -72.62 -6.38 43.84 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 112.918 0.71 . . . . 74.51 112.918 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.11 38.67 5.94 Favored Glycine 0 N--CA 1.472 1.098 0 N-CA-C 111.789 -0.524 . . . . 42.13 111.789 -169.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.14 158.94 26.05 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.338 -0.431 . . . . 74.32 112.479 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -56.26 122.99 13.07 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.173 0.589 . . . . 72.24 110.961 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.89 124.19 14.67 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.152 0.981 . . . . 74.42 111.628 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.687 HG22 ' HE1' ' A' ' 78' ' ' MET . 46.9 t -103.99 124.56 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.75 0.82 . . . . 70.25 111.298 -174.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -117.32 148.62 41.55 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.638 0.775 . . . . 75.4 111.054 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 m170 57.62 38.02 27.64 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.434 1.093 . . . . 75.13 112.991 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -69.13 138.58 54.33 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.426 0.69 . . . . 75.34 111.477 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -153.88 153.36 31.95 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 123.75 0.82 . . . . 74.25 111.069 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -106.88 128.69 54.51 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.542 1.537 . . . . 71.3 111.693 -0.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.74 142.31 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.893 -1.151 . . . . 73.22 107.893 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.2 pt -124.13 176.88 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.556 -0.715 . . . . 74.52 112.076 -175.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -49.88 -50.45 45.79 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.172 1.175 . . . . 75.2 114.172 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -6.94 52.27 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 112.864 0.69 . . . . 73.41 112.864 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -79.16 -31.17 43.91 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.954 0.901 . . . . 74.12 110.066 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.7 mt -96.08 131.1 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 123.688 0.795 . . . . 71.32 111.02 -169.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -63.0 -47.51 82.79 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 122.092 0.949 . . . . 72.15 111.207 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.26 -2.65 22.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.912 1.285 . . . . 74.23 113.543 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -40.7 -60.84 1.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.602 1.161 . . . . 63.43 113.665 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.73 17.52 65.0 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 115.848 1.099 . . . . 72.42 115.848 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.64 12.91 7.92 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.45 1.1 . . . . 62.22 113.46 -174.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -106.26 157.24 17.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.362 0.665 . . . . 74.52 110.435 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.4 m -76.1 111.05 11.11 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.046 0.539 . . . . 72.42 110.432 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.423 HD12 HG12 ' A' ' 71' ' ' VAL . 92.9 mt -75.57 124.53 27.36 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.346 0.659 . . . . 74.55 110.679 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -120.57 157.74 53.35 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.325 1.05 . . . . 74.11 110.518 -170.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 32.8 Cg_exo -41.58 116.49 0.52 Allowed 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.032 2.488 . . . . 65.5 114.27 171.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.81 -9.73 16.15 Favored Glycine 0 N--CA 1.478 1.45 0 CA-C-N 115.137 -0.938 . . . . 75.14 113.499 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -84.37 102.38 12.69 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 117.519 0.659 . . . . 74.32 112.451 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -69.87 120.98 16.43 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.736 -0.468 . . . . 75.41 109.736 164.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.423 HG12 HD12 ' A' ' 65' ' ' LEU . 30.1 m -131.96 157.31 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.596 1.159 . . . . 72.12 110.428 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.9 mm -105.82 137.0 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.855 -0.528 . . . . 74.32 110.308 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.5 mt -87.54 128.0 35.25 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.67 0.788 . . . . 73.04 112.299 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -92.69 -31.33 15.14 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.798 0.839 . . . . 71.55 111.943 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.5 161.02 14.39 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.463 0.649 . . . . 71.03 110.29 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.1 p -147.24 128.46 14.74 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.784 -0.644 . . . . 75.12 110.623 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -88.68 6.84 36.56 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.817 0.847 . . . . 75.35 110.886 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.687 ' HE1' HG22 ' A' ' 46' ' ' VAL . 21.5 ptt? -172.35 158.35 4.35 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.501 1.52 . . . . 74.33 109.824 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -75.99 133.46 40.42 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 122.274 -0.266 . . . . 73.03 110.987 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.63 -29.03 12.58 Favored Glycine 0 N--CA 1.482 1.711 0 CA-C-N 116.56 -0.291 . . . . 75.21 112.44 -172.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.0 ttt -68.36 -37.54 80.56 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.065 0.946 . . . . 64.24 111.253 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -65.35 119.24 10.61 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.988 0.515 . . . . 72.31 109.793 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.7 3.03 74.81 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 120.064 -0.298 . . . . 64.1 113.275 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.13 144.31 31.78 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 117.19 0.495 . . . . 73.15 111.429 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.4 m -80.84 110.67 16.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.693 -0.685 . . . . 71.13 109.174 176.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -101.2 159.73 15.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.316 1.047 . . . . 73.22 108.973 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.95 129.49 30.14 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.047 -1.094 . . . . 74.41 108.047 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.421 HD13 HG11 ' A' ' 35' ' ' VAL . 38.5 mm -63.26 100.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.562 0.745 . . . . 61.33 110.389 -176.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.19 -40.55 71.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.02 0.928 . . . . 74.42 110.519 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 68.0 m -153.96 151.41 29.37 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.987 0.915 . . . . 75.3 110.059 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.01 129.89 56.82 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.114 0.566 . . . . 63.42 109.61 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -140.61 151.83 44.96 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.724 0.81 . . . . 73.12 109.537 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -124.81 95.27 4.45 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.036 0.922 . . . . 75.42 109.156 177.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 t -134.9 151.89 51.27 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.288 -0.869 . . . . 53.42 110.552 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.8 m -78.39 123.69 27.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 122.613 0.365 . . . . 74.24 110.54 -173.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 15.2 m -118.33 140.06 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.193 0.997 . . . . 72.43 110.089 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.421 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 77.7 m-85 -122.53 145.85 47.95 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.702 0.801 . . . . 75.15 111.543 -172.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.476 ' SD ' ' NZ ' ' A' ' 114' ' ' LYS . 49.5 ttp -89.9 121.38 31.97 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.974 -1.121 . . . . 74.41 107.974 163.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.2 m -120.94 153.76 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-O 121.488 0.661 . . . . 74.43 112.367 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -118.12 122.42 43.05 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.836 1.254 . . . . 51.41 107.747 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.432 ' CE2' ' HG2' ' A' ' 17' ' ' MET . 56.1 p90 -148.65 177.87 9.13 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.939 0.496 . . . . 74.4 111.681 -174.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.2 m -125.38 128.87 48.82 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.49 0.716 . . . . 70.33 109.726 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.4 t -62.48 120.7 11.6 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.662 0.785 . . . . 72.32 110.925 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.0 p -60.15 -41.13 92.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.895 0.878 . . . . 75.15 112.408 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.4 p -75.15 -57.5 3.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.143 0.577 . . . . 71.22 112.104 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.0 m -71.04 -40.35 71.76 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.272 0.629 . . . . 71.24 111.905 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.06 1.31 82.2 Favored Glycine 0 N--CA 1.479 1.528 0 CA-C-N 116.188 -0.46 . . . . 55.13 113.033 -170.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -75.11 129.89 38.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.64 1.176 . . . . 55.34 112.937 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -82.54 98.94 9.21 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.806 0.842 . . . . 74.2 109.881 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -88.39 118.26 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.012 0.525 . . . . 74.44 110.211 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -107.94 148.06 30.17 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.506 0.723 . . . . 65.43 112.18 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 m120 58.46 34.2 23.75 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.631 1.172 . . . . 64.2 113.349 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -65.35 125.4 24.98 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.622 0.769 . . . . 72.12 112.316 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.476 ' NZ ' ' SD ' ' A' ' 98' ' ' MET . 64.4 mttp -132.42 135.77 46.32 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.877 0.871 . . . . 75.23 111.096 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 97.9 m95 -116.52 160.71 20.23 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 126.018 1.727 . . . . 70.05 111.644 -12.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.33 139.72 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.047 0.939 . . . . 73.53 110.692 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.3 p -91.73 159.4 15.86 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.03 0.532 . . . . 73.53 112.028 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.439 ' HG3' ' HE3' ' A' ' 1' ' ' MET . 36.5 tt0 -65.33 -26.42 68.04 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.115 0.483 . . . . 75.22 111.173 173.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -63.9 -34.29 77.62 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.859 0.864 . . . . 75.32 111.614 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.811 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 11.0 pt-20 -95.66 -2.51 47.95 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.881 0.697 . . . . 74.51 112.881 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.8 mt -111.78 168.69 9.38 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.551 0.741 . . . . 75.43 109.633 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.2 m -143.47 123.19 13.35 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.396 0.679 . . . . 74.25 109.812 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.491 ' HA ' HG13 ' A' ' 7' ' ' VAL . . . -63.77 144.32 57.14 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.075 0.55 . . . . 75.24 111.465 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.6 tptm . . . . . 0 CA--C 1.558 1.265 0 CA-C-O 122.035 0.921 . . . . 73.14 111.213 -177.134 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 110.204 -0.295 . . . . 74.15 110.204 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -75.0 137.42 41.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.835 0.854 . . . . 74.21 111.006 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.3 t -67.3 126.06 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 CA-C-O 121.353 0.596 . . . . 71.51 110.728 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.49 -18.03 38.92 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 115.189 -0.914 . . . . 72.21 113.07 -171.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 t -85.97 161.14 19.14 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.666 0.787 . . . . 75.21 110.202 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -124.62 149.59 46.93 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.084 0.468 . . . . 74.31 111.369 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.565 HG13 ' HA ' ' A' ' 123' ' ' ALA . 24.5 m -138.27 163.92 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.256 1.022 . . . . 75.51 111.92 -171.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 mm -98.81 132.22 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.413 1.085 . . . . 75.11 109.169 165.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.9 mt -91.73 125.5 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 N-CA-C 109.782 -0.451 . . . . 75.44 109.782 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -96.16 -58.98 1.94 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.64 1.176 . . . . 65.12 111.222 -171.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.5 ' HB ' ' HG2' ' A' ' 120' ' ' GLU . 23.7 m -91.75 140.75 29.39 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.451 -0.944 . . . . 73.53 108.451 169.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 75.5 m -148.19 136.62 21.44 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.238 0.542 . . . . 64.35 111.484 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.48 ' CE1' ' HZ1' ' A' ' 50' ' ' LYS . 43.6 m-70 -83.89 -22.78 31.5 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.647 -1.16 . . . . 75.54 109.46 175.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.1 mmt -97.7 122.04 40.31 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.498 1.119 . . . . 74.22 108.906 167.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -32.01 72.59 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.638 0.977 . . . . 75.43 113.638 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.98 -4.31 77.22 Favored Glycine 0 N--CA 1.476 1.307 0 N-CA-C 114.03 0.372 . . . . 51.31 114.03 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 54.8 ttp -100.85 -22.25 14.89 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.473 0.709 . . . . 74.04 110.562 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 58.8 tttm -68.12 120.09 13.76 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.159 0.584 . . . . 74.34 111.87 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.22 -6.01 82.79 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 115.214 -0.903 . . . . 75.12 113.99 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.91 159.97 24.82 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.27 0.841 . . . . 75.54 113.27 -171.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.75 115.76 21.81 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.091 -0.959 . . . . 73.13 110.403 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -113.41 164.13 14.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.033 0.933 . . . . 55.42 112.221 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 62.1 m -133.55 125.37 28.72 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.277 0.631 . . . . 73.12 110.987 174.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.91 104.55 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.656 0.782 . . . . 74.53 110.371 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.3 p -111.57 3.69 18.17 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.455 0.539 . . . . 73.24 112.455 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.9 146.44 14.11 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 120.002 -0.332 . . . . 74.1 112.812 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.69 108.26 6.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.626 0.77 . . . . 73.01 110.731 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -112.14 116.89 31.21 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.194 0.998 . . . . 71.21 110.378 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -99.35 88.62 3.95 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 122.086 0.946 . . . . 72.13 109.731 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -134.25 179.8 6.04 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.646 0.779 . . . . 72.33 111.041 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -83.15 123.01 29.12 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.566 -0.531 . . . . 74.34 109.566 171.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.86 155.15 20.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.096 0.558 . . . . 72.5 109.562 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -132.48 147.95 52.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.875 0.845 . . . . 72.51 111.663 -173.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.31 108.7 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.906 -1.516 . . . . 75.2 106.906 169.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.418 HG13 HD11 ' A' ' 88' ' ' ILE . 19.1 m -107.02 155.51 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.356 0.598 . . . . 73.14 111.924 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 68.5 m -134.31 122.96 23.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.894 0.877 . . . . 62.24 108.92 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -153.23 159.2 42.56 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.299 0.571 . . . . 62.11 110.81 -167.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.9 m -101.65 124.49 40.48 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.679 -1.23 . . . . 74.22 107.679 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.72 145.75 94.76 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.024 1.816 . . . . 74.33 111.922 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -62.82 -17.74 61.76 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.358 0.663 . . . . 75.42 112.527 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.466 HD22 ' HG2' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -70.25 -20.82 63.04 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.533 0.733 . . . . 73.41 111.539 172.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.12 29.57 45.48 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 115.108 0.803 . . . . 72.05 115.108 168.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.86 -127.48 5.33 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 117.912 0.856 . . . . 52.42 113.103 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.75 119.59 18.18 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.448 0.699 . . . . 74.32 110.551 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -57.29 105.67 0.25 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.764 0.826 . . . . 73.25 112.059 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.23 104.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 121.218 0.533 . . . . 74.32 109.998 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 6.8 p-10 -110.48 155.3 22.44 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.233 0.613 . . . . 74.2 109.855 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.0 m170 58.69 30.48 19.99 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.556 0.742 . . . . 74.32 112.101 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -65.07 125.58 25.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.904 0.882 . . . . 71.35 110.962 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' HZ1' ' CE1' ' A' ' 13' ' ' HIS . 6.9 mtmp? -139.94 144.35 37.04 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 124.082 0.953 . . . . 73.22 111.25 -174.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.5 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 97.5 m95 -112.32 138.07 49.57 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 125.32 1.448 . . . . 74.35 111.474 -4.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.81 138.69 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.322 -0.854 . . . . 72.1 109.077 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.3 pt -99.35 162.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.089 0.471 . . . . 74.22 111.737 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -51.36 -41.06 60.38 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.375 1.07 . . . . 74.44 113.322 175.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.74 -13.69 61.38 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.436 0.636 . . . . 70.04 112.363 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.553 ' HG3' ' HB2' ' A' ' 75' ' ' ALA . 15.4 tt0 -92.18 -16.72 25.87 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.347 1.059 . . . . 75.11 111.204 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.9 mt -102.67 132.38 48.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.904 0.882 . . . . 74.4 110.159 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.543 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 87.2 tttt -64.51 -54.88 25.36 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.761 0.824 . . . . 63.34 111.508 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -72.96 -5.88 41.61 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.046 1.128 . . . . 64.43 114.046 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.91 -39.61 62.89 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.163 1.171 . . . . 73.34 114.163 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.7 28.32 73.51 Favored Glycine 0 N--CA 1.481 1.697 0 N-CA-C 116.189 1.236 . . . . 74.44 116.189 163.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 61.47 14.28 5.73 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.275 1.03 . . . . 74.4 112.999 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -119.5 170.47 9.13 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.782 0.833 . . . . 71.54 111.023 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.0 m -96.6 114.59 26.26 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.159 -0.682 . . . . 75.31 109.159 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.482 HD11 HG12 ' A' ' 71' ' ' VAL . 34.9 mt -76.68 140.38 40.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.372 0.669 . . . . 71.03 110.988 -173.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -91.0 151.85 43.67 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.109 0.563 . . . . 74.12 110.951 -174.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.1 120.24 7.95 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.361 2.041 . . . . 74.11 112.35 170.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.79 -17.45 17.87 Favored Glycine 0 CA--C 1.538 1.484 0 CA-C-O 119.515 -0.603 . . . . 71.52 114.427 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.18 154.47 41.02 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.336 1.068 . . . . 73.42 111.844 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -120.6 136.9 54.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.267 0.627 . . . . 75.52 110.812 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 65' ' ' LEU . 35.8 m -132.89 172.38 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 124.841 1.256 . . . . 74.3 111.848 -170.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.46 138.86 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 124.231 1.012 . . . . 74.34 109.739 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.5 mt -97.94 118.2 33.98 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.669 0.788 . . . . 74.42 111.579 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.543 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 30.5 mm-40 -82.19 -22.59 35.91 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.157 0.583 . . . . 72.41 112.511 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.553 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . . . -104.78 172.12 6.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.095 0.558 . . . . 72.24 111.464 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.1 t -137.26 126.22 24.25 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.149 0.579 . . . . 62.14 111.487 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.541 ' H ' ' HG2' ' A' ' 81' ' ' MET . 32.8 m170 -92.92 -20.16 20.92 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.483 0.713 . . . . 74.44 111.003 164.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.0 ptp -151.43 158.73 44.07 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.296 0.638 . . . . 72.35 111.566 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.466 ' HG2' HD22 ' A' ' 41' ' ' ASN . 38.0 ttpt -66.78 95.91 0.38 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.447 0.699 . . . . 74.45 110.143 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.13 -12.4 4.41 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 115.859 -0.61 . . . . 64.32 113.354 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.541 ' HG2' ' H ' ' A' ' 77' ' ' HIS . 9.4 tpt -75.93 -59.57 2.7 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.389 1.076 . . . . 72.53 111.865 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -67.21 131.05 45.0 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.74 0.816 . . . . 75.21 112.267 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.61 -26.33 14.6 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.397 -0.365 . . . . 73.01 113.539 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.08 156.78 38.08 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.335 0.654 . . . . 72.14 111.914 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.9 m -84.5 116.35 23.06 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.909 -0.774 . . . . 65.13 108.909 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.63 150.82 22.33 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.721 0.809 . . . . 70.13 109.354 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -118.9 118.68 32.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.15 0.58 . . . . 74.32 109.472 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.418 HD11 HG13 ' A' ' 35' ' ' VAL . 36.9 mm -60.1 98.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.092 0.557 . . . . 74.24 109.869 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.11 -39.84 82.69 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.768 0.827 . . . . 73.13 109.254 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.6 t -163.44 163.25 24.97 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.064 -0.971 . . . . 71.21 110.473 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.6 139.27 52.85 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.661 0.785 . . . . 73.51 110.403 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -139.23 124.55 19.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.223 0.609 . . . . 74.55 111.102 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -86.81 94.11 9.46 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.088 -1.078 . . . . 73.53 108.088 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 t -136.79 155.04 50.34 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.8 0.84 . . . . 74.45 111.706 -170.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.4 m -87.46 125.06 34.07 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.794 -0.817 . . . . 74.24 108.794 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.5 134.16 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.012 0.925 . . . . 74.35 109.703 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.485 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 93.9 m-85 -112.63 154.98 25.2 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.764 0.792 . . . . 74.44 112.71 -169.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.3 ttp -102.55 112.49 25.25 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.546 -1.206 . . . . 73.15 108.734 173.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.515 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 23.6 m -121.5 148.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 112.909 0.707 . . . . 75.33 112.909 -172.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.3 122.86 48.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.839 0.856 . . . . 74.24 109.455 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -138.88 167.72 21.39 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.593 0.711 . . . . 74.34 112.591 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.1 m -106.84 118.64 37.22 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.102 -1.073 . . . . 73.5 108.102 168.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.6 p -64.96 124.64 22.59 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.421 0.288 . . . . 72.01 111.072 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.3 p -69.85 -41.42 74.9 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.119 0.968 . . . . 63.53 112.596 -176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.3 p -78.6 -48.48 15.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.041 0.537 . . . . 61.04 111.785 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.3 t -81.2 -36.38 30.18 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.405 0.682 . . . . 64.23 112.577 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.8 2.58 89.72 Favored Glycine 0 N--CA 1.483 1.768 0 CA-C-O 120.877 0.154 . . . . 73.42 113.478 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -82.08 137.79 34.95 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.91 0.884 . . . . 74.45 111.208 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.28 111.14 19.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.677 0.791 . . . . 73.43 109.138 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -110.8 120.17 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.181 0.592 . . . . 64.32 109.502 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -113.59 152.16 30.7 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.654 0.382 . . . . 74.42 110.412 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.4 m120 53.74 34.8 19.83 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 124.494 1.118 . . . . 71.31 113.224 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -58.27 135.99 57.25 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.645 1.178 . . . . 73.41 112.256 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 61.8 mttp -137.37 137.4 38.82 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.425 1.09 . . . . 74.45 110.45 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.5 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.4 m95 -115.17 156.94 24.36 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.64 1.576 . . . . 71.31 112.031 -9.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.5 m -128.02 154.12 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.637 1.175 . . . . 74.42 109.245 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.414 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 75.2 p -103.66 160.75 14.49 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 122.075 -0.391 . . . . 64.41 110.905 174.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.485 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 40.3 tt0 -63.07 -27.41 69.38 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.444 0.698 . . . . 74.25 111.552 178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -63.62 -25.42 68.22 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.168 0.987 . . . . 75.24 112.227 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.5 ' HG2' ' HB ' ' A' ' 11' ' ' THR . 40.2 mt-10 -91.86 0.03 57.5 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.914 0.885 . . . . 74.21 111.818 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 117' ' ' THR . 68.8 mt -119.95 140.48 50.84 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.344 0.52 . . . . 64.21 110.351 -172.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -131.56 122.94 26.93 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.848 0.859 . . . . 73.1 109.087 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.565 ' HA ' HG13 ' A' ' 7' ' ' VAL . . . -56.35 117.78 4.13 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.38 0.672 . . . . 72.51 111.728 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 64.8 tttm . . . . . 0 CA--C 1.55 0.96 0 CA-C-O 121.616 0.722 . . . . 72.23 111.821 -172.114 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.018 -0.364 . . . . 72.33 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.449 ' HZ2' ' HB3' ' A' ' 2' ' ' LYS . 0.2 OUTLIER -71.01 147.22 48.83 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.838 0.455 . . . . 73.54 110.326 176.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.66 132.39 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 CA-C-O 121.209 0.528 . . . . 75.2 111.133 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.32 -5.55 49.08 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.338 -0.847 . . . . 72.4 113.757 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.2 m -68.08 136.1 53.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.988 0.736 . . . . 70.41 112.988 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -84.63 113.69 21.45 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.007 -0.738 . . . . 63.32 109.007 167.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 123' ' ' ALA . 29.8 m -123.76 174.03 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.555 0.742 . . . . 71.35 111.29 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.7 mt -130.64 134.72 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.141 0.976 . . . . 73.02 109.341 170.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.5 mt -86.39 108.12 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.008 0.923 . . . . 73.03 110.144 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -89.18 -48.21 7.54 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.251 0.62 . . . . 72.42 111.133 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 28.0 m -102.14 143.07 32.42 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 107.987 -1.116 . . . . 64.33 107.987 173.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.554 ' HG ' ' HB3' ' A' ' 17' ' ' MET . 31.1 t -157.45 155.62 30.74 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.472 0.916 . . . . 72.34 113.472 -172.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -83.86 -42.71 16.09 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.147 -1.388 . . . . 70.42 109.111 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.7 mmt -90.67 128.6 36.69 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.185 0.994 . . . . 72.31 109.557 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -17.86 65.1 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.558 0.577 . . . . 74.52 112.558 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.52 -11.08 62.8 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 113.937 0.335 . . . . 52.01 113.937 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.554 ' HB3' ' HG ' ' A' ' 12' ' ' SER . 53.4 ttp -88.06 -23.05 23.85 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.31 0.555 . . . . 71.32 111.51 -177.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 141.97 57.77 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 121.025 0.44 . . . . 65.43 111.348 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.68 -8.65 41.05 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-N 116.003 -0.544 . . . . 73.4 114.116 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.41 148.25 32.03 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.498 0.719 . . . . 71.23 111.529 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -96.17 110.55 22.81 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 121.272 0.558 . . . . 73.45 109.976 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.51 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -101.86 172.28 7.03 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.209 1.004 . . . . 75.51 113.303 -174.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.2 m -125.79 123.89 39.77 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.028 0.931 . . . . 73.32 109.806 172.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.41 122.21 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.053 0.541 . . . . 61.03 110.08 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 p -126.72 -6.33 6.27 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.543 0.737 . . . . 61.3 112.591 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.38 145.71 13.38 Favored Glycine 0 N--CA 1.476 1.314 0 CA-C-O 119.648 -0.529 . . . . 74.22 112.019 173.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.29 123.48 12.95 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.618 0.767 . . . . 73.44 110.689 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -133.1 130.24 39.04 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.663 0.785 . . . . 75.31 111.926 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -104.24 87.47 2.75 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.617 0.767 . . . . 74.3 109.165 169.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -134.53 170.98 14.96 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.847 0.859 . . . . 72.4 110.921 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.5 m -75.47 107.71 7.78 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.492 -0.558 . . . . 73.11 109.492 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.01 110.5 23.1 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.601 0.76 . . . . 74.44 109.004 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.5 ' HE2' ' HA ' ' A' ' 54' ' ' GLN . 95.7 m-85 -89.33 151.86 21.85 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.873 0.844 . . . . 75.23 112.158 -172.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.0 t -99.68 120.41 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.255 -1.387 . . . . 74.12 107.255 164.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -125.72 148.55 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.514 0.673 . . . . 73.32 112.671 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.6 p -115.81 124.99 52.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.241 1.017 . . . . 54.45 109.14 170.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.423 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 47.2 p90 -152.11 156.19 39.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.767 0.427 . . . . 74.24 110.678 -174.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 15.1 m -113.31 110.85 50.3 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 109.123 -0.695 . . . . 72.05 109.123 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 38' ' ' THR . 9.2 Cg_endo -53.01 118.44 4.8 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.248 2.632 . . . . 65.33 112.791 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.3 p -64.71 -17.19 63.88 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.723 1.209 . . . . 75.2 113.596 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -67.47 -10.21 49.32 Favored 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 123.669 0.788 . . . . 74.42 112.466 174.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.77 51.38 2.14 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 122.255 -0.278 . . . . 64.14 112.717 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.57 -151.05 21.12 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 120.903 0.168 . . . . 54.51 113.421 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -106.14 133.86 50.19 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.725 0.81 . . . . 73.22 109.636 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -59.5 118.6 6.23 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.915 0.486 . . . . 74.14 111.208 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.574 HG22 ' HE3' ' A' ' 78' ' ' MET . 39.7 t -84.01 110.57 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.316 0.646 . . . . 60.31 110.638 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -95.72 130.65 42.57 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.934 0.894 . . . . 72.3 110.777 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 m170 54.01 57.93 5.51 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.065 0.946 . . . . 74.51 112.547 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.473 ' HD2' HG12 ' A' ' 52' ' ' VAL . 63.9 t60 -73.14 126.31 29.73 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.092 0.557 . . . . 72.11 111.446 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 66.4 mttm -131.21 139.36 49.69 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.44 1.096 . . . . 72.25 109.732 173.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.6 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 85.9 m95 -114.12 133.32 55.64 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.424 1.49 . . . . 74.32 111.474 -5.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.473 HG12 ' HD2' ' A' ' 49' ' ' HIS . 14.2 m -110.74 142.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 108.477 -0.935 . . . . 73.43 108.477 167.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.81 161.92 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-O 120.817 0.341 . . . . 73.33 111.241 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.5 ' HA ' ' HE2' ' A' ' 33' ' ' TYR . 63.3 tt0 -52.01 -47.98 64.71 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.189 0.996 . . . . 73.34 113.487 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -74.94 -8.1 55.51 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.509 0.723 . . . . 74.44 112.124 -174.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.413 ' HG3' ' HB1' ' A' ' 75' ' ' ALA . 35.7 tt0 -90.7 -8.84 48.81 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 124.842 1.257 . . . . 74.44 110.931 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.64 142.16 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 C-N-CA 124.506 1.123 . . . . 73.24 110.311 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -63.56 -50.37 69.77 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.228 1.011 . . . . 73.31 112.968 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.36 -6.58 57.1 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.225 0.824 . . . . 75.5 113.225 -170.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -33.19 -56.22 0.4 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.761 1.763 . . . . 64.5 115.761 -170.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.39 15.18 63.24 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 115.119 0.807 . . . . 50.25 115.119 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.37 3.52 1.87 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.2 1.4 . . . . 73.51 113.146 -170.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -100.54 160.37 14.4 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.931 0.892 . . . . 74.32 110.942 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.1 m -83.25 109.54 17.32 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.423 -0.584 . . . . 61.05 109.423 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.506 HD13 HG12 ' A' ' 71' ' ' VAL . 63.7 mt -72.02 122.13 20.35 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.724 -0.843 . . . . 73.14 108.724 175.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -97.55 149.09 35.35 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.212 0.605 . . . . 74.45 112.324 -164.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -46.25 115.65 1.22 Allowed 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.806 3.004 . . . . 74.4 114.623 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.77 -16.96 15.98 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 115.887 -0.597 . . . . 73.24 114.053 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.53 154.66 32.23 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 117.811 0.805 . . . . 74.3 111.714 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -126.07 137.29 53.61 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.344 0.658 . . . . 61.23 110.448 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.506 HG12 HD13 ' A' ' 65' ' ' LEU . 16.9 m -141.29 -179.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.621 1.169 . . . . 74.21 110.908 -168.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.53 146.44 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.494 0.718 . . . . 75.53 110.398 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.1 mt -96.09 123.92 39.89 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.673 0.789 . . . . 73.41 111.193 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -86.75 -6.03 58.94 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.525 0.565 . . . . 73.41 112.525 173.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.413 ' HB1' ' HG3' ' A' ' 56' ' ' GLU . . . -122.95 170.62 9.95 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.554 0.693 . . . . 75.41 110.525 170.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 66.1 p -146.99 127.72 14.3 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.281 -0.872 . . . . 71.23 110.458 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -82.82 -31.27 28.22 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.553 0.741 . . . . 71.11 109.524 168.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.574 ' HE3' HG22 ' A' ' 46' ' ' VAL . 66.6 mtm -125.77 177.61 6.18 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.971 0.908 . . . . 74.03 112.086 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -81.84 128.82 34.42 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.682 0.793 . . . . 73.13 111.394 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.67 11.48 83.96 Favored Glycine 0 N--CA 1.477 1.416 0 C-N-CA 123.179 0.418 . . . . 64.53 113.73 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.7 ttt -86.32 -44.0 12.44 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.882 0.873 . . . . 73.2 111.447 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 88.1 tttt -67.69 127.53 33.09 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.728 0.411 . . . . 74.34 111.209 174.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.15 -16.6 60.62 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 116.537 -0.301 . . . . 62.54 112.817 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.77 152.39 42.76 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.405 0.682 . . . . 74.2 111.116 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.8 m -84.18 114.0 21.48 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.971 -0.559 . . . . 65.52 109.914 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -100.44 130.14 46.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.863 0.865 . . . . 75.24 109.752 -177.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -99.87 117.58 34.48 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.343 -0.984 . . . . 73.2 108.343 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.3 mm -64.35 94.46 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 109.486 -0.561 . . . . 75.51 109.486 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.59 -33.17 68.82 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.884 0.873 . . . . 65.32 109.832 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.9 t -167.08 166.2 15.27 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.187 0.995 . . . . 62.44 110.506 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.03 131.48 42.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.978 0.911 . . . . 72.34 109.538 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -130.42 140.01 50.58 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.832 0.453 . . . . 72.35 111.168 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -94.12 96.71 9.81 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.518 0.727 . . . . 72.5 109.091 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.1 t -137.39 157.1 47.33 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.631 0.773 . . . . 74.53 111.116 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.9 m -86.43 125.84 33.97 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.764 -0.458 . . . . 53.12 109.764 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 8.6 m -117.34 138.23 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.735 0.814 . . . . 74.44 110.321 -176.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -122.11 164.0 18.52 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.314 1.045 . . . . 73.2 112.613 -169.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 ttp -119.35 116.92 27.18 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.95 -1.477 . . . . 70.31 107.984 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 24.5 m -125.72 149.67 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 123.544 0.737 . . . . 73.33 112.667 -172.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -115.88 116.77 28.56 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.018 0.927 . . . . 64.54 109.9 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -136.68 177.7 7.65 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.53 0.681 . . . . 75.32 111.781 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.5 m -123.78 125.01 43.95 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.326 1.051 . . . . 72.41 108.803 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.3 t -61.19 127.77 33.14 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.413 0.685 . . . . 75.14 112.216 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.6 p -69.33 -44.52 71.52 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.892 0.877 . . . . 72.11 111.441 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.0 m -81.07 -57.46 3.51 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.693 -0.685 . . . . 71.14 111.775 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.2 m -86.49 -21.13 27.17 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.185 0.809 . . . . 71.03 113.185 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.98 -17.96 38.5 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 115.121 0.809 . . . . 62.33 115.121 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.51 124.76 22.17 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.5 0.72 . . . . 73.31 112.258 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -81.57 101.97 10.32 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.414 0.686 . . . . 75.25 109.275 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.0 t -98.74 119.21 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.69 0.796 . . . . 75.11 110.396 -170.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.626 ' HD3' ' H ' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -105.3 137.53 42.95 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.645 0.778 . . . . 75.11 111.276 -174.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.8 m120 56.53 40.09 29.62 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.737 1.215 . . . . 75.22 113.174 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -64.72 132.83 50.71 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.936 0.894 . . . . 73.34 111.233 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -152.06 151.76 31.53 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.101 0.56 . . . . 72.22 111.37 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.6 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 92.3 m95 -105.88 144.54 32.47 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 125.984 1.713 . . . . 74.21 110.777 -4.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.7 148.92 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 123.903 0.881 . . . . 74.42 110.888 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.6 p -94.37 168.57 10.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.682 -0.636 . . . . 60.03 112.17 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -71.22 -25.56 62.55 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.001 0.52 . . . . 65.45 111.07 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -60.46 -20.02 58.49 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 124.275 1.03 . . . . 72.14 111.295 170.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.445 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 41.4 mt-10 -100.74 -2.67 31.85 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.344 1.058 . . . . 75.53 112.881 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.5 mt -119.45 157.5 28.12 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.51 0.724 . . . . 74.52 110.907 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.9 t -144.97 122.8 11.93 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.324 0.65 . . . . 74.31 110.292 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.475 ' HA ' HG13 ' A' ' 7' ' ' VAL . . . -68.28 117.67 10.38 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 122.784 0.434 . . . . 72.52 111.619 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt . . . . . 0 CA--C 1.553 1.072 0 C-N-CA 123.625 0.77 . . . . 73.2 111.995 -170.241 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.556 ' SD ' HG11 ' A' ' 7' ' ' VAL . 17.9 ptp . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 110.784 -0.08 . . . . 73.21 110.784 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.0 158.87 16.45 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.045 0.538 . . . . 71.03 111.798 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.92 123.48 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 CA-C-O 121.017 0.437 . . . . 73.31 110.691 173.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.22 -4.42 38.16 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.694 -0.685 . . . . 63.34 113.02 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.5 m -76.8 140.65 40.78 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.501 0.556 . . . . 65.53 112.501 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -91.02 114.78 27.39 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.964 -1.125 . . . . 73.22 107.964 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.556 HG11 ' SD ' ' A' ' 1' ' ' MET . 27.3 m -128.33 153.62 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.571 0.748 . . . . 74.24 111.329 -170.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -100.59 121.91 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.599 0.76 . . . . 74.14 110.164 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.663 HD13 ' HB3' ' A' ' 22' ' ' ALA . 46.0 mt -80.18 120.79 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.632 0.373 . . . . 75.32 110.459 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -92.49 1.0 57.5 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 123.426 0.69 . . . . 64.05 111.977 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.409 HG23 ' HG2' ' A' ' 120' ' ' GLU . 21.7 m -142.61 154.51 44.45 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.226 0.61 . . . . 74.5 111.686 -171.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.756 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 33.0 p -117.84 116.58 27.26 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.579 0.704 . . . . 73.24 112.042 173.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.453 ' H ' ' HE3' ' A' ' 17' ' ' MET . 38.2 m-70 -96.36 -33.06 12.07 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 107.616 -1.253 . . . . 72.14 107.616 160.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 26.6 mmt -107.87 149.49 28.21 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.786 1.234 . . . . 75.22 109.283 167.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -58.33 -45.19 88.55 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.853 0.861 . . . . 75.13 113.102 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.96 2.27 87.77 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 115.172 0.829 . . . . 62.41 115.172 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.535 ' HG2' HG21 ' A' ' 9' ' ' ILE . 47.8 ttp -87.76 -26.65 22.78 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.539 0.669 . . . . 75.4 111.991 -170.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.756 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 28.0 ttpp -66.28 119.28 11.25 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.546 0.338 . . . . 72.04 110.646 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.93 0.62 88.86 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 115.793 -0.64 . . . . 73.14 114.494 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.06 151.08 35.66 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.997 0.519 . . . . 73.12 111.214 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -95.43 113.02 24.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.525 0.33 . . . . 75.41 110.775 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.663 ' HB3' HD13 ' A' ' 9' ' ' ILE . . . -96.1 168.5 10.57 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.713 0.768 . . . . 64.05 113.058 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.4 m -126.26 123.61 38.5 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.096 -1.446 . . . . 73.12 107.096 166.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.08 110.29 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.871 0.468 . . . . 70.21 110.203 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.6 p -95.4 -14.02 24.17 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.116 0.567 . . . . 71.34 111.799 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.443 ' HA3' ' HE2' ' A' ' 98' ' ' MET . . . -162.95 154.41 25.35 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 113.44 0.136 . . . . 52.52 113.44 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.39 110.45 11.05 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.942 0.897 . . . . 71.15 110.725 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -115.1 123.19 48.34 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.847 0.859 . . . . 75.1 110.683 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.9 86.25 2.35 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 122.408 1.099 . . . . 71.52 109.757 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -134.57 173.02 12.12 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.122 -0.945 . . . . 72.31 111.045 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.1 m -78.6 123.74 27.42 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.683 -0.488 . . . . 72.15 109.683 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.08 144.87 31.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.91 0.884 . . . . 62.51 109.818 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -128.79 149.54 50.68 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.891 0.853 . . . . 74.23 111.888 -170.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.3 t -105.75 127.11 60.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 114.144 -1.389 . . . . 74.51 108.069 172.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 86' ' ' ALA . 15.8 m -127.78 161.39 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 112.781 0.659 . . . . 75.1 112.781 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.0 t -128.99 125.25 36.99 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.13 0.972 . . . . 74.45 109.408 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -153.79 158.42 40.87 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.463 0.705 . . . . 74.21 110.87 -172.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.4 m -109.65 112.31 58.66 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 108.566 -0.902 . . . . 74.31 108.566 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.32 128.69 28.48 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.183 2.589 . . . . 73.0 113.593 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.9 p -62.6 -18.39 62.08 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.968 1.307 . . . . 74.43 113.408 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -64.82 -10.05 25.25 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 123.938 0.895 . . . . 65.03 112.526 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.71 53.51 2.71 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-O 121.117 0.287 . . . . 52.53 112.467 -175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.68 171.16 14.31 Favored Glycine 0 N--CA 1.471 1.005 0 CA-C-N 115.352 -0.424 . . . . 74.21 113.408 -175.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -62.91 134.94 56.98 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.556 0.742 . . . . 74.45 111.512 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -58.99 123.92 18.19 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.379 0.672 . . . . 72.41 112.223 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.5 t -87.2 108.76 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.515 0.726 . . . . 63.43 109.723 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -101.78 139.21 37.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.681 0.793 . . . . 70.41 110.526 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.5 m170 57.82 37.41 27.03 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.089 0.956 . . . . 74.23 112.746 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -60.77 129.69 42.76 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.168 0.987 . . . . 75.35 111.408 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 61.1 mttp -130.2 137.24 49.97 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.936 0.895 . . . . 74.24 110.862 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 79.8 m95 -118.03 145.78 44.53 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 125.468 1.507 . . . . 75.42 111.242 -11.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -114.09 132.4 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 107.99 -1.115 . . . . 70.31 107.99 169.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.0 pt -102.02 167.27 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 121.598 -0.689 . . . . 74.44 109.909 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -47.6 -33.61 6.82 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.68 1.192 . . . . 72.01 113.393 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.51 -13.09 60.64 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.707 1.003 . . . . 65.02 113.707 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.516 ' HG3' ' HB1' ' A' ' 75' ' ' ALA . 0.5 OUTLIER -89.51 -12.91 38.66 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.623 0.601 . . . . 65.3 112.623 -179.283 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 mp -98.57 132.79 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 122.961 0.504 . . . . 73.33 111.293 -169.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -60.83 -44.16 97.3 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.81 1.244 . . . . 74.31 112.854 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -78.97 -16.32 57.1 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 118.189 -0.91 . . . . 73.45 112.813 -175.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -30.42 -62.19 0.16 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.813 1.412 . . . . 74.43 114.813 -160.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.19 23.2 65.98 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 114.602 0.601 . . . . 75.1 114.602 169.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 t70 72.54 -2.63 2.58 Favored 'General case' 0 CA--C 1.577 1.984 0 C-N-CA 125.304 1.442 . . . . 71.3 112.401 -176.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.437 ' HE3' HD21 ' A' ' 65' ' ' LEU . 53.0 pttt -79.65 153.71 29.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.376 -0.828 . . . . 75.23 110.954 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.4 m -84.48 118.73 24.48 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.142 -0.688 . . . . 75.33 109.142 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.53 ' HB3' HG13 ' A' ' 88' ' ' ILE . 41.6 mt -73.09 124.37 25.41 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.755 0.822 . . . . 73.45 110.598 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -109.02 155.94 40.01 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 123.584 0.754 . . . . 74.34 111.358 -171.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 84.5 Cg_exo -45.89 111.53 0.35 Allowed 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.123 2.549 . . . . 72.34 114.172 174.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.64 -16.39 14.11 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 114.611 0.604 . . . . 44.4 114.611 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.48 130.97 45.19 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 117.932 0.866 . . . . 75.32 112.33 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.414 HE22 ' HB2' ' A' ' 87' ' ' GLU . 31.9 mm-40 -87.8 122.06 30.99 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.827 -0.805 . . . . 75.41 108.827 171.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.14 146.74 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.596 0.758 . . . . 70.41 110.763 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -101.23 135.75 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 109.449 -0.574 . . . . 74.31 109.449 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.3 mt -91.19 109.15 20.4 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.98 0.512 . . . . 73.41 111.152 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.11 -40.04 65.28 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.63 0.772 . . . . 74.53 111.243 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.516 ' HB1' ' HG3' ' A' ' 56' ' ' GLU . . . -89.39 173.78 8.18 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.95 0.5 . . . . 72.22 111.044 174.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.638 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 29.4 t -149.17 125.44 10.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.866 -0.606 . . . . 53.44 109.804 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -86.73 -18.4 31.26 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.456 0.702 . . . . 70.53 110.976 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -155.14 147.61 24.06 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.31 1.044 . . . . 74.03 109.811 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.636 ' HZ3' ' HB3' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -51.1 124.11 10.81 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.105 0.962 . . . . 65.31 113.593 -174.178 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.2 -15.6 56.25 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 115.891 -0.595 . . . . 74.44 114.201 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.2 ttt -68.91 -39.02 79.91 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.539 0.736 . . . . 73.42 112.518 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.638 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 87.7 tttt -66.39 134.94 53.56 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.689 0.396 . . . . 65.03 111.66 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.79 -7.08 79.65 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.134 -0.485 . . . . 34.13 112.901 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.42 143.15 37.02 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.103 0.561 . . . . 70.12 111.58 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.1 m -87.01 116.74 25.27 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.705 -0.85 . . . . 75.22 108.705 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.457 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . . . -112.34 156.99 21.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.819 0.848 . . . . 53.42 110.136 -173.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.414 ' HB2' HE22 ' A' ' 70' ' ' GLN . 35.4 tt0 -120.07 125.97 49.61 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.293 -0.632 . . . . 73.4 109.293 174.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.53 HG13 ' HB3' ' A' ' 65' ' ' LEU . 34.6 mm -63.08 105.29 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 N-CA-C 109.691 -0.485 . . . . 73.0 109.691 175.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -75.94 -37.86 58.22 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.987 0.915 . . . . 73.35 109.889 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.4 t -157.42 152.0 25.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.674 0.79 . . . . 50.32 111.111 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.08 132.17 54.35 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.885 0.874 . . . . 74.32 109.949 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -142.16 140.68 32.48 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.099 0.476 . . . . 75.11 112.171 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -96.66 95.6 8.05 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.126 -0.488 . . . . 74.24 109.703 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.2 t -136.88 149.91 47.94 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.455 0.702 . . . . 74.12 110.764 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.0 m -82.49 124.88 30.5 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.459 -0.571 . . . . 64.2 109.459 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.637 HG12 HG23 ' A' ' 117' ' ' THR . 16.5 m -112.03 132.97 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.455 0.702 . . . . 73.23 109.464 -173.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.428 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 96.4 m-85 -109.63 139.0 45.18 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.937 0.875 . . . . 75.35 112.048 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.443 ' HE2' ' HA3' ' A' ' 26' ' ' GLY . 60.9 ttp -91.27 120.3 32.05 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 107.493 -1.299 . . . . 74.03 107.493 170.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.423 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 27.6 m -130.65 163.31 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 113.826 1.047 . . . . 71.35 113.826 -171.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -125.69 118.32 25.36 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.292 1.037 . . . . 64.23 110.61 174.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -131.87 178.47 6.75 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.067 0.947 . . . . 75.34 110.76 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.1 m -114.73 114.31 25.44 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.081 -0.711 . . . . 72.1 109.081 170.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.3 t -55.54 103.48 0.1 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.97 0.908 . . . . 64.42 110.684 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.2 p -65.53 -17.93 64.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.511 1.125 . . . . 74.31 113.578 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 65.1 p -92.9 -24.21 18.51 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.357 0.503 . . . . 74.13 112.357 177.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.3 m -112.26 -22.57 10.85 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.133 0.79 . . . . 73.21 113.133 -170.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.15 -12.5 49.85 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 113.717 0.247 . . . . 72.51 113.717 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -72.82 129.29 37.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.202 1.001 . . . . 71.5 112.202 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -84.45 111.63 19.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.05 0.54 . . . . 74.3 110.177 170.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.0 t -101.06 117.99 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.898 0.879 . . . . 74.31 110.145 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.436 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -113.67 148.89 35.53 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.293 0.637 . . . . 74.32 111.677 -175.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.406 ' HA ' ' HG2' ' A' ' 98' ' ' MET . 81.5 m-20 55.74 36.74 27.82 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 124.143 0.977 . . . . 75.21 112.416 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -62.11 134.91 57.2 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.198 0.999 . . . . 74.24 111.911 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 98.3 mttt -140.02 136.03 33.28 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.887 0.875 . . . . 72.01 111.381 -175.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 91.9 m95 -114.46 142.96 45.7 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.114 1.366 . . . . 71.4 112.961 -12.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.5 146.48 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 114.016 -1.447 . . . . 75.21 108.19 166.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.637 HG23 HG12 ' A' ' 96' ' ' VAL . 18.8 p -103.55 173.46 6.29 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.948 -0.47 . . . . 63.53 111.289 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.428 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 13.4 tp10 -58.23 -29.93 66.13 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.791 0.836 . . . . 74.11 111.258 170.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.53 -35.11 79.43 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.831 0.853 . . . . 75.33 111.72 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.409 ' HG2' HG23 ' A' ' 11' ' ' THR . 1.3 mt-10 -92.56 -3.18 55.47 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.133 0.573 . . . . 74.43 112.463 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.4 mt -118.78 143.77 46.71 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.662 0.785 . . . . 72.43 110.283 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 57.5 m -122.29 149.52 43.61 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.427 -0.953 . . . . 74.22 108.427 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.03 170.86 7.64 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.49 0.316 . . . . 50.21 111.268 173.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 tptt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.713 0.768 . . . . 74.43 110.474 174.458 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.489 ' HE3' ' HG3' ' A' ' 118' ' ' GLU . 58.3 mtt . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.446 0.165 . . . . 64.41 111.167 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -90.79 137.9 32.0 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.404 0.682 . . . . 74.01 112.756 -171.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.28 136.49 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 C-N-CA 123.597 0.759 . . . . 74.42 110.975 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.67 -12.6 68.95 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 116.007 -0.542 . . . . 61.54 113.129 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.9 t -87.1 159.12 19.03 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.426 0.69 . . . . 74.1 110.802 175.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -101.25 147.51 26.2 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.919 0.487 . . . . 62.25 109.756 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 123' ' ' ALA . 16.6 m -130.89 151.25 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.733 0.813 . . . . 71.1 110.399 176.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.2 mm -98.76 124.99 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.792 0.837 . . . . 74.5 109.743 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.418 HD11 ' HB1' ' A' ' 22' ' ' ALA . 30.1 mt -78.31 107.41 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 109.14 -0.689 . . . . 75.21 109.14 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -87.22 -34.28 19.03 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.061 0.458 . . . . 73.14 111.946 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.9 m -133.33 141.31 47.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.678 1.191 . . . . 51.15 108.223 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.473 ' HB2' ' HE3' ' A' ' 17' ' ' MET . 77.8 p -162.64 173.16 14.27 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.602 0.715 . . . . 75.02 111.555 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -86.29 -6.95 58.85 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 114.964 -1.016 . . . . 70.5 111.353 -175.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.595 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 51.5 mtt -133.2 144.66 49.96 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.371 1.068 . . . . 75.45 110.367 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -60.27 -38.2 82.82 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.232 0.613 . . . . 75.54 111.343 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.68 -24.07 63.81 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 114.766 0.666 . . . . 65.32 114.766 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.595 ' HG3' ' HB2' ' A' ' 14' ' ' MET . 27.0 mtm -94.14 -26.74 16.57 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.637 0.375 . . . . 72.2 110.968 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -67.71 121.04 15.08 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.025 0.53 . . . . 73.25 111.431 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.44 0.96 88.13 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 115.671 -0.695 . . . . 74.25 114.117 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.79 158.87 19.88 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.195 0.598 . . . . 72.53 112.491 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -89.69 123.51 33.78 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.751 -0.659 . . . . 74.11 109.641 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.418 ' HB1' HD11 ' A' ' 9' ' ' ILE . . . -114.83 168.7 9.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.244 1.018 . . . . 65.24 110.905 171.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 m -133.9 128.35 34.39 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.663 0.785 . . . . 74.22 109.24 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.24 105.21 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 109.692 -0.484 . . . . 73.52 109.692 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.2 p -103.87 -4.73 23.12 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.957 0.503 . . . . 64.41 111.085 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.81 133.06 3.27 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 111.21 -0.756 . . . . 62.41 111.21 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.01 107.02 12.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.62 0.768 . . . . 63.41 109.532 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -110.12 133.2 53.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.847 0.859 . . . . 74.31 109.745 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -122.24 86.38 2.57 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.993 0.901 . . . . 61.43 110.142 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -135.43 -178.54 5.16 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.751 0.82 . . . . 63.32 111.206 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.2 m -75.27 119.54 19.53 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.748 0.419 . . . . 72.34 110.136 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.03 150.19 25.17 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.582 0.753 . . . . 74.5 109.613 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.42 ' HB2' HG22 ' A' ' 52' ' ' VAL . 90.0 m-85 -128.61 142.91 50.89 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.784 0.802 . . . . 65.34 111.75 -173.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.18 109.65 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 114.146 -1.388 . . . . 75.14 107.29 171.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.9 148.31 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 113.816 1.043 . . . . 75.14 113.816 -170.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.4 t -116.7 125.03 51.12 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.112 0.965 . . . . 73.52 110.542 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -150.9 156.3 40.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 122.143 -0.348 . . . . 73.25 111.649 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 m -105.36 119.48 52.73 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.139 0.576 . . . . 74.02 109.826 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.34 124.4 15.97 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.801 2.334 . . . . 74.13 112.391 169.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.4 p -63.48 -10.32 17.02 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.013 1.486 . . . . 74.3 115.013 -167.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -90.95 10.1 27.88 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 122.845 0.458 . . . . 71.0 112.074 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.59 47.19 5.76 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.923 -0.471 . . . . 75.25 111.923 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.51 160.65 18.98 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 123.039 0.352 . . . . 61.02 112.514 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -62.89 130.1 43.31 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.017 0.527 . . . . 74.32 110.709 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -64.48 123.87 20.35 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.026 0.441 . . . . 74.24 111.453 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.64 HG22 ' HE3' ' A' ' 78' ' ' MET . 84.6 t -86.87 113.25 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.542 -0.754 . . . . 71.03 109.51 176.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -97.95 143.44 28.52 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.984 0.914 . . . . 70.33 110.115 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.6 m80 55.92 35.3 25.23 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.642 0.777 . . . . 74.5 112.801 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.424 ' HD2' HG13 ' A' ' 52' ' ' VAL . 66.7 t60 -57.86 118.3 5.19 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.826 0.85 . . . . 74.24 111.597 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 97.9 mttt -118.32 131.37 56.33 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.837 0.855 . . . . 71.41 110.414 176.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.632 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 94.4 m95 -118.84 154.83 32.25 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.642 -1.286 . . . . 73.23 111.499 -10.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' A' ' 49' ' ' HIS . 18.4 m -122.38 148.3 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 114.443 -1.253 . . . . 73.44 107.979 166.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.9 pt -103.01 170.4 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.606 0.717 . . . . 73.21 112.186 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -54.4 -34.35 61.11 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.206 1.002 . . . . 64.43 113.243 172.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.46 -1.04 49.03 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.493 0.717 . . . . 65.03 112.373 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -80.12 -17.96 51.14 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.202 1.001 . . . . 63.34 111.156 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.416 HD13 HG22 ' A' ' 71' ' ' VAL . 82.2 mt -122.2 140.29 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.725 1.21 . . . . 74.2 111.076 -165.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -75.42 -49.86 17.63 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.265 0.626 . . . . 72.41 112.027 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -68.14 -5.2 16.66 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.606 0.965 . . . . 75.01 113.606 -174.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.48 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -61.01 -58.6 7.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 122.854 0.462 . . . . 64.25 111.626 169.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.85 32.76 83.8 Favored Glycine 0 N--CA 1.48 1.577 0 O-C-N 121.967 -0.458 . . . . 74.33 112.441 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.4 p30 44.6 28.28 0.31 Allowed 'General case' 0 CA--C 1.57 1.733 0 C-N-CA 126.236 1.814 . . . . 75.32 114.268 -166.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 42.4 pttt -100.22 166.23 11.09 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.537 -0.542 . . . . 52.24 109.537 174.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 m -80.97 108.98 15.12 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.621 0.368 . . . . 74.52 110.537 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.557 HD13 HG12 ' A' ' 71' ' ' VAL . 50.9 mt -78.85 129.16 34.27 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.45 0.7 . . . . 73.13 110.63 175.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -98.32 145.27 29.55 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.601 0.76 . . . . 75.43 111.29 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.45 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 97.9 Cg_exo -47.07 130.12 15.99 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.536 2.824 . . . . 71.21 114.327 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.16 -12.68 48.69 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 123.17 0.414 . . . . 61.52 113.221 -174.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.1 143.77 41.08 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.604 0.762 . . . . 60.4 112.561 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -107.03 130.33 54.67 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.956 0.902 . . . . 73.34 110.428 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.557 HG12 HD13 ' A' ' 65' ' ' LEU . 28.0 m -133.36 175.77 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 124.159 0.984 . . . . 73.23 111.493 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -117.61 136.02 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.571 0.748 . . . . 73.1 109.864 171.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.5 mt -88.72 120.7 30.36 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.818 0.847 . . . . 74.24 110.791 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.04 1.32 56.23 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.09 0.556 . . . . 75.22 112.457 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.91 157.83 18.85 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.448 0.699 . . . . 64.33 112.108 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.9 p -118.03 128.95 55.26 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.924 -0.769 . . . . 61.35 108.924 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -141.5 -42.85 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.524 -1.288 . . . . 74.43 107.524 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.64 ' HE3' HG22 ' A' ' 46' ' ' VAL . 24.8 ptt? -157.21 -176.17 5.82 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 114.058 -1.428 . . . . 73.31 110.596 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -60.74 124.15 19.59 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.595 0.758 . . . . 74.32 112.493 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.9 14.36 82.42 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 114.718 0.647 . . . . 75.33 114.718 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.5 tpt -69.71 -59.51 2.9 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.36 0.58 . . . . 72.45 111.174 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -67.55 129.29 39.45 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 115.998 -0.547 . . . . 75.03 111.453 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.86 -9.48 61.89 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 116.473 -0.33 . . . . 71.54 113.553 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.67 148.62 31.53 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.261 0.624 . . . . 74.33 111.852 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.3 m -89.7 122.32 32.7 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.196 0.598 . . . . 72.35 109.629 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.84 141.71 36.79 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.461 0.704 . . . . 41.34 111.359 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -98.79 115.62 29.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.318 1.447 . . . . 73.45 108.78 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.7 mm -69.09 96.23 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 109.03 -0.73 . . . . 75.41 109.03 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -71.65 -36.87 70.84 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.778 0.431 . . . . 73.43 110.154 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.45 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . 26.5 t -166.65 162.69 16.58 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.5 -0.773 . . . . 74.0 111.37 -177.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.14 135.76 49.29 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.253 1.021 . . . . 74.21 110.355 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -138.51 135.2 34.86 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.378 0.671 . . . . 73.43 111.399 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -90.0 94.87 9.97 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.463 -0.94 . . . . 75.22 108.463 171.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -136.08 154.99 50.85 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.427 0.691 . . . . 61.55 110.803 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 m -87.78 116.59 26.03 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.151 -0.685 . . . . 72.51 109.151 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.2 m -111.47 134.99 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.189 0.996 . . . . 71.23 109.529 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.92 148.61 36.52 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.989 0.9 . . . . 70.44 112.871 -169.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.7 ttp -103.11 111.35 23.68 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.966 -1.47 . . . . 74.5 107.312 167.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.8 m -123.84 147.62 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 112.891 0.7 . . . . 74.24 112.891 -170.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -105.24 117.65 34.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.926 0.89 . . . . 73.11 108.835 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -130.56 169.13 15.99 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.617 0.723 . . . . 74.14 111.692 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.2 m -116.82 133.3 56.18 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 108.931 -0.766 . . . . 73.32 108.931 167.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.2 t -72.82 129.31 37.89 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.78 0.432 . . . . 72.43 111.671 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.6 p -66.04 -41.54 90.75 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.066 0.946 . . . . 75.42 112.094 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.0 p -85.63 -50.05 7.52 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.31 0.644 . . . . 74.32 112.282 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.0 m -88.81 -24.02 22.69 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.0 0.741 . . . . 75.53 113.0 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 4.34 79.26 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 114.334 0.494 . . . . 72.2 114.334 -177.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -68.36 131.59 45.58 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.359 0.874 . . . . 64.32 113.359 -176.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -84.72 86.21 7.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.793 0.837 . . . . 65.04 109.405 174.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.91 125.61 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 115.866 -0.607 . . . . 74.55 109.726 -172.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.93 153.61 33.31 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.093 0.473 . . . . 73.41 111.471 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.432 HD21 ' N ' ' A' ' 112' ' ' ASN . 0.8 OUTLIER 60.5 28.45 18.12 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 114.522 -1.217 . . . . 73.11 112.563 177.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -66.78 130.1 42.05 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.525 0.73 . . . . 75.34 110.807 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -162.3 154.79 19.46 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 115.672 -0.695 . . . . 72.2 111.465 -169.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.632 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 96.6 m95 -103.23 133.04 48.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.473 -1.392 . . . . 74.3 111.862 0.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -126.88 139.72 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.604 1.162 . . . . 73.31 109.051 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.3 p -94.72 173.48 7.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.826 -0.546 . . . . 74.44 112.055 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.489 ' HG3' ' HE3' ' A' ' 1' ' ' MET . 33.5 tt0 -64.43 -19.99 65.88 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.367 0.667 . . . . 72.15 111.24 172.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.65 -33.98 71.56 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.953 0.901 . . . . 73.4 110.807 173.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.95 -2.64 58.47 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.166 0.586 . . . . 64.44 111.742 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.16 160.86 28.16 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.032 0.92 . . . . 74.21 111.018 -173.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.3 m -140.63 146.98 38.64 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 107.206 -1.405 . . . . 75.02 107.206 168.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.499 ' HA ' HG13 ' A' ' 7' ' ' VAL . . . -58.76 162.14 4.25 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 119.177 0.899 . . . . 72.33 111.567 176.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 tptm . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.454 0.645 . . . . 75.22 111.33 -176.749 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.461 ' SD ' HG11 ' A' ' 7' ' ' VAL . 64.2 mtt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 110.274 -0.269 . . . . 71.12 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.17 161.86 14.09 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.398 0.679 . . . . 75.11 111.128 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.4 t -65.96 125.36 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 121.116 0.484 . . . . 73.24 111.315 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.02 -1.68 35.49 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.532 0.587 . . . . 55.12 112.993 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.3 m -73.58 129.77 38.65 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.319 0.647 . . . . 62.55 111.897 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -99.24 117.27 33.33 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.367 0.667 . . . . 73.35 109.639 174.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.461 HG11 ' SD ' ' A' ' 1' ' ' MET . 30.5 m -134.38 153.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 124.114 0.966 . . . . 71.41 110.917 -168.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.56 126.29 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 123.301 0.64 . . . . 73.42 110.059 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.591 HD12 ' HB2' ' A' ' 22' ' ' ALA . 25.7 mt -83.88 131.56 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 122.013 -0.429 . . . . 70.35 110.849 -171.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -96.08 -51.24 4.51 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 118.116 0.416 . . . . 73.02 111.724 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m -93.21 140.69 29.25 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.049 0.54 . . . . 75.22 109.56 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 14' ' ' MET . 93.0 p -128.44 125.45 38.54 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.758 0.651 . . . . 64.31 112.758 -171.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -84.05 -41.35 17.29 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.755 0.822 . . . . 72.24 108.841 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.416 ' O ' ' HB2' ' A' ' 12' ' ' SER . 25.1 mmt -101.56 153.22 19.92 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.34 1.056 . . . . 72.03 109.478 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -63.71 -35.52 80.84 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.209 0.818 . . . . 73.25 113.209 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.62 -1.26 89.2 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 114.347 0.499 . . . . 63.42 114.347 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.488 ' HG2' HG23 ' A' ' 9' ' ' ILE . 52.7 ttm -75.2 -30.12 60.53 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 122.979 0.512 . . . . 63.41 110.05 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HB3' ' HZ1' ' A' ' 18' ' ' LYS . 7.2 ttpm? -63.21 119.25 9.22 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.896 0.878 . . . . 74.45 111.79 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.42 2.25 78.96 Favored Glycine 0 CA--C 1.539 1.548 0 N-CA-C 114.667 0.627 . . . . 62.43 114.667 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.76 149.12 38.06 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.22 0.608 . . . . 75.12 111.93 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -85.14 102.32 13.18 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.652 -0.499 . . . . 70.21 109.652 174.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.591 ' HB2' HD12 ' A' ' 9' ' ' ILE . . . -85.24 147.07 26.76 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.559 0.744 . . . . 74.22 111.552 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.0 m -119.3 116.5 26.36 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.1 -1.074 . . . . 72.43 108.1 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.37 100.49 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 N-CA-C 109.607 -0.516 . . . . 72.3 109.607 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.1 p -91.72 -9.18 44.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.158 0.583 . . . . 74.25 110.927 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.05 137.32 4.73 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.833 -0.507 . . . . 70.14 111.833 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.87 106.93 13.5 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.888 0.875 . . . . 74.34 109.297 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -112.48 128.18 56.26 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.808 0.843 . . . . 73.41 110.298 -172.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -114.36 93.13 4.21 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.382 -0.599 . . . . 72.35 109.382 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.522 HG22 HD13 ' A' ' 53' ' ' ILE . 8.2 t -137.09 -179.53 5.77 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.853 0.861 . . . . 64.11 111.356 -176.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.8 m -75.8 116.94 17.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.976 0.511 . . . . 75.43 110.305 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.05 151.0 22.32 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.411 0.684 . . . . 63.13 110.191 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.41 ' HE2' ' HA ' ' A' ' 54' ' ' GLN . 82.1 m-85 -130.6 146.11 52.04 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.485 0.659 . . . . 73.32 111.373 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.82 118.8 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.665 -1.235 . . . . 74.0 107.665 168.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 27.0 m -123.79 144.71 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.331 0.493 . . . . 75.21 112.331 -175.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.7 m -114.5 132.65 56.22 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.73 0.812 . . . . 74.43 110.303 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 46.1 p90 -160.5 160.52 32.07 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.08 0.552 . . . . 64.44 111.276 -174.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.9 m -113.99 114.96 46.08 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 108.501 -0.926 . . . . 73.0 108.501 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.31 127.18 24.92 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.972 2.448 . . . . 75.22 113.025 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.6 p -64.44 -17.34 63.72 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.462 1.105 . . . . 55.43 113.833 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -82.93 11.11 6.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.251 0.62 . . . . 74.53 112.335 176.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.66 51.24 5.62 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 122.735 0.207 . . . . 71.21 113.306 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.97 -171.61 26.33 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 122.559 0.123 . . . . 71.33 113.072 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.74 124.78 28.19 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.12 -1.067 . . . . 62.43 108.12 174.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -50.35 114.01 1.02 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.798 0.839 . . . . 73.42 112.469 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.581 HG23 ' HE1' ' A' ' 78' ' ' MET . 32.9 t -75.17 96.86 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.468 -0.787 . . . . 74.52 109.825 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -85.46 117.96 24.69 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.498 -0.774 . . . . 70.35 109.915 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.8 m170 58.22 59.88 2.87 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.129 0.972 . . . . 74.42 112.136 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -59.8 121.47 11.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.011 0.925 . . . . 73.04 111.562 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 98.5 mttt -126.66 136.17 52.14 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.854 0.861 . . . . 72.04 110.234 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 89.1 m95 -115.46 146.56 41.53 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.906 1.282 . . . . 73.43 111.698 -10.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.02 151.83 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 113.813 -1.539 . . . . 72.43 108.205 166.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.581 HG23 HG21 ' A' ' 96' ' ' VAL . 33.0 pt -118.93 -177.07 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 120.96 0.409 . . . . 74.23 110.948 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.434 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 30.5 tt0 -49.73 -33.13 15.2 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.734 1.214 . . . . 75.41 113.822 175.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.423 ' H ' HG13 ' A' ' 53' ' ' ILE . 7.5 tp10 -62.59 -26.43 68.59 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 113.117 0.784 . . . . 75.05 113.117 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.44 -13.62 54.38 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 112.654 0.613 . . . . 74.51 112.654 -173.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.41 137.37 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.285 0.634 . . . . 74.45 110.958 -171.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.513 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 27.1 ttpt -78.28 -37.08 45.76 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.455 1.102 . . . . 73.3 112.434 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.07 -14.7 59.78 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.093 0.957 . . . . 74.33 112.821 -173.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -49.86 -63.35 1.14 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.881 1.067 . . . . 74.12 113.881 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.67 33.85 88.35 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 115.234 0.853 . . . . 70.13 115.234 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 67.07 16.81 10.37 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.607 1.163 . . . . 70.14 113.24 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 12.0 ptpt -106.47 176.43 5.17 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.256 0.551 . . . . 74.33 111.073 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.3 m -96.48 113.82 25.43 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.031 0.933 . . . . 75.2 109.156 168.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.0 mt -77.03 136.93 38.7 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.25 0.62 . . . . 72.34 110.168 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -95.55 152.59 39.31 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 123.522 0.729 . . . . 71.44 111.489 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 82.7 Cg_exo -50.86 119.88 5.87 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.124 2.549 . . . . 73.24 113.395 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.85 -13.98 26.84 Favored Glycine 0 N--CA 1.48 1.609 0 CA-C-O 119.959 -0.356 . . . . 60.42 113.815 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.55 120.63 14.89 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.736 0.768 . . . . 73.44 112.123 176.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -89.1 120.68 30.71 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.6 -0.727 . . . . 74.51 109.839 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.88 166.43 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.695 1.198 . . . . 73.3 110.906 -172.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.9 mm -112.11 135.81 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.612 0.765 . . . . 73.0 110.116 171.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.7 mt -83.29 122.82 28.95 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.064 0.545 . . . . 71.34 111.291 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 45.5 mm-40 -93.29 13.19 22.09 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 123.173 0.589 . . . . 73.23 112.043 173.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.14 156.44 32.32 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.358 0.663 . . . . 73.15 110.138 169.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.4 t -139.83 126.65 20.69 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.929 -0.578 . . . . 75.41 110.149 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -110.37 2.01 18.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.852 0.861 . . . . 71.44 109.859 171.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.581 ' HE1' HG23 ' A' ' 46' ' ' VAL . 24.4 ptt? -173.44 161.03 4.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.737 1.215 . . . . 64.22 110.336 -174.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -68.22 124.28 23.04 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 120.728 0.299 . . . . 61.3 110.65 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.92 41.42 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.575 -0.569 . . . . 72.13 113.897 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.6 ttt -98.69 -58.42 1.96 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 117.469 0.635 . . . . 73.45 110.172 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -66.96 131.2 45.38 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.333 0.253 . . . . 74.14 110.522 171.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.69 -15.91 59.34 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 116.587 -0.279 . . . . 75.43 113.218 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.38 151.82 30.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.289 0.636 . . . . 60.12 111.687 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.1 m -87.55 118.82 27.27 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.478 -0.783 . . . . 75.03 110.165 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . . . -116.98 149.5 40.12 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.195 0.998 . . . . 74.32 110.112 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -115.03 129.23 56.66 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.968 -0.382 . . . . 73.42 109.968 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 67' ' ' PRO . 32.0 mm -66.21 108.7 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 N-CA-C 109.415 -0.587 . . . . 72.0 109.415 174.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -75.16 -38.91 60.76 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.184 0.516 . . . . 65.31 109.951 170.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.8 t -161.73 152.7 18.07 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.22 -0.9 . . . . 71.43 111.388 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -128.55 132.74 48.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.946 0.899 . . . . 75.14 110.076 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -134.57 143.83 47.6 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.413 0.685 . . . . 63.52 111.415 -171.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -98.27 94.16 6.62 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.69 -0.856 . . . . 75.53 108.69 170.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -136.56 155.9 49.32 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.522 0.729 . . . . 74.21 110.992 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.2 m -84.11 119.54 25.1 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.15 -0.685 . . . . 71.04 109.15 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 53' ' ' ILE . 15.8 m -107.24 135.33 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.853 0.861 . . . . 74.0 109.049 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.453 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 86.3 m-85 -109.82 135.88 50.01 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.451 0.643 . . . . 72.52 111.475 -174.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.461 ' SD ' ' NZ ' ' A' ' 114' ' ' LYS . 56.3 ttp -90.18 111.74 23.01 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.319 -1.363 . . . . 74.14 107.319 167.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 22' ' ' ALA . 27.3 m -124.08 144.91 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 113.435 0.902 . . . . 75.54 113.435 -170.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -109.61 118.22 36.01 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.942 1.297 . . . . 63.01 108.315 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.461 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 55.0 p90 -139.6 166.66 24.0 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.265 0.839 . . . . 74.23 113.265 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.2 m -100.39 109.34 21.5 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.963 -1.017 . . . . 72.01 109.333 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.2 m -57.54 106.06 0.3 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.3 0.64 . . . . 65.33 111.181 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.7 p -61.4 -23.05 65.53 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.0 0.92 . . . . 75.04 113.295 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.8 t -65.88 -25.99 67.43 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.428 0.899 . . . . 73.23 113.428 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.2 t -142.63 -42.55 0.32 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.636 0.606 . . . . 74.04 112.636 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.01 -8.89 18.6 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 123.259 0.457 . . . . 72.32 113.141 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.21 139.54 54.53 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.86 0.864 . . . . 74.02 111.955 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -85.0 114.74 22.39 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.4 0.68 . . . . 74.5 111.151 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.1 t -88.84 104.9 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 108.075 -1.083 . . . . 73.12 108.075 171.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -93.84 131.8 38.89 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.396 -0.82 . . . . 74.22 110.721 -168.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.5 p30 45.48 52.9 8.8 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 125.29 1.436 . . . . 74.42 114.286 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -57.83 139.7 53.48 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.542 1.137 . . . . 75.45 112.876 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.461 ' NZ ' ' SD ' ' A' ' 98' ' ' MET . 68.1 mttm -131.67 128.39 38.92 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 124.249 1.02 . . . . 71.12 111.063 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 94.3 m95 -120.81 160.97 22.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.918 1.687 . . . . 73.42 111.203 -13.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.73 166.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 124.31 1.044 . . . . 74.43 109.806 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 53.2 p -117.18 167.4 11.23 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.098 0.559 . . . . 62.22 111.214 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.453 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 36.0 tt0 -67.24 -24.57 65.83 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.782 0.433 . . . . 73.52 111.601 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.2 -30.91 71.94 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.442 0.697 . . . . 70.22 111.441 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -93.65 -3.11 53.06 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.15 0.98 . . . . 71.43 111.942 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.6 mt -117.1 123.46 46.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.808 0.843 . . . . 64.12 109.639 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.424 ' O ' ' HB ' ' A' ' 7' ' ' VAL . 58.0 m -104.0 150.63 24.07 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.682 -0.858 . . . . 74.2 108.682 172.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.17 169.8 9.7 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.205 0.457 . . . . 74.04 111.38 174.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.5 tptp . . . . . 0 CA--C 1.564 1.487 0 C-N-CA 123.011 0.525 . . . . 72.14 111.285 177.802 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 110.934 -0.025 . . . . 61.44 110.934 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.463 ' HD2' ' H ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -110.36 149.19 30.59 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.35 0.66 . . . . 72.12 110.669 178.009 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.37 130.04 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 123.333 0.653 . . . . 73.43 111.414 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.73 -8.75 56.56 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 115.42 -0.809 . . . . 72.52 113.081 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.1 t -85.4 151.51 23.95 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.577 0.584 . . . . 74.11 112.577 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -100.59 117.46 34.77 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.153 0.981 . . . . 74.11 110.266 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.48 154.88 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.947 0.899 . . . . 71.14 111.293 -176.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.8 mm -100.61 133.51 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.23 1.012 . . . . 74.43 110.511 172.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 17' ' ' MET . 33.0 mt -84.63 123.91 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 122.162 -0.336 . . . . 74.4 110.325 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -100.66 -46.55 5.14 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.274 0.63 . . . . 73.13 112.46 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.45 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 79.0 m -109.14 140.83 42.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.717 0.807 . . . . 62.54 109.293 -176.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.7 m -160.46 163.46 32.97 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.631 0.604 . . . . 64.44 112.631 -169.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.656 ' HE2' ' HG3' ' A' ' 50' ' ' LYS . 11.2 m-70 -95.79 -40.34 9.4 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.414 -0.812 . . . . 75.02 109.053 164.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.6 mpt? -84.02 142.06 30.73 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.998 0.919 . . . . 72.25 111.028 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 12.2 mptt -72.18 -26.71 62.18 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.299 0.64 . . . . 74.12 112.016 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.62 -4.77 81.89 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 114.999 0.76 . . . . 33.45 114.999 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.427 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 63.4 mtt -87.87 -26.29 22.85 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 117.558 0.679 . . . . 72.25 112.364 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 25.6 pttm -61.75 118.84 7.67 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.154 0.502 . . . . 72.42 111.522 -175.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.1 1.94 70.5 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 113.939 0.336 . . . . 64.4 113.939 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.12 138.38 47.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.292 0.637 . . . . 73.33 112.279 -177.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -78.87 97.61 6.04 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.521 0.728 . . . . 75.21 110.11 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.56 157.31 16.04 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.23 1.012 . . . . 72.25 111.601 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.3 m -126.73 124.27 39.37 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.992 -0.744 . . . . 65.13 108.992 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.417 ' HA ' HG12 ' A' ' 99' ' ' VAL . 46.6 t -72.75 102.17 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.241 0.616 . . . . 72.11 110.001 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.9 p -99.92 -2.76 33.91 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.334 0.654 . . . . 75.32 112.718 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.07 151.81 20.95 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 112.283 -0.327 . . . . 72.3 112.283 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.93 108.82 7.59 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.756 0.822 . . . . 74.41 110.558 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.408 ' HB2' HG22 ' A' ' 96' ' ' VAL . 4.6 m-85 -108.87 122.63 47.59 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.959 0.904 . . . . 71.31 110.597 -174.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -100.01 83.24 2.67 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 122.058 0.932 . . . . 64.02 109.74 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.3 t -133.95 170.4 15.68 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 115.506 -0.77 . . . . 70.11 111.443 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.2 m -87.51 122.66 31.51 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.97 0.508 . . . . 70.0 109.96 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.1 154.77 27.18 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.16 0.984 . . . . 44.12 109.989 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.422 ' HB2' HG22 ' A' ' 52' ' ' VAL . 91.5 m-85 -130.28 149.4 51.99 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.916 0.865 . . . . 75.13 113.099 -169.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -102.25 111.17 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 113.941 -1.482 . . . . 74.11 108.055 171.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.487 HG13 HD13 ' A' ' 88' ' ' ILE . 22.2 m -125.12 146.99 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 113.203 0.816 . . . . 72.03 113.203 -172.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 66.6 p -117.73 129.98 56.04 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.374 1.07 . . . . 74.33 110.775 176.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.641 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 37.9 p90 -159.09 160.35 35.61 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.569 0.7 . . . . 75.21 111.639 -171.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.0 m -113.55 116.76 45.69 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 107.511 -1.292 . . . . 72.11 107.511 173.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.43 147.17 17.37 Favored 'Trans proline' 0 CA--C 1.564 2.013 0 C-N-CA 123.228 2.618 . . . . 73.35 113.271 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.5 p -63.55 -18.79 64.23 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.697 0.799 . . . . 75.33 111.998 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.76 -21.4 66.51 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.957 0.903 . . . . 74.14 111.984 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 33.35 70.63 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 114.782 0.673 . . . . 75.13 114.782 172.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.09 -113.62 2.68 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-N 117.16 0.48 . . . . 60.53 111.961 174.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -70.65 175.36 4.96 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.684 0.794 . . . . 72.42 112.934 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -116.78 129.29 56.01 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.165 -0.925 . . . . 74.11 108.64 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.404 HG22 ' HE2' ' A' ' 78' ' ' MET . 40.9 t -104.29 102.62 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 122.969 0.508 . . . . 71.1 109.952 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.566 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.7 p-10 -109.97 153.91 23.9 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.698 0.799 . . . . 65.11 111.218 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 34.5 m80 55.63 33.78 21.92 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.21 1.004 . . . . 73.14 112.303 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -70.91 134.74 47.49 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.912 1.285 . . . . 70.53 111.59 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.656 ' HG3' ' HE2' ' A' ' 13' ' ' HIS . 18.0 ptpt -139.7 139.38 36.56 Favored 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.68 0.792 . . . . 74.03 110.723 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 92.3 m95 -115.97 149.28 39.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 119.86 -1.775 . . . . 73.45 112.419 -3.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.422 HG22 ' HB2' ' A' ' 33' ' ' TYR . 15.8 m -127.36 132.84 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 114.519 -1.219 . . . . 73.51 109.131 170.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.2 pt -104.31 176.17 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.9 -0.5 . . . . 74.25 112.324 -171.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -45.07 -52.55 8.9 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.544 1.138 . . . . 73.4 113.773 171.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.01 -16.26 63.14 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.59 0.756 . . . . 74.52 111.976 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.567 ' HG3' ' HB1' ' A' ' 75' ' ' ALA . 7.9 tt0 -93.53 -17.03 23.84 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.418 1.087 . . . . 70.24 111.423 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.2 mt -111.94 127.4 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.208 1.003 . . . . 74.15 110.838 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -61.82 -56.16 22.31 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.685 0.794 . . . . 71.15 112.057 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.27 -17.43 62.49 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.633 0.975 . . . . 74.22 113.633 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HA ' HD11 ' A' ' 65' ' ' LEU . . . -38.12 -47.03 1.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.869 1.433 . . . . 70.12 114.869 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.65 18.04 67.63 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 114.871 0.708 . . . . 74.32 114.871 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 63.65 17.86 10.71 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.945 1.298 . . . . 73.2 112.719 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HZ1' ' HB3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -112.2 171.54 7.45 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.84 0.856 . . . . 75.21 110.466 177.443 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.1 m -89.97 112.68 24.15 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.306 -0.628 . . . . 71.23 109.306 173.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.65 HD11 ' HA ' ' A' ' 60' ' ' ALA . 49.5 mt -74.45 130.23 39.24 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.617 0.767 . . . . 73.42 110.618 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -100.43 152.91 37.97 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 123.634 0.773 . . . . 75.24 111.269 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -54.24 114.42 1.81 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.971 2.447 . . . . 52.35 113.685 177.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.95 -10.34 18.2 Favored Glycine 0 N--CA 1.481 1.655 0 CA-C-N 115.845 -0.616 . . . . 51.42 114.13 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -77.56 133.49 38.48 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.626 0.713 . . . . 75.13 112.353 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -98.31 120.36 38.6 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.2 -0.909 . . . . 73.21 109.184 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.576 HG11 HD12 ' A' ' 65' ' ' LEU . 19.4 m -124.7 169.98 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.574 0.75 . . . . 73.11 112.355 -171.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mm -117.37 141.15 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.936 0.894 . . . . 75.41 109.938 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.29 124.2 40.2 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.56 0.744 . . . . 73.03 111.363 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.01 -36.39 19.79 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 122.936 0.494 . . . . 74.44 112.322 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.567 ' HB1' ' HG3' ' A' ' 56' ' ' GLU . . . -86.82 169.52 12.51 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.07 0.462 . . . . 70.05 111.305 175.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.73 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 8.7 t -142.62 126.1 16.75 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.308 -0.405 . . . . 73.3 111.122 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -95.73 -28.05 14.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.588 0.755 . . . . 74.0 111.024 169.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.404 ' HE2' HG22 ' A' ' 46' ' ' VAL . 60.1 mtm -133.75 177.04 8.02 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.669 0.788 . . . . 74.51 111.86 -170.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -68.07 106.23 2.31 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-O 121.586 0.707 . . . . 71.13 112.043 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.14 22.98 36.2 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 116.023 -0.535 . . . . 75.13 114.293 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -85.06 -38.66 18.89 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 117.495 0.647 . . . . 65.2 111.04 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.73 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 59.3 tttp -67.04 124.83 24.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.038 0.535 . . . . 73.14 110.845 170.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.74 0.24 87.79 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-O 120.196 -0.224 . . . . 75.41 113.013 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.55 151.51 25.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.181 0.592 . . . . 75.11 111.358 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 51.2 m -92.08 117.74 30.13 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.332 -0.849 . . . . 75.54 109.888 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.641 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -105.69 150.79 25.15 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.557 0.743 . . . . 73.45 110.902 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -114.86 121.08 42.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.296 1.038 . . . . 73.1 110.153 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.487 HD13 HG13 ' A' ' 35' ' ' VAL . 36.9 mm -68.87 109.26 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 122.346 0.258 . . . . 61.24 110.753 -178.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -82.58 -37.13 25.51 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.262 0.625 . . . . 74.03 110.713 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.9 t -162.79 153.92 17.37 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.23 0.612 . . . . 73.51 111.727 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.89 132.57 56.66 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.25 1.02 . . . . 71.42 110.442 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -129.26 130.91 46.82 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.382 0.673 . . . . 74.44 112.222 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -92.91 93.26 8.29 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 108.248 -1.019 . . . . 73.42 108.248 167.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.8 t -138.25 154.22 49.07 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.275 0.63 . . . . 75.02 111.627 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.0 m -88.26 124.54 33.97 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.52 -0.548 . . . . 74.44 109.52 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 28' ' ' TYR . 16.5 m -110.02 131.95 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 108.921 -0.77 . . . . 75.04 108.921 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.73 141.69 36.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.212 1.005 . . . . 70.11 111.423 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.6 ttp -93.65 115.76 28.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 108.367 -0.975 . . . . 75.11 108.367 171.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 24' ' ' VAL . 35.5 m -126.21 166.88 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 112.482 0.549 . . . . 62.31 112.482 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -133.74 129.12 36.25 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.781 0.432 . . . . 74.11 111.767 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -138.29 176.04 9.05 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.883 0.873 . . . . 73.52 111.541 -173.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.5 m -114.41 134.57 54.89 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.652 0.781 . . . . 74.4 109.496 171.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.3 t -68.25 119.53 12.95 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.319 0.648 . . . . 71.12 111.589 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.5 p -71.0 -26.11 62.98 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.862 0.865 . . . . 73.21 112.651 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.3 p -81.55 -56.64 3.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.82 0.448 . . . . 64.44 111.417 175.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.7 t -92.25 -51.06 5.34 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.72 0.808 . . . . 44.33 112.789 -172.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.44 -15.96 19.78 Favored Glycine 0 N--CA 1.478 1.492 0 CA-C-N 116.03 -0.532 . . . . 62.13 112.7 -168.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -51.29 113.48 0.96 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.854 1.262 . . . . 73.21 112.467 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -80.48 120.65 24.76 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.265 -0.643 . . . . 61.33 109.265 173.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.0 t -111.11 123.22 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.646 0.778 . . . . 72.24 109.111 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -113.4 153.76 28.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.943 0.497 . . . . 74.12 111.606 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 56.4 29.12 14.64 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.448 1.099 . . . . 62.44 113.211 177.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -59.31 139.68 56.77 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.033 0.933 . . . . 74.23 113.27 -174.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 66.6 mttm -142.11 135.07 28.72 Favored 'General case' 0 CA--C 1.572 1.804 0 C-N-CA 125.361 1.464 . . . . 74.34 110.088 -175.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 80.7 m95 -114.4 143.51 44.81 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.36 1.891 . . . . 74.31 111.5 -11.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.57 141.86 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 124.435 1.094 . . . . 72.44 108.944 170.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 69.3 p -100.6 -177.93 3.63 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.67 0.748 . . . . 74.54 112.264 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -55.95 -28.47 57.11 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 124.821 1.249 . . . . 74.44 111.776 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.07 -28.48 60.37 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.902 0.881 . . . . 74.24 112.095 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.45 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 1.5 mp0 -87.77 -9.23 54.56 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.6 0.36 . . . . 73.32 111.881 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.4 mt -121.45 127.26 50.93 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.171 0.589 . . . . 73.4 110.815 -172.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.5 m -118.91 133.12 56.04 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.162 0.985 . . . . 71.02 109.289 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.35 155.77 31.28 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.64 0.376 . . . . 62.14 111.896 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.5 tptp . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 121.066 0.46 . . . . 73.22 110.482 178.731 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.574 ' HE2' ' HB2' ' A' ' 123' ' ' ALA . 49.4 tpp . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 110.102 -0.333 . . . . 73.22 110.102 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -92.96 155.99 17.2 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.291 0.567 . . . . 75.11 112.343 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.8 t -68.12 136.12 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 123.859 0.863 . . . . 75.04 110.821 173.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.22 -12.04 66.96 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 116.077 -0.51 . . . . 74.13 113.399 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.1 t -76.38 141.05 41.59 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 117.417 0.608 . . . . 71.23 111.738 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -99.25 121.46 41.08 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.236 0.615 . . . . 74.34 110.218 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.461 ' HA ' ' H ' ' A' ' 124' ' ' LYS . 32.7 m -125.24 156.16 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.091 0.956 . . . . 70.43 111.571 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 21' ' ' GLU . 35.9 mm -103.96 135.71 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.493 -0.929 . . . . 73.54 108.493 165.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.3 mt -88.59 119.86 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 109.268 -0.641 . . . . 74.42 109.268 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.66 -28.82 17.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 122.089 -0.382 . . . . 72.23 111.814 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.483 ' HB ' ' HG2' ' A' ' 120' ' ' GLU . 66.4 m -136.28 141.95 43.9 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.043 0.937 . . . . 72.34 109.416 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.585 ' HB2' ' HE2' ' A' ' 17' ' ' MET . 79.7 p -169.4 174.0 6.24 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.41 0.624 . . . . 75.51 112.148 176.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -98.41 2.19 47.6 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.238 -0.892 . . . . 74.43 112.425 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 23.3 mmt -115.4 127.34 55.3 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.508 0.723 . . . . 73.25 109.278 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.98 -41.87 65.0 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.393 1.077 . . . . 65.2 112.877 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.35 -8.23 85.46 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.371 0.509 . . . . 74.51 114.371 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.585 ' HE2' ' HB2' ' A' ' 12' ' ' SER . 42.7 ttp -96.14 -28.93 14.34 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 117.285 0.542 . . . . 74.34 110.334 -178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -69.26 119.64 13.84 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.152 0.581 . . . . 74.21 109.627 173.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.6 2.5 89.97 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 115.399 -0.819 . . . . 62.31 114.358 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.88 161.89 18.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 113.55 0.945 . . . . 73.43 113.55 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 8' ' ' ILE . 10.9 tp10 -76.99 138.73 39.79 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.89 -1.05 . . . . 74.44 110.439 172.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.77 166.67 30.66 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.436 0.636 . . . . 74.51 112.672 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.5 m -138.53 129.22 26.42 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.702 0.801 . . . . 75.22 110.408 173.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 80.8 t -77.71 104.73 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.513 0.725 . . . . 72.43 109.741 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.7 p -103.02 -2.42 27.59 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.567 0.747 . . . . 62.11 112.394 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.47 142.44 9.05 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-O 120.076 -0.291 . . . . 72.01 112.494 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.97 111.36 14.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.421 0.688 . . . . 73.41 111.231 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -118.08 110.11 17.24 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.303 1.041 . . . . 74.11 110.203 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.21 76.3 3.02 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 122.159 0.981 . . . . 74.3 108.99 174.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -133.06 168.95 17.57 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.736 -0.665 . . . . 74.13 112.258 -169.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 m -70.55 119.77 15.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.122 0.569 . . . . 72.35 111.116 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.36 146.51 28.72 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.6 0.76 . . . . 65.4 109.421 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -127.98 148.04 50.51 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.985 0.898 . . . . 74.23 111.713 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.0 t -102.61 109.7 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 114.156 -1.383 . . . . 74.04 107.707 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.458 HG11 HD11 ' A' ' 88' ' ' ILE . 30.6 m -111.63 167.43 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 118.533 0.606 . . . . 72.33 112.301 -175.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.3 p -141.59 126.58 18.3 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.192 0.597 . . . . 62.12 110.588 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -161.99 128.29 3.67 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 112.772 0.656 . . . . 75.5 112.772 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 73.3 m -71.07 117.76 59.38 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-O 119.083 -0.484 . . . . 73.2 110.099 159.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.57 140.6 94.62 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.143 2.562 . . . . 70.44 113.235 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.7 p -64.61 -16.05 62.1 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 114.43 1.27 . . . . 72.34 114.43 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' ' 79' ' ' LYS . 28.0 p-10 -79.39 -6.02 55.89 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.061 0.545 . . . . 72.45 112.429 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.34 45.99 5.99 Favored Glycine 0 CA--C 1.535 1.281 0 N-CA-C 112.108 -0.397 . . . . 64.15 112.108 -172.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.57 -177.9 39.79 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 122.932 0.301 . . . . 71.52 112.961 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -65.16 123.32 19.22 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 119.277 -0.392 . . . . 75.13 110.177 173.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 12.2 ttm180 -51.95 111.08 0.55 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.216 0.606 . . . . 75.14 111.6 173.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.703 HG21 ' HE3' ' A' ' 78' ' ' MET . 21.6 t -88.54 102.76 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 115.532 -0.758 . . . . 74.45 110.248 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -97.89 143.01 28.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.703 0.801 . . . . 75.43 110.43 -177.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.7 m170 56.96 33.92 24.07 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.763 0.825 . . . . 73.22 111.871 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.564 ' HB2' HG11 ' A' ' 46' ' ' VAL . 85.7 t60 -62.95 132.67 52.83 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.409 1.084 . . . . 74.1 111.85 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -154.99 152.31 29.53 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 114.562 -1.199 . . . . 72.13 109.492 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.579 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 72.7 m95 -106.36 126.17 51.91 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.254 -1.529 . . . . 72.44 112.35 4.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.3 m -113.89 133.67 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.377 1.071 . . . . 75.42 108.625 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.6 pt -97.12 157.6 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-O 120.85 0.357 . . . . 71.54 110.675 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -54.57 -36.59 64.55 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.606 0.762 . . . . 74.31 112.922 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -70.76 -14.34 62.4 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.142 0.577 . . . . 72.12 112.211 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -94.69 -19.66 20.21 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.246 1.018 . . . . 75.12 111.268 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.5 mt -89.07 137.32 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.583 0.753 . . . . 74.41 109.968 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 36.8 ttpt -76.67 -45.29 30.34 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.039 0.536 . . . . 74.23 111.496 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.451 ' HB3' HG11 ' A' ' 71' ' ' VAL . 5.9 t70 -68.51 -9.54 49.78 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.686 0.794 . . . . 75.25 112.625 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -42.21 -65.23 0.48 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.781 1.4 . . . . 75.03 114.781 176.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.47 13.53 58.57 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 114.894 0.718 . . . . 61.15 114.894 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.71 13.89 7.76 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.197 1.399 . . . . 64.22 112.779 -172.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -98.96 155.18 17.54 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.768 0.827 . . . . 72.3 110.48 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.9 m -72.65 109.21 6.12 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.389 0.276 . . . . 70.12 111.009 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 60' ' ' ALA . 62.9 mt -86.63 146.23 26.41 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.361 0.665 . . . . 75.15 109.242 173.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -139.28 169.06 13.22 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 124.01 0.924 . . . . 74.21 110.741 -171.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -44.1 109.6 0.16 Allowed 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 123.331 2.687 . . . . 73.22 114.459 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.91 -17.27 13.12 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.262 0.865 . . . . 71.42 115.262 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.99 120.94 14.02 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 118.413 1.106 . . . . 75.32 111.526 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -89.72 119.34 30.04 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.289 -0.634 . . . . 74.13 109.289 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.451 HG11 ' HB3' ' A' ' 59' ' ' ASP . 32.0 m -124.07 168.01 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.644 0.777 . . . . 73.32 111.76 -172.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.8 mm -118.74 137.91 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 123.409 0.684 . . . . 75.03 110.083 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.5 mt -92.4 109.34 20.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.821 0.848 . . . . 73.54 110.638 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.528 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 67.9 mm-40 -83.11 -9.93 58.95 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.55 0.945 . . . . 73.22 113.55 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.2 170.55 8.38 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.403 0.62 . . . . 63.22 111.065 174.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.455 ' HA ' ' HB3' ' A' ' 81' ' ' MET . 31.1 t -143.81 125.42 14.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.403 -0.817 . . . . 75.23 109.173 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -103.72 -4.74 23.3 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.626 0.77 . . . . 73.45 110.465 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.703 ' HE3' HG21 ' A' ' 46' ' ' VAL . 25.5 ptt? -165.88 -176.07 3.67 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.691 0.796 . . . . 72.42 111.386 -168.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.485 ' HB3' ' ND2' ' A' ' 41' ' ' ASN . 5.5 mptp? -59.35 114.36 2.63 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 112.803 0.668 . . . . 72.44 112.803 177.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.82 27.36 67.1 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.807 1.083 . . . . 74.52 115.807 169.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.455 ' HB3' ' HA ' ' A' ' 76' ' ' SER . 27.2 ttt -83.58 -42.18 17.06 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 118.025 0.913 . . . . 74.33 111.809 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.29 130.89 44.98 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 120.693 0.282 . . . . 73.23 111.612 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.12 80.77 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.102 -0.499 . . . . 71.24 113.054 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.58 139.68 42.23 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.096 0.558 . . . . 72.2 111.982 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.9 m -84.01 120.05 25.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.228 -0.896 . . . . 71.15 108.889 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.45 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . . . -117.46 162.92 17.18 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.971 0.908 . . . . 65.34 110.06 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -127.72 134.08 49.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.632 -0.507 . . . . 73.34 109.632 172.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.458 HD11 HG11 ' A' ' 35' ' ' VAL . 28.5 mm -66.93 104.21 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 N-CA-C 109.378 -0.601 . . . . 73.32 109.378 174.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.25 -40.74 77.67 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.377 1.071 . . . . 74.31 110.419 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.8 m -154.77 149.02 26.02 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.731 0.813 . . . . 74.23 110.599 -176.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.0 130.76 53.14 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.898 0.879 . . . . 64.13 108.89 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -140.88 115.47 9.51 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 121.132 0.491 . . . . 70.24 112.281 -168.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.04 94.2 9.86 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.365 0.666 . . . . 73.24 109.56 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 t -137.96 154.17 49.4 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.493 0.717 . . . . 71.01 110.068 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.7 m -84.21 128.26 34.45 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.889 -0.412 . . . . 72.21 109.889 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 m -111.61 134.55 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.612 0.765 . . . . 74.24 109.539 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.05 140.22 49.49 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.423 0.689 . . . . 73.23 112.314 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.3 ttp -89.69 112.44 23.71 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.881 -1.054 . . . . 75.24 108.28 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.68 145.85 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 112.826 0.676 . . . . 72.23 112.826 -170.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.84 115.68 30.93 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.488 -0.93 . . . . 73.52 108.488 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -127.97 158.82 36.83 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.218 0.463 . . . . 75.31 111.758 -173.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.7 m -104.25 104.16 14.02 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.425 -0.583 . . . . 74.05 109.425 172.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 108' ' ' GLU . 36.0 t -59.61 109.24 0.86 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.862 0.865 . . . . 74.42 111.546 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.2 p -62.26 -14.21 36.21 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.824 1.25 . . . . 72.13 113.297 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 78.8 m -58.79 -57.28 13.71 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.68 0.792 . . . . 75.23 112.498 174.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.5 p -126.32 -2.06 6.92 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.214 0.606 . . . . 73.21 112.574 -172.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.97 84.91 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 120.063 -0.298 . . . . 74.4 113.404 -170.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 103' ' ' SER . 38.1 tt0 -59.35 113.26 2.08 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.517 1.127 . . . . 65.31 112.003 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -88.7 125.63 34.94 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.681 0.753 . . . . 73.54 109.184 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -119.14 132.28 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.39 1.076 . . . . 74.23 109.12 -170.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 133.51 50.74 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 120.775 0.322 . . . . 73.04 110.297 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.6 m120 55.28 54.78 8.24 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 125.079 1.352 . . . . 73.51 113.857 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -63.91 141.92 58.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.416 0.686 . . . . 70.32 111.598 170.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 98.9 mttt -137.67 127.42 25.38 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.742 0.817 . . . . 72.24 111.053 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.579 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 85.7 m95 -120.55 165.46 14.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.198 -1.564 . . . . 74.25 112.258 -12.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.409 HG21 HD22 ' A' ' 121' ' ' LEU . 20.2 m -124.05 168.32 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 113.786 -1.552 . . . . 63.34 107.72 162.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 40.3 p -117.61 169.84 9.24 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.827 0.739 . . . . 74.04 112.282 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -53.2 -40.86 64.76 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.13 0.972 . . . . 75.54 111.279 172.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.66 -29.45 70.68 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.385 1.074 . . . . 54.0 111.774 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.483 ' HG2' ' HB ' ' A' ' 11' ' ' THR . 56.8 mt-10 -94.0 0.19 55.86 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.891 0.876 . . . . 63.44 112.078 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.409 HD22 HG21 ' A' ' 116' ' ' VAL . 83.6 mt -117.87 152.65 34.96 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.805 0.842 . . . . 74.32 110.244 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.5 m -146.84 122.94 10.8 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.099 -1.075 . . . . 73.3 108.099 173.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.574 ' HB2' ' HE2' ' A' ' 1' ' ' MET . . . -59.77 105.6 0.39 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 118.28 0.491 . . . . 75.52 110.975 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.461 ' H ' ' HA ' ' A' ' 7' ' ' VAL . 56.2 tptt . . . . . 0 CA--C 1.569 1.682 0 C-N-CA 124.992 1.317 . . . . 75.35 113.251 -167.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.402 ' SD ' HG13 ' A' ' 7' ' ' VAL . 61.4 mtt . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.319 -0.252 . . . . 74.35 110.319 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.4 160.73 18.1 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.295 0.638 . . . . 71.55 111.849 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.18 131.6 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.461 0.704 . . . . 74.13 111.704 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.18 -10.28 43.38 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 115.818 -0.628 . . . . 63.15 112.782 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.4 t -81.13 145.14 31.21 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.236 0.614 . . . . 72.34 112.186 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -94.92 116.5 28.78 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.84 0.856 . . . . 73.2 109.058 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.402 HG13 ' SD ' ' A' ' 1' ' ' MET . 35.0 m -122.23 153.43 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.131 0.972 . . . . 75.11 110.678 -174.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 mm -100.15 134.68 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 109.292 -0.633 . . . . 71.34 109.292 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.429 HG23 ' HG2' ' A' ' 17' ' ' MET . 63.3 mt -78.42 104.07 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.946 -0.472 . . . . 74.42 109.732 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -78.35 -32.8 49.22 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.188 0.595 . . . . 63.41 111.367 -168.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 t -144.47 164.97 29.28 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.205 0.602 . . . . 63.54 110.061 168.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 98.8 p -157.18 167.07 31.45 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.379 0.609 . . . . 63.31 112.431 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -91.4 -37.49 13.17 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.091 -0.959 . . . . 61.43 109.884 168.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.5 mpt? -85.49 132.85 34.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.835 0.854 . . . . 73.11 110.748 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -58.97 -38.45 79.13 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.553 0.741 . . . . 74.44 112.494 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.22 -6.65 87.76 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 114.545 0.578 . . . . 71.3 114.545 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.429 ' HG2' HG23 ' A' ' 9' ' ' ILE . 41.8 ttp -94.85 -28.66 15.12 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 117.821 0.811 . . . . 71.45 112.13 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.441 ' HZ3' ' HB2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -68.19 128.6 37.15 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.13 0.49 . . . . 75.52 111.85 179.472 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.47 0.27 88.89 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-N 115.563 -0.744 . . . . 64.15 113.958 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.55 149.46 29.95 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.357 0.663 . . . . 64.3 110.851 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -90.95 106.53 18.59 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.919 0.39 . . . . 63.42 110.267 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.539 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -88.55 169.84 11.38 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.681 0.792 . . . . 72.11 111.767 175.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.7 m -136.89 134.54 36.95 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.165 -0.68 . . . . 70.11 109.165 171.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.79 105.69 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 123.127 0.571 . . . . 73.25 110.856 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.4 p -92.63 -15.76 26.42 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.31 0.644 . . . . 63.42 111.738 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.51 146.3 13.66 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.4 -0.28 . . . . 72.3 112.4 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.17 125.35 31.01 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.868 0.867 . . . . 73.32 109.544 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.594 ' HB2' HG23 ' A' ' 96' ' ' VAL . 58.1 m-85 -128.46 130.64 47.85 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.584 0.754 . . . . 72.44 110.816 -171.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -107.31 79.49 1.31 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 122.153 0.978 . . . . 70.01 110.073 174.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 t -133.43 162.61 31.4 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.186 -0.915 . . . . 70.41 110.425 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.8 m -65.89 119.9 12.12 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.833 0.453 . . . . 74.23 110.577 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.41 153.48 23.94 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.011 0.924 . . . . 71.32 109.846 -176.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -133.95 147.42 51.05 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.902 0.858 . . . . 64.5 112.078 -170.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.95 115.0 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 106.804 -1.554 . . . . 72.03 106.804 167.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG13 HD13 ' A' ' 88' ' ' ILE . 31.6 m -122.13 154.75 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-O 121.492 0.663 . . . . 72.43 112.751 -173.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 61.7 p -121.22 124.52 44.86 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.248 1.019 . . . . 75.04 109.667 173.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -142.64 154.59 44.51 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.308 0.643 . . . . 73.42 110.682 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.0 m -102.89 107.22 54.06 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.902 -1.147 . . . . 72.22 107.902 171.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.32 133.9 45.8 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.304 2.002 . . . . 74.03 111.326 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 72.8 p -68.66 -2.27 8.78 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.502 0.927 . . . . 73.41 113.502 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -64.24 -21.47 66.59 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.298 0.639 . . . . 75.14 111.087 165.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.57 29.73 38.72 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 114.981 0.752 . . . . 75.31 114.981 169.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.35 -109.03 1.55 Allowed Glycine 0 CA--C 1.537 1.439 0 CA-C-N 117.519 0.66 . . . . 64.33 112.9 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -109.6 141.33 42.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.943 0.897 . . . . 73.12 110.172 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -63.11 124.42 21.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.283 0.633 . . . . 74.41 111.182 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.636 HG21 ' SD ' ' A' ' 78' ' ' MET . 48.5 t -90.28 114.01 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.362 0.665 . . . . 73.42 109.985 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -105.96 151.52 24.5 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.017 0.527 . . . . 74.35 110.97 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.9 m80 55.72 29.99 14.8 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.213 1.005 . . . . 70.42 113.166 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.424 ' HB2' HG11 ' A' ' 46' ' ' VAL . 60.0 t60 -72.3 118.72 15.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.992 0.917 . . . . 72.41 110.43 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 59.2 pttt -133.06 146.8 52.01 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 115.929 -0.578 . . . . 75.04 111.629 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 92.7 m95 -110.83 152.46 26.64 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.446 -1.409 . . . . 75.12 112.209 0.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.16 136.41 60.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.1 -1.409 . . . . 73.32 107.747 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.471 HG21 HG22 ' A' ' 96' ' ' VAL . 39.9 pt -101.55 166.37 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.637 -0.664 . . . . 74.31 112.143 -172.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.86 -33.74 67.13 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.841 0.856 . . . . 72.51 111.88 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -71.94 -21.23 61.64 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.064 0.546 . . . . 72.15 112.422 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -83.08 -33.83 26.3 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.938 0.895 . . . . 74.3 110.948 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.0 mt -86.85 132.19 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.079 0.552 . . . . 74.45 110.984 -171.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.526 ' HB2' ' HG3' ' A' ' 74' ' ' GLU . 59.0 tttm -60.43 -43.67 96.54 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.998 0.919 . . . . 74.35 112.167 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.36 -7.63 50.63 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 123.775 0.83 . . . . 73.42 113.154 -174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -33.98 -67.02 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.96 1.467 . . . . 60.22 114.96 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.81 25.7 70.71 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 114.956 0.742 . . . . 65.4 114.956 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 64.32 9.43 4.87 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.527 1.131 . . . . 63.41 113.231 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 24.8 pttm -109.66 167.59 10.04 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.457 0.703 . . . . 65.43 111.357 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 m -91.89 119.54 31.75 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.286 0.634 . . . . 73.24 110.225 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.609 HD11 HG13 ' A' ' 71' ' ' VAL . 44.6 mt -79.64 127.92 32.76 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.362 0.665 . . . . 61.52 110.8 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -89.46 153.37 48.24 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.671 0.788 . . . . 74.21 111.283 -173.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.27 115.39 2.26 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.423 2.082 . . . . 74.42 113.277 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.33 -19.39 14.86 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.534 -0.757 . . . . 74.33 113.608 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.04 130.82 47.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.381 0.673 . . . . 75.52 112.189 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -90.84 120.43 31.86 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.504 -0.771 . . . . 74.42 109.312 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.609 HG13 HD11 ' A' ' 65' ' ' LEU . 32.4 m -134.43 174.68 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 C-N-CA 124.367 1.067 . . . . 74.22 111.321 -171.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.31 141.95 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.895 0.878 . . . . 64.32 109.861 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 mt -96.96 131.04 44.16 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.641 0.777 . . . . 72.13 111.596 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.526 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 36.2 mt-10 -101.0 9.44 42.24 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 113.464 0.913 . . . . 75.25 113.464 175.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.38 165.85 17.64 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.379 0.672 . . . . 73.53 110.055 169.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.4 t -139.57 123.56 17.72 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.954 -0.567 . . . . 64.22 110.517 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -99.09 -5.43 30.25 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.912 0.885 . . . . 74.32 110.173 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.636 ' SD ' HG21 ' A' ' 46' ' ' VAL . 26.0 ptp -159.07 147.45 18.07 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.539 1.135 . . . . 73.12 109.682 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -53.77 121.74 8.51 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.117 0.567 . . . . 75.24 112.296 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.9 -15.91 54.94 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 119.361 -0.688 . . . . 74.42 114.572 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.0 ttt -64.01 -46.02 86.35 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.559 0.744 . . . . 63.02 112.781 -175.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -67.53 118.5 10.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.95 -0.389 . . . . 74.23 109.95 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 3.16 74.41 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 116.383 -0.371 . . . . 73.24 113.49 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.22 145.63 32.13 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.222 0.511 . . . . 51.31 110.341 172.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m -80.32 114.56 19.31 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 109.443 -0.577 . . . . 74.35 109.443 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.51 145.63 32.87 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.598 0.759 . . . . 74.33 111.257 -173.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -123.15 117.07 24.53 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.378 1.071 . . . . 74.32 109.135 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.441 HD13 HG13 ' A' ' 35' ' ' VAL . 28.2 mm -61.55 115.07 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.188 0.595 . . . . 73.13 111.028 -178.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -83.35 -36.46 24.36 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.821 0.449 . . . . 72.35 110.967 173.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.9 t -157.83 150.65 22.89 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.24 0.616 . . . . 72.21 111.745 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.81 131.64 56.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.19 0.996 . . . . 74.03 109.37 173.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -146.68 128.9 15.71 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.942 0.497 . . . . 74.34 111.739 -171.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -91.62 95.35 9.87 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.253 -0.647 . . . . 71.43 109.253 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.3 t -136.87 155.39 49.83 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.444 1.098 . . . . 71.1 110.202 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.4 m -80.94 120.0 24.19 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.887 -0.412 . . . . 75.44 109.887 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 28' ' ' TYR . 9.0 m -104.68 132.45 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.317 0.647 . . . . 74.34 109.535 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.56 135.02 51.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.36 1.064 . . . . 74.11 111.118 -176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.6 ttp -94.1 120.98 35.12 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.924 -1.139 . . . . 71.34 107.924 166.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 24.2 m -124.85 169.6 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 112.779 0.659 . . . . 73.4 112.779 -169.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -137.06 133.14 35.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.282 0.633 . . . . 72.34 110.909 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -143.32 177.61 8.31 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.853 0.861 . . . . 64.44 111.299 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.6 m -119.96 119.18 32.69 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 108.248 -1.019 . . . . 74.31 108.248 169.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.9 m -61.22 134.71 57.29 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.363 0.665 . . . . 60.32 112.396 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -65.18 -47.96 75.11 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.293 1.037 . . . . 72.44 112.176 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.4 p -75.67 -50.8 14.36 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.447 0.699 . . . . 53.42 112.052 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.8 m -75.38 -33.57 61.03 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.495 0.718 . . . . 75.21 112.677 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.37 11.92 79.88 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-N 116.543 -0.298 . . . . 71.43 113.498 -172.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -100.21 140.11 34.92 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.59 0.756 . . . . 73.4 111.239 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -81.1 115.57 20.6 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.634 0.773 . . . . 75.44 110.998 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.9 t -104.85 122.34 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.874 0.87 . . . . 74.12 109.534 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.77 160.7 17.07 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.014 0.526 . . . . 74.11 111.289 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.0 m120 56.5 28.89 14.45 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.133 0.973 . . . . 73.52 112.897 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -64.75 137.73 57.97 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.537 0.735 . . . . 74.53 111.888 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 8.0 ptpp? -155.56 148.42 24.33 Favored 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 123.513 0.725 . . . . 74.21 111.941 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 98.9 m95 -112.15 144.51 41.41 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.461 1.505 . . . . 73.01 112.536 -8.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.81 154.34 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.2 1.4 . . . . 65.24 109.048 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.3 p -117.33 177.7 4.64 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.812 0.445 . . . . 74.22 110.911 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -66.12 -14.28 61.52 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.469 0.708 . . . . 54.35 111.888 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.54 -35.4 65.52 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 122.971 0.508 . . . . 71.24 110.863 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -94.84 -5.08 45.88 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.021 0.528 . . . . 74.05 111.643 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 66.0 mt -108.24 134.41 51.12 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.851 0.834 . . . . 75.42 110.962 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.4 t -101.57 156.72 17.31 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.399 1.48 . . . . 75.52 108.925 170.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.68 160.73 15.48 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.637 0.375 . . . . 61.44 110.301 175.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 110.081 -0.34 . . . . 75.15 110.081 174.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 120.814 0.34 . . . . 75.55 111.865 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -120.46 174.37 6.58 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.639 0.776 . . . . 72.11 112.481 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.75 136.01 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 C-N-CA 123.844 0.858 . . . . 64.04 111.718 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.38 -9.76 75.48 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 115.825 -0.625 . . . . 64.2 113.702 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.8 t -83.65 142.14 31.0 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.149 0.579 . . . . 74.04 111.707 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -90.48 122.15 33.07 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.637 0.775 . . . . 73.24 110.318 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . 33.2 m -122.29 153.44 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.638 0.775 . . . . 73.31 111.886 -176.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.4 mm -104.56 123.79 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.333 1.053 . . . . 72.15 108.472 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.4 mt -77.21 125.25 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 120.967 0.413 . . . . 73.31 111.06 -172.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -89.19 -68.4 0.78 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.697 0.799 . . . . 74.1 109.725 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.0 m -98.8 144.64 27.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.941 0.897 . . . . 73.34 110.25 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' A' ' 18' ' ' LYS . 84.8 p -159.28 152.7 22.56 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.704 0.631 . . . . 73.04 112.704 -172.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -85.82 -37.53 19.13 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.469 0.708 . . . . 72.21 110.309 168.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.462 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.4 mpt? -83.32 129.1 34.98 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.262 0.625 . . . . 73.43 110.259 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -30.8 71.05 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.611 0.967 . . . . 74.45 113.611 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.14 -9.1 70.9 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 114.023 0.369 . . . . 72.52 114.023 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 55.2 ttp -82.72 -28.65 30.36 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.901 0.481 . . . . 74.02 110.197 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.574 ' HZ2' ' HB2' ' A' ' 18' ' ' LYS . 3.4 ttmp? -67.77 118.68 11.34 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.711 0.404 . . . . 72.14 111.134 173.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.95 2.07 86.45 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 116.134 -0.485 . . . . 75.4 113.553 -177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.97 152.17 29.64 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.108 0.563 . . . . 74.42 112.035 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -86.39 131.94 34.08 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.134 0.974 . . . . 75.52 110.359 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.55 173.86 11.08 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.728 0.811 . . . . 72.41 112.22 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.7 m -137.99 146.52 43.22 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.441 1.097 . . . . 74.14 108.754 170.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.5 t -79.75 117.95 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 122.756 0.423 . . . . 71.44 110.556 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.3 p -94.86 -18.3 21.3 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.51 0.724 . . . . 75.53 111.58 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.44 145.18 11.52 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 120.201 -0.222 . . . . 72.51 112.701 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.54 119.61 19.73 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.665 0.786 . . . . 74.15 110.725 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -130.18 149.67 51.78 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.315 1.046 . . . . 64.51 110.42 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -125.82 90.97 3.3 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.158 0.98 . . . . 71.44 109.965 167.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.0 t -135.19 177.46 7.79 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.282 -0.872 . . . . 73.52 111.144 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -73.35 110.26 7.5 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.528 0.68 . . . . 74.13 110.454 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.09 161.02 13.9 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.375 1.47 . . . . 62.35 109.918 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -138.59 144.64 39.9 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.567 0.747 . . . . 74.5 111.606 -172.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.9 110.96 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 107.048 -1.464 . . . . 72.45 107.048 164.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 21.1 m -112.16 144.09 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.378 0.609 . . . . 73.01 112.231 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 p -116.65 128.24 55.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.204 1.002 . . . . 74.4 109.634 173.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -151.17 158.29 43.77 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.94 0.496 . . . . 74.25 111.386 -169.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.2 m -108.15 117.06 55.8 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 109.008 -0.738 . . . . 74.43 109.008 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -60.77 124.04 14.19 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.656 2.237 . . . . 74.12 111.887 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -63.05 -14.45 48.26 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.575 1.324 . . . . 71.23 114.575 -168.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.446 ' N ' HD21 ' A' ' 41' ' ' ASN . 0.8 OUTLIER -85.73 11.35 11.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.532 0.733 . . . . 72.44 112.718 -176.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.46 53.15 3.93 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 120.977 0.209 . . . . 65.32 112.9 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.34 168.91 13.91 Favored Glycine 0 N--CA 1.476 1.312 0 C-N-CA 122.96 0.314 . . . . 64.21 112.854 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -58.75 135.36 57.43 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.33 0.652 . . . . 75.03 111.331 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -56.59 136.5 54.55 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-O 121.186 0.517 . . . . 71.31 111.065 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.466 HG22 ' SD ' ' A' ' 78' ' ' MET . 57.8 t -86.72 103.13 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.246 0.618 . . . . 65.25 109.709 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.69 108.7 14.56 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.902 0.881 . . . . 72.23 110.828 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.2 m170 57.7 79.11 0.21 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.152 0.981 . . . . 73.44 112.992 176.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -94.29 109.67 21.48 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.125 0.97 . . . . 73.13 109.671 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 22.2 pttp -121.01 140.16 52.3 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.286 0.235 . . . . 75.34 111.551 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 79.6 m95 -117.83 158.33 25.01 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.054 1.342 . . . . 74.32 112.478 2.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.49 143.67 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 113.183 -1.826 . . . . 72.41 107.18 167.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.448 HG13 ' H ' ' A' ' 55' ' ' GLU . 29.8 pt -106.93 179.56 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.678 -0.639 . . . . 72.3 109.676 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -48.71 -33.9 11.0 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.205 1.002 . . . . 74.55 113.093 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' H ' HG13 ' A' ' 53' ' ' ILE . 28.5 tt0 -69.78 -23.96 63.43 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.072 0.949 . . . . 74.14 113.493 -175.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.2 -10.78 59.56 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.553 0.575 . . . . 73.31 112.553 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.1 mt -113.18 134.22 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 123.433 0.693 . . . . 74.22 111.808 -169.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.417 ' HB2' ' HG3' ' A' ' 74' ' ' GLU . 40.8 ttmt -67.82 -46.37 72.06 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.025 0.93 . . . . 73.55 111.999 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -62.84 -22.28 66.56 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.802 0.841 . . . . 74.3 112.675 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.533 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -35.79 -57.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.292 1.59 . . . . 70.52 115.292 -171.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.85 19.48 67.55 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 115.984 1.154 . . . . 75.11 115.984 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 t70 61.84 15.77 7.38 Favored 'General case' 0 CA--C 1.572 1.806 0 C-N-CA 124.959 1.304 . . . . 75.34 112.212 -172.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 22.9 pttm -107.59 160.15 15.9 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.787 0.835 . . . . 64.24 109.771 175.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 p -76.88 128.16 34.05 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 110.034 -0.358 . . . . 73.45 110.034 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.575 HD13 HG11 ' A' ' 71' ' ' VAL . 38.7 mt -87.95 136.51 32.93 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.696 -0.483 . . . . 73.3 109.696 170.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -105.89 153.49 40.05 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.58 0.752 . . . . 74.35 110.593 -173.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.83 130.37 40.02 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 122.538 2.159 . . . . 75.32 112.427 171.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.86 -22.61 29.6 Favored Glycine 0 N--CA 1.479 1.507 0 N-CA-C 113.992 0.357 . . . . 73.52 113.992 -175.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -73.14 157.18 37.72 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.255 0.527 . . . . 65.43 112.226 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -125.7 135.48 52.14 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.576 -0.738 . . . . 74.23 109.737 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.575 HG11 HD13 ' A' ' 65' ' ' LEU . 36.0 m -138.79 -178.36 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 125.41 1.484 . . . . 75.02 110.355 -167.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.3 mt -128.22 140.94 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.315 0.646 . . . . 73.25 110.252 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.2 mt -90.33 130.22 36.46 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.275 1.03 . . . . 72.41 111.622 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.417 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 43.0 mt-10 -91.31 -12.97 33.47 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.218 0.607 . . . . 71.31 112.192 169.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.93 160.66 14.23 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.271 0.628 . . . . 72.51 111.193 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.784 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 10.4 t -140.2 125.9 19.29 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.691 0.396 . . . . 72.24 110.324 178.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -113.41 0.74 14.85 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.466 0.706 . . . . 74.04 110.723 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.466 ' SD ' HG22 ' A' ' 46' ' ' VAL . 23.7 ptp -157.57 167.38 30.33 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.814 0.845 . . . . 74.43 111.515 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -63.89 101.61 0.39 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.073 0.949 . . . . 72.23 111.901 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.77 23.92 9.63 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-O 119.733 -0.482 . . . . 73.43 114.101 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.4 ttt -93.23 -39.46 10.99 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 117.664 0.732 . . . . 74.42 111.689 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.784 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 60.7 tttm -67.76 119.73 12.95 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.443 0.297 . . . . 72.53 110.389 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.33 -8.44 75.16 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 123.462 0.476 . . . . 73.3 113.149 -176.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.54 146.97 36.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.055 0.542 . . . . 65.32 111.612 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.0 m -86.31 119.72 26.88 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.734 -0.666 . . . . 75.35 110.069 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.55 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . . . -112.62 149.3 33.01 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.89 0.876 . . . . 72.25 110.653 -177.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -118.43 126.47 52.13 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.939 0.496 . . . . 74.24 110.261 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.401 HD11 HG11 ' A' ' 35' ' ' VAL . 25.8 mm -68.36 102.56 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 123.456 0.702 . . . . 74.54 110.276 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -71.79 -39.35 69.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.187 0.595 . . . . 55.33 110.166 173.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 t -154.98 147.93 24.62 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.05 -0.977 . . . . 65.31 111.286 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.78 132.96 42.82 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.0 0.92 . . . . 72.44 109.924 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -148.38 142.25 25.76 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.303 0.641 . . . . 72.52 110.803 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.03 94.6 9.7 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.427 -1.323 . . . . 75.15 107.427 172.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.3 t -134.81 156.81 48.23 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.927 0.891 . . . . 73.23 111.103 -171.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 93.5 m -79.95 120.24 23.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.934 0.494 . . . . 75.41 110.614 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.86 134.49 58.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.037 0.935 . . . . 72.53 110.239 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.489 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 98.2 m-85 -110.32 135.83 50.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.041 0.936 . . . . 73.42 112.004 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 52.8 ttp -90.26 121.07 31.94 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 107.844 -1.169 . . . . 63.52 107.844 167.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.14 145.63 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 113.17 0.804 . . . . 73.33 113.17 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -106.77 120.47 42.09 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.732 0.813 . . . . 72.32 109.747 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -127.44 165.56 19.59 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.374 0.607 . . . . 75.02 112.077 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.8 m -104.02 108.64 20.08 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.768 -0.827 . . . . 73.44 108.768 171.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.1 t -62.21 107.44 0.89 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.286 0.634 . . . . 74.04 110.682 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.7 p -59.24 -31.8 69.4 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.148 0.979 . . . . 74.43 113.142 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 t -76.49 -13.17 60.12 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.035 0.934 . . . . 75.22 112.958 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 t -123.82 -43.96 2.1 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.4 0.68 . . . . 75.42 112.663 -172.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.8 -18.47 57.19 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 116.5 -0.318 . . . . 74.23 112.436 -166.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.41 137.15 44.46 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.22 1.008 . . . . 73.42 111.493 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -91.31 118.2 30.3 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 121.322 0.582 . . . . 72.21 110.263 174.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.8 t -104.37 119.09 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.946 0.898 . . . . 64.54 108.616 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -103.63 153.29 20.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.559 0.344 . . . . 74.32 111.68 -169.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 53.73 42.42 31.81 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.541 1.137 . . . . 75.43 114.03 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -58.91 134.36 56.86 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.245 1.018 . . . . 74.12 111.903 175.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 62.1 mttp -132.3 132.12 42.67 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.093 0.957 . . . . 72.41 111.167 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 99.8 m95 -119.19 153.9 34.2 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.258 -1.526 . . . . 73.23 111.603 -15.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.36 158.15 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 114.524 -1.216 . . . . 64.11 108.831 168.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.9 p -105.84 175.51 5.47 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.251 0.548 . . . . 74.13 111.712 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.489 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 34.8 tt0 -67.54 -26.6 66.39 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.924 -0.58 . . . . 75.23 110.727 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.13 -29.13 70.55 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 123.982 0.913 . . . . 73.04 111.418 171.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -98.39 3.61 48.49 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.077 0.951 . . . . 73.41 112.715 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.93 142.55 51.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.351 0.66 . . . . 74.41 111.367 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.5 p -130.09 119.64 23.38 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.32 1.048 . . . . 75.2 108.297 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -85.69 105.02 15.94 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.919 0.782 . . . . 63.45 112.495 -167.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.5 tptm . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 116.229 1.937 . . . . 75.21 116.229 172.297 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.457 ' HE2' ' HB2' ' A' ' 123' ' ' ALA . 54.1 tpp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.08 -0.341 . . . . 75.32 110.08 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.612 ' HZ3' ' HB3' ' A' ' 2' ' ' LYS . 9.4 mtpm? -78.51 155.92 29.54 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.511 0.672 . . . . 73.41 112.693 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.07 122.87 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-N 115.331 -0.85 . . . . 74.01 109.593 165.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.71 41.85 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-N 115.869 -0.605 . . . . 55.12 113.583 -175.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.9 m -74.85 136.43 41.54 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.091 0.556 . . . . 55.15 111.721 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -94.12 125.16 38.59 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.931 0.893 . . . . 74.03 109.63 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.28 153.43 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.393 0.677 . . . . 75.42 112.635 -168.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.3 mm -98.37 125.44 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 124.679 1.192 . . . . 73.13 109.931 172.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.52 HD12 ' HB1' ' A' ' 22' ' ' ALA . 41.4 mt -87.28 125.4 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.19 0.596 . . . . 75.54 111.223 -176.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -98.66 -59.02 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.381 0.672 . . . . 74.35 111.063 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.6 m -94.44 144.57 25.45 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.692 0.797 . . . . 64.51 109.448 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.501 ' HB2' ' HB3' ' A' ' 17' ' ' MET . 77.2 p -149.88 144.46 25.94 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.112 0.482 . . . . 71.51 111.574 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -92.42 -24.43 18.86 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.809 0.844 . . . . 74.01 110.465 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 23.2 mmt -95.97 134.47 38.94 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.688 0.795 . . . . 75.45 109.316 169.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HG2' HG21 ' A' ' 105' ' ' THR . 62.5 tttp -59.01 -44.25 91.65 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.732 0.813 . . . . 71.34 112.728 -175.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.98 -0.26 64.43 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 114.889 0.715 . . . . 63.02 114.889 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.501 ' HB3' ' HB2' ' A' ' 12' ' ' SER . 41.1 ttp -91.47 -24.84 19.55 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.725 0.763 . . . . 74.33 111.235 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -67.02 121.83 16.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.916 0.487 . . . . 74.12 111.282 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.58 1.71 90.54 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 115.837 -0.62 . . . . 60.11 114.297 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.34 146.46 36.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.043 0.537 . . . . 72.53 111.206 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -95.75 99.59 11.4 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.36 -0.607 . . . . 65.42 109.36 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.52 ' HB1' HD12 ' A' ' 9' ' ' ILE . . . -91.15 175.98 6.75 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.717 0.807 . . . . 52.55 112.724 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.9 m -136.13 138.67 42.26 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.118 -1.067 . . . . 74.44 108.118 169.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.4 t -83.45 126.88 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.213 0.605 . . . . 70.22 110.398 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.6 p -113.44 -2.07 14.02 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.406 0.682 . . . . 63.01 112.102 170.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.5 136.03 4.67 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 118.365 0.53 . . . . 75.34 113.004 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.01 107.68 13.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.848 0.859 . . . . 62.23 109.768 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -108.95 120.33 42.21 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.678 0.791 . . . . 73.42 110.669 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.94 87.01 3.18 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 108.644 -0.872 . . . . 71.54 108.644 174.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -137.24 174.95 10.06 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 112.858 0.688 . . . . 70.13 112.858 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.3 m -82.87 124.98 30.84 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.743 0.817 . . . . 74.21 110.306 172.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.02 120.4 37.11 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.187 0.995 . . . . 71.51 110.297 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -92.22 149.75 21.28 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.765 0.826 . . . . 74.32 112.538 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.96 111.61 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 107.764 -1.199 . . . . 73.5 107.764 170.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.511 HG13 HD11 ' A' ' 88' ' ' ILE . 27.1 m -114.3 165.72 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 112.869 0.692 . . . . 72.22 112.869 -172.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -135.68 123.88 23.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.829 0.852 . . . . 70.32 109.438 173.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -150.52 154.36 37.46 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 122.116 -0.365 . . . . 74.32 111.61 -170.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.3 m -104.52 115.32 63.02 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 107.856 -1.164 . . . . 75.24 107.856 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.95 133.22 56.53 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.628 2.218 . . . . 74.01 112.471 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.4 p -63.22 -14.64 51.5 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.27 1.028 . . . . 72.54 112.459 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -62.64 -17.69 60.89 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 124.333 1.053 . . . . 71.11 112.598 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.26 60.09 2.3 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 112.453 -0.259 . . . . 73.21 112.453 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 -152.31 8.04 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 115.626 -0.287 . . . . 74.22 113.695 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -81.2 126.92 32.1 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.222 0.609 . . . . 74.44 109.98 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.83 112.57 1.2 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.069 0.461 . . . . 74.14 110.452 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.426 HG23 ' SD ' ' A' ' 78' ' ' MET . 15.1 t -80.84 104.15 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.65 -0.704 . . . . 75.22 109.64 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -101.12 150.72 22.64 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.988 0.515 . . . . 64.23 109.942 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.1 m80 56.54 29.23 15.13 Favored 'General case' 0 CA--C 1.559 1.317 0 O-C-N 124.089 0.868 . . . . 72.14 111.754 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -61.99 127.46 31.5 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.948 0.899 . . . . 73.32 111.739 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -132.61 141.68 48.79 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.386 1.074 . . . . 65.42 109.947 -178.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 93.8 m95 -113.02 134.53 54.47 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 120.418 -1.426 . . . . 75.22 111.273 -7.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.75 148.36 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.456 -0.942 . . . . 75.53 108.456 169.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.8 pt -111.51 166.74 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 120.806 0.336 . . . . 74.42 110.983 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -53.15 -34.71 58.01 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.131 0.972 . . . . 73.11 113.405 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.6 -18.66 60.53 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 123.634 0.774 . . . . 74.31 112.382 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -90.5 1.31 56.8 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.255 0.622 . . . . 75.23 111.899 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 55.0 mt -121.62 125.37 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 124.059 0.944 . . . . 74.3 109.751 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -68.62 -54.48 16.2 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 118.193 0.451 . . . . 74.03 112.024 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.19 -4.33 17.17 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.183 0.809 . . . . 62.4 113.183 -177.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.501 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . . . -54.78 -30.4 56.67 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.995 0.739 . . . . 63.32 112.995 172.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.14 14.84 66.73 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 114.828 0.691 . . . . 74.35 114.828 170.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 59.31 23.14 11.55 Favored 'General case' 0 CA--C 1.566 1.565 0 C-N-CA 124.51 1.124 . . . . 75.23 112.016 -172.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -120.56 171.54 8.49 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.362 1.065 . . . . 74.04 111.341 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.3 m -77.36 109.35 11.2 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.273 0.629 . . . . 75.54 110.078 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 60' ' ' ALA . 86.9 mt -78.34 121.28 24.26 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.949 0.5 . . . . 75.2 110.784 174.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -88.97 150.7 45.91 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.891 0.876 . . . . 72.41 109.94 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -50.49 121.98 8.75 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.341 2.028 . . . . 71.25 113.239 173.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.93 -21.03 12.63 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-O 119.457 -0.635 . . . . 52.42 114.151 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -69.19 133.17 47.64 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.227 1.014 . . . . 72.32 111.936 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -100.37 121.43 41.5 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.388 0.675 . . . . 75.43 109.564 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.94 165.33 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.8 1.24 . . . . 72.45 110.982 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.93 137.95 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.897 -0.502 . . . . 64.41 111.186 175.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.8 mt -85.44 122.05 29.03 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.208 1.003 . . . . 74.54 111.203 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -87.54 -17.61 31.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.382 0.512 . . . . 65.55 112.382 171.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -88.51 162.67 16.3 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.333 0.587 . . . . 74.11 111.108 170.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -142.49 124.89 15.62 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.686 -0.688 . . . . 71.33 110.085 173.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -104.14 -4.19 23.48 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 123.789 0.836 . . . . 72.45 110.841 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.426 ' SD ' HG23 ' A' ' 46' ' ' VAL . 24.4 ptp -154.69 -179.16 7.74 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.3 0.64 . . . . 74.52 112.433 -173.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.69 108.97 0.71 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.817 0.847 . . . . 75.04 112.438 174.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.65 24.38 67.67 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 115.026 0.77 . . . . 61.52 115.026 172.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -75.91 -42.31 49.3 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.801 0.8 . . . . 73.12 111.551 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.33 123.74 21.2 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 120.506 0.193 . . . . 74.05 110.69 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.5 -18.34 57.12 Favored Glycine 0 N--CA 1.471 0.97 0 CA-C-N 116.206 -0.452 . . . . 62.52 113.12 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.12 137.23 56.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.243 0.617 . . . . 71.34 111.743 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.7 m -73.48 111.09 8.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.378 0.671 . . . . 74.33 110.519 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.26 147.61 27.29 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.165 0.986 . . . . 64.22 110.419 -175.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -130.35 129.18 42.82 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 108.79 -0.819 . . . . 75.14 108.79 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.511 HD11 HG13 ' A' ' 35' ' ' VAL . 47.1 mm -74.1 112.72 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.865 0.866 . . . . 74.22 111.54 -170.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.58 -41.42 27.19 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.068 0.947 . . . . 74.4 110.582 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.5 t -163.27 172.24 15.0 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 115.681 -0.69 . . . . 75.45 111.345 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.42 132.16 24.1 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.078 0.951 . . . . 71.13 110.609 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -125.97 141.52 51.93 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.583 0.753 . . . . 73.0 112.329 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -100.5 95.35 6.66 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.452 -1.314 . . . . 75.14 107.452 163.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.9 t -136.42 154.8 50.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.072 0.949 . . . . 74.13 110.6 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.9 p -78.33 124.05 27.67 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.532 -0.544 . . . . 70.34 109.532 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.83 133.01 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.87 0.868 . . . . 71.45 108.734 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -115.1 152.83 31.84 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.723 0.773 . . . . 74.43 112.487 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.444 ' SD ' ' HE3' ' A' ' 114' ' ' LYS . 59.1 ttp -100.57 112.4 24.77 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.496 -1.229 . . . . 73.32 108.134 171.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 29.7 m -120.89 151.82 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 112.543 0.571 . . . . 74.24 112.543 -172.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.67 117.09 28.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.283 1.033 . . . . 74.54 108.97 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -136.87 175.66 9.41 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.247 0.619 . . . . 71.12 111.385 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.3 m -107.63 126.08 52.13 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.728 -0.842 . . . . 74.42 108.728 169.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.8 t -60.87 108.06 0.8 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.919 0.488 . . . . 74.24 110.526 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.0 p -58.88 -24.31 62.07 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.367 1.067 . . . . 72.44 112.887 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.443 HG21 ' HG2' ' A' ' 15' ' ' LYS . 71.1 p -87.96 -60.04 2.08 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 123.325 0.65 . . . . 70.32 112.151 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.8 p -84.57 -37.17 21.51 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.421 0.526 . . . . 73.15 112.421 -173.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.08 -2.16 51.33 Favored Glycine 0 N--CA 1.48 1.604 0 CA-C-N 116.453 -0.339 . . . . 63.24 113.151 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.73 128.28 35.89 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.461 0.704 . . . . 64.35 111.895 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -75.52 96.84 3.58 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.045 -0.724 . . . . 72.13 109.045 174.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.72 114.49 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.191 0.597 . . . . 71.31 109.799 -175.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.464 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -112.02 144.77 40.83 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 120.986 0.422 . . . . 73.21 111.376 -175.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.0 m120 56.3 36.92 28.29 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.794 1.238 . . . . 64.02 113.152 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -64.54 137.95 58.13 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.505 0.722 . . . . 73.34 112.265 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.444 ' HE3' ' SD ' ' A' ' 98' ' ' MET . 99.7 mttt -138.88 144.19 39.05 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 124.487 1.115 . . . . 75.31 110.638 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 98.5 m95 -110.2 142.62 41.49 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.539 1.536 . . . . 75.32 112.263 -11.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.57 154.41 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.225 1.01 . . . . 73.12 109.147 166.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.4 p -100.82 177.5 4.96 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.289 0.495 . . . . 74.01 112.26 173.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -69.3 -43.13 74.43 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.049 0.54 . . . . 72.43 111.197 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.33 -14.95 62.8 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.556 0.742 . . . . 73.11 111.466 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.08 -21.84 56.28 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.228 1.011 . . . . 74.33 110.149 176.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.0 mt -117.18 178.49 4.34 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.968 1.307 . . . . 74.4 109.92 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.3 m -155.31 150.37 26.79 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.019 1.328 . . . . 71.3 107.81 166.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.457 ' HB2' ' HE2' ' A' ' 1' ' ' MET . . . -70.98 164.02 26.37 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.535 0.607 . . . . 74.33 112.586 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.5 tptt . . . . . 0 CA--C 1.56 1.331 0 C-N-CA 123.5 0.72 . . . . 65.04 111.416 176.391 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.406 ' HE1' ' HB2' ' A' ' 123' ' ' ALA . 5.2 tpt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.432 -0.581 . . . . 75.53 109.432 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -73.54 133.51 43.59 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.22 0.608 . . . . 74.1 112.152 -174.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.0 124.2 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 115.925 -0.579 . . . . 73.24 110.177 169.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.3 1.69 38.23 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.895 -0.593 . . . . 64.3 113.195 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.0 t -78.87 136.21 37.23 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.39 0.676 . . . . 75.33 111.591 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -87.71 110.74 20.66 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.005 -0.739 . . . . 74.13 109.005 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.21 160.0 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-O 121.63 0.728 . . . . 75.11 112.464 -168.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.59 137.53 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.12 0.968 . . . . 74.12 109.047 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.459 HD11 ' HB1' ' A' ' 20' ' ' ALA . 60.9 mt -79.46 118.87 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 109.684 -0.487 . . . . 73.41 109.684 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -77.66 -42.5 34.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.786 0.834 . . . . 74.03 110.48 -176.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.8 m -142.34 147.74 36.81 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.466 1.106 . . . . 74.5 110.142 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.7 p -155.14 157.47 37.48 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.119 0.485 . . . . 75.14 111.599 173.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -84.15 -17.79 38.88 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.007 -0.997 . . . . 74.51 110.705 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.468 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.4 mpt? -86.88 168.22 13.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.765 0.826 . . . . 64.41 110.131 169.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -87.8 -50.08 6.7 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.112 0.482 . . . . 74.23 110.685 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.21 -13.2 79.7 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 115.086 0.794 . . . . 74.22 115.086 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.4 ttp -89.01 -29.32 19.57 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.135 0.467 . . . . 72.14 111.315 -176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -69.09 122.04 17.94 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.61 0.364 . . . . 73.11 111.331 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.43 1.6 89.27 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.981 -0.554 . . . . 63.11 113.501 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.459 ' HB1' HD11 ' A' ' 9' ' ' ILE . . . -72.73 146.84 46.14 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.626 0.602 . . . . 62.22 112.626 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.84 98.84 4.97 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.363 0.665 . . . . 75.22 110.152 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -103.11 169.48 8.53 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.782 0.833 . . . . 63.44 112.307 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.5 m -141.05 134.59 30.0 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.57 -0.741 . . . . 74.42 109.195 168.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.23 114.05 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.914 0.486 . . . . 74.4 110.077 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.3 p -106.51 -4.12 20.1 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.063 0.545 . . . . 74.3 112.403 175.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.14 150.43 18.77 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-O 120.148 -0.251 . . . . 72.41 112.805 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.73 113.08 14.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.124 0.969 . . . . 71.01 110.336 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -114.17 115.76 28.0 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.793 0.837 . . . . 73.4 110.522 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -99.71 88.0 3.7 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 109.057 -0.72 . . . . 70.13 109.057 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.421 HG22 HD12 ' A' ' 53' ' ' ILE . 6.0 t -136.45 168.19 19.93 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.641 1.176 . . . . 74.43 111.133 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.7 m -75.31 129.93 38.22 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.886 -0.412 . . . . 64.24 109.886 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.7 154.93 20.76 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.751 0.821 . . . . 64.23 109.629 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -134.96 147.18 49.69 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.95 0.881 . . . . 74.45 112.129 -173.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.72 111.39 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 113.804 -1.544 . . . . 71.33 107.784 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.525 HG11 HD11 ' A' ' 88' ' ' ILE . 29.0 m -116.11 147.36 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.363 0.601 . . . . 75.51 112.214 -175.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -121.96 125.69 46.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.335 1.054 . . . . 71.52 110.057 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -147.1 158.49 43.95 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.431 0.692 . . . . 71.43 110.878 -172.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.6 m -109.87 111.46 58.66 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 108.824 -0.806 . . . . 74.41 108.824 174.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -46.82 118.29 2.6 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.719 2.946 . . . . 74.51 114.304 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.0 p -59.29 -24.68 63.48 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.903 1.281 . . . . 75.25 113.411 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -79.91 11.21 3.46 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 123.329 0.652 . . . . 73.44 112.107 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.03 51.61 3.72 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 121.97 -0.456 . . . . 73.25 112.729 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.53 163.89 12.39 Favored Glycine 0 C--N 1.344 0.991 0 N-CA-C 113.623 0.209 . . . . 75.13 113.623 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -60.19 132.91 55.4 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.398 0.679 . . . . 73.3 111.135 174.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.05 116.65 3.12 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.753 0.821 . . . . 74.32 111.626 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.461 HG23 ' SD ' ' A' ' 78' ' ' MET . 39.9 t -87.4 111.62 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 123.77 0.828 . . . . 74.35 109.657 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -104.32 138.78 40.25 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.682 0.793 . . . . 72.01 110.253 -173.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 54.42 40.48 31.81 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.151 0.98 . . . . 73.04 113.178 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.428 ' HB2' HG12 ' A' ' 46' ' ' VAL . 42.7 t60 -66.62 129.2 39.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.683 0.793 . . . . 62.52 111.118 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -135.48 151.42 50.36 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 123.793 0.837 . . . . 73.41 110.482 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -111.86 137.39 49.88 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.446 1.499 . . . . 71.45 112.293 -4.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.06 138.48 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.872 1.269 . . . . 73.33 108.002 169.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.421 HD12 HG22 ' A' ' 30' ' ' THR . 34.0 pt -106.59 170.84 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.705 -0.622 . . . . 75.44 111.617 -176.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -57.27 -35.17 69.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.744 0.818 . . . . 65.24 112.721 178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -71.14 -25.07 62.41 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 123.35 0.66 . . . . 70.53 111.691 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -86.72 -12.2 48.94 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 124.034 0.933 . . . . 74.41 112.102 -172.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.7 mt -107.88 137.96 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 124.062 0.945 . . . . 73.11 110.906 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -72.27 -54.01 10.82 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.301 0.64 . . . . 65.25 112.353 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.59 -10.2 17.26 Favored 'General case' 0 CA--C 1.568 1.667 0 C-N-CA 123.961 0.904 . . . . 63.24 113.156 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HA ' HD23 ' A' ' 65' ' ' LEU . . . -52.56 -65.89 0.48 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.714 0.806 . . . . 73.12 112.608 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.51 28.66 72.78 Favored Glycine 0 N--CA 1.478 1.485 0 N-CA-C 114.998 0.759 . . . . 71.25 114.998 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.38 13.66 6.22 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 124.191 0.996 . . . . 75.25 112.895 -171.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.656 ' HB3' ' HZ1' ' A' ' 63' ' ' LYS . 5.8 ttpm? -94.27 143.59 26.26 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.897 1.279 . . . . 75.01 110.218 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.6 m -71.48 109.27 5.34 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.139 0.576 . . . . 75.44 110.009 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.632 HD13 HG13 ' A' ' 71' ' ' VAL . 53.1 mt -78.74 128.58 33.61 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.438 0.695 . . . . 74.21 110.009 178.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -119.26 157.29 51.51 Favored Pre-proline 0 N--CA 1.487 1.376 0 C-N-CA 123.714 0.806 . . . . 71.42 110.315 -167.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -49.72 118.87 4.11 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.219 2.612 . . . . 73.1 114.308 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.95 -22.3 25.82 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 123.161 0.41 . . . . 75.45 113.875 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.55 138.62 51.12 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.529 0.664 . . . . 70.2 111.712 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -102.11 122.19 43.65 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.333 0.653 . . . . 73.43 110.569 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.632 HG13 HD13 ' A' ' 65' ' ' LEU . 30.2 m -120.98 166.74 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.059 0.944 . . . . 74.41 112.244 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mm -110.97 135.47 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.845 0.858 . . . . 71.44 110.107 173.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.7 mt -96.07 114.55 26.27 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.963 0.905 . . . . 75.44 111.118 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -78.33 -34.68 48.39 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.306 0.642 . . . . 72.04 111.425 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.66 165.13 18.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.312 0.645 . . . . 54.52 111.712 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 51.0 p -143.59 125.91 15.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.231 -0.895 . . . . 61.22 110.779 173.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -99.67 1.13 43.2 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.988 0.915 . . . . 72.43 109.694 167.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.461 ' SD ' HG23 ' A' ' 46' ' ' VAL . 23.5 ptp -156.02 166.24 34.04 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.332 1.053 . . . . 73.41 111.353 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -54.14 -32.15 54.43 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 115.456 1.65 . . . . 75.22 115.456 -169.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.29 26.64 6.31 Favored Glycine 0 N--CA 1.484 1.853 0 CA-C-N 118.054 0.388 . . . . 54.21 114.01 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.7 ttt -89.82 -41.62 11.73 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 117.185 0.492 . . . . 72.13 112.071 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 88.4 tttt -67.52 120.68 14.37 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 122.354 -0.216 . . . . 72.21 110.634 173.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.1 76.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.232 -0.44 . . . . 75.32 112.504 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.0 145.6 35.87 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-O 121.428 0.632 . . . . 74.34 111.696 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.5 m -88.27 122.5 31.87 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.779 -1.101 . . . . 70.13 109.0 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -118.74 162.89 17.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.893 0.877 . . . . 64.54 110.773 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -131.91 128.25 38.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.779 0.832 . . . . 73.34 109.815 175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.542 HG13 ' HB3' ' A' ' 65' ' ' LEU . 31.3 mm -66.48 116.42 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.646 0.779 . . . . 74.34 110.491 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -82.08 -36.75 27.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.487 0.715 . . . . 72.23 111.201 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.9 t -161.9 151.75 16.61 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.567 -0.742 . . . . 74.41 111.258 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.89 130.69 56.94 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.919 0.888 . . . . 72.25 109.353 172.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -134.68 119.97 18.94 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.211 0.604 . . . . 71.44 110.295 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 93' ' ' LYS . 6.8 mptt -90.31 93.79 9.48 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.173 -1.047 . . . . 74.22 108.173 -177.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.3 t -136.99 154.03 50.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.337 0.655 . . . . 74.53 110.945 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.8 m -80.77 128.11 33.28 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.146 -0.687 . . . . 64.44 109.146 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 m -120.53 135.71 59.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.572 1.149 . . . . 74.24 108.801 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.591 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 82.7 m-85 -109.72 157.27 19.29 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.108 0.956 . . . . 75.02 112.738 -171.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.515 ' SD ' ' HE3' ' A' ' 114' ' ' LYS . 35.7 ttp -100.28 117.59 34.81 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.071 -1.422 . . . . 74.14 107.699 165.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.7 m -125.07 148.25 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-O 121.37 0.605 . . . . 72.13 111.784 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.62 116.05 31.25 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.294 -1.002 . . . . 72.32 108.294 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -127.05 170.34 12.43 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.325 0.583 . . . . 75.43 111.978 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 m -112.07 111.2 21.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.205 -0.907 . . . . 75.4 109.071 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.8 m -57.21 96.82 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.209 -0.663 . . . . 65.33 109.209 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 52.0 p -56.83 -47.1 81.1 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.044 1.127 . . . . 74.13 114.044 -166.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.3 t -72.72 -32.23 65.56 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.392 0.515 . . . . 74.53 112.392 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.4 m -87.14 -26.93 23.37 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.545 0.738 . . . . 72.32 112.256 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.33 -22.2 10.98 Favored Glycine 0 CA--C 1.545 1.951 0 CA-C-N 116.004 -0.544 . . . . 73.23 114.313 -172.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -71.22 136.64 48.13 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.622 0.769 . . . . 75.31 112.094 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.33 131.63 44.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.629 0.771 . . . . 74.43 110.673 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.5 t -115.01 128.21 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.339 1.056 . . . . 71.32 109.302 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -107.19 143.44 35.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.006 0.522 . . . . 74.21 111.09 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.6 m120 58.78 39.5 24.09 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.281 1.432 . . . . 73.52 113.431 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -69.21 133.58 48.13 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.629 -0.714 . . . . 74.14 111.733 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.515 ' HE3' ' SD ' ' A' ' 98' ' ' MET . 96.7 mttt -142.47 145.77 34.07 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.565 1.146 . . . . 74.24 110.497 -175.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 87.5 m95 -106.98 122.32 46.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.703 1.601 . . . . 73.15 110.884 -9.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.7 m -99.37 154.81 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 109.208 -0.664 . . . . 73.14 109.208 170.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 31.7 m -113.81 158.16 21.37 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.827 0.451 . . . . 74.1 110.868 -175.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.591 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 67.0 tt0 -59.42 -35.83 74.72 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.189 0.519 . . . . 74.24 111.67 175.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -52.39 -32.96 41.32 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.816 1.247 . . . . 72.22 112.129 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -101.43 7.16 42.67 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.572 1.149 . . . . 70.11 112.5 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.2 mt -125.17 158.92 32.77 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.54 0.736 . . . . 74.23 110.871 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.2 t -148.05 140.89 24.73 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.026 0.93 . . . . 71.14 109.939 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.406 ' HB2' ' HE1' ' A' ' 1' ' ' MET . . . -75.69 130.25 38.4 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.628 0.371 . . . . 73.41 110.902 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.4 tttm . . . . . 0 CA--C 1.556 1.204 0 CA-C-O 121.183 0.516 . . . . 75.53 110.661 179.472 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 110.288 -0.264 . . . . 74.02 110.288 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -86.44 143.24 27.88 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.443 0.697 . . . . 74.31 111.633 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.5 t -66.58 126.58 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 C-N-CA 122.82 0.448 . . . . 73.23 110.215 170.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.97 -12.53 62.34 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 116.239 -0.437 . . . . 54.0 113.156 -171.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.3 t -88.66 161.04 17.09 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.259 0.623 . . . . 73.24 111.027 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -121.98 138.7 54.32 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.123 0.569 . . . . 62.51 111.207 -176.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.17 170.84 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 124.966 1.307 . . . . 73.33 111.118 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.5 mm -105.09 141.93 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.124 0.97 . . . . 75.21 109.814 171.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.629 HG22 ' HG2' ' A' ' 17' ' ' MET . 27.1 mm -65.04 129.31 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.5 0 C-N-CA 123.445 0.698 . . . . 73.24 111.263 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -108.07 -13.98 14.83 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.37 0.668 . . . . 65.34 111.604 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.9 m -145.49 139.17 26.62 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.241 0.616 . . . . 75.34 110.511 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.41 ' HA ' ' SD ' ' A' ' 17' ' ' MET . 58.8 p -113.49 118.5 34.66 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.301 0.64 . . . . 71.11 112.109 -173.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -89.58 -36.23 15.43 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.744 0.817 . . . . 74.11 109.441 169.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.45 ' HB3' ' HB2' ' A' ' 17' ' ' MET . 41.0 tpp -96.21 144.7 26.18 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.482 1.113 . . . . 75.44 108.901 175.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -23.72 66.74 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.331 0.863 . . . . 72.54 113.331 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.489 ' HA2' HG22 ' A' ' 105' ' ' THR . . . -89.84 -2.26 75.55 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 113.815 0.286 . . . . 73.52 113.815 174.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.629 ' HG2' HG22 ' A' ' 9' ' ' ILE . 49.8 ttm -81.39 -29.34 34.0 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.2 0.5 . . . . 75.05 110.942 -172.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.16 119.75 8.45 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.488 0.715 . . . . 73.33 112.144 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.96 1.27 87.29 Favored Glycine 0 N--CA 1.476 1.308 0 N-CA-C 114.519 0.567 . . . . 72.41 114.519 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.87 149.48 39.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.043 0.537 . . . . 72.02 111.661 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -92.72 102.87 15.28 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 122.984 0.514 . . . . 62.14 110.552 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.578 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -86.02 150.66 24.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.932 0.893 . . . . 60.2 111.766 -175.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.1 m -123.48 115.62 21.86 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.204 0.602 . . . . 72.24 109.763 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.47 96.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.272 0.629 . . . . 74.3 110.352 -174.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.8 p -98.59 -4.36 34.22 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.416 0.686 . . . . 60.43 111.448 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.92 139.46 6.61 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 111.984 -0.446 . . . . 53.12 111.984 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.61 108.69 12.31 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.808 0.843 . . . . 75.05 109.688 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -111.96 112.1 23.5 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.802 0.841 . . . . 71.0 110.338 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -94.98 82.76 3.85 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.494 0.664 . . . . 71.13 109.312 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.6 t -134.94 177.27 7.94 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.86 0.864 . . . . 70.25 111.72 -173.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.7 m -85.74 125.9 33.58 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 122.823 0.449 . . . . 75.2 110.192 173.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -103.53 154.45 19.46 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.648 1.179 . . . . 70.12 110.524 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.539 ' HB2' HG22 ' A' ' 52' ' ' VAL . 92.0 m-85 -137.61 146.03 43.47 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.715 0.769 . . . . 75.31 111.583 -174.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.85 121.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 106.939 -1.504 . . . . 75.11 106.939 167.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.8 m -123.02 162.18 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.479 0.657 . . . . 63.43 112.761 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 71.5 p -131.01 122.12 26.25 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.295 -0.866 . . . . 74.33 109.732 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -148.01 151.24 35.41 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.344 0.498 . . . . 75.33 112.344 -170.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.2 m -96.37 109.15 46.19 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 107.814 -1.18 . . . . 73.34 107.814 170.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.32 148.64 40.77 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.371 2.047 . . . . 65.14 112.901 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.8 p -64.27 -17.21 63.4 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.176 0.99 . . . . 74.35 113.029 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.446 ' N ' HD21 ' A' ' 41' ' ' ASN . 0.8 OUTLIER -70.54 -19.51 62.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.76 0.424 . . . . 74.54 111.197 172.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.26 24.75 65.22 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 114.898 0.719 . . . . 74.44 114.898 168.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.18 -96.49 0.35 Allowed Glycine 0 CA--C 1.537 1.428 0 CA-C-N 117.03 0.415 . . . . 61.21 112.746 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -116.83 142.19 47.25 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.707 0.803 . . . . 71.3 110.539 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -69.71 115.3 8.8 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.675 0.39 . . . . 75.21 110.501 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.431 HG13 ' HE1' ' A' ' 78' ' ' MET . 87.1 t -84.43 85.54 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-O 121.766 0.793 . . . . 74.11 109.837 176.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.0 p-10 -67.26 158.21 31.99 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.961 1.097 . . . . 71.51 113.961 163.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 42.3 m80 56.33 29.17 14.58 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 113.829 -1.532 . . . . 72.34 113.654 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -64.87 128.83 37.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.048 0.539 . . . . 74.43 111.167 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 98.3 mttt -129.66 133.75 47.29 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.801 0.84 . . . . 74.45 111.273 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.602 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 84.6 m95 -120.07 160.91 21.9 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.436 1.494 . . . . 72.24 111.159 -9.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 33' ' ' TYR . 19.3 m -127.83 141.88 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.334 1.054 . . . . 74.33 109.301 170.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.6 pt -106.97 167.63 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 122.129 -0.357 . . . . 74.25 111.632 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.493 ' HG2' ' HB3' ' A' ' 60' ' ' ALA . 53.6 tt0 -47.75 -57.35 5.69 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.847 1.054 . . . . 74.41 113.847 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -82.09 7.02 14.51 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 112.866 0.691 . . . . 71.53 112.866 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -91.59 -11.39 37.34 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.386 1.074 . . . . 64.41 110.506 172.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.8 mt -116.88 140.01 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 125.031 1.332 . . . . 75.35 109.382 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.455 ' HB3' ' HG2' ' A' ' 74' ' ' GLU . 16.0 ptmt -71.99 -36.21 69.7 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.758 0.651 . . . . 74.02 112.758 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -72.9 -8.99 58.16 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.756 0.822 . . . . 71.44 112.627 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.493 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . . . -33.69 -63.3 0.26 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.228 1.411 . . . . 74.13 114.69 176.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.7 19.98 65.69 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 115.269 0.868 . . . . 74.33 115.269 169.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.1 t70 71.81 -3.08 2.28 Favored 'General case' 0 CA--C 1.573 1.853 0 C-N-CA 125.336 1.454 . . . . 74.31 112.843 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.68 168.15 10.11 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.68 0.792 . . . . 74.34 111.72 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.0 m -90.91 119.37 31.05 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.296 0.639 . . . . 74.34 110.409 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.497 HD12 HG13 ' A' ' 71' ' ' VAL . 49.6 mt -73.69 118.16 16.32 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.194 0.598 . . . . 73.23 110.21 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -101.27 144.55 28.79 Favored Pre-proline 0 N--CA 1.489 1.52 0 C-N-CA 123.614 0.765 . . . . 72.42 112.172 -165.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.39 124.95 16.22 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 123.082 2.521 . . . . 54.03 114.324 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.2 -19.22 29.93 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 123.841 0.734 . . . . 73.25 113.393 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -74.35 148.49 41.24 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.546 0.739 . . . . 74.13 112.291 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -113.07 123.24 49.82 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.726 0.81 . . . . 73.14 111.216 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.497 HG13 HD12 ' A' ' 65' ' ' LEU . 26.9 m -121.42 177.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 125.392 1.477 . . . . 62.15 111.496 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 85' ' ' THR . 38.5 mm -120.52 137.0 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 123.935 0.894 . . . . 74.13 109.821 170.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.4 mt -90.43 121.54 32.5 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.097 0.959 . . . . 74.22 111.818 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.455 ' HG2' ' HB3' ' A' ' 58' ' ' LYS . 33.8 mm-40 -89.66 -4.06 57.95 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.447 0.536 . . . . 70.33 112.447 174.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.48 167.62 12.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.255 0.55 . . . . 73.55 111.056 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 t -141.96 125.01 16.23 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.503 -0.771 . . . . 65.2 111.683 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -98.73 -11.81 21.57 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.89 0.876 . . . . 74.32 111.527 170.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.431 ' HE1' HG13 ' A' ' 46' ' ' VAL . 20.4 ptp -144.14 -175.6 4.68 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.545 0.738 . . . . 63.43 111.951 -172.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -70.05 100.81 1.68 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.793 0.664 . . . . 73.11 112.793 -178.017 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.35 38.97 8.62 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.387 -0.824 . . . . 62.43 114.426 172.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.6 ttt -86.49 -28.98 23.1 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 117.402 0.601 . . . . 71.3 111.765 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -64.59 129.24 39.08 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 120.908 0.385 . . . . 72.41 111.848 172.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.23 -4.15 84.34 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.924 -0.58 . . . . 74.33 113.143 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.78 146.93 32.04 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.463 0.705 . . . . 71.21 111.588 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.431 ' HA ' HD13 ' A' ' 72' ' ' ILE . 57.9 m -84.11 117.06 23.21 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.989 -0.55 . . . . 70.43 109.699 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -106.5 152.81 23.18 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.529 0.732 . . . . 72.21 110.36 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -123.1 121.47 36.08 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.555 -0.906 . . . . 75.21 108.555 174.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.34 106.38 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.537 0.735 . . . . 73.42 110.133 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -76.59 -37.71 56.05 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.512 0.725 . . . . 74.51 109.735 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.0 t -159.77 158.62 31.53 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.671 -0.695 . . . . 74.14 111.286 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -135.17 139.33 44.49 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.957 0.903 . . . . 62.01 109.905 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -151.44 142.98 23.58 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.763 0.425 . . . . 65.02 110.751 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.505 ' HD2' ' H ' ' A' ' 93' ' ' LYS . 1.3 mptt -96.78 92.52 6.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 107.986 -1.116 . . . . 75.04 107.986 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.3 t -138.11 153.17 49.28 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.532 0.733 . . . . 74.05 111.337 -172.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.2 m -77.69 122.99 26.09 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.926 -0.398 . . . . 74.42 109.926 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.515 HG12 HG22 ' A' ' 117' ' ' THR . 24.0 m -109.31 134.2 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.728 0.811 . . . . 71.3 108.976 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -110.96 144.11 40.57 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.366 0.666 . . . . 73.5 111.684 -174.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.9 ttp -93.58 111.17 22.79 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.671 -1.233 . . . . 74.14 107.671 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.578 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 27.4 m -124.42 146.76 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 112.822 0.675 . . . . 73.2 112.822 -168.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.55 116.18 29.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.945 0.898 . . . . 75.12 109.827 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.411 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 50.8 p90 -130.96 175.5 9.03 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.188 0.595 . . . . 74.5 111.524 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.8 m -117.56 119.98 36.66 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.878 -0.786 . . . . 72.14 108.878 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 106' ' ' SER . 72.9 p -60.95 126.09 26.1 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.336 0.654 . . . . 74.21 111.558 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.5 p -70.71 -48.42 54.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.451 0.7 . . . . 64.3 112.87 -172.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.489 HG22 ' HA2' ' A' ' 16' ' ' GLY . 11.6 t -86.03 -4.2 59.11 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.304 0.853 . . . . 60.33 113.304 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.42 ' HB2' ' OG ' ' A' ' 103' ' ' SER . 16.5 m -119.12 -49.16 2.41 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.945 0.498 . . . . 75.23 111.4 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.5 -6.52 55.43 Favored Glycine 0 N--CA 1.481 1.635 0 CA-C-N 116.219 -0.446 . . . . 74.31 113.618 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.53 130.64 39.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.463 0.705 . . . . 74.44 110.894 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -81.3 100.61 9.27 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.837 -0.801 . . . . 74.33 108.837 178.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 113' ' ' HIS . 46.9 t -88.0 108.67 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.052 0.941 . . . . 73.44 110.004 -172.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.533 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -102.73 139.93 37.67 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.105 0.562 . . . . 74.33 111.777 -169.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.5 m120 51.67 36.99 18.86 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.509 1.123 . . . . 74.2 113.249 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.429 ' HB2' HG13 ' A' ' 110' ' ' VAL . 64.8 t60 -64.75 132.52 49.82 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.884 -0.598 . . . . 71.11 110.819 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -158.39 146.96 18.77 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 115.188 -0.915 . . . . 75.23 111.019 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.602 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 87.9 m95 -106.87 136.6 46.43 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.08 1.352 . . . . 73.21 112.735 4.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.4 m -122.16 141.58 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 124.881 1.272 . . . . 75.31 108.313 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.515 HG22 HG12 ' A' ' 96' ' ' VAL . 30.7 p -96.37 178.01 5.51 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.781 -0.574 . . . . 72.44 112.202 -174.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -59.65 -52.92 63.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.021 0.928 . . . . 75.34 112.868 -176.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.52 -21.15 66.6 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.942 0.897 . . . . 71.31 112.223 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -88.53 3.06 51.65 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.646 0.778 . . . . 74.22 111.521 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.6 mt -121.95 166.65 14.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.63 1.172 . . . . 70.32 109.289 171.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.3 t -151.13 130.78 13.09 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.439 0.696 . . . . 73.35 110.16 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.3 143.72 50.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.832 0.453 . . . . 73.41 111.524 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.3 tptt . . . . . 0 CA--C 1.556 1.199 0 C-N-CA 123.16 0.584 . . . . 73.44 111.039 178.774 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mmt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.952 -0.388 . . . . 63.13 109.952 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -100.8 154.24 18.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.38 0.672 . . . . 72.43 111.219 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.24 122.74 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 121.084 0.468 . . . . 62.0 110.397 173.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.7 -7.77 42.55 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 115.53 -0.759 . . . . 75.14 112.689 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -80.9 151.22 28.71 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.412 0.685 . . . . 71.23 112.349 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -93.06 136.96 32.84 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.163 0.985 . . . . 74.31 109.136 170.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.95 153.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.7 0.8 . . . . 74.15 110.308 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.8 mm -104.95 121.53 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.889 0.876 . . . . 74.24 109.828 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.464 HD13 ' HB1' ' A' ' 22' ' ' ALA . 35.3 mt -82.01 120.41 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 122.938 0.495 . . . . 74.23 109.886 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -96.86 -56.08 2.68 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.865 0.466 . . . . 70.35 110.833 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.482 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 84.3 m -95.3 140.03 30.77 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.85 -1.167 . . . . 75.54 107.85 174.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 17' ' ' MET . 79.6 p -154.71 141.28 18.86 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.976 0.732 . . . . 75.43 112.976 -164.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -75.18 -43.63 51.07 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.157 0.983 . . . . 75.34 109.6 174.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.474 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 25.3 mmt -96.34 140.42 31.03 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.377 -0.829 . . . . 74.44 110.535 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -60.96 -35.19 76.11 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.763 0.825 . . . . 71.13 111.468 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.46 -4.54 24.91 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 115.118 0.807 . . . . 73.13 115.118 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.509 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 48.6 mtm -99.52 -25.38 14.45 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 117.401 0.6 . . . . 72.14 111.678 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HZ1' ' HB2' ' A' ' 18' ' ' LYS . 4.3 ttmp? -68.34 116.93 9.48 Favored 'General case' 0 CA--C 1.556 1.178 0 CA-C-N 118.475 0.579 . . . . 74.51 110.375 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.81 2.0 89.81 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 115.383 -0.826 . . . . 44.13 113.689 -174.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.9 148.29 27.03 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.205 0.602 . . . . 73.42 111.797 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -95.18 104.26 16.14 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.643 0.777 . . . . 71.02 109.635 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.533 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -90.61 161.12 15.56 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.828 0.851 . . . . 74.3 112.189 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.4 m -124.11 121.77 36.05 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.363 -0.976 . . . . 63.32 108.363 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.07 100.4 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 122.8 0.44 . . . . 63.34 109.906 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.5 p -91.98 -8.1 47.11 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.167 0.587 . . . . 74.15 111.32 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.26 148.96 15.42 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.369 -0.378 . . . . 72.22 112.386 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.78 114.53 14.22 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.821 0.848 . . . . 52.31 109.915 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.44 ' HB2' HG21 ' A' ' 96' ' ' VAL . 5.9 m-85 -116.06 130.54 56.86 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.173 0.989 . . . . 73.31 111.155 -171.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -103.83 81.65 1.9 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.938 0.895 . . . . 75.24 110.319 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -133.88 166.15 23.34 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.088 0.555 . . . . 75.43 111.307 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.402 ' HB ' ' HG2' ' A' ' 54' ' ' GLN . 4.0 m -76.83 121.93 24.07 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.372 -0.603 . . . . 64.41 109.372 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.89 151.62 26.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.452 0.701 . . . . 74.24 109.635 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -136.42 149.18 48.14 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.934 0.873 . . . . 64.34 112.25 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.52 111.58 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 113.892 -1.503 . . . . 73.04 107.149 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.525 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 26.7 m -119.92 149.49 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.321 0.648 . . . . 75.12 112.165 -176.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.1 t -117.41 132.21 56.61 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.655 0.782 . . . . 71.4 109.908 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -150.71 156.1 40.64 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.09 0.472 . . . . 74.43 111.968 -173.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 m -109.3 111.66 59.79 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.332 -0.988 . . . . 74.21 108.332 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.79 117.2 3.11 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.376 2.718 . . . . 72.11 114.125 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.467 HG22 ' HA ' ' A' ' 84' ' ' ALA . 25.6 p -59.49 -24.4 63.57 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.741 1.216 . . . . 70.04 113.892 -173.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -79.38 14.69 1.47 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.483 0.713 . . . . 74.24 112.858 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.95 43.7 6.63 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 113.774 0.27 . . . . 64.34 113.774 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.93 163.61 12.94 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 122.708 0.194 . . . . 71.14 113.024 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -66.28 135.12 53.98 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.372 0.669 . . . . 74.55 111.099 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -58.19 116.83 3.82 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.584 0.754 . . . . 72.13 112.376 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' A' ' 49' ' ' HIS . 30.7 t -84.82 104.94 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.202 -0.908 . . . . 73.33 109.198 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -99.41 135.5 40.72 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.414 0.686 . . . . 75.52 110.668 -172.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.8 m170 57.45 39.06 28.36 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.233 1.013 . . . . 71.55 112.446 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.528 ' HB2' HG11 ' A' ' 46' ' ' VAL . 46.0 t60 -66.25 135.29 54.25 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.908 0.883 . . . . 70.51 110.701 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -150.81 153.61 35.75 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.889 -0.596 . . . . 74.23 110.46 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 98.0 m95 -106.43 139.61 40.63 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.39 1.476 . . . . 75.21 111.824 -2.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.5 137.43 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.333 1.053 . . . . 75.01 108.377 169.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.2 pt -113.74 174.1 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.965 0.506 . . . . 75.41 111.722 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.402 ' HG2' ' HB ' ' A' ' 31' ' ' THR . 14.1 mm100 -48.85 -49.16 40.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.57 1.322 . . . . 73.42 114.57 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.46 -1.22 40.66 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 122.856 0.462 . . . . 75.33 112.163 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.421 ' HG3' ' HB1' ' A' ' 75' ' ' ALA . 0.9 OUTLIER -83.81 -22.06 31.92 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.826 0.85 . . . . 71.52 110.27 175.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.4 mt -117.34 136.14 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 124.715 1.206 . . . . 72.35 111.079 -168.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.457 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 38.4 ttpt -72.01 -57.41 4.31 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.489 0.716 . . . . 64.1 111.539 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.09 -4.61 14.12 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.581 1.152 . . . . 74.21 113.685 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.705 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -54.55 -55.74 26.12 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.45 0.7 . . . . 75.22 112.006 171.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.91 19.79 65.93 Favored Glycine 0 N--CA 1.479 1.565 0 N-CA-C 114.676 0.63 . . . . 54.33 114.676 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 62.79 20.14 11.93 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.06 1.344 . . . . 73.15 113.813 -172.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.574 ' HZ2' HD22 ' A' ' 65' ' ' LEU . 16.6 pttp -98.32 160.18 14.46 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 122.914 0.486 . . . . 74.23 109.91 173.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.8 m -76.46 110.81 11.31 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.891 -0.411 . . . . 75.01 109.891 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.705 HD21 ' HA ' ' A' ' 60' ' ' ALA . 61.1 mt -74.68 114.07 12.68 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.267 0.627 . . . . 74.44 110.458 177.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -81.23 147.81 61.73 Favored Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 123.561 0.744 . . . . 73.05 111.731 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.42 114.63 1.65 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.836 2.358 . . . . 75.15 113.339 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.81 -14.21 24.39 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-N 115.826 -0.625 . . . . 61.23 113.96 -174.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -75.24 141.84 43.47 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.423 0.689 . . . . 75.34 111.03 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -111.38 133.22 53.84 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.536 0.684 . . . . 74.35 110.975 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.9 m -140.09 156.39 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 125.389 1.476 . . . . 73.33 110.634 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -103.46 136.13 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 122.853 0.461 . . . . 74.42 109.769 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.3 mt -87.44 120.88 29.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.167 0.987 . . . . 74.43 111.44 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 8.2 mm-40 -81.73 -36.97 28.01 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.317 0.647 . . . . 75.22 112.43 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HB1' ' HG3' ' A' ' 56' ' ' GLU . . . -83.73 164.99 19.26 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.058 0.456 . . . . 71.5 111.214 176.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 96.5 p -143.74 124.81 14.44 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.737 -0.468 . . . . 74.05 109.737 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -91.66 -4.28 55.37 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.777 0.831 . . . . 71.45 110.602 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -164.33 175.78 9.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.304 1.042 . . . . 74.14 111.141 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -80.4 116.38 20.43 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.352 0.661 . . . . 74.31 111.387 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.31 27.34 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 123.019 0.342 . . . . 75.33 113.821 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.9 ttt -82.53 -50.52 8.73 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.587 0.755 . . . . 73.34 112.906 -173.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -63.31 128.78 37.39 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.834 0.453 . . . . 73.32 111.893 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.2 -10.3 67.58 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.562 -0.29 . . . . 51.52 113.227 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.63 145.9 38.55 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.018 0.527 . . . . 73.34 111.775 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.0 m -84.17 117.25 23.37 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.693 -0.685 . . . . 72.54 109.554 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -110.95 149.27 30.9 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.758 1.223 . . . . 71.31 109.94 -175.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.47 132.24 52.71 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 109.483 -0.562 . . . . 73.32 109.483 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.507 HD11 HG11 ' A' ' 35' ' ' VAL . 30.4 mm -67.42 109.4 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.607 0.763 . . . . 73.1 110.354 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -78.06 -38.36 44.61 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.217 0.607 . . . . 74.12 109.743 172.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.2 t -154.92 141.15 18.55 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.458 -0.792 . . . . 75.43 111.301 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.16 131.89 52.07 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.907 0.883 . . . . 75.13 108.955 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -132.5 139.29 47.87 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.788 0.662 . . . . 74.52 112.788 -168.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -111.22 95.39 5.5 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.06 0.944 . . . . 73.0 109.414 169.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -137.56 157.25 46.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.116 0.966 . . . . 72.31 110.841 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.6 m -85.38 119.37 25.66 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.307 -0.997 . . . . 72.13 108.307 171.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.44 HG21 ' HB2' ' A' ' 28' ' ' TYR . 13.7 m -106.51 132.76 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.398 0.618 . . . . 63.14 109.624 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.406 ' HB2' HG21 ' A' ' 116' ' ' VAL . 89.7 m-85 -111.97 140.43 46.65 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.935 0.894 . . . . 70.34 111.231 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.8 ttp -94.21 119.88 33.65 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.268 -1.382 . . . . 72.51 107.268 167.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 23.5 m -128.03 156.56 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 113.789 1.033 . . . . 72.34 113.789 -171.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -110.29 118.28 35.91 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.124 1.37 . . . . 63.23 109.087 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -133.72 166.86 21.64 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.174 0.511 . . . . 71.21 110.947 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.4 m -105.61 119.14 38.37 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 108.791 -0.818 . . . . 75.55 108.791 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.8 m -56.84 95.98 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.754 0.821 . . . . 73.54 110.834 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.4 p -58.3 -26.0 62.51 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.351 1.06 . . . . 71.23 113.709 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 m -62.6 -38.3 89.63 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 123.734 0.813 . . . . 73.21 112.421 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.9 p -113.94 -50.76 2.81 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 123.357 0.663 . . . . 71.32 112.068 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.21 15.85 7.52 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.158 0.885 . . . . 71.35 111.945 -172.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -86.49 141.54 29.02 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.727 0.811 . . . . 52.14 111.547 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -85.01 117.71 24.15 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.752 1.221 . . . . 73.5 111.093 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -120.53 132.6 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 124.03 0.932 . . . . 73.32 110.591 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.8 168.7 9.82 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.263 0.625 . . . . 74.43 111.365 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.79 37.58 2.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 126.516 1.926 . . . . 74.42 115.221 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -61.53 133.0 55.2 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.483 0.713 . . . . 71.25 111.642 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 90.5 mttt -137.11 132.61 34.31 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.025 0.93 . . . . 74.23 110.951 -175.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.7 m95 -116.37 154.35 30.4 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.824 1.65 . . . . 74.15 111.564 -11.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.406 HG21 ' HB2' ' A' ' 97' ' ' TYR . 15.4 m -124.51 142.47 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.865 0.866 . . . . 61.03 109.637 172.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.1 p -109.98 168.26 9.56 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.52 0.563 . . . . 72.14 112.52 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -57.2 -35.23 69.37 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.678 0.791 . . . . 71.31 111.686 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.49 -43.01 93.4 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.34 1.056 . . . . 64.44 111.799 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.482 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 52.2 mt-10 -85.73 -2.79 58.56 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.903 0.881 . . . . 73.32 112.892 -172.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.07 150.49 40.49 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.636 0.731 . . . . 74.51 111.578 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 m -122.77 147.7 46.2 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.312 -1.366 . . . . 74.15 107.312 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.17 151.85 33.03 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.95 0.795 . . . . 72.33 111.692 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -65.62 -46.01 80.9 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.075 0.55 . . . . 73.04 110.766 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.5 tt -70.54 -64.94 0.8 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.697 0.799 . . . . 71.42 109.42 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.12 74.08 10.32 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.509 0.671 . . . . 72.21 110.298 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -76.44 145.61 39.17 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 115.551 -0.75 . . . . 74.44 110.013 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.9 m80 75.49 -21.65 0.3 Allowed 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 125.321 1.448 . . . . 71.42 112.741 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -70.37 105.02 2.88 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.731 0.812 . . . . 73.43 111.274 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -111.98 148.13 34.46 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.308 -0.86 . . . . 73.22 110.248 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -104.25 124.06 48.46 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.975 -0.75 . . . . 74.11 108.975 171.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 . . . . . 0 CA--C 1.566 1.573 0 CA-C-O 118.11 -0.948 . . . . 71.22 109.774 176.491 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.505 ' HG2' HG11 ' A' ' 7' ' ' VAL . 1.8 mpt? . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.431 0.158 . . . . 72.24 110.95 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -109.13 164.13 12.71 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.613 0.765 . . . . 74.54 110.392 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.2 123.06 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-O 121.132 0.492 . . . . 75.41 110.532 172.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.57 -4.37 50.61 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 115.797 -0.638 . . . . 64.2 113.572 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -83.41 142.86 30.68 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.222 0.609 . . . . 64.5 111.455 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -109.13 135.73 49.79 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.42 0.629 . . . . 75.53 111.005 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.544 HG13 ' HA ' ' A' ' 123' ' ' ALA . 23.7 m -139.81 155.29 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.967 1.307 . . . . 64.55 110.475 -170.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.1 mm -98.56 132.53 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.173 0.589 . . . . 73.13 109.714 170.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.673 HG21 ' HG2' ' A' ' 17' ' ' MET . 39.8 mt -81.71 123.34 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 122.387 0.275 . . . . 72.52 110.357 -175.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -95.11 -60.06 1.76 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.433 0.693 . . . . 75.14 110.247 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.633 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 79.7 m -98.24 140.03 33.14 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.073 -1.084 . . . . 74.41 108.073 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' A' ' 17' ' ' MET . 74.1 m -140.16 139.88 35.82 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.991 1.108 . . . . 64.3 113.991 -167.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -91.31 -15.92 28.34 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 113.994 -1.457 . . . . 75.41 110.417 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 26.5 mmt -126.56 155.43 42.44 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.646 1.179 . . . . 73.33 110.226 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -67.05 -36.9 83.06 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.095 0.558 . . . . 73.22 112.193 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.43 -9.98 86.58 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 114.046 0.379 . . . . 75.12 114.046 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.673 ' HG2' HG21 ' A' ' 9' ' ' ILE . 44.0 ttm -80.69 -32.1 36.01 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 122.69 0.396 . . . . 74.23 111.718 -172.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -68.87 122.34 18.42 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.13 0.572 . . . . 64.45 112.201 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.61 -8.48 79.05 Favored Glycine 0 CA--C 1.537 1.469 0 CA-C-N 115.729 -0.669 . . . . 71.12 114.147 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.18 149.68 42.73 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.169 0.588 . . . . 75.34 112.131 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -87.94 101.93 14.23 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.623 0.369 . . . . 73.55 110.04 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . . . -86.56 156.96 19.85 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.604 0.762 . . . . 73.12 111.374 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.0 m -131.25 127.51 37.95 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.454 -0.943 . . . . 73.4 108.454 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.95 113.83 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 123.207 0.603 . . . . 73.14 111.017 -173.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.4 p -89.9 -21.04 22.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.102 0.561 . . . . 74.34 110.53 173.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.6 142.57 8.52 Favored Glycine 0 C--N 1.354 1.547 0 C-N-CA 122.741 0.21 . . . . 65.32 112.612 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.98 107.55 9.7 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.66 0.784 . . . . 61.04 110.067 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -111.58 132.91 54.21 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.801 0.84 . . . . 75.44 110.674 -175.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.4 82.71 1.77 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.77 0.795 . . . . 75.33 109.97 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -134.96 -179.51 5.66 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.816 0.846 . . . . 75.53 111.321 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 m -83.91 128.26 34.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.918 -0.489 . . . . 74.45 110.383 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.11 140.18 48.1 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.141 0.976 . . . . 74.14 109.895 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -113.72 152.51 30.41 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 122.081 0.943 . . . . 74.32 112.6 -174.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.54 111.41 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.069 -1.423 . . . . 74.13 107.753 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 88' ' ' ILE . 19.3 m -112.39 150.85 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.386 0.612 . . . . 75.2 112.444 -176.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -122.0 125.57 46.59 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.298 1.039 . . . . 72.25 109.263 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -152.27 159.03 43.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.564 0.745 . . . . 74.55 111.294 -174.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.9 m -105.52 116.73 59.64 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.724 -1.213 . . . . 74.53 107.724 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -58.96 133.32 52.79 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.096 1.864 . . . . 74.13 110.873 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.1 p -68.83 2.06 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.109 0.781 . . . . 64.11 113.109 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.14 -21.2 66.04 Favored 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 123.663 0.785 . . . . 72.31 111.317 165.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.19 15.13 56.46 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 115.066 0.786 . . . . 64.34 115.066 171.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.62 -131.43 7.38 Favored Glycine 0 N--CA 1.476 1.357 0 CA-C-N 117.655 0.728 . . . . 25.55 113.688 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -71.21 128.27 35.36 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.919 0.888 . . . . 73.32 111.974 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -62.24 122.3 15.28 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.587 0.755 . . . . 72.3 111.938 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.574 HG22 ' SD ' ' A' ' 78' ' ' MET . 68.0 t -84.47 110.77 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.396 0.679 . . . . 71.13 110.256 176.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -101.44 148.33 25.31 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.903 0.481 . . . . 73.22 109.958 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 34.3 m80 54.59 38.95 30.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.732 0.813 . . . . 75.03 112.779 173.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -60.46 128.35 36.21 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.857 0.863 . . . . 71.41 111.198 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 66.1 mttm -126.3 132.68 51.6 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 123.504 0.722 . . . . 72.34 110.594 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 94.4 m95 -117.86 156.14 28.92 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.154 1.382 . . . . 71.23 111.53 -11.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.55 160.4 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.96 1.304 . . . . 75.43 108.169 169.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.435 HG23 HG23 ' A' ' 96' ' ' VAL . 37.4 pt -126.7 163.65 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 118.983 0.81 . . . . 65.41 112.546 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -44.14 -51.59 7.96 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.499 1.519 . . . . 64.43 112.538 174.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -82.15 -5.92 58.81 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.787 0.835 . . . . 74.55 112.97 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -88.32 -33.67 17.92 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.686 0.795 . . . . 62.31 110.234 173.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.8 mt -78.93 130.25 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 115.754 -0.657 . . . . 74.41 110.468 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -69.34 -35.45 75.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.492 0.717 . . . . 71.23 112.351 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.24 -8.9 58.35 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.971 0.73 . . . . 73.1 112.971 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -34.17 -59.43 0.43 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 114.945 1.461 . . . . 73.0 114.945 -173.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.51 21.01 68.4 Favored Glycine 0 N--CA 1.479 1.519 0 N-CA-C 115.352 0.901 . . . . 75.54 115.352 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 68.84 -2.94 1.57 Allowed 'General case' 0 CA--C 1.573 1.85 0 C-N-CA 124.862 1.265 . . . . 64.44 112.472 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -95.68 152.78 18.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.628 -0.67 . . . . 75.51 111.022 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.6 m -84.08 112.36 20.15 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.006 -0.739 . . . . 74.32 109.006 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.52 ' HB3' HG13 ' A' ' 88' ' ' ILE . 42.3 mt -71.31 120.5 16.98 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.817 0.847 . . . . 71.51 110.763 -174.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -91.19 157.48 42.7 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 123.682 0.793 . . . . 75.54 111.292 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -50.99 112.25 0.74 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.644 2.229 . . . . 72.04 113.163 172.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.64 -9.93 16.52 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 115.975 -0.557 . . . . 73.2 114.031 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.6 122.73 19.12 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 117.772 0.786 . . . . 74.5 109.495 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -100.91 118.35 36.78 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.471 -0.937 . . . . 75.15 108.471 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.417 HG12 HD12 ' A' ' 65' ' ' LEU . 33.3 m -125.29 171.92 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.607 1.163 . . . . 63.42 110.877 -166.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.3 mm -116.17 135.95 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 122.863 0.465 . . . . 64.51 110.033 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.9 mt -90.93 134.73 34.24 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.74 0.816 . . . . 75.24 110.996 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.16 -5.62 27.49 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 113.0 0.741 . . . . 75.55 113.0 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.6 156.27 16.89 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.139 0.575 . . . . 74.3 110.618 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.9 p -136.04 124.4 23.34 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.193 0.521 . . . . 65.31 110.319 171.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -100.35 -16.22 17.72 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.793 0.837 . . . . 75.14 108.991 162.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.574 ' SD ' HG22 ' A' ' 46' ' ' VAL . 43.3 mtt -128.57 173.42 10.28 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.39 1.076 . . . . 73.21 112.213 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.59 105.67 8.89 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.0 0.92 . . . . 73.4 110.836 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.1 33.58 17.34 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.23 -0.441 . . . . 72.11 113.207 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -89.59 -49.4 6.69 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.303 0.641 . . . . 73.43 109.97 173.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -69.04 120.57 15.1 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.34 0.656 . . . . 74.43 111.036 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.71 2.35 75.82 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 123.103 0.252 . . . . 71.35 113.263 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.44 158.09 19.06 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.4 0.68 . . . . 72.44 111.551 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 m -87.51 118.33 26.9 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.2 -0.909 . . . . 72.11 110.023 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -115.43 162.17 17.52 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.112 0.965 . . . . 72.13 110.114 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -130.75 130.28 43.57 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.051 0.54 . . . . 71.3 109.873 173.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.52 HG13 ' HB3' ' A' ' 65' ' ' LEU . 36.7 mm -64.78 104.61 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.503 0.721 . . . . 74.4 110.137 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.6 -37.59 65.38 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.696 0.798 . . . . 72.32 110.601 172.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.6 t -162.66 159.04 23.95 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.287 0.635 . . . . 62.22 111.829 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.42 150.52 39.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.518 1.127 . . . . 62.2 110.645 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -154.54 134.0 12.68 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 112.02 0.378 . . . . 71.42 112.02 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -93.59 96.57 9.94 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.105 -0.702 . . . . 73.33 109.105 172.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.8 t -137.09 154.4 50.32 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.621 0.768 . . . . 71.31 111.68 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.2 m -80.11 119.21 22.6 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.055 -0.72 . . . . 72.42 109.055 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.435 HG23 HG23 ' A' ' 53' ' ' ILE . 24.8 m -108.65 136.42 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.811 0.845 . . . . 71.14 110.728 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.07 146.62 36.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.358 1.075 . . . . 72.11 112.912 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.7 ttp -108.03 118.93 38.03 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 113.466 -1.697 . . . . 73.45 106.825 165.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.2 m -127.99 173.27 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 112.699 0.629 . . . . 74.31 112.699 -170.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.676 ' HB2' ' HD3' ' A' ' 111' ' ' LYS . 4.8 p-10 -138.16 133.48 33.38 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.127 0.571 . . . . 75.32 110.441 172.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.455 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 47.7 p90 -151.18 177.23 10.42 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.165 0.586 . . . . 75.42 111.571 -174.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.2 m -111.59 112.34 23.99 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.291 -1.003 . . . . 72.4 108.291 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.5 p -59.01 116.57 3.9 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.3 0.64 . . . . 54.43 111.281 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.4 p -58.07 -32.81 68.4 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.846 1.258 . . . . 75.32 113.876 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.4 p -87.82 -45.13 10.57 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.262 0.467 . . . . 73.2 112.262 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -89.04 -31.89 17.85 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.401 0.68 . . . . 74.52 112.548 -169.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.14 -6.1 83.82 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 116.228 -0.442 . . . . 52.32 113.592 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -77.26 132.76 38.84 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.161 0.984 . . . . 75.33 112.142 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -80.27 94.15 6.03 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.476 0.71 . . . . 73.13 109.395 174.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 113' ' ' HIS . 58.5 t -77.35 104.62 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.234 -0.893 . . . . 75.14 109.713 -176.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.676 ' HD3' ' HB2' ' A' ' 100' ' ' ASP . 74.9 mmtt -99.93 133.75 43.85 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.597 0.759 . . . . 73.23 111.697 -172.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 m120 61.58 35.66 17.19 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.299 1.04 . . . . 51.01 112.21 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.441 ' HB2' HG13 ' A' ' 110' ' ' VAL . 86.3 t60 -58.78 129.52 42.5 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.98 0.912 . . . . 71.22 112.23 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 19.2 ptpt -152.49 147.45 26.25 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.899 0.88 . . . . 73.43 110.787 -176.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 97.6 m95 -109.14 138.48 45.43 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.33 1.452 . . . . 73.42 111.77 -4.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.78 172.38 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.438 1.095 . . . . 73.33 108.895 170.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.41 ' OG1' ' HG2' ' A' ' 120' ' ' GLU . 30.3 p -118.58 178.22 4.54 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.362 0.665 . . . . 61.3 111.01 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -67.28 -28.18 67.8 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.455 0.302 . . . . 74.51 111.385 174.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.42 -15.27 53.25 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 122.939 0.496 . . . . 72.04 111.754 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.633 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 4.7 mm-40 -81.19 -18.82 44.89 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.199 0.523 . . . . 70.42 110.407 171.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.0 mt -115.05 159.18 21.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.024 0.93 . . . . 75.33 110.593 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.1 m -137.71 138.18 39.08 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.019 -1.104 . . . . 60.3 108.019 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.544 ' HA ' HG13 ' A' ' 7' ' ' VAL . . . -57.38 158.08 5.95 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.73 0.695 . . . . 63.44 111.454 176.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -54.01 -34.51 60.12 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.924 0.49 . . . . 71.13 112.026 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.7 tp -75.9 -49.72 17.07 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.666 0.786 . . . . 74.12 111.23 169.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -64.44 142.79 58.3 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.992 0.917 . . . . 74.41 113.202 -171.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -157.96 104.07 1.9 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.433 0.693 . . . . 75.42 110.496 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -137.83 98.12 3.59 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.61 0.764 . . . . 75.2 110.455 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -69.94 126.94 31.19 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.6 0.36 . . . . 71.21 110.747 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -147.35 -2.46 0.59 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.814 0.672 . . . . 74.23 112.814 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -166.01 167.56 16.42 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.456 1.102 . . . . 71.3 110.602 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 . . . . . 0 CA--C 1.562 1.406 0 C-N-CA 123.995 0.918 . . . . 71.1 110.493 173.609 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.56 ' HE3' ' HB2' ' A' ' 123' ' ' ALA . 24.9 mmt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.535 0.207 . . . . 71.44 110.93 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -70.97 157.14 38.72 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.464 1.105 . . . . 74.24 111.212 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -62.23 127.57 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 C-N-CA 122.589 0.356 . . . . 75.24 110.868 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.44 -3.62 56.52 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.246 0.45 . . . . 70.22 113.412 -175.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.8 t -73.15 127.85 33.78 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.229 0.612 . . . . 71.02 111.82 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -87.58 109.92 19.99 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.341 0.656 . . . . 74.51 110.14 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.424 HG22 HD11 ' A' ' 121' ' ' LEU . 30.4 m -125.99 157.66 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 124.011 0.924 . . . . 74.1 111.074 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.2 mm -105.54 136.99 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.344 1.057 . . . . 71.32 109.241 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 17' ' ' MET . 54.0 mt -76.76 118.43 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 CA-C-O 120.759 0.314 . . . . 74.22 110.192 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -84.54 -59.27 2.42 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.04 0.936 . . . . 71.42 110.127 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 94.0 m -91.88 139.69 30.41 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.527 -0.76 . . . . 73.11 109.767 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 14' ' ' MET . 80.6 p -130.34 122.42 27.86 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.091 0.472 . . . . 60.43 111.707 -174.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -83.12 -44.86 14.64 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.565 -0.902 . . . . 74.24 108.565 171.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.452 ' O ' ' HB2' ' A' ' 12' ' ' SER . 1.8 mpt? -94.18 130.9 40.22 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 114.164 -1.38 . . . . 73.33 107.536 166.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -63.0 -24.2 67.81 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 119.363 0.983 . . . . 72.25 113.234 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.01 -4.61 68.01 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 114.694 0.638 . . . . 74.02 114.694 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.429 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 35.0 mtp -84.97 -29.73 24.84 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.308 0.643 . . . . 73.2 110.722 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -67.94 117.73 10.2 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.571 0.348 . . . . 74.12 111.075 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.2 1.09 90.48 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 116.087 -0.506 . . . . 61.3 113.645 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.92 135.46 43.28 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.239 0.616 . . . . 72.33 111.141 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -82.29 103.94 12.24 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.641 -0.709 . . . . 73.42 110.323 -176.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.33 160.48 14.25 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.059 0.943 . . . . 70.44 113.301 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.3 m -133.14 136.36 45.73 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.841 1.257 . . . . 74.41 108.611 171.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 1' ' ' MET . 61.1 t -82.66 111.19 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 122.888 0.475 . . . . 73.55 110.868 -177.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.5 p -86.32 -19.9 29.14 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.824 0.45 . . . . 72.52 111.571 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.34 166.45 39.23 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 113.843 0.297 . . . . 54.23 113.843 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.63 138.51 47.39 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.091 0.957 . . . . 73.25 110.935 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.437 ' HB2' HG21 ' A' ' 96' ' ' VAL . 42.8 m-85 -128.55 111.84 13.67 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.32 1.048 . . . . 75.42 109.756 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -97.91 79.24 2.62 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.874 0.845 . . . . 72.4 110.401 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -133.91 170.89 14.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.658 0.783 . . . . 74.22 111.624 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -73.74 121.26 20.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.977 0.511 . . . . 71.33 109.879 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.35 147.86 43.08 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.638 0.775 . . . . 74.03 110.383 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -131.96 154.56 49.17 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.163 0.982 . . . . 75.33 112.591 -167.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 90' ' ' SER . 64.6 t -105.14 133.66 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 113.729 -1.578 . . . . 74.13 107.62 167.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.5 m -131.18 166.03 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.8 0.809 . . . . 75.12 112.788 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.2 t -132.92 127.78 35.07 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 114.38 -1.282 . . . . 74.31 108.658 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.496 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 43.8 p90 -155.87 160.27 40.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.596 0.758 . . . . 74.23 111.062 -171.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.1 m -109.28 119.48 48.31 Favored Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 108.783 -0.821 . . . . 65.44 108.783 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.27 133.17 45.0 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.127 1.885 . . . . 60.4 111.902 172.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.8 p -65.19 -7.28 12.02 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.99 0.916 . . . . 72.05 113.081 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.33 -18.0 60.29 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 124.728 1.211 . . . . 71.04 113.046 171.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.69 57.46 3.54 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 111.624 -0.59 . . . . 75.52 111.624 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.47 -155.56 8.16 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 115.007 -0.597 . . . . 72.04 113.005 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -69.48 119.05 13.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.469 0.708 . . . . 71.1 110.808 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -56.95 116.28 3.11 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 109.317 -0.623 . . . . 73.55 109.317 168.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.477 HG12 ' HB2' ' A' ' 49' ' ' HIS . 40.7 t -88.67 115.51 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 123.311 0.645 . . . . 74.43 110.154 -176.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -109.35 155.69 20.91 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.376 0.671 . . . . 75.41 110.491 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.2 m170 57.82 26.4 13.15 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.902 0.881 . . . . 74.45 112.376 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.477 ' HB2' HG12 ' A' ' 46' ' ' VAL . 84.9 t60 -71.65 136.95 47.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.811 0.844 . . . . 74.33 110.908 -178.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -158.11 148.71 20.56 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-N 116.313 -0.403 . . . . 74.44 111.508 -176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -107.59 147.75 30.2 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.022 1.329 . . . . 72.05 111.471 -0.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.92 135.5 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.436 1.095 . . . . 74.23 108.272 172.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.5 pt -115.53 169.98 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.284 -0.885 . . . . 74.41 112.754 -168.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -50.85 -39.76 54.42 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.299 1.039 . . . . 73.31 113.791 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -72.61 -20.86 61.21 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.479 0.712 . . . . 75.14 111.882 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.465 ' HG3' ' HB2' ' A' ' 75' ' ' ALA . 27.3 tt0 -91.98 -24.76 19.14 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.59 0.756 . . . . 73.21 111.446 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.1 mt -101.22 129.36 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.867 0.867 . . . . 74.42 110.35 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -72.02 -57.09 4.58 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.581 0.705 . . . . 72.1 111.567 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.99 -2.99 6.02 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.687 1.195 . . . . 74.04 113.98 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.519 ' HA ' HD12 ' A' ' 65' ' ' LEU . . . -39.53 -58.34 1.29 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.126 1.37 . . . . 74.31 114.166 171.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.07 27.6 73.5 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 114.76 0.664 . . . . 73.33 114.76 174.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 63.17 16.56 9.48 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.686 1.194 . . . . 71.34 113.561 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 14.5 ptpt -105.6 167.94 9.43 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 122.882 0.473 . . . . 75.13 111.18 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.4 m -82.87 108.95 16.58 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.742 -0.836 . . . . 74.14 108.742 169.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.631 ' HB3' HG13 ' A' ' 88' ' ' ILE . 86.9 mt -75.91 138.37 40.99 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.47 -0.567 . . . . 72.43 109.47 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -118.19 161.39 35.1 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 123.713 0.805 . . . . 73.33 111.275 -169.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -44.71 106.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.082 2.521 . . . . 73.04 113.937 171.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.48 -12.8 15.86 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 114.901 0.72 . . . . 61.51 114.901 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.95 100.46 1.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.252 1.026 . . . . 71.14 111.305 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -79.93 122.58 26.87 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 115.996 -0.547 . . . . 70.3 110.726 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.98 173.14 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 125.115 1.366 . . . . 73.35 111.68 -170.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.0 mm -115.13 139.79 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 123.845 0.858 . . . . 74.41 110.41 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.28 123.31 35.52 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.758 0.823 . . . . 64.12 111.76 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -79.98 -44.87 19.45 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.827 0.851 . . . . 73.33 112.457 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.465 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . . . -83.56 174.17 10.8 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.27 0.557 . . . . 74.01 111.542 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 80.0 p -143.73 126.28 15.92 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.05 -0.523 . . . . 71.35 111.055 175.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.468 ' H ' ' HG2' ' A' ' 81' ' ' MET . 19.9 m-70 -91.5 -23.48 19.94 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.991 0.916 . . . . 65.34 110.868 171.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -155.96 -176.9 6.2 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.838 0.855 . . . . 74.53 110.839 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -65.74 131.63 46.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.411 0.684 . . . . 74.13 112.213 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.64 10.93 84.61 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 115.871 -0.604 . . . . 65.25 114.567 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.468 ' HG2' ' H ' ' A' ' 77' ' ' HIS . 11.6 tpt -84.97 -52.43 5.99 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.58 0.752 . . . . 75.43 110.644 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 86.9 tttt -66.54 129.0 38.38 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.387 0.675 . . . . 75.12 111.379 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.11 -9.25 73.34 Favored Glycine 0 N--CA 1.476 1.316 0 O-C-N 123.004 0.19 . . . . 70.51 113.186 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 152.84 30.58 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.386 0.675 . . . . 65.53 111.118 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.7 m -90.26 120.07 31.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.228 -0.897 . . . . 74.03 109.774 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.496 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -104.15 162.97 12.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.885 0.874 . . . . 44.41 109.428 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -137.71 126.95 24.56 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.055 -0.72 . . . . 70.22 109.055 168.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.631 HG13 ' HB3' ' A' ' 65' ' ' LEU . 26.1 mm -60.47 110.27 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.381 0.672 . . . . 75.11 110.357 -177.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -77.93 -36.37 49.41 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.167 0.987 . . . . 71.4 110.284 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.526 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 47.3 t -160.1 163.27 33.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.353 1.061 . . . . 75.32 110.277 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.64 148.12 51.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.493 0.717 . . . . 75.54 111.535 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -156.05 148.27 23.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.302 0.482 . . . . 73.43 112.302 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.51 95.44 7.0 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 107.757 -1.201 . . . . 73.14 107.757 163.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 t -136.26 154.55 50.87 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.302 0.641 . . . . 73.12 110.317 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.8 m -84.99 120.48 26.57 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.383 -0.599 . . . . 62.43 109.383 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.437 HG21 ' HB2' ' A' ' 28' ' ' TYR . 13.4 m -107.67 132.68 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.875 -0.787 . . . . 75.15 108.875 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.527 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 96.3 m-85 -109.62 166.7 10.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.489 1.138 . . . . 75.14 112.648 -171.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.2 ttp -120.96 111.09 17.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 112.832 -1.986 . . . . 74.35 107.199 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.26 147.11 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 112.921 0.711 . . . . 74.02 112.921 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 111' ' ' LYS . 4.6 p30 -105.51 138.03 42.38 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.612 0.765 . . . . 74.13 110.165 172.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -156.69 178.25 10.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.642 0.777 . . . . 73.4 111.126 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.0 m -118.11 114.57 23.29 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.438 0.695 . . . . 71.44 109.242 173.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -56.85 109.3 0.61 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.679 0.792 . . . . 75.41 111.02 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.8 p -54.47 -31.17 55.2 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.669 1.188 . . . . 73.03 113.293 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.6 m -64.54 -60.77 2.75 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.392 0.677 . . . . 61.24 112.313 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 36.2 m -101.92 -12.95 17.83 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.296 0.85 . . . . 64.4 113.296 -166.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.5 12.32 83.76 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 113.723 0.249 . . . . 63.24 113.723 -172.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -71.38 125.51 27.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.709 0.804 . . . . 72.45 112.314 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -75.98 96.8 3.85 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.786 0.435 . . . . 75.31 109.94 171.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.65 107.88 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 109.458 -0.571 . . . . 74.41 109.458 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 92.5 mttt -106.78 143.84 34.29 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.647 0.379 . . . . 75.1 110.948 -174.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 54.62 39.43 31.22 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.151 0.981 . . . . 73.13 113.151 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -61.79 131.74 50.84 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.646 0.778 . . . . 75.43 111.399 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 97.5 mttt -134.76 146.61 49.54 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.301 1.04 . . . . 74.41 110.492 -175.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 85.1 m95 -109.54 127.55 54.56 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.658 1.583 . . . . 73.44 110.513 -10.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.6 m -119.63 162.09 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 C-N-CA 124.452 1.101 . . . . 72.25 109.814 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 50.0 p -117.82 171.12 8.27 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.931 0.715 . . . . 74.43 112.931 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.527 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 38.0 tt0 -67.18 -32.17 73.08 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.715 0.806 . . . . 72.4 111.891 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -70.76 -20.12 62.65 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.245 0.618 . . . . 73.43 111.948 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -91.87 4.06 53.76 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.602 0.761 . . . . 74.13 111.666 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.424 HD11 HG22 ' A' ' 7' ' ' VAL . 81.8 mt -121.11 171.92 8.34 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.861 1.265 . . . . 75.24 109.612 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.8 m -147.22 122.54 10.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.681 0.792 . . . . 64.35 109.962 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.56 ' HB2' ' HE3' ' A' ' 1' ' ' MET . . . -68.08 111.11 4.27 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.885 0.474 . . . . 74.11 110.871 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -84.08 83.18 8.05 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 121.486 0.66 . . . . 75.45 110.899 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.1 tp -77.53 -56.96 4.09 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.661 0.784 . . . . 75.22 109.685 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.2 178.54 4.74 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.862 0.839 . . . . 72.42 112.361 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -45.94 127.25 8.11 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 125.412 1.485 . . . . 73.32 113.328 166.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -135.39 108.21 7.55 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.411 1.085 . . . . 74.43 110.283 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -110.43 104.81 13.61 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.575 0.75 . . . . 74.23 109.392 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -63.32 125.96 25.85 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.85 0.685 . . . . 74.31 112.85 -170.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -117.59 118.05 31.08 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.223 1.009 . . . . 73.01 110.192 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.8 m80 . . . . . 0 N--CA 1.494 1.761 0 C-N-CA 124.855 1.262 . . . . 74.12 112.755 179.599 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mmt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.695 0.283 . . . . 75.41 111.037 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -105.92 157.99 17.09 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.576 0.75 . . . . 74.34 109.913 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.97 122.76 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 CA-C-O 121.193 0.521 . . . . 71.51 110.118 170.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.77 -6.52 48.43 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-N 115.323 -0.853 . . . . 72.32 112.966 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.7 m -75.15 128.15 34.83 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.019 0.527 . . . . 42.22 111.559 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -85.57 117.58 24.56 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.282 -1.007 . . . . 72.14 108.282 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.4 HG13 ' HA ' ' A' ' 123' ' ' ALA . 27.2 m -125.09 150.84 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.287 0.635 . . . . 74.14 111.777 -174.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.1 mm -98.77 128.55 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.364 1.065 . . . . 72.43 108.406 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.405 HG23 ' HG2' ' A' ' 17' ' ' MET . 24.3 mt -91.58 115.89 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.872 -0.418 . . . . 74.13 109.872 -173.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -93.36 -24.44 18.09 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.065 0.546 . . . . 72.31 112.306 -171.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 m -110.62 142.57 42.3 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.401 0.68 . . . . 71.51 109.594 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' MET . 78.0 p -123.62 120.26 32.27 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.827 0.677 . . . . 73.41 112.827 -173.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -84.81 -41.75 15.8 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.23 1.012 . . . . 73.23 108.503 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.455 ' O ' ' HB2' ' A' ' 12' ' ' SER . 24.1 mmt -100.65 137.26 39.29 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.057 0.943 . . . . 74.42 108.698 167.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.525 ' HG3' HG22 ' A' ' 105' ' ' THR . 17.6 ptpt -60.65 -31.23 70.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.22 0.822 . . . . 74.22 113.22 -175.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.04 0.59 72.42 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 114.062 0.385 . . . . 74.3 114.062 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.405 ' HG2' HG23 ' A' ' 9' ' ' ILE . 39.6 ttp -99.04 -15.44 19.04 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.053 0.541 . . . . 63.2 110.893 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -65.96 117.0 7.69 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.171 0.588 . . . . 75.55 110.16 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.71 2.51 70.12 Favored Glycine 0 CA--C 1.542 1.772 0 N-CA-C 114.358 0.503 . . . . 54.34 114.358 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.38 146.34 43.06 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 117.575 0.687 . . . . 65.41 112.76 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -85.21 131.2 34.46 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.672 0.789 . . . . 72.33 110.219 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 100' ' ' ASP . . . -141.6 172.1 13.15 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.314 0.857 . . . . 74.14 113.314 -170.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.7 m -140.72 138.2 34.04 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.02 0.928 . . . . 74.23 109.801 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -81.76 112.93 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.371 0.669 . . . . 74.44 109.974 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.9 p -99.55 -4.99 29.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.749 0.82 . . . . 64.14 112.297 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.85 149.6 17.07 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 120.09 -0.283 . . . . 55.31 112.56 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.75 114.46 10.52 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.525 0.73 . . . . 75.0 110.464 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -115.42 111.92 21.53 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.972 0.909 . . . . 74.22 111.233 -173.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.97 80.28 5.76 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 122.163 0.982 . . . . 62.01 109.856 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -133.61 174.63 10.22 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 115.69 -0.686 . . . . 71.34 111.987 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.1 m -82.5 119.53 24.34 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.894 0.478 . . . . 71.35 109.87 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.96 162.63 13.42 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.639 1.176 . . . . 63.41 109.286 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -139.54 149.02 43.4 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.683 0.754 . . . . 73.44 111.26 -173.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.9 121.13 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 106.677 -1.601 . . . . 72.14 106.677 168.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.0 m -124.3 151.35 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 118.881 0.764 . . . . 62.41 112.681 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.5 p -119.52 125.45 48.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.168 0.987 . . . . 74.5 109.132 171.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.46 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 49.4 p90 -147.46 152.6 38.35 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.702 0.401 . . . . 74.4 112.057 -172.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.9 m -99.17 106.61 39.62 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 108.122 -1.066 . . . . 74.34 108.122 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.11 146.1 23.81 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.55 2.833 . . . . 55.13 113.984 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.5 p -66.09 -16.57 64.05 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.79 0.836 . . . . 71.05 112.554 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.57 -20.82 65.96 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 123.224 0.609 . . . . 71.31 111.292 170.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.06 14.72 76.48 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.682 -0.69 . . . . 71.21 114.483 172.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.53 -112.55 0.37 Allowed Glycine 0 CA--C 1.539 1.583 0 CA-C-N 117.272 0.536 . . . . 74.12 113.536 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -106.53 142.75 35.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.355 0.662 . . . . 74.25 111.259 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -66.91 133.94 51.02 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.374 0.669 . . . . 74.52 111.687 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.545 HG21 ' HE2' ' A' ' 78' ' ' MET . 41.6 t -91.48 118.8 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 124.1 0.96 . . . . 71.22 110.099 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -102.1 138.28 39.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.324 0.65 . . . . 74.41 110.493 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 m170 57.28 41.92 25.97 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.191 0.996 . . . . 75.44 113.351 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -67.1 124.18 22.33 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 116.07 -0.514 . . . . 75.5 110.654 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 31.3 mtmm -131.49 144.59 51.25 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.86 0.864 . . . . 74.21 110.216 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 94.4 m95 -112.69 141.66 46.22 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.347 1.459 . . . . 75.51 110.624 -9.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.86 142.48 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.696 -0.853 . . . . 74.25 108.696 170.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.1 pt -110.55 167.34 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 O-C-N 121.934 -0.479 . . . . 74.31 110.862 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -53.65 -35.02 60.54 Favored 'General case' 0 CA--C 1.563 1.442 0 C-N-CA 123.976 0.91 . . . . 73.15 113.201 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -67.21 -24.95 65.89 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.415 0.686 . . . . 73.34 112.296 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -91.44 1.47 57.1 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.548 0.739 . . . . 75.31 112.096 -175.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.7 mt -108.78 131.65 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.904 0.882 . . . . 73.31 110.151 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -72.65 -42.42 64.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.056 0.942 . . . . 75.31 112.019 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -78.71 -10.4 59.75 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.701 0.8 . . . . 73.34 112.35 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.45 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -43.45 -58.33 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.872 1.064 . . . . 72.01 113.872 -173.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.94 31.31 78.03 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 116.502 1.361 . . . . 73.43 116.502 167.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.8 t70 73.76 -10.58 1.06 Allowed 'General case' 0 CA--C 1.578 2.027 0 C-N-CA 124.551 1.14 . . . . 62.35 113.06 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 24.2 pttm -90.53 153.68 20.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.497 -0.752 . . . . 70.15 110.865 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.7 m -85.87 129.82 34.72 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.183 0.593 . . . . 75.12 109.645 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.8 mt -88.79 146.21 25.13 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.508 0.723 . . . . 72.15 111.492 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.58 158.68 42.81 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 124.966 1.306 . . . . 71.32 109.523 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.65 114.04 1.51 Allowed 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.621 2.214 . . . . 73.32 112.991 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.02 -17.52 12.79 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 115.23 -0.895 . . . . 72.15 114.426 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.0 125.99 27.73 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 117.936 0.868 . . . . 75.4 111.131 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.55 124.95 50.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.286 0.635 . . . . 73.24 109.913 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.71 174.74 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.84 1.256 . . . . 75.54 111.307 -169.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.3 mm -111.7 142.31 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 123.364 0.666 . . . . 74.11 109.741 170.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.1 mt -89.41 126.99 35.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.469 0.708 . . . . 74.44 112.26 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -87.29 -22.89 24.88 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.833 0.853 . . . . 75.05 111.847 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.86 158.93 19.83 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.048 0.451 . . . . 75.22 111.831 174.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.652 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 25.4 t -137.86 122.86 19.05 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.278 -0.874 . . . . 73.3 108.707 169.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -107.26 -9.52 16.06 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.045 0.538 . . . . 75.24 111.048 173.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.545 ' HE2' HG21 ' A' ' 46' ' ' VAL . 58.7 mtm -138.15 -175.75 4.21 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.588 1.155 . . . . 74.51 110.31 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -72.84 131.72 42.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 122.017 -0.427 . . . . 75.24 110.898 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.22 20.28 60.49 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 114.574 0.59 . . . . 74.44 114.574 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.54 ' SD ' ' HA ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -77.89 -43.26 30.66 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.6 0.76 . . . . 73.55 110.954 -174.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.652 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 88.8 tttt -65.36 134.85 54.43 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.975 0.51 . . . . 74.54 111.55 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.66 65.11 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.178 -0.464 . . . . 60.05 112.8 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.91 143.18 56.99 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.571 0.748 . . . . 73.12 112.243 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.0 m -77.95 105.92 9.47 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.737 -0.665 . . . . 73.3 109.931 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -103.77 150.11 24.39 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.23 1.012 . . . . 63.34 110.946 -172.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.43 128.98 44.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.319 -0.623 . . . . 75.55 109.319 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.0 mm -64.77 106.47 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 122.891 0.477 . . . . 74.43 110.009 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.39 -36.25 58.19 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.911 0.885 . . . . 75.35 109.991 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.1 t -158.57 147.78 19.09 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.661 0.784 . . . . 72.43 110.563 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.14 133.3 56.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.467 0.707 . . . . 75.11 110.55 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -145.07 123.76 12.55 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.734 0.814 . . . . 73.52 111.139 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.581 ' HZ2' ' HB2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -91.26 97.19 10.97 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.238 -0.653 . . . . 63.01 109.238 175.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.5 t -135.54 154.71 51.29 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.756 0.822 . . . . 74.13 111.108 -173.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.2 m -81.98 120.72 25.6 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.62 -0.881 . . . . 75.32 108.62 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 11.4 m -110.48 133.33 56.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.892 0.877 . . . . 75.0 108.952 -176.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.07 145.26 38.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.192 0.997 . . . . 75.03 111.511 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.7 ttm -92.51 120.87 33.4 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.31 -1.367 . . . . 73.44 107.31 166.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.69 152.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.627 0.771 . . . . 73.14 111.814 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 5.7 t70 -117.81 114.4 23.22 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.298 1.039 . . . . 72.12 109.002 175.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -129.0 170.48 13.41 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.48 0.657 . . . . 75.41 112.203 -174.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.0 m -114.02 127.78 56.1 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.06 -0.719 . . . . 55.33 109.06 170.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.9 t -64.7 125.52 25.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.962 0.905 . . . . 73.54 112.548 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 70.5 p -71.23 -36.67 71.9 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.937 0.895 . . . . 74.41 112.424 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.525 HG22 ' HG3' ' A' ' 15' ' ' LYS . 11.0 t -80.12 -40.0 28.34 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.946 0.721 . . . . 70.22 112.946 -175.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.6 p -113.83 -24.84 8.91 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 112.332 0.493 . . . . 73.34 112.332 -172.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.15 7.56 80.0 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-O 119.89 -0.395 . . . . 70.35 113.877 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -78.99 133.34 36.85 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 117.288 0.544 . . . . 74.43 111.323 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -83.09 109.74 17.41 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 109.206 -0.665 . . . . 74.41 109.206 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.23 127.09 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.975 0.91 . . . . 62.32 110.704 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.84 157.36 27.75 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.503 0.721 . . . . 75.44 111.548 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 57.66 30.67 19.22 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.428 1.091 . . . . 71.23 111.616 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -73.76 135.84 43.59 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.053 0.541 . . . . 73.02 111.179 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -164.41 154.46 14.31 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 122.964 0.505 . . . . 70.13 111.903 -172.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.505 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 81.9 m95 -106.53 137.14 45.08 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.747 1.619 . . . . 72.03 112.039 1.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 m -120.23 144.44 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.279 1.032 . . . . 74.02 109.452 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.3 p -100.31 178.41 4.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.487 -0.758 . . . . 63.43 112.014 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -56.38 -50.81 70.48 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.338 1.055 . . . . 71.0 112.336 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -66.53 -17.9 65.07 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.591 0.756 . . . . 71.32 113.02 -178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -90.37 -6.2 55.29 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.062 0.545 . . . . 74.42 111.482 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 75.2 mt -115.23 160.7 19.42 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.376 1.07 . . . . 75.52 109.47 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -146.6 120.75 9.48 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.166 -0.679 . . . . 72.13 109.166 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HA ' HG13 ' A' ' 7' ' ' VAL . . . -62.99 139.87 58.81 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.029 0.531 . . . . 65.34 112.028 -174.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -64.37 87.39 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.865 0.84 . . . . 74.15 110.65 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.7 mt -145.26 142.75 29.77 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.042 1.337 . . . . 72.33 109.744 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -77.12 -13.53 59.93 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.48 0.712 . . . . 73.13 111.186 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -52.14 -32.49 35.94 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.296 1.038 . . . . 74.25 112.178 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -119.94 102.94 8.91 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.365 0.666 . . . . 75.52 109.4 170.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.98 122.22 14.93 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.712 -0.848 . . . . 72.12 108.712 172.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -62.22 -16.56 54.16 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 112.942 0.719 . . . . 75.35 112.942 -173.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -159.66 120.29 3.1 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.895 0.878 . . . . 74.02 109.549 170.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.0 p80 . . . . . 0 CA--C 1.567 1.598 0 CA-C-O 118.747 -0.644 . . . . 72.33 111.293 -177.94 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.668 0.271 . . . . 60.05 110.627 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -101.44 142.28 33.07 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.208 1.003 . . . . 53.45 110.195 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.85 132.51 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-O 121.038 0.446 . . . . 75.32 111.077 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.45 -3.57 68.96 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 115.776 -0.647 . . . . 72.04 112.948 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.0 m -85.1 151.6 24.02 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.773 0.657 . . . . 71.44 112.773 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -92.89 122.65 35.48 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.97 -1.014 . . . . 73.24 109.808 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.451 HG22 HD11 ' A' ' 121' ' ' LEU . 27.0 m -121.56 151.89 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.36 0.664 . . . . 74.12 109.72 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.7 mm -107.51 134.78 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.43 -0.952 . . . . 65.24 108.43 172.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.9 mt -75.29 105.57 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.327 0 CA-C-O 120.95 0.405 . . . . 74.1 109.927 -176.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -83.18 -34.25 26.0 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.931 0.892 . . . . 73.35 111.034 -172.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.7 m -131.47 141.13 49.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.578 1.151 . . . . 74.23 108.244 172.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' A' ' 17' ' ' MET . 95.7 p -143.5 159.3 42.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.855 0.836 . . . . 64.32 112.366 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.495 ' HE1' ' HG3' ' A' ' 50' ' ' LYS . 7.9 m-70 -91.29 -17.58 25.72 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 114.114 -1.403 . . . . 74.44 110.457 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.653 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 53.6 mtt -131.34 144.37 51.2 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.418 1.087 . . . . 71.33 109.788 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -54.07 -41.23 67.94 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.206 1.187 . . . . 75.03 114.206 -173.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.33 -11.98 83.63 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 114.339 0.496 . . . . 65.01 114.339 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.653 ' HG3' ' HB2' ' A' ' 14' ' ' MET . 20.6 mtm -81.24 -29.27 34.5 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.398 0.599 . . . . 73.24 109.921 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -64.11 122.81 17.48 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 122.739 0.415 . . . . 74.41 111.008 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.4 1.74 89.25 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 115.694 -0.684 . . . . 73.43 113.545 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 149.62 31.72 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.776 0.658 . . . . 54.51 112.776 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -84.66 105.64 15.61 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.17 0.588 . . . . 65.01 110.251 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.43 154.37 19.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.938 0.895 . . . . 71.31 111.532 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.5 m -120.84 122.3 39.99 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.362 0.665 . . . . 61.33 109.661 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -73.27 103.35 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.855 0.462 . . . . 74.42 109.906 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.4 p -113.94 -5.78 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.482 0.549 . . . . 74.51 112.482 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.17 123.39 1.75 Allowed Glycine 0 C--N 1.344 1.015 0 N-CA-C 111.834 -0.506 . . . . 71.25 111.834 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.98 116.59 32.22 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.384 0.674 . . . . 72.14 110.493 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.431 ' HB2' HG21 ' A' ' 96' ' ' VAL . 38.8 m-85 -127.12 119.44 26.53 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.392 0.677 . . . . 73.32 109.961 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -113.82 87.4 2.61 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.906 0.86 . . . . 74.53 109.721 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -135.95 179.93 6.05 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.792 0.837 . . . . 74.43 110.669 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -78.76 123.75 27.5 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 122.022 -0.424 . . . . 71.04 110.433 176.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.89 126.27 54.93 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.102 0.961 . . . . 74.11 110.17 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -103.34 150.32 23.9 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.971 0.891 . . . . 74.44 113.02 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.401 HG22 ' HB3' ' A' ' 50' ' ' LYS . 21.7 t -107.49 114.1 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 114.084 -1.416 . . . . 74.5 107.915 169.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.478 HG11 HD13 ' A' ' 88' ' ' ILE . 34.1 m -125.89 146.7 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 112.908 0.707 . . . . 75.24 112.908 -170.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.1 m -110.08 131.4 55.09 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.177 0.591 . . . . 75.14 110.491 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -157.04 159.78 38.3 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.36 0.6 . . . . 74.44 112.079 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.9 m -111.95 113.78 52.06 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 107.771 -1.196 . . . . 71.35 107.771 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.83 116.8 2.99 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.003 2.469 . . . . 74.04 112.108 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 p -68.94 -7.04 31.31 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.329 1.052 . . . . 71.31 113.745 -169.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -77.8 -3.06 39.52 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 123.433 0.693 . . . . 64.13 111.585 171.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.02 34.95 8.45 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 122.198 -0.313 . . . . 72.52 112.319 -173.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.42 -173.48 44.62 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 122.911 0.291 . . . . 72.33 113.444 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.08 117.47 15.92 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.443 0.697 . . . . 73.01 110.16 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.56 117.85 2.45 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.512 0.725 . . . . 74.22 110.969 169.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.96 115.38 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.371 -0.831 . . . . 74.04 109.609 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -100.38 140.78 34.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.145 0.578 . . . . 72.32 109.482 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.8 m170 57.92 39.58 26.55 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.423 0.689 . . . . 64.34 112.396 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -61.22 131.71 51.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.352 1.061 . . . . 72.54 111.455 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.495 ' HG3' ' HE1' ' A' ' 13' ' ' HIS . 25.2 pttm -149.13 148.49 29.73 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.288 -0.869 . . . . 74.51 109.665 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 92.1 m95 -109.95 135.88 50.1 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.456 -1.402 . . . . 74.04 111.502 0.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.01 147.15 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.782 1.233 . . . . 73.11 108.306 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.3 pt -111.47 167.17 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 122.046 -0.409 . . . . 73.32 111.669 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -53.96 -36.18 62.59 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.943 0.897 . . . . 75.51 113.265 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -70.24 -19.24 63.14 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 123.464 0.706 . . . . 62.14 112.092 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -94.54 8.28 42.77 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.589 0.756 . . . . 72.11 112.442 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.5 mt -124.23 136.64 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.692 0.797 . . . . 65.15 110.631 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -72.08 -53.72 11.96 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.796 0.839 . . . . 62.52 111.614 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.08 -3.96 11.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.705 1.202 . . . . 64.23 113.381 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.407 ' HA ' HD11 ' A' ' 65' ' ' LEU . . . -41.23 -46.75 3.22 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.534 1.309 . . . . 73.25 114.534 173.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.69 19.06 68.88 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.924 1.13 . . . . 71.21 115.924 165.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 66.19 11.17 7.68 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.051 1.341 . . . . 71.03 112.801 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -110.47 167.93 9.84 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.016 0.926 . . . . 71.25 110.817 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.3 m -82.93 118.17 23.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.487 -0.931 . . . . 72.3 108.487 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.599 HD12 HG12 ' A' ' 71' ' ' VAL . 76.4 mt -74.48 118.3 17.28 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.315 0.579 . . . . 73.41 110.24 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -110.91 155.25 42.72 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.426 1.091 . . . . 73.52 110.712 -169.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 76.1 Cg_exo -45.64 111.84 0.36 Allowed 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.702 2.935 . . . . 70.44 114.506 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.44 -11.54 16.43 Favored Glycine 0 N--CA 1.485 1.963 0 CA-C-N 116.182 -0.463 . . . . 73.31 113.938 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -79.88 124.04 28.3 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.386 0.593 . . . . 72.43 111.222 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -98.23 122.18 41.07 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.742 -0.836 . . . . 71.32 108.742 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.599 HG12 HD12 ' A' ' 65' ' ' LEU . 32.4 m -121.62 175.81 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.927 0.891 . . . . 74.52 112.115 -172.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mm -121.65 136.71 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.336 1.055 . . . . 73.3 109.079 170.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.5 mt -83.49 119.19 24.37 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.574 0.75 . . . . 73.35 111.411 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -81.92 -26.64 33.88 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.526 0.73 . . . . 74.11 111.473 171.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.51 153.99 25.29 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.029 0.442 . . . . 62.12 111.152 173.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 42.9 t -142.25 124.31 15.38 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.71 -0.677 . . . . 65.04 110.698 173.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -106.43 -24.86 12.11 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.331 1.053 . . . . 64.32 109.784 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.2 mtm -127.28 164.64 21.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.083 0.953 . . . . 74.15 110.867 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.519 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.37 127.92 33.63 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.877 0.471 . . . . 74.43 111.986 174.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.41 14.81 82.11 Favored Glycine 0 N--CA 1.476 1.315 0 N-CA-C 114.328 0.491 . . . . 64.34 114.328 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.4 ttt -84.71 -40.9 16.78 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 117.632 0.716 . . . . 63.51 110.739 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 21.0 tptm -66.53 119.57 11.91 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.209 -0.663 . . . . 72.23 109.209 166.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.55 74.66 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 116.063 -0.517 . . . . 74.44 112.914 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.31 137.63 46.81 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.753 0.776 . . . . 44.25 111.529 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 78.7 m -79.09 114.55 18.12 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.176 0.59 . . . . 73.2 109.531 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.67 157.24 21.49 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.785 0.834 . . . . 61.02 109.739 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -129.42 131.88 46.87 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.79 -0.819 . . . . 70.2 108.79 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 ' HB3' ' A' ' 65' ' ' LEU . 24.3 mm -74.27 107.5 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.28 0.632 . . . . 64.35 110.724 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -68.91 -39.72 79.53 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.926 0.394 . . . . 75.21 110.662 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.0 t -164.41 157.36 17.33 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.207 -0.906 . . . . 63.53 111.357 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -114.14 131.27 56.49 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.216 1.007 . . . . 72.34 109.131 171.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -126.7 135.51 51.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.007 0.523 . . . . 73.21 111.522 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -97.14 95.77 7.99 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.587 0.708 . . . . 71.14 109.657 168.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -135.85 148.3 48.6 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.929 -1.032 . . . . 74.42 109.4 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.4 m -84.24 123.61 30.32 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.221 -0.659 . . . . 74.13 109.221 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 28' ' ' TYR . 16.1 m -112.87 135.96 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.375 0.67 . . . . 73.32 109.553 -173.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.439 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 98.2 m-85 -120.03 141.54 49.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.43 0.692 . . . . 72.3 111.965 -175.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.415 ' SD ' ' HA ' ' A' ' 112' ' ' ASN . 19.4 tmm? -90.14 112.47 23.97 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.879 -1.055 . . . . 72.45 108.254 169.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.51 160.83 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 112.668 0.618 . . . . 74.55 112.668 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -119.57 116.98 27.16 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.87 0.868 . . . . 72.43 108.7 172.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -124.27 165.29 17.89 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 122.96 0.504 . . . . 75.32 111.918 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.8 m -109.21 111.67 23.41 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.3 0.64 . . . . 74.42 110.552 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.3 p -58.8 122.48 13.67 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.144 0.577 . . . . 73.14 111.87 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.7 p -70.91 -23.23 62.23 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.414 1.086 . . . . 73.33 112.767 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -87.86 -10.73 49.88 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.234 0.828 . . . . 73.54 113.234 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.4 m -134.74 -40.19 0.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.234 0.614 . . . . 74.43 111.833 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.81 -1.82 59.9 Favored Glycine 0 N--CA 1.48 1.582 0 CA-C-N 116.197 -0.456 . . . . 54.01 113.077 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -80.84 140.16 35.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.008 0.923 . . . . 71.22 111.124 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -96.37 132.81 41.51 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 121.156 0.503 . . . . 74.23 110.783 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.96 128.39 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.115 1.366 . . . . 75.22 109.723 -175.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 136.71 42.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.876 0.87 . . . . 74.03 111.105 -173.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.415 ' HA ' ' SD ' ' A' ' 98' ' ' MET . 11.8 m120 56.0 43.01 27.89 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.694 1.198 . . . . 74.44 113.84 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -62.3 132.8 53.87 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.672 0.789 . . . . 73.45 112.104 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 59.4 mttp -133.76 136.35 44.51 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.137 0.975 . . . . 74.42 111.491 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.7 m95 -114.44 146.11 41.03 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.511 1.524 . . . . 72.4 111.122 -15.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -119.67 148.23 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.022 0.929 . . . . 74.44 109.331 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.4 p -97.93 163.96 12.56 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.018 0.748 . . . . 75.11 113.018 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.439 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 44.0 tt0 -60.99 -33.91 73.98 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.489 1.116 . . . . 75.33 110.916 173.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.1 -36.84 85.56 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.701 1.2 . . . . 74.34 112.428 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.99 10.02 38.78 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.202 0.445 . . . . 62.02 112.202 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.451 HD11 HG22 ' A' ' 7' ' ' VAL . 91.2 mt -120.24 162.27 19.68 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.017 0.927 . . . . 73.4 109.215 175.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -138.83 120.67 15.4 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.074 0.549 . . . . 73.12 109.752 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.41 ' HA ' HG13 ' A' ' 7' ' ' VAL . . . -71.75 115.25 10.73 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.639 0.376 . . . . 64.33 110.676 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -119.75 119.18 32.88 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.905 0.482 . . . . 71.41 111.541 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.464 HD21 ' H ' ' A' ' 125' ' ' LEU . 2.7 pt? -98.97 178.24 5.0 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.537 0.735 . . . . 71.53 110.2 172.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -65.41 143.04 57.98 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.751 0.82 . . . . 70.43 111.562 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -74.57 158.46 33.68 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.388 0.675 . . . . 75.21 110.715 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -70.54 82.17 0.59 Allowed 'General case' 0 CA--C 1.558 1.258 0 CA-C-O 121.76 0.79 . . . . 74.14 111.378 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -133.11 -10.47 2.96 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.526 1.13 . . . . 75.33 109.563 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -72.25 161.46 30.83 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.45 0.7 . . . . 75.52 110.923 169.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -83.64 77.29 9.88 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.559 0.744 . . . . 75.23 110.992 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 . . . . . 0 CA--C 1.571 1.759 0 C-N-CA 123.762 0.825 . . . . 72.11 110.225 177.207 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.7 mmt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 109.725 -0.472 . . . . 70.34 109.725 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.496 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -72.44 158.87 34.94 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 120.965 0.412 . . . . 74.42 111.824 -179.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.81 130.1 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 123.609 0.763 . . . . 72.33 112.262 -175.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.57 -13.03 47.1 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.268 -0.878 . . . . 55.31 113.343 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.9 m -82.67 152.9 25.64 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.387 0.675 . . . . 71.21 111.638 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -108.74 141.03 41.32 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.143 -0.688 . . . . 72.45 109.143 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 123' ' ' ALA . 33.4 m -135.9 157.63 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.047 0.939 . . . . 61.22 111.063 -172.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.1 mm -96.46 129.06 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.423 -0.954 . . . . 74.14 108.423 166.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.67 HD11 ' HB1' ' A' ' 22' ' ' ALA . 48.7 mt -82.65 127.0 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.186 0.594 . . . . 75.45 109.945 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.546 HD22 ' HB3' ' A' ' 122' ' ' SER . 62.6 m-20 -96.8 -63.05 1.17 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 120.951 0.405 . . . . 73.45 110.386 -177.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.8 m -91.79 140.97 29.17 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.13 -0.692 . . . . 73.14 109.13 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.9 p -132.04 140.42 48.88 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.569 0.7 . . . . 72.3 112.24 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -85.66 -37.97 18.87 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.02 1.328 . . . . 65.33 109.326 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 52.0 mtt -99.34 130.53 45.63 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.316 1.046 . . . . 74.22 109.219 169.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' H ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -55.92 -37.98 69.66 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 113.0 0.741 . . . . 75.23 113.0 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.62 0.8 60.03 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 114.439 0.536 . . . . 75.21 114.439 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.481 ' HG2' HG23 ' A' ' 9' ' ' ILE . 52.9 ttp -93.3 -25.21 17.85 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.324 0.65 . . . . 72.44 111.13 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -67.36 123.34 20.1 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.994 0.518 . . . . 74.33 111.39 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.99 -12.18 66.89 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.658 -0.701 . . . . 75.13 113.868 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.43 155.42 40.13 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.642 0.777 . . . . 63.03 112.212 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -91.07 100.28 13.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.302 0.641 . . . . 70.22 110.946 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 9' ' ' ILE . . . -89.65 158.14 17.72 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.78 -0.645 . . . . 72.4 111.137 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.4 m -131.7 126.01 33.49 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.865 -0.791 . . . . 65.21 108.865 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.3 t -76.57 102.0 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.346 0.658 . . . . 73.41 110.281 -170.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.2 p -96.25 -10.63 27.52 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.331 0.652 . . . . 72.23 111.561 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.49 149.09 19.5 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 112.125 -0.39 . . . . 75.01 112.125 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.06 119.47 15.81 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.645 0.778 . . . . 61.1 110.694 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -121.92 117.22 25.91 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.852 0.861 . . . . 63.21 110.445 -172.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -95.49 83.82 3.88 Favored 'General case' 0 CA--C 1.565 1.519 0 CA-C-O 122.236 1.017 . . . . 72.01 110.645 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -134.39 -178.61 5.13 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.473 0.709 . . . . 74.33 111.878 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 m -90.87 128.58 36.8 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.714 -0.476 . . . . 64.44 109.714 170.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.46 157.93 19.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.716 0.806 . . . . 74.53 110.43 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.485 ' HB2' HG22 ' A' ' 52' ' ' VAL . 97.2 m-85 -135.15 149.55 49.99 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.726 0.774 . . . . 74.11 111.383 -173.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.54 109.65 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.188 -1.369 . . . . 61.13 107.439 171.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 86' ' ' ALA . 29.6 m -121.82 148.01 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.525 0.679 . . . . 75.21 112.699 -173.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.1 t -112.3 139.24 48.02 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.915 0.886 . . . . 75.55 109.152 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -158.92 159.42 34.91 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.171 0.589 . . . . 74.21 111.777 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.5 m -107.91 108.78 61.78 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 107.29 -1.374 . . . . 61.14 107.29 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -47.59 152.82 2.47 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 123.949 3.099 . . . . 72.14 115.715 -175.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.8 p -64.92 -24.29 67.48 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.228 1.011 . . . . 61.31 112.393 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.513 HD21 ' HA3' ' A' ' 80' ' ' GLY . 10.9 p30 -67.55 -19.81 65.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.657 0.265 . . . . 75.24 111.213 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 19.21 71.18 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 114.812 0.685 . . . . 74.44 114.812 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.0 -130.18 2.89 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 117.62 0.71 . . . . 74.52 113.085 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -69.99 129.04 38.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.282 0.633 . . . . 75.42 111.493 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -58.5 133.16 55.56 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.296 0.638 . . . . 75.21 111.5 171.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.43 108.85 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.435 0.694 . . . . 72.43 110.128 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -102.57 148.78 25.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.736 0.814 . . . . 74.14 111.04 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.3 m80 55.63 33.97 22.29 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.25 1.02 . . . . 71.4 112.86 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -62.4 122.78 16.56 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.132 0.973 . . . . 73.52 111.036 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 41.3 mtmt -121.37 143.9 48.95 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.531 0.733 . . . . 74.03 110.933 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.537 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 92.8 m95 -110.55 144.44 39.41 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.295 1.438 . . . . 75.45 109.4 -14.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 33' ' ' TYR . 25.4 m -115.65 130.06 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 107.748 -1.205 . . . . 74.31 107.748 169.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.427 HG21 HG22 ' A' ' 96' ' ' VAL . 26.0 pt -104.9 163.69 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 121.794 -0.566 . . . . 74.23 111.696 -169.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -52.56 -39.19 61.22 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.852 1.261 . . . . 73.34 113.494 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -73.71 -28.91 61.96 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 120.885 0.374 . . . . 75.51 111.703 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.454 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 28.1 tt0 -80.38 -13.42 59.17 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.378 1.071 . . . . 74.51 110.956 -174.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.37 139.9 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 124.369 1.068 . . . . 75.21 109.84 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -75.58 -55.8 5.32 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.489 0.715 . . . . 72.21 111.477 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.22 -5.38 13.6 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.161 0.985 . . . . 74.15 113.285 -175.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.566 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -51.59 -50.24 60.55 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.569 0.951 . . . . 74.24 113.569 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.51 25.44 71.46 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 114.917 0.727 . . . . 73.25 114.917 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 64.78 16.3 10.34 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 124.831 1.253 . . . . 63.41 113.434 -175.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 64.1 pttt -115.26 179.65 3.9 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.0 0.52 . . . . 72.34 111.161 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.2 m -84.75 114.9 22.39 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.691 -0.686 . . . . 70.43 109.902 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.675 HD12 HG12 ' A' ' 71' ' ' VAL . 70.5 mt -76.29 115.69 16.26 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.624 -0.51 . . . . 72.12 109.624 170.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -89.6 147.91 38.94 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.474 0.71 . . . . 74.04 111.643 -168.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.24 116.23 2.15 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.408 2.739 . . . . 73.23 114.44 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.07 -22.92 11.04 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 115.053 0.781 . . . . 62.14 115.053 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -79.35 149.1 31.8 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.083 0.942 . . . . 73.23 112.04 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -107.17 132.82 52.62 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.179 0.592 . . . . 74.14 111.552 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.675 HG12 HD12 ' A' ' 65' ' ' LEU . 26.8 m -138.73 155.55 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.361 1.065 . . . . 74.5 111.063 -174.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.07 135.33 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 123.189 0.595 . . . . 73.42 109.785 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.2 mt -88.33 118.17 27.76 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.974 0.909 . . . . 74.32 110.837 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -84.12 -3.19 57.93 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 112.808 0.67 . . . . 64.33 112.808 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.454 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -128.81 173.15 10.61 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.272 0.629 . . . . 65.12 111.015 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 66.1 p -149.32 127.77 12.27 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.435 -0.802 . . . . 71.34 110.998 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -85.27 -14.75 45.66 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.813 0.845 . . . . 73.35 110.253 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -156.85 -179.04 7.82 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.253 1.021 . . . . 71.22 111.139 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -67.19 135.88 54.16 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.786 0.662 . . . . 74.05 112.786 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.513 ' HA3' HD21 ' A' ' 41' ' ' ASN . . . 71.33 17.67 76.23 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 115.103 0.801 . . . . 74.13 115.103 175.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.7 ttt -90.95 -42.8 10.36 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 117.625 0.713 . . . . 73.43 111.273 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 4.1 ttpm? -67.79 129.25 39.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.873 0.469 . . . . 74.51 111.156 175.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.38 -15.72 62.64 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 116.48 -0.327 . . . . 74.12 112.629 -178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.73 141.99 49.79 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.224 0.61 . . . . 71.33 111.665 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.7 m -90.36 110.33 21.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.474 -0.936 . . . . 71.32 108.474 176.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.469 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . . . -98.05 167.94 10.58 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.45 0.7 . . . . 62.22 110.972 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.22 138.34 52.41 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.969 0.908 . . . . 74.53 109.281 171.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.441 HD11 HG13 ' A' ' 35' ' ' VAL . 28.0 mm -72.14 120.58 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 123.106 0.562 . . . . 71.53 110.777 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -85.43 -42.13 14.78 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.925 0.49 . . . . 75.3 109.757 170.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.0 m -155.11 153.99 31.69 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.975 0.91 . . . . 71.33 110.841 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.29 146.99 49.79 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.681 0.792 . . . . 75.0 110.453 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -156.2 131.52 9.4 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.865 0.466 . . . . 73.52 111.493 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -88.93 96.33 10.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.482 -0.933 . . . . 74.05 108.482 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.6 t -136.63 153.74 50.84 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.534 0.734 . . . . 74.4 111.256 -171.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 48.7 m -84.52 123.94 30.83 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.81 -0.441 . . . . 71.14 109.81 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 18.0 m -113.2 138.8 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.727 0.811 . . . . 73.32 109.451 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -115.37 150.07 36.93 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.588 0.755 . . . . 61.02 112.126 -171.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 58.2 ttp -96.36 115.37 27.32 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.421 -1.326 . . . . 74.53 107.421 163.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 30.0 m -122.79 160.21 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.219 0.533 . . . . 74.23 112.413 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -121.94 116.84 25.08 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.369 1.068 . . . . 74.32 109.591 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -132.47 173.79 10.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.085 0.554 . . . . 73.43 110.508 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 31.8 m -119.28 116.76 26.91 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.588 -0.523 . . . . 75.42 109.588 173.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.8 t -54.71 121.88 9.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.456 1.102 . . . . 75.44 112.408 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p -66.62 -30.44 70.72 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.25 1.02 . . . . 74.2 112.584 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.7 t -83.17 -34.24 26.04 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.037 0.755 . . . . 74.3 113.037 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.0 p -106.78 -28.12 10.34 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.567 0.58 . . . . 75.34 112.567 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.93 9.33 85.5 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 116.611 -0.268 . . . . 64.32 113.177 -172.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -91.13 138.57 31.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.053 0.941 . . . . 73.25 110.659 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.538 ' HZ2' ' HB3' ' A' ' 109' ' ' LYS . 5.7 ttpm? -84.88 120.59 26.64 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 120.984 0.421 . . . . 75.21 110.513 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.67 114.29 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 109.369 -0.604 . . . . 72.54 109.369 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.25 150.37 29.69 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.008 0.923 . . . . 71.24 111.208 -171.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 57.28 31.9 20.87 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.382 1.073 . . . . 75.42 112.243 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -64.41 124.49 21.91 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.249 0.62 . . . . 73.14 111.649 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.541 ' HB2' ' HZ3' ' A' ' 114' ' ' LYS . 10.2 mtmp? -140.85 140.02 34.55 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 124.177 0.991 . . . . 73.33 110.681 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.537 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 87.8 m95 -112.51 148.53 34.26 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.875 1.67 . . . . 75.41 111.928 -4.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.8 m -131.47 142.36 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 124.347 1.059 . . . . 74.34 110.3 174.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 81.3 p -100.41 167.86 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 112.644 0.609 . . . . 63.41 112.644 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -56.12 -38.01 70.21 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.69 1.196 . . . . 74.54 111.701 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -58.39 -39.87 80.84 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.926 1.29 . . . . 75.43 112.111 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -88.39 -0.62 57.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.017 0.927 . . . . 75.34 113.367 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.53 163.86 17.32 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.438 0.695 . . . . 72.22 110.988 -177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.546 ' HB3' HD22 ' A' ' 10' ' ' ASN . 80.9 p -145.35 124.08 12.59 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.547 0.739 . . . . 74.34 110.447 174.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.563 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -66.11 133.47 50.78 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 113.268 0.84 . . . . 75.52 113.268 -172.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.591 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -95.95 102.05 13.79 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.652 0.781 . . . . 72.42 111.077 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.79 -58.32 1.9 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.445 0.698 . . . . 75.12 110.284 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.5 167.71 14.32 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.86 0.864 . . . . 75.51 111.678 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.6 m80 61.93 33.86 17.2 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.117 0.967 . . . . 75.21 112.168 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -62.7 114.99 3.92 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.664 -0.698 . . . . 64.43 110.752 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -80.57 102.28 9.68 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.259 0.623 . . . . 73.12 111.38 -170.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -64.76 121.26 14.14 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 110.024 -0.361 . . . . 72.04 110.024 172.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -60.67 136.74 58.15 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 112.511 0.56 . . . . 64.12 112.511 -176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.7 m80 . . . . . 0 CA--C 1.56 1.346 0 C-N-CA 123.995 0.918 . . . . 73.34 109.558 174.117 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.644 ' HE2' ' HG3' ' A' ' 118' ' ' GLU . 14.5 mmt . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.415 -0.587 . . . . 73.12 109.415 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -113.59 159.32 19.74 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.131 0.572 . . . . 71.1 110.176 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.1 t -65.22 124.73 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 CA-C-O 121.376 0.608 . . . . 64.11 111.688 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.32 -2.99 43.37 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 115.559 -0.746 . . . . 62.55 113.094 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 p -81.56 145.34 30.71 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 117.343 0.571 . . . . 73.23 112.359 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -94.02 128.74 40.54 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.583 0.753 . . . . 73.44 110.276 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.523 HG23 HD11 ' A' ' 121' ' ' LEU . 29.5 m -131.35 152.88 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.639 0.776 . . . . 73.42 110.111 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.1 mm -102.76 132.6 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.521 0.728 . . . . 72.43 109.241 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.6 mt -78.85 113.02 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 C-N-CA 122.739 0.416 . . . . 75.5 109.915 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.441 HD21 ' HB2' ' A' ' 122' ' ' SER . 33.9 p30 -91.49 -31.07 16.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 122.002 -0.437 . . . . 74.23 111.672 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.2 m -125.88 141.16 52.11 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.256 1.022 . . . . 74.31 109.905 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 m -154.1 139.66 17.85 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.987 0.515 . . . . 73.34 111.198 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.404 ' CE1' ' HB2' ' A' ' 50' ' ' LYS . 73.0 m-70 -79.23 -25.61 42.6 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.345 0.658 . . . . 71.32 110.1 170.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.608 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 1.6 mpt? -97.55 125.23 42.14 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.171 0.988 . . . . 73.22 109.527 171.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.68 -28.46 68.63 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.23 0.826 . . . . 74.14 113.23 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.79 -12.8 84.1 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 114.597 0.599 . . . . 62.45 114.597 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.608 ' SD ' ' HB2' ' A' ' 14' ' ' MET . 39.3 mtp -91.47 -24.36 19.7 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.549 0.74 . . . . 73.42 111.761 -177.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.45 119.41 12.23 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.073 0.549 . . . . 72.44 111.659 -176.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.92 2.17 69.5 Favored Glycine 0 CA--C 1.541 1.677 0 CA-C-N 115.799 -0.637 . . . . 64.34 113.78 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.25 156.77 21.83 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.371 0.668 . . . . 74.24 112.792 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -83.83 114.31 21.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.352 0.661 . . . . 75.54 111.204 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . . . -107.03 150.63 26.31 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.861 0.864 . . . . 42.41 111.895 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -124.6 121.05 33.66 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.634 0.774 . . . . 71.24 108.968 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.2 t -72.75 106.29 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 122.823 0.449 . . . . 72.22 110.277 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.7 p -99.08 -11.33 21.54 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.352 0.661 . . . . 72.31 111.9 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.11 145.31 11.81 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 112.187 -0.365 . . . . 73.52 112.187 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.87 121.7 27.21 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.911 0.884 . . . . 73.13 110.503 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.479 ' HB2' HG21 ' A' ' 96' ' ' VAL . 26.3 m-85 -125.6 125.97 44.01 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.665 0.786 . . . . 71.24 111.249 -175.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.18 78.87 1.34 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.263 1.03 . . . . 75.3 110.35 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.534 HG22 HD12 ' A' ' 53' ' ' ILE . 10.2 t -134.79 174.86 10.11 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.726 -0.67 . . . . 65.32 111.867 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.5 m -78.98 125.03 28.84 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.97 0.508 . . . . 72.44 110.752 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . . . -100.27 163.54 12.35 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.478 1.111 . . . . 72.25 109.215 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -134.11 138.03 44.98 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.54 0.686 . . . . 74.34 111.208 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.0 t -99.15 107.75 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 107.711 -1.218 . . . . 74.35 107.711 172.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG13 HD11 ' A' ' 88' ' ' ILE . 34.3 m -119.88 145.16 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-O 121.314 0.578 . . . . 74.03 112.056 -173.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -115.16 132.88 56.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.817 0.847 . . . . 74.22 109.091 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -148.88 157.14 43.21 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.241 0.543 . . . . 74.42 112.361 -172.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.4 m -105.7 112.11 64.59 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 108.163 -1.051 . . . . 74.14 108.163 170.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.26 118.74 5.59 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.344 2.029 . . . . 74.33 111.399 174.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.0 t -60.8 -14.22 20.25 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 124.361 1.064 . . . . 74.34 113.552 -170.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -82.8 10.83 6.87 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 123.789 0.836 . . . . 75.43 111.92 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.94 46.97 7.4 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 113.672 0.229 . . . . 73.44 113.672 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.23 -177.91 21.4 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 113.542 0.177 . . . . 64.3 113.542 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -65.36 122.42 17.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.924 0.49 . . . . 71.31 110.984 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -58.81 115.35 3.03 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.988 0.423 . . . . 73.54 110.593 173.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -86.57 120.46 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.713 -0.676 . . . . 62.44 110.399 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -92.84 120.69 33.46 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.334 0.653 . . . . 74.31 109.683 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.6 m170 58.64 54.8 5.13 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.597 1.159 . . . . 75.41 113.147 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -65.04 132.07 48.24 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.063 0.945 . . . . 74.42 111.892 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HB2' ' CE1' ' A' ' 13' ' ' HIS . 99.5 mttt -136.94 150.13 48.0 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.743 0.817 . . . . 64.44 110.652 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -107.43 130.81 54.78 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.888 1.275 . . . . 73.21 111.908 -7.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.84 142.68 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.716 1.207 . . . . 75.42 108.088 168.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.612 HG23 HG23 ' A' ' 96' ' ' VAL . 27.8 pt -117.02 -175.37 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.075 0.55 . . . . 74.15 110.032 175.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -47.73 -33.18 6.7 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.623 1.169 . . . . 73.42 113.357 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.579 ' H ' HG13 ' A' ' 53' ' ' ILE . 7.0 tp10 -69.94 -28.86 65.92 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 113.924 1.083 . . . . 74.21 113.924 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -80.89 -10.98 59.66 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.487 -0.758 . . . . 73.15 112.589 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.9 mt -110.12 138.92 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 C-N-CA 123.543 0.737 . . . . 74.13 111.759 -172.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.58 ' HE3' ' HB ' ' A' ' 72' ' ' ILE . 27.8 ttpp -65.68 -53.22 44.13 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.312 1.045 . . . . 70.51 112.336 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.19 -3.33 39.04 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.014 -0.994 . . . . 75.43 113.138 -170.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -40.87 -58.76 1.6 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.444 1.276 . . . . 74.55 114.444 177.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.0 23.71 69.69 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 115.537 0.975 . . . . 53.14 115.537 170.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 61.53 17.35 8.43 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.621 1.168 . . . . 75.51 113.113 -173.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 12.3 ptpt -108.75 167.07 10.33 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.364 0.666 . . . . 73.44 110.54 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.5 m -87.02 112.5 21.91 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.293 -0.632 . . . . 75.14 109.293 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.545 HD11 HG13 ' A' ' 71' ' ' VAL . 54.5 mt -75.26 120.71 21.12 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.443 0.697 . . . . 73.14 109.353 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -96.77 154.1 38.47 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.913 0.885 . . . . 61.44 111.513 -167.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.486 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 84.8 Cg_exo -49.25 113.92 1.1 Allowed 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.995 2.463 . . . . 73.23 113.736 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.56 -17.91 18.01 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-N 115.975 -0.557 . . . . 74.52 114.135 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.8 133.14 47.09 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.327 0.564 . . . . 63.5 110.626 173.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -111.27 121.24 44.75 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.899 -0.778 . . . . 75.11 108.899 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.545 HG13 HD11 ' A' ' 65' ' ' LEU . 27.0 m -131.21 164.53 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.543 1.137 . . . . 74.34 111.027 -167.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.58 ' HB ' ' HE3' ' A' ' 58' ' ' LYS . 46.3 mm -110.51 141.47 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.01 0.524 . . . . 75.22 110.534 176.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.2 mt -88.71 123.64 33.34 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.806 0.843 . . . . 74.35 111.565 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -88.77 -28.74 20.28 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.239 0.615 . . . . 71.31 112.352 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.52 158.55 20.93 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.12 0.486 . . . . 75.52 110.572 171.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 21.1 t -143.58 125.02 14.74 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.728 -0.669 . . . . 75.4 109.703 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.7 m170 -95.34 -13.88 24.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.953 0.901 . . . . 72.33 111.272 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -156.3 177.35 11.54 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.617 0.767 . . . . 71.22 111.896 -173.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -63.95 104.96 0.77 Allowed 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.113 0.965 . . . . 72.52 112.566 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.56 12.94 56.46 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 115.182 0.833 . . . . 73.3 115.182 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -74.36 -42.23 59.71 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 117.481 0.641 . . . . 73.01 111.677 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 50.5 tttm -66.22 132.63 48.86 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 122.414 -0.179 . . . . 73.13 110.522 172.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.57 -9.52 75.7 Favored Glycine 0 N--CA 1.472 1.094 0 CA-C-O 120.337 -0.146 . . . . 72.31 112.89 -177.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.11 141.48 50.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.47 0.708 . . . . 74.22 111.903 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -81.83 113.44 19.78 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.965 -0.561 . . . . 75.01 109.945 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -110.1 150.68 28.25 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.5 1.12 . . . . 75.31 110.388 -175.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -125.06 130.34 52.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.12 0.568 . . . . 65.01 109.958 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.502 HD11 HG13 ' A' ' 35' ' ' VAL . 27.4 mm -69.86 101.64 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.442 0.697 . . . . 71.11 109.639 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.61 -32.97 70.52 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.319 0.581 . . . . 75.35 110.346 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.486 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . 40.0 t -168.89 150.31 4.61 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.669 -1.151 . . . . 74.01 109.849 -175.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.84 128.49 54.31 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.536 -0.913 . . . . 74.14 108.536 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -114.07 125.77 54.35 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.708 0.803 . . . . 72.13 111.551 -169.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -93.91 95.12 8.88 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.5 -0.555 . . . . 75.02 109.5 170.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.0 t -137.06 154.39 50.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.786 0.835 . . . . 74.13 110.592 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.3 m -86.37 125.47 33.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.509 -0.552 . . . . 74.04 109.509 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.612 HG23 HG23 ' A' ' 53' ' ' ILE . 14.9 m -114.42 134.83 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.361 0.664 . . . . 71.3 110.092 -172.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.21 143.03 46.04 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.434 0.694 . . . . 72.54 112.049 -174.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.5 ttp -89.57 115.86 27.29 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.109 -1.441 . . . . 75.44 107.109 164.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.4 m -118.16 152.95 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.866 0.841 . . . . 71.12 112.135 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -121.28 121.56 37.98 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.608 1.563 . . . . 74.11 107.4 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.541 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 51.2 p90 -152.45 178.85 9.12 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.143 0.497 . . . . 75.14 112.098 -171.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.2 m -118.49 117.49 29.15 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.761 0.824 . . . . 75.31 109.631 172.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.5 t -60.95 119.25 7.91 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.449 0.7 . . . . 75.32 110.378 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.1 p -59.4 -45.18 92.23 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.815 0.846 . . . . 72.52 113.139 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.4 m -64.06 -52.86 57.35 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.108 0.563 . . . . 71.53 111.793 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.1 m -79.06 -24.08 43.78 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.137 0.575 . . . . 73.11 112.319 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.41 17.27 74.26 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 116.35 -0.386 . . . . 75.25 113.566 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -108.6 144.09 36.79 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.876 0.87 . . . . 75.02 111.661 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -77.13 105.1 8.01 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.013 0.925 . . . . 75.25 111.304 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.2 t -90.46 110.55 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 108.297 -1.001 . . . . 75.52 108.297 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -112.94 145.96 39.85 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.692 0.797 . . . . 71.35 111.76 -166.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 17.8 m120 57.45 32.41 21.76 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 124.064 0.946 . . . . 64.4 113.225 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -64.59 133.42 52.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.675 0.79 . . . . 75.1 112.573 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 99.7 mttt -135.59 134.42 39.31 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.199 1.0 . . . . 75.13 110.72 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 97.7 m95 -115.15 155.61 26.81 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.321 1.448 . . . . 74.31 112.521 -10.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.22 160.98 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.774 1.23 . . . . 74.32 109.084 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.8 p -118.2 162.76 17.71 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.735 0.414 . . . . 74.32 111.557 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.644 ' HG3' ' HE2' ' A' ' 1' ' ' MET . 30.5 tt0 -61.36 -36.18 79.49 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.891 0.476 . . . . 73.43 111.671 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -66.28 -32.55 74.03 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.309 0.644 . . . . 74.32 110.885 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -83.33 -9.91 58.8 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.119 0.967 . . . . 73.41 111.376 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.523 HD11 HG23 ' A' ' 7' ' ' VAL . 82.6 mt -112.08 173.37 6.4 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.993 0.917 . . . . 71.01 109.857 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.441 ' HB2' HD21 ' A' ' 10' ' ' ASN . 47.8 t -137.28 136.68 38.25 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.657 0.783 . . . . 70.32 109.171 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.484 ' HB2' ' HE3' ' A' ' 1' ' ' MET . . . -70.63 138.09 50.46 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 120.863 0.364 . . . . 74.05 111.522 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -86.17 67.77 10.06 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.727 0.775 . . . . 75.12 110.846 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.18 -39.1 3.1 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.713 0.805 . . . . 75.44 110.983 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -81.22 159.26 24.6 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.958 0.725 . . . . 75.43 112.958 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -74.31 86.09 1.96 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 115.413 -0.812 . . . . 75.14 109.745 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -79.99 69.71 6.42 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.228 1.011 . . . . 72.3 112.452 -174.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -91.02 5.28 49.47 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.415 0.686 . . . . 72.35 111.856 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -113.5 114.05 25.99 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.813 0.845 . . . . 72.54 109.855 175.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -81.0 121.77 26.45 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.346 -0.612 . . . . 75.15 109.346 172.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 . . . . . 0 C--O 1.257 1.499 0 CA-C-O 118.155 -0.926 . . . . 64.33 110.527 179.515 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.524 ' SD ' HG11 ' A' ' 7' ' ' VAL . 24.2 ptp . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.629 0.252 . . . . 75.21 110.574 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -99.41 161.61 13.52 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.31 0.644 . . . . 74.21 111.575 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.56 132.29 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 123.592 0.757 . . . . 70.23 111.779 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.41 -7.21 39.67 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.508 -0.769 . . . . 74.25 113.566 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 m -75.4 134.85 40.82 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.01 0.524 . . . . 71.44 111.782 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -95.81 123.64 39.47 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.317 0.647 . . . . 62.04 109.636 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.524 HG11 ' SD ' ' A' ' 1' ' ' MET . 31.8 m -130.04 154.54 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.735 0.814 . . . . 70.14 111.818 -172.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.8 mm -98.05 128.76 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.93 0.892 . . . . 60.21 109.656 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.425 ' HB ' ' O ' ' A' ' 17' ' ' MET . 49.8 mt -78.01 109.96 13.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.38 0.672 . . . . 74.02 109.968 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -87.53 -53.22 4.92 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.79 0.436 . . . . 75.34 110.76 -173.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.811 ' HB ' ' HB2' ' A' ' 120' ' ' GLU . 72.0 m -91.42 140.36 29.84 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.694 -0.854 . . . . 74.23 108.694 170.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 14' ' ' MET . 86.0 p -133.06 124.83 28.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.502 0.321 . . . . 74.43 111.825 -173.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -71.36 -33.37 69.51 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.347 0.659 . . . . 75.52 110.088 171.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.686 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 1.8 mpt? -115.58 137.48 52.03 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.518 1.127 . . . . 73.51 108.938 172.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -30.87 69.79 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.591 1.33 . . . . 74.33 114.591 -169.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.82 -3.34 87.46 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 114.599 0.6 . . . . 74.25 114.599 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.686 ' SD ' ' HB2' ' A' ' 14' ' ' MET . 61.6 mtp -86.63 -26.99 24.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.622 0.769 . . . . 74.51 111.196 -178.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -67.46 121.96 16.94 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.587 0.355 . . . . 74.05 111.05 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.69 -3.84 86.03 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 116.134 -0.485 . . . . 73.11 113.606 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.78 150.69 32.31 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 117.503 0.651 . . . . 60.03 112.651 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -90.1 100.61 13.4 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.765 0.826 . . . . 72.42 111.464 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.97 163.56 13.44 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.804 0.842 . . . . 65.35 112.297 176.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.6 m -130.79 130.94 44.34 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.108 0.963 . . . . 64.03 108.958 172.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.4 t -74.01 103.36 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.085 0.554 . . . . 74.31 109.515 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.8 p -95.79 -12.19 25.73 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.09 0.556 . . . . 75.22 111.756 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.6 139.69 6.45 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.747 -0.541 . . . . 64.31 111.747 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.74 122.08 37.14 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.298 0.639 . . . . 74.5 111.184 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -128.88 122.44 30.34 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.277 1.031 . . . . 74.01 110.688 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -103.98 79.67 1.66 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.947 0.879 . . . . 74.15 110.085 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -133.63 175.75 9.16 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.588 -0.733 . . . . 73.21 112.467 -169.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 93' ' ' LYS . 54.9 m -77.93 118.95 20.73 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.851 0.86 . . . . 73.34 110.931 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.81 111.61 24.21 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.04 0.936 . . . . 72.24 110.373 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -87.86 149.9 23.85 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.868 0.842 . . . . 75.21 111.956 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 55.8 t -106.92 118.84 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 107.907 -1.146 . . . . 71.34 107.907 170.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.421 HG11 HD13 ' A' ' 88' ' ' ILE . 30.0 m -117.59 168.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 112.492 0.552 . . . . 73.13 112.492 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 91.1 p -137.33 134.87 36.52 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.568 0.747 . . . . 73.43 109.467 170.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.411 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 43.5 p90 -151.66 157.6 42.33 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.469 0.652 . . . . 73.13 111.96 -174.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 m -101.19 110.98 62.85 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.182 -1.044 . . . . 73.05 108.182 171.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.97 123.39 13.71 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.861 2.374 . . . . 74.32 112.846 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.3 p -58.02 -25.32 60.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.525 1.306 . . . . 73.41 114.525 -171.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -72.62 -6.38 43.84 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 112.918 0.71 . . . . 74.51 112.918 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.11 38.67 5.94 Favored Glycine 0 N--CA 1.472 1.098 0 N-CA-C 111.789 -0.524 . . . . 42.13 111.789 -169.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.14 158.94 26.05 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.338 -0.431 . . . . 74.32 112.479 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -56.26 122.99 13.07 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.173 0.589 . . . . 72.24 110.961 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.89 124.19 14.67 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.152 0.981 . . . . 74.42 111.628 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.687 HG22 ' HE1' ' A' ' 78' ' ' MET . 46.9 t -103.99 124.56 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.75 0.82 . . . . 70.25 111.298 -174.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -117.32 148.62 41.55 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.638 0.775 . . . . 75.4 111.054 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 m170 57.62 38.02 27.64 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.434 1.093 . . . . 75.13 112.991 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -69.13 138.58 54.33 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.426 0.69 . . . . 75.34 111.477 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -153.88 153.36 31.95 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 123.75 0.82 . . . . 74.25 111.069 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -106.88 128.69 54.51 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.542 1.537 . . . . 71.3 111.693 -0.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.74 142.31 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.893 -1.151 . . . . 73.22 107.893 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.2 pt -124.13 176.88 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.556 -0.715 . . . . 74.52 112.076 -175.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -49.88 -50.45 45.79 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.172 1.175 . . . . 75.2 114.172 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -6.94 52.27 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 112.864 0.69 . . . . 73.41 112.864 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -79.16 -31.17 43.91 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.954 0.901 . . . . 74.12 110.066 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.7 mt -96.08 131.1 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 123.688 0.795 . . . . 71.32 111.02 -169.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -63.0 -47.51 82.79 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 122.092 0.949 . . . . 72.15 111.207 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.26 -2.65 22.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.912 1.285 . . . . 74.23 113.543 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -40.7 -60.84 1.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.602 1.161 . . . . 63.43 113.665 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.73 17.52 65.0 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 115.848 1.099 . . . . 72.42 115.848 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.64 12.91 7.92 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.45 1.1 . . . . 62.22 113.46 -174.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -106.26 157.24 17.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.362 0.665 . . . . 74.52 110.435 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.4 m -76.1 111.05 11.11 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.046 0.539 . . . . 72.42 110.432 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.423 HD12 HG12 ' A' ' 71' ' ' VAL . 92.9 mt -75.57 124.53 27.36 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.346 0.659 . . . . 74.55 110.679 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -120.57 157.74 53.35 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.325 1.05 . . . . 74.11 110.518 -170.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 32.8 Cg_exo -41.58 116.49 0.52 Allowed 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.032 2.488 . . . . 65.5 114.27 171.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.81 -9.73 16.15 Favored Glycine 0 N--CA 1.478 1.45 0 CA-C-N 115.137 -0.938 . . . . 75.14 113.499 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -84.37 102.38 12.69 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 117.519 0.659 . . . . 74.32 112.451 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -69.87 120.98 16.43 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.736 -0.468 . . . . 75.41 109.736 164.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.423 HG12 HD12 ' A' ' 65' ' ' LEU . 30.1 m -131.96 157.31 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.596 1.159 . . . . 72.12 110.428 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.9 mm -105.82 137.0 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.855 -0.528 . . . . 74.32 110.308 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.5 mt -87.54 128.0 35.25 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.67 0.788 . . . . 73.04 112.299 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -92.69 -31.33 15.14 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.798 0.839 . . . . 71.55 111.943 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.5 161.02 14.39 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.463 0.649 . . . . 71.03 110.29 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.1 p -147.24 128.46 14.74 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.784 -0.644 . . . . 75.12 110.623 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -88.68 6.84 36.56 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.817 0.847 . . . . 75.35 110.886 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.687 ' HE1' HG22 ' A' ' 46' ' ' VAL . 21.5 ptt? -172.35 158.35 4.35 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.501 1.52 . . . . 74.33 109.824 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -75.99 133.46 40.42 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 122.274 -0.266 . . . . 73.03 110.987 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.63 -29.03 12.58 Favored Glycine 0 N--CA 1.482 1.711 0 CA-C-N 116.56 -0.291 . . . . 75.21 112.44 -172.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.0 ttt -68.36 -37.54 80.56 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.065 0.946 . . . . 64.24 111.253 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -65.35 119.24 10.61 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.988 0.515 . . . . 72.31 109.793 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.7 3.03 74.81 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 120.064 -0.298 . . . . 64.1 113.275 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.13 144.31 31.78 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 117.19 0.495 . . . . 73.15 111.429 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.4 m -80.84 110.67 16.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.693 -0.685 . . . . 71.13 109.174 176.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -101.2 159.73 15.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.316 1.047 . . . . 73.22 108.973 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.95 129.49 30.14 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.047 -1.094 . . . . 74.41 108.047 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.421 HD13 HG11 ' A' ' 35' ' ' VAL . 38.5 mm -63.26 100.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.562 0.745 . . . . 61.33 110.389 -176.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.19 -40.55 71.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.02 0.928 . . . . 74.42 110.519 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 68.0 m -153.96 151.41 29.37 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.987 0.915 . . . . 75.3 110.059 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.01 129.89 56.82 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.114 0.566 . . . . 63.42 109.61 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -140.61 151.83 44.96 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.724 0.81 . . . . 73.12 109.537 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -124.81 95.27 4.45 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.036 0.922 . . . . 75.42 109.156 177.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 t -134.9 151.89 51.27 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.288 -0.869 . . . . 53.42 110.552 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.8 m -78.39 123.69 27.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 122.613 0.365 . . . . 74.24 110.54 -173.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 15.2 m -118.33 140.06 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.193 0.997 . . . . 72.43 110.089 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.421 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 77.7 m-85 -122.53 145.85 47.95 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.702 0.801 . . . . 75.15 111.543 -172.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.476 ' SD ' ' NZ ' ' A' ' 114' ' ' LYS . 49.5 ttp -89.9 121.38 31.97 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.974 -1.121 . . . . 74.41 107.974 163.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.2 m -120.94 153.76 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-O 121.488 0.661 . . . . 74.43 112.367 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -118.12 122.42 43.05 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.836 1.254 . . . . 51.41 107.747 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.432 ' CE2' ' HG2' ' A' ' 17' ' ' MET . 56.1 p90 -148.65 177.87 9.13 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.939 0.496 . . . . 74.4 111.681 -174.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.2 m -125.38 128.87 48.82 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.49 0.716 . . . . 70.33 109.726 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.4 t -62.48 120.7 11.6 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.662 0.785 . . . . 72.32 110.925 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.0 p -60.15 -41.13 92.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.895 0.878 . . . . 75.15 112.408 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.4 p -75.15 -57.5 3.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.143 0.577 . . . . 71.22 112.104 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.0 m -71.04 -40.35 71.76 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.272 0.629 . . . . 71.24 111.905 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.06 1.31 82.2 Favored Glycine 0 N--CA 1.479 1.528 0 CA-C-N 116.188 -0.46 . . . . 55.13 113.033 -170.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -75.11 129.89 38.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.64 1.176 . . . . 55.34 112.937 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -82.54 98.94 9.21 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.806 0.842 . . . . 74.2 109.881 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -88.39 118.26 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.012 0.525 . . . . 74.44 110.211 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -107.94 148.06 30.17 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.506 0.723 . . . . 65.43 112.18 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 m120 58.46 34.2 23.75 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.631 1.172 . . . . 64.2 113.349 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -65.35 125.4 24.98 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.622 0.769 . . . . 72.12 112.316 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.476 ' NZ ' ' SD ' ' A' ' 98' ' ' MET . 64.4 mttp -132.42 135.77 46.32 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.877 0.871 . . . . 75.23 111.096 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 97.9 m95 -116.52 160.71 20.23 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 126.018 1.727 . . . . 70.05 111.644 -12.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.33 139.72 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.047 0.939 . . . . 73.53 110.692 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.3 p -91.73 159.4 15.86 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.03 0.532 . . . . 73.53 112.028 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.439 ' HG3' ' HE3' ' A' ' 1' ' ' MET . 36.5 tt0 -65.33 -26.42 68.04 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.115 0.483 . . . . 75.22 111.173 173.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -63.9 -34.29 77.62 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.859 0.864 . . . . 75.32 111.614 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.811 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 11.0 pt-20 -95.66 -2.51 47.95 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.881 0.697 . . . . 74.51 112.881 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.8 mt -111.78 168.69 9.38 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.551 0.741 . . . . 75.43 109.633 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.2 m -143.47 123.19 13.35 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.396 0.679 . . . . 74.25 109.812 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.491 ' HA ' HG13 ' A' ' 7' ' ' VAL . . . -63.77 144.32 57.14 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.075 0.55 . . . . 75.24 111.465 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -74.75 76.43 2.08 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 122.035 0.921 . . . . 73.14 111.213 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.4 mt -121.11 -39.52 2.69 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.158 1.383 . . . . 74.33 109.359 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -139.88 156.65 46.59 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.6 1.16 . . . . 73.31 110.007 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -159.34 96.37 1.29 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.485 0.714 . . . . 74.22 110.145 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -89.83 135.18 33.78 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.871 0.469 . . . . 73.11 111.293 172.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -71.51 -32.61 68.4 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.76 0.424 . . . . 75.03 110.506 171.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.53 102.73 14.68 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.574 0.749 . . . . 72.24 109.488 170.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -84.5 155.53 22.13 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.274 0.63 . . . . 72.12 112.472 -172.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.7 m170 . . . . . 0 N--CA 1.491 1.577 0 C-N-CA 123.606 0.762 . . . . 75.55 111.989 175.234 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 110.204 -0.295 . . . . 74.15 110.204 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -75.0 137.42 41.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.835 0.854 . . . . 74.21 111.006 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.3 t -67.3 126.06 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 CA-C-O 121.353 0.596 . . . . 71.51 110.728 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.49 -18.03 38.92 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 115.189 -0.914 . . . . 72.21 113.07 -171.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 t -85.97 161.14 19.14 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.666 0.787 . . . . 75.21 110.202 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -124.62 149.59 46.93 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.084 0.468 . . . . 74.31 111.369 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.565 HG13 ' HA ' ' A' ' 123' ' ' ALA . 24.5 m -138.27 163.92 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.256 1.022 . . . . 75.51 111.92 -171.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 mm -98.81 132.22 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.413 1.085 . . . . 75.11 109.169 165.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.9 mt -91.73 125.5 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 N-CA-C 109.782 -0.451 . . . . 75.44 109.782 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -96.16 -58.98 1.94 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.64 1.176 . . . . 65.12 111.222 -171.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.5 ' HB ' ' HG2' ' A' ' 120' ' ' GLU . 23.7 m -91.75 140.75 29.39 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.451 -0.944 . . . . 73.53 108.451 169.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 75.5 m -148.19 136.62 21.44 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.238 0.542 . . . . 64.35 111.484 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.48 ' CE1' ' HZ1' ' A' ' 50' ' ' LYS . 43.6 m-70 -83.89 -22.78 31.5 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.647 -1.16 . . . . 75.54 109.46 175.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.1 mmt -97.7 122.04 40.31 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.498 1.119 . . . . 74.22 108.906 167.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -32.01 72.59 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.638 0.977 . . . . 75.43 113.638 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.98 -4.31 77.22 Favored Glycine 0 N--CA 1.476 1.307 0 N-CA-C 114.03 0.372 . . . . 51.31 114.03 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 54.8 ttp -100.85 -22.25 14.89 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.473 0.709 . . . . 74.04 110.562 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 58.8 tttm -68.12 120.09 13.76 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.159 0.584 . . . . 74.34 111.87 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.22 -6.01 82.79 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 115.214 -0.903 . . . . 75.12 113.99 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.91 159.97 24.82 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.27 0.841 . . . . 75.54 113.27 -171.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.75 115.76 21.81 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.091 -0.959 . . . . 73.13 110.403 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -113.41 164.13 14.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.033 0.933 . . . . 55.42 112.221 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 62.1 m -133.55 125.37 28.72 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.277 0.631 . . . . 73.12 110.987 174.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.91 104.55 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.656 0.782 . . . . 74.53 110.371 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.3 p -111.57 3.69 18.17 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.455 0.539 . . . . 73.24 112.455 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.9 146.44 14.11 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 120.002 -0.332 . . . . 74.1 112.812 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.69 108.26 6.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.626 0.77 . . . . 73.01 110.731 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -112.14 116.89 31.21 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.194 0.998 . . . . 71.21 110.378 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -99.35 88.62 3.95 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 122.086 0.946 . . . . 72.13 109.731 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -134.25 179.8 6.04 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.646 0.779 . . . . 72.33 111.041 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -83.15 123.01 29.12 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.566 -0.531 . . . . 74.34 109.566 171.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.86 155.15 20.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.096 0.558 . . . . 72.5 109.562 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -132.48 147.95 52.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.875 0.845 . . . . 72.51 111.663 -173.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.31 108.7 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.906 -1.516 . . . . 75.2 106.906 169.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.418 HG13 HD11 ' A' ' 88' ' ' ILE . 19.1 m -107.02 155.51 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.356 0.598 . . . . 73.14 111.924 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 68.5 m -134.31 122.96 23.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.894 0.877 . . . . 62.24 108.92 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -153.23 159.2 42.56 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.299 0.571 . . . . 62.11 110.81 -167.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.9 m -101.65 124.49 40.48 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.679 -1.23 . . . . 74.22 107.679 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.72 145.75 94.76 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.024 1.816 . . . . 74.33 111.922 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -62.82 -17.74 61.76 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.358 0.663 . . . . 75.42 112.527 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.466 HD22 ' HG2' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -70.25 -20.82 63.04 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.533 0.733 . . . . 73.41 111.539 172.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.12 29.57 45.48 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 115.108 0.803 . . . . 72.05 115.108 168.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.86 -127.48 5.33 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 117.912 0.856 . . . . 52.42 113.103 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.75 119.59 18.18 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.448 0.699 . . . . 74.32 110.551 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -57.29 105.67 0.25 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.764 0.826 . . . . 73.25 112.059 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.23 104.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 121.218 0.533 . . . . 74.32 109.998 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 6.8 p-10 -110.48 155.3 22.44 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.233 0.613 . . . . 74.2 109.855 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.0 m170 58.69 30.48 19.99 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.556 0.742 . . . . 74.32 112.101 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -65.07 125.58 25.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.904 0.882 . . . . 71.35 110.962 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' HZ1' ' CE1' ' A' ' 13' ' ' HIS . 6.9 mtmp? -139.94 144.35 37.04 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 124.082 0.953 . . . . 73.22 111.25 -174.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.5 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 97.5 m95 -112.32 138.07 49.57 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 125.32 1.448 . . . . 74.35 111.474 -4.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.81 138.69 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.322 -0.854 . . . . 72.1 109.077 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.3 pt -99.35 162.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.089 0.471 . . . . 74.22 111.737 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -51.36 -41.06 60.38 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.375 1.07 . . . . 74.44 113.322 175.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.74 -13.69 61.38 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.436 0.636 . . . . 70.04 112.363 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.553 ' HG3' ' HB2' ' A' ' 75' ' ' ALA . 15.4 tt0 -92.18 -16.72 25.87 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.347 1.059 . . . . 75.11 111.204 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.9 mt -102.67 132.38 48.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.904 0.882 . . . . 74.4 110.159 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.543 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 87.2 tttt -64.51 -54.88 25.36 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.761 0.824 . . . . 63.34 111.508 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -72.96 -5.88 41.61 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.046 1.128 . . . . 64.43 114.046 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.91 -39.61 62.89 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.163 1.171 . . . . 73.34 114.163 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.7 28.32 73.51 Favored Glycine 0 N--CA 1.481 1.697 0 N-CA-C 116.189 1.236 . . . . 74.44 116.189 163.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 61.47 14.28 5.73 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.275 1.03 . . . . 74.4 112.999 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -119.5 170.47 9.13 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.782 0.833 . . . . 71.54 111.023 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.0 m -96.6 114.59 26.26 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.159 -0.682 . . . . 75.31 109.159 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.482 HD11 HG12 ' A' ' 71' ' ' VAL . 34.9 mt -76.68 140.38 40.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.372 0.669 . . . . 71.03 110.988 -173.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -91.0 151.85 43.67 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.109 0.563 . . . . 74.12 110.951 -174.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.1 120.24 7.95 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.361 2.041 . . . . 74.11 112.35 170.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.79 -17.45 17.87 Favored Glycine 0 CA--C 1.538 1.484 0 CA-C-O 119.515 -0.603 . . . . 71.52 114.427 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.18 154.47 41.02 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.336 1.068 . . . . 73.42 111.844 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -120.6 136.9 54.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.267 0.627 . . . . 75.52 110.812 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 65' ' ' LEU . 35.8 m -132.89 172.38 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 124.841 1.256 . . . . 74.3 111.848 -170.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.46 138.86 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 124.231 1.012 . . . . 74.34 109.739 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.5 mt -97.94 118.2 33.98 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.669 0.788 . . . . 74.42 111.579 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.543 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 30.5 mm-40 -82.19 -22.59 35.91 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.157 0.583 . . . . 72.41 112.511 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.553 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . . . -104.78 172.12 6.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.095 0.558 . . . . 72.24 111.464 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.1 t -137.26 126.22 24.25 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.149 0.579 . . . . 62.14 111.487 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.541 ' H ' ' HG2' ' A' ' 81' ' ' MET . 32.8 m170 -92.92 -20.16 20.92 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.483 0.713 . . . . 74.44 111.003 164.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.0 ptp -151.43 158.73 44.07 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.296 0.638 . . . . 72.35 111.566 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.466 ' HG2' HD22 ' A' ' 41' ' ' ASN . 38.0 ttpt -66.78 95.91 0.38 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.447 0.699 . . . . 74.45 110.143 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.13 -12.4 4.41 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 115.859 -0.61 . . . . 64.32 113.354 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.541 ' HG2' ' H ' ' A' ' 77' ' ' HIS . 9.4 tpt -75.93 -59.57 2.7 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.389 1.076 . . . . 72.53 111.865 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -67.21 131.05 45.0 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.74 0.816 . . . . 75.21 112.267 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.61 -26.33 14.6 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.397 -0.365 . . . . 73.01 113.539 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.08 156.78 38.08 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.335 0.654 . . . . 72.14 111.914 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.9 m -84.5 116.35 23.06 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.909 -0.774 . . . . 65.13 108.909 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.63 150.82 22.33 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.721 0.809 . . . . 70.13 109.354 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -118.9 118.68 32.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.15 0.58 . . . . 74.32 109.472 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.418 HD11 HG13 ' A' ' 35' ' ' VAL . 36.9 mm -60.1 98.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.092 0.557 . . . . 74.24 109.869 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.11 -39.84 82.69 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.768 0.827 . . . . 73.13 109.254 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.6 t -163.44 163.25 24.97 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.064 -0.971 . . . . 71.21 110.473 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.6 139.27 52.85 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.661 0.785 . . . . 73.51 110.403 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -139.23 124.55 19.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.223 0.609 . . . . 74.55 111.102 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -86.81 94.11 9.46 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.088 -1.078 . . . . 73.53 108.088 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 t -136.79 155.04 50.34 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.8 0.84 . . . . 74.45 111.706 -170.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.4 m -87.46 125.06 34.07 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.794 -0.817 . . . . 74.24 108.794 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.5 134.16 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.012 0.925 . . . . 74.35 109.703 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.485 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 93.9 m-85 -112.63 154.98 25.2 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.764 0.792 . . . . 74.44 112.71 -169.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.3 ttp -102.55 112.49 25.25 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.546 -1.206 . . . . 73.15 108.734 173.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.515 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 23.6 m -121.5 148.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 112.909 0.707 . . . . 75.33 112.909 -172.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.3 122.86 48.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.839 0.856 . . . . 74.24 109.455 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -138.88 167.72 21.39 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.593 0.711 . . . . 74.34 112.591 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.1 m -106.84 118.64 37.22 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.102 -1.073 . . . . 73.5 108.102 168.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.6 p -64.96 124.64 22.59 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.421 0.288 . . . . 72.01 111.072 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.3 p -69.85 -41.42 74.9 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.119 0.968 . . . . 63.53 112.596 -176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.3 p -78.6 -48.48 15.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.041 0.537 . . . . 61.04 111.785 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.3 t -81.2 -36.38 30.18 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.405 0.682 . . . . 64.23 112.577 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.8 2.58 89.72 Favored Glycine 0 N--CA 1.483 1.768 0 CA-C-O 120.877 0.154 . . . . 73.42 113.478 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -82.08 137.79 34.95 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.91 0.884 . . . . 74.45 111.208 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.28 111.14 19.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.677 0.791 . . . . 73.43 109.138 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -110.8 120.17 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.181 0.592 . . . . 64.32 109.502 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -113.59 152.16 30.7 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.654 0.382 . . . . 74.42 110.412 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.4 m120 53.74 34.8 19.83 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 124.494 1.118 . . . . 71.31 113.224 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -58.27 135.99 57.25 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.645 1.178 . . . . 73.41 112.256 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 61.8 mttp -137.37 137.4 38.82 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.425 1.09 . . . . 74.45 110.45 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.5 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.4 m95 -115.17 156.94 24.36 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.64 1.576 . . . . 71.31 112.031 -9.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.5 m -128.02 154.12 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.637 1.175 . . . . 74.42 109.245 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.414 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 75.2 p -103.66 160.75 14.49 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 122.075 -0.391 . . . . 64.41 110.905 174.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.485 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 40.3 tt0 -63.07 -27.41 69.38 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.444 0.698 . . . . 74.25 111.552 178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -63.62 -25.42 68.22 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.168 0.987 . . . . 75.24 112.227 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.5 ' HG2' ' HB ' ' A' ' 11' ' ' THR . 40.2 mt-10 -91.86 0.03 57.5 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.914 0.885 . . . . 74.21 111.818 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 117' ' ' THR . 68.8 mt -119.95 140.48 50.84 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.344 0.52 . . . . 64.21 110.351 -172.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -131.56 122.94 26.93 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.848 0.859 . . . . 73.1 109.087 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.565 ' HA ' HG13 ' A' ' 7' ' ' VAL . . . -56.35 117.78 4.13 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.38 0.672 . . . . 72.51 111.728 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -81.13 86.98 6.09 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-O 121.616 0.722 . . . . 72.23 111.821 -172.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.7 mp -82.63 169.04 16.71 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.146 -0.933 . . . . 74.33 110.108 168.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.94 -24.32 67.68 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.097 0.559 . . . . 74.11 112.113 176.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -65.95 104.44 1.11 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.594 0.758 . . . . 74.55 110.562 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -86.64 116.45 24.76 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.316 0.647 . . . . 73.34 110.553 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -65.97 -31.29 72.11 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.36 0.664 . . . . 73.45 112.491 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -155.05 115.16 3.79 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.593 0.757 . . . . 75.34 109.266 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -79.05 177.76 8.55 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.284 0.634 . . . . 74.41 112.171 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 . . . . . 0 CA--C 1.568 1.672 0 CA-C-O 118.88 -0.581 . . . . 75.15 110.984 175.17 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.018 -0.364 . . . . 72.33 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.449 ' HZ2' ' HB3' ' A' ' 2' ' ' LYS . 0.2 OUTLIER -71.01 147.22 48.83 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.838 0.455 . . . . 73.54 110.326 176.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.66 132.39 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 CA-C-O 121.209 0.528 . . . . 75.2 111.133 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.32 -5.55 49.08 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.338 -0.847 . . . . 72.4 113.757 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.2 m -68.08 136.1 53.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.988 0.736 . . . . 70.41 112.988 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -84.63 113.69 21.45 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.007 -0.738 . . . . 63.32 109.007 167.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 123' ' ' ALA . 29.8 m -123.76 174.03 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.555 0.742 . . . . 71.35 111.29 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.7 mt -130.64 134.72 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.141 0.976 . . . . 73.02 109.341 170.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.5 mt -86.39 108.12 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.008 0.923 . . . . 73.03 110.144 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -89.18 -48.21 7.54 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.251 0.62 . . . . 72.42 111.133 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 28.0 m -102.14 143.07 32.42 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 107.987 -1.116 . . . . 64.33 107.987 173.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.554 ' HG ' ' HB3' ' A' ' 17' ' ' MET . 31.1 t -157.45 155.62 30.74 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.472 0.916 . . . . 72.34 113.472 -172.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -83.86 -42.71 16.09 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.147 -1.388 . . . . 70.42 109.111 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.7 mmt -90.67 128.6 36.69 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.185 0.994 . . . . 72.31 109.557 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -17.86 65.1 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.558 0.577 . . . . 74.52 112.558 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.52 -11.08 62.8 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 113.937 0.335 . . . . 52.01 113.937 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.554 ' HB3' ' HG ' ' A' ' 12' ' ' SER . 53.4 ttp -88.06 -23.05 23.85 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.31 0.555 . . . . 71.32 111.51 -177.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 141.97 57.77 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 121.025 0.44 . . . . 65.43 111.348 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.68 -8.65 41.05 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-N 116.003 -0.544 . . . . 73.4 114.116 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.41 148.25 32.03 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.498 0.719 . . . . 71.23 111.529 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -96.17 110.55 22.81 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 121.272 0.558 . . . . 73.45 109.976 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.51 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -101.86 172.28 7.03 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.209 1.004 . . . . 75.51 113.303 -174.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.2 m -125.79 123.89 39.77 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.028 0.931 . . . . 73.32 109.806 172.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.41 122.21 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.053 0.541 . . . . 61.03 110.08 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 p -126.72 -6.33 6.27 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.543 0.737 . . . . 61.3 112.591 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.38 145.71 13.38 Favored Glycine 0 N--CA 1.476 1.314 0 CA-C-O 119.648 -0.529 . . . . 74.22 112.019 173.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.29 123.48 12.95 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.618 0.767 . . . . 73.44 110.689 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -133.1 130.24 39.04 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.663 0.785 . . . . 75.31 111.926 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -104.24 87.47 2.75 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.617 0.767 . . . . 74.3 109.165 169.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -134.53 170.98 14.96 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.847 0.859 . . . . 72.4 110.921 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.5 m -75.47 107.71 7.78 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.492 -0.558 . . . . 73.11 109.492 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.01 110.5 23.1 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.601 0.76 . . . . 74.44 109.004 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.5 ' HE2' ' HA ' ' A' ' 54' ' ' GLN . 95.7 m-85 -89.33 151.86 21.85 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.873 0.844 . . . . 75.23 112.158 -172.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.0 t -99.68 120.41 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.255 -1.387 . . . . 74.12 107.255 164.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -125.72 148.55 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.514 0.673 . . . . 73.32 112.671 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.6 p -115.81 124.99 52.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.241 1.017 . . . . 54.45 109.14 170.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.423 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 47.2 p90 -152.11 156.19 39.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.767 0.427 . . . . 74.24 110.678 -174.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 15.1 m -113.31 110.85 50.3 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 109.123 -0.695 . . . . 72.05 109.123 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 38' ' ' THR . 9.2 Cg_endo -53.01 118.44 4.8 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.248 2.632 . . . . 65.33 112.791 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.3 p -64.71 -17.19 63.88 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.723 1.209 . . . . 75.2 113.596 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -67.47 -10.21 49.32 Favored 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 123.669 0.788 . . . . 74.42 112.466 174.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.77 51.38 2.14 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 122.255 -0.278 . . . . 64.14 112.717 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.57 -151.05 21.12 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 120.903 0.168 . . . . 54.51 113.421 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -106.14 133.86 50.19 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.725 0.81 . . . . 73.22 109.636 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -59.5 118.6 6.23 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.915 0.486 . . . . 74.14 111.208 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.574 HG22 ' HE3' ' A' ' 78' ' ' MET . 39.7 t -84.01 110.57 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.316 0.646 . . . . 60.31 110.638 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -95.72 130.65 42.57 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.934 0.894 . . . . 72.3 110.777 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 m170 54.01 57.93 5.51 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.065 0.946 . . . . 74.51 112.547 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.473 ' HD2' HG12 ' A' ' 52' ' ' VAL . 63.9 t60 -73.14 126.31 29.73 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.092 0.557 . . . . 72.11 111.446 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 66.4 mttm -131.21 139.36 49.69 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.44 1.096 . . . . 72.25 109.732 173.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.6 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 85.9 m95 -114.12 133.32 55.64 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.424 1.49 . . . . 74.32 111.474 -5.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.473 HG12 ' HD2' ' A' ' 49' ' ' HIS . 14.2 m -110.74 142.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 108.477 -0.935 . . . . 73.43 108.477 167.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.81 161.92 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-O 120.817 0.341 . . . . 73.33 111.241 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.5 ' HA ' ' HE2' ' A' ' 33' ' ' TYR . 63.3 tt0 -52.01 -47.98 64.71 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.189 0.996 . . . . 73.34 113.487 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -74.94 -8.1 55.51 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.509 0.723 . . . . 74.44 112.124 -174.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.413 ' HG3' ' HB1' ' A' ' 75' ' ' ALA . 35.7 tt0 -90.7 -8.84 48.81 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 124.842 1.257 . . . . 74.44 110.931 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.64 142.16 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 C-N-CA 124.506 1.123 . . . . 73.24 110.311 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -63.56 -50.37 69.77 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.228 1.011 . . . . 73.31 112.968 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.36 -6.58 57.1 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.225 0.824 . . . . 75.5 113.225 -170.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -33.19 -56.22 0.4 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.761 1.763 . . . . 64.5 115.761 -170.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.39 15.18 63.24 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 115.119 0.807 . . . . 50.25 115.119 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.37 3.52 1.87 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.2 1.4 . . . . 73.51 113.146 -170.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -100.54 160.37 14.4 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.931 0.892 . . . . 74.32 110.942 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.1 m -83.25 109.54 17.32 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.423 -0.584 . . . . 61.05 109.423 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.506 HD13 HG12 ' A' ' 71' ' ' VAL . 63.7 mt -72.02 122.13 20.35 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.724 -0.843 . . . . 73.14 108.724 175.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -97.55 149.09 35.35 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.212 0.605 . . . . 74.45 112.324 -164.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -46.25 115.65 1.22 Allowed 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.806 3.004 . . . . 74.4 114.623 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.77 -16.96 15.98 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 115.887 -0.597 . . . . 73.24 114.053 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.53 154.66 32.23 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 117.811 0.805 . . . . 74.3 111.714 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -126.07 137.29 53.61 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.344 0.658 . . . . 61.23 110.448 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.506 HG12 HD13 ' A' ' 65' ' ' LEU . 16.9 m -141.29 -179.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.621 1.169 . . . . 74.21 110.908 -168.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.53 146.44 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.494 0.718 . . . . 75.53 110.398 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.1 mt -96.09 123.92 39.89 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.673 0.789 . . . . 73.41 111.193 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -86.75 -6.03 58.94 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.525 0.565 . . . . 73.41 112.525 173.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.413 ' HB1' ' HG3' ' A' ' 56' ' ' GLU . . . -122.95 170.62 9.95 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.554 0.693 . . . . 75.41 110.525 170.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 66.1 p -146.99 127.72 14.3 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.281 -0.872 . . . . 71.23 110.458 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -82.82 -31.27 28.22 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.553 0.741 . . . . 71.11 109.524 168.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.574 ' HE3' HG22 ' A' ' 46' ' ' VAL . 66.6 mtm -125.77 177.61 6.18 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.971 0.908 . . . . 74.03 112.086 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -81.84 128.82 34.42 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.682 0.793 . . . . 73.13 111.394 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.67 11.48 83.96 Favored Glycine 0 N--CA 1.477 1.416 0 C-N-CA 123.179 0.418 . . . . 64.53 113.73 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.7 ttt -86.32 -44.0 12.44 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.882 0.873 . . . . 73.2 111.447 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 88.1 tttt -67.69 127.53 33.09 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.728 0.411 . . . . 74.34 111.209 174.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.15 -16.6 60.62 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 116.537 -0.301 . . . . 62.54 112.817 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.77 152.39 42.76 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.405 0.682 . . . . 74.2 111.116 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.8 m -84.18 114.0 21.48 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.971 -0.559 . . . . 65.52 109.914 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -100.44 130.14 46.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.863 0.865 . . . . 75.24 109.752 -177.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -99.87 117.58 34.48 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.343 -0.984 . . . . 73.2 108.343 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.3 mm -64.35 94.46 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 109.486 -0.561 . . . . 75.51 109.486 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.59 -33.17 68.82 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.884 0.873 . . . . 65.32 109.832 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.9 t -167.08 166.2 15.27 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.187 0.995 . . . . 62.44 110.506 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.03 131.48 42.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.978 0.911 . . . . 72.34 109.538 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -130.42 140.01 50.58 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.832 0.453 . . . . 72.35 111.168 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -94.12 96.71 9.81 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.518 0.727 . . . . 72.5 109.091 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.1 t -137.39 157.1 47.33 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.631 0.773 . . . . 74.53 111.116 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.9 m -86.43 125.84 33.97 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.764 -0.458 . . . . 53.12 109.764 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 8.6 m -117.34 138.23 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.735 0.814 . . . . 74.44 110.321 -176.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -122.11 164.0 18.52 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.314 1.045 . . . . 73.2 112.613 -169.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 ttp -119.35 116.92 27.18 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.95 -1.477 . . . . 70.31 107.984 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 24.5 m -125.72 149.67 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 123.544 0.737 . . . . 73.33 112.667 -172.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -115.88 116.77 28.56 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.018 0.927 . . . . 64.54 109.9 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -136.68 177.7 7.65 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.53 0.681 . . . . 75.32 111.781 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.5 m -123.78 125.01 43.95 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.326 1.051 . . . . 72.41 108.803 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.3 t -61.19 127.77 33.14 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.413 0.685 . . . . 75.14 112.216 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.6 p -69.33 -44.52 71.52 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.892 0.877 . . . . 72.11 111.441 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.0 m -81.07 -57.46 3.51 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.693 -0.685 . . . . 71.14 111.775 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.2 m -86.49 -21.13 27.17 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.185 0.809 . . . . 71.03 113.185 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.98 -17.96 38.5 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 115.121 0.809 . . . . 62.33 115.121 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.51 124.76 22.17 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.5 0.72 . . . . 73.31 112.258 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -81.57 101.97 10.32 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.414 0.686 . . . . 75.25 109.275 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.0 t -98.74 119.21 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.69 0.796 . . . . 75.11 110.396 -170.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.626 ' HD3' ' H ' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -105.3 137.53 42.95 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.645 0.778 . . . . 75.11 111.276 -174.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.8 m120 56.53 40.09 29.62 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.737 1.215 . . . . 75.22 113.174 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -64.72 132.83 50.71 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.936 0.894 . . . . 73.34 111.233 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -152.06 151.76 31.53 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.101 0.56 . . . . 72.22 111.37 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.6 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 92.3 m95 -105.88 144.54 32.47 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 125.984 1.713 . . . . 74.21 110.777 -4.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.7 148.92 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 123.903 0.881 . . . . 74.42 110.888 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.6 p -94.37 168.57 10.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.682 -0.636 . . . . 60.03 112.17 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -71.22 -25.56 62.55 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.001 0.52 . . . . 65.45 111.07 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -60.46 -20.02 58.49 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 124.275 1.03 . . . . 72.14 111.295 170.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.445 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 41.4 mt-10 -100.74 -2.67 31.85 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.344 1.058 . . . . 75.53 112.881 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.5 mt -119.45 157.5 28.12 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.51 0.724 . . . . 74.52 110.907 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.9 t -144.97 122.8 11.93 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.324 0.65 . . . . 74.31 110.292 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.475 ' HA ' HG13 ' A' ' 7' ' ' VAL . . . -68.28 117.67 10.38 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 122.784 0.434 . . . . 72.52 111.619 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -105.83 133.56 50.35 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.625 0.77 . . . . 73.2 111.995 -170.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.6 tp -118.9 137.78 53.22 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.658 0.783 . . . . 74.41 110.406 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -129.06 132.32 47.43 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.088 0.955 . . . . 74.52 110.285 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -85.03 128.97 34.86 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.771 0.828 . . . . 64.1 109.719 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -56.26 -70.52 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.494 0.718 . . . . 74.34 112.453 -172.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -86.68 72.92 10.13 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.954 0.883 . . . . 74.3 109.754 174.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -83.86 -33.61 24.79 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 114.992 -1.004 . . . . 75.14 111.85 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -73.13 118.24 15.84 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.176 0.59 . . . . 73.14 111.405 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.1 m80 . . . . . 0 CA--C 1.564 1.51 0 C-N-CA 123.55 0.74 . . . . 73.21 109.836 173.898 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.556 ' SD ' HG11 ' A' ' 7' ' ' VAL . 17.9 ptp . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 110.784 -0.08 . . . . 73.21 110.784 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.0 158.87 16.45 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.045 0.538 . . . . 71.03 111.798 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.92 123.48 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 CA-C-O 121.017 0.437 . . . . 73.31 110.691 173.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.22 -4.42 38.16 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.694 -0.685 . . . . 63.34 113.02 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.5 m -76.8 140.65 40.78 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.501 0.556 . . . . 65.53 112.501 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -91.02 114.78 27.39 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.964 -1.125 . . . . 73.22 107.964 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.556 HG11 ' SD ' ' A' ' 1' ' ' MET . 27.3 m -128.33 153.62 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.571 0.748 . . . . 74.24 111.329 -170.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -100.59 121.91 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.599 0.76 . . . . 74.14 110.164 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.663 HD13 ' HB3' ' A' ' 22' ' ' ALA . 46.0 mt -80.18 120.79 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.632 0.373 . . . . 75.32 110.459 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -92.49 1.0 57.5 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 123.426 0.69 . . . . 64.05 111.977 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.409 HG23 ' HG2' ' A' ' 120' ' ' GLU . 21.7 m -142.61 154.51 44.45 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.226 0.61 . . . . 74.5 111.686 -171.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.756 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 33.0 p -117.84 116.58 27.26 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.579 0.704 . . . . 73.24 112.042 173.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.453 ' H ' ' HE3' ' A' ' 17' ' ' MET . 38.2 m-70 -96.36 -33.06 12.07 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 107.616 -1.253 . . . . 72.14 107.616 160.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 26.6 mmt -107.87 149.49 28.21 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.786 1.234 . . . . 75.22 109.283 167.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -58.33 -45.19 88.55 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.853 0.861 . . . . 75.13 113.102 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.96 2.27 87.77 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 115.172 0.829 . . . . 62.41 115.172 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.535 ' HG2' HG21 ' A' ' 9' ' ' ILE . 47.8 ttp -87.76 -26.65 22.78 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.539 0.669 . . . . 75.4 111.991 -170.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.756 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 28.0 ttpp -66.28 119.28 11.25 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.546 0.338 . . . . 72.04 110.646 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.93 0.62 88.86 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 115.793 -0.64 . . . . 73.14 114.494 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.06 151.08 35.66 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.997 0.519 . . . . 73.12 111.214 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -95.43 113.02 24.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.525 0.33 . . . . 75.41 110.775 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.663 ' HB3' HD13 ' A' ' 9' ' ' ILE . . . -96.1 168.5 10.57 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.713 0.768 . . . . 64.05 113.058 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.4 m -126.26 123.61 38.5 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.096 -1.446 . . . . 73.12 107.096 166.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.08 110.29 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.871 0.468 . . . . 70.21 110.203 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.6 p -95.4 -14.02 24.17 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.116 0.567 . . . . 71.34 111.799 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.443 ' HA3' ' HE2' ' A' ' 98' ' ' MET . . . -162.95 154.41 25.35 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 113.44 0.136 . . . . 52.52 113.44 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.39 110.45 11.05 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.942 0.897 . . . . 71.15 110.725 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -115.1 123.19 48.34 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.847 0.859 . . . . 75.1 110.683 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.9 86.25 2.35 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 122.408 1.099 . . . . 71.52 109.757 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -134.57 173.02 12.12 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.122 -0.945 . . . . 72.31 111.045 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.1 m -78.6 123.74 27.42 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.683 -0.488 . . . . 72.15 109.683 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.08 144.87 31.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.91 0.884 . . . . 62.51 109.818 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -128.79 149.54 50.68 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.891 0.853 . . . . 74.23 111.888 -170.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.3 t -105.75 127.11 60.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 114.144 -1.389 . . . . 74.51 108.069 172.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 86' ' ' ALA . 15.8 m -127.78 161.39 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 112.781 0.659 . . . . 75.1 112.781 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.0 t -128.99 125.25 36.99 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.13 0.972 . . . . 74.45 109.408 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -153.79 158.42 40.87 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.463 0.705 . . . . 74.21 110.87 -172.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.4 m -109.65 112.31 58.66 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 108.566 -0.902 . . . . 74.31 108.566 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.32 128.69 28.48 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.183 2.589 . . . . 73.0 113.593 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.9 p -62.6 -18.39 62.08 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.968 1.307 . . . . 74.43 113.408 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -64.82 -10.05 25.25 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 123.938 0.895 . . . . 65.03 112.526 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.71 53.51 2.71 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-O 121.117 0.287 . . . . 52.53 112.467 -175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.68 171.16 14.31 Favored Glycine 0 N--CA 1.471 1.005 0 CA-C-N 115.352 -0.424 . . . . 74.21 113.408 -175.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -62.91 134.94 56.98 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.556 0.742 . . . . 74.45 111.512 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -58.99 123.92 18.19 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.379 0.672 . . . . 72.41 112.223 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.5 t -87.2 108.76 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.515 0.726 . . . . 63.43 109.723 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -101.78 139.21 37.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.681 0.793 . . . . 70.41 110.526 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.5 m170 57.82 37.41 27.03 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.089 0.956 . . . . 74.23 112.746 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -60.77 129.69 42.76 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.168 0.987 . . . . 75.35 111.408 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 61.1 mttp -130.2 137.24 49.97 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.936 0.895 . . . . 74.24 110.862 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 79.8 m95 -118.03 145.78 44.53 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 125.468 1.507 . . . . 75.42 111.242 -11.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -114.09 132.4 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 107.99 -1.115 . . . . 70.31 107.99 169.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.0 pt -102.02 167.27 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 121.598 -0.689 . . . . 74.44 109.909 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -47.6 -33.61 6.82 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.68 1.192 . . . . 72.01 113.393 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.51 -13.09 60.64 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.707 1.003 . . . . 65.02 113.707 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.516 ' HG3' ' HB1' ' A' ' 75' ' ' ALA . 0.5 OUTLIER -89.51 -12.91 38.66 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.623 0.601 . . . . 65.3 112.623 -179.283 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 mp -98.57 132.79 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 122.961 0.504 . . . . 73.33 111.293 -169.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -60.83 -44.16 97.3 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.81 1.244 . . . . 74.31 112.854 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -78.97 -16.32 57.1 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 118.189 -0.91 . . . . 73.45 112.813 -175.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -30.42 -62.19 0.16 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.813 1.412 . . . . 74.43 114.813 -160.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.19 23.2 65.98 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 114.602 0.601 . . . . 75.1 114.602 169.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 t70 72.54 -2.63 2.58 Favored 'General case' 0 CA--C 1.577 1.984 0 C-N-CA 125.304 1.442 . . . . 71.3 112.401 -176.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.437 ' HE3' HD21 ' A' ' 65' ' ' LEU . 53.0 pttt -79.65 153.71 29.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.376 -0.828 . . . . 75.23 110.954 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.4 m -84.48 118.73 24.48 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.142 -0.688 . . . . 75.33 109.142 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.53 ' HB3' HG13 ' A' ' 88' ' ' ILE . 41.6 mt -73.09 124.37 25.41 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.755 0.822 . . . . 73.45 110.598 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -109.02 155.94 40.01 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 123.584 0.754 . . . . 74.34 111.358 -171.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 84.5 Cg_exo -45.89 111.53 0.35 Allowed 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.123 2.549 . . . . 72.34 114.172 174.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.64 -16.39 14.11 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 114.611 0.604 . . . . 44.4 114.611 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.48 130.97 45.19 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 117.932 0.866 . . . . 75.32 112.33 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.414 HE22 ' HB2' ' A' ' 87' ' ' GLU . 31.9 mm-40 -87.8 122.06 30.99 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.827 -0.805 . . . . 75.41 108.827 171.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.14 146.74 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.596 0.758 . . . . 70.41 110.763 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -101.23 135.75 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 109.449 -0.574 . . . . 74.31 109.449 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.3 mt -91.19 109.15 20.4 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.98 0.512 . . . . 73.41 111.152 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.11 -40.04 65.28 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.63 0.772 . . . . 74.53 111.243 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.516 ' HB1' ' HG3' ' A' ' 56' ' ' GLU . . . -89.39 173.78 8.18 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.95 0.5 . . . . 72.22 111.044 174.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.638 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 29.4 t -149.17 125.44 10.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.866 -0.606 . . . . 53.44 109.804 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -86.73 -18.4 31.26 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.456 0.702 . . . . 70.53 110.976 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -155.14 147.61 24.06 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.31 1.044 . . . . 74.03 109.811 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.636 ' HZ3' ' HB3' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -51.1 124.11 10.81 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.105 0.962 . . . . 65.31 113.593 -174.178 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.2 -15.6 56.25 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 115.891 -0.595 . . . . 74.44 114.201 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.2 ttt -68.91 -39.02 79.91 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.539 0.736 . . . . 73.42 112.518 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.638 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 87.7 tttt -66.39 134.94 53.56 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.689 0.396 . . . . 65.03 111.66 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.79 -7.08 79.65 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.134 -0.485 . . . . 34.13 112.901 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.42 143.15 37.02 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.103 0.561 . . . . 70.12 111.58 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.1 m -87.01 116.74 25.27 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.705 -0.85 . . . . 75.22 108.705 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.457 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . . . -112.34 156.99 21.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.819 0.848 . . . . 53.42 110.136 -173.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.414 ' HB2' HE22 ' A' ' 70' ' ' GLN . 35.4 tt0 -120.07 125.97 49.61 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.293 -0.632 . . . . 73.4 109.293 174.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.53 HG13 ' HB3' ' A' ' 65' ' ' LEU . 34.6 mm -63.08 105.29 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 N-CA-C 109.691 -0.485 . . . . 73.0 109.691 175.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -75.94 -37.86 58.22 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.987 0.915 . . . . 73.35 109.889 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.4 t -157.42 152.0 25.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.674 0.79 . . . . 50.32 111.111 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.08 132.17 54.35 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.885 0.874 . . . . 74.32 109.949 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -142.16 140.68 32.48 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.099 0.476 . . . . 75.11 112.171 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -96.66 95.6 8.05 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.126 -0.488 . . . . 74.24 109.703 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.2 t -136.88 149.91 47.94 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.455 0.702 . . . . 74.12 110.764 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.0 m -82.49 124.88 30.5 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.459 -0.571 . . . . 64.2 109.459 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.637 HG12 HG23 ' A' ' 117' ' ' THR . 16.5 m -112.03 132.97 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.455 0.702 . . . . 73.23 109.464 -173.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.428 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 96.4 m-85 -109.63 139.0 45.18 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.937 0.875 . . . . 75.35 112.048 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.443 ' HE2' ' HA3' ' A' ' 26' ' ' GLY . 60.9 ttp -91.27 120.3 32.05 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 107.493 -1.299 . . . . 74.03 107.493 170.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.423 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 27.6 m -130.65 163.31 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 113.826 1.047 . . . . 71.35 113.826 -171.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -125.69 118.32 25.36 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.292 1.037 . . . . 64.23 110.61 174.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -131.87 178.47 6.75 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.067 0.947 . . . . 75.34 110.76 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.1 m -114.73 114.31 25.44 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.081 -0.711 . . . . 72.1 109.081 170.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.3 t -55.54 103.48 0.1 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.97 0.908 . . . . 64.42 110.684 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.2 p -65.53 -17.93 64.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.511 1.125 . . . . 74.31 113.578 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 65.1 p -92.9 -24.21 18.51 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.357 0.503 . . . . 74.13 112.357 177.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.3 m -112.26 -22.57 10.85 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.133 0.79 . . . . 73.21 113.133 -170.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.15 -12.5 49.85 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 113.717 0.247 . . . . 72.51 113.717 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -72.82 129.29 37.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.202 1.001 . . . . 71.5 112.202 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -84.45 111.63 19.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.05 0.54 . . . . 74.3 110.177 170.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.0 t -101.06 117.99 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.898 0.879 . . . . 74.31 110.145 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.436 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -113.67 148.89 35.53 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.293 0.637 . . . . 74.32 111.677 -175.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.406 ' HA ' ' HG2' ' A' ' 98' ' ' MET . 81.5 m-20 55.74 36.74 27.82 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 124.143 0.977 . . . . 75.21 112.416 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -62.11 134.91 57.2 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.198 0.999 . . . . 74.24 111.911 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 98.3 mttt -140.02 136.03 33.28 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.887 0.875 . . . . 72.01 111.381 -175.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 91.9 m95 -114.46 142.96 45.7 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.114 1.366 . . . . 71.4 112.961 -12.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.5 146.48 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 114.016 -1.447 . . . . 75.21 108.19 166.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.637 HG23 HG12 ' A' ' 96' ' ' VAL . 18.8 p -103.55 173.46 6.29 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.948 -0.47 . . . . 63.53 111.289 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.428 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 13.4 tp10 -58.23 -29.93 66.13 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.791 0.836 . . . . 74.11 111.258 170.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.53 -35.11 79.43 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.831 0.853 . . . . 75.33 111.72 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.409 ' HG2' HG23 ' A' ' 11' ' ' THR . 1.3 mt-10 -92.56 -3.18 55.47 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.133 0.573 . . . . 74.43 112.463 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.4 mt -118.78 143.77 46.71 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.662 0.785 . . . . 72.43 110.283 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 57.5 m -122.29 149.52 43.61 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.427 -0.953 . . . . 74.22 108.427 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.03 170.86 7.64 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.49 0.316 . . . . 50.21 111.268 173.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -61.16 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.713 0.768 . . . . 74.43 110.474 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.82 -175.41 3.83 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.284 1.434 . . . . 75.2 109.479 -178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.37 142.38 58.41 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.283 0.633 . . . . 73.13 112.217 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -154.92 61.2 0.66 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 112.253 0.464 . . . . 71.33 112.253 -175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -65.43 -42.01 92.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 122.119 -0.363 . . . . 73.33 111.86 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -167.83 105.25 0.5 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.732 0.813 . . . . 74.15 109.653 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -141.73 152.77 44.12 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.745 0.818 . . . . 72.42 111.757 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -151.27 -178.92 6.93 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.247 1.019 . . . . 74.44 109.663 173.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 CA--C 1.559 1.29 0 CA-C-O 118.968 -0.539 . . . . 73.03 110.096 175.189 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.489 ' HE3' ' HG3' ' A' ' 118' ' ' GLU . 58.3 mtt . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.446 0.165 . . . . 64.41 111.167 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -90.79 137.9 32.0 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.404 0.682 . . . . 74.01 112.756 -171.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.28 136.49 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 C-N-CA 123.597 0.759 . . . . 74.42 110.975 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.67 -12.6 68.95 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 116.007 -0.542 . . . . 61.54 113.129 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.9 t -87.1 159.12 19.03 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.426 0.69 . . . . 74.1 110.802 175.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -101.25 147.51 26.2 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.919 0.487 . . . . 62.25 109.756 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 123' ' ' ALA . 16.6 m -130.89 151.25 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.733 0.813 . . . . 71.1 110.399 176.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.2 mm -98.76 124.99 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.792 0.837 . . . . 74.5 109.743 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.418 HD11 ' HB1' ' A' ' 22' ' ' ALA . 30.1 mt -78.31 107.41 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 109.14 -0.689 . . . . 75.21 109.14 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -87.22 -34.28 19.03 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.061 0.458 . . . . 73.14 111.946 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.9 m -133.33 141.31 47.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.678 1.191 . . . . 51.15 108.223 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.473 ' HB2' ' HE3' ' A' ' 17' ' ' MET . 77.8 p -162.64 173.16 14.27 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.602 0.715 . . . . 75.02 111.555 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -86.29 -6.95 58.85 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 114.964 -1.016 . . . . 70.5 111.353 -175.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.595 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 51.5 mtt -133.2 144.66 49.96 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.371 1.068 . . . . 75.45 110.367 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -60.27 -38.2 82.82 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.232 0.613 . . . . 75.54 111.343 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.68 -24.07 63.81 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 114.766 0.666 . . . . 65.32 114.766 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.595 ' HG3' ' HB2' ' A' ' 14' ' ' MET . 27.0 mtm -94.14 -26.74 16.57 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.637 0.375 . . . . 72.2 110.968 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -67.71 121.04 15.08 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.025 0.53 . . . . 73.25 111.431 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.44 0.96 88.13 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 115.671 -0.695 . . . . 74.25 114.117 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.79 158.87 19.88 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.195 0.598 . . . . 72.53 112.491 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -89.69 123.51 33.78 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.751 -0.659 . . . . 74.11 109.641 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.418 ' HB1' HD11 ' A' ' 9' ' ' ILE . . . -114.83 168.7 9.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.244 1.018 . . . . 65.24 110.905 171.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 m -133.9 128.35 34.39 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.663 0.785 . . . . 74.22 109.24 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.24 105.21 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 109.692 -0.484 . . . . 73.52 109.692 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.2 p -103.87 -4.73 23.12 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.957 0.503 . . . . 64.41 111.085 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.81 133.06 3.27 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 111.21 -0.756 . . . . 62.41 111.21 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.01 107.02 12.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.62 0.768 . . . . 63.41 109.532 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -110.12 133.2 53.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.847 0.859 . . . . 74.31 109.745 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -122.24 86.38 2.57 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.993 0.901 . . . . 61.43 110.142 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -135.43 -178.54 5.16 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.751 0.82 . . . . 63.32 111.206 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.2 m -75.27 119.54 19.53 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.748 0.419 . . . . 72.34 110.136 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.03 150.19 25.17 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.582 0.753 . . . . 74.5 109.613 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.42 ' HB2' HG22 ' A' ' 52' ' ' VAL . 90.0 m-85 -128.61 142.91 50.89 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.784 0.802 . . . . 65.34 111.75 -173.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.18 109.65 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 114.146 -1.388 . . . . 75.14 107.29 171.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.9 148.31 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 113.816 1.043 . . . . 75.14 113.816 -170.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.4 t -116.7 125.03 51.12 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.112 0.965 . . . . 73.52 110.542 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -150.9 156.3 40.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 122.143 -0.348 . . . . 73.25 111.649 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 m -105.36 119.48 52.73 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.139 0.576 . . . . 74.02 109.826 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.34 124.4 15.97 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.801 2.334 . . . . 74.13 112.391 169.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.4 p -63.48 -10.32 17.02 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.013 1.486 . . . . 74.3 115.013 -167.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -90.95 10.1 27.88 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 122.845 0.458 . . . . 71.0 112.074 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.59 47.19 5.76 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.923 -0.471 . . . . 75.25 111.923 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.51 160.65 18.98 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 123.039 0.352 . . . . 61.02 112.514 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -62.89 130.1 43.31 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.017 0.527 . . . . 74.32 110.709 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -64.48 123.87 20.35 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.026 0.441 . . . . 74.24 111.453 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.64 HG22 ' HE3' ' A' ' 78' ' ' MET . 84.6 t -86.87 113.25 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.542 -0.754 . . . . 71.03 109.51 176.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -97.95 143.44 28.52 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.984 0.914 . . . . 70.33 110.115 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.6 m80 55.92 35.3 25.23 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.642 0.777 . . . . 74.5 112.801 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.424 ' HD2' HG13 ' A' ' 52' ' ' VAL . 66.7 t60 -57.86 118.3 5.19 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.826 0.85 . . . . 74.24 111.597 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 97.9 mttt -118.32 131.37 56.33 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.837 0.855 . . . . 71.41 110.414 176.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.632 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 94.4 m95 -118.84 154.83 32.25 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.642 -1.286 . . . . 73.23 111.499 -10.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' A' ' 49' ' ' HIS . 18.4 m -122.38 148.3 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 114.443 -1.253 . . . . 73.44 107.979 166.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.9 pt -103.01 170.4 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.606 0.717 . . . . 73.21 112.186 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -54.4 -34.35 61.11 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.206 1.002 . . . . 64.43 113.243 172.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.46 -1.04 49.03 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.493 0.717 . . . . 65.03 112.373 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -80.12 -17.96 51.14 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.202 1.001 . . . . 63.34 111.156 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.416 HD13 HG22 ' A' ' 71' ' ' VAL . 82.2 mt -122.2 140.29 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.725 1.21 . . . . 74.2 111.076 -165.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -75.42 -49.86 17.63 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.265 0.626 . . . . 72.41 112.027 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -68.14 -5.2 16.66 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.606 0.965 . . . . 75.01 113.606 -174.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.48 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -61.01 -58.6 7.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 122.854 0.462 . . . . 64.25 111.626 169.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.85 32.76 83.8 Favored Glycine 0 N--CA 1.48 1.577 0 O-C-N 121.967 -0.458 . . . . 74.33 112.441 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.4 p30 44.6 28.28 0.31 Allowed 'General case' 0 CA--C 1.57 1.733 0 C-N-CA 126.236 1.814 . . . . 75.32 114.268 -166.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 42.4 pttt -100.22 166.23 11.09 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.537 -0.542 . . . . 52.24 109.537 174.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 m -80.97 108.98 15.12 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.621 0.368 . . . . 74.52 110.537 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.557 HD13 HG12 ' A' ' 71' ' ' VAL . 50.9 mt -78.85 129.16 34.27 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.45 0.7 . . . . 73.13 110.63 175.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -98.32 145.27 29.55 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.601 0.76 . . . . 75.43 111.29 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.45 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 97.9 Cg_exo -47.07 130.12 15.99 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.536 2.824 . . . . 71.21 114.327 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.16 -12.68 48.69 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 123.17 0.414 . . . . 61.52 113.221 -174.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.1 143.77 41.08 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.604 0.762 . . . . 60.4 112.561 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -107.03 130.33 54.67 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.956 0.902 . . . . 73.34 110.428 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.557 HG12 HD13 ' A' ' 65' ' ' LEU . 28.0 m -133.36 175.77 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 124.159 0.984 . . . . 73.23 111.493 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -117.61 136.02 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.571 0.748 . . . . 73.1 109.864 171.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.5 mt -88.72 120.7 30.36 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.818 0.847 . . . . 74.24 110.791 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.04 1.32 56.23 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.09 0.556 . . . . 75.22 112.457 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.91 157.83 18.85 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.448 0.699 . . . . 64.33 112.108 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.9 p -118.03 128.95 55.26 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.924 -0.769 . . . . 61.35 108.924 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -141.5 -42.85 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.524 -1.288 . . . . 74.43 107.524 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.64 ' HE3' HG22 ' A' ' 46' ' ' VAL . 24.8 ptt? -157.21 -176.17 5.82 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 114.058 -1.428 . . . . 73.31 110.596 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -60.74 124.15 19.59 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.595 0.758 . . . . 74.32 112.493 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.9 14.36 82.42 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 114.718 0.647 . . . . 75.33 114.718 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.5 tpt -69.71 -59.51 2.9 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.36 0.58 . . . . 72.45 111.174 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -67.55 129.29 39.45 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 115.998 -0.547 . . . . 75.03 111.453 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.86 -9.48 61.89 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 116.473 -0.33 . . . . 71.54 113.553 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.67 148.62 31.53 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.261 0.624 . . . . 74.33 111.852 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.3 m -89.7 122.32 32.7 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.196 0.598 . . . . 72.35 109.629 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.84 141.71 36.79 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.461 0.704 . . . . 41.34 111.359 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -98.79 115.62 29.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.318 1.447 . . . . 73.45 108.78 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.7 mm -69.09 96.23 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 109.03 -0.73 . . . . 75.41 109.03 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -71.65 -36.87 70.84 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.778 0.431 . . . . 73.43 110.154 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.45 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . 26.5 t -166.65 162.69 16.58 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.5 -0.773 . . . . 74.0 111.37 -177.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.14 135.76 49.29 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.253 1.021 . . . . 74.21 110.355 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -138.51 135.2 34.86 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.378 0.671 . . . . 73.43 111.399 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -90.0 94.87 9.97 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.463 -0.94 . . . . 75.22 108.463 171.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -136.08 154.99 50.85 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.427 0.691 . . . . 61.55 110.803 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 m -87.78 116.59 26.03 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.151 -0.685 . . . . 72.51 109.151 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.2 m -111.47 134.99 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.189 0.996 . . . . 71.23 109.529 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.92 148.61 36.52 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.989 0.9 . . . . 70.44 112.871 -169.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.7 ttp -103.11 111.35 23.68 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.966 -1.47 . . . . 74.5 107.312 167.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.8 m -123.84 147.62 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 112.891 0.7 . . . . 74.24 112.891 -170.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -105.24 117.65 34.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.926 0.89 . . . . 73.11 108.835 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -130.56 169.13 15.99 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.617 0.723 . . . . 74.14 111.692 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.2 m -116.82 133.3 56.18 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 108.931 -0.766 . . . . 73.32 108.931 167.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.2 t -72.82 129.31 37.89 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.78 0.432 . . . . 72.43 111.671 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.6 p -66.04 -41.54 90.75 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.066 0.946 . . . . 75.42 112.094 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.0 p -85.63 -50.05 7.52 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.31 0.644 . . . . 74.32 112.282 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.0 m -88.81 -24.02 22.69 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.0 0.741 . . . . 75.53 113.0 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 4.34 79.26 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 114.334 0.494 . . . . 72.2 114.334 -177.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -68.36 131.59 45.58 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.359 0.874 . . . . 64.32 113.359 -176.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -84.72 86.21 7.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.793 0.837 . . . . 65.04 109.405 174.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.91 125.61 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 115.866 -0.607 . . . . 74.55 109.726 -172.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.93 153.61 33.31 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.093 0.473 . . . . 73.41 111.471 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.432 HD21 ' N ' ' A' ' 112' ' ' ASN . 0.8 OUTLIER 60.5 28.45 18.12 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 114.522 -1.217 . . . . 73.11 112.563 177.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -66.78 130.1 42.05 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.525 0.73 . . . . 75.34 110.807 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -162.3 154.79 19.46 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 115.672 -0.695 . . . . 72.2 111.465 -169.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.632 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 96.6 m95 -103.23 133.04 48.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.473 -1.392 . . . . 74.3 111.862 0.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -126.88 139.72 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.604 1.162 . . . . 73.31 109.051 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.3 p -94.72 173.48 7.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.826 -0.546 . . . . 74.44 112.055 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.489 ' HG3' ' HE3' ' A' ' 1' ' ' MET . 33.5 tt0 -64.43 -19.99 65.88 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.367 0.667 . . . . 72.15 111.24 172.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.65 -33.98 71.56 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.953 0.901 . . . . 73.4 110.807 173.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.95 -2.64 58.47 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.166 0.586 . . . . 64.44 111.742 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.16 160.86 28.16 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.032 0.92 . . . . 74.21 111.018 -173.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.3 m -140.63 146.98 38.64 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 107.206 -1.405 . . . . 75.02 107.206 168.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.499 ' HA ' HG13 ' A' ' 7' ' ' VAL . . . -58.76 162.14 4.25 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 119.177 0.899 . . . . 72.33 111.567 176.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -54.79 98.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.454 0.645 . . . . 75.22 111.33 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 14.9 tp -120.72 175.48 6.0 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.278 1.031 . . . . 73.44 110.845 -164.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.27 154.2 41.82 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 123.123 0.569 . . . . 73.31 111.4 173.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -63.97 -11.18 26.23 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.778 1.231 . . . . 65.05 113.872 -175.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 48.05 113.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 126.242 1.817 . . . . 75.32 114.48 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -75.54 19.83 0.18 Allowed 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 115.388 1.625 . . . . 74.5 115.388 -166.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -163.53 106.74 0.99 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.368 0.531 . . . . 73.33 110.795 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -164.47 151.95 11.81 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.284 0.634 . . . . 72.11 111.758 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 64.9 m80 . . . . . 0 CA--C 1.568 1.649 0 C-N-CA 123.916 0.886 . . . . 75.52 109.794 172.198 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.461 ' SD ' HG11 ' A' ' 7' ' ' VAL . 64.2 mtt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 110.274 -0.269 . . . . 71.12 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.17 161.86 14.09 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.398 0.679 . . . . 75.11 111.128 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.4 t -65.96 125.36 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 121.116 0.484 . . . . 73.24 111.315 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.02 -1.68 35.49 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.532 0.587 . . . . 55.12 112.993 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.3 m -73.58 129.77 38.65 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.319 0.647 . . . . 62.55 111.897 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -99.24 117.27 33.33 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.367 0.667 . . . . 73.35 109.639 174.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.461 HG11 ' SD ' ' A' ' 1' ' ' MET . 30.5 m -134.38 153.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 124.114 0.966 . . . . 71.41 110.917 -168.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.56 126.29 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 123.301 0.64 . . . . 73.42 110.059 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.591 HD12 ' HB2' ' A' ' 22' ' ' ALA . 25.7 mt -83.88 131.56 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 122.013 -0.429 . . . . 70.35 110.849 -171.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -96.08 -51.24 4.51 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 118.116 0.416 . . . . 73.02 111.724 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m -93.21 140.69 29.25 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.049 0.54 . . . . 75.22 109.56 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 14' ' ' MET . 93.0 p -128.44 125.45 38.54 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.758 0.651 . . . . 64.31 112.758 -171.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -84.05 -41.35 17.29 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.755 0.822 . . . . 72.24 108.841 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.416 ' O ' ' HB2' ' A' ' 12' ' ' SER . 25.1 mmt -101.56 153.22 19.92 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.34 1.056 . . . . 72.03 109.478 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -63.71 -35.52 80.84 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.209 0.818 . . . . 73.25 113.209 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.62 -1.26 89.2 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 114.347 0.499 . . . . 63.42 114.347 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.488 ' HG2' HG23 ' A' ' 9' ' ' ILE . 52.7 ttm -75.2 -30.12 60.53 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 122.979 0.512 . . . . 63.41 110.05 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HB3' ' HZ1' ' A' ' 18' ' ' LYS . 7.2 ttpm? -63.21 119.25 9.22 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.896 0.878 . . . . 74.45 111.79 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.42 2.25 78.96 Favored Glycine 0 CA--C 1.539 1.548 0 N-CA-C 114.667 0.627 . . . . 62.43 114.667 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.76 149.12 38.06 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.22 0.608 . . . . 75.12 111.93 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -85.14 102.32 13.18 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.652 -0.499 . . . . 70.21 109.652 174.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.591 ' HB2' HD12 ' A' ' 9' ' ' ILE . . . -85.24 147.07 26.76 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.559 0.744 . . . . 74.22 111.552 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.0 m -119.3 116.5 26.36 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.1 -1.074 . . . . 72.43 108.1 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.37 100.49 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 N-CA-C 109.607 -0.516 . . . . 72.3 109.607 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.1 p -91.72 -9.18 44.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.158 0.583 . . . . 74.25 110.927 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.05 137.32 4.73 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.833 -0.507 . . . . 70.14 111.833 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.87 106.93 13.5 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.888 0.875 . . . . 74.34 109.297 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -112.48 128.18 56.26 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.808 0.843 . . . . 73.41 110.298 -172.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -114.36 93.13 4.21 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.382 -0.599 . . . . 72.35 109.382 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.522 HG22 HD13 ' A' ' 53' ' ' ILE . 8.2 t -137.09 -179.53 5.77 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.853 0.861 . . . . 64.11 111.356 -176.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.8 m -75.8 116.94 17.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.976 0.511 . . . . 75.43 110.305 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.05 151.0 22.32 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.411 0.684 . . . . 63.13 110.191 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.41 ' HE2' ' HA ' ' A' ' 54' ' ' GLN . 82.1 m-85 -130.6 146.11 52.04 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.485 0.659 . . . . 73.32 111.373 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.82 118.8 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.665 -1.235 . . . . 74.0 107.665 168.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 27.0 m -123.79 144.71 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.331 0.493 . . . . 75.21 112.331 -175.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.7 m -114.5 132.65 56.22 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.73 0.812 . . . . 74.43 110.303 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 46.1 p90 -160.5 160.52 32.07 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.08 0.552 . . . . 64.44 111.276 -174.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.9 m -113.99 114.96 46.08 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 108.501 -0.926 . . . . 73.0 108.501 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.31 127.18 24.92 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.972 2.448 . . . . 75.22 113.025 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.6 p -64.44 -17.34 63.72 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.462 1.105 . . . . 55.43 113.833 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -82.93 11.11 6.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.251 0.62 . . . . 74.53 112.335 176.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.66 51.24 5.62 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 122.735 0.207 . . . . 71.21 113.306 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.97 -171.61 26.33 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 122.559 0.123 . . . . 71.33 113.072 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.74 124.78 28.19 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.12 -1.067 . . . . 62.43 108.12 174.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -50.35 114.01 1.02 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.798 0.839 . . . . 73.42 112.469 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.581 HG23 ' HE1' ' A' ' 78' ' ' MET . 32.9 t -75.17 96.86 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.468 -0.787 . . . . 74.52 109.825 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -85.46 117.96 24.69 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.498 -0.774 . . . . 70.35 109.915 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.8 m170 58.22 59.88 2.87 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.129 0.972 . . . . 74.42 112.136 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -59.8 121.47 11.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.011 0.925 . . . . 73.04 111.562 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 98.5 mttt -126.66 136.17 52.14 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.854 0.861 . . . . 72.04 110.234 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 89.1 m95 -115.46 146.56 41.53 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.906 1.282 . . . . 73.43 111.698 -10.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.02 151.83 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 113.813 -1.539 . . . . 72.43 108.205 166.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.581 HG23 HG21 ' A' ' 96' ' ' VAL . 33.0 pt -118.93 -177.07 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 120.96 0.409 . . . . 74.23 110.948 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.434 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 30.5 tt0 -49.73 -33.13 15.2 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.734 1.214 . . . . 75.41 113.822 175.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.423 ' H ' HG13 ' A' ' 53' ' ' ILE . 7.5 tp10 -62.59 -26.43 68.59 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 113.117 0.784 . . . . 75.05 113.117 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.44 -13.62 54.38 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 112.654 0.613 . . . . 74.51 112.654 -173.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.41 137.37 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.285 0.634 . . . . 74.45 110.958 -171.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.513 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 27.1 ttpt -78.28 -37.08 45.76 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.455 1.102 . . . . 73.3 112.434 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.07 -14.7 59.78 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.093 0.957 . . . . 74.33 112.821 -173.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -49.86 -63.35 1.14 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.881 1.067 . . . . 74.12 113.881 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.67 33.85 88.35 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 115.234 0.853 . . . . 70.13 115.234 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 67.07 16.81 10.37 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.607 1.163 . . . . 70.14 113.24 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 12.0 ptpt -106.47 176.43 5.17 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.256 0.551 . . . . 74.33 111.073 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.3 m -96.48 113.82 25.43 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.031 0.933 . . . . 75.2 109.156 168.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.0 mt -77.03 136.93 38.7 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.25 0.62 . . . . 72.34 110.168 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -95.55 152.59 39.31 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 123.522 0.729 . . . . 71.44 111.489 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 82.7 Cg_exo -50.86 119.88 5.87 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.124 2.549 . . . . 73.24 113.395 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.85 -13.98 26.84 Favored Glycine 0 N--CA 1.48 1.609 0 CA-C-O 119.959 -0.356 . . . . 60.42 113.815 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.55 120.63 14.89 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.736 0.768 . . . . 73.44 112.123 176.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -89.1 120.68 30.71 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.6 -0.727 . . . . 74.51 109.839 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.88 166.43 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.695 1.198 . . . . 73.3 110.906 -172.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.9 mm -112.11 135.81 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.612 0.765 . . . . 73.0 110.116 171.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.7 mt -83.29 122.82 28.95 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.064 0.545 . . . . 71.34 111.291 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 45.5 mm-40 -93.29 13.19 22.09 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 123.173 0.589 . . . . 73.23 112.043 173.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.14 156.44 32.32 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.358 0.663 . . . . 73.15 110.138 169.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.4 t -139.83 126.65 20.69 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.929 -0.578 . . . . 75.41 110.149 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -110.37 2.01 18.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.852 0.861 . . . . 71.44 109.859 171.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.581 ' HE1' HG23 ' A' ' 46' ' ' VAL . 24.4 ptt? -173.44 161.03 4.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.737 1.215 . . . . 64.22 110.336 -174.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -68.22 124.28 23.04 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 120.728 0.299 . . . . 61.3 110.65 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.92 41.42 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.575 -0.569 . . . . 72.13 113.897 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.6 ttt -98.69 -58.42 1.96 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 117.469 0.635 . . . . 73.45 110.172 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -66.96 131.2 45.38 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.333 0.253 . . . . 74.14 110.522 171.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.69 -15.91 59.34 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 116.587 -0.279 . . . . 75.43 113.218 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.38 151.82 30.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.289 0.636 . . . . 60.12 111.687 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.1 m -87.55 118.82 27.27 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.478 -0.783 . . . . 75.03 110.165 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . . . -116.98 149.5 40.12 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.195 0.998 . . . . 74.32 110.112 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -115.03 129.23 56.66 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.968 -0.382 . . . . 73.42 109.968 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 67' ' ' PRO . 32.0 mm -66.21 108.7 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 N-CA-C 109.415 -0.587 . . . . 72.0 109.415 174.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -75.16 -38.91 60.76 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.184 0.516 . . . . 65.31 109.951 170.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.8 t -161.73 152.7 18.07 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.22 -0.9 . . . . 71.43 111.388 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -128.55 132.74 48.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.946 0.899 . . . . 75.14 110.076 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -134.57 143.83 47.6 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.413 0.685 . . . . 63.52 111.415 -171.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -98.27 94.16 6.62 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.69 -0.856 . . . . 75.53 108.69 170.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -136.56 155.9 49.32 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.522 0.729 . . . . 74.21 110.992 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.2 m -84.11 119.54 25.1 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.15 -0.685 . . . . 71.04 109.15 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 53' ' ' ILE . 15.8 m -107.24 135.33 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.853 0.861 . . . . 74.0 109.049 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.453 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 86.3 m-85 -109.82 135.88 50.01 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.451 0.643 . . . . 72.52 111.475 -174.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.461 ' SD ' ' NZ ' ' A' ' 114' ' ' LYS . 56.3 ttp -90.18 111.74 23.01 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.319 -1.363 . . . . 74.14 107.319 167.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 22' ' ' ALA . 27.3 m -124.08 144.91 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 113.435 0.902 . . . . 75.54 113.435 -170.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -109.61 118.22 36.01 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.942 1.297 . . . . 63.01 108.315 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.461 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 55.0 p90 -139.6 166.66 24.0 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.265 0.839 . . . . 74.23 113.265 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.2 m -100.39 109.34 21.5 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.963 -1.017 . . . . 72.01 109.333 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.2 m -57.54 106.06 0.3 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.3 0.64 . . . . 65.33 111.181 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.7 p -61.4 -23.05 65.53 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.0 0.92 . . . . 75.04 113.295 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.8 t -65.88 -25.99 67.43 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.428 0.899 . . . . 73.23 113.428 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.2 t -142.63 -42.55 0.32 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.636 0.606 . . . . 74.04 112.636 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.01 -8.89 18.6 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 123.259 0.457 . . . . 72.32 113.141 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.21 139.54 54.53 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.86 0.864 . . . . 74.02 111.955 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -85.0 114.74 22.39 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.4 0.68 . . . . 74.5 111.151 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.1 t -88.84 104.9 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 108.075 -1.083 . . . . 73.12 108.075 171.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -93.84 131.8 38.89 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.396 -0.82 . . . . 74.22 110.721 -168.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.5 p30 45.48 52.9 8.8 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 125.29 1.436 . . . . 74.42 114.286 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -57.83 139.7 53.48 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.542 1.137 . . . . 75.45 112.876 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.461 ' NZ ' ' SD ' ' A' ' 98' ' ' MET . 68.1 mttm -131.67 128.39 38.92 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 124.249 1.02 . . . . 71.12 111.063 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 94.3 m95 -120.81 160.97 22.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.918 1.687 . . . . 73.42 111.203 -13.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.73 166.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 124.31 1.044 . . . . 74.43 109.806 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 53.2 p -117.18 167.4 11.23 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.098 0.559 . . . . 62.22 111.214 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.453 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 36.0 tt0 -67.24 -24.57 65.83 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.782 0.433 . . . . 73.52 111.601 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.2 -30.91 71.94 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.442 0.697 . . . . 70.22 111.441 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -93.65 -3.11 53.06 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.15 0.98 . . . . 71.43 111.942 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.6 mt -117.1 123.46 46.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.808 0.843 . . . . 64.12 109.639 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.424 ' O ' ' HB ' ' A' ' 7' ' ' VAL . 58.0 m -104.0 150.63 24.07 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.682 -0.858 . . . . 74.2 108.682 172.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.17 169.8 9.7 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.205 0.457 . . . . 74.04 111.38 174.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -54.39 99.88 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.011 0.525 . . . . 72.14 111.285 177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 48.8 tp -137.23 137.77 39.44 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.635 0.774 . . . . 75.21 110.933 -172.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.13 11.24 8.19 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.327 1.051 . . . . 72.23 111.712 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -74.42 103.11 4.66 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.854 0.862 . . . . 73.03 110.778 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -135.08 151.07 50.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.351 1.06 . . . . 73.14 110.572 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -113.25 157.78 21.33 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.627 0.771 . . . . 73.12 111.765 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -94.2 -176.52 4.0 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.18 0.992 . . . . 74.43 110.799 174.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -74.66 90.12 2.28 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.031 0.532 . . . . 75.04 111.102 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 C--O 1.255 1.38 0 C-N-CA 123.546 0.738 . . . . 74.45 109.8 170.335 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 110.934 -0.025 . . . . 61.44 110.934 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.463 ' HD2' ' H ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -110.36 149.19 30.59 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.35 0.66 . . . . 72.12 110.669 178.009 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.37 130.04 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 123.333 0.653 . . . . 73.43 111.414 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.73 -8.75 56.56 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 115.42 -0.809 . . . . 72.52 113.081 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.1 t -85.4 151.51 23.95 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.577 0.584 . . . . 74.11 112.577 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -100.59 117.46 34.77 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.153 0.981 . . . . 74.11 110.266 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.48 154.88 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.947 0.899 . . . . 71.14 111.293 -176.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.8 mm -100.61 133.51 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.23 1.012 . . . . 74.43 110.511 172.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 17' ' ' MET . 33.0 mt -84.63 123.91 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 122.162 -0.336 . . . . 74.4 110.325 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -100.66 -46.55 5.14 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.274 0.63 . . . . 73.13 112.46 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.45 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 79.0 m -109.14 140.83 42.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.717 0.807 . . . . 62.54 109.293 -176.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.7 m -160.46 163.46 32.97 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.631 0.604 . . . . 64.44 112.631 -169.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.656 ' HE2' ' HG3' ' A' ' 50' ' ' LYS . 11.2 m-70 -95.79 -40.34 9.4 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.414 -0.812 . . . . 75.02 109.053 164.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.6 mpt? -84.02 142.06 30.73 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.998 0.919 . . . . 72.25 111.028 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 12.2 mptt -72.18 -26.71 62.18 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.299 0.64 . . . . 74.12 112.016 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.62 -4.77 81.89 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 114.999 0.76 . . . . 33.45 114.999 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.427 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 63.4 mtt -87.87 -26.29 22.85 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 117.558 0.679 . . . . 72.25 112.364 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 25.6 pttm -61.75 118.84 7.67 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.154 0.502 . . . . 72.42 111.522 -175.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.1 1.94 70.5 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 113.939 0.336 . . . . 64.4 113.939 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.12 138.38 47.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.292 0.637 . . . . 73.33 112.279 -177.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -78.87 97.61 6.04 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.521 0.728 . . . . 75.21 110.11 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.56 157.31 16.04 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.23 1.012 . . . . 72.25 111.601 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.3 m -126.73 124.27 39.37 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.992 -0.744 . . . . 65.13 108.992 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.417 ' HA ' HG12 ' A' ' 99' ' ' VAL . 46.6 t -72.75 102.17 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.241 0.616 . . . . 72.11 110.001 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.9 p -99.92 -2.76 33.91 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.334 0.654 . . . . 75.32 112.718 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.07 151.81 20.95 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 112.283 -0.327 . . . . 72.3 112.283 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.93 108.82 7.59 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.756 0.822 . . . . 74.41 110.558 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.408 ' HB2' HG22 ' A' ' 96' ' ' VAL . 4.6 m-85 -108.87 122.63 47.59 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.959 0.904 . . . . 71.31 110.597 -174.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -100.01 83.24 2.67 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 122.058 0.932 . . . . 64.02 109.74 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.3 t -133.95 170.4 15.68 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 115.506 -0.77 . . . . 70.11 111.443 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.2 m -87.51 122.66 31.51 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.97 0.508 . . . . 70.0 109.96 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.1 154.77 27.18 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.16 0.984 . . . . 44.12 109.989 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.422 ' HB2' HG22 ' A' ' 52' ' ' VAL . 91.5 m-85 -130.28 149.4 51.99 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.916 0.865 . . . . 75.13 113.099 -169.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -102.25 111.17 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 113.941 -1.482 . . . . 74.11 108.055 171.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.487 HG13 HD13 ' A' ' 88' ' ' ILE . 22.2 m -125.12 146.99 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 113.203 0.816 . . . . 72.03 113.203 -172.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 66.6 p -117.73 129.98 56.04 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.374 1.07 . . . . 74.33 110.775 176.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.641 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 37.9 p90 -159.09 160.35 35.61 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.569 0.7 . . . . 75.21 111.639 -171.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.0 m -113.55 116.76 45.69 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 107.511 -1.292 . . . . 72.11 107.511 173.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.43 147.17 17.37 Favored 'Trans proline' 0 CA--C 1.564 2.013 0 C-N-CA 123.228 2.618 . . . . 73.35 113.271 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.5 p -63.55 -18.79 64.23 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.697 0.799 . . . . 75.33 111.998 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.76 -21.4 66.51 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.957 0.903 . . . . 74.14 111.984 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 33.35 70.63 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 114.782 0.673 . . . . 75.13 114.782 172.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.09 -113.62 2.68 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-N 117.16 0.48 . . . . 60.53 111.961 174.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -70.65 175.36 4.96 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.684 0.794 . . . . 72.42 112.934 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -116.78 129.29 56.01 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.165 -0.925 . . . . 74.11 108.64 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.404 HG22 ' HE2' ' A' ' 78' ' ' MET . 40.9 t -104.29 102.62 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 122.969 0.508 . . . . 71.1 109.952 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.566 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.7 p-10 -109.97 153.91 23.9 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.698 0.799 . . . . 65.11 111.218 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 34.5 m80 55.63 33.78 21.92 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.21 1.004 . . . . 73.14 112.303 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -70.91 134.74 47.49 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.912 1.285 . . . . 70.53 111.59 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.656 ' HG3' ' HE2' ' A' ' 13' ' ' HIS . 18.0 ptpt -139.7 139.38 36.56 Favored 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.68 0.792 . . . . 74.03 110.723 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 92.3 m95 -115.97 149.28 39.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 119.86 -1.775 . . . . 73.45 112.419 -3.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.422 HG22 ' HB2' ' A' ' 33' ' ' TYR . 15.8 m -127.36 132.84 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 114.519 -1.219 . . . . 73.51 109.131 170.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.2 pt -104.31 176.17 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.9 -0.5 . . . . 74.25 112.324 -171.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -45.07 -52.55 8.9 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.544 1.138 . . . . 73.4 113.773 171.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.01 -16.26 63.14 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.59 0.756 . . . . 74.52 111.976 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.567 ' HG3' ' HB1' ' A' ' 75' ' ' ALA . 7.9 tt0 -93.53 -17.03 23.84 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.418 1.087 . . . . 70.24 111.423 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.2 mt -111.94 127.4 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.208 1.003 . . . . 74.15 110.838 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -61.82 -56.16 22.31 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.685 0.794 . . . . 71.15 112.057 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.27 -17.43 62.49 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.633 0.975 . . . . 74.22 113.633 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HA ' HD11 ' A' ' 65' ' ' LEU . . . -38.12 -47.03 1.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.869 1.433 . . . . 70.12 114.869 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.65 18.04 67.63 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 114.871 0.708 . . . . 74.32 114.871 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 63.65 17.86 10.71 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.945 1.298 . . . . 73.2 112.719 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HZ1' ' HB3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -112.2 171.54 7.45 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.84 0.856 . . . . 75.21 110.466 177.443 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.1 m -89.97 112.68 24.15 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.306 -0.628 . . . . 71.23 109.306 173.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.65 HD11 ' HA ' ' A' ' 60' ' ' ALA . 49.5 mt -74.45 130.23 39.24 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.617 0.767 . . . . 73.42 110.618 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -100.43 152.91 37.97 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 123.634 0.773 . . . . 75.24 111.269 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -54.24 114.42 1.81 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.971 2.447 . . . . 52.35 113.685 177.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.95 -10.34 18.2 Favored Glycine 0 N--CA 1.481 1.655 0 CA-C-N 115.845 -0.616 . . . . 51.42 114.13 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -77.56 133.49 38.48 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.626 0.713 . . . . 75.13 112.353 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -98.31 120.36 38.6 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.2 -0.909 . . . . 73.21 109.184 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.576 HG11 HD12 ' A' ' 65' ' ' LEU . 19.4 m -124.7 169.98 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.574 0.75 . . . . 73.11 112.355 -171.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mm -117.37 141.15 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.936 0.894 . . . . 75.41 109.938 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.29 124.2 40.2 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.56 0.744 . . . . 73.03 111.363 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.01 -36.39 19.79 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 122.936 0.494 . . . . 74.44 112.322 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.567 ' HB1' ' HG3' ' A' ' 56' ' ' GLU . . . -86.82 169.52 12.51 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.07 0.462 . . . . 70.05 111.305 175.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.73 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 8.7 t -142.62 126.1 16.75 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.308 -0.405 . . . . 73.3 111.122 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -95.73 -28.05 14.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.588 0.755 . . . . 74.0 111.024 169.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.404 ' HE2' HG22 ' A' ' 46' ' ' VAL . 60.1 mtm -133.75 177.04 8.02 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.669 0.788 . . . . 74.51 111.86 -170.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -68.07 106.23 2.31 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-O 121.586 0.707 . . . . 71.13 112.043 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.14 22.98 36.2 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 116.023 -0.535 . . . . 75.13 114.293 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -85.06 -38.66 18.89 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 117.495 0.647 . . . . 65.2 111.04 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.73 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 59.3 tttp -67.04 124.83 24.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.038 0.535 . . . . 73.14 110.845 170.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.74 0.24 87.79 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-O 120.196 -0.224 . . . . 75.41 113.013 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.55 151.51 25.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.181 0.592 . . . . 75.11 111.358 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 51.2 m -92.08 117.74 30.13 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.332 -0.849 . . . . 75.54 109.888 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.641 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -105.69 150.79 25.15 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.557 0.743 . . . . 73.45 110.902 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -114.86 121.08 42.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.296 1.038 . . . . 73.1 110.153 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.487 HD13 HG13 ' A' ' 35' ' ' VAL . 36.9 mm -68.87 109.26 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 122.346 0.258 . . . . 61.24 110.753 -178.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -82.58 -37.13 25.51 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.262 0.625 . . . . 74.03 110.713 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.9 t -162.79 153.92 17.37 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.23 0.612 . . . . 73.51 111.727 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.89 132.57 56.66 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.25 1.02 . . . . 71.42 110.442 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -129.26 130.91 46.82 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.382 0.673 . . . . 74.44 112.222 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -92.91 93.26 8.29 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 108.248 -1.019 . . . . 73.42 108.248 167.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.8 t -138.25 154.22 49.07 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.275 0.63 . . . . 75.02 111.627 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.0 m -88.26 124.54 33.97 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.52 -0.548 . . . . 74.44 109.52 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 28' ' ' TYR . 16.5 m -110.02 131.95 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 108.921 -0.77 . . . . 75.04 108.921 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.73 141.69 36.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.212 1.005 . . . . 70.11 111.423 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.6 ttp -93.65 115.76 28.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 108.367 -0.975 . . . . 75.11 108.367 171.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 24' ' ' VAL . 35.5 m -126.21 166.88 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 112.482 0.549 . . . . 62.31 112.482 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -133.74 129.12 36.25 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.781 0.432 . . . . 74.11 111.767 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -138.29 176.04 9.05 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.883 0.873 . . . . 73.52 111.541 -173.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.5 m -114.41 134.57 54.89 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.652 0.781 . . . . 74.4 109.496 171.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.3 t -68.25 119.53 12.95 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.319 0.648 . . . . 71.12 111.589 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.5 p -71.0 -26.11 62.98 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.862 0.865 . . . . 73.21 112.651 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.3 p -81.55 -56.64 3.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.82 0.448 . . . . 64.44 111.417 175.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.7 t -92.25 -51.06 5.34 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.72 0.808 . . . . 44.33 112.789 -172.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.44 -15.96 19.78 Favored Glycine 0 N--CA 1.478 1.492 0 CA-C-N 116.03 -0.532 . . . . 62.13 112.7 -168.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -51.29 113.48 0.96 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.854 1.262 . . . . 73.21 112.467 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -80.48 120.65 24.76 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.265 -0.643 . . . . 61.33 109.265 173.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.0 t -111.11 123.22 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.646 0.778 . . . . 72.24 109.111 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -113.4 153.76 28.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.943 0.497 . . . . 74.12 111.606 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 56.4 29.12 14.64 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.448 1.099 . . . . 62.44 113.211 177.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -59.31 139.68 56.77 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.033 0.933 . . . . 74.23 113.27 -174.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 66.6 mttm -142.11 135.07 28.72 Favored 'General case' 0 CA--C 1.572 1.804 0 C-N-CA 125.361 1.464 . . . . 74.34 110.088 -175.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 80.7 m95 -114.4 143.51 44.81 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.36 1.891 . . . . 74.31 111.5 -11.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.57 141.86 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 124.435 1.094 . . . . 72.44 108.944 170.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 69.3 p -100.6 -177.93 3.63 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.67 0.748 . . . . 74.54 112.264 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -55.95 -28.47 57.11 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 124.821 1.249 . . . . 74.44 111.776 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.07 -28.48 60.37 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.902 0.881 . . . . 74.24 112.095 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.45 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 1.5 mp0 -87.77 -9.23 54.56 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.6 0.36 . . . . 73.32 111.881 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.4 mt -121.45 127.26 50.93 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.171 0.589 . . . . 73.4 110.815 -172.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.5 m -118.91 133.12 56.04 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.162 0.985 . . . . 71.02 109.289 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.35 155.77 31.28 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.64 0.376 . . . . 62.14 111.896 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -62.47 93.31 0.05 Allowed 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.066 0.46 . . . . 73.22 110.482 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.2 tp -130.35 133.44 46.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.175 0.99 . . . . 74.34 110.143 -174.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -79.57 102.3 8.78 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.766 0.426 . . . . 72.13 111.803 -174.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.2 m170 -133.86 160.47 37.54 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.342 1.057 . . . . 70.42 109.916 170.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -70.19 163.67 25.89 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 116.052 -0.522 . . . . 74.1 111.095 170.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -57.0 110.83 0.88 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.306 0.642 . . . . 74.5 112.067 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -69.12 131.65 45.32 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.89 0.876 . . . . 72.33 111.739 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -129.73 160.6 32.89 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.31 0.644 . . . . 74.44 110.569 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.1 p80 . . . . . 0 CA--C 1.573 1.854 0 C-N-CA 123.892 0.877 . . . . 73.41 111.859 174.667 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.574 ' HE2' ' HB2' ' A' ' 123' ' ' ALA . 49.4 tpp . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 110.102 -0.333 . . . . 73.22 110.102 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -92.96 155.99 17.2 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.291 0.567 . . . . 75.11 112.343 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.8 t -68.12 136.12 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 123.859 0.863 . . . . 75.04 110.821 173.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.22 -12.04 66.96 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 116.077 -0.51 . . . . 74.13 113.399 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.1 t -76.38 141.05 41.59 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 117.417 0.608 . . . . 71.23 111.738 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -99.25 121.46 41.08 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.236 0.615 . . . . 74.34 110.218 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.461 ' HA ' ' H ' ' A' ' 124' ' ' LYS . 32.7 m -125.24 156.16 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.091 0.956 . . . . 70.43 111.571 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 21' ' ' GLU . 35.9 mm -103.96 135.71 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.493 -0.929 . . . . 73.54 108.493 165.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.3 mt -88.59 119.86 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 109.268 -0.641 . . . . 74.42 109.268 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.66 -28.82 17.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 122.089 -0.382 . . . . 72.23 111.814 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.483 ' HB ' ' HG2' ' A' ' 120' ' ' GLU . 66.4 m -136.28 141.95 43.9 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.043 0.937 . . . . 72.34 109.416 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.585 ' HB2' ' HE2' ' A' ' 17' ' ' MET . 79.7 p -169.4 174.0 6.24 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.41 0.624 . . . . 75.51 112.148 176.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -98.41 2.19 47.6 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.238 -0.892 . . . . 74.43 112.425 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 23.3 mmt -115.4 127.34 55.3 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.508 0.723 . . . . 73.25 109.278 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.98 -41.87 65.0 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.393 1.077 . . . . 65.2 112.877 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.35 -8.23 85.46 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.371 0.509 . . . . 74.51 114.371 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.585 ' HE2' ' HB2' ' A' ' 12' ' ' SER . 42.7 ttp -96.14 -28.93 14.34 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 117.285 0.542 . . . . 74.34 110.334 -178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -69.26 119.64 13.84 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.152 0.581 . . . . 74.21 109.627 173.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.6 2.5 89.97 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 115.399 -0.819 . . . . 62.31 114.358 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.88 161.89 18.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 113.55 0.945 . . . . 73.43 113.55 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 8' ' ' ILE . 10.9 tp10 -76.99 138.73 39.79 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.89 -1.05 . . . . 74.44 110.439 172.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.77 166.67 30.66 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.436 0.636 . . . . 74.51 112.672 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.5 m -138.53 129.22 26.42 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.702 0.801 . . . . 75.22 110.408 173.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 80.8 t -77.71 104.73 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.513 0.725 . . . . 72.43 109.741 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.7 p -103.02 -2.42 27.59 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.567 0.747 . . . . 62.11 112.394 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.47 142.44 9.05 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-O 120.076 -0.291 . . . . 72.01 112.494 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.97 111.36 14.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.421 0.688 . . . . 73.41 111.231 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -118.08 110.11 17.24 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.303 1.041 . . . . 74.11 110.203 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.21 76.3 3.02 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 122.159 0.981 . . . . 74.3 108.99 174.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -133.06 168.95 17.57 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.736 -0.665 . . . . 74.13 112.258 -169.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 m -70.55 119.77 15.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.122 0.569 . . . . 72.35 111.116 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.36 146.51 28.72 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.6 0.76 . . . . 65.4 109.421 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -127.98 148.04 50.51 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.985 0.898 . . . . 74.23 111.713 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.0 t -102.61 109.7 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 114.156 -1.383 . . . . 74.04 107.707 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.458 HG11 HD11 ' A' ' 88' ' ' ILE . 30.6 m -111.63 167.43 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 118.533 0.606 . . . . 72.33 112.301 -175.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.3 p -141.59 126.58 18.3 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.192 0.597 . . . . 62.12 110.588 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -161.99 128.29 3.67 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 112.772 0.656 . . . . 75.5 112.772 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 73.3 m -71.07 117.76 59.38 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-O 119.083 -0.484 . . . . 73.2 110.099 159.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.57 140.6 94.62 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.143 2.562 . . . . 70.44 113.235 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.7 p -64.61 -16.05 62.1 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 114.43 1.27 . . . . 72.34 114.43 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' ' 79' ' ' LYS . 28.0 p-10 -79.39 -6.02 55.89 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.061 0.545 . . . . 72.45 112.429 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.34 45.99 5.99 Favored Glycine 0 CA--C 1.535 1.281 0 N-CA-C 112.108 -0.397 . . . . 64.15 112.108 -172.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.57 -177.9 39.79 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 122.932 0.301 . . . . 71.52 112.961 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -65.16 123.32 19.22 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 119.277 -0.392 . . . . 75.13 110.177 173.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 12.2 ttm180 -51.95 111.08 0.55 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.216 0.606 . . . . 75.14 111.6 173.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.703 HG21 ' HE3' ' A' ' 78' ' ' MET . 21.6 t -88.54 102.76 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 115.532 -0.758 . . . . 74.45 110.248 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -97.89 143.01 28.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.703 0.801 . . . . 75.43 110.43 -177.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.7 m170 56.96 33.92 24.07 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.763 0.825 . . . . 73.22 111.871 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.564 ' HB2' HG11 ' A' ' 46' ' ' VAL . 85.7 t60 -62.95 132.67 52.83 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.409 1.084 . . . . 74.1 111.85 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -154.99 152.31 29.53 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 114.562 -1.199 . . . . 72.13 109.492 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.579 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 72.7 m95 -106.36 126.17 51.91 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.254 -1.529 . . . . 72.44 112.35 4.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.3 m -113.89 133.67 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.377 1.071 . . . . 75.42 108.625 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.6 pt -97.12 157.6 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-O 120.85 0.357 . . . . 71.54 110.675 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -54.57 -36.59 64.55 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.606 0.762 . . . . 74.31 112.922 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -70.76 -14.34 62.4 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.142 0.577 . . . . 72.12 112.211 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -94.69 -19.66 20.21 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.246 1.018 . . . . 75.12 111.268 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.5 mt -89.07 137.32 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.583 0.753 . . . . 74.41 109.968 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 36.8 ttpt -76.67 -45.29 30.34 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.039 0.536 . . . . 74.23 111.496 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.451 ' HB3' HG11 ' A' ' 71' ' ' VAL . 5.9 t70 -68.51 -9.54 49.78 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.686 0.794 . . . . 75.25 112.625 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -42.21 -65.23 0.48 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.781 1.4 . . . . 75.03 114.781 176.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.47 13.53 58.57 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 114.894 0.718 . . . . 61.15 114.894 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.71 13.89 7.76 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.197 1.399 . . . . 64.22 112.779 -172.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -98.96 155.18 17.54 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.768 0.827 . . . . 72.3 110.48 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.9 m -72.65 109.21 6.12 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.389 0.276 . . . . 70.12 111.009 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 60' ' ' ALA . 62.9 mt -86.63 146.23 26.41 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.361 0.665 . . . . 75.15 109.242 173.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -139.28 169.06 13.22 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 124.01 0.924 . . . . 74.21 110.741 -171.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -44.1 109.6 0.16 Allowed 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 123.331 2.687 . . . . 73.22 114.459 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.91 -17.27 13.12 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.262 0.865 . . . . 71.42 115.262 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.99 120.94 14.02 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 118.413 1.106 . . . . 75.32 111.526 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -89.72 119.34 30.04 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.289 -0.634 . . . . 74.13 109.289 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.451 HG11 ' HB3' ' A' ' 59' ' ' ASP . 32.0 m -124.07 168.01 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.644 0.777 . . . . 73.32 111.76 -172.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.8 mm -118.74 137.91 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 123.409 0.684 . . . . 75.03 110.083 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.5 mt -92.4 109.34 20.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.821 0.848 . . . . 73.54 110.638 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.528 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 67.9 mm-40 -83.11 -9.93 58.95 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.55 0.945 . . . . 73.22 113.55 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.2 170.55 8.38 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.403 0.62 . . . . 63.22 111.065 174.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.455 ' HA ' ' HB3' ' A' ' 81' ' ' MET . 31.1 t -143.81 125.42 14.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.403 -0.817 . . . . 75.23 109.173 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -103.72 -4.74 23.3 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.626 0.77 . . . . 73.45 110.465 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.703 ' HE3' HG21 ' A' ' 46' ' ' VAL . 25.5 ptt? -165.88 -176.07 3.67 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.691 0.796 . . . . 72.42 111.386 -168.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.485 ' HB3' ' ND2' ' A' ' 41' ' ' ASN . 5.5 mptp? -59.35 114.36 2.63 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 112.803 0.668 . . . . 72.44 112.803 177.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.82 27.36 67.1 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.807 1.083 . . . . 74.52 115.807 169.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.455 ' HB3' ' HA ' ' A' ' 76' ' ' SER . 27.2 ttt -83.58 -42.18 17.06 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 118.025 0.913 . . . . 74.33 111.809 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.29 130.89 44.98 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 120.693 0.282 . . . . 73.23 111.612 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.12 80.77 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.102 -0.499 . . . . 71.24 113.054 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.58 139.68 42.23 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.096 0.558 . . . . 72.2 111.982 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.9 m -84.01 120.05 25.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.228 -0.896 . . . . 71.15 108.889 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.45 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . . . -117.46 162.92 17.18 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.971 0.908 . . . . 65.34 110.06 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -127.72 134.08 49.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.632 -0.507 . . . . 73.34 109.632 172.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.458 HD11 HG11 ' A' ' 35' ' ' VAL . 28.5 mm -66.93 104.21 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 N-CA-C 109.378 -0.601 . . . . 73.32 109.378 174.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.25 -40.74 77.67 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.377 1.071 . . . . 74.31 110.419 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.8 m -154.77 149.02 26.02 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.731 0.813 . . . . 74.23 110.599 -176.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.0 130.76 53.14 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.898 0.879 . . . . 64.13 108.89 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -140.88 115.47 9.51 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 121.132 0.491 . . . . 70.24 112.281 -168.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.04 94.2 9.86 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.365 0.666 . . . . 73.24 109.56 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 t -137.96 154.17 49.4 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.493 0.717 . . . . 71.01 110.068 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.7 m -84.21 128.26 34.45 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.889 -0.412 . . . . 72.21 109.889 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 m -111.61 134.55 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.612 0.765 . . . . 74.24 109.539 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.05 140.22 49.49 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.423 0.689 . . . . 73.23 112.314 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.3 ttp -89.69 112.44 23.71 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.881 -1.054 . . . . 75.24 108.28 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.68 145.85 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 112.826 0.676 . . . . 72.23 112.826 -170.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.84 115.68 30.93 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.488 -0.93 . . . . 73.52 108.488 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -127.97 158.82 36.83 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.218 0.463 . . . . 75.31 111.758 -173.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.7 m -104.25 104.16 14.02 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.425 -0.583 . . . . 74.05 109.425 172.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 108' ' ' GLU . 36.0 t -59.61 109.24 0.86 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.862 0.865 . . . . 74.42 111.546 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.2 p -62.26 -14.21 36.21 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.824 1.25 . . . . 72.13 113.297 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 78.8 m -58.79 -57.28 13.71 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.68 0.792 . . . . 75.23 112.498 174.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.5 p -126.32 -2.06 6.92 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.214 0.606 . . . . 73.21 112.574 -172.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.97 84.91 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 120.063 -0.298 . . . . 74.4 113.404 -170.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 103' ' ' SER . 38.1 tt0 -59.35 113.26 2.08 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.517 1.127 . . . . 65.31 112.003 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -88.7 125.63 34.94 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.681 0.753 . . . . 73.54 109.184 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -119.14 132.28 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.39 1.076 . . . . 74.23 109.12 -170.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 133.51 50.74 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 120.775 0.322 . . . . 73.04 110.297 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.6 m120 55.28 54.78 8.24 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 125.079 1.352 . . . . 73.51 113.857 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -63.91 141.92 58.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.416 0.686 . . . . 70.32 111.598 170.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 98.9 mttt -137.67 127.42 25.38 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.742 0.817 . . . . 72.24 111.053 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.579 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 85.7 m95 -120.55 165.46 14.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.198 -1.564 . . . . 74.25 112.258 -12.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.409 HG21 HD22 ' A' ' 121' ' ' LEU . 20.2 m -124.05 168.32 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 113.786 -1.552 . . . . 63.34 107.72 162.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 40.3 p -117.61 169.84 9.24 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.827 0.739 . . . . 74.04 112.282 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -53.2 -40.86 64.76 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.13 0.972 . . . . 75.54 111.279 172.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.66 -29.45 70.68 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.385 1.074 . . . . 54.0 111.774 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.483 ' HG2' ' HB ' ' A' ' 11' ' ' THR . 56.8 mt-10 -94.0 0.19 55.86 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.891 0.876 . . . . 63.44 112.078 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.409 HD22 HG21 ' A' ' 116' ' ' VAL . 83.6 mt -117.87 152.65 34.96 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.805 0.842 . . . . 74.32 110.244 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 125' ' ' LEU . 50.5 m -146.84 122.94 10.8 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.099 -1.075 . . . . 73.3 108.099 173.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.574 ' HB2' ' HE2' ' A' ' 1' ' ' MET . . . -59.77 105.6 0.39 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 118.28 0.491 . . . . 75.52 110.975 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.461 ' H ' ' HA ' ' A' ' 7' ' ' VAL . 56.2 tptt 33.94 74.4 0.06 Allowed 'General case' 0 CA--C 1.569 1.682 0 C-N-CA 124.992 1.317 . . . . 75.35 113.251 -167.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 122' ' ' SER . 30.2 tp -66.71 123.46 20.17 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.388 0.675 . . . . 74.33 110.152 173.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 123.54 17.56 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-O 121.025 0.441 . . . . 72.33 111.53 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -53.55 123.63 12.68 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.784 1.234 . . . . 73.35 113.247 -172.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -154.95 122.55 5.7 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.61 0.364 . . . . 64.31 110.948 177.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -144.24 177.09 8.85 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.979 0.912 . . . . 73.41 110.779 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -159.29 170.13 22.55 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.478 0.711 . . . . 74.42 112.4 -175.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -65.97 97.58 0.37 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.639 0.775 . . . . 63.24 111.84 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 84.7 t60 . . . . . 0 CA--C 1.564 1.486 0 C-N-CA 124.664 1.186 . . . . 75.22 110.03 -177.049 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' SD ' HG13 ' A' ' 7' ' ' VAL . 61.4 mtt . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.319 -0.252 . . . . 74.35 110.319 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.4 160.73 18.1 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.295 0.638 . . . . 71.55 111.849 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.18 131.6 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.461 0.704 . . . . 74.13 111.704 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.18 -10.28 43.38 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 115.818 -0.628 . . . . 63.15 112.782 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.4 t -81.13 145.14 31.21 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.236 0.614 . . . . 72.34 112.186 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -94.92 116.5 28.78 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.84 0.856 . . . . 73.2 109.058 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.402 HG13 ' SD ' ' A' ' 1' ' ' MET . 35.0 m -122.23 153.43 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.131 0.972 . . . . 75.11 110.678 -174.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 mm -100.15 134.68 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 109.292 -0.633 . . . . 71.34 109.292 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.429 HG23 ' HG2' ' A' ' 17' ' ' MET . 63.3 mt -78.42 104.07 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.946 -0.472 . . . . 74.42 109.732 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -78.35 -32.8 49.22 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.188 0.595 . . . . 63.41 111.367 -168.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 t -144.47 164.97 29.28 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.205 0.602 . . . . 63.54 110.061 168.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 98.8 p -157.18 167.07 31.45 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.379 0.609 . . . . 63.31 112.431 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -91.4 -37.49 13.17 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.091 -0.959 . . . . 61.43 109.884 168.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.5 mpt? -85.49 132.85 34.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.835 0.854 . . . . 73.11 110.748 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -58.97 -38.45 79.13 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.553 0.741 . . . . 74.44 112.494 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.22 -6.65 87.76 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 114.545 0.578 . . . . 71.3 114.545 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.429 ' HG2' HG23 ' A' ' 9' ' ' ILE . 41.8 ttp -94.85 -28.66 15.12 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 117.821 0.811 . . . . 71.45 112.13 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.441 ' HZ3' ' HB2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -68.19 128.6 37.15 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.13 0.49 . . . . 75.52 111.85 179.472 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.47 0.27 88.89 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-N 115.563 -0.744 . . . . 64.15 113.958 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.55 149.46 29.95 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.357 0.663 . . . . 64.3 110.851 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -90.95 106.53 18.59 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.919 0.39 . . . . 63.42 110.267 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.539 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -88.55 169.84 11.38 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.681 0.792 . . . . 72.11 111.767 175.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.7 m -136.89 134.54 36.95 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.165 -0.68 . . . . 70.11 109.165 171.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.79 105.69 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 123.127 0.571 . . . . 73.25 110.856 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.4 p -92.63 -15.76 26.42 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.31 0.644 . . . . 63.42 111.738 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.51 146.3 13.66 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.4 -0.28 . . . . 72.3 112.4 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.17 125.35 31.01 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.868 0.867 . . . . 73.32 109.544 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.594 ' HB2' HG23 ' A' ' 96' ' ' VAL . 58.1 m-85 -128.46 130.64 47.85 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.584 0.754 . . . . 72.44 110.816 -171.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -107.31 79.49 1.31 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 122.153 0.978 . . . . 70.01 110.073 174.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 t -133.43 162.61 31.4 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.186 -0.915 . . . . 70.41 110.425 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.8 m -65.89 119.9 12.12 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.833 0.453 . . . . 74.23 110.577 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.41 153.48 23.94 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.011 0.924 . . . . 71.32 109.846 -176.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -133.95 147.42 51.05 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.902 0.858 . . . . 64.5 112.078 -170.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.95 115.0 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 106.804 -1.554 . . . . 72.03 106.804 167.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG13 HD13 ' A' ' 88' ' ' ILE . 31.6 m -122.13 154.75 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-O 121.492 0.663 . . . . 72.43 112.751 -173.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 61.7 p -121.22 124.52 44.86 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.248 1.019 . . . . 75.04 109.667 173.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -142.64 154.59 44.51 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.308 0.643 . . . . 73.42 110.682 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.0 m -102.89 107.22 54.06 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.902 -1.147 . . . . 72.22 107.902 171.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.32 133.9 45.8 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.304 2.002 . . . . 74.03 111.326 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 72.8 p -68.66 -2.27 8.78 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.502 0.927 . . . . 73.41 113.502 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -64.24 -21.47 66.59 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.298 0.639 . . . . 75.14 111.087 165.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.57 29.73 38.72 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 114.981 0.752 . . . . 75.31 114.981 169.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.35 -109.03 1.55 Allowed Glycine 0 CA--C 1.537 1.439 0 CA-C-N 117.519 0.66 . . . . 64.33 112.9 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -109.6 141.33 42.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.943 0.897 . . . . 73.12 110.172 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -63.11 124.42 21.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.283 0.633 . . . . 74.41 111.182 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.636 HG21 ' SD ' ' A' ' 78' ' ' MET . 48.5 t -90.28 114.01 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.362 0.665 . . . . 73.42 109.985 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -105.96 151.52 24.5 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.017 0.527 . . . . 74.35 110.97 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.9 m80 55.72 29.99 14.8 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.213 1.005 . . . . 70.42 113.166 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.424 ' HB2' HG11 ' A' ' 46' ' ' VAL . 60.0 t60 -72.3 118.72 15.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.992 0.917 . . . . 72.41 110.43 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 59.2 pttt -133.06 146.8 52.01 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 115.929 -0.578 . . . . 75.04 111.629 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 92.7 m95 -110.83 152.46 26.64 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.446 -1.409 . . . . 75.12 112.209 0.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.16 136.41 60.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.1 -1.409 . . . . 73.32 107.747 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.471 HG21 HG22 ' A' ' 96' ' ' VAL . 39.9 pt -101.55 166.37 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.637 -0.664 . . . . 74.31 112.143 -172.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.86 -33.74 67.13 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.841 0.856 . . . . 72.51 111.88 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -71.94 -21.23 61.64 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.064 0.546 . . . . 72.15 112.422 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -83.08 -33.83 26.3 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.938 0.895 . . . . 74.3 110.948 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.0 mt -86.85 132.19 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.079 0.552 . . . . 74.45 110.984 -171.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.526 ' HB2' ' HG3' ' A' ' 74' ' ' GLU . 59.0 tttm -60.43 -43.67 96.54 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.998 0.919 . . . . 74.35 112.167 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.36 -7.63 50.63 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 123.775 0.83 . . . . 73.42 113.154 -174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -33.98 -67.02 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.96 1.467 . . . . 60.22 114.96 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.81 25.7 70.71 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 114.956 0.742 . . . . 65.4 114.956 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 64.32 9.43 4.87 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.527 1.131 . . . . 63.41 113.231 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 24.8 pttm -109.66 167.59 10.04 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.457 0.703 . . . . 65.43 111.357 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 m -91.89 119.54 31.75 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.286 0.634 . . . . 73.24 110.225 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.609 HD11 HG13 ' A' ' 71' ' ' VAL . 44.6 mt -79.64 127.92 32.76 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.362 0.665 . . . . 61.52 110.8 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -89.46 153.37 48.24 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.671 0.788 . . . . 74.21 111.283 -173.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.27 115.39 2.26 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.423 2.082 . . . . 74.42 113.277 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.33 -19.39 14.86 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.534 -0.757 . . . . 74.33 113.608 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.04 130.82 47.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.381 0.673 . . . . 75.52 112.189 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -90.84 120.43 31.86 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.504 -0.771 . . . . 74.42 109.312 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.609 HG13 HD11 ' A' ' 65' ' ' LEU . 32.4 m -134.43 174.68 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 C-N-CA 124.367 1.067 . . . . 74.22 111.321 -171.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.31 141.95 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.895 0.878 . . . . 64.32 109.861 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 mt -96.96 131.04 44.16 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.641 0.777 . . . . 72.13 111.596 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.526 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 36.2 mt-10 -101.0 9.44 42.24 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 113.464 0.913 . . . . 75.25 113.464 175.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.38 165.85 17.64 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.379 0.672 . . . . 73.53 110.055 169.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.4 t -139.57 123.56 17.72 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.954 -0.567 . . . . 64.22 110.517 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -99.09 -5.43 30.25 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.912 0.885 . . . . 74.32 110.173 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.636 ' SD ' HG21 ' A' ' 46' ' ' VAL . 26.0 ptp -159.07 147.45 18.07 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.539 1.135 . . . . 73.12 109.682 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -53.77 121.74 8.51 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.117 0.567 . . . . 75.24 112.296 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.9 -15.91 54.94 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 119.361 -0.688 . . . . 74.42 114.572 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.0 ttt -64.01 -46.02 86.35 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.559 0.744 . . . . 63.02 112.781 -175.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -67.53 118.5 10.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.95 -0.389 . . . . 74.23 109.95 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 3.16 74.41 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 116.383 -0.371 . . . . 73.24 113.49 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.22 145.63 32.13 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.222 0.511 . . . . 51.31 110.341 172.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m -80.32 114.56 19.31 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 109.443 -0.577 . . . . 74.35 109.443 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.51 145.63 32.87 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.598 0.759 . . . . 74.33 111.257 -173.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -123.15 117.07 24.53 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.378 1.071 . . . . 74.32 109.135 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.441 HD13 HG13 ' A' ' 35' ' ' VAL . 28.2 mm -61.55 115.07 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.188 0.595 . . . . 73.13 111.028 -178.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -83.35 -36.46 24.36 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.821 0.449 . . . . 72.35 110.967 173.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.9 t -157.83 150.65 22.89 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.24 0.616 . . . . 72.21 111.745 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.81 131.64 56.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.19 0.996 . . . . 74.03 109.37 173.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -146.68 128.9 15.71 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.942 0.497 . . . . 74.34 111.739 -171.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -91.62 95.35 9.87 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.253 -0.647 . . . . 71.43 109.253 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.3 t -136.87 155.39 49.83 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.444 1.098 . . . . 71.1 110.202 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.4 m -80.94 120.0 24.19 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.887 -0.412 . . . . 75.44 109.887 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 28' ' ' TYR . 9.0 m -104.68 132.45 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.317 0.647 . . . . 74.34 109.535 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.56 135.02 51.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.36 1.064 . . . . 74.11 111.118 -176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.6 ttp -94.1 120.98 35.12 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.924 -1.139 . . . . 71.34 107.924 166.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 24.2 m -124.85 169.6 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 112.779 0.659 . . . . 73.4 112.779 -169.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -137.06 133.14 35.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.282 0.633 . . . . 72.34 110.909 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -143.32 177.61 8.31 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.853 0.861 . . . . 64.44 111.299 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.6 m -119.96 119.18 32.69 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 108.248 -1.019 . . . . 74.31 108.248 169.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.9 m -61.22 134.71 57.29 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.363 0.665 . . . . 60.32 112.396 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -65.18 -47.96 75.11 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.293 1.037 . . . . 72.44 112.176 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.4 p -75.67 -50.8 14.36 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.447 0.699 . . . . 53.42 112.052 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.8 m -75.38 -33.57 61.03 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.495 0.718 . . . . 75.21 112.677 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.37 11.92 79.88 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-N 116.543 -0.298 . . . . 71.43 113.498 -172.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -100.21 140.11 34.92 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.59 0.756 . . . . 73.4 111.239 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -81.1 115.57 20.6 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.634 0.773 . . . . 75.44 110.998 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.9 t -104.85 122.34 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.874 0.87 . . . . 74.12 109.534 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.77 160.7 17.07 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.014 0.526 . . . . 74.11 111.289 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.0 m120 56.5 28.89 14.45 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.133 0.973 . . . . 73.52 112.897 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -64.75 137.73 57.97 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.537 0.735 . . . . 74.53 111.888 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 8.0 ptpp? -155.56 148.42 24.33 Favored 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 123.513 0.725 . . . . 74.21 111.941 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 98.9 m95 -112.15 144.51 41.41 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.461 1.505 . . . . 73.01 112.536 -8.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.81 154.34 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.2 1.4 . . . . 65.24 109.048 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.3 p -117.33 177.7 4.64 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.812 0.445 . . . . 74.22 110.911 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -66.12 -14.28 61.52 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.469 0.708 . . . . 54.35 111.888 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.54 -35.4 65.52 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 122.971 0.508 . . . . 71.24 110.863 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -94.84 -5.08 45.88 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.021 0.528 . . . . 74.05 111.643 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 66.0 mt -108.24 134.41 51.12 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.851 0.834 . . . . 75.42 110.962 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.4 t -101.57 156.72 17.31 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.399 1.48 . . . . 75.52 108.925 170.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.68 160.73 15.48 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.637 0.375 . . . . 61.44 110.301 175.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 0.8 OUTLIER -111.7 159.33 18.33 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 110.081 -0.34 . . . . 75.15 110.081 174.385 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.3 mp 69.99 10.25 7.36 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 124.505 1.122 . . . . 72.53 112.086 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -82.51 169.35 16.45 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.652 0.781 . . . . 72.41 111.2 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -131.67 4.01 4.2 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.02 0.528 . . . . 73.52 112.377 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -84.42 71.63 10.68 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.402 1.096 . . . . 73.12 111.139 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -87.26 6.19 34.49 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.03 -0.986 . . . . 73.33 112.803 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -69.98 126.79 30.71 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 122.219 -0.3 . . . . 75.24 110.891 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 64.9 8.78 4.86 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.465 1.106 . . . . 71.24 111.585 -175.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 . . . . . 0 CA--C 1.566 1.565 0 C-N-CA 123.315 0.646 . . . . 73.43 111.747 -164.37 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 120.814 0.34 . . . . 75.55 111.865 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -120.46 174.37 6.58 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.639 0.776 . . . . 72.11 112.481 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.75 136.01 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 C-N-CA 123.844 0.858 . . . . 64.04 111.718 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.38 -9.76 75.48 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 115.825 -0.625 . . . . 64.2 113.702 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.8 t -83.65 142.14 31.0 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.149 0.579 . . . . 74.04 111.707 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -90.48 122.15 33.07 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.637 0.775 . . . . 73.24 110.318 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . 33.2 m -122.29 153.44 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.638 0.775 . . . . 73.31 111.886 -176.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.4 mm -104.56 123.79 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.333 1.053 . . . . 72.15 108.472 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.4 mt -77.21 125.25 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 120.967 0.413 . . . . 73.31 111.06 -172.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -89.19 -68.4 0.78 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.697 0.799 . . . . 74.1 109.725 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.0 m -98.8 144.64 27.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.941 0.897 . . . . 73.34 110.25 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' A' ' 18' ' ' LYS . 84.8 p -159.28 152.7 22.56 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.704 0.631 . . . . 73.04 112.704 -172.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -85.82 -37.53 19.13 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.469 0.708 . . . . 72.21 110.309 168.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.462 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.4 mpt? -83.32 129.1 34.98 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.262 0.625 . . . . 73.43 110.259 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -30.8 71.05 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.611 0.967 . . . . 74.45 113.611 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.14 -9.1 70.9 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 114.023 0.369 . . . . 72.52 114.023 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 55.2 ttp -82.72 -28.65 30.36 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.901 0.481 . . . . 74.02 110.197 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.574 ' HZ2' ' HB2' ' A' ' 18' ' ' LYS . 3.4 ttmp? -67.77 118.68 11.34 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.711 0.404 . . . . 72.14 111.134 173.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.95 2.07 86.45 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 116.134 -0.485 . . . . 75.4 113.553 -177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.97 152.17 29.64 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.108 0.563 . . . . 74.42 112.035 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -86.39 131.94 34.08 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.134 0.974 . . . . 75.52 110.359 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.55 173.86 11.08 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.728 0.811 . . . . 72.41 112.22 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.7 m -137.99 146.52 43.22 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.441 1.097 . . . . 74.14 108.754 170.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.5 t -79.75 117.95 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 122.756 0.423 . . . . 71.44 110.556 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.3 p -94.86 -18.3 21.3 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.51 0.724 . . . . 75.53 111.58 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.44 145.18 11.52 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 120.201 -0.222 . . . . 72.51 112.701 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.54 119.61 19.73 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.665 0.786 . . . . 74.15 110.725 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -130.18 149.67 51.78 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.315 1.046 . . . . 64.51 110.42 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -125.82 90.97 3.3 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.158 0.98 . . . . 71.44 109.965 167.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.0 t -135.19 177.46 7.79 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.282 -0.872 . . . . 73.52 111.144 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -73.35 110.26 7.5 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.528 0.68 . . . . 74.13 110.454 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.09 161.02 13.9 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.375 1.47 . . . . 62.35 109.918 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -138.59 144.64 39.9 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.567 0.747 . . . . 74.5 111.606 -172.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.9 110.96 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 107.048 -1.464 . . . . 72.45 107.048 164.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 86' ' ' ALA . 21.1 m -112.16 144.09 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.378 0.609 . . . . 73.01 112.231 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 p -116.65 128.24 55.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.204 1.002 . . . . 74.4 109.634 173.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -151.17 158.29 43.77 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.94 0.496 . . . . 74.25 111.386 -169.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.2 m -108.15 117.06 55.8 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 109.008 -0.738 . . . . 74.43 109.008 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -60.77 124.04 14.19 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.656 2.237 . . . . 74.12 111.887 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -63.05 -14.45 48.26 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.575 1.324 . . . . 71.23 114.575 -168.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.446 ' N ' HD21 ' A' ' 41' ' ' ASN . 0.8 OUTLIER -85.73 11.35 11.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.532 0.733 . . . . 72.44 112.718 -176.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.46 53.15 3.93 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 120.977 0.209 . . . . 65.32 112.9 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.34 168.91 13.91 Favored Glycine 0 N--CA 1.476 1.312 0 C-N-CA 122.96 0.314 . . . . 64.21 112.854 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -58.75 135.36 57.43 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.33 0.652 . . . . 75.03 111.331 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -56.59 136.5 54.55 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-O 121.186 0.517 . . . . 71.31 111.065 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.466 HG22 ' SD ' ' A' ' 78' ' ' MET . 57.8 t -86.72 103.13 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.246 0.618 . . . . 65.25 109.709 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.69 108.7 14.56 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.902 0.881 . . . . 72.23 110.828 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.2 m170 57.7 79.11 0.21 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.152 0.981 . . . . 73.44 112.992 176.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -94.29 109.67 21.48 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.125 0.97 . . . . 73.13 109.671 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 22.2 pttp -121.01 140.16 52.3 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.286 0.235 . . . . 75.34 111.551 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 79.6 m95 -117.83 158.33 25.01 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.054 1.342 . . . . 74.32 112.478 2.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.49 143.67 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 113.183 -1.826 . . . . 72.41 107.18 167.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.448 HG13 ' H ' ' A' ' 55' ' ' GLU . 29.8 pt -106.93 179.56 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.678 -0.639 . . . . 72.3 109.676 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -48.71 -33.9 11.0 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.205 1.002 . . . . 74.55 113.093 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' H ' HG13 ' A' ' 53' ' ' ILE . 28.5 tt0 -69.78 -23.96 63.43 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.072 0.949 . . . . 74.14 113.493 -175.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.2 -10.78 59.56 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.553 0.575 . . . . 73.31 112.553 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.1 mt -113.18 134.22 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 123.433 0.693 . . . . 74.22 111.808 -169.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.417 ' HB2' ' HG3' ' A' ' 74' ' ' GLU . 40.8 ttmt -67.82 -46.37 72.06 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.025 0.93 . . . . 73.55 111.999 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -62.84 -22.28 66.56 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.802 0.841 . . . . 74.3 112.675 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.533 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -35.79 -57.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.292 1.59 . . . . 70.52 115.292 -171.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.85 19.48 67.55 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 115.984 1.154 . . . . 75.11 115.984 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 t70 61.84 15.77 7.38 Favored 'General case' 0 CA--C 1.572 1.806 0 C-N-CA 124.959 1.304 . . . . 75.34 112.212 -172.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 22.9 pttm -107.59 160.15 15.9 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.787 0.835 . . . . 64.24 109.771 175.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 p -76.88 128.16 34.05 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 110.034 -0.358 . . . . 73.45 110.034 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.575 HD13 HG11 ' A' ' 71' ' ' VAL . 38.7 mt -87.95 136.51 32.93 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.696 -0.483 . . . . 73.3 109.696 170.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -105.89 153.49 40.05 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.58 0.752 . . . . 74.35 110.593 -173.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.83 130.37 40.02 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 122.538 2.159 . . . . 75.32 112.427 171.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.86 -22.61 29.6 Favored Glycine 0 N--CA 1.479 1.507 0 N-CA-C 113.992 0.357 . . . . 73.52 113.992 -175.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -73.14 157.18 37.72 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.255 0.527 . . . . 65.43 112.226 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -125.7 135.48 52.14 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.576 -0.738 . . . . 74.23 109.737 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.575 HG11 HD13 ' A' ' 65' ' ' LEU . 36.0 m -138.79 -178.36 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 125.41 1.484 . . . . 75.02 110.355 -167.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.3 mt -128.22 140.94 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.315 0.646 . . . . 73.25 110.252 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.2 mt -90.33 130.22 36.46 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.275 1.03 . . . . 72.41 111.622 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.417 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 43.0 mt-10 -91.31 -12.97 33.47 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.218 0.607 . . . . 71.31 112.192 169.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.93 160.66 14.23 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.271 0.628 . . . . 72.51 111.193 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.784 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 10.4 t -140.2 125.9 19.29 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.691 0.396 . . . . 72.24 110.324 178.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -113.41 0.74 14.85 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.466 0.706 . . . . 74.04 110.723 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.466 ' SD ' HG22 ' A' ' 46' ' ' VAL . 23.7 ptp -157.57 167.38 30.33 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.814 0.845 . . . . 74.43 111.515 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -63.89 101.61 0.39 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.073 0.949 . . . . 72.23 111.901 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.77 23.92 9.63 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-O 119.733 -0.482 . . . . 73.43 114.101 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.4 ttt -93.23 -39.46 10.99 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 117.664 0.732 . . . . 74.42 111.689 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.784 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 60.7 tttm -67.76 119.73 12.95 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.443 0.297 . . . . 72.53 110.389 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.33 -8.44 75.16 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 123.462 0.476 . . . . 73.3 113.149 -176.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.54 146.97 36.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.055 0.542 . . . . 65.32 111.612 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.0 m -86.31 119.72 26.88 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.734 -0.666 . . . . 75.35 110.069 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.55 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . . . -112.62 149.3 33.01 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.89 0.876 . . . . 72.25 110.653 -177.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -118.43 126.47 52.13 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.939 0.496 . . . . 74.24 110.261 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.401 HD11 HG11 ' A' ' 35' ' ' VAL . 25.8 mm -68.36 102.56 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 123.456 0.702 . . . . 74.54 110.276 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -71.79 -39.35 69.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.187 0.595 . . . . 55.33 110.166 173.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 t -154.98 147.93 24.62 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.05 -0.977 . . . . 65.31 111.286 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.78 132.96 42.82 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.0 0.92 . . . . 72.44 109.924 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -148.38 142.25 25.76 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.303 0.641 . . . . 72.52 110.803 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.03 94.6 9.7 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.427 -1.323 . . . . 75.15 107.427 172.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.3 t -134.81 156.81 48.23 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.927 0.891 . . . . 73.23 111.103 -171.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 93.5 m -79.95 120.24 23.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.934 0.494 . . . . 75.41 110.614 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.86 134.49 58.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.037 0.935 . . . . 72.53 110.239 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.489 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 98.2 m-85 -110.32 135.83 50.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.041 0.936 . . . . 73.42 112.004 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 52.8 ttp -90.26 121.07 31.94 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 107.844 -1.169 . . . . 63.52 107.844 167.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.14 145.63 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 113.17 0.804 . . . . 73.33 113.17 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -106.77 120.47 42.09 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.732 0.813 . . . . 72.32 109.747 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -127.44 165.56 19.59 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.374 0.607 . . . . 75.02 112.077 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.8 m -104.02 108.64 20.08 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.768 -0.827 . . . . 73.44 108.768 171.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.1 t -62.21 107.44 0.89 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.286 0.634 . . . . 74.04 110.682 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.7 p -59.24 -31.8 69.4 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.148 0.979 . . . . 74.43 113.142 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 t -76.49 -13.17 60.12 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.035 0.934 . . . . 75.22 112.958 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 t -123.82 -43.96 2.1 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.4 0.68 . . . . 75.42 112.663 -172.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.8 -18.47 57.19 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 116.5 -0.318 . . . . 74.23 112.436 -166.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.41 137.15 44.46 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.22 1.008 . . . . 73.42 111.493 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -91.31 118.2 30.3 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 121.322 0.582 . . . . 72.21 110.263 174.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.8 t -104.37 119.09 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.946 0.898 . . . . 64.54 108.616 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -103.63 153.29 20.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.559 0.344 . . . . 74.32 111.68 -169.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 53.73 42.42 31.81 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.541 1.137 . . . . 75.43 114.03 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -58.91 134.36 56.86 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.245 1.018 . . . . 74.12 111.903 175.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 62.1 mttp -132.3 132.12 42.67 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.093 0.957 . . . . 72.41 111.167 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 99.8 m95 -119.19 153.9 34.2 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.258 -1.526 . . . . 73.23 111.603 -15.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.36 158.15 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 114.524 -1.216 . . . . 64.11 108.831 168.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.9 p -105.84 175.51 5.47 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.251 0.548 . . . . 74.13 111.712 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.489 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 34.8 tt0 -67.54 -26.6 66.39 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.924 -0.58 . . . . 75.23 110.727 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.13 -29.13 70.55 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 123.982 0.913 . . . . 73.04 111.418 171.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -98.39 3.61 48.49 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.077 0.951 . . . . 73.41 112.715 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.93 142.55 51.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.351 0.66 . . . . 74.41 111.367 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.5 p -130.09 119.64 23.38 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.32 1.048 . . . . 75.2 108.297 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -85.69 105.02 15.94 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.919 0.782 . . . . 63.45 112.495 -167.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.5 tptm 64.62 -59.49 0.23 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.229 1.937 . . . . 75.21 116.229 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -55.01 144.2 24.14 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.294 1.037 . . . . 74.04 113.674 -169.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 129' ' ' HIS . 25.5 mm-40 57.61 26.37 12.77 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 124.64 1.176 . . . . 73.41 113.877 175.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -51.6 150.52 3.75 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.666 0.786 . . . . 74.12 112.537 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 80.94 4.44 1.55 Allowed 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 125.514 1.526 . . . . 73.23 110.778 -163.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 126' ' ' GLU . 27.8 t-80 -66.09 95.74 0.29 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.315 1.046 . . . . 73.45 110.095 174.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -65.78 144.82 56.63 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.951 0.5 . . . . 65.14 111.879 -177.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -157.29 153.98 28.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.348 0.659 . . . . 71.52 111.166 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.5 m80 . . . . . 0 CA--C 1.562 1.427 0 C-N-CA 123.774 0.83 . . . . 74.22 111.94 -174.921 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.457 ' HE2' ' HB2' ' A' ' 123' ' ' ALA . 54.1 tpp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.08 -0.341 . . . . 75.32 110.08 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.612 ' HZ3' ' HB3' ' A' ' 2' ' ' LYS . 9.4 mtpm? -78.51 155.92 29.54 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.511 0.672 . . . . 73.41 112.693 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.07 122.87 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-N 115.331 -0.85 . . . . 74.01 109.593 165.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.71 41.85 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-N 115.869 -0.605 . . . . 55.12 113.583 -175.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.9 m -74.85 136.43 41.54 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.091 0.556 . . . . 55.15 111.721 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -94.12 125.16 38.59 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.931 0.893 . . . . 74.03 109.63 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.28 153.43 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.393 0.677 . . . . 75.42 112.635 -168.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.3 mm -98.37 125.44 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 124.679 1.192 . . . . 73.13 109.931 172.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.52 HD12 ' HB1' ' A' ' 22' ' ' ALA . 41.4 mt -87.28 125.4 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.19 0.596 . . . . 75.54 111.223 -176.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -98.66 -59.02 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.381 0.672 . . . . 74.35 111.063 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.6 m -94.44 144.57 25.45 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.692 0.797 . . . . 64.51 109.448 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.501 ' HB2' ' HB3' ' A' ' 17' ' ' MET . 77.2 p -149.88 144.46 25.94 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.112 0.482 . . . . 71.51 111.574 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -92.42 -24.43 18.86 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.809 0.844 . . . . 74.01 110.465 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 23.2 mmt -95.97 134.47 38.94 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.688 0.795 . . . . 75.45 109.316 169.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HG2' HG21 ' A' ' 105' ' ' THR . 62.5 tttp -59.01 -44.25 91.65 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.732 0.813 . . . . 71.34 112.728 -175.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.98 -0.26 64.43 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 114.889 0.715 . . . . 63.02 114.889 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.501 ' HB3' ' HB2' ' A' ' 12' ' ' SER . 41.1 ttp -91.47 -24.84 19.55 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.725 0.763 . . . . 74.33 111.235 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -67.02 121.83 16.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.916 0.487 . . . . 74.12 111.282 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.58 1.71 90.54 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 115.837 -0.62 . . . . 60.11 114.297 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.34 146.46 36.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.043 0.537 . . . . 72.53 111.206 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -95.75 99.59 11.4 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.36 -0.607 . . . . 65.42 109.36 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.52 ' HB1' HD12 ' A' ' 9' ' ' ILE . . . -91.15 175.98 6.75 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.717 0.807 . . . . 52.55 112.724 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.9 m -136.13 138.67 42.26 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.118 -1.067 . . . . 74.44 108.118 169.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.4 t -83.45 126.88 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.213 0.605 . . . . 70.22 110.398 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.6 p -113.44 -2.07 14.02 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.406 0.682 . . . . 63.01 112.102 170.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.5 136.03 4.67 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 118.365 0.53 . . . . 75.34 113.004 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.01 107.68 13.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.848 0.859 . . . . 62.23 109.768 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -108.95 120.33 42.21 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.678 0.791 . . . . 73.42 110.669 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.94 87.01 3.18 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 108.644 -0.872 . . . . 71.54 108.644 174.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -137.24 174.95 10.06 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 112.858 0.688 . . . . 70.13 112.858 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.3 m -82.87 124.98 30.84 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.743 0.817 . . . . 74.21 110.306 172.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.02 120.4 37.11 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.187 0.995 . . . . 71.51 110.297 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -92.22 149.75 21.28 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.765 0.826 . . . . 74.32 112.538 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.96 111.61 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 107.764 -1.199 . . . . 73.5 107.764 170.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.511 HG13 HD11 ' A' ' 88' ' ' ILE . 27.1 m -114.3 165.72 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 112.869 0.692 . . . . 72.22 112.869 -172.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -135.68 123.88 23.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.829 0.852 . . . . 70.32 109.438 173.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -150.52 154.36 37.46 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 122.116 -0.365 . . . . 74.32 111.61 -170.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.3 m -104.52 115.32 63.02 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 107.856 -1.164 . . . . 75.24 107.856 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.95 133.22 56.53 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.628 2.218 . . . . 74.01 112.471 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.4 p -63.22 -14.64 51.5 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.27 1.028 . . . . 72.54 112.459 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -62.64 -17.69 60.89 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 124.333 1.053 . . . . 71.11 112.598 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.26 60.09 2.3 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 112.453 -0.259 . . . . 73.21 112.453 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 -152.31 8.04 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 115.626 -0.287 . . . . 74.22 113.695 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -81.2 126.92 32.1 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.222 0.609 . . . . 74.44 109.98 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.83 112.57 1.2 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.069 0.461 . . . . 74.14 110.452 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.426 HG23 ' SD ' ' A' ' 78' ' ' MET . 15.1 t -80.84 104.15 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.65 -0.704 . . . . 75.22 109.64 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -101.12 150.72 22.64 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.988 0.515 . . . . 64.23 109.942 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.1 m80 56.54 29.23 15.13 Favored 'General case' 0 CA--C 1.559 1.317 0 O-C-N 124.089 0.868 . . . . 72.14 111.754 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -61.99 127.46 31.5 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.948 0.899 . . . . 73.32 111.739 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -132.61 141.68 48.79 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.386 1.074 . . . . 65.42 109.947 -178.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 93.8 m95 -113.02 134.53 54.47 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 120.418 -1.426 . . . . 75.22 111.273 -7.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.75 148.36 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.456 -0.942 . . . . 75.53 108.456 169.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.8 pt -111.51 166.74 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 120.806 0.336 . . . . 74.42 110.983 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -53.15 -34.71 58.01 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.131 0.972 . . . . 73.11 113.405 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.6 -18.66 60.53 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 123.634 0.774 . . . . 74.31 112.382 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -90.5 1.31 56.8 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.255 0.622 . . . . 75.23 111.899 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 55.0 mt -121.62 125.37 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 124.059 0.944 . . . . 74.3 109.751 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -68.62 -54.48 16.2 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 118.193 0.451 . . . . 74.03 112.024 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.19 -4.33 17.17 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.183 0.809 . . . . 62.4 113.183 -177.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.501 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . . . -54.78 -30.4 56.67 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.995 0.739 . . . . 63.32 112.995 172.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.14 14.84 66.73 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 114.828 0.691 . . . . 74.35 114.828 170.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 59.31 23.14 11.55 Favored 'General case' 0 CA--C 1.566 1.565 0 C-N-CA 124.51 1.124 . . . . 75.23 112.016 -172.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -120.56 171.54 8.49 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.362 1.065 . . . . 74.04 111.341 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.3 m -77.36 109.35 11.2 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.273 0.629 . . . . 75.54 110.078 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 60' ' ' ALA . 86.9 mt -78.34 121.28 24.26 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.949 0.5 . . . . 75.2 110.784 174.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -88.97 150.7 45.91 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.891 0.876 . . . . 72.41 109.94 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -50.49 121.98 8.75 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.341 2.028 . . . . 71.25 113.239 173.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.93 -21.03 12.63 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-O 119.457 -0.635 . . . . 52.42 114.151 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -69.19 133.17 47.64 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.227 1.014 . . . . 72.32 111.936 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -100.37 121.43 41.5 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.388 0.675 . . . . 75.43 109.564 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.94 165.33 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.8 1.24 . . . . 72.45 110.982 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.93 137.95 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.897 -0.502 . . . . 64.41 111.186 175.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.8 mt -85.44 122.05 29.03 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.208 1.003 . . . . 74.54 111.203 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -87.54 -17.61 31.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.382 0.512 . . . . 65.55 112.382 171.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -88.51 162.67 16.3 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.333 0.587 . . . . 74.11 111.108 170.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -142.49 124.89 15.62 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.686 -0.688 . . . . 71.33 110.085 173.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -104.14 -4.19 23.48 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 123.789 0.836 . . . . 72.45 110.841 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.426 ' SD ' HG23 ' A' ' 46' ' ' VAL . 24.4 ptp -154.69 -179.16 7.74 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.3 0.64 . . . . 74.52 112.433 -173.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.69 108.97 0.71 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.817 0.847 . . . . 75.04 112.438 174.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.65 24.38 67.67 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 115.026 0.77 . . . . 61.52 115.026 172.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -75.91 -42.31 49.3 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.801 0.8 . . . . 73.12 111.551 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.33 123.74 21.2 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 120.506 0.193 . . . . 74.05 110.69 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.5 -18.34 57.12 Favored Glycine 0 N--CA 1.471 0.97 0 CA-C-N 116.206 -0.452 . . . . 62.52 113.12 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.12 137.23 56.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.243 0.617 . . . . 71.34 111.743 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.7 m -73.48 111.09 8.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.378 0.671 . . . . 74.33 110.519 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.26 147.61 27.29 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.165 0.986 . . . . 64.22 110.419 -175.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -130.35 129.18 42.82 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 108.79 -0.819 . . . . 75.14 108.79 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.511 HD11 HG13 ' A' ' 35' ' ' VAL . 47.1 mm -74.1 112.72 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.865 0.866 . . . . 74.22 111.54 -170.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.58 -41.42 27.19 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.068 0.947 . . . . 74.4 110.582 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.5 t -163.27 172.24 15.0 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 115.681 -0.69 . . . . 75.45 111.345 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.42 132.16 24.1 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.078 0.951 . . . . 71.13 110.609 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -125.97 141.52 51.93 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.583 0.753 . . . . 73.0 112.329 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -100.5 95.35 6.66 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.452 -1.314 . . . . 75.14 107.452 163.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.9 t -136.42 154.8 50.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.072 0.949 . . . . 74.13 110.6 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.9 p -78.33 124.05 27.67 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.532 -0.544 . . . . 70.34 109.532 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.83 133.01 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.87 0.868 . . . . 71.45 108.734 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -115.1 152.83 31.84 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.723 0.773 . . . . 74.43 112.487 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.444 ' SD ' ' HE3' ' A' ' 114' ' ' LYS . 59.1 ttp -100.57 112.4 24.77 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.496 -1.229 . . . . 73.32 108.134 171.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 29.7 m -120.89 151.82 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 112.543 0.571 . . . . 74.24 112.543 -172.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.67 117.09 28.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.283 1.033 . . . . 74.54 108.97 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -136.87 175.66 9.41 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.247 0.619 . . . . 71.12 111.385 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.3 m -107.63 126.08 52.13 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.728 -0.842 . . . . 74.42 108.728 169.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.8 t -60.87 108.06 0.8 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.919 0.488 . . . . 74.24 110.526 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.0 p -58.88 -24.31 62.07 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.367 1.067 . . . . 72.44 112.887 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.443 HG21 ' HG2' ' A' ' 15' ' ' LYS . 71.1 p -87.96 -60.04 2.08 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 123.325 0.65 . . . . 70.32 112.151 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.8 p -84.57 -37.17 21.51 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.421 0.526 . . . . 73.15 112.421 -173.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.08 -2.16 51.33 Favored Glycine 0 N--CA 1.48 1.604 0 CA-C-N 116.453 -0.339 . . . . 63.24 113.151 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.73 128.28 35.89 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.461 0.704 . . . . 64.35 111.895 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -75.52 96.84 3.58 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.045 -0.724 . . . . 72.13 109.045 174.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.72 114.49 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.191 0.597 . . . . 71.31 109.799 -175.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.464 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -112.02 144.77 40.83 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 120.986 0.422 . . . . 73.21 111.376 -175.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.0 m120 56.3 36.92 28.29 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.794 1.238 . . . . 64.02 113.152 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -64.54 137.95 58.13 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.505 0.722 . . . . 73.34 112.265 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.444 ' HE3' ' SD ' ' A' ' 98' ' ' MET . 99.7 mttt -138.88 144.19 39.05 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 124.487 1.115 . . . . 75.31 110.638 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 98.5 m95 -110.2 142.62 41.49 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.539 1.536 . . . . 75.32 112.263 -11.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.57 154.41 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.225 1.01 . . . . 73.12 109.147 166.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.4 p -100.82 177.5 4.96 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.289 0.495 . . . . 74.01 112.26 173.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -69.3 -43.13 74.43 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.049 0.54 . . . . 72.43 111.197 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.33 -14.95 62.8 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.556 0.742 . . . . 73.11 111.466 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.08 -21.84 56.28 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.228 1.011 . . . . 74.33 110.149 176.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.0 mt -117.18 178.49 4.34 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.968 1.307 . . . . 74.4 109.92 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.3 m -155.31 150.37 26.79 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.019 1.328 . . . . 71.3 107.81 166.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.457 ' HB2' ' HE2' ' A' ' 1' ' ' MET . . . -70.98 164.02 26.37 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.535 0.607 . . . . 74.33 112.586 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.558 ' HG3' ' HG ' ' A' ' 125' ' ' LEU . 56.5 tptt -68.85 142.82 54.73 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.5 0.72 . . . . 65.04 111.416 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.558 ' HG ' ' HG3' ' A' ' 124' ' ' LYS . 96.3 mt 65.58 28.3 11.35 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 124.601 1.16 . . . . 75.42 113.216 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.7 -177.76 3.89 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.576 0.954 . . . . 61.03 113.576 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -61.66 143.72 55.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.295 1.038 . . . . 71.24 111.588 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -98.16 88.8 4.3 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.009 0.524 . . . . 75.24 111.054 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -107.76 94.49 5.11 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.413 0.685 . . . . 71.43 110.997 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -69.96 132.95 46.74 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.019 0.928 . . . . 73.42 112.8 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -144.62 142.6 30.25 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.869 1.267 . . . . 74.2 109.414 174.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 112.45 0.537 . . . . 74.21 112.45 -176.81 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HE1' ' HB2' ' A' ' 123' ' ' ALA . 5.2 tpt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.432 -0.581 . . . . 75.53 109.432 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -73.54 133.51 43.59 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.22 0.608 . . . . 74.1 112.152 -174.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.0 124.2 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 115.925 -0.579 . . . . 73.24 110.177 169.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.3 1.69 38.23 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.895 -0.593 . . . . 64.3 113.195 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.0 t -78.87 136.21 37.23 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.39 0.676 . . . . 75.33 111.591 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -87.71 110.74 20.66 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.005 -0.739 . . . . 74.13 109.005 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.21 160.0 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-O 121.63 0.728 . . . . 75.11 112.464 -168.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.59 137.53 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.12 0.968 . . . . 74.12 109.047 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.459 HD11 ' HB1' ' A' ' 20' ' ' ALA . 60.9 mt -79.46 118.87 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 109.684 -0.487 . . . . 73.41 109.684 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -77.66 -42.5 34.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.786 0.834 . . . . 74.03 110.48 -176.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.8 m -142.34 147.74 36.81 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.466 1.106 . . . . 74.5 110.142 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.7 p -155.14 157.47 37.48 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.119 0.485 . . . . 75.14 111.599 173.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -84.15 -17.79 38.88 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.007 -0.997 . . . . 74.51 110.705 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.468 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.4 mpt? -86.88 168.22 13.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.765 0.826 . . . . 64.41 110.131 169.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -87.8 -50.08 6.7 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.112 0.482 . . . . 74.23 110.685 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.21 -13.2 79.7 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 115.086 0.794 . . . . 74.22 115.086 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.4 ttp -89.01 -29.32 19.57 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.135 0.467 . . . . 72.14 111.315 -176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -69.09 122.04 17.94 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.61 0.364 . . . . 73.11 111.331 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.43 1.6 89.27 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.981 -0.554 . . . . 63.11 113.501 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.459 ' HB1' HD11 ' A' ' 9' ' ' ILE . . . -72.73 146.84 46.14 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.626 0.602 . . . . 62.22 112.626 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.84 98.84 4.97 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.363 0.665 . . . . 75.22 110.152 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -103.11 169.48 8.53 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.782 0.833 . . . . 63.44 112.307 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.5 m -141.05 134.59 30.0 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.57 -0.741 . . . . 74.42 109.195 168.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.23 114.05 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.914 0.486 . . . . 74.4 110.077 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.3 p -106.51 -4.12 20.1 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.063 0.545 . . . . 74.3 112.403 175.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.14 150.43 18.77 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-O 120.148 -0.251 . . . . 72.41 112.805 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.73 113.08 14.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.124 0.969 . . . . 71.01 110.336 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -114.17 115.76 28.0 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.793 0.837 . . . . 73.4 110.522 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -99.71 88.0 3.7 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 109.057 -0.72 . . . . 70.13 109.057 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.421 HG22 HD12 ' A' ' 53' ' ' ILE . 6.0 t -136.45 168.19 19.93 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.641 1.176 . . . . 74.43 111.133 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.7 m -75.31 129.93 38.22 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.886 -0.412 . . . . 64.24 109.886 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.7 154.93 20.76 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.751 0.821 . . . . 64.23 109.629 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -134.96 147.18 49.69 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.95 0.881 . . . . 74.45 112.129 -173.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.72 111.39 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 113.804 -1.544 . . . . 71.33 107.784 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.525 HG11 HD11 ' A' ' 88' ' ' ILE . 29.0 m -116.11 147.36 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.363 0.601 . . . . 75.51 112.214 -175.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -121.96 125.69 46.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.335 1.054 . . . . 71.52 110.057 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -147.1 158.49 43.95 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.431 0.692 . . . . 71.43 110.878 -172.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.6 m -109.87 111.46 58.66 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 108.824 -0.806 . . . . 74.41 108.824 174.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -46.82 118.29 2.6 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.719 2.946 . . . . 74.51 114.304 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.0 p -59.29 -24.68 63.48 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.903 1.281 . . . . 75.25 113.411 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -79.91 11.21 3.46 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 123.329 0.652 . . . . 73.44 112.107 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.03 51.61 3.72 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 121.97 -0.456 . . . . 73.25 112.729 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.53 163.89 12.39 Favored Glycine 0 C--N 1.344 0.991 0 N-CA-C 113.623 0.209 . . . . 75.13 113.623 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -60.19 132.91 55.4 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.398 0.679 . . . . 73.3 111.135 174.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.05 116.65 3.12 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.753 0.821 . . . . 74.32 111.626 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG23 ' SD ' ' A' ' 78' ' ' MET . 39.9 t -87.4 111.62 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 123.77 0.828 . . . . 74.35 109.657 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -104.32 138.78 40.25 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.682 0.793 . . . . 72.01 110.253 -173.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 54.42 40.48 31.81 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.151 0.98 . . . . 73.04 113.178 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.428 ' HB2' HG12 ' A' ' 46' ' ' VAL . 42.7 t60 -66.62 129.2 39.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.683 0.793 . . . . 62.52 111.118 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -135.48 151.42 50.36 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 123.793 0.837 . . . . 73.41 110.482 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -111.86 137.39 49.88 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.446 1.499 . . . . 71.45 112.293 -4.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.06 138.48 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.872 1.269 . . . . 73.33 108.002 169.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.421 HD12 HG22 ' A' ' 30' ' ' THR . 34.0 pt -106.59 170.84 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.705 -0.622 . . . . 75.44 111.617 -176.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -57.27 -35.17 69.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.744 0.818 . . . . 65.24 112.721 178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -71.14 -25.07 62.41 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 123.35 0.66 . . . . 70.53 111.691 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -86.72 -12.2 48.94 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 124.034 0.933 . . . . 74.41 112.102 -172.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.7 mt -107.88 137.96 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 124.062 0.945 . . . . 73.11 110.906 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -72.27 -54.01 10.82 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.301 0.64 . . . . 65.25 112.353 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.59 -10.2 17.26 Favored 'General case' 0 CA--C 1.568 1.667 0 C-N-CA 123.961 0.904 . . . . 63.24 113.156 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HA ' HD23 ' A' ' 65' ' ' LEU . . . -52.56 -65.89 0.48 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.714 0.806 . . . . 73.12 112.608 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.51 28.66 72.78 Favored Glycine 0 N--CA 1.478 1.485 0 N-CA-C 114.998 0.759 . . . . 71.25 114.998 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.38 13.66 6.22 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 124.191 0.996 . . . . 75.25 112.895 -171.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.656 ' HB3' ' HZ1' ' A' ' 63' ' ' LYS . 5.8 ttpm? -94.27 143.59 26.26 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.897 1.279 . . . . 75.01 110.218 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.6 m -71.48 109.27 5.34 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.139 0.576 . . . . 75.44 110.009 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.632 HD13 HG13 ' A' ' 71' ' ' VAL . 53.1 mt -78.74 128.58 33.61 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.438 0.695 . . . . 74.21 110.009 178.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -119.26 157.29 51.51 Favored Pre-proline 0 N--CA 1.487 1.376 0 C-N-CA 123.714 0.806 . . . . 71.42 110.315 -167.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -49.72 118.87 4.11 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.219 2.612 . . . . 73.1 114.308 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.95 -22.3 25.82 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 123.161 0.41 . . . . 75.45 113.875 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.55 138.62 51.12 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.529 0.664 . . . . 70.2 111.712 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -102.11 122.19 43.65 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.333 0.653 . . . . 73.43 110.569 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.632 HG13 HD13 ' A' ' 65' ' ' LEU . 30.2 m -120.98 166.74 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.059 0.944 . . . . 74.41 112.244 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mm -110.97 135.47 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.845 0.858 . . . . 71.44 110.107 173.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.7 mt -96.07 114.55 26.27 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.963 0.905 . . . . 75.44 111.118 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -78.33 -34.68 48.39 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.306 0.642 . . . . 72.04 111.425 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.66 165.13 18.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.312 0.645 . . . . 54.52 111.712 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 51.0 p -143.59 125.91 15.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.231 -0.895 . . . . 61.22 110.779 173.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -99.67 1.13 43.2 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.988 0.915 . . . . 72.43 109.694 167.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.461 ' SD ' HG23 ' A' ' 46' ' ' VAL . 23.5 ptp -156.02 166.24 34.04 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.332 1.053 . . . . 73.41 111.353 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -54.14 -32.15 54.43 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 115.456 1.65 . . . . 75.22 115.456 -169.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.29 26.64 6.31 Favored Glycine 0 N--CA 1.484 1.853 0 CA-C-N 118.054 0.388 . . . . 54.21 114.01 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.7 ttt -89.82 -41.62 11.73 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 117.185 0.492 . . . . 72.13 112.071 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 88.4 tttt -67.52 120.68 14.37 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 122.354 -0.216 . . . . 72.21 110.634 173.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.1 76.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.232 -0.44 . . . . 75.32 112.504 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.0 145.6 35.87 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-O 121.428 0.632 . . . . 74.34 111.696 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.5 m -88.27 122.5 31.87 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.779 -1.101 . . . . 70.13 109.0 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -118.74 162.89 17.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.893 0.877 . . . . 64.54 110.773 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -131.91 128.25 38.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.779 0.832 . . . . 73.34 109.815 175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.542 HG13 ' HB3' ' A' ' 65' ' ' LEU . 31.3 mm -66.48 116.42 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.646 0.779 . . . . 74.34 110.491 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -82.08 -36.75 27.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.487 0.715 . . . . 72.23 111.201 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.9 t -161.9 151.75 16.61 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.567 -0.742 . . . . 74.41 111.258 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.89 130.69 56.94 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.919 0.888 . . . . 72.25 109.353 172.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -134.68 119.97 18.94 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.211 0.604 . . . . 71.44 110.295 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 93' ' ' LYS . 6.8 mptt -90.31 93.79 9.48 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.173 -1.047 . . . . 74.22 108.173 -177.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.3 t -136.99 154.03 50.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.337 0.655 . . . . 74.53 110.945 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.8 m -80.77 128.11 33.28 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.146 -0.687 . . . . 64.44 109.146 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 m -120.53 135.71 59.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.572 1.149 . . . . 74.24 108.801 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.591 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 82.7 m-85 -109.72 157.27 19.29 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.108 0.956 . . . . 75.02 112.738 -171.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.515 ' SD ' ' HE3' ' A' ' 114' ' ' LYS . 35.7 ttp -100.28 117.59 34.81 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.071 -1.422 . . . . 74.14 107.699 165.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.7 m -125.07 148.25 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-O 121.37 0.605 . . . . 72.13 111.784 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.62 116.05 31.25 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.294 -1.002 . . . . 72.32 108.294 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -127.05 170.34 12.43 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.325 0.583 . . . . 75.43 111.978 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 m -112.07 111.2 21.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.205 -0.907 . . . . 75.4 109.071 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.8 m -57.21 96.82 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.209 -0.663 . . . . 65.33 109.209 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 52.0 p -56.83 -47.1 81.1 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.044 1.127 . . . . 74.13 114.044 -166.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.3 t -72.72 -32.23 65.56 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.392 0.515 . . . . 74.53 112.392 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.4 m -87.14 -26.93 23.37 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.545 0.738 . . . . 72.32 112.256 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.33 -22.2 10.98 Favored Glycine 0 CA--C 1.545 1.951 0 CA-C-N 116.004 -0.544 . . . . 73.23 114.313 -172.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -71.22 136.64 48.13 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.622 0.769 . . . . 75.31 112.094 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.33 131.63 44.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.629 0.771 . . . . 74.43 110.673 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.5 t -115.01 128.21 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.339 1.056 . . . . 71.32 109.302 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -107.19 143.44 35.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.006 0.522 . . . . 74.21 111.09 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.6 m120 58.78 39.5 24.09 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.281 1.432 . . . . 73.52 113.431 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -69.21 133.58 48.13 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.629 -0.714 . . . . 74.14 111.733 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.515 ' HE3' ' SD ' ' A' ' 98' ' ' MET . 96.7 mttt -142.47 145.77 34.07 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.565 1.146 . . . . 74.24 110.497 -175.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 87.5 m95 -106.98 122.32 46.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.703 1.601 . . . . 73.15 110.884 -9.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.7 m -99.37 154.81 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 109.208 -0.664 . . . . 73.14 109.208 170.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 31.7 m -113.81 158.16 21.37 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.827 0.451 . . . . 74.1 110.868 -175.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.591 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 67.0 tt0 -59.42 -35.83 74.72 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.189 0.519 . . . . 74.24 111.67 175.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -52.39 -32.96 41.32 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.816 1.247 . . . . 72.22 112.129 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -101.43 7.16 42.67 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.572 1.149 . . . . 70.11 112.5 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.2 mt -125.17 158.92 32.77 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.54 0.736 . . . . 74.23 110.871 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.2 t -148.05 140.89 24.73 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.026 0.93 . . . . 71.14 109.939 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.406 ' HB2' ' HE1' ' A' ' 1' ' ' MET . . . -75.69 130.25 38.4 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.628 0.371 . . . . 73.41 110.902 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -73.05 90.49 1.52 Allowed 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.183 0.516 . . . . 75.53 110.661 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.5 mt -112.56 -65.54 1.17 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.683 0.793 . . . . 74.41 110.548 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -92.52 159.04 15.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.928 0.891 . . . . 72.55 111.6 -178.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -81.7 72.35 8.74 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.434 0.694 . . . . 73.32 109.866 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -148.77 114.6 5.71 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.518 1.127 . . . . 74.32 109.841 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -87.78 -56.75 3.21 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.991 0.916 . . . . 74.21 109.663 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -167.99 145.13 4.2 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.353 1.061 . . . . 75.51 110.225 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.36 -164.6 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.591 0.757 . . . . 73.23 111.971 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.2 p80 . . . . . 0 CA--C 1.57 1.724 0 C-N-CA 122.938 0.495 . . . . 64.24 112.266 173.772 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 110.288 -0.264 . . . . 74.02 110.288 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -86.44 143.24 27.88 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.443 0.697 . . . . 74.31 111.633 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.5 t -66.58 126.58 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 C-N-CA 122.82 0.448 . . . . 73.23 110.215 170.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.97 -12.53 62.34 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 116.239 -0.437 . . . . 54.0 113.156 -171.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.3 t -88.66 161.04 17.09 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.259 0.623 . . . . 73.24 111.027 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -121.98 138.7 54.32 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.123 0.569 . . . . 62.51 111.207 -176.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.17 170.84 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 124.966 1.307 . . . . 73.33 111.118 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.5 mm -105.09 141.93 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.124 0.97 . . . . 75.21 109.814 171.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.629 HG22 ' HG2' ' A' ' 17' ' ' MET . 27.1 mm -65.04 129.31 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.5 0 C-N-CA 123.445 0.698 . . . . 73.24 111.263 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -108.07 -13.98 14.83 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.37 0.668 . . . . 65.34 111.604 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.9 m -145.49 139.17 26.62 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.241 0.616 . . . . 75.34 110.511 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.41 ' HA ' ' SD ' ' A' ' 17' ' ' MET . 58.8 p -113.49 118.5 34.66 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.301 0.64 . . . . 71.11 112.109 -173.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -89.58 -36.23 15.43 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.744 0.817 . . . . 74.11 109.441 169.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.45 ' HB3' ' HB2' ' A' ' 17' ' ' MET . 41.0 tpp -96.21 144.7 26.18 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.482 1.113 . . . . 75.44 108.901 175.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -23.72 66.74 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.331 0.863 . . . . 72.54 113.331 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.489 ' HA2' HG22 ' A' ' 105' ' ' THR . . . -89.84 -2.26 75.55 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 113.815 0.286 . . . . 73.52 113.815 174.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.629 ' HG2' HG22 ' A' ' 9' ' ' ILE . 49.8 ttm -81.39 -29.34 34.0 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.2 0.5 . . . . 75.05 110.942 -172.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.16 119.75 8.45 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.488 0.715 . . . . 73.33 112.144 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.96 1.27 87.29 Favored Glycine 0 N--CA 1.476 1.308 0 N-CA-C 114.519 0.567 . . . . 72.41 114.519 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.87 149.48 39.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.043 0.537 . . . . 72.02 111.661 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -92.72 102.87 15.28 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 122.984 0.514 . . . . 62.14 110.552 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.578 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -86.02 150.66 24.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.932 0.893 . . . . 60.2 111.766 -175.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.1 m -123.48 115.62 21.86 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.204 0.602 . . . . 72.24 109.763 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.47 96.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.272 0.629 . . . . 74.3 110.352 -174.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.8 p -98.59 -4.36 34.22 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.416 0.686 . . . . 60.43 111.448 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.92 139.46 6.61 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 111.984 -0.446 . . . . 53.12 111.984 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.61 108.69 12.31 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.808 0.843 . . . . 75.05 109.688 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -111.96 112.1 23.5 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.802 0.841 . . . . 71.0 110.338 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -94.98 82.76 3.85 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.494 0.664 . . . . 71.13 109.312 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.6 t -134.94 177.27 7.94 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.86 0.864 . . . . 70.25 111.72 -173.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.7 m -85.74 125.9 33.58 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 122.823 0.449 . . . . 75.2 110.192 173.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -103.53 154.45 19.46 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.648 1.179 . . . . 70.12 110.524 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.539 ' HB2' HG22 ' A' ' 52' ' ' VAL . 92.0 m-85 -137.61 146.03 43.47 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.715 0.769 . . . . 75.31 111.583 -174.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.85 121.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 106.939 -1.504 . . . . 75.11 106.939 167.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.8 m -123.02 162.18 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.479 0.657 . . . . 63.43 112.761 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 71.5 p -131.01 122.12 26.25 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.295 -0.866 . . . . 74.33 109.732 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -148.01 151.24 35.41 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.344 0.498 . . . . 75.33 112.344 -170.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.2 m -96.37 109.15 46.19 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 107.814 -1.18 . . . . 73.34 107.814 170.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.32 148.64 40.77 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.371 2.047 . . . . 65.14 112.901 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.8 p -64.27 -17.21 63.4 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.176 0.99 . . . . 74.35 113.029 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.446 ' N ' HD21 ' A' ' 41' ' ' ASN . 0.8 OUTLIER -70.54 -19.51 62.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.76 0.424 . . . . 74.54 111.197 172.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.26 24.75 65.22 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 114.898 0.719 . . . . 74.44 114.898 168.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.18 -96.49 0.35 Allowed Glycine 0 CA--C 1.537 1.428 0 CA-C-N 117.03 0.415 . . . . 61.21 112.746 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -116.83 142.19 47.25 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.707 0.803 . . . . 71.3 110.539 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -69.71 115.3 8.8 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.675 0.39 . . . . 75.21 110.501 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.431 HG13 ' HE1' ' A' ' 78' ' ' MET . 87.1 t -84.43 85.54 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-O 121.766 0.793 . . . . 74.11 109.837 176.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.0 p-10 -67.26 158.21 31.99 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.961 1.097 . . . . 71.51 113.961 163.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 42.3 m80 56.33 29.17 14.58 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 113.829 -1.532 . . . . 72.34 113.654 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -64.87 128.83 37.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.048 0.539 . . . . 74.43 111.167 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 98.3 mttt -129.66 133.75 47.29 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.801 0.84 . . . . 74.45 111.273 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.602 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 84.6 m95 -120.07 160.91 21.9 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.436 1.494 . . . . 72.24 111.159 -9.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 33' ' ' TYR . 19.3 m -127.83 141.88 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.334 1.054 . . . . 74.33 109.301 170.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.6 pt -106.97 167.63 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 122.129 -0.357 . . . . 74.25 111.632 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.493 ' HG2' ' HB3' ' A' ' 60' ' ' ALA . 53.6 tt0 -47.75 -57.35 5.69 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.847 1.054 . . . . 74.41 113.847 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -82.09 7.02 14.51 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 112.866 0.691 . . . . 71.53 112.866 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -91.59 -11.39 37.34 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.386 1.074 . . . . 64.41 110.506 172.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.8 mt -116.88 140.01 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 125.031 1.332 . . . . 75.35 109.382 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.455 ' HB3' ' HG2' ' A' ' 74' ' ' GLU . 16.0 ptmt -71.99 -36.21 69.7 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.758 0.651 . . . . 74.02 112.758 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -72.9 -8.99 58.16 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.756 0.822 . . . . 71.44 112.627 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.493 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . . . -33.69 -63.3 0.26 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.228 1.411 . . . . 74.13 114.69 176.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.7 19.98 65.69 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 115.269 0.868 . . . . 74.33 115.269 169.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.1 t70 71.81 -3.08 2.28 Favored 'General case' 0 CA--C 1.573 1.853 0 C-N-CA 125.336 1.454 . . . . 74.31 112.843 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.68 168.15 10.11 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.68 0.792 . . . . 74.34 111.72 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.0 m -90.91 119.37 31.05 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.296 0.639 . . . . 74.34 110.409 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.497 HD12 HG13 ' A' ' 71' ' ' VAL . 49.6 mt -73.69 118.16 16.32 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.194 0.598 . . . . 73.23 110.21 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -101.27 144.55 28.79 Favored Pre-proline 0 N--CA 1.489 1.52 0 C-N-CA 123.614 0.765 . . . . 72.42 112.172 -165.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.39 124.95 16.22 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 123.082 2.521 . . . . 54.03 114.324 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.2 -19.22 29.93 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 123.841 0.734 . . . . 73.25 113.393 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -74.35 148.49 41.24 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.546 0.739 . . . . 74.13 112.291 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -113.07 123.24 49.82 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.726 0.81 . . . . 73.14 111.216 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.497 HG13 HD12 ' A' ' 65' ' ' LEU . 26.9 m -121.42 177.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 125.392 1.477 . . . . 62.15 111.496 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 85' ' ' THR . 38.5 mm -120.52 137.0 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 123.935 0.894 . . . . 74.13 109.821 170.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.4 mt -90.43 121.54 32.5 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.097 0.959 . . . . 74.22 111.818 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.455 ' HG2' ' HB3' ' A' ' 58' ' ' LYS . 33.8 mm-40 -89.66 -4.06 57.95 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.447 0.536 . . . . 70.33 112.447 174.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.48 167.62 12.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.255 0.55 . . . . 73.55 111.056 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 t -141.96 125.01 16.23 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.503 -0.771 . . . . 65.2 111.683 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -98.73 -11.81 21.57 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.89 0.876 . . . . 74.32 111.527 170.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.431 ' HE1' HG13 ' A' ' 46' ' ' VAL . 20.4 ptp -144.14 -175.6 4.68 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.545 0.738 . . . . 63.43 111.951 -172.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -70.05 100.81 1.68 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.793 0.664 . . . . 73.11 112.793 -178.017 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.35 38.97 8.62 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.387 -0.824 . . . . 62.43 114.426 172.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.6 ttt -86.49 -28.98 23.1 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 117.402 0.601 . . . . 71.3 111.765 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -64.59 129.24 39.08 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 120.908 0.385 . . . . 72.41 111.848 172.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.23 -4.15 84.34 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.924 -0.58 . . . . 74.33 113.143 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.78 146.93 32.04 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.463 0.705 . . . . 71.21 111.588 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.431 ' HA ' HD13 ' A' ' 72' ' ' ILE . 57.9 m -84.11 117.06 23.21 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.989 -0.55 . . . . 70.43 109.699 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -106.5 152.81 23.18 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.529 0.732 . . . . 72.21 110.36 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -123.1 121.47 36.08 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.555 -0.906 . . . . 75.21 108.555 174.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.34 106.38 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.537 0.735 . . . . 73.42 110.133 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -76.59 -37.71 56.05 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.512 0.725 . . . . 74.51 109.735 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.0 t -159.77 158.62 31.53 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.671 -0.695 . . . . 74.14 111.286 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -135.17 139.33 44.49 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.957 0.903 . . . . 62.01 109.905 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -151.44 142.98 23.58 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.763 0.425 . . . . 65.02 110.751 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.505 ' HD2' ' H ' ' A' ' 93' ' ' LYS . 1.3 mptt -96.78 92.52 6.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 107.986 -1.116 . . . . 75.04 107.986 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.3 t -138.11 153.17 49.28 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.532 0.733 . . . . 74.05 111.337 -172.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.2 m -77.69 122.99 26.09 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.926 -0.398 . . . . 74.42 109.926 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.515 HG12 HG22 ' A' ' 117' ' ' THR . 24.0 m -109.31 134.2 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.728 0.811 . . . . 71.3 108.976 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -110.96 144.11 40.57 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.366 0.666 . . . . 73.5 111.684 -174.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.9 ttp -93.58 111.17 22.79 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.671 -1.233 . . . . 74.14 107.671 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.578 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 27.4 m -124.42 146.76 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 112.822 0.675 . . . . 73.2 112.822 -168.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.55 116.18 29.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.945 0.898 . . . . 75.12 109.827 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.411 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 50.8 p90 -130.96 175.5 9.03 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.188 0.595 . . . . 74.5 111.524 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.8 m -117.56 119.98 36.66 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.878 -0.786 . . . . 72.14 108.878 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 106' ' ' SER . 72.9 p -60.95 126.09 26.1 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.336 0.654 . . . . 74.21 111.558 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.5 p -70.71 -48.42 54.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.451 0.7 . . . . 64.3 112.87 -172.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.489 HG22 ' HA2' ' A' ' 16' ' ' GLY . 11.6 t -86.03 -4.2 59.11 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.304 0.853 . . . . 60.33 113.304 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.42 ' HB2' ' OG ' ' A' ' 103' ' ' SER . 16.5 m -119.12 -49.16 2.41 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.945 0.498 . . . . 75.23 111.4 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.5 -6.52 55.43 Favored Glycine 0 N--CA 1.481 1.635 0 CA-C-N 116.219 -0.446 . . . . 74.31 113.618 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.53 130.64 39.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.463 0.705 . . . . 74.44 110.894 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -81.3 100.61 9.27 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.837 -0.801 . . . . 74.33 108.837 178.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 113' ' ' HIS . 46.9 t -88.0 108.67 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.052 0.941 . . . . 73.44 110.004 -172.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.533 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -102.73 139.93 37.67 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.105 0.562 . . . . 74.33 111.777 -169.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.5 m120 51.67 36.99 18.86 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.509 1.123 . . . . 74.2 113.249 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.429 ' HB2' HG13 ' A' ' 110' ' ' VAL . 64.8 t60 -64.75 132.52 49.82 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.884 -0.598 . . . . 71.11 110.819 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -158.39 146.96 18.77 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 115.188 -0.915 . . . . 75.23 111.019 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.602 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 87.9 m95 -106.87 136.6 46.43 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.08 1.352 . . . . 73.21 112.735 4.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.4 m -122.16 141.58 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 124.881 1.272 . . . . 75.31 108.313 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.515 HG22 HG12 ' A' ' 96' ' ' VAL . 30.7 p -96.37 178.01 5.51 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.781 -0.574 . . . . 72.44 112.202 -174.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -59.65 -52.92 63.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.021 0.928 . . . . 75.34 112.868 -176.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.52 -21.15 66.6 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.942 0.897 . . . . 71.31 112.223 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -88.53 3.06 51.65 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.646 0.778 . . . . 74.22 111.521 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.6 mt -121.95 166.65 14.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.63 1.172 . . . . 70.32 109.289 171.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.3 t -151.13 130.78 13.09 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.439 0.696 . . . . 73.35 110.16 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.3 143.72 50.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.832 0.453 . . . . 73.41 111.524 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -83.09 113.68 20.78 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.16 0.584 . . . . 73.44 111.039 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.29 139.43 41.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.419 0.688 . . . . 73.45 110.657 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.51 19.82 12.76 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.845 0.858 . . . . 73.01 112.25 -174.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -60.47 142.68 54.85 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.706 0.802 . . . . 71.14 113.072 -173.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -74.18 130.44 39.76 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.313 0.645 . . . . 72.34 111.009 -176.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -107.4 74.1 0.95 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.578 0.704 . . . . 73.42 111.978 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -136.31 76.37 1.6 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.85 0.86 . . . . 75.42 109.559 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -130.65 157.62 42.26 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.443 0.697 . . . . 75.54 111.827 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 . . . . . 0 CA--C 1.572 1.806 0 C-N-CA 123.149 0.58 . . . . 72.02 112.385 179.403 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mmt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.952 -0.388 . . . . 62.43 109.952 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -100.8 154.24 18.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.38 0.672 . . . . 72.430000000000007 111.219 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.24 122.74 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 121.084 0.468 . . . . 62.0 110.397 173.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.7 -7.77 42.55 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 115.53 -0.759 . . . . 42.200000000000003 112.689 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -80.9 151.22 28.71 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.412 0.685 . . . . 71.230000000000004 112.349 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -93.06 136.96 32.84 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.163 0.985 . . . . 73.409999999999997 109.136 170.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.95 153.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.7 0.8 . . . . 63.439999999999998 110.308 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.8 mm -104.95 121.53 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.889 0.876 . . . . 72.5 109.828 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 22' ' ' ALA . 35.3 mt -82.01 120.41 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 122.938 0.495 . . . . 62.310000000000002 109.886 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -96.86 -56.08 2.68 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.865 0.466 . . . . 70.349999999999994 110.833 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.454 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 84.3 m -95.3 140.03 30.77 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.85 -1.167 . . . . 75.019999999999996 107.85 174.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 17' ' ' MET . 79.6 p -154.71 141.28 18.86 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.976 0.732 . . . . 74.219999999999999 112.976 -164.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -75.18 -43.63 51.07 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.157 0.983 . . . . 75.340000000000003 109.6 174.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.485 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 25.3 mmt -96.34 140.42 31.03 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.377 -0.829 . . . . 74.319999999999993 110.535 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -60.96 -35.19 76.11 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.763 0.825 . . . . 71.129999999999995 111.468 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.46 -4.54 24.91 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 115.118 0.807 . . . . 73.129999999999995 115.118 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.531 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 48.6 mtm -99.52 -25.38 14.45 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 117.401 0.6 . . . . 65.25 111.678 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -68.34 116.93 9.48 Favored 'General case' 0 CA--C 1.556 1.178 0 CA-C-N 118.475 0.579 . . . . 72.409999999999997 110.375 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.81 2.0 89.81 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 115.383 -0.826 . . . . 44.130000000000003 113.689 -174.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.9 148.29 27.03 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.205 0.602 . . . . 42.119999999999997 111.797 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -95.18 104.26 16.14 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.643 0.777 . . . . 71.019999999999996 109.635 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.535 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -90.61 161.12 15.56 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.828 0.851 . . . . 64.219999999999999 112.189 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.4 m -124.11 121.77 36.05 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.363 -0.976 . . . . 63.32 108.363 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.07 100.4 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 122.8 0.44 . . . . 51.119999999999997 109.906 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.5 p -91.98 -8.1 47.11 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.167 0.587 . . . . 73.120000000000005 111.32 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.26 148.96 15.42 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.369 -0.378 . . . . 72.219999999999999 112.386 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.78 114.53 14.22 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.821 0.848 . . . . 52.310000000000002 109.915 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.453 ' HB2' HG23 ' A' ' 96' ' ' VAL . 5.9 m-85 -116.06 130.54 56.86 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.173 0.989 . . . . 72.329999999999998 111.155 -171.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -103.83 81.65 1.9 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.938 0.895 . . . . 75.239999999999995 110.319 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -133.88 166.15 23.34 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.088 0.555 . . . . 60.43 111.307 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.412 ' HB ' ' HG2' ' A' ' 54' ' ' GLN . 4.0 m -76.83 121.93 24.07 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.372 -0.603 . . . . 62.200000000000003 109.372 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.89 151.62 26.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.452 0.701 . . . . 74.239999999999995 109.635 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -136.42 149.18 48.14 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.934 0.873 . . . . 64.340000000000003 112.25 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.52 111.58 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 113.892 -1.503 . . . . 73.040000000000006 107.149 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.541 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 26.7 m -119.92 149.49 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.321 0.648 . . . . 74.409999999999997 112.165 -176.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.1 t -117.41 132.21 56.61 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.655 0.782 . . . . 71.400000000000006 109.908 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -150.71 156.1 40.64 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.09 0.472 . . . . 74.430000000000007 111.968 -173.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 m -109.3 111.66 59.79 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.332 -0.988 . . . . 44.039999999999999 108.332 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.79 117.2 3.11 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.376 2.718 . . . . 72.109999999999999 114.125 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.466 HG23 ' HA ' ' A' ' 84' ' ' ALA . 25.6 p -59.49 -24.4 63.57 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.741 1.216 . . . . 70.040000000000006 113.892 -173.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -79.38 14.69 1.47 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.483 0.713 . . . . 74.239999999999995 112.858 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.95 43.7 6.63 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 113.774 0.27 . . . . 44.539999999999999 113.774 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.93 163.61 12.94 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 122.708 0.194 . . . . 71.140000000000001 113.024 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -66.28 135.12 53.98 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.372 0.669 . . . . 52.509999999999998 111.099 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -58.19 116.83 3.82 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.584 0.754 . . . . 72.129999999999995 112.376 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.55 HG12 ' HB2' ' A' ' 49' ' ' HIS . 30.7 t -84.82 104.94 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.202 -0.908 . . . . 72.430000000000007 109.198 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -99.41 135.5 40.72 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.414 0.686 . . . . 75.519999999999996 110.668 -172.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.8 m170 57.45 39.06 28.36 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.233 1.013 . . . . 71.549999999999997 112.446 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.55 ' HB2' HG12 ' A' ' 46' ' ' VAL . 46.0 t60 -66.25 135.29 54.25 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.908 0.883 . . . . 70.510000000000005 110.701 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -150.81 153.61 35.75 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.889 -0.596 . . . . 71.310000000000002 110.46 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.559 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 98.0 m95 -106.43 139.61 40.63 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.39 1.476 . . . . 65.239999999999995 111.824 -2.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.5 137.43 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.333 1.053 . . . . 41.409999999999997 108.377 169.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.2 pt -113.74 174.1 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.965 0.506 . . . . 62.130000000000003 111.722 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.412 ' HG2' ' HB ' ' A' ' 31' ' ' THR . 14.1 mm100 -48.85 -49.16 40.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.57 1.322 . . . . 73.420000000000002 114.57 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.46 -1.22 40.66 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 122.856 0.462 . . . . 63.509999999999998 112.163 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.45 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 0.9 OUTLIER -83.81 -22.06 31.92 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.826 0.85 . . . . 71.519999999999996 110.27 175.105 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.4 mt -117.34 136.14 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 124.715 1.206 . . . . 72.349999999999994 111.079 -168.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.485 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 38.4 ttpt -72.01 -57.41 4.31 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.489 0.716 . . . . 62.020000000000003 111.539 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.09 -4.61 14.12 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.581 1.152 . . . . 74.209999999999994 113.685 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.728 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -54.55 -55.74 26.12 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.45 0.7 . . . . 75.219999999999999 112.006 171.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.91 19.79 65.93 Favored Glycine 0 N--CA 1.479 1.565 0 N-CA-C 114.676 0.63 . . . . 53.140000000000001 114.676 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 62.79 20.14 11.93 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.06 1.344 . . . . 73.150000000000006 113.813 -172.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 16.6 pttp -98.32 160.18 14.46 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 122.914 0.486 . . . . 64.510000000000005 109.91 173.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.8 m -76.46 110.81 11.31 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.891 -0.411 . . . . 73.409999999999997 109.891 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 60' ' ' ALA . 61.1 mt -74.68 114.07 12.68 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.267 0.627 . . . . 74.439999999999998 110.458 177.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -81.23 147.81 61.73 Favored Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 123.561 0.744 . . . . 42.219999999999999 111.731 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.42 114.63 1.65 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.836 2.358 . . . . 75.150000000000006 113.339 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.81 -14.21 24.39 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-N 115.826 -0.625 . . . . 61.229999999999997 113.96 -174.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -75.24 141.84 43.47 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.423 0.689 . . . . 75.340000000000003 111.03 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -111.38 133.22 53.84 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.536 0.684 . . . . 74.349999999999994 110.975 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.9 m -140.09 156.39 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 125.389 1.476 . . . . 63.039999999999999 110.634 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -103.46 136.13 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 122.853 0.461 . . . . 73.409999999999997 109.769 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.3 mt -87.44 120.88 29.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.167 0.987 . . . . 74.430000000000007 111.44 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.485 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 8.2 mm-40 -81.73 -36.97 28.01 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.317 0.647 . . . . 75.219999999999999 112.43 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.45 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -83.73 164.99 19.26 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.058 0.456 . . . . 71.5 111.214 176.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 96.5 p -143.74 124.81 14.44 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.737 -0.468 . . . . 63.210000000000001 109.737 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -91.66 -4.28 55.37 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.777 0.831 . . . . 71.450000000000003 110.602 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -164.33 175.78 9.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.304 1.042 . . . . 74.140000000000001 111.141 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -80.4 116.38 20.43 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.352 0.661 . . . . 74.310000000000002 111.387 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.31 27.34 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 123.019 0.342 . . . . 75.329999999999998 113.821 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.9 ttt -82.53 -50.52 8.73 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.587 0.755 . . . . 73.340000000000003 112.906 -173.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -63.31 128.78 37.39 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.834 0.453 . . . . 64.040000000000006 111.893 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.2 -10.3 67.58 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.562 -0.29 . . . . 50.109999999999999 113.227 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.466 ' HA ' HG23 ' A' ' 40' ' ' THR . . . -76.63 145.9 38.55 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.018 0.527 . . . . 73.340000000000003 111.775 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.0 m -84.17 117.25 23.37 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.693 -0.685 . . . . 62.329999999999998 109.554 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.541 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -110.95 149.27 30.9 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.758 1.223 . . . . 71.310000000000002 109.94 -175.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.47 132.24 52.71 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 109.483 -0.562 . . . . 63.340000000000003 109.483 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.525 HD13 HG12 ' A' ' 35' ' ' VAL . 30.4 mm -67.42 109.4 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.607 0.763 . . . . 73.030000000000001 110.354 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -78.06 -38.36 44.61 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.217 0.607 . . . . 74.120000000000005 109.743 172.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.2 t -154.92 141.15 18.55 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.458 -0.792 . . . . 71.549999999999997 111.301 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.16 131.89 52.07 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.907 0.883 . . . . 75.129999999999995 108.955 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -132.5 139.29 47.87 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.788 0.662 . . . . 74.519999999999996 112.788 -168.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -111.22 95.39 5.5 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.06 0.944 . . . . 63.340000000000003 109.414 169.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -137.56 157.25 46.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.116 0.966 . . . . 45.32 110.841 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.6 m -85.38 119.37 25.66 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.307 -0.997 . . . . 72.129999999999995 108.307 171.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.453 HG23 ' HB2' ' A' ' 28' ' ' TYR . 13.7 m -106.51 132.76 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.398 0.618 . . . . 63.140000000000001 109.624 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.402 ' HB2' HG23 ' A' ' 116' ' ' VAL . 89.7 m-85 -111.97 140.43 46.65 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.935 0.894 . . . . 62.329999999999998 111.231 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.8 ttp -94.21 119.88 33.65 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.268 -1.382 . . . . 51.140000000000001 107.268 167.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.535 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 23.5 m -128.03 156.56 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 113.789 1.033 . . . . 71.099999999999994 113.789 -171.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -110.29 118.28 35.91 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.124 1.37 . . . . 63.229999999999997 109.087 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -133.72 166.86 21.64 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.174 0.511 . . . . 71.209999999999994 110.947 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.4 m -105.61 119.14 38.37 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 108.791 -0.818 . . . . 75.329999999999998 108.791 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.8 m -56.84 95.98 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.754 0.821 . . . . 71.140000000000001 110.834 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.4 p -58.3 -26.0 62.51 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.351 1.06 . . . . 64.310000000000002 113.709 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 m -62.6 -38.3 89.63 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 123.734 0.813 . . . . 73.209999999999994 112.421 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.9 p -113.94 -50.76 2.81 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 123.357 0.663 . . . . 70.120000000000005 112.068 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.21 15.85 7.52 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.158 0.885 . . . . 71.349999999999994 111.945 -172.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -86.49 141.54 29.02 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.727 0.811 . . . . 43.299999999999997 111.547 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -85.01 117.71 24.15 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.752 1.221 . . . . 73.040000000000006 111.093 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -120.53 132.6 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 124.03 0.932 . . . . 71.219999999999999 110.591 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.453 ' HD3' ' H ' ' A' ' 111' ' ' LYS . 0.4 OUTLIER -115.8 168.7 9.82 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.263 0.625 . . . . 63.329999999999998 111.365 178.744 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.7 p30 44.79 37.58 2.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 126.516 1.926 . . . . 74.420000000000002 115.221 176.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -61.53 133.0 55.2 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.483 0.713 . . . . 71.25 111.642 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 90.5 mttt -137.11 132.61 34.31 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.025 0.93 . . . . 74.230000000000004 110.951 -175.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.559 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.7 m95 -116.37 154.35 30.4 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.824 1.65 . . . . 74.150000000000006 111.564 -11.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.402 HG23 ' HB2' ' A' ' 97' ' ' TYR . 15.4 m -124.51 142.47 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.865 0.866 . . . . 61.030000000000001 109.637 172.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.1 p -109.98 168.26 9.56 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.52 0.563 . . . . 72.140000000000001 112.52 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -57.2 -35.23 69.37 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.678 0.791 . . . . 71.310000000000002 111.686 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.49 -43.01 93.4 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.34 1.056 . . . . 64.439999999999998 111.799 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.454 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 52.2 mt-10 -85.73 -2.79 58.56 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.903 0.881 . . . . 72.030000000000001 112.892 -172.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.07 150.49 40.49 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.636 0.731 . . . . 72.349999999999994 111.578 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 m -122.77 147.7 46.2 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.312 -1.366 . . . . 74.150000000000006 107.312 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.17 151.85 33.03 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.95 0.795 . . . . 33.240000000000002 111.692 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.7 tptt . . . . . 0 N--CA 1.484 1.228 0 C-N-CA 123.075 0.55 . . . . 72.099999999999994 110.766 175.406 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.529 ' HG2' HG11 ' A' ' 7' ' ' VAL . 1.8 mpt? . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.431 0.158 . . . . 52.219999999999999 110.95 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -109.13 164.13 12.71 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.613 0.765 . . . . 74.540000000000006 110.392 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.2 123.06 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-O 121.132 0.492 . . . . 75.409999999999997 110.532 172.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.57 -4.37 50.61 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 115.797 -0.638 . . . . 64.200000000000003 113.572 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -83.41 142.86 30.68 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.222 0.609 . . . . 54.409999999999997 111.455 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -109.13 135.73 49.79 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.42 0.629 . . . . 64.439999999999998 111.005 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 123' ' ' ALA . 23.7 m -139.81 155.29 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.967 1.307 . . . . 64.549999999999997 110.475 -170.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.1 mm -98.56 132.53 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.173 0.589 . . . . 73.129999999999995 109.714 170.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.687 HG21 ' HG2' ' A' ' 17' ' ' MET . 39.8 mt -81.71 123.34 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 122.387 0.275 . . . . 72.519999999999996 110.357 -175.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -95.11 -60.06 1.76 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.433 0.693 . . . . 73.439999999999998 110.247 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.627 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 79.7 m -98.24 140.03 33.14 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.073 -1.084 . . . . 73.540000000000006 108.073 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.437 ' HB3' ' HB3' ' A' ' 17' ' ' MET . 74.1 m -140.16 139.88 35.82 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.991 1.108 . . . . 64.299999999999997 113.991 -167.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -91.31 -15.92 28.34 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 113.994 -1.457 . . . . 71.420000000000002 110.417 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 26.5 mmt -126.56 155.43 42.44 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.646 1.179 . . . . 62.439999999999998 110.226 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -67.05 -36.9 83.06 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.095 0.558 . . . . 73.219999999999999 112.193 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.43 -9.98 86.58 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 114.046 0.379 . . . . 75.120000000000005 114.046 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.687 ' HG2' HG21 ' A' ' 9' ' ' ILE . 44.0 ttm -80.69 -32.1 36.01 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 122.69 0.396 . . . . 62.020000000000003 111.718 -172.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -68.87 122.34 18.42 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.13 0.572 . . . . 64.450000000000003 112.201 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.61 -8.48 79.05 Favored Glycine 0 CA--C 1.537 1.469 0 CA-C-N 115.729 -0.669 . . . . 71.120000000000005 114.147 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.18 149.68 42.73 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.169 0.588 . . . . 52.229999999999997 112.131 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -87.94 101.93 14.23 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.623 0.369 . . . . 73.549999999999997 110.04 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . . . -86.56 156.96 19.85 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.604 0.762 . . . . 73.120000000000005 111.374 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.0 m -131.25 127.51 37.95 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.454 -0.943 . . . . 73.150000000000006 108.454 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.95 113.83 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 123.207 0.603 . . . . 73.140000000000001 111.017 -173.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.4 p -89.9 -21.04 22.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.102 0.561 . . . . 74.340000000000003 110.53 173.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.6 142.57 8.52 Favored Glycine 0 C--N 1.354 1.547 0 C-N-CA 122.741 0.21 . . . . 54.299999999999997 112.612 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.98 107.55 9.7 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.66 0.784 . . . . 51.420000000000002 110.067 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -111.58 132.91 54.21 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.801 0.84 . . . . 75.439999999999998 110.674 -175.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.4 82.71 1.77 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.77 0.795 . . . . 52.32 109.97 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -134.96 -179.51 5.66 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.816 0.846 . . . . 75.530000000000001 111.321 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 m -83.91 128.26 34.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.918 -0.489 . . . . 74.450000000000003 110.383 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.11 140.18 48.1 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.141 0.976 . . . . 74.140000000000001 109.895 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -113.72 152.51 30.41 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 122.081 0.943 . . . . 74.319999999999993 112.6 -174.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.54 111.41 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.069 -1.423 . . . . 42.340000000000003 107.753 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.426 HG12 HD13 ' A' ' 88' ' ' ILE . 19.3 m -112.39 150.85 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.386 0.612 . . . . 75.200000000000003 112.444 -176.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -122.0 125.57 46.59 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.298 1.039 . . . . 72.239999999999995 109.263 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -152.27 159.03 43.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.564 0.745 . . . . 74.549999999999997 111.294 -174.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.9 m -105.52 116.73 59.64 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.724 -1.213 . . . . 74.530000000000001 107.724 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -58.96 133.32 52.79 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.096 1.864 . . . . 74.129999999999995 110.873 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.1 p -68.83 2.06 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.109 0.781 . . . . 61.049999999999997 113.109 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.14 -21.2 66.04 Favored 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 123.663 0.785 . . . . 65.129999999999995 111.317 165.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.19 15.13 56.46 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 115.066 0.786 . . . . 64.340000000000003 115.066 171.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.62 -131.43 7.38 Favored Glycine 0 N--CA 1.476 1.357 0 CA-C-N 117.655 0.728 . . . . 25.550000000000001 113.688 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -71.21 128.27 35.36 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.919 0.888 . . . . 73.019999999999996 111.974 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -62.24 122.3 15.28 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.587 0.755 . . . . 72.299999999999997 111.938 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.593 HG21 ' SD ' ' A' ' 78' ' ' MET . 68.0 t -84.47 110.77 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.396 0.679 . . . . 70.439999999999998 110.256 176.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -101.44 148.33 25.31 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.903 0.481 . . . . 73.219999999999999 109.958 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 34.3 m80 54.59 38.95 30.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.732 0.813 . . . . 75.030000000000001 112.779 173.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -60.46 128.35 36.21 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.857 0.863 . . . . 71.409999999999997 111.198 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 66.1 mttm -126.3 132.68 51.6 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 123.504 0.722 . . . . 71.239999999999995 110.594 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 94.4 m95 -117.86 156.14 28.92 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.154 1.382 . . . . 70.450000000000003 111.53 -11.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.55 160.4 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.96 1.304 . . . . 75.430000000000007 108.169 169.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.416 HG21 HG21 ' A' ' 96' ' ' VAL . 37.4 pt -126.7 163.65 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 118.983 0.81 . . . . 54.039999999999999 112.546 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -44.14 -51.59 7.96 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.499 1.519 . . . . 64.430000000000007 112.538 174.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -82.15 -5.92 58.81 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.787 0.835 . . . . 70.040000000000006 112.97 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -88.32 -33.67 17.92 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.686 0.795 . . . . 35.450000000000003 110.234 173.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.8 mt -78.93 130.25 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 115.754 -0.657 . . . . 74.409999999999997 110.468 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -69.34 -35.45 75.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.492 0.717 . . . . 71.230000000000004 112.351 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.24 -8.9 58.35 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.971 0.73 . . . . 73.099999999999994 112.971 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -34.17 -59.43 0.43 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 114.945 1.461 . . . . 51.43 114.945 -173.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.51 21.01 68.4 Favored Glycine 0 N--CA 1.479 1.519 0 N-CA-C 115.352 0.901 . . . . 75.540000000000006 115.352 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 68.84 -2.94 1.57 Allowed 'General case' 0 CA--C 1.573 1.85 0 C-N-CA 124.862 1.265 . . . . 64.439999999999998 112.472 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 25.0 pttm -95.68 152.78 18.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.628 -0.67 . . . . 74.349999999999994 111.022 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.6 m -84.08 112.36 20.15 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.006 -0.739 . . . . 74.129999999999995 109.006 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.534 ' HB3' HG13 ' A' ' 88' ' ' ILE . 42.3 mt -71.31 120.5 16.98 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.817 0.847 . . . . 63.399999999999999 110.763 -174.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -91.19 157.48 42.7 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 123.682 0.793 . . . . 72.219999999999999 111.292 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 87.2 Cg_exo -50.99 112.25 0.74 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.644 2.229 . . . . 72.040000000000006 113.163 172.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.64 -9.93 16.52 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 115.975 -0.557 . . . . 63.009999999999998 114.031 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.6 122.73 19.12 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 117.772 0.786 . . . . 74.5 109.495 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -100.91 118.35 36.78 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.471 -0.937 . . . . 75.150000000000006 108.471 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.423 HG11 HD13 ' A' ' 65' ' ' LEU . 33.3 m -125.29 171.92 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.607 1.163 . . . . 52.420000000000002 110.877 -166.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.3 mm -116.17 135.95 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 122.863 0.465 . . . . 62.210000000000001 110.033 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.9 mt -90.93 134.73 34.24 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.74 0.816 . . . . 63.450000000000003 110.996 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.16 -5.62 27.49 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 113.0 0.741 . . . . 75.549999999999997 113.0 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.6 156.27 16.89 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.139 0.575 . . . . 74.299999999999997 110.618 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.9 p -136.04 124.4 23.34 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.193 0.521 . . . . 65.310000000000002 110.319 171.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -100.35 -16.22 17.72 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.793 0.837 . . . . 75.140000000000001 108.991 162.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.593 ' SD ' HG21 ' A' ' 46' ' ' VAL . 43.3 mtt -128.57 173.42 10.28 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.39 1.076 . . . . 73.209999999999994 112.213 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.59 105.67 8.89 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.0 0.92 . . . . 63.329999999999998 110.836 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.1 33.58 17.34 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.23 -0.441 . . . . 72.109999999999999 113.207 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -89.59 -49.4 6.69 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.303 0.641 . . . . 71.099999999999994 109.97 173.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -69.04 120.57 15.1 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.34 0.656 . . . . 73.120000000000005 111.036 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.71 2.35 75.82 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 123.103 0.252 . . . . 70.109999999999999 113.263 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.44 158.09 19.06 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.4 0.68 . . . . 72.439999999999998 111.551 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 m -87.51 118.33 26.9 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.2 -0.909 . . . . 72.109999999999999 110.023 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -115.43 162.17 17.52 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.112 0.965 . . . . 61.530000000000001 110.114 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -130.75 130.28 43.57 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.051 0.54 . . . . 65.219999999999999 109.873 173.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 65' ' ' LEU . 36.7 mm -64.78 104.61 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.503 0.721 . . . . 73.510000000000005 110.137 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.6 -37.59 65.38 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.696 0.798 . . . . 72.319999999999993 110.601 172.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.6 t -162.66 159.04 23.95 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.287 0.635 . . . . 62.219999999999999 111.829 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.42 150.52 39.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.518 1.127 . . . . 61.509999999999998 110.645 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -154.54 134.0 12.68 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 112.02 0.378 . . . . 63.530000000000001 112.02 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -93.59 96.57 9.94 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.105 -0.702 . . . . 73.329999999999998 109.105 172.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.8 t -137.09 154.4 50.32 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.621 0.768 . . . . 64.319999999999993 111.68 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.2 m -80.11 119.21 22.6 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.055 -0.72 . . . . 72.420000000000002 109.055 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.416 HG21 HG21 ' A' ' 53' ' ' ILE . 24.8 m -108.65 136.42 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.811 0.845 . . . . 71.140000000000001 110.728 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.07 146.62 36.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.358 1.075 . . . . 72.109999999999999 112.912 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.7 ttp -108.03 118.93 38.03 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 113.466 -1.697 . . . . 73.450000000000003 106.825 165.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.2 m -127.99 173.27 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 112.699 0.629 . . . . 74.310000000000002 112.699 -170.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.69 ' HB2' ' HD3' ' A' ' 111' ' ' LYS . 4.8 p-10 -138.16 133.48 33.38 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.127 0.571 . . . . 75.319999999999993 110.441 172.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.445 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 47.7 p90 -151.18 177.23 10.42 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.165 0.586 . . . . 75.420000000000002 111.571 -174.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.2 m -111.59 112.34 23.99 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.291 -1.003 . . . . 63.310000000000002 108.291 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.5 p -59.01 116.57 3.9 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.3 0.64 . . . . 54.43 111.281 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.4 p -58.07 -32.81 68.4 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.846 1.258 . . . . 75.319999999999993 113.876 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.4 p -87.82 -45.13 10.57 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.262 0.467 . . . . 73.200000000000003 112.262 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -89.04 -31.89 17.85 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.401 0.68 . . . . 74.519999999999996 112.548 -169.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.14 -6.1 83.82 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 116.228 -0.442 . . . . 31.219999999999999 113.592 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -77.26 132.76 38.84 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.161 0.984 . . . . 75.329999999999998 112.142 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -80.27 94.15 6.03 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.476 0.71 . . . . 73.129999999999995 109.395 174.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 113' ' ' HIS . 58.5 t -77.35 104.62 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.234 -0.893 . . . . 72.420000000000002 109.713 -176.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.69 ' HD3' ' HB2' ' A' ' 100' ' ' ASP . 74.9 mmtt -99.93 133.75 43.85 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.597 0.759 . . . . 73.230000000000004 111.697 -172.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 m120 61.58 35.66 17.19 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.299 1.04 . . . . 51.009999999999998 112.21 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.447 ' HB2' HG12 ' A' ' 110' ' ' VAL . 86.3 t60 -58.78 129.52 42.5 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.98 0.912 . . . . 63.109999999999999 112.23 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 19.2 ptpt -152.49 147.45 26.25 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.899 0.88 . . . . 64.310000000000002 110.787 -176.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 97.6 m95 -109.14 138.48 45.43 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.33 1.452 . . . . 73.420000000000002 111.77 -4.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.78 172.38 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.438 1.095 . . . . 72.120000000000005 108.895 170.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 120' ' ' GLU . 30.3 p -118.58 178.22 4.54 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.362 0.665 . . . . 61.299999999999997 111.01 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -67.28 -28.18 67.8 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.455 0.302 . . . . 74.510000000000005 111.385 174.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.42 -15.27 53.25 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 122.939 0.496 . . . . 72.040000000000006 111.754 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.627 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 4.7 mm-40 -81.19 -18.82 44.89 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.199 0.523 . . . . 70.420000000000002 110.407 171.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.0 mt -115.05 159.18 21.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.024 0.93 . . . . 75.299999999999997 110.593 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.1 m -137.71 138.18 39.08 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.019 -1.104 . . . . 60.299999999999997 108.019 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.548 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -57.38 158.08 5.95 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.73 0.695 . . . . 63.439999999999998 111.454 176.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.3 tptm . . . . . 0 N--CA 1.491 1.605 0 C-N-CA 122.924 0.49 . . . . 64.450000000000003 112.026 -178.219 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.519 ' HB3' HG21 ' A' ' 24' ' ' VAL . 24.9 mmt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.535 0.207 . . . . 71.439999999999998 110.93 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -70.97 157.14 38.72 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.464 1.105 . . . . 65.340000000000003 111.212 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -62.23 127.57 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 C-N-CA 122.589 0.356 . . . . 75.239999999999995 110.868 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.44 -3.62 56.52 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.246 0.45 . . . . 70.219999999999999 113.412 -175.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.8 t -73.15 127.85 33.78 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.229 0.612 . . . . 45.450000000000003 111.82 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -87.58 109.92 19.99 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.341 0.656 . . . . 74.420000000000002 110.14 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.427 HG21 HD13 ' A' ' 121' ' ' LEU . 30.4 m -125.99 157.66 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 124.011 0.924 . . . . 74.099999999999994 111.074 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.2 mm -105.54 136.99 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.344 1.057 . . . . 70.319999999999993 109.241 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 17' ' ' MET . 54.0 mt -76.76 118.43 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 CA-C-O 120.759 0.314 . . . . 74.219999999999999 110.192 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -84.54 -59.27 2.42 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.04 0.936 . . . . 71.420000000000002 110.127 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 94.0 m -91.88 139.69 30.41 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.527 -0.76 . . . . 71.340000000000003 109.767 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 14' ' ' MET . 80.6 p -130.34 122.42 27.86 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.091 0.472 . . . . 60.43 111.707 -174.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -83.12 -44.86 14.64 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.565 -0.902 . . . . 74.239999999999995 108.565 171.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.462 ' O ' ' HB2' ' A' ' 12' ' ' SER . 1.8 mpt? -94.18 130.9 40.22 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 114.164 -1.38 . . . . 63.420000000000002 107.536 166.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -63.0 -24.2 67.81 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 119.363 0.983 . . . . 65.230000000000004 113.234 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.01 -4.61 68.01 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 114.694 0.638 . . . . 53.229999999999997 114.694 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.432 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 35.0 mtp -84.97 -29.73 24.84 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.308 0.643 . . . . 73.200000000000003 110.722 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -67.94 117.73 10.2 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.571 0.348 . . . . 73.109999999999999 111.075 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.2 1.09 90.48 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 116.087 -0.506 . . . . 34.109999999999999 113.645 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.92 135.46 43.28 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.239 0.616 . . . . 72.329999999999998 111.141 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -82.29 103.94 12.24 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.641 -0.709 . . . . 73.409999999999997 110.323 -176.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.33 160.48 14.25 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.059 0.943 . . . . 70.439999999999998 113.301 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.3 m -133.14 136.36 45.73 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.841 1.257 . . . . 74.209999999999994 108.611 171.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.519 HG21 ' HB3' ' A' ' 1' ' ' MET . 61.1 t -82.66 111.19 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 122.888 0.475 . . . . 61.219999999999999 110.868 -177.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.5 p -86.32 -19.9 29.14 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.824 0.45 . . . . 72.519999999999996 111.571 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.34 166.45 39.23 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 113.843 0.297 . . . . 54.229999999999997 113.843 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.63 138.51 47.39 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.091 0.957 . . . . 73.25 110.935 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.457 ' HB2' HG23 ' A' ' 96' ' ' VAL . 42.8 m-85 -128.55 111.84 13.67 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.32 1.048 . . . . 65.019999999999996 109.756 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -97.91 79.24 2.62 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.874 0.845 . . . . 72.400000000000006 110.401 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -133.91 170.89 14.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.658 0.783 . . . . 73.019999999999996 111.624 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -73.74 121.26 20.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.977 0.511 . . . . 65.239999999999995 109.879 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.35 147.86 43.08 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.638 0.775 . . . . 63.409999999999997 110.383 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -131.96 154.56 49.17 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.163 0.982 . . . . 75.329999999999998 112.591 -167.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 90' ' ' SER . 64.6 t -105.14 133.66 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 113.729 -1.578 . . . . 70.439999999999998 107.62 167.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.43 ' HA ' ' H ' ' A' ' 89' ' ' ASP . 12.5 m -131.18 166.03 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.8 0.809 . . . . 74.549999999999997 112.788 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.2 t -132.92 127.78 35.07 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 114.38 -1.282 . . . . 71.120000000000005 108.658 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.52 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 43.8 p90 -155.87 160.27 40.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.596 0.758 . . . . 74.230000000000004 111.062 -171.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.1 m -109.28 119.48 48.31 Favored Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 108.783 -0.821 . . . . 65.209999999999994 108.783 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.27 133.17 45.0 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.127 1.885 . . . . 60.399999999999999 111.902 172.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.8 p -65.19 -7.28 12.02 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.99 0.916 . . . . 72.049999999999997 113.081 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.33 -18.0 60.29 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 124.728 1.211 . . . . 71.040000000000006 113.046 171.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.69 57.46 3.54 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 111.624 -0.59 . . . . 75.519999999999996 111.624 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.47 -155.56 8.16 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 115.007 -0.597 . . . . 72.040000000000006 113.005 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -69.48 119.05 13.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.469 0.708 . . . . 61.240000000000002 110.808 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -56.95 116.28 3.11 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 109.317 -0.623 . . . . 73.349999999999994 109.317 168.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.492 HG12 ' HB2' ' A' ' 49' ' ' HIS . 40.7 t -88.67 115.51 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 123.311 0.645 . . . . 74.430000000000007 110.154 -176.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -109.35 155.69 20.91 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.376 0.671 . . . . 50.409999999999997 110.491 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.2 m170 57.82 26.4 13.15 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.902 0.881 . . . . 70.400000000000006 112.376 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.492 ' HB2' HG12 ' A' ' 46' ' ' VAL . 84.9 t60 -71.65 136.95 47.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.811 0.844 . . . . 74.230000000000004 110.908 -178.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 65.1 pttt -158.11 148.71 20.56 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-N 116.313 -0.403 . . . . 63.439999999999998 111.508 -176.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 82.4 m95 -107.59 147.75 30.2 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.022 1.329 . . . . 72.049999999999997 111.471 -0.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.92 135.5 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.436 1.095 . . . . 74.230000000000004 108.272 172.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.5 pt -115.53 169.98 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.284 -0.885 . . . . 71.439999999999998 112.754 -168.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -50.85 -39.76 54.42 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.299 1.039 . . . . 73.310000000000002 113.791 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -72.61 -20.86 61.21 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.479 0.712 . . . . 60.299999999999997 111.882 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.531 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 27.3 tt0 -91.98 -24.76 19.14 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.59 0.756 . . . . 73.209999999999994 111.446 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.1 mt -101.22 129.36 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.867 0.867 . . . . 65.299999999999997 110.35 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -72.02 -57.09 4.58 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.581 0.705 . . . . 64.140000000000001 111.567 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.99 -2.99 6.02 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.687 1.195 . . . . 74.040000000000006 113.98 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.499 ' HA ' HD11 ' A' ' 65' ' ' LEU . . . -39.53 -58.34 1.29 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.126 1.37 . . . . 71.549999999999997 114.166 171.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.07 27.6 73.5 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 114.76 0.664 . . . . 72.040000000000006 114.76 174.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 63.17 16.56 9.48 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.686 1.194 . . . . 63.140000000000001 113.561 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 14.5 ptpt -105.6 167.94 9.43 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 122.882 0.473 . . . . 74.209999999999994 111.18 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.4 m -82.87 108.95 16.58 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.742 -0.836 . . . . 73.219999999999999 108.742 169.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.639 ' HB3' HG13 ' A' ' 88' ' ' ILE . 86.9 mt -75.91 138.37 40.99 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.47 -0.567 . . . . 70.109999999999999 109.47 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -118.19 161.39 35.1 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 123.713 0.805 . . . . 73.329999999999998 111.275 -169.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 71.3 Cg_exo -44.71 106.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.082 2.521 . . . . 73.040000000000006 113.937 171.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.48 -12.8 15.86 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 114.901 0.72 . . . . 60.210000000000001 114.901 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.95 100.46 1.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.252 1.026 . . . . 71.140000000000001 111.305 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -79.93 122.58 26.87 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 115.996 -0.547 . . . . 70.299999999999997 110.726 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.98 173.14 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 125.115 1.366 . . . . 73.239999999999995 111.68 -170.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.0 mm -115.13 139.79 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 123.845 0.858 . . . . 74.340000000000003 110.41 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.28 123.31 35.52 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.758 0.823 . . . . 63.450000000000003 111.76 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -79.98 -44.87 19.45 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.827 0.851 . . . . 60.109999999999999 112.457 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.531 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -83.56 174.17 10.8 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.27 0.557 . . . . 74.010000000000005 111.542 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 80.0 p -143.73 126.28 15.92 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.05 -0.523 . . . . 71.349999999999994 111.055 175.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.507 ' H ' ' HG2' ' A' ' 81' ' ' MET . 19.9 m-70 -91.5 -23.48 19.94 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.991 0.916 . . . . 65.340000000000003 110.868 171.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -155.96 -176.9 6.2 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.838 0.855 . . . . 74.530000000000001 110.839 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -65.74 131.63 46.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.411 0.684 . . . . 74.129999999999995 112.213 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.64 10.93 84.61 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 115.871 -0.604 . . . . 65.25 114.567 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.507 ' HG2' ' H ' ' A' ' 77' ' ' HIS . 11.6 tpt -84.97 -52.43 5.99 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.58 0.752 . . . . 75.430000000000007 110.644 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 86.9 tttt -66.54 129.0 38.38 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.387 0.675 . . . . 65.129999999999995 111.379 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.11 -9.25 73.34 Favored Glycine 0 N--CA 1.476 1.316 0 O-C-N 123.004 0.19 . . . . 54.520000000000003 113.186 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 152.84 30.58 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.386 0.675 . . . . 65.530000000000001 111.118 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.7 m -90.26 120.07 31.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.228 -0.897 . . . . 64.329999999999998 109.774 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -104.15 162.97 12.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.885 0.874 . . . . 42.439999999999998 109.428 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -137.71 126.95 24.56 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.055 -0.72 . . . . 70.219999999999999 109.055 168.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.639 HG13 ' HB3' ' A' ' 65' ' ' LEU . 26.1 mm -60.47 110.27 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.381 0.672 . . . . 54.420000000000002 110.357 -177.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.43 ' H ' ' HA ' ' A' ' 35' ' ' VAL . 22.7 t70 -77.93 -36.37 49.41 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.167 0.987 . . . . 71.400000000000006 110.284 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.526 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 47.3 t -160.1 163.27 33.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.353 1.061 . . . . 73.310000000000002 110.277 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.64 148.12 51.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.493 0.717 . . . . 75.540000000000006 111.535 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -156.05 148.27 23.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.302 0.482 . . . . 62.420000000000002 112.302 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.51 95.44 7.0 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 107.757 -1.201 . . . . 73.140000000000001 107.757 163.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 t -136.26 154.55 50.87 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.302 0.641 . . . . 73.120000000000005 110.317 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.8 m -84.99 120.48 26.57 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.383 -0.599 . . . . 35.030000000000001 109.383 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.457 HG23 ' HB2' ' A' ' 28' ' ' TYR . 13.4 m -107.67 132.68 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.875 -0.787 . . . . 72.230000000000004 108.875 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.538 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 96.3 m-85 -109.62 166.7 10.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.489 1.138 . . . . 73.200000000000003 112.648 -171.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.2 ttp -120.96 111.09 17.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 112.832 -1.986 . . . . 64.109999999999999 107.199 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.26 147.11 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 112.921 0.711 . . . . 74.019999999999996 112.921 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 111' ' ' LYS . 4.6 p30 -105.51 138.03 42.38 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.612 0.765 . . . . 55.439999999999998 110.165 172.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -156.69 178.25 10.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.642 0.777 . . . . 73.400000000000006 111.126 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.0 m -118.11 114.57 23.29 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.438 0.695 . . . . 71.439999999999998 109.242 173.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -56.85 109.3 0.61 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.679 0.792 . . . . 75.409999999999997 111.02 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.8 p -54.47 -31.17 55.2 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.669 1.188 . . . . 73.030000000000001 113.293 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.6 m -64.54 -60.77 2.75 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.392 0.677 . . . . 45.329999999999998 112.313 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 36.2 m -101.92 -12.95 17.83 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.296 0.85 . . . . 64.400000000000006 113.296 -166.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.5 12.32 83.76 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 113.723 0.249 . . . . 63.240000000000002 113.723 -172.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -71.38 125.51 27.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.709 0.804 . . . . 72.450000000000003 112.314 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -75.98 96.8 3.85 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.786 0.435 . . . . 75.310000000000002 109.94 171.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.65 107.88 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 109.458 -0.571 . . . . 74.409999999999997 109.458 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 92.5 mttt -106.78 143.84 34.29 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.647 0.379 . . . . 75.099999999999994 110.948 -174.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 54.62 39.43 31.22 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.151 0.981 . . . . 43.439999999999998 113.151 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -61.79 131.74 50.84 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.646 0.778 . . . . 75.430000000000007 111.399 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 97.5 mttt -134.76 146.61 49.54 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.301 1.04 . . . . 65.120000000000005 110.492 -175.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 85.1 m95 -109.54 127.55 54.56 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.658 1.583 . . . . 73.439999999999998 110.513 -10.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.6 m -119.63 162.09 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 C-N-CA 124.452 1.101 . . . . 53.5 109.814 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 50.0 p -117.82 171.12 8.27 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.931 0.715 . . . . 71.540000000000006 112.931 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.538 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 38.0 tt0 -67.18 -32.17 73.08 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.715 0.806 . . . . 42.240000000000002 111.891 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -70.76 -20.12 62.65 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.245 0.618 . . . . 73.430000000000007 111.948 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -91.87 4.06 53.76 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.602 0.761 . . . . 71.150000000000006 111.666 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.427 HD13 HG21 ' A' ' 7' ' ' VAL . 81.8 mt -121.11 171.92 8.34 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.861 1.265 . . . . 75.239999999999995 109.612 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.8 m -147.22 122.54 10.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.681 0.792 . . . . 62.149999999999999 109.962 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.08 111.11 4.27 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.885 0.474 . . . . 72.530000000000001 110.871 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp . . . . . 0 CA--C 1.553 1.063 0 CA-C-O 121.486 0.66 . . . . 75.450000000000003 110.899 -176.872 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mmt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.695 0.283 . . . . 75.310000000000002 111.037 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -105.92 157.99 17.09 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.576 0.75 . . . . 74.340000000000003 109.913 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.97 122.76 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 CA-C-O 121.193 0.521 . . . . 70.140000000000001 110.118 170.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.77 -6.52 48.43 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-N 115.323 -0.853 . . . . 72.319999999999993 112.966 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.7 m -75.15 128.15 34.83 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.019 0.527 . . . . 24.140000000000001 111.559 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -85.57 117.58 24.56 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.282 -1.007 . . . . 72.140000000000001 108.282 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.09 150.84 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.287 0.635 . . . . 71.530000000000001 111.777 -174.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.1 mm -98.77 128.55 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.364 1.065 . . . . 70.219999999999999 108.406 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.3 mt -91.58 115.89 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.872 -0.418 . . . . 74.129999999999995 109.872 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -93.36 -24.44 18.09 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.065 0.546 . . . . 72.310000000000002 112.306 -171.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 m -110.62 142.57 42.3 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.401 0.68 . . . . 62.130000000000003 109.594 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 14' ' ' MET . 78.0 p -123.62 120.26 32.27 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.827 0.677 . . . . 64.219999999999999 112.827 -173.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -84.81 -41.75 15.8 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.23 1.012 . . . . 73.230000000000004 108.503 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.471 ' O ' ' HB2' ' A' ' 12' ' ' SER . 24.1 mmt -100.65 137.26 39.29 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.057 0.943 . . . . 73.319999999999993 108.698 167.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.509 ' HG3' HG21 ' A' ' 105' ' ' THR . 17.6 ptpt -60.65 -31.23 70.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.22 0.822 . . . . 74.219999999999999 113.22 -175.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.04 0.59 72.42 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 114.062 0.385 . . . . 74.299999999999997 114.062 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.6 ttp -99.04 -15.44 19.04 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.053 0.541 . . . . 63.200000000000003 110.893 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -65.96 117.0 7.69 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.171 0.588 . . . . 75.549999999999997 110.16 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.71 2.51 70.12 Favored Glycine 0 CA--C 1.542 1.772 0 N-CA-C 114.358 0.503 . . . . 54.340000000000003 114.358 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.38 146.34 43.06 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 117.575 0.687 . . . . 65.409999999999997 112.76 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -85.21 131.2 34.46 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.672 0.789 . . . . 72.329999999999998 110.219 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.6 172.1 13.15 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.314 0.857 . . . . 74.140000000000001 113.314 -170.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.7 m -140.72 138.2 34.04 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.02 0.928 . . . . 74.230000000000004 109.801 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -81.76 112.93 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.371 0.669 . . . . 73.219999999999999 109.974 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.9 p -99.55 -4.99 29.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.749 0.82 . . . . 63.399999999999999 112.297 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.85 149.6 17.07 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 120.09 -0.283 . . . . 55.310000000000002 112.56 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.75 114.46 10.52 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.525 0.73 . . . . 75.0 110.464 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -115.42 111.92 21.53 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.972 0.909 . . . . 74.219999999999999 111.233 -173.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.97 80.28 5.76 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 122.163 0.982 . . . . 62.009999999999998 109.856 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -133.61 174.63 10.22 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 115.69 -0.686 . . . . 64.219999999999999 111.987 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.1 m -82.5 119.53 24.34 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.894 0.478 . . . . 65.209999999999994 109.87 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.96 162.63 13.42 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.639 1.176 . . . . 63.409999999999997 109.286 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -139.54 149.02 43.4 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.683 0.754 . . . . 73.439999999999998 111.26 -173.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.9 121.13 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 106.677 -1.601 . . . . 71.400000000000006 106.677 168.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.404 HG12 HD13 ' A' ' 88' ' ' ILE . 17.0 m -124.3 151.35 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 118.881 0.764 . . . . 62.409999999999997 112.681 -175.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.5 p -119.52 125.45 48.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.168 0.987 . . . . 74.439999999999998 109.132 171.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.458 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 49.4 p90 -147.46 152.6 38.35 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.702 0.401 . . . . 74.400000000000006 112.057 -172.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.9 m -99.17 106.61 39.62 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 108.122 -1.066 . . . . 72.299999999999997 108.122 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.11 146.1 23.81 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.55 2.833 . . . . 53.229999999999997 113.984 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.5 p -66.09 -16.57 64.05 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.79 0.836 . . . . 71.049999999999997 112.554 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.57 -20.82 65.96 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 123.224 0.609 . . . . 64.319999999999993 111.292 170.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.06 14.72 76.48 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.682 -0.69 . . . . 40.350000000000001 114.483 172.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.53 -112.55 0.37 Allowed Glycine 0 CA--C 1.539 1.583 0 CA-C-N 117.272 0.536 . . . . 72.540000000000006 113.536 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -106.53 142.75 35.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.355 0.662 . . . . 74.25 111.259 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -66.91 133.94 51.02 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.374 0.669 . . . . 74.049999999999997 111.687 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.6 t -91.48 118.8 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 124.1 0.96 . . . . 65.030000000000001 110.099 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -102.1 138.28 39.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.324 0.65 . . . . 64.409999999999997 110.493 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 m170 57.28 41.92 25.97 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.191 0.996 . . . . 75.439999999999998 113.351 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -67.1 124.18 22.33 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 116.07 -0.514 . . . . 71.540000000000006 110.654 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 31.3 mtmm -131.49 144.59 51.25 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.86 0.864 . . . . 73.129999999999995 110.216 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 94.4 m95 -112.69 141.66 46.22 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.347 1.459 . . . . 75.510000000000005 110.624 -9.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.86 142.48 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.696 -0.853 . . . . 70.230000000000004 108.696 170.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.1 pt -110.55 167.34 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 O-C-N 121.934 -0.479 . . . . 74.310000000000002 110.862 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -53.65 -35.02 60.54 Favored 'General case' 0 CA--C 1.563 1.442 0 C-N-CA 123.976 0.91 . . . . 64.099999999999994 113.201 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -67.21 -24.95 65.89 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.415 0.686 . . . . 70.340000000000003 112.296 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -91.44 1.47 57.1 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.548 0.739 . . . . 75.310000000000002 112.096 -175.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.7 mt -108.78 131.65 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.904 0.882 . . . . 64.310000000000002 110.151 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -72.65 -42.42 64.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.056 0.942 . . . . 74.129999999999995 112.019 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -78.71 -10.4 59.75 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.701 0.8 . . . . 73.340000000000003 112.35 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -43.45 -58.33 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.872 1.064 . . . . 72.010000000000005 113.872 -173.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.94 31.31 78.03 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 116.502 1.361 . . . . 73.430000000000007 116.502 167.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.8 t70 73.76 -10.58 1.06 Allowed 'General case' 0 CA--C 1.578 2.027 0 C-N-CA 124.551 1.14 . . . . 62.350000000000001 113.06 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 24.2 pttm -90.53 153.68 20.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.497 -0.752 . . . . 70.150000000000006 110.865 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.7 m -85.87 129.82 34.72 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.183 0.593 . . . . 73.439999999999998 109.645 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.8 mt -88.79 146.21 25.13 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.508 0.723 . . . . 72.150000000000006 111.492 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -116.58 158.68 42.81 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 124.966 1.306 . . . . 71.319999999999993 109.523 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.65 114.04 1.51 Allowed 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.621 2.214 . . . . 52.229999999999997 112.991 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.02 -17.52 12.79 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 115.23 -0.895 . . . . 72.150000000000006 114.426 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.0 125.99 27.73 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 117.936 0.868 . . . . 52.340000000000003 111.131 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.55 124.95 50.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.286 0.635 . . . . 63.530000000000001 109.913 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.71 174.74 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.84 1.256 . . . . 75.540000000000006 111.307 -169.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.3 mm -111.7 142.31 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 123.364 0.666 . . . . 74.109999999999999 109.741 170.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.1 mt -89.41 126.99 35.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.469 0.708 . . . . 74.439999999999998 112.26 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -87.29 -22.89 24.88 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.833 0.853 . . . . 73.219999999999999 111.847 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.86 158.93 19.83 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.048 0.451 . . . . 60.149999999999999 111.831 174.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.678 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 25.4 t -137.86 122.86 19.05 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.278 -0.874 . . . . 51.310000000000002 108.707 169.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -107.26 -9.52 16.06 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.045 0.538 . . . . 75.239999999999995 111.048 173.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.7 mtm -138.15 -175.75 4.21 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.588 1.155 . . . . 71.510000000000005 110.31 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -72.84 131.72 42.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 122.017 -0.427 . . . . 74.0 110.898 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.22 20.28 60.49 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 114.574 0.59 . . . . 74.019999999999996 114.574 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -77.89 -43.26 30.66 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.6 0.76 . . . . 73.549999999999997 110.954 -174.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 88.8 tttt -65.36 134.85 54.43 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.975 0.51 . . . . 65.299999999999997 111.55 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.66 65.11 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.178 -0.464 . . . . 42.149999999999999 112.8 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.91 143.18 56.99 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.571 0.748 . . . . 43.219999999999999 112.243 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.0 m -77.95 105.92 9.47 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.737 -0.665 . . . . 61.43 109.931 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -103.77 150.11 24.39 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.23 1.012 . . . . 44.43 110.946 -172.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.43 128.98 44.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.319 -0.623 . . . . 75.549999999999997 109.319 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.404 HD13 HG12 ' A' ' 35' ' ' VAL . 38.0 mm -64.77 106.47 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 122.891 0.477 . . . . 74.430000000000007 110.009 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.39 -36.25 58.19 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.911 0.885 . . . . 71.099999999999994 109.991 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.1 t -158.57 147.78 19.09 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.661 0.784 . . . . 43.109999999999999 110.563 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.14 133.3 56.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.467 0.707 . . . . 72.099999999999994 110.55 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -145.07 123.76 12.55 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.734 0.814 . . . . 73.519999999999996 111.139 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.26 97.19 10.97 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.238 -0.653 . . . . 63.009999999999998 109.238 175.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.5 t -135.54 154.71 51.29 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.756 0.822 . . . . 71.530000000000001 111.108 -173.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.2 m -81.98 120.72 25.6 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.62 -0.881 . . . . 75.319999999999993 108.62 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.486 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 11.4 m -110.48 133.33 56.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.892 0.877 . . . . 74.109999999999999 108.952 -176.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.07 145.26 38.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.192 0.997 . . . . 75.030000000000001 111.511 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.7 ttm -92.51 120.87 33.4 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.31 -1.367 . . . . 60.340000000000003 107.31 166.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.69 152.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.627 0.771 . . . . 73.140000000000001 111.814 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -117.81 114.4 23.22 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.298 1.039 . . . . 65.5 109.002 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -129.0 170.48 13.41 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.48 0.657 . . . . 75.409999999999997 112.203 -174.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.0 m -114.02 127.78 56.1 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.06 -0.719 . . . . 55.329999999999998 109.06 170.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.9 t -64.7 125.52 25.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.962 0.905 . . . . 73.540000000000006 112.548 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 70.5 p -71.23 -36.67 71.9 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.937 0.895 . . . . 54.520000000000003 112.424 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.509 HG21 ' HG3' ' A' ' 15' ' ' LYS . 11.0 t -80.12 -40.0 28.34 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.946 0.721 . . . . 70.219999999999999 112.946 -175.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.6 p -113.83 -24.84 8.91 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 112.332 0.493 . . . . 73.340000000000003 112.332 -172.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.15 7.56 80.0 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-O 119.89 -0.395 . . . . 55.200000000000003 113.877 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -78.99 133.34 36.85 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 117.288 0.544 . . . . 74.430000000000007 111.323 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -83.09 109.74 17.41 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 109.206 -0.665 . . . . 72.209999999999994 109.206 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.23 127.09 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.975 0.91 . . . . 55.539999999999999 110.704 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.84 157.36 27.75 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.503 0.721 . . . . 72.329999999999998 111.548 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.66 30.67 19.22 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.428 1.091 . . . . 71.230000000000004 111.616 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -73.76 135.84 43.59 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.053 0.541 . . . . 73.019999999999996 111.179 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -164.41 154.46 14.31 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 122.964 0.505 . . . . 70.129999999999995 111.903 -172.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.486 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 81.9 m95 -106.53 137.14 45.08 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.747 1.619 . . . . 72.030000000000001 112.039 1.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 m -120.23 144.44 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.279 1.032 . . . . 61.450000000000003 109.452 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.3 p -100.31 178.41 4.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.487 -0.758 . . . . 61.399999999999999 112.014 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -56.38 -50.81 70.48 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.338 1.055 . . . . 71.0 112.336 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -66.53 -17.9 65.07 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.591 0.756 . . . . 71.319999999999993 113.02 -178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -90.37 -6.2 55.29 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.062 0.545 . . . . 72.319999999999993 111.482 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 75.2 mt -115.23 160.7 19.42 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.376 1.07 . . . . 75.519999999999996 109.47 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -146.6 120.75 9.48 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.166 -0.679 . . . . 70.209999999999994 109.166 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.99 139.87 58.81 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.029 0.531 . . . . 65.340000000000003 112.028 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.5 tptt . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.865 0.84 . . . . 74.150000000000006 110.65 -178.681 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.668 0.271 . . . . 55.240000000000002 110.627 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -101.44 142.28 33.07 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.208 1.003 . . . . 52.420000000000002 110.195 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.85 132.51 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-O 121.038 0.446 . . . . 75.319999999999993 111.077 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.45 -3.57 68.96 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 115.776 -0.647 . . . . 71.530000000000001 112.948 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.0 m -85.1 151.6 24.02 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.773 0.657 . . . . 71.439999999999998 112.773 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -92.89 122.65 35.48 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.97 -1.014 . . . . 65.340000000000003 109.808 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 121' ' ' LEU . 27.0 m -121.56 151.89 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.36 0.664 . . . . 74.120000000000005 109.72 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.7 mm -107.51 134.78 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.43 -0.952 . . . . 65.239999999999995 108.43 172.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.9 mt -75.29 105.57 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.327 0 CA-C-O 120.95 0.405 . . . . 74.099999999999994 109.927 -176.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -83.18 -34.25 26.0 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.931 0.892 . . . . 73.349999999999994 111.034 -172.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.7 m -131.47 141.13 49.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.578 1.151 . . . . 74.230000000000004 108.244 172.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 17' ' ' MET . 95.7 p -143.5 159.3 42.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.855 0.836 . . . . 60.299999999999997 112.366 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -91.29 -17.58 25.72 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 114.114 -1.403 . . . . 72.310000000000002 110.457 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.666 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 53.6 mtt -131.34 144.37 51.2 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.418 1.087 . . . . 71.209999999999994 109.788 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -54.07 -41.23 67.94 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.206 1.187 . . . . 75.030000000000001 114.206 -173.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.33 -11.98 83.63 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 114.339 0.496 . . . . 65.010000000000005 114.339 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.666 ' HG3' ' HB2' ' A' ' 14' ' ' MET . 20.6 mtm -81.24 -29.27 34.5 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.398 0.599 . . . . 73.239999999999995 109.921 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -64.11 122.81 17.48 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 122.739 0.415 . . . . 63.119999999999997 111.008 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.4 1.74 89.25 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 115.694 -0.684 . . . . 73.349999999999994 113.545 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 149.62 31.72 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.776 0.658 . . . . 33.119999999999997 112.776 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -84.66 105.64 15.61 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.17 0.588 . . . . 65.010000000000005 110.251 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.43 154.37 19.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.938 0.895 . . . . 51.109999999999999 111.532 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.5 m -120.84 122.3 39.99 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.362 0.665 . . . . 55.420000000000002 109.661 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -73.27 103.35 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.855 0.462 . . . . 74.420000000000002 109.906 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.4 p -113.94 -5.78 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.482 0.549 . . . . 64.450000000000003 112.482 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.17 123.39 1.75 Allowed Glycine 0 C--N 1.344 1.015 0 N-CA-C 111.834 -0.506 . . . . 71.25 111.834 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.98 116.59 32.22 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.384 0.674 . . . . 54.149999999999999 110.493 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.439 ' HB2' HG23 ' A' ' 96' ' ' VAL . 38.8 m-85 -127.12 119.44 26.53 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.392 0.677 . . . . 73.319999999999993 109.961 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -113.82 87.4 2.61 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.906 0.86 . . . . 74.530000000000001 109.721 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -135.95 179.93 6.05 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.792 0.837 . . . . 74.430000000000007 110.669 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -78.76 123.75 27.5 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 122.022 -0.424 . . . . 71.040000000000006 110.433 176.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.89 126.27 54.93 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.102 0.961 . . . . 74.109999999999999 110.17 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -103.34 150.32 23.9 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.971 0.891 . . . . 74.439999999999998 113.02 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 50' ' ' LYS . 21.7 t -107.49 114.1 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 114.084 -1.416 . . . . 71.319999999999993 107.915 169.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.507 HG12 HD13 ' A' ' 88' ' ' ILE . 34.1 m -125.89 146.7 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 112.908 0.707 . . . . 75.239999999999995 112.908 -170.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.1 m -110.08 131.4 55.09 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.177 0.591 . . . . 75.140000000000001 110.491 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -157.04 159.78 38.3 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.36 0.6 . . . . 72.519999999999996 112.079 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.9 m -111.95 113.78 52.06 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 107.771 -1.196 . . . . 64.109999999999999 107.771 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.83 116.8 2.99 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.003 2.469 . . . . 73.319999999999993 112.108 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 p -68.94 -7.04 31.31 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.329 1.052 . . . . 60.399999999999999 113.745 -169.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -77.8 -3.06 39.52 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 123.433 0.693 . . . . 64.129999999999995 111.585 171.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.02 34.95 8.45 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 122.198 -0.313 . . . . 60.109999999999999 112.319 -173.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.42 -173.48 44.62 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 122.911 0.291 . . . . 72.329999999999998 113.444 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.08 117.47 15.92 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.443 0.697 . . . . 61.219999999999999 110.16 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.56 117.85 2.45 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.512 0.725 . . . . 74.219999999999999 110.969 169.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.96 115.38 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.371 -0.831 . . . . 72.519999999999996 109.609 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -100.38 140.78 34.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.145 0.578 . . . . 72.319999999999993 109.482 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.8 m170 57.92 39.58 26.55 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.423 0.689 . . . . 64.340000000000003 112.396 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -61.22 131.71 51.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.352 1.061 . . . . 72.540000000000006 111.455 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HB3' HG22 ' A' ' 34' ' ' VAL . 25.2 pttm -149.13 148.49 29.73 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.288 -0.869 . . . . 64.340000000000003 109.665 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 92.1 m95 -109.95 135.88 50.1 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.456 -1.402 . . . . 64.420000000000002 111.502 0.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.01 147.15 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.782 1.233 . . . . 73.109999999999999 108.306 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.3 pt -111.47 167.17 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 122.046 -0.409 . . . . 70.409999999999997 111.669 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -53.96 -36.18 62.59 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.943 0.897 . . . . 75.510000000000005 113.265 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -70.24 -19.24 63.14 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 123.464 0.706 . . . . 62.140000000000001 112.092 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -94.54 8.28 42.77 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.589 0.756 . . . . 72.109999999999999 112.442 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.5 mt -124.23 136.64 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.692 0.797 . . . . 64.239999999999995 110.631 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -72.08 -53.72 11.96 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.796 0.839 . . . . 62.520000000000003 111.614 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.08 -3.96 11.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.705 1.202 . . . . 63.310000000000002 113.381 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -41.23 -46.75 3.22 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.534 1.309 . . . . 73.25 114.534 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.69 19.06 68.88 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.924 1.13 . . . . 71.209999999999994 115.924 165.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 66.19 11.17 7.68 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.051 1.341 . . . . 71.030000000000001 112.801 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -110.47 167.93 9.84 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.016 0.926 . . . . 71.25 110.817 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.3 m -82.93 118.17 23.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.487 -0.931 . . . . 71.239999999999995 108.487 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.606 HD13 HG11 ' A' ' 71' ' ' VAL . 76.4 mt -74.48 118.3 17.28 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.315 0.579 . . . . 42.130000000000003 110.24 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -110.91 155.25 42.72 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.426 1.091 . . . . 73.099999999999994 110.712 -169.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 76.1 Cg_exo -45.64 111.84 0.36 Allowed 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.702 2.935 . . . . 70.439999999999998 114.506 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.44 -11.54 16.43 Favored Glycine 0 N--CA 1.485 1.963 0 CA-C-N 116.182 -0.463 . . . . 73.310000000000002 113.938 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -79.88 124.04 28.3 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.386 0.593 . . . . 64.340000000000003 111.222 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -98.23 122.18 41.07 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.742 -0.836 . . . . 63.399999999999999 108.742 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.606 HG11 HD13 ' A' ' 65' ' ' LEU . 32.4 m -121.62 175.81 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.927 0.891 . . . . 74.450000000000003 112.115 -172.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mm -121.65 136.71 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.336 1.055 . . . . 70.5 109.079 170.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.5 mt -83.49 119.19 24.37 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.574 0.75 . . . . 70.299999999999997 111.411 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -81.92 -26.64 33.88 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.526 0.73 . . . . 74.109999999999999 111.473 171.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.51 153.99 25.29 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.029 0.442 . . . . 53.219999999999999 111.152 173.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 42.9 t -142.25 124.31 15.38 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.71 -0.677 . . . . 43.43 110.698 173.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -106.43 -24.86 12.11 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.331 1.053 . . . . 64.319999999999993 109.784 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.2 mtm -127.28 164.64 21.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.083 0.953 . . . . 71.420000000000002 110.867 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.598 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.37 127.92 33.63 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.877 0.471 . . . . 64.450000000000003 111.986 174.395 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.41 14.81 82.11 Favored Glycine 0 N--CA 1.476 1.315 0 N-CA-C 114.328 0.491 . . . . 64.340000000000003 114.328 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.4 ttt -84.71 -40.9 16.78 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 117.632 0.716 . . . . 63.509999999999998 110.739 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.438 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 21.0 tptm -66.53 119.57 11.91 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.209 -0.663 . . . . 54.439999999999998 109.209 166.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.55 74.66 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 116.063 -0.517 . . . . 70.129999999999995 112.914 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.31 137.63 46.81 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.753 0.776 . . . . 44.25 111.529 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 78.7 m -79.09 114.55 18.12 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.176 0.59 . . . . 72.409999999999997 109.531 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.67 157.24 21.49 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.785 0.834 . . . . 44.530000000000001 109.739 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -129.42 131.88 46.87 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.79 -0.819 . . . . 65.349999999999994 108.79 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.561 HG13 ' HB3' ' A' ' 65' ' ' LEU . 24.3 mm -74.27 107.5 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.28 0.632 . . . . 64.349999999999994 110.724 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -68.91 -39.72 79.53 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.926 0.394 . . . . 75.209999999999994 110.662 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.0 t -164.41 157.36 17.33 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.207 -0.906 . . . . 63.530000000000001 111.357 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -114.14 131.27 56.49 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.216 1.007 . . . . 61.329999999999998 109.131 171.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -126.7 135.51 51.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.007 0.523 . . . . 64.329999999999998 111.522 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -97.14 95.77 7.99 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.587 0.708 . . . . 71.140000000000001 109.657 168.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -135.85 148.3 48.6 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.929 -1.032 . . . . 72.519999999999996 109.4 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.4 m -84.24 123.61 30.32 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.221 -0.659 . . . . 53.409999999999997 109.221 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 28' ' ' TYR . 16.1 m -112.87 135.96 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.375 0.67 . . . . 73.299999999999997 109.553 -173.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.43 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 98.2 m-85 -120.03 141.54 49.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.43 0.692 . . . . 64.129999999999995 111.965 -175.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.41 ' SD ' ' HA ' ' A' ' 112' ' ' ASN . 19.4 tmm? -90.14 112.47 23.97 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.879 -1.055 . . . . 72.150000000000006 108.254 169.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.51 160.83 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 112.668 0.618 . . . . 74.319999999999993 112.668 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -119.57 116.98 27.16 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.87 0.868 . . . . 72.430000000000007 108.7 172.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -124.27 165.29 17.89 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 122.96 0.504 . . . . 75.319999999999993 111.918 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.8 m -109.21 111.67 23.41 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.3 0.64 . . . . 72.120000000000005 110.552 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.3 p -58.8 122.48 13.67 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.144 0.577 . . . . 71.519999999999996 111.87 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.7 p -70.91 -23.23 62.23 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.414 1.086 . . . . 73.329999999999998 112.767 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -87.86 -10.73 49.88 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.234 0.828 . . . . 72.010000000000005 113.234 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.4 m -134.74 -40.19 0.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.234 0.614 . . . . 74.430000000000007 111.833 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.81 -1.82 59.9 Favored Glycine 0 N--CA 1.48 1.582 0 CA-C-N 116.197 -0.456 . . . . 54.009999999999998 113.077 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -80.84 140.16 35.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.008 0.923 . . . . 63.130000000000003 111.124 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -96.37 132.81 41.51 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 121.156 0.503 . . . . 73.239999999999995 110.783 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.96 128.39 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.115 1.366 . . . . 64.409999999999997 109.723 -175.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 136.71 42.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.876 0.87 . . . . 71.219999999999999 111.105 -173.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.41 ' HA ' ' SD ' ' A' ' 98' ' ' MET . 11.8 m120 56.0 43.01 27.89 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.694 1.198 . . . . 74.439999999999998 113.84 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -62.3 132.8 53.87 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.672 0.789 . . . . 73.450000000000003 112.104 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 59.4 mttp -133.76 136.35 44.51 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.137 0.975 . . . . 70.099999999999994 111.491 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.7 m95 -114.44 146.11 41.03 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.511 1.524 . . . . 72.400000000000006 111.122 -15.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -119.67 148.23 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.022 0.929 . . . . 74.420000000000002 109.331 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.4 p -97.93 163.96 12.56 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.018 0.748 . . . . 74.239999999999995 113.018 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.43 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 44.0 tt0 -60.99 -33.91 73.98 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.489 1.116 . . . . 75.329999999999998 110.916 173.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.1 -36.84 85.56 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.701 1.2 . . . . 74.340000000000003 112.428 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.99 10.02 38.78 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.202 0.445 . . . . 62.020000000000003 112.202 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.462 HD13 HG21 ' A' ' 7' ' ' VAL . 91.2 mt -120.24 162.27 19.68 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.017 0.927 . . . . 73.400000000000006 109.215 175.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -138.83 120.67 15.4 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.074 0.549 . . . . 73.120000000000005 109.752 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.75 115.25 10.73 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.639 0.376 . . . . 64.099999999999994 110.676 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt . . . . . 0 N--CA 1.478 0.959 0 C-N-CA 122.905 0.482 . . . . 62.32 111.541 -177.348 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.405 ' HB3' HG21 ' A' ' 24' ' ' VAL . 18.7 mmt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 109.725 -0.472 . . . . 60.509999999999998 109.725 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.581 ' HD3' ' H ' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -72.44 158.87 34.94 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 120.965 0.412 . . . . 62.439999999999998 111.824 -179.535 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.81 130.1 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 123.609 0.763 . . . . 53.140000000000001 112.262 -175.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.57 -13.03 47.1 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.268 -0.878 . . . . 55.310000000000002 113.343 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.9 m -82.67 152.9 25.64 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.387 0.675 . . . . 71.209999999999994 111.638 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -108.74 141.03 41.32 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.143 -0.688 . . . . 72.450000000000003 109.143 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 123' ' ' ALA . 33.4 m -135.9 157.63 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.047 0.939 . . . . 61.219999999999999 111.063 -172.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.1 mm -96.46 129.06 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.423 -0.954 . . . . 74.140000000000001 108.423 166.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.716 HD11 ' HB2' ' A' ' 22' ' ' ALA . 48.7 mt -82.65 127.0 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.186 0.594 . . . . 63.219999999999999 109.945 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -96.8 -63.05 1.17 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 120.951 0.405 . . . . 73.450000000000003 110.386 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.8 m -91.79 140.97 29.17 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.13 -0.692 . . . . 72.150000000000006 109.13 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.9 p -132.04 140.42 48.88 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.569 0.7 . . . . 54.009999999999998 112.24 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -85.66 -37.97 18.87 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.02 1.328 . . . . 62.549999999999997 109.326 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 52.0 mtt -99.34 130.53 45.63 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.316 1.046 . . . . 74.219999999999999 109.219 169.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -55.92 -37.98 69.66 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 113.0 0.741 . . . . 75.230000000000004 113.0 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.62 0.8 60.03 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 114.439 0.536 . . . . 75.209999999999994 114.439 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.496 ' HG2' HG21 ' A' ' 9' ' ' ILE . 52.9 ttp -93.3 -25.21 17.85 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.324 0.65 . . . . 71.200000000000003 111.13 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -67.36 123.34 20.1 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.994 0.518 . . . . 71.109999999999999 111.39 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.99 -12.18 66.89 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.658 -0.701 . . . . 75.129999999999995 113.868 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.43 155.42 40.13 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.642 0.777 . . . . 40.310000000000002 112.212 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -91.07 100.28 13.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.302 0.641 . . . . 70.0 110.946 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.716 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -89.65 158.14 17.72 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.78 -0.645 . . . . 72.400000000000006 111.137 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.4 m -131.7 126.01 33.49 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.865 -0.791 . . . . 65.209999999999994 108.865 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' A' ' 1' ' ' MET . 41.3 t -76.57 102.0 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.346 0.658 . . . . 71.150000000000006 110.281 -170.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.2 p -96.25 -10.63 27.52 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.331 0.652 . . . . 72.230000000000004 111.561 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.49 149.09 19.5 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 112.125 -0.39 . . . . 75.010000000000005 112.125 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.06 119.47 15.81 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.645 0.778 . . . . 44.210000000000001 110.694 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -121.92 117.22 25.91 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.852 0.861 . . . . 63.210000000000001 110.445 -172.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -95.49 83.82 3.88 Favored 'General case' 0 CA--C 1.565 1.519 0 CA-C-O 122.236 1.017 . . . . 72.010000000000005 110.645 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -134.39 -178.61 5.13 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.473 0.709 . . . . 73.549999999999997 111.878 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 m -90.87 128.58 36.8 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.714 -0.476 . . . . 64.439999999999998 109.714 170.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.46 157.93 19.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.716 0.806 . . . . 74.530000000000001 110.43 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.491 ' HB2' HG23 ' A' ' 52' ' ' VAL . 97.2 m-85 -135.15 149.55 49.99 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.726 0.774 . . . . 74.109999999999999 111.383 -173.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.54 109.65 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.188 -1.369 . . . . 61.130000000000003 107.439 171.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.483 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 29.6 m -121.82 148.01 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.525 0.679 . . . . 52.310000000000002 112.699 -173.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.1 t -112.3 139.24 48.02 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.915 0.886 . . . . 75.549999999999997 109.152 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -158.92 159.42 34.91 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.171 0.589 . . . . 74.209999999999994 111.777 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.5 m -107.91 108.78 61.78 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 107.29 -1.374 . . . . 52.5 107.29 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -47.59 152.82 2.47 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 123.949 3.099 . . . . 71.310000000000002 115.715 -175.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.8 p -64.92 -24.29 67.48 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.228 1.011 . . . . 43.030000000000001 112.393 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.434 ' ND2' ' H ' ' A' ' 43' ' ' GLY . 1.3 p-10 -67.55 -19.81 65.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.657 0.265 . . . . 75.239999999999995 111.213 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 19.21 71.18 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 114.812 0.685 . . . . 74.120000000000005 114.812 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' H ' ' ND2' ' A' ' 41' ' ' ASN . . . -87.0 -130.18 2.89 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 117.62 0.71 . . . . 74.519999999999996 113.085 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -69.99 129.04 38.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.282 0.633 . . . . 75.420000000000002 111.493 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -58.5 133.16 55.56 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.296 0.638 . . . . 75.209999999999994 111.5 171.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.43 108.85 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.435 0.694 . . . . 70.340000000000003 110.128 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -102.57 148.78 25.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.736 0.814 . . . . 74.140000000000001 111.04 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.3 m80 55.63 33.97 22.29 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.25 1.02 . . . . 71.400000000000006 112.86 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -62.4 122.78 16.56 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.132 0.973 . . . . 63.520000000000003 111.036 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 41.3 mtmt -121.37 143.9 48.95 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.531 0.733 . . . . 73.310000000000002 110.933 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 92.8 m95 -110.55 144.44 39.41 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.295 1.438 . . . . 75.450000000000003 109.4 -14.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 33' ' ' TYR . 25.4 m -115.65 130.06 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 107.748 -1.205 . . . . 74.310000000000002 107.748 169.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.421 HG21 HG21 ' A' ' 96' ' ' VAL . 26.0 pt -104.9 163.69 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 121.794 -0.566 . . . . 65.209999999999994 111.696 -169.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -52.56 -39.19 61.22 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.852 1.261 . . . . 71.010000000000005 113.494 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -73.71 -28.91 61.96 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 120.885 0.374 . . . . 75.510000000000005 111.703 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.515 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 28.1 tt0 -80.38 -13.42 59.17 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.378 1.071 . . . . 74.510000000000005 110.956 -174.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.37 139.9 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 124.369 1.068 . . . . 75.209999999999994 109.84 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -75.58 -55.8 5.32 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.489 0.715 . . . . 72.209999999999994 111.477 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.22 -5.38 13.6 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.161 0.985 . . . . 74.150000000000006 113.285 -175.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.607 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -51.59 -50.24 60.55 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.569 0.951 . . . . 74.239999999999995 113.569 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.51 25.44 71.46 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 114.917 0.727 . . . . 73.25 114.917 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 64.78 16.3 10.34 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 124.831 1.253 . . . . 63.409999999999997 113.434 -175.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 64.1 pttt -115.26 179.65 3.9 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.0 0.52 . . . . 72.219999999999999 111.161 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.2 m -84.75 114.9 22.39 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.691 -0.686 . . . . 62.439999999999998 109.902 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.704 HD13 HG11 ' A' ' 71' ' ' VAL . 70.5 mt -76.29 115.69 16.26 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.624 -0.51 . . . . 64.209999999999994 109.624 170.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -89.6 147.91 38.94 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.474 0.71 . . . . 74.040000000000006 111.643 -168.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.24 116.23 2.15 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.408 2.739 . . . . 73.230000000000004 114.44 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.07 -22.92 11.04 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 115.053 0.781 . . . . 43.420000000000002 115.053 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -79.35 149.1 31.8 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.083 0.942 . . . . 73.230000000000004 112.04 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -107.17 132.82 52.62 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.179 0.592 . . . . 65.430000000000007 111.552 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.704 HG11 HD13 ' A' ' 65' ' ' LEU . 26.8 m -138.73 155.55 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.361 1.065 . . . . 72.439999999999998 111.063 -174.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.07 135.33 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 123.189 0.595 . . . . 71.040000000000006 109.785 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.2 mt -88.33 118.17 27.76 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.974 0.909 . . . . 71.310000000000002 110.837 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -84.12 -3.19 57.93 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 112.808 0.67 . . . . 54.439999999999998 112.808 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.515 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -128.81 173.15 10.61 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.272 0.629 . . . . 65.120000000000005 111.015 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.418 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 66.1 p -149.32 127.77 12.27 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.435 -0.802 . . . . 65.230000000000004 110.998 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -85.27 -14.75 45.66 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.813 0.845 . . . . 72.439999999999998 110.253 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -156.85 -179.04 7.82 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.253 1.021 . . . . 71.219999999999999 111.139 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -67.19 135.88 54.16 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.786 0.662 . . . . 74.049999999999997 112.786 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.33 17.67 76.23 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 115.103 0.801 . . . . 74.129999999999995 115.103 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.7 ttt -90.95 -42.8 10.36 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 117.625 0.713 . . . . 72.450000000000003 111.273 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 4.1 ttpm? -67.79 129.25 39.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.873 0.469 . . . . 64.200000000000003 111.156 175.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.38 -15.72 62.64 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 116.48 -0.327 . . . . 71.239999999999995 112.629 -178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.73 141.99 49.79 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.224 0.61 . . . . 71.329999999999998 111.665 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.7 m -90.36 110.33 21.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.474 -0.936 . . . . 62.350000000000001 108.474 176.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.483 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -98.05 167.94 10.58 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.45 0.7 . . . . 53.130000000000003 110.972 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.22 138.34 52.41 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.969 0.908 . . . . 74.530000000000001 109.281 171.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.459 HD13 HG12 ' A' ' 35' ' ' VAL . 28.0 mm -72.14 120.58 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 123.106 0.562 . . . . 63.310000000000002 110.777 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -85.43 -42.13 14.78 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.925 0.49 . . . . 75.299999999999997 109.757 170.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.0 m -155.11 153.99 31.69 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.975 0.91 . . . . 71.329999999999998 110.841 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.29 146.99 49.79 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.681 0.792 . . . . 61.039999999999999 110.453 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -156.2 131.52 9.4 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.865 0.466 . . . . 61.119999999999997 111.493 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -88.93 96.33 10.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.482 -0.933 . . . . 74.049999999999997 108.482 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.6 t -136.63 153.74 50.84 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.534 0.734 . . . . 74.400000000000006 111.256 -171.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 48.7 m -84.52 123.94 30.83 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.81 -0.441 . . . . 70.409999999999997 109.81 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 18.0 m -113.2 138.8 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.727 0.811 . . . . 72.530000000000001 109.451 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -115.37 150.07 36.93 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.588 0.755 . . . . 61.020000000000003 112.126 -171.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 58.2 ttp -96.36 115.37 27.32 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.421 -1.326 . . . . 74.530000000000001 107.421 163.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.462 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 30.0 m -122.79 160.21 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.219 0.533 . . . . 74.230000000000004 112.413 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -121.94 116.84 25.08 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.369 1.068 . . . . 74.319999999999993 109.591 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -132.47 173.79 10.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.085 0.554 . . . . 65.030000000000001 110.508 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 31.8 m -119.28 116.76 26.91 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.588 -0.523 . . . . 75.420000000000002 109.588 173.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.8 t -54.71 121.88 9.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.456 1.102 . . . . 75.439999999999998 112.408 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p -66.62 -30.44 70.72 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.25 1.02 . . . . 73.230000000000004 112.584 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.7 t -83.17 -34.24 26.04 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.037 0.755 . . . . 71.219999999999999 113.037 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.0 p -106.78 -28.12 10.34 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.567 0.58 . . . . 75.340000000000003 112.567 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.93 9.33 85.5 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 116.611 -0.268 . . . . 44.310000000000002 113.177 -172.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -91.13 138.57 31.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.053 0.941 . . . . 72.209999999999994 110.659 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 5.7 ttpm? -84.88 120.59 26.64 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 120.984 0.421 . . . . 52.009999999999998 110.513 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.67 114.29 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 109.369 -0.604 . . . . 64.150000000000006 109.369 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.25 150.37 29.69 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.008 0.923 . . . . 50.340000000000003 111.208 -171.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 57.28 31.9 20.87 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.382 1.073 . . . . 74.400000000000006 112.243 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -64.41 124.49 21.91 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.249 0.62 . . . . 73.140000000000001 111.649 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 10.2 mtmp? -140.85 140.02 34.55 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 124.177 0.991 . . . . 73.329999999999998 110.681 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 87.8 m95 -112.51 148.53 34.26 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.875 1.67 . . . . 72.109999999999999 111.928 -4.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.8 m -131.47 142.36 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 124.347 1.059 . . . . 74.340000000000003 110.3 174.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 81.3 p -100.41 167.86 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 112.644 0.609 . . . . 44.25 112.644 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -56.12 -38.01 70.21 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.69 1.196 . . . . 73.349999999999994 111.701 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -58.39 -39.87 80.84 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.926 1.29 . . . . 75.430000000000007 112.111 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -88.39 -0.62 57.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.017 0.927 . . . . 75.340000000000003 113.367 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.53 163.86 17.32 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.438 0.695 . . . . 63.329999999999998 110.988 -177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.9 p -145.35 124.08 12.59 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.547 0.739 . . . . 74.340000000000003 110.447 174.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.562 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -66.11 133.47 50.78 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 113.268 0.84 . . . . 53.030000000000001 113.268 -172.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.612 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 C-N-CA 123.652 0.781 . . . . 72.420000000000002 111.077 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 mmt . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.415 -0.587 . . . . 73.120000000000005 109.415 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -113.59 159.32 19.74 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.131 0.572 . . . . 70.409999999999997 110.176 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.1 t -65.22 124.73 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 CA-C-O 121.376 0.608 . . . . 50.350000000000001 111.688 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.32 -2.99 43.37 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 115.559 -0.746 . . . . 62.549999999999997 113.094 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 p -81.56 145.34 30.71 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 117.343 0.571 . . . . 73.230000000000004 112.359 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -94.02 128.74 40.54 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.583 0.753 . . . . 65.549999999999997 110.276 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.529 HG21 HD13 ' A' ' 121' ' ' LEU . 29.5 m -131.35 152.88 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.639 0.776 . . . . 72.25 110.111 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.1 mm -102.76 132.6 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.521 0.728 . . . . 72.430000000000007 109.241 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.6 mt -78.85 113.02 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 C-N-CA 122.739 0.416 . . . . 72.140000000000001 109.915 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.492 HD22 ' HB2' ' A' ' 122' ' ' SER . 33.9 p30 -91.49 -31.07 16.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 122.002 -0.437 . . . . 54.109999999999999 111.672 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.2 m -125.88 141.16 52.11 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.256 1.022 . . . . 74.310000000000002 109.905 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 m -154.1 139.66 17.85 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.987 0.515 . . . . 53.119999999999997 111.198 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.414 ' CE1' ' HB2' ' A' ' 50' ' ' LYS . 73.0 m-70 -79.23 -25.61 42.6 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.345 0.658 . . . . 71.0 110.1 170.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.603 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 1.6 mpt? -97.55 125.23 42.14 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.171 0.988 . . . . 73.219999999999999 109.527 171.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.68 -28.46 68.63 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.23 0.826 . . . . 71.519999999999996 113.23 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.79 -12.8 84.1 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 114.597 0.599 . . . . 62.450000000000003 114.597 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' A' ' 14' ' ' MET . 39.3 mtp -91.47 -24.36 19.7 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.549 0.74 . . . . 73.420000000000002 111.761 -177.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.45 119.41 12.23 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.073 0.549 . . . . 72.439999999999998 111.659 -176.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.92 2.17 69.5 Favored Glycine 0 CA--C 1.541 1.677 0 CA-C-N 115.799 -0.637 . . . . 64.340000000000003 113.78 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.25 156.77 21.83 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.371 0.668 . . . . 72.209999999999994 112.792 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -83.83 114.31 21.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.352 0.661 . . . . 75.540000000000006 111.204 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . . . -107.03 150.63 26.31 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.861 0.864 . . . . 35.439999999999998 111.895 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -124.6 121.05 33.66 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.634 0.774 . . . . 71.239999999999995 108.968 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.2 t -72.75 106.29 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 122.823 0.449 . . . . 71.420000000000002 110.277 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.7 p -99.08 -11.33 21.54 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.352 0.661 . . . . 60.539999999999999 111.9 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.11 145.31 11.81 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 112.187 -0.365 . . . . 73.120000000000005 112.187 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.87 121.7 27.21 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.911 0.884 . . . . 73.129999999999995 110.503 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.485 ' HB2' HG23 ' A' ' 96' ' ' VAL . 26.3 m-85 -125.6 125.97 44.01 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.665 0.786 . . . . 71.239999999999995 111.249 -175.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.18 78.87 1.34 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.263 1.03 . . . . 75.299999999999997 110.35 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.569 HG21 HD12 ' A' ' 53' ' ' ILE . 10.2 t -134.79 174.86 10.11 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.726 -0.67 . . . . 53.299999999999997 111.867 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.5 m -78.98 125.03 28.84 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.97 0.508 . . . . 72.439999999999998 110.752 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . . . -100.27 163.54 12.35 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.478 1.111 . . . . 43.25 109.215 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -134.11 138.03 44.98 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.54 0.686 . . . . 63.149999999999999 111.208 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.0 t -99.15 107.75 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 107.711 -1.218 . . . . 74.349999999999994 107.711 172.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.514 HG12 HD13 ' A' ' 88' ' ' ILE . 34.3 m -119.88 145.16 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-O 121.314 0.578 . . . . 73.0 112.056 -173.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -115.16 132.88 56.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.817 0.847 . . . . 74.219999999999999 109.091 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -148.88 157.14 43.21 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.241 0.543 . . . . 74.420000000000002 112.361 -172.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.4 m -105.7 112.11 64.59 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 108.163 -1.051 . . . . 74.140000000000001 108.163 170.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.449 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 11.5 Cg_endo -56.26 118.74 5.59 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.344 2.029 . . . . 74.319999999999993 111.399 174.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.0 t -60.8 -14.22 20.25 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 124.361 1.064 . . . . 74.340000000000003 113.552 -170.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -82.8 10.83 6.87 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 123.789 0.836 . . . . 75.430000000000007 111.92 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.94 46.97 7.4 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 113.672 0.229 . . . . 44.119999999999997 113.672 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.23 -177.91 21.4 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 113.542 0.177 . . . . 64.299999999999997 113.542 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -65.36 122.42 17.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.924 0.49 . . . . 71.030000000000001 110.984 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -58.81 115.35 3.03 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.988 0.423 . . . . 73.540000000000006 110.593 173.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -86.57 120.46 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.713 -0.676 . . . . 62.439999999999998 110.399 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -92.84 120.69 33.46 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.334 0.653 . . . . 54.310000000000002 109.683 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 58.64 54.8 5.13 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.597 1.159 . . . . 75.019999999999996 113.147 175.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -65.04 132.07 48.24 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.063 0.945 . . . . 74.420000000000002 111.892 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 99.5 mttt -136.94 150.13 48.0 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.743 0.817 . . . . 51.109999999999999 110.652 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 96.9 m95 -107.43 130.81 54.78 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.888 1.275 . . . . 73.209999999999994 111.908 -7.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.84 142.68 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.716 1.207 . . . . 75.420000000000002 108.088 168.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.625 HG13 ' H ' ' A' ' 55' ' ' GLU . 27.8 pt -117.02 -175.37 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.075 0.55 . . . . 74.150000000000006 110.032 175.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -47.73 -33.18 6.7 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.623 1.169 . . . . 73.420000000000002 113.357 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.625 ' H ' HG13 ' A' ' 53' ' ' ILE . 7.0 tp10 -69.94 -28.86 65.92 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 113.924 1.083 . . . . 61.210000000000001 113.924 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -80.89 -10.98 59.66 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.487 -0.758 . . . . 54.109999999999999 112.589 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.9 mt -110.12 138.92 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 C-N-CA 123.543 0.737 . . . . 74.129999999999995 111.759 -172.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.592 ' HE3' ' HB ' ' A' ' 72' ' ' ILE . 27.8 ttpp -65.68 -53.22 44.13 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.312 1.045 . . . . 64.310000000000002 112.336 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.19 -3.33 39.04 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.014 -0.994 . . . . 63.25 113.138 -170.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.514 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -40.87 -58.76 1.6 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.444 1.276 . . . . 74.549999999999997 114.444 177.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.0 23.71 69.69 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 115.537 0.975 . . . . 23.23 115.537 170.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 61.53 17.35 8.43 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.621 1.168 . . . . 71.239999999999995 113.113 -173.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 12.3 ptpt -108.75 167.07 10.33 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.364 0.666 . . . . 73.439999999999998 110.54 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.5 m -87.02 112.5 21.91 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.293 -0.632 . . . . 75.140000000000001 109.293 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.546 HD13 HG11 ' A' ' 71' ' ' VAL . 54.5 mt -75.26 120.71 21.12 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.443 0.697 . . . . 62.109999999999999 109.353 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -96.77 154.1 38.47 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.913 0.885 . . . . 53.32 111.513 -167.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.486 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 84.8 Cg_exo -49.25 113.92 1.1 Allowed 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.995 2.463 . . . . 73.230000000000004 113.736 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.56 -17.91 18.01 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-N 115.975 -0.557 . . . . 73.329999999999998 114.135 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.8 133.14 47.09 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.327 0.564 . . . . 63.5 110.626 173.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -111.27 121.24 44.75 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.899 -0.778 . . . . 42.420000000000002 108.899 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.546 HG11 HD13 ' A' ' 65' ' ' LEU . 27.0 m -131.21 164.53 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.543 1.137 . . . . 74.340000000000003 111.027 -167.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.592 ' HB ' ' HE3' ' A' ' 58' ' ' LYS . 46.3 mm -110.51 141.47 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.01 0.524 . . . . 75.219999999999999 110.534 176.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.2 mt -88.71 123.64 33.34 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.806 0.843 . . . . 74.349999999999994 111.565 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -88.77 -28.74 20.28 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.239 0.615 . . . . 52.140000000000001 112.352 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.52 158.55 20.93 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.12 0.486 . . . . 64.209999999999994 110.572 171.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 21.1 t -143.58 125.02 14.74 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.728 -0.669 . . . . 74.430000000000007 109.703 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.7 m170 -95.34 -13.88 24.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.953 0.901 . . . . 70.099999999999994 111.272 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -156.3 177.35 11.54 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.617 0.767 . . . . 71.219999999999999 111.896 -173.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -63.95 104.96 0.77 Allowed 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.113 0.965 . . . . 71.129999999999995 112.566 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.56 12.94 56.46 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 115.182 0.833 . . . . 52.32 115.182 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -74.36 -42.23 59.71 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 117.481 0.641 . . . . 62.520000000000003 111.677 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.595 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 50.5 tttm -66.22 132.63 48.86 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 122.414 -0.179 . . . . 73.129999999999995 110.522 172.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.57 -9.52 75.7 Favored Glycine 0 N--CA 1.472 1.094 0 CA-C-O 120.337 -0.146 . . . . 72.310000000000002 112.89 -177.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 39' ' ' PRO . . . -71.11 141.48 50.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.47 0.708 . . . . 74.219999999999999 111.903 177.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -81.83 113.44 19.78 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.965 -0.561 . . . . 75.010000000000005 109.945 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -110.1 150.68 28.25 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.5 1.12 . . . . 75.310000000000002 110.388 -175.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -125.06 130.34 52.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.12 0.568 . . . . 65.010000000000005 109.958 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.514 HD13 HG12 ' A' ' 35' ' ' VAL . 27.4 mm -69.86 101.64 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.442 0.697 . . . . 52.439999999999998 109.639 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.61 -32.97 70.52 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.319 0.581 . . . . 73.25 110.346 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.486 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . 40.0 t -168.89 150.31 4.61 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.669 -1.151 . . . . 61.030000000000001 109.849 -175.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.84 128.49 54.31 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.536 -0.913 . . . . 74.140000000000001 108.536 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -114.07 125.77 54.35 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.708 0.803 . . . . 72.129999999999995 111.551 -169.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -93.91 95.12 8.88 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.5 -0.555 . . . . 75.019999999999996 109.5 170.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.0 t -137.06 154.39 50.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.786 0.835 . . . . 74.129999999999995 110.592 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.3 m -86.37 125.47 33.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.509 -0.552 . . . . 74.040000000000006 109.509 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.625 HG21 HG21 ' A' ' 53' ' ' ILE . 14.9 m -114.42 134.83 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.361 0.664 . . . . 52.539999999999999 110.092 -172.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.401 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 89.8 m-85 -116.21 143.03 46.04 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.434 0.694 . . . . 60.329999999999998 112.049 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.5 ttp -89.57 115.86 27.29 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.109 -1.441 . . . . 75.219999999999999 107.109 164.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.4 m -118.16 152.95 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.866 0.841 . . . . 62.130000000000003 112.135 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -121.28 121.56 37.98 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.608 1.563 . . . . 74.109999999999999 107.4 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.533 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 51.2 p90 -152.45 178.85 9.12 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.143 0.497 . . . . 74.099999999999994 112.098 -171.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.2 m -118.49 117.49 29.15 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.761 0.824 . . . . 75.310000000000002 109.631 172.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.5 t -60.95 119.25 7.91 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.449 0.7 . . . . 75.319999999999993 110.378 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.1 p -59.4 -45.18 92.23 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.815 0.846 . . . . 63.240000000000002 113.139 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.4 m -64.06 -52.86 57.35 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.108 0.563 . . . . 71.530000000000001 111.793 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.1 m -79.06 -24.08 43.78 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.137 0.575 . . . . 44.240000000000002 112.319 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.41 17.27 74.26 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 116.35 -0.386 . . . . 75.25 113.566 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -108.6 144.09 36.79 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.876 0.87 . . . . 73.439999999999998 111.661 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -77.13 105.1 8.01 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.013 0.925 . . . . 73.129999999999995 111.304 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.2 t -90.46 110.55 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 108.297 -1.001 . . . . 75.519999999999996 108.297 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -112.94 145.96 39.85 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.692 0.797 . . . . 71.349999999999994 111.76 -166.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 17.8 m120 57.45 32.41 21.76 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 124.064 0.946 . . . . 64.400000000000006 113.225 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -64.59 133.42 52.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.675 0.79 . . . . 75.099999999999994 112.573 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 99.7 mttt -135.59 134.42 39.31 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.199 1.0 . . . . 71.219999999999999 110.72 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 97.7 m95 -115.15 155.61 26.81 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.321 1.448 . . . . 63.200000000000003 112.521 -10.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.22 160.98 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.774 1.23 . . . . 73.420000000000002 109.084 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.8 p -118.2 162.76 17.71 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.735 0.414 . . . . 50.439999999999998 111.557 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.401 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 30.5 tt0 -61.36 -36.18 79.49 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.891 0.476 . . . . 73.430000000000007 111.671 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -66.28 -32.55 74.03 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.309 0.644 . . . . 74.319999999999993 110.885 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -83.33 -9.91 58.8 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.119 0.967 . . . . 72.219999999999999 111.376 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.529 HD13 HG21 ' A' ' 7' ' ' VAL . 82.6 mt -112.08 173.37 6.4 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.993 0.917 . . . . 70.109999999999999 109.857 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB2' HD22 ' A' ' 10' ' ' ASN . 47.8 t -137.28 136.68 38.25 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.657 0.783 . . . . 70.319999999999993 109.171 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.63 138.09 50.46 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 120.863 0.364 . . . . 74.049999999999997 111.522 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.0 tttt . . . . . 0 CA--C 1.558 1.263 0 CA-C-O 121.727 0.775 . . . . 75.120000000000005 110.846 -176.455 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.532 ' SD ' HG11 ' A' ' 7' ' ' VAL . 24.2 ptp . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.629 0.252 . . . . 52.329999999999998 110.574 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -99.41 161.61 13.52 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.31 0.644 . . . . 74.209999999999994 111.575 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.56 132.29 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 123.592 0.757 . . . . 64.209999999999994 111.779 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.41 -7.21 39.67 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.508 -0.769 . . . . 51.439999999999998 113.566 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 m -75.4 134.85 40.82 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.01 0.524 . . . . 64.239999999999995 111.782 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -95.81 123.64 39.47 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.317 0.647 . . . . 62.039999999999999 109.636 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.532 HG11 ' SD ' ' A' ' 1' ' ' MET . 31.8 m -130.04 154.54 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.735 0.814 . . . . 70.140000000000001 111.818 -172.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.8 mm -98.05 128.76 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.93 0.892 . . . . 60.210000000000001 109.656 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 17' ' ' MET . 49.8 mt -78.01 109.96 13.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.38 0.672 . . . . 72.209999999999994 109.968 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -87.53 -53.22 4.92 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.79 0.436 . . . . 75.340000000000003 110.76 -173.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.808 ' HB ' ' HB2' ' A' ' 120' ' ' GLU . 72.0 m -91.42 140.36 29.84 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.694 -0.854 . . . . 41.539999999999999 108.694 170.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 14' ' ' MET . 86.0 p -133.06 124.83 28.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.502 0.321 . . . . 71.010000000000005 111.825 -173.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -71.36 -33.37 69.51 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.347 0.659 . . . . 75.519999999999996 110.088 171.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.676 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 1.8 mpt? -115.58 137.48 52.03 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.518 1.127 . . . . 71.010000000000005 108.938 172.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -30.87 69.79 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.591 1.33 . . . . 74.329999999999998 114.591 -169.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.82 -3.34 87.46 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 114.599 0.6 . . . . 74.25 114.599 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.676 ' SD ' ' HB2' ' A' ' 14' ' ' MET . 61.6 mtp -86.63 -26.99 24.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.622 0.769 . . . . 73.140000000000001 111.196 -178.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -67.46 121.96 16.94 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.587 0.355 . . . . 64.310000000000002 111.05 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.69 -3.84 86.03 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 116.134 -0.485 . . . . 41.229999999999997 113.606 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.78 150.69 32.31 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 117.503 0.651 . . . . 60.030000000000001 112.651 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -90.1 100.61 13.4 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.765 0.826 . . . . 72.219999999999999 111.464 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.97 163.56 13.44 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.804 0.842 . . . . 42.210000000000001 112.297 176.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.6 m -130.79 130.94 44.34 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.108 0.963 . . . . 62.140000000000001 108.958 172.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.4 t -74.01 103.36 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.085 0.554 . . . . 74.239999999999995 109.515 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.8 p -95.79 -12.19 25.73 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.09 0.556 . . . . 73.109999999999999 111.756 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.6 139.69 6.45 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.747 -0.541 . . . . 64.310000000000002 111.747 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.74 122.08 37.14 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.298 0.639 . . . . 74.5 111.184 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -128.88 122.44 30.34 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.277 1.031 . . . . 74.010000000000005 110.688 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -103.98 79.67 1.66 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.947 0.879 . . . . 70.510000000000005 110.085 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -133.63 175.75 9.16 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.588 -0.733 . . . . 73.209999999999994 112.467 -169.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 93' ' ' LYS . 54.9 m -77.93 118.95 20.73 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.851 0.86 . . . . 73.340000000000003 110.931 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.81 111.61 24.21 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.04 0.936 . . . . 65.010000000000005 110.373 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -87.86 149.9 23.85 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.868 0.842 . . . . 75.209999999999994 111.956 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 55.8 t -106.92 118.84 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 107.907 -1.146 . . . . 71.340000000000003 107.907 170.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.438 HG12 HD13 ' A' ' 88' ' ' ILE . 30.0 m -117.59 168.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 112.492 0.552 . . . . 72.239999999999995 112.492 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 91.1 p -137.33 134.87 36.52 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.568 0.747 . . . . 61.130000000000003 109.467 170.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 43.5 p90 -151.66 157.6 42.33 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.469 0.652 . . . . 64.430000000000007 111.96 -174.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 m -101.19 110.98 62.85 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.182 -1.044 . . . . 73.049999999999997 108.182 171.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.97 123.39 13.71 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.861 2.374 . . . . 74.319999999999993 112.846 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.3 p -58.02 -25.32 60.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.525 1.306 . . . . 70.129999999999995 114.525 -171.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -72.62 -6.38 43.84 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 112.918 0.71 . . . . 74.510000000000005 112.918 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.11 38.67 5.94 Favored Glycine 0 N--CA 1.472 1.098 0 N-CA-C 111.789 -0.524 . . . . 30.210000000000001 111.789 -169.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.14 158.94 26.05 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.338 -0.431 . . . . 52.119999999999997 112.479 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -56.26 122.99 13.07 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.173 0.589 . . . . 72.239999999999995 110.961 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.89 124.19 14.67 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.152 0.981 . . . . 71.510000000000005 111.628 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.9 t -103.99 124.56 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.75 0.82 . . . . 63.420000000000002 111.298 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -117.32 148.62 41.55 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.638 0.775 . . . . 72.329999999999998 111.054 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 m170 57.62 38.02 27.64 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.434 1.093 . . . . 55.43 112.991 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -69.13 138.58 54.33 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.426 0.69 . . . . 72.140000000000001 111.477 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -153.88 153.36 31.95 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 123.75 0.82 . . . . 65.420000000000002 111.069 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -106.88 128.69 54.51 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.542 1.537 . . . . 71.299999999999997 111.693 -0.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.74 142.31 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.893 -1.151 . . . . 72.329999999999998 107.893 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.2 pt -124.13 176.88 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.556 -0.715 . . . . 74.519999999999996 112.076 -175.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -49.88 -50.45 45.79 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.172 1.175 . . . . 75.200000000000003 114.172 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -6.94 52.27 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 112.864 0.69 . . . . 71.25 112.864 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -79.16 -31.17 43.91 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.954 0.901 . . . . 73.540000000000006 110.066 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.7 mt -96.08 131.1 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 123.688 0.795 . . . . 71.319999999999993 111.02 -169.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -63.0 -47.51 82.79 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 122.092 0.949 . . . . 52.140000000000001 111.207 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.26 -2.65 22.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.912 1.285 . . . . 74.230000000000004 113.543 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -40.7 -60.84 1.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.602 1.161 . . . . 62.119999999999997 113.665 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.73 17.52 65.0 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 115.848 1.099 . . . . 53.439999999999998 115.848 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.64 12.91 7.92 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.45 1.1 . . . . 62.219999999999999 113.46 -174.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -106.26 157.24 17.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.362 0.665 . . . . 74.519999999999996 110.435 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.4 m -76.1 111.05 11.11 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.046 0.539 . . . . 71.420000000000002 110.432 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.424 HD13 HG11 ' A' ' 71' ' ' VAL . 92.9 mt -75.57 124.53 27.36 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.346 0.659 . . . . 74.340000000000003 110.679 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -120.57 157.74 53.35 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.325 1.05 . . . . 55.210000000000001 110.518 -170.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 32.8 Cg_exo -41.58 116.49 0.52 Allowed 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.032 2.488 . . . . 65.5 114.27 171.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.81 -9.73 16.15 Favored Glycine 0 N--CA 1.478 1.45 0 CA-C-N 115.137 -0.938 . . . . 75.140000000000001 113.499 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -84.37 102.38 12.69 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 117.519 0.659 . . . . 74.319999999999993 112.451 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -69.87 120.98 16.43 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.736 -0.468 . . . . 75.409999999999997 109.736 164.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.424 HG11 HD13 ' A' ' 65' ' ' LEU . 30.1 m -131.96 157.31 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.596 1.159 . . . . 64.439999999999998 110.428 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.9 mm -105.82 137.0 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.855 -0.528 . . . . 73.450000000000003 110.308 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.5 mt -87.54 128.0 35.25 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.67 0.788 . . . . 73.040000000000006 112.299 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -92.69 -31.33 15.14 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.798 0.839 . . . . 60.229999999999997 111.943 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.5 161.02 14.39 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.463 0.649 . . . . 62.149999999999999 110.29 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.1 p -147.24 128.46 14.74 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.784 -0.644 . . . . 75.120000000000005 110.623 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -88.68 6.84 36.56 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.817 0.847 . . . . 75.25 110.886 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -172.35 158.35 4.35 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.501 1.52 . . . . 64.519999999999996 109.824 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -75.99 133.46 40.42 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 122.274 -0.266 . . . . 72.409999999999997 110.987 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.63 -29.03 12.58 Favored Glycine 0 N--CA 1.482 1.711 0 CA-C-N 116.56 -0.291 . . . . 75.209999999999994 112.44 -172.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.0 ttt -68.36 -37.54 80.56 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.065 0.946 . . . . 64.140000000000001 111.253 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -65.35 119.24 10.61 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.988 0.515 . . . . 72.310000000000002 109.793 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.7 3.03 74.81 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 120.064 -0.298 . . . . 64.099999999999994 113.275 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.13 144.31 31.78 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 117.19 0.495 . . . . 64.030000000000001 111.429 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.4 m -80.84 110.67 16.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.693 -0.685 . . . . 64.019999999999996 109.174 176.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -101.2 159.73 15.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.316 1.047 . . . . 72.109999999999999 108.973 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.95 129.49 30.14 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.047 -1.094 . . . . 74.409999999999997 108.047 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.438 HD13 HG12 ' A' ' 35' ' ' VAL . 38.5 mm -63.26 100.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.562 0.745 . . . . 61.329999999999998 110.389 -176.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.19 -40.55 71.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.02 0.928 . . . . 74.420000000000002 110.519 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.408 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 68.0 m -153.96 151.41 29.37 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.987 0.915 . . . . 75.299999999999997 110.059 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.01 129.89 56.82 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.114 0.566 . . . . 63.420000000000002 109.61 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -140.61 151.83 44.96 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.724 0.81 . . . . 72.420000000000002 109.537 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -124.81 95.27 4.45 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.036 0.922 . . . . 73.349999999999994 109.156 177.22 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 t -134.9 151.89 51.27 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.288 -0.869 . . . . 53.0 110.552 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.8 m -78.39 123.69 27.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 122.613 0.365 . . . . 74.239999999999995 110.54 -173.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 15.2 m -118.33 140.06 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.193 0.997 . . . . 60.130000000000003 110.089 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.424 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 77.7 m-85 -122.53 145.85 47.95 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.702 0.801 . . . . 71.420000000000002 111.543 -172.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.5 ttp -89.9 121.38 31.97 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.974 -1.121 . . . . 62.43 107.974 163.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.2 m -120.94 153.76 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-O 121.488 0.661 . . . . 74.430000000000007 112.367 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -118.12 122.42 43.05 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.836 1.254 . . . . 51.409999999999997 107.747 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.444 ' CE2' ' HG2' ' A' ' 17' ' ' MET . 56.1 p90 -148.65 177.87 9.13 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.939 0.496 . . . . 73.230000000000004 111.681 -174.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.2 m -125.38 128.87 48.82 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.49 0.716 . . . . 64.340000000000003 109.726 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.4 t -62.48 120.7 11.6 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.662 0.785 . . . . 71.319999999999993 110.925 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.0 p -60.15 -41.13 92.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.895 0.878 . . . . 63.409999999999997 112.408 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.4 p -75.15 -57.5 3.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.143 0.577 . . . . 64.329999999999998 112.104 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.0 m -71.04 -40.35 71.76 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.272 0.629 . . . . 71.239999999999995 111.905 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.06 1.31 82.2 Favored Glycine 0 N--CA 1.479 1.528 0 CA-C-N 116.188 -0.46 . . . . 55.130000000000003 113.033 -170.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -75.11 129.89 38.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.64 1.176 . . . . 55.340000000000003 112.937 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -82.54 98.94 9.21 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.806 0.842 . . . . 74.200000000000003 109.881 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -88.39 118.26 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.012 0.525 . . . . 74.439999999999998 110.211 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -107.94 148.06 30.17 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.506 0.723 . . . . 64.340000000000003 112.18 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 m120 58.46 34.2 23.75 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.631 1.172 . . . . 64.200000000000003 113.349 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -65.35 125.4 24.98 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.622 0.769 . . . . 72.120000000000005 112.316 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 64.4 mttp -132.42 135.77 46.32 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.877 0.871 . . . . 74.109999999999999 111.096 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.476 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 97.9 m95 -116.52 160.71 20.23 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 126.018 1.727 . . . . 64.010000000000005 111.644 -12.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.33 139.72 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.047 0.939 . . . . 62.049999999999997 110.692 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.3 p -91.73 159.4 15.86 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.03 0.532 . . . . 73.409999999999997 112.028 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 36.5 tt0 -65.33 -26.42 68.04 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.115 0.483 . . . . 75.219999999999999 111.173 173.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -63.9 -34.29 77.62 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.859 0.864 . . . . 75.319999999999993 111.614 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.808 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 11.0 pt-20 -95.66 -2.51 47.95 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.881 0.697 . . . . 74.510000000000005 112.881 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.8 mt -111.78 168.69 9.38 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.551 0.741 . . . . 44.43 109.633 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.2 m -143.47 123.19 13.35 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.396 0.679 . . . . 74.25 109.812 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.485 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -63.77 144.32 57.14 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.075 0.55 . . . . 75.239999999999995 111.465 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.6 tptm . . . . . 0 CA--C 1.558 1.265 0 CA-C-O 122.035 0.921 . . . . 73.140000000000001 111.213 -177.134 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 110.204 -0.295 . . . . 65.420000000000002 110.204 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -75.0 137.42 41.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.835 0.854 . . . . 71.430000000000007 111.006 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.3 t -67.3 126.06 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 CA-C-O 121.353 0.596 . . . . 70.299999999999997 110.728 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.49 -18.03 38.92 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 115.189 -0.914 . . . . 72.209999999999994 113.07 -171.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 t -85.97 161.14 19.14 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.666 0.787 . . . . 75.209999999999994 110.202 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -124.62 149.59 46.93 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.084 0.468 . . . . 74.310000000000002 111.369 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 123' ' ' ALA . 24.5 m -138.27 163.92 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.256 1.022 . . . . 75.510000000000005 111.92 -171.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 mm -98.81 132.22 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.413 1.085 . . . . 53.229999999999997 109.169 165.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.9 mt -91.73 125.5 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 N-CA-C 109.782 -0.451 . . . . 54.030000000000001 109.782 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -96.16 -58.98 1.94 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.64 1.176 . . . . 61.43 111.222 -171.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.515 ' HB ' ' HG2' ' A' ' 120' ' ' GLU . 23.7 m -91.75 140.75 29.39 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.451 -0.944 . . . . 73.530000000000001 108.451 169.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 75.5 m -148.19 136.62 21.44 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.238 0.542 . . . . 62.439999999999998 111.484 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -83.89 -22.78 31.5 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.647 -1.16 . . . . 72.349999999999994 109.46 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.1 mmt -97.7 122.04 40.31 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.498 1.119 . . . . 70.140000000000001 108.906 167.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -32.01 72.59 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.638 0.977 . . . . 75.430000000000007 113.638 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.98 -4.31 77.22 Favored Glycine 0 N--CA 1.476 1.307 0 N-CA-C 114.03 0.372 . . . . 51.310000000000002 114.03 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 54.8 ttp -100.85 -22.25 14.89 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.473 0.709 . . . . 72.120000000000005 110.562 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 58.8 tttm -68.12 120.09 13.76 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.159 0.584 . . . . 74.230000000000004 111.87 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.22 -6.01 82.79 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 115.214 -0.903 . . . . 71.409999999999997 113.99 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.91 159.97 24.82 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.27 0.841 . . . . 71.400000000000006 113.27 -171.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.75 115.76 21.81 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.091 -0.959 . . . . 73.129999999999995 110.403 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.513 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -113.41 164.13 14.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.033 0.933 . . . . 55.420000000000002 112.221 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 62.1 m -133.55 125.37 28.72 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.277 0.631 . . . . 73.120000000000005 110.987 174.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.91 104.55 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.656 0.782 . . . . 74.340000000000003 110.371 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.3 p -111.57 3.69 18.17 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.455 0.539 . . . . 72.200000000000003 112.455 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.9 146.44 14.11 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 120.002 -0.332 . . . . 74.099999999999994 112.812 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.69 108.26 6.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.626 0.77 . . . . 32.439999999999998 110.731 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -112.14 116.89 31.21 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.194 0.998 . . . . 71.209999999999994 110.378 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -99.35 88.62 3.95 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 122.086 0.946 . . . . 64.140000000000001 109.731 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -134.25 179.8 6.04 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.646 0.779 . . . . 72.310000000000002 111.041 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -83.15 123.01 29.12 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.566 -0.531 . . . . 72.420000000000002 109.566 171.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.86 155.15 20.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.096 0.558 . . . . 70.150000000000006 109.562 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -132.48 147.95 52.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.875 0.845 . . . . 72.510000000000005 111.663 -173.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.31 108.7 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.906 -1.516 . . . . 75.200000000000003 106.906 169.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.425 HG12 HD13 ' A' ' 88' ' ' ILE . 19.1 m -107.02 155.51 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.356 0.598 . . . . 73.140000000000001 111.924 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 68.5 m -134.31 122.96 23.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.894 0.877 . . . . 62.240000000000002 108.92 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -153.23 159.2 42.56 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.299 0.571 . . . . 62.109999999999999 110.81 -167.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.9 m -101.65 124.49 40.48 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.679 -1.23 . . . . 74.219999999999999 107.679 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.72 145.75 94.76 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.024 1.816 . . . . 74.329999999999998 111.922 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -62.82 -17.74 61.76 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.358 0.663 . . . . 74.230000000000004 112.527 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.488 HD21 ' HG2' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -70.25 -20.82 63.04 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.533 0.733 . . . . 72.310000000000002 111.539 172.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.12 29.57 45.48 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 115.108 0.803 . . . . 72.049999999999997 115.108 168.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.86 -127.48 5.33 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 117.912 0.856 . . . . 43.119999999999997 113.103 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.75 119.59 18.18 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.448 0.699 . . . . 74.319999999999993 110.551 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -57.29 105.67 0.25 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.764 0.826 . . . . 62.210000000000001 112.059 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.23 104.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 121.218 0.533 . . . . 72.310000000000002 109.998 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 6.8 p-10 -110.48 155.3 22.44 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.233 0.613 . . . . 74.200000000000003 109.855 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.0 m170 58.69 30.48 19.99 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.556 0.742 . . . . 63.520000000000003 112.101 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -65.07 125.58 25.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.904 0.882 . . . . 60.439999999999998 110.962 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 6.9 mtmp? -139.94 144.35 37.04 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 124.082 0.953 . . . . 73.219999999999999 111.25 -174.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 97.5 m95 -112.32 138.07 49.57 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 125.32 1.448 . . . . 74.349999999999994 111.474 -4.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.81 138.69 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.322 -0.854 . . . . 71.239999999999995 109.077 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.3 pt -99.35 162.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.089 0.471 . . . . 74.219999999999999 111.737 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.423 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 63.5 tt0 -51.36 -41.06 60.38 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.375 1.07 . . . . 74.140000000000001 113.322 175.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.74 -13.69 61.38 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.436 0.636 . . . . 70.040000000000006 112.363 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 15.4 tt0 -92.18 -16.72 25.87 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.347 1.059 . . . . 61.530000000000001 111.204 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.9 mt -102.67 132.38 48.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.904 0.882 . . . . 74.400000000000006 110.159 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.556 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 87.2 tttt -64.51 -54.88 25.36 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.761 0.824 . . . . 62.409999999999997 111.508 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -72.96 -5.88 41.61 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.046 1.128 . . . . 64.430000000000007 114.046 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 54' ' ' GLN . . . -52.91 -39.61 62.89 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.163 1.171 . . . . 51.140000000000001 114.163 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.7 28.32 73.51 Favored Glycine 0 N--CA 1.481 1.697 0 N-CA-C 116.189 1.236 . . . . 74.439999999999998 116.189 163.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 61.47 14.28 5.73 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.275 1.03 . . . . 74.400000000000006 112.999 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -119.5 170.47 9.13 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.782 0.833 . . . . 45.130000000000003 111.023 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.0 m -96.6 114.59 26.26 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.159 -0.682 . . . . 75.310000000000002 109.159 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.474 HD13 HG11 ' A' ' 71' ' ' VAL . 34.9 mt -76.68 140.38 40.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.372 0.669 . . . . 71.030000000000001 110.988 -173.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -91.0 151.85 43.67 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.109 0.563 . . . . 71.439999999999998 110.951 -174.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.1 120.24 7.95 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.361 2.041 . . . . 74.109999999999999 112.35 170.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.79 -17.45 17.87 Favored Glycine 0 CA--C 1.538 1.484 0 CA-C-O 119.515 -0.603 . . . . 63.100000000000001 114.427 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.18 154.47 41.02 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.336 1.068 . . . . 73.420000000000002 111.844 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -120.6 136.9 54.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.267 0.627 . . . . 74.430000000000007 110.812 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.474 HG11 HD13 ' A' ' 65' ' ' LEU . 35.8 m -132.89 172.38 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 124.841 1.256 . . . . 74.219999999999999 111.848 -170.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.46 138.86 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 124.231 1.012 . . . . 73.5 109.739 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.5 mt -97.94 118.2 33.98 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.669 0.788 . . . . 74.420000000000002 111.579 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.556 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 30.5 mm-40 -82.19 -22.59 35.91 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.157 0.583 . . . . 72.409999999999997 112.511 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.592 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -104.78 172.12 6.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.095 0.558 . . . . 71.049999999999997 111.464 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 29.1 t -137.26 126.22 24.25 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.149 0.579 . . . . 43.109999999999999 111.487 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.576 ' H ' ' HG2' ' A' ' 81' ' ' MET . 32.8 m170 -92.92 -20.16 20.92 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.483 0.713 . . . . 74.120000000000005 111.003 164.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.0 ptp -151.43 158.73 44.07 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.296 0.638 . . . . 54.350000000000001 111.566 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.488 ' HG2' HD21 ' A' ' 41' ' ' ASN . 38.0 ttpt -66.78 95.91 0.38 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.447 0.699 . . . . 74.450000000000003 110.143 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.13 -12.4 4.41 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 115.859 -0.61 . . . . 64.319999999999993 113.354 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.576 ' HG2' ' H ' ' A' ' 77' ' ' HIS . 9.4 tpt -75.93 -59.57 2.7 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.389 1.076 . . . . 54.43 111.865 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 58.5 tttm -67.21 131.05 45.0 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.74 0.816 . . . . 54.020000000000003 112.267 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.61 -26.33 14.6 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.397 -0.365 . . . . 65.310000000000002 113.539 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.08 156.78 38.08 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.335 0.654 . . . . 72.140000000000001 111.914 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.9 m -84.5 116.35 23.06 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.909 -0.774 . . . . 62.340000000000003 108.909 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.63 150.82 22.33 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.721 0.809 . . . . 70.129999999999995 109.354 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -118.9 118.68 32.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.15 0.58 . . . . 71.310000000000002 109.472 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.425 HD13 HG12 ' A' ' 35' ' ' VAL . 36.9 mm -60.1 98.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.092 0.557 . . . . 74.239999999999995 109.869 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.11 -39.84 82.69 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.768 0.827 . . . . 62.409999999999997 109.254 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.6 t -163.44 163.25 24.97 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.064 -0.971 . . . . 71.209999999999994 110.473 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.6 139.27 52.85 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.661 0.785 . . . . 73.239999999999995 110.403 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -139.23 124.55 19.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.223 0.609 . . . . 74.549999999999997 111.102 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -86.81 94.11 9.46 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.088 -1.078 . . . . 71.150000000000006 108.088 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 t -136.79 155.04 50.34 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.8 0.84 . . . . 74.450000000000003 111.706 -170.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.4 m -87.46 125.06 34.07 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.794 -0.817 . . . . 55.549999999999997 108.794 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.5 134.16 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.012 0.925 . . . . 74.349999999999994 109.703 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.499 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 93.9 m-85 -112.63 154.98 25.2 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.764 0.792 . . . . 74.439999999999998 112.71 -169.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.3 ttp -102.55 112.49 25.25 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.546 -1.206 . . . . 70.120000000000005 108.734 173.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.513 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 23.6 m -121.5 148.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 112.909 0.707 . . . . 61.119999999999997 112.909 -172.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.3 122.86 48.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.839 0.856 . . . . 74.239999999999995 109.455 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -138.88 167.72 21.39 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.593 0.711 . . . . 63.229999999999997 112.591 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.1 m -106.84 118.64 37.22 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.102 -1.073 . . . . 72.310000000000002 108.102 168.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.6 p -64.96 124.64 22.59 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.421 0.288 . . . . 61.420000000000002 111.072 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.3 p -69.85 -41.42 74.9 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.119 0.968 . . . . 63.530000000000001 112.596 -176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.3 p -78.6 -48.48 15.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.041 0.537 . . . . 53.420000000000002 111.785 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.3 t -81.2 -36.38 30.18 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.405 0.682 . . . . 63.130000000000003 112.577 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.8 2.58 89.72 Favored Glycine 0 N--CA 1.483 1.768 0 CA-C-O 120.877 0.154 . . . . 52.43 113.478 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -82.08 137.79 34.95 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.91 0.884 . . . . 63.219999999999999 111.208 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.28 111.14 19.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.677 0.791 . . . . 73.329999999999998 109.138 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -110.8 120.17 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.181 0.592 . . . . 60.219999999999999 109.502 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -113.59 152.16 30.7 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.654 0.382 . . . . 72.420000000000002 110.412 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.4 m120 53.74 34.8 19.83 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 124.494 1.118 . . . . 71.310000000000002 113.224 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -58.27 135.99 57.25 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.645 1.178 . . . . 70.200000000000003 112.256 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 61.8 mttp -137.37 137.4 38.82 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.425 1.09 . . . . 74.450000000000003 110.45 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.4 m95 -115.17 156.94 24.36 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.64 1.576 . . . . 71.310000000000002 112.031 -9.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.5 m -128.02 154.12 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.637 1.175 . . . . 71.209999999999994 109.245 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 75.2 p -103.66 160.75 14.49 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 122.075 -0.391 . . . . 60.329999999999998 110.905 174.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.499 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 40.3 tt0 -63.07 -27.41 69.38 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.444 0.698 . . . . 64.349999999999994 111.552 178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -63.62 -25.42 68.22 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.168 0.987 . . . . 75.239999999999995 112.227 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.515 ' HG2' ' HB ' ' A' ' 11' ' ' THR . 40.2 mt-10 -91.86 0.03 57.5 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.914 0.885 . . . . 74.209999999999994 111.818 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 117' ' ' THR . 68.8 mt -119.95 140.48 50.84 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.344 0.52 . . . . 64.209999999999994 110.351 -172.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -131.56 122.94 26.93 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.848 0.859 . . . . 73.099999999999994 109.087 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.551 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -56.35 117.78 4.13 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.38 0.672 . . . . 45.439999999999998 111.728 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 64.8 tttm . . . . . 0 CA--C 1.55 0.96 0 CA-C-O 121.616 0.722 . . . . 72.230000000000004 111.821 -172.114 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.018 -0.364 . . . . 71.040000000000006 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.01 147.22 48.83 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.838 0.455 . . . . 65.209999999999994 110.326 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.66 132.39 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 CA-C-O 121.209 0.528 . . . . 75.200000000000003 111.133 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.32 -5.55 49.08 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.338 -0.847 . . . . 72.400000000000006 113.757 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.2 m -68.08 136.1 53.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.988 0.736 . . . . 70.409999999999997 112.988 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -84.63 113.69 21.45 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.007 -0.738 . . . . 63.020000000000003 109.007 167.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 123' ' ' ALA . 29.8 m -123.76 174.03 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.555 0.742 . . . . 71.200000000000003 111.29 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 21' ' ' GLU . 9.7 mt -130.64 134.72 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.141 0.976 . . . . 65.230000000000004 109.341 170.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.5 mt -86.39 108.12 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.008 0.923 . . . . 73.030000000000001 110.144 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -89.18 -48.21 7.54 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.251 0.62 . . . . 72.420000000000002 111.133 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 28.0 m -102.14 143.07 32.42 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 107.987 -1.116 . . . . 64.329999999999998 107.987 173.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 17' ' ' MET . 31.1 t -157.45 155.62 30.74 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.472 0.916 . . . . 62.130000000000003 113.472 -172.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -83.86 -42.71 16.09 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.147 -1.388 . . . . 61.32 109.111 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.7 mmt -90.67 128.6 36.69 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.185 0.994 . . . . 52.439999999999998 109.557 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HE2' HG21 ' A' ' 105' ' ' THR . 0.0 OUTLIER -66.88 -17.86 65.1 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.558 0.577 . . . . 71.400000000000006 112.558 -177.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.52 -11.08 62.8 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 113.937 0.335 . . . . 52.009999999999998 113.937 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.457 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 53.4 ttp -88.06 -23.05 23.85 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.31 0.555 . . . . 71.319999999999993 111.51 -177.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 141.97 57.77 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 121.025 0.44 . . . . 60.0 111.348 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.68 -8.65 41.05 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-N 116.003 -0.544 . . . . 73.400000000000006 114.116 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.41 148.25 32.03 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.498 0.719 . . . . 71.230000000000004 111.529 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HA ' HG12 ' A' ' 8' ' ' ILE . 8.8 pt-20 -96.17 110.55 22.81 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 121.272 0.558 . . . . 65.329999999999998 109.976 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.518 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -101.86 172.28 7.03 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.209 1.004 . . . . 75.510000000000005 113.303 -174.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.2 m -125.79 123.89 39.77 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.028 0.931 . . . . 73.319999999999993 109.806 172.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.41 122.21 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.053 0.541 . . . . 61.030000000000001 110.08 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 p -126.72 -6.33 6.27 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.543 0.737 . . . . 61.299999999999997 112.591 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.38 145.71 13.38 Favored Glycine 0 N--CA 1.476 1.314 0 CA-C-O 119.648 -0.529 . . . . 71.430000000000007 112.019 173.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.29 123.48 12.95 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.618 0.767 . . . . 73.439999999999998 110.689 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -133.1 130.24 39.04 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.663 0.785 . . . . 75.310000000000002 111.926 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -104.24 87.47 2.75 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.617 0.767 . . . . 74.299999999999997 109.165 169.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -134.53 170.98 14.96 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.847 0.859 . . . . 51.32 110.921 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.5 m -75.47 107.71 7.78 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.492 -0.558 . . . . 61.399999999999999 109.492 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.01 110.5 23.1 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.601 0.76 . . . . 70.140000000000001 109.004 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.458 ' HE2' ' HA ' ' A' ' 54' ' ' GLN . 95.7 m-85 -89.33 151.86 21.85 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.873 0.844 . . . . 71.219999999999999 112.158 -172.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.0 t -99.68 120.41 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.255 -1.387 . . . . 74.120000000000005 107.255 164.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -125.72 148.55 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.514 0.673 . . . . 73.319999999999993 112.671 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.6 p -115.81 124.99 52.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.241 1.017 . . . . 54.450000000000003 109.14 170.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.425 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 47.2 p90 -152.11 156.19 39.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.767 0.427 . . . . 74.239999999999995 110.678 -174.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.423 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 15.1 m -113.31 110.85 50.3 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 109.123 -0.695 . . . . 72.049999999999997 109.123 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 38' ' ' THR . 9.2 Cg_endo -53.01 118.44 4.8 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.248 2.632 . . . . 64.239999999999995 112.791 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.3 p -64.71 -17.19 63.88 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.723 1.209 . . . . 75.200000000000003 113.596 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -67.47 -10.21 49.32 Favored 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 123.669 0.788 . . . . 74.420000000000002 112.466 174.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.77 51.38 2.14 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 122.255 -0.278 . . . . 64.140000000000001 112.717 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.57 -151.05 21.12 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 120.903 0.168 . . . . 45.130000000000003 113.421 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -106.14 133.86 50.19 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.725 0.81 . . . . 72.310000000000002 109.636 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -59.5 118.6 6.23 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.915 0.486 . . . . 73.150000000000006 111.208 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.7 t -84.01 110.57 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.316 0.646 . . . . 60.310000000000002 110.638 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -95.72 130.65 42.57 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.934 0.894 . . . . 72.299999999999997 110.777 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 m170 54.01 57.93 5.51 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.065 0.946 . . . . 74.420000000000002 112.547 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.465 ' HD2' HG13 ' A' ' 52' ' ' VAL . 63.9 t60 -73.14 126.31 29.73 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.092 0.557 . . . . 72.109999999999999 111.446 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 66.4 mttm -131.21 139.36 49.69 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.44 1.096 . . . . 72.25 109.732 173.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.622 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 85.9 m95 -114.12 133.32 55.64 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.424 1.49 . . . . 74.319999999999993 111.474 -5.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.465 HG13 ' HD2' ' A' ' 49' ' ' HIS . 14.2 m -110.74 142.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 108.477 -0.935 . . . . 62.439999999999998 108.477 167.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.81 161.92 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-O 120.817 0.341 . . . . 52.409999999999997 111.241 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.458 ' HA ' ' HE2' ' A' ' 33' ' ' TYR . 63.3 tt0 -52.01 -47.98 64.71 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.189 0.996 . . . . 73.340000000000003 113.487 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -74.94 -8.1 55.51 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.509 0.723 . . . . 73.510000000000005 112.124 -174.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 35.7 tt0 -90.7 -8.84 48.81 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 124.842 1.257 . . . . 52.100000000000001 110.931 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.64 142.16 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 C-N-CA 124.506 1.123 . . . . 73.239999999999995 110.311 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -63.56 -50.37 69.77 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.228 1.011 . . . . 70.400000000000006 112.968 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.36 -6.58 57.1 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.225 0.824 . . . . 72.209999999999994 113.225 -170.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -33.19 -56.22 0.4 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.761 1.763 . . . . 55.32 115.761 -170.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.39 15.18 63.24 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 115.119 0.807 . . . . 41.119999999999997 115.119 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.37 3.52 1.87 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.2 1.4 . . . . 73.510000000000005 113.146 -170.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -100.54 160.37 14.4 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.931 0.892 . . . . 61.149999999999999 110.942 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.1 m -83.25 109.54 17.32 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.423 -0.584 . . . . 61.049999999999997 109.423 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.511 HD13 HG11 ' A' ' 71' ' ' VAL . 63.7 mt -72.02 122.13 20.35 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.724 -0.843 . . . . 65.549999999999997 108.724 175.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -97.55 149.09 35.35 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.212 0.605 . . . . 65.400000000000006 112.324 -164.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -46.25 115.65 1.22 Allowed 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.806 3.004 . . . . 74.349999999999994 114.623 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.77 -16.96 15.98 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 115.887 -0.597 . . . . 63.530000000000001 114.053 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.53 154.66 32.23 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 117.811 0.805 . . . . 74.299999999999997 111.714 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -126.07 137.29 53.61 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.344 0.658 . . . . 61.229999999999997 110.448 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.511 HG11 HD13 ' A' ' 65' ' ' LEU . 16.9 m -141.29 -179.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.621 1.169 . . . . 74.209999999999994 110.908 -168.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.53 146.44 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.494 0.718 . . . . 60.210000000000001 110.398 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.1 mt -96.09 123.92 39.89 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.673 0.789 . . . . 73.409999999999997 111.193 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -86.75 -6.03 58.94 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.525 0.565 . . . . 73.409999999999997 112.525 173.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -122.95 170.62 9.95 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.554 0.693 . . . . 72.549999999999997 110.525 170.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.448 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 66.1 p -146.99 127.72 14.3 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.281 -0.872 . . . . 71.230000000000004 110.458 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -82.82 -31.27 28.22 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.553 0.741 . . . . 71.109999999999999 109.524 168.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 66.6 mtm -125.77 177.61 6.18 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.971 0.908 . . . . 74.030000000000001 112.086 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -81.84 128.82 34.42 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.682 0.793 . . . . 73.129999999999995 111.394 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.67 11.48 83.96 Favored Glycine 0 N--CA 1.477 1.416 0 C-N-CA 123.179 0.418 . . . . 64.530000000000001 113.73 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.7 ttt -86.32 -44.0 12.44 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.882 0.873 . . . . 73.120000000000005 111.447 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 88.1 tttt -67.69 127.53 33.09 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.728 0.411 . . . . 74.340000000000003 111.209 174.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.15 -16.6 60.62 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 116.537 -0.301 . . . . 50.039999999999999 112.817 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.77 152.39 42.76 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.405 0.682 . . . . 74.200000000000003 111.116 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.8 m -84.18 114.0 21.48 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.971 -0.559 . . . . 65.519999999999996 109.914 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -100.44 130.14 46.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.863 0.865 . . . . 73.239999999999995 109.752 -177.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -99.87 117.58 34.48 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.343 -0.984 . . . . 73.200000000000003 108.343 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.3 mm -64.35 94.46 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 109.486 -0.561 . . . . 75.510000000000005 109.486 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.59 -33.17 68.82 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.884 0.873 . . . . 65.319999999999993 109.832 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.9 t -167.08 166.2 15.27 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.187 0.995 . . . . 62.439999999999998 110.506 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.03 131.48 42.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.978 0.911 . . . . 72.340000000000003 109.538 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -130.42 140.01 50.58 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.832 0.453 . . . . 72.349999999999994 111.168 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -94.12 96.71 9.81 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.518 0.727 . . . . 72.5 109.091 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.1 t -137.39 157.1 47.33 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.631 0.773 . . . . 74.530000000000001 111.116 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.9 m -86.43 125.84 33.97 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.764 -0.458 . . . . 45.009999999999998 109.764 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 8.6 m -117.34 138.23 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.735 0.814 . . . . 74.150000000000006 110.321 -176.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -122.11 164.0 18.52 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.314 1.045 . . . . 71.329999999999998 112.613 -169.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 ttp -119.35 116.92 27.18 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.95 -1.477 . . . . 70.310000000000002 107.984 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.518 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 24.5 m -125.72 149.67 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 123.544 0.737 . . . . 52.149999999999999 112.667 -172.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -115.88 116.77 28.56 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.018 0.927 . . . . 64.540000000000006 109.9 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -136.68 177.7 7.65 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.53 0.681 . . . . 75.319999999999993 111.781 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.5 m -123.78 125.01 43.95 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.326 1.051 . . . . 72.409999999999997 108.803 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.3 t -61.19 127.77 33.14 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.413 0.685 . . . . 72.310000000000002 112.216 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.6 p -69.33 -44.52 71.52 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.892 0.877 . . . . 64.200000000000003 111.441 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.409 HG21 ' HE2' ' A' ' 15' ' ' LYS . 38.0 m -81.07 -57.46 3.51 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.693 -0.685 . . . . 71.140000000000001 111.775 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.2 m -86.49 -21.13 27.17 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.185 0.809 . . . . 71.030000000000001 113.185 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.98 -17.96 38.5 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 115.121 0.809 . . . . 62.329999999999998 115.121 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.51 124.76 22.17 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.5 0.72 . . . . 73.310000000000002 112.258 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -81.57 101.97 10.32 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.414 0.686 . . . . 75.25 109.275 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.0 t -98.74 119.21 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.69 0.796 . . . . 72.219999999999999 110.396 -170.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.716 ' H ' ' HD3' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -105.3 137.53 42.95 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.645 0.778 . . . . 74.430000000000007 111.276 -174.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.8 m120 56.53 40.09 29.62 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.737 1.215 . . . . 63.039999999999999 113.174 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -64.72 132.83 50.71 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.936 0.894 . . . . 73.340000000000003 111.233 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -152.06 151.76 31.53 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.101 0.56 . . . . 65.319999999999993 111.37 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.622 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 92.3 m95 -105.88 144.54 32.47 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 125.984 1.713 . . . . 74.209999999999994 110.777 -4.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.7 148.92 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 123.903 0.881 . . . . 63.130000000000003 110.888 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.6 p -94.37 168.57 10.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.682 -0.636 . . . . 53.130000000000003 112.17 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -71.22 -25.56 62.55 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.001 0.52 . . . . 63.310000000000002 111.07 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -60.46 -20.02 58.49 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 124.275 1.03 . . . . 72.140000000000001 111.295 170.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.405 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 41.4 mt-10 -100.74 -2.67 31.85 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.344 1.058 . . . . 75.530000000000001 112.881 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.5 mt -119.45 157.5 28.12 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.51 0.724 . . . . 52.119999999999997 110.907 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.9 t -144.97 122.8 11.93 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.324 0.65 . . . . 74.310000000000002 110.292 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -68.28 117.67 10.38 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 122.784 0.434 . . . . 62.420000000000002 111.619 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt . . . . . 0 CA--C 1.553 1.072 0 C-N-CA 123.625 0.77 . . . . 62.450000000000003 111.995 -170.241 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.563 ' SD ' HG11 ' A' ' 7' ' ' VAL . 17.9 ptp . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 110.784 -0.08 . . . . 63.219999999999999 110.784 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.0 158.87 16.45 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.045 0.538 . . . . 71.030000000000001 111.798 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.92 123.48 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 CA-C-O 121.017 0.437 . . . . 54.310000000000002 110.691 173.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.22 -4.42 38.16 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.694 -0.685 . . . . 62.530000000000001 113.02 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.5 m -76.8 140.65 40.78 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.501 0.556 . . . . 65.530000000000001 112.501 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -91.02 114.78 27.39 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.964 -1.125 . . . . 72.439999999999998 107.964 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.563 HG11 ' SD ' ' A' ' 1' ' ' MET . 27.3 m -128.33 153.62 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.571 0.748 . . . . 74.239999999999995 111.329 -170.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -100.59 121.91 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.599 0.76 . . . . 62.119999999999997 110.164 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.663 HD11 ' HB2' ' A' ' 22' ' ' ALA . 46.0 mt -80.18 120.79 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.632 0.373 . . . . 75.319999999999993 110.459 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -92.49 1.0 57.5 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 123.426 0.69 . . . . 64.049999999999997 111.977 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.426 HG21 ' HG2' ' A' ' 120' ' ' GLU . 21.7 m -142.61 154.51 44.45 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.226 0.61 . . . . 72.329999999999998 111.686 -171.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.766 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 33.0 p -117.84 116.58 27.26 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.579 0.704 . . . . 73.239999999999995 112.042 173.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.529 ' H ' ' HE2' ' A' ' 17' ' ' MET . 38.2 m-70 -96.36 -33.06 12.07 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 107.616 -1.253 . . . . 72.140000000000001 107.616 160.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 26.6 mmt -107.87 149.49 28.21 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.786 1.234 . . . . 51.240000000000002 109.283 167.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HG3' HG21 ' A' ' 105' ' ' THR . 17.4 tppt? -58.33 -45.19 88.55 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.853 0.861 . . . . 52.229999999999997 113.102 -172.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.96 2.27 87.77 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 115.172 0.829 . . . . 35.210000000000001 115.172 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.537 ' HG2' HG21 ' A' ' 9' ' ' ILE . 47.8 ttp -87.76 -26.65 22.78 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.539 0.669 . . . . 75.400000000000006 111.991 -170.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.766 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 28.0 ttpp -66.28 119.28 11.25 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.546 0.338 . . . . 71.420000000000002 110.646 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.93 0.62 88.86 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 115.793 -0.64 . . . . 22.34 114.494 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.06 151.08 35.66 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.997 0.519 . . . . 73.120000000000005 111.214 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -95.43 113.02 24.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.525 0.33 . . . . 73.230000000000004 110.775 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.663 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -96.1 168.5 10.57 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.713 0.768 . . . . 63.310000000000002 113.058 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.4 m -126.26 123.61 38.5 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.096 -1.446 . . . . 73.120000000000005 107.096 166.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.08 110.29 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.871 0.468 . . . . 42.329999999999998 110.203 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.6 p -95.4 -14.02 24.17 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.116 0.567 . . . . 71.340000000000003 111.799 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.95 154.41 25.35 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 113.44 0.136 . . . . 42.310000000000002 113.44 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.39 110.45 11.05 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.942 0.897 . . . . 71.150000000000006 110.725 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -115.1 123.19 48.34 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.847 0.859 . . . . 74.200000000000003 110.683 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.9 86.25 2.35 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 122.408 1.099 . . . . 71.519999999999996 109.757 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -134.57 173.02 12.12 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.122 -0.945 . . . . 72.239999999999995 111.045 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.1 m -78.6 123.74 27.42 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.683 -0.488 . . . . 63.149999999999999 109.683 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.08 144.87 31.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.91 0.884 . . . . 54.130000000000003 109.818 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -128.79 149.54 50.68 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.891 0.853 . . . . 74.230000000000004 111.888 -170.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.3 t -105.75 127.11 60.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 114.144 -1.389 . . . . 74.510000000000005 108.069 172.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.458 HG12 HD13 ' A' ' 88' ' ' ILE . 15.8 m -127.78 161.39 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 112.781 0.659 . . . . 45.539999999999999 112.781 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.0 t -128.99 125.25 36.99 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.13 0.972 . . . . 74.239999999999995 109.408 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -153.79 158.42 40.87 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.463 0.705 . . . . 74.120000000000005 110.87 -172.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.4 m -109.65 112.31 58.66 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 108.566 -0.902 . . . . 74.239999999999995 108.566 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.32 128.69 28.48 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.183 2.589 . . . . 71.150000000000006 113.593 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.9 p -62.6 -18.39 62.08 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.968 1.307 . . . . 70.420000000000002 113.408 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -64.82 -10.05 25.25 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 123.938 0.895 . . . . 65.030000000000001 112.526 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.71 53.51 2.71 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-O 121.117 0.287 . . . . 45.109999999999999 112.467 -175.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.68 171.16 14.31 Favored Glycine 0 N--CA 1.471 1.005 0 CA-C-N 115.352 -0.424 . . . . 74.209999999999994 113.408 -175.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -62.91 134.94 56.98 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.556 0.742 . . . . 74.219999999999999 111.512 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -58.99 123.92 18.19 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.379 0.672 . . . . 72.409999999999997 112.223 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.5 t -87.2 108.76 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.515 0.726 . . . . 63.43 109.723 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -101.78 139.21 37.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.681 0.793 . . . . 62.409999999999997 110.526 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.5 m170 57.82 37.41 27.03 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.089 0.956 . . . . 64.420000000000002 112.746 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -60.77 129.69 42.76 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.168 0.987 . . . . 75.349999999999994 111.408 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 61.1 mttp -130.2 137.24 49.97 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.936 0.895 . . . . 63.140000000000001 110.862 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 79.8 m95 -118.03 145.78 44.53 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 125.468 1.507 . . . . 74.230000000000004 111.242 -11.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -114.09 132.4 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 107.99 -1.115 . . . . 70.310000000000002 107.99 169.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.0 pt -102.02 167.27 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 121.598 -0.689 . . . . 74.439999999999998 109.909 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -47.6 -33.61 6.82 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.68 1.192 . . . . 72.010000000000005 113.393 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.51 -13.09 60.64 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.707 1.003 . . . . 64.019999999999996 113.707 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.548 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 0.5 OUTLIER -89.51 -12.91 38.66 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.623 0.601 . . . . 65.299999999999997 112.623 -179.283 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 mp -98.57 132.79 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 122.961 0.504 . . . . 73.329999999999998 111.293 -169.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -60.83 -44.16 97.3 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.81 1.244 . . . . 74.310000000000002 112.854 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -78.97 -16.32 57.1 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 118.189 -0.91 . . . . 73.409999999999997 112.813 -175.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -30.42 -62.19 0.16 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.813 1.412 . . . . 74.430000000000007 114.813 -160.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.19 23.2 65.98 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 114.602 0.601 . . . . 64.200000000000003 114.602 169.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 t70 72.54 -2.63 2.58 Favored 'General case' 0 CA--C 1.577 1.984 0 C-N-CA 125.304 1.442 . . . . 71.299999999999997 112.401 -176.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.452 ' HE3' HD23 ' A' ' 65' ' ' LEU . 53.0 pttt -79.65 153.71 29.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.376 -0.828 . . . . 62.009999999999998 110.954 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.4 m -84.48 118.73 24.48 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.142 -0.688 . . . . 75.329999999999998 109.142 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.531 ' HB3' HG13 ' A' ' 88' ' ' ILE . 41.6 mt -73.09 124.37 25.41 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.755 0.822 . . . . 70.420000000000002 110.598 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -109.02 155.94 40.01 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 123.584 0.754 . . . . 74.340000000000003 111.358 -171.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 84.5 Cg_exo -45.89 111.53 0.35 Allowed 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.123 2.549 . . . . 61.409999999999997 114.172 174.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.64 -16.39 14.11 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 114.611 0.604 . . . . 41.149999999999999 114.611 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.48 130.97 45.19 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 117.932 0.866 . . . . 75.319999999999993 112.33 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -87.8 122.06 30.99 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.827 -0.805 . . . . 70.340000000000003 108.827 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.14 146.74 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.596 0.758 . . . . 70.409999999999997 110.763 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -101.23 135.75 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 109.449 -0.574 . . . . 62.039999999999999 109.449 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.3 mt -91.19 109.15 20.4 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.98 0.512 . . . . 71.420000000000002 111.152 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.11 -40.04 65.28 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.63 0.772 . . . . 53.119999999999997 111.243 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.548 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -89.39 173.78 8.18 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.95 0.5 . . . . 51.130000000000003 111.044 174.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.658 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 29.4 t -149.17 125.44 10.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.866 -0.606 . . . . 43.32 109.804 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -86.73 -18.4 31.26 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.456 0.702 . . . . 63.310000000000002 110.976 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -155.14 147.61 24.06 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.31 1.044 . . . . 74.030000000000001 109.811 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.4 ' HB3' ' NZ ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -51.1 124.11 10.81 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.105 0.962 . . . . 60.520000000000003 113.593 -174.178 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.2 -15.6 56.25 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 115.891 -0.595 . . . . 74.439999999999998 114.201 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.2 ttt -68.91 -39.02 79.91 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.539 0.736 . . . . 73.420000000000002 112.518 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 87.7 tttt -66.39 134.94 53.56 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.689 0.396 . . . . 60.5 111.66 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.79 -7.08 79.65 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.134 -0.485 . . . . 32.049999999999997 112.901 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.42 143.15 37.02 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.103 0.561 . . . . 64.510000000000005 111.58 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.1 m -87.01 116.74 25.27 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.705 -0.85 . . . . 75.219999999999999 108.705 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -112.34 156.99 21.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.819 0.848 . . . . 53.420000000000002 110.136 -173.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -120.07 125.97 49.61 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.293 -0.632 . . . . 73.400000000000006 109.293 174.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.531 HG13 ' HB3' ' A' ' 65' ' ' LEU . 34.6 mm -63.08 105.29 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 N-CA-C 109.691 -0.485 . . . . 55.420000000000002 109.691 175.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -75.94 -37.86 58.22 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.987 0.915 . . . . 64.329999999999998 109.889 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.4 t -157.42 152.0 25.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.674 0.79 . . . . 50.32 111.111 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.08 132.17 54.35 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.885 0.874 . . . . 74.319999999999993 109.949 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -142.16 140.68 32.48 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.099 0.476 . . . . 64.439999999999998 112.171 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -96.66 95.6 8.05 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.126 -0.488 . . . . 73.209999999999994 109.703 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.2 t -136.88 149.91 47.94 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.455 0.702 . . . . 74.120000000000005 110.764 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.0 m -82.49 124.88 30.5 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.459 -0.571 . . . . 64.200000000000003 109.459 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.637 HG12 HG22 ' A' ' 117' ' ' THR . 16.5 m -112.03 132.97 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.455 0.702 . . . . 44.210000000000001 109.464 -173.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.422 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 96.4 m-85 -109.63 139.0 45.18 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.937 0.875 . . . . 71.329999999999998 112.048 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.434 ' HG2' ' HA ' ' A' ' 112' ' ' ASN . 60.9 ttp -91.27 120.3 32.05 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 107.493 -1.299 . . . . 64.209999999999994 107.493 170.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.425 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 27.6 m -130.65 163.31 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 113.826 1.047 . . . . 70.420000000000002 113.826 -171.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -125.69 118.32 25.36 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.292 1.037 . . . . 64.230000000000004 110.61 174.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -131.87 178.47 6.75 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.067 0.947 . . . . 75.340000000000003 110.76 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.1 m -114.73 114.31 25.44 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.081 -0.711 . . . . 72.099999999999994 109.081 170.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.3 t -55.54 103.48 0.1 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.97 0.908 . . . . 53.5 110.684 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.2 p -65.53 -17.93 64.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.511 1.125 . . . . 74.310000000000002 113.578 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.406 HG21 ' HG3' ' A' ' 15' ' ' LYS . 65.1 p -92.9 -24.21 18.51 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.357 0.503 . . . . 74.129999999999995 112.357 177.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.3 m -112.26 -22.57 10.85 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.133 0.79 . . . . 73.209999999999994 113.133 -170.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.15 -12.5 49.85 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 113.717 0.247 . . . . 64.109999999999999 113.717 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -72.82 129.29 37.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.202 1.001 . . . . 61.509999999999998 112.202 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -84.45 111.63 19.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.05 0.54 . . . . 71.329999999999998 110.177 170.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.0 t -101.06 117.99 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.898 0.879 . . . . 73.049999999999997 110.145 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.529 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -113.67 148.89 35.53 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.293 0.637 . . . . 62.119999999999997 111.677 -175.075 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.434 ' HA ' ' HG2' ' A' ' 98' ' ' MET . 81.5 m-20 55.74 36.74 27.82 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 124.143 0.977 . . . . 75.209999999999994 112.416 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -62.11 134.91 57.2 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.198 0.999 . . . . 74.230000000000004 111.911 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 98.3 mttt -140.02 136.03 33.28 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.887 0.875 . . . . 60.43 111.381 -175.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 91.9 m95 -114.46 142.96 45.7 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.114 1.366 . . . . 71.400000000000006 112.961 -12.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.5 146.48 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 114.016 -1.447 . . . . 75.209999999999994 108.19 166.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.637 HG22 HG12 ' A' ' 96' ' ' VAL . 18.8 p -103.55 173.46 6.29 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.948 -0.47 . . . . 63.530000000000001 111.289 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.422 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 13.4 tp10 -58.23 -29.93 66.13 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.791 0.836 . . . . 71.129999999999995 111.258 170.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.53 -35.11 79.43 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.831 0.853 . . . . 70.209999999999994 111.72 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.426 ' HG2' HG21 ' A' ' 11' ' ' THR . 1.3 mt-10 -92.56 -3.18 55.47 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.133 0.573 . . . . 74.030000000000001 112.463 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.4 mt -118.78 143.77 46.71 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.662 0.785 . . . . 70.109999999999999 110.283 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 57.5 m -122.29 149.52 43.61 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.427 -0.953 . . . . 74.219999999999999 108.427 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.03 170.86 7.64 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.49 0.316 . . . . 42.009999999999998 111.268 173.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 tptt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.713 0.768 . . . . 71.219999999999999 110.474 174.458 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.417 ' SD ' HG11 ' A' ' 7' ' ' VAL . 58.3 mtt . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.446 0.165 . . . . 64.349999999999994 111.167 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -90.79 137.9 32.0 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.404 0.682 . . . . 62.130000000000003 112.756 -171.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.28 136.49 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 C-N-CA 123.597 0.759 . . . . 73.140000000000001 110.975 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.67 -12.6 68.95 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 116.007 -0.542 . . . . 61.539999999999999 113.129 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.9 t -87.1 159.12 19.03 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.426 0.69 . . . . 61.009999999999998 110.802 175.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -101.25 147.51 26.2 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.919 0.487 . . . . 62.25 109.756 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' A' ' 123' ' ' ALA . 16.6 m -130.89 151.25 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.733 0.813 . . . . 61.340000000000003 110.399 176.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.2 mm -98.76 124.99 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.792 0.837 . . . . 74.5 109.743 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 22' ' ' ALA . 30.1 mt -78.31 107.41 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 109.14 -0.689 . . . . 74.310000000000002 109.14 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -87.22 -34.28 19.03 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.061 0.458 . . . . 54.25 111.946 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.9 m -133.33 141.31 47.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.678 1.191 . . . . 44.100000000000001 108.223 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.8 p -162.64 173.16 14.27 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.602 0.715 . . . . 63.100000000000001 111.555 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -86.29 -6.95 58.85 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 114.964 -1.016 . . . . 70.5 111.353 -175.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.6 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 51.5 mtt -133.2 144.66 49.96 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.371 1.068 . . . . 75.450000000000003 110.367 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -60.27 -38.2 82.82 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.232 0.613 . . . . 71.409999999999997 111.343 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.68 -24.07 63.81 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 114.766 0.666 . . . . 65.140000000000001 114.766 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.6 ' HG3' ' HB2' ' A' ' 14' ' ' MET . 27.0 mtm -94.14 -26.74 16.57 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.637 0.375 . . . . 71.329999999999998 110.968 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -67.71 121.04 15.08 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.025 0.53 . . . . 73.25 111.431 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.44 0.96 88.13 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 115.671 -0.695 . . . . 64.319999999999993 114.117 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.79 158.87 19.88 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.195 0.598 . . . . 61.5 112.491 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -89.69 123.51 33.78 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.751 -0.659 . . . . 74.109999999999999 109.641 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -114.83 168.7 9.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.244 1.018 . . . . 65.239999999999995 110.905 171.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 m -133.9 128.35 34.39 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.663 0.785 . . . . 73.329999999999998 109.24 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.24 105.21 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 109.692 -0.484 . . . . 55.25 109.692 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.2 p -103.87 -4.73 23.12 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.957 0.503 . . . . 64.409999999999997 111.085 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.81 133.06 3.27 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 111.21 -0.756 . . . . 61.509999999999998 111.21 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.01 107.02 12.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.62 0.768 . . . . 63.409999999999997 109.532 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -110.12 133.2 53.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.847 0.859 . . . . 74.310000000000002 109.745 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -122.24 86.38 2.57 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.993 0.901 . . . . 61.32 110.142 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -135.43 -178.54 5.16 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.751 0.82 . . . . 63.32 111.206 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.2 m -75.27 119.54 19.53 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.748 0.419 . . . . 64.219999999999999 110.136 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.03 150.19 25.17 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.582 0.753 . . . . 74.5 109.613 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HB2' HG23 ' A' ' 52' ' ' VAL . 90.0 m-85 -128.61 142.91 50.89 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.784 0.802 . . . . 54.509999999999998 111.75 -173.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.18 109.65 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 114.146 -1.388 . . . . 62.130000000000003 107.29 171.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.9 148.31 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 113.816 1.043 . . . . 61.219999999999999 113.816 -170.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.4 t -116.7 125.03 51.12 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.112 0.965 . . . . 71.439999999999998 110.542 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -150.9 156.3 40.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 122.143 -0.348 . . . . 72.150000000000006 111.649 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 m -105.36 119.48 52.73 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.139 0.576 . . . . 73.25 109.826 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.34 124.4 15.97 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.801 2.334 . . . . 62.020000000000003 112.391 169.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.4 p -63.48 -10.32 17.02 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.013 1.486 . . . . 74.299999999999997 115.013 -167.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -90.95 10.1 27.88 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 122.845 0.458 . . . . 71.0 112.074 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.59 47.19 5.76 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.923 -0.471 . . . . 71.329999999999998 111.923 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.51 160.65 18.98 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 123.039 0.352 . . . . 61.020000000000003 112.514 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -62.89 130.1 43.31 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.017 0.527 . . . . 71.340000000000003 110.709 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -64.48 123.87 20.35 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.026 0.441 . . . . 74.239999999999995 111.453 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.6 t -86.87 113.25 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.542 -0.754 . . . . 71.030000000000001 109.51 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -97.95 143.44 28.52 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.984 0.914 . . . . 70.329999999999998 110.115 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.6 m80 55.92 35.3 25.23 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.642 0.777 . . . . 74.5 112.801 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.415 ' HD2' HG13 ' A' ' 52' ' ' VAL . 66.7 t60 -57.86 118.3 5.19 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.826 0.85 . . . . 74.239999999999995 111.597 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 97.9 mttt -118.32 131.37 56.33 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.837 0.855 . . . . 65.5 110.414 176.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.672 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 94.4 m95 -118.84 154.83 32.25 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.642 -1.286 . . . . 71.329999999999998 111.499 -10.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 33' ' ' TYR . 18.4 m -122.38 148.3 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 114.443 -1.253 . . . . 73.439999999999998 107.979 166.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.9 pt -103.01 170.4 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.606 0.717 . . . . 73.209999999999994 112.186 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -54.4 -34.35 61.11 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.206 1.002 . . . . 64.430000000000007 113.243 172.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.46 -1.04 49.03 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.493 0.717 . . . . 61.409999999999997 112.373 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -80.12 -17.96 51.14 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.202 1.001 . . . . 63.340000000000003 111.156 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 71' ' ' VAL . 82.2 mt -122.2 140.29 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.725 1.21 . . . . 74.200000000000003 111.076 -165.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -75.42 -49.86 17.63 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.265 0.626 . . . . 71.329999999999998 112.027 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -68.14 -5.2 16.66 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.606 0.965 . . . . 75.010000000000005 113.606 -174.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.486 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -61.01 -58.6 7.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 122.854 0.462 . . . . 35.130000000000003 111.626 169.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.85 32.76 83.8 Favored Glycine 0 N--CA 1.48 1.577 0 O-C-N 121.967 -0.458 . . . . 74.329999999999998 112.441 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.4 p30 44.6 28.28 0.31 Allowed 'General case' 0 CA--C 1.57 1.733 0 C-N-CA 126.236 1.814 . . . . 72.129999999999995 114.268 -166.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 42.4 pttt -100.22 166.23 11.09 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.537 -0.542 . . . . 52.240000000000002 109.537 174.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 m -80.97 108.98 15.12 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.621 0.368 . . . . 71.310000000000002 110.537 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.561 HD13 HG11 ' A' ' 71' ' ' VAL . 50.9 mt -78.85 129.16 34.27 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.45 0.7 . . . . 72.430000000000007 110.63 175.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -98.32 145.27 29.55 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.601 0.76 . . . . 63.240000000000002 111.29 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.461 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 97.9 Cg_exo -47.07 130.12 15.99 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.536 2.824 . . . . 52.140000000000001 114.327 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.16 -12.68 48.69 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 123.17 0.414 . . . . 53.020000000000003 113.221 -174.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.1 143.77 41.08 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.604 0.762 . . . . 60.399999999999999 112.561 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -107.03 130.33 54.67 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.956 0.902 . . . . 73.340000000000003 110.428 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 65' ' ' LEU . 28.0 m -133.36 175.77 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 124.159 0.984 . . . . 73.230000000000004 111.493 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -117.61 136.02 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.571 0.748 . . . . 73.099999999999994 109.864 171.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.5 mt -88.72 120.7 30.36 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.818 0.847 . . . . 73.120000000000005 110.791 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.04 1.32 56.23 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.09 0.556 . . . . 70.230000000000004 112.457 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.91 157.83 18.85 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.448 0.699 . . . . 53.130000000000003 112.108 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.9 p -118.03 128.95 55.26 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.924 -0.769 . . . . 24.219999999999999 108.924 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -141.5 -42.85 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.524 -1.288 . . . . 71.340000000000003 107.524 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -157.21 -176.17 5.82 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 114.058 -1.428 . . . . 61.049999999999997 110.596 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -60.74 124.15 19.59 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.595 0.758 . . . . 61.32 112.493 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.9 14.36 82.42 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 114.718 0.647 . . . . 33.439999999999998 114.718 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.5 tpt -69.71 -59.51 2.9 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.36 0.58 . . . . 72.450000000000003 111.174 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -67.55 129.29 39.45 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 115.998 -0.547 . . . . 75.030000000000001 111.453 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.86 -9.48 61.89 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 116.473 -0.33 . . . . 52.530000000000001 113.553 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.67 148.62 31.53 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.261 0.624 . . . . 74.329999999999998 111.852 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.3 m -89.7 122.32 32.7 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.196 0.598 . . . . 62.140000000000001 109.629 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.84 141.71 36.79 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.461 0.704 . . . . 41.340000000000003 111.359 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -98.79 115.62 29.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.318 1.447 . . . . 73.450000000000003 108.78 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.7 mm -69.09 96.23 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 109.03 -0.73 . . . . 50.299999999999997 109.03 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -71.65 -36.87 70.84 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.778 0.431 . . . . 73.430000000000007 110.154 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.461 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . 26.5 t -166.65 162.69 16.58 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.5 -0.773 . . . . 74.0 111.37 -177.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.14 135.76 49.29 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.253 1.021 . . . . 74.209999999999994 110.355 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -138.51 135.2 34.86 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.378 0.671 . . . . 72.120000000000005 111.399 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -90.0 94.87 9.97 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.463 -0.94 . . . . 74.310000000000002 108.463 171.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -136.08 154.99 50.85 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.427 0.691 . . . . 61.549999999999997 110.803 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 m -87.78 116.59 26.03 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.151 -0.685 . . . . 72.510000000000005 109.151 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.2 m -111.47 134.99 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.189 0.996 . . . . 44.439999999999998 109.529 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.92 148.61 36.52 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.989 0.9 . . . . 70.439999999999998 112.871 -169.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.7 ttp -103.11 111.35 23.68 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.966 -1.47 . . . . 74.5 107.312 167.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.8 m -123.84 147.62 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 112.891 0.7 . . . . 74.239999999999995 112.891 -170.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -105.24 117.65 34.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.926 0.89 . . . . 73.109999999999999 108.835 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -130.56 169.13 15.99 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.617 0.723 . . . . 74.140000000000001 111.692 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.2 m -116.82 133.3 56.18 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 108.931 -0.766 . . . . 64.439999999999998 108.931 167.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.2 t -72.82 129.31 37.89 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.78 0.432 . . . . 72.030000000000001 111.671 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.6 p -66.04 -41.54 90.75 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.066 0.946 . . . . 75.420000000000002 112.094 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.0 p -85.63 -50.05 7.52 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.31 0.644 . . . . 72.209999999999994 112.282 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.0 m -88.81 -24.02 22.69 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.0 0.741 . . . . 75.530000000000001 113.0 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 4.34 79.26 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 114.334 0.494 . . . . 53.299999999999997 114.334 -177.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -68.36 131.59 45.58 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.359 0.874 . . . . 64.319999999999993 113.359 -176.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -84.72 86.21 7.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.793 0.837 . . . . 63.030000000000001 109.405 174.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.91 125.61 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 115.866 -0.607 . . . . 61.140000000000001 109.726 -172.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.93 153.61 33.31 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.093 0.473 . . . . 73.409999999999997 111.471 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 60.5 28.45 18.12 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 114.522 -1.217 . . . . 73.109999999999999 112.563 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -66.78 130.1 42.05 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.525 0.73 . . . . 75.340000000000003 110.807 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -162.3 154.79 19.46 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 115.672 -0.695 . . . . 72.200000000000003 111.465 -169.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.672 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 96.6 m95 -103.23 133.04 48.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.473 -1.392 . . . . 72.400000000000006 111.862 0.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -126.88 139.72 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.604 1.162 . . . . 65.230000000000004 109.051 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.3 p -94.72 173.48 7.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.826 -0.546 . . . . 74.439999999999998 112.055 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.43 -19.99 65.88 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.367 0.667 . . . . 72.150000000000006 111.24 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.65 -33.98 71.56 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.953 0.901 . . . . 73.400000000000006 110.807 173.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.95 -2.64 58.47 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.166 0.586 . . . . 64.439999999999998 111.742 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.16 160.86 28.16 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.032 0.92 . . . . 74.209999999999994 111.018 -173.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.3 m -140.63 146.98 38.64 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 107.206 -1.405 . . . . 75.019999999999996 107.206 168.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.494 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -58.76 162.14 4.25 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 119.177 0.899 . . . . 42.0 111.567 176.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 tptm . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.454 0.645 . . . . 72.129999999999995 111.33 -176.749 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.464 ' SD ' HG11 ' A' ' 7' ' ' VAL . 64.2 mtt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 110.274 -0.269 . . . . 65.420000000000002 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.17 161.86 14.09 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.398 0.679 . . . . 64.510000000000005 111.128 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.4 t -65.96 125.36 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 121.116 0.484 . . . . 73.239999999999995 111.315 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.02 -1.68 35.49 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.532 0.587 . . . . 25.140000000000001 112.993 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.3 m -73.58 129.77 38.65 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.319 0.647 . . . . 53.049999999999997 111.897 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -99.24 117.27 33.33 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.367 0.667 . . . . 73.349999999999994 109.639 174.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.464 HG11 ' SD ' ' A' ' 1' ' ' MET . 30.5 m -134.38 153.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 124.114 0.966 . . . . 61.5 110.917 -168.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.56 126.29 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 123.301 0.64 . . . . 73.099999999999994 110.059 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 22' ' ' ALA . 25.7 mt -83.88 131.56 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 122.013 -0.429 . . . . 70.349999999999994 110.849 -171.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -96.08 -51.24 4.51 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 118.116 0.416 . . . . 71.409999999999997 111.724 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m -93.21 140.69 29.25 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.049 0.54 . . . . 71.439999999999998 109.56 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 14' ' ' MET . 93.0 p -128.44 125.45 38.54 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.758 0.651 . . . . 64.310000000000002 112.758 -171.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -84.05 -41.35 17.29 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.755 0.822 . . . . 72.239999999999995 108.841 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' SER . 25.1 mmt -101.56 153.22 19.92 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.34 1.056 . . . . 65.340000000000003 109.478 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -63.71 -35.52 80.84 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.209 0.818 . . . . 73.25 113.209 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.62 -1.26 89.2 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 114.347 0.499 . . . . 63.420000000000002 114.347 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.492 ' HG2' HG21 ' A' ' 9' ' ' ILE . 52.7 ttm -75.2 -30.12 60.53 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 122.979 0.512 . . . . 62.219999999999999 110.05 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -63.21 119.25 9.22 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.896 0.878 . . . . 74.450000000000003 111.79 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.42 2.25 78.96 Favored Glycine 0 CA--C 1.539 1.548 0 N-CA-C 114.667 0.627 . . . . 51.350000000000001 114.667 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.76 149.12 38.06 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.22 0.608 . . . . 63.229999999999997 111.93 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -85.14 102.32 13.18 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.652 -0.499 . . . . 65.140000000000001 109.652 174.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.609 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -85.24 147.07 26.76 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.559 0.744 . . . . 53.210000000000001 111.552 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.0 m -119.3 116.5 26.36 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.1 -1.074 . . . . 72.430000000000007 108.1 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.37 100.49 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 N-CA-C 109.607 -0.516 . . . . 71.400000000000006 109.607 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.1 p -91.72 -9.18 44.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.158 0.583 . . . . 42.439999999999998 110.927 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.05 137.32 4.73 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.833 -0.507 . . . . 31.43 111.833 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.87 106.93 13.5 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.888 0.875 . . . . 65.239999999999995 109.297 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -112.48 128.18 56.26 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.808 0.843 . . . . 72.040000000000006 110.298 -172.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -114.36 93.13 4.21 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.382 -0.599 . . . . 60.420000000000002 109.382 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.515 HG21 HD12 ' A' ' 53' ' ' ILE . 8.2 t -137.09 -179.53 5.77 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.853 0.861 . . . . 41.200000000000003 111.356 -176.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.8 m -75.8 116.94 17.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.976 0.511 . . . . 75.430000000000007 110.305 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.05 151.0 22.32 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.411 0.684 . . . . 44.420000000000002 110.191 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -130.6 146.11 52.04 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.485 0.659 . . . . 73.319999999999993 111.373 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.82 118.8 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.665 -1.235 . . . . 62.439999999999998 107.665 168.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.475 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 27.0 m -123.79 144.71 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.331 0.493 . . . . 74.530000000000001 112.331 -175.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.7 m -114.5 132.65 56.22 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.73 0.812 . . . . 74.430000000000007 110.303 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.419 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 46.1 p90 -160.5 160.52 32.07 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.08 0.552 . . . . 64.439999999999998 111.276 -174.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.9 m -113.99 114.96 46.08 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 108.501 -0.926 . . . . 61.310000000000002 108.501 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.31 127.18 24.92 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.972 2.448 . . . . 72.209999999999994 113.025 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.6 p -64.44 -17.34 63.72 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.462 1.105 . . . . 51.229999999999997 113.833 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -82.93 11.11 6.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.251 0.62 . . . . 74.530000000000001 112.335 176.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.66 51.24 5.62 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 122.735 0.207 . . . . 71.209999999999994 113.306 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.97 -171.61 26.33 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 122.559 0.123 . . . . 63.539999999999999 113.072 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.74 124.78 28.19 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.12 -1.067 . . . . 62.43 108.12 174.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -50.35 114.01 1.02 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.798 0.839 . . . . 73.420000000000002 112.469 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.9 t -75.17 96.86 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.468 -0.787 . . . . 54.009999999999998 109.825 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -85.46 117.96 24.69 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.498 -0.774 . . . . 70.349999999999994 109.915 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 58.22 59.88 2.87 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.129 0.972 . . . . 74.420000000000002 112.136 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -59.8 121.47 11.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.011 0.925 . . . . 73.040000000000006 111.562 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 98.5 mttt -126.66 136.17 52.14 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.854 0.861 . . . . 62.439999999999998 110.234 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 89.1 m95 -115.46 146.56 41.53 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.906 1.282 . . . . 73.430000000000007 111.698 -10.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.02 151.83 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 113.813 -1.539 . . . . 70.319999999999993 108.205 166.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 96' ' ' VAL . 33.0 pt -118.93 -177.07 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 120.96 0.409 . . . . 65.120000000000005 110.948 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.453 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 30.5 tt0 -49.73 -33.13 15.2 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.734 1.214 . . . . 63.43 113.822 175.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.486 ' H ' HG13 ' A' ' 53' ' ' ILE . 7.5 tp10 -62.59 -26.43 68.59 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 113.117 0.784 . . . . 65.219999999999999 113.117 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.44 -13.62 54.38 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 112.654 0.613 . . . . 71.420000000000002 112.654 -173.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.41 137.37 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.285 0.634 . . . . 73.030000000000001 110.958 -171.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.527 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 27.1 ttpt -78.28 -37.08 45.76 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.455 1.102 . . . . 71.510000000000005 112.434 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.07 -14.7 59.78 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.093 0.957 . . . . 74.329999999999998 112.821 -173.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -49.86 -63.35 1.14 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.881 1.067 . . . . 74.120000000000005 113.881 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.67 33.85 88.35 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 115.234 0.853 . . . . 70.129999999999995 115.234 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 67.07 16.81 10.37 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.607 1.163 . . . . 65.230000000000004 113.24 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 12.0 ptpt -106.47 176.43 5.17 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.256 0.551 . . . . 63.240000000000002 111.073 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.3 m -96.48 113.82 25.43 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.031 0.933 . . . . 75.200000000000003 109.156 168.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.0 mt -77.03 136.93 38.7 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.25 0.62 . . . . 53.219999999999999 110.168 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -95.55 152.59 39.31 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 123.522 0.729 . . . . 71.439999999999998 111.489 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 82.7 Cg_exo -50.86 119.88 5.87 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.124 2.549 . . . . 73.239999999999995 113.395 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.85 -13.98 26.84 Favored Glycine 0 N--CA 1.48 1.609 0 CA-C-O 119.959 -0.356 . . . . 54.43 113.815 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.55 120.63 14.89 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.736 0.768 . . . . 70.340000000000003 112.123 176.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -89.1 120.68 30.71 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.6 -0.727 . . . . 74.510000000000005 109.839 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.88 166.43 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.695 1.198 . . . . 73.299999999999997 110.906 -172.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.9 mm -112.11 135.81 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.612 0.765 . . . . 71.409999999999997 110.116 171.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.7 mt -83.29 122.82 28.95 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.064 0.545 . . . . 70.319999999999993 111.291 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 45.5 mm-40 -93.29 13.19 22.09 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 123.173 0.589 . . . . 54.109999999999999 112.043 173.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.14 156.44 32.32 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.358 0.663 . . . . 73.150000000000006 110.138 169.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.4 t -139.83 126.65 20.69 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.929 -0.578 . . . . 75.409999999999997 110.149 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -110.37 2.01 18.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.852 0.861 . . . . 71.439999999999998 109.859 171.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -173.44 161.03 4.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.737 1.215 . . . . 63.109999999999999 110.336 -174.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -68.22 124.28 23.04 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 120.728 0.299 . . . . 60.100000000000001 110.65 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.92 41.42 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.575 -0.569 . . . . 72.129999999999995 113.897 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.6 ttt -98.69 -58.42 1.96 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 117.469 0.635 . . . . 73.450000000000003 110.172 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -66.96 131.2 45.38 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.333 0.253 . . . . 74.140000000000001 110.522 171.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.69 -15.91 59.34 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 116.587 -0.279 . . . . 75.430000000000007 113.218 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.38 151.82 30.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.289 0.636 . . . . 35.310000000000002 111.687 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.1 m -87.55 118.82 27.27 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.478 -0.783 . . . . 75.030000000000001 110.165 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.475 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -116.98 149.5 40.12 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.195 0.998 . . . . 74.319999999999993 110.112 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -115.03 129.23 56.66 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.968 -0.382 . . . . 73.420000000000002 109.968 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 67' ' ' PRO . 32.0 mm -66.21 108.7 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 N-CA-C 109.415 -0.587 . . . . 71.319999999999993 109.415 174.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -75.16 -38.91 60.76 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.184 0.516 . . . . 65.310000000000002 109.951 170.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.8 t -161.73 152.7 18.07 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.22 -0.9 . . . . 71.430000000000007 111.388 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -128.55 132.74 48.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.946 0.899 . . . . 72.409999999999997 110.076 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -134.57 143.83 47.6 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.413 0.685 . . . . 63.520000000000003 111.415 -171.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -98.27 94.16 6.62 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.69 -0.856 . . . . 71.239999999999995 108.69 170.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -136.56 155.9 49.32 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.522 0.729 . . . . 74.209999999999994 110.992 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.2 m -84.11 119.54 25.1 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.15 -0.685 . . . . 54.210000000000001 109.15 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 53' ' ' ILE . 15.8 m -107.24 135.33 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.853 0.861 . . . . 60.130000000000003 109.049 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.462 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 86.3 m-85 -109.82 135.88 50.01 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.451 0.643 . . . . 72.519999999999996 111.475 -174.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.3 ttp -90.18 111.74 23.01 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.319 -1.363 . . . . 74.140000000000001 107.319 167.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.49 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 27.3 m -124.08 144.91 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 113.435 0.902 . . . . 61.130000000000003 113.435 -170.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -109.61 118.22 36.01 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.942 1.297 . . . . 55.100000000000001 108.315 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.45 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 55.0 p90 -139.6 166.66 24.0 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.265 0.839 . . . . 53.240000000000002 113.265 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.2 m -100.39 109.34 21.5 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.963 -1.017 . . . . 55.439999999999998 109.333 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.2 m -57.54 106.06 0.3 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.3 0.64 . . . . 65.329999999999998 111.181 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.7 p -61.4 -23.05 65.53 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.0 0.92 . . . . 75.040000000000006 113.295 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.8 t -65.88 -25.99 67.43 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.428 0.899 . . . . 73.230000000000004 113.428 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.2 t -142.63 -42.55 0.32 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.636 0.606 . . . . 74.040000000000006 112.636 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.01 -8.89 18.6 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 123.259 0.457 . . . . 71.120000000000005 113.141 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.21 139.54 54.53 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.86 0.864 . . . . 64.219999999999999 111.955 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -85.0 114.74 22.39 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.4 0.68 . . . . 74.120000000000005 111.151 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.1 t -88.84 104.9 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 108.075 -1.083 . . . . 73.120000000000005 108.075 171.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -93.84 131.8 38.89 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.396 -0.82 . . . . 74.219999999999999 110.721 -168.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.5 p30 45.48 52.9 8.8 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 125.29 1.436 . . . . 74.420000000000002 114.286 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -57.83 139.7 53.48 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.542 1.137 . . . . 75.450000000000003 112.876 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 68.1 mttm -131.67 128.39 38.92 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 124.249 1.02 . . . . 71.120000000000005 111.063 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 94.3 m95 -120.81 160.97 22.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.918 1.687 . . . . 65.239999999999995 111.203 -13.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.73 166.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 124.31 1.044 . . . . 74.140000000000001 109.806 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 53.2 p -117.18 167.4 11.23 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.098 0.559 . . . . 62.219999999999999 111.214 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.462 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 36.0 tt0 -67.24 -24.57 65.83 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.782 0.433 . . . . 73.519999999999996 111.601 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.2 -30.91 71.94 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.442 0.697 . . . . 70.219999999999999 111.441 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -93.65 -3.11 53.06 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.15 0.98 . . . . 70.0 111.942 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.6 mt -117.1 123.46 46.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.808 0.843 . . . . 61.240000000000002 109.639 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.43 ' O ' ' HB ' ' A' ' 7' ' ' VAL . 58.0 m -104.0 150.63 24.07 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.682 -0.858 . . . . 74.200000000000003 108.682 172.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.17 169.8 9.7 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.205 0.457 . . . . 74.040000000000006 111.38 174.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.5 tptp . . . . . 0 CA--C 1.564 1.487 0 C-N-CA 123.011 0.525 . . . . 65.329999999999998 111.285 177.802 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.404 ' HB3' HG21 ' A' ' 24' ' ' VAL . 23.7 mmt . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 110.934 -0.025 . . . . 44.399999999999999 110.934 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.532 ' H ' ' HD2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -110.36 149.19 30.59 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.35 0.66 . . . . 65.420000000000002 110.669 178.009 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.37 130.04 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 123.333 0.653 . . . . 73.430000000000007 111.414 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.73 -8.75 56.56 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 115.42 -0.809 . . . . 72.519999999999996 113.081 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.1 t -85.4 151.51 23.95 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.577 0.584 . . . . 74.109999999999999 112.577 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -100.59 117.46 34.77 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.153 0.981 . . . . 74.109999999999999 110.266 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.48 154.88 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.947 0.899 . . . . 55.140000000000001 111.293 -176.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.8 mm -100.61 133.51 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.23 1.012 . . . . 74.430000000000007 110.511 172.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 17' ' ' MET . 33.0 mt -84.63 123.91 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 122.162 -0.336 . . . . 74.400000000000006 110.325 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -100.66 -46.55 5.14 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.274 0.63 . . . . 62.509999999999998 112.46 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 79.0 m -109.14 140.83 42.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.717 0.807 . . . . 62.539999999999999 109.293 -176.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 17' ' ' MET . 13.7 m -160.46 163.46 32.97 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.631 0.604 . . . . 41.25 112.631 -169.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -95.79 -40.34 9.4 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.414 -0.812 . . . . 75.019999999999996 109.053 164.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.6 mpt? -84.02 142.06 30.73 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.998 0.919 . . . . 45.420000000000002 111.028 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 12.2 mptt -72.18 -26.71 62.18 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.299 0.64 . . . . 70.140000000000001 112.016 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.62 -4.77 81.89 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 114.999 0.76 . . . . 33.450000000000003 114.999 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.43 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 63.4 mtt -87.87 -26.29 22.85 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 117.558 0.679 . . . . 52.240000000000002 112.364 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 25.6 pttm -61.75 118.84 7.67 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.154 0.502 . . . . 72.420000000000002 111.522 -175.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.1 1.94 70.5 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 113.939 0.336 . . . . 64.400000000000006 113.939 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.12 138.38 47.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.292 0.637 . . . . 73.329999999999998 112.279 -177.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -78.87 97.61 6.04 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.521 0.728 . . . . 71.140000000000001 110.11 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.56 157.31 16.04 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.23 1.012 . . . . 72.25 111.601 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.3 m -126.73 124.27 39.37 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.992 -0.744 . . . . 65.129999999999995 108.992 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.423 ' HA ' HG12 ' A' ' 99' ' ' VAL . 46.6 t -72.75 102.17 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.241 0.616 . . . . 55.530000000000001 110.001 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.9 p -99.92 -2.76 33.91 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.334 0.654 . . . . 71.140000000000001 112.718 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.07 151.81 20.95 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 112.283 -0.327 . . . . 72.299999999999997 112.283 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.93 108.82 7.59 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.756 0.822 . . . . 74.409999999999997 110.558 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.407 ' HB2' HG23 ' A' ' 96' ' ' VAL . 4.6 m-85 -108.87 122.63 47.59 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.959 0.904 . . . . 71.310000000000002 110.597 -174.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -100.01 83.24 2.67 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 122.058 0.932 . . . . 64.019999999999996 109.74 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.3 t -133.95 170.4 15.68 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 115.506 -0.77 . . . . 54.020000000000003 111.443 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.2 m -87.51 122.66 31.51 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.97 0.508 . . . . 50.350000000000001 109.96 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.1 154.77 27.18 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.16 0.984 . . . . 44.119999999999997 109.989 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.429 ' HB2' HG23 ' A' ' 52' ' ' VAL . 91.5 m-85 -130.28 149.4 51.99 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.916 0.865 . . . . 75.129999999999995 113.099 -169.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -102.25 111.17 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 113.941 -1.482 . . . . 74.109999999999999 108.055 171.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.494 HG12 HD13 ' A' ' 88' ' ' ILE . 22.2 m -125.12 146.99 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 113.203 0.816 . . . . 54.409999999999997 113.203 -172.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 66.6 p -117.73 129.98 56.04 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.374 1.07 . . . . 74.329999999999998 110.775 176.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.642 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 37.9 p90 -159.09 160.35 35.61 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.569 0.7 . . . . 75.209999999999994 111.639 -171.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.0 m -113.55 116.76 45.69 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 107.511 -1.292 . . . . 54.310000000000002 107.511 173.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.43 147.17 17.37 Favored 'Trans proline' 0 CA--C 1.564 2.013 0 C-N-CA 123.228 2.618 . . . . 73.129999999999995 113.271 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.5 p -63.55 -18.79 64.23 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.697 0.799 . . . . 75.329999999999998 111.998 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.76 -21.4 66.51 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.957 0.903 . . . . 70.299999999999997 111.984 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 33.35 70.63 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 114.782 0.673 . . . . 75.129999999999995 114.782 172.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.09 -113.62 2.68 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-N 117.16 0.48 . . . . 60.530000000000001 111.961 174.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -70.65 175.36 4.96 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.684 0.794 . . . . 72.420000000000002 112.934 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -116.78 129.29 56.01 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.165 -0.925 . . . . 73.329999999999998 108.64 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.29 102.62 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 122.969 0.508 . . . . 71.099999999999994 109.952 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.7 p-10 -109.97 153.91 23.9 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.698 0.799 . . . . 65.109999999999999 111.218 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 34.5 m80 55.63 33.78 21.92 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.21 1.004 . . . . 63.039999999999999 112.303 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -70.91 134.74 47.49 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.912 1.285 . . . . 70.530000000000001 111.59 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 18.0 ptpt -139.7 139.38 36.56 Favored 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.68 0.792 . . . . 73.200000000000003 110.723 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 92.3 m95 -115.97 149.28 39.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 119.86 -1.775 . . . . 73.450000000000003 112.419 -3.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.429 HG23 ' HB2' ' A' ' 33' ' ' TYR . 15.8 m -127.36 132.84 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 114.519 -1.219 . . . . 73.510000000000005 109.131 170.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.2 pt -104.31 176.17 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.9 -0.5 . . . . 74.200000000000003 112.324 -171.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.457 ' NE2' ' HB1' ' A' ' 60' ' ' ALA . 16.1 mm100 -45.07 -52.55 8.9 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.544 1.138 . . . . 64.040000000000006 113.773 171.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.01 -16.26 63.14 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.59 0.756 . . . . 74.519999999999996 111.976 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.607 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 7.9 tt0 -93.53 -17.03 23.84 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.418 1.087 . . . . 70.239999999999995 111.423 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.2 mt -111.94 127.4 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.208 1.003 . . . . 74.150000000000006 110.838 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -61.82 -56.16 22.31 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.685 0.794 . . . . 71.150000000000006 112.057 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.27 -17.43 62.49 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.633 0.975 . . . . 74.219999999999999 113.633 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.623 ' HA ' HD11 ' A' ' 65' ' ' LEU . . . -38.12 -47.03 1.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.869 1.433 . . . . 60.350000000000001 114.869 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.65 18.04 67.63 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 114.871 0.708 . . . . 74.239999999999995 114.871 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 63.65 17.86 10.71 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.945 1.298 . . . . 73.200000000000003 112.719 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.2 171.54 7.45 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.84 0.856 . . . . 72.439999999999998 110.466 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.1 m -89.97 112.68 24.15 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.306 -0.628 . . . . 71.230000000000004 109.306 173.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.623 HD11 ' HA ' ' A' ' 60' ' ' ALA . 49.5 mt -74.45 130.23 39.24 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.617 0.767 . . . . 73.019999999999996 110.618 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -100.43 152.91 37.97 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 123.634 0.773 . . . . 75.239999999999995 111.269 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -54.24 114.42 1.81 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.971 2.447 . . . . 44.509999999999998 113.685 177.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.95 -10.34 18.2 Favored Glycine 0 N--CA 1.481 1.655 0 CA-C-N 115.845 -0.616 . . . . 42.109999999999999 114.13 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -77.56 133.49 38.48 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.626 0.713 . . . . 74.310000000000002 112.353 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -98.31 120.36 38.6 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.2 -0.909 . . . . 45.140000000000001 109.184 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.568 HG11 HD13 ' A' ' 65' ' ' LEU . 19.4 m -124.7 169.98 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.574 0.75 . . . . 65.140000000000001 112.355 -171.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mm -117.37 141.15 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.936 0.894 . . . . 75.409999999999997 109.938 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.29 124.2 40.2 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.56 0.744 . . . . 64.519999999999996 111.363 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.01 -36.39 19.79 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 122.936 0.494 . . . . 74.439999999999998 112.322 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.607 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -86.82 169.52 12.51 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.07 0.462 . . . . 61.409999999999997 111.305 175.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.759 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 8.7 t -142.62 126.1 16.75 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.308 -0.405 . . . . 70.439999999999998 111.122 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -95.73 -28.05 14.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.588 0.755 . . . . 74.0 111.024 169.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 60.1 mtm -133.75 177.04 8.02 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.669 0.788 . . . . 74.510000000000005 111.86 -170.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -68.07 106.23 2.31 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-O 121.586 0.707 . . . . 65.530000000000001 112.043 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.14 22.98 36.2 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 116.023 -0.535 . . . . 75.129999999999995 114.293 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -85.06 -38.66 18.89 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 117.495 0.647 . . . . 65.200000000000003 111.04 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.759 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 59.3 tttp -67.04 124.83 24.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.038 0.535 . . . . 55.219999999999999 110.845 170.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.74 0.24 87.79 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-O 120.196 -0.224 . . . . 61.409999999999997 113.013 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.55 151.51 25.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.181 0.592 . . . . 75.109999999999999 111.358 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 51.2 m -92.08 117.74 30.13 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.332 -0.849 . . . . 75.540000000000006 109.888 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.642 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -105.69 150.79 25.15 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.557 0.743 . . . . 73.450000000000003 110.902 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -114.86 121.08 42.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.296 1.038 . . . . 73.099999999999994 110.153 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.494 HD13 HG12 ' A' ' 35' ' ' VAL . 36.9 mm -68.87 109.26 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 122.346 0.258 . . . . 61.210000000000001 110.753 -178.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -82.58 -37.13 25.51 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.262 0.625 . . . . 74.030000000000001 110.713 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.9 t -162.79 153.92 17.37 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.23 0.612 . . . . 73.510000000000005 111.727 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.89 132.57 56.66 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.25 1.02 . . . . 61.409999999999997 110.442 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -129.26 130.91 46.82 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.382 0.673 . . . . 70.430000000000007 112.222 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -92.91 93.26 8.29 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 108.248 -1.019 . . . . 73.420000000000002 108.248 167.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.8 t -138.25 154.22 49.07 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.275 0.63 . . . . 62.350000000000001 111.627 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.0 m -88.26 124.54 33.97 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.52 -0.548 . . . . 71.430000000000007 109.52 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.407 HG23 ' HB2' ' A' ' 28' ' ' TYR . 16.5 m -110.02 131.95 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 108.921 -0.77 . . . . 72.109999999999999 108.921 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.73 141.69 36.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.212 1.005 . . . . 70.109999999999999 111.423 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.6 ttp -93.65 115.76 28.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 108.367 -0.975 . . . . 74.340000000000003 108.367 171.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 24' ' ' VAL . 35.5 m -126.21 166.88 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 112.482 0.549 . . . . 60.240000000000002 112.482 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -133.74 129.12 36.25 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.781 0.432 . . . . 62.100000000000001 111.767 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -138.29 176.04 9.05 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.883 0.873 . . . . 62.539999999999999 111.541 -173.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.5 m -114.41 134.57 54.89 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.652 0.781 . . . . 72.530000000000001 109.496 171.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.3 t -68.25 119.53 12.95 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.319 0.648 . . . . 71.120000000000005 111.589 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.5 p -71.0 -26.11 62.98 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.862 0.865 . . . . 70.450000000000003 112.651 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.3 p -81.55 -56.64 3.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.82 0.448 . . . . 64.439999999999998 111.417 175.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.7 t -92.25 -51.06 5.34 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.72 0.808 . . . . 40.520000000000003 112.789 -172.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.44 -15.96 19.78 Favored Glycine 0 N--CA 1.478 1.492 0 CA-C-N 116.03 -0.532 . . . . 20.120000000000001 112.7 -168.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -51.29 113.48 0.96 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.854 1.262 . . . . 53.399999999999999 112.467 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -80.48 120.65 24.76 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.265 -0.643 . . . . 44.329999999999998 109.265 173.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.0 t -111.11 123.22 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.646 0.778 . . . . 72.239999999999995 109.111 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -113.4 153.76 28.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.943 0.497 . . . . 63.240000000000002 111.606 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 56.4 29.12 14.64 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.448 1.099 . . . . 62.439999999999998 113.211 177.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -59.31 139.68 56.77 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.033 0.933 . . . . 74.230000000000004 113.27 -174.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 66.6 mttm -142.11 135.07 28.72 Favored 'General case' 0 CA--C 1.572 1.804 0 C-N-CA 125.361 1.464 . . . . 62.450000000000003 110.088 -175.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 80.7 m95 -114.4 143.51 44.81 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.36 1.891 . . . . 72.310000000000002 111.5 -11.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.57 141.86 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 124.435 1.094 . . . . 72.439999999999998 108.944 170.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 69.3 p -100.6 -177.93 3.63 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.67 0.748 . . . . 74.540000000000006 112.264 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -55.95 -28.47 57.11 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 124.821 1.249 . . . . 64.409999999999997 111.776 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.07 -28.48 60.37 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.902 0.881 . . . . 74.239999999999995 112.095 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.452 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 1.5 mp0 -87.77 -9.23 54.56 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.6 0.36 . . . . 73.319999999999993 111.881 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.4 mt -121.45 127.26 50.93 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.171 0.589 . . . . 73.010000000000005 110.815 -172.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.5 m -118.91 133.12 56.04 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.162 0.985 . . . . 61.509999999999998 109.289 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.35 155.77 31.28 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.64 0.376 . . . . 61.329999999999998 111.896 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.5 tptp . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 121.066 0.46 . . . . 70.519999999999996 110.482 178.731 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.417 ' HG2' HG21 ' A' ' 24' ' ' VAL . 49.4 tpp . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 110.102 -0.333 . . . . 71.340000000000003 110.102 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -92.96 155.99 17.2 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.291 0.567 . . . . 71.010000000000005 112.343 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.8 t -68.12 136.12 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 123.859 0.863 . . . . 75.040000000000006 110.821 173.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.22 -12.04 66.96 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 116.077 -0.51 . . . . 74.129999999999995 113.399 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.1 t -76.38 141.05 41.59 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 117.417 0.608 . . . . 33.340000000000003 111.738 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -99.25 121.46 41.08 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.236 0.615 . . . . 74.340000000000003 110.218 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.512 ' HA ' ' H ' ' A' ' 124' ' ' LYS . 32.7 m -125.24 156.16 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.091 0.956 . . . . 70.430000000000007 111.571 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.518 HD13 ' HA ' ' A' ' 21' ' ' GLU . 35.9 mm -103.96 135.71 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.493 -0.929 . . . . 73.129999999999995 108.493 165.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.3 mt -88.59 119.86 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 109.268 -0.641 . . . . 71.219999999999999 109.268 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.66 -28.82 17.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 122.089 -0.382 . . . . 72.230000000000004 111.814 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.495 ' HB ' ' HG2' ' A' ' 120' ' ' GLU . 66.4 m -136.28 141.95 43.9 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.043 0.937 . . . . 72.340000000000003 109.416 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -169.4 174.0 6.24 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.41 0.624 . . . . 72.120000000000005 112.148 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -98.41 2.19 47.6 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.238 -0.892 . . . . 74.430000000000007 112.425 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 23.3 mmt -115.4 127.34 55.3 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.508 0.723 . . . . 73.25 109.278 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' HD3' ' H ' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -52.98 -41.87 65.0 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.393 1.077 . . . . 61.100000000000001 112.877 179.322 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.35 -8.23 85.46 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.371 0.509 . . . . 74.510000000000005 114.371 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 42.7 ttp -96.14 -28.93 14.34 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 117.285 0.542 . . . . 74.340000000000003 110.334 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -69.26 119.64 13.84 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.152 0.581 . . . . 74.209999999999994 109.627 173.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.6 2.5 89.97 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 115.399 -0.819 . . . . 44.329999999999998 114.358 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.88 161.89 18.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 113.55 0.945 . . . . 73.430000000000007 113.55 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.518 ' HA ' HD13 ' A' ' 8' ' ' ILE . 10.9 tp10 -76.99 138.73 39.79 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.89 -1.05 . . . . 74.439999999999998 110.439 172.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.77 166.67 30.66 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.436 0.636 . . . . 62.350000000000001 112.672 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.5 m -138.53 129.22 26.42 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.702 0.801 . . . . 53.130000000000003 110.408 173.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.417 HG21 ' HG2' ' A' ' 1' ' ' MET . 80.8 t -77.71 104.73 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.513 0.725 . . . . 54.350000000000001 109.741 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.7 p -103.02 -2.42 27.59 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.567 0.747 . . . . 62.109999999999999 112.394 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.47 142.44 9.05 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-O 120.076 -0.291 . . . . 54.420000000000002 112.494 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.97 111.36 14.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.421 0.688 . . . . 70.310000000000002 111.231 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -118.08 110.11 17.24 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.303 1.041 . . . . 74.109999999999999 110.203 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.21 76.3 3.02 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 122.159 0.981 . . . . 70.349999999999994 108.99 174.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -133.06 168.95 17.57 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.736 -0.665 . . . . 43.5 112.258 -169.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 m -70.55 119.77 15.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.122 0.569 . . . . 72.349999999999994 111.116 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.36 146.51 28.72 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.6 0.76 . . . . 65.400000000000006 109.421 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -127.98 148.04 50.51 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.985 0.898 . . . . 64.230000000000004 111.713 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.0 t -102.61 109.7 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 114.156 -1.383 . . . . 74.040000000000006 107.707 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.456 HG12 HD13 ' A' ' 88' ' ' ILE . 30.6 m -111.63 167.43 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 118.533 0.606 . . . . 64.219999999999999 112.301 -175.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.3 p -141.59 126.58 18.3 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.192 0.597 . . . . 43.32 110.588 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -161.99 128.29 3.67 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 112.772 0.656 . . . . 73.209999999999994 112.772 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 73.3 m -71.07 117.76 59.38 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-O 119.083 -0.484 . . . . 73.200000000000003 110.099 159.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.57 140.6 94.62 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.143 2.562 . . . . 70.439999999999998 113.235 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.7 p -64.61 -16.05 62.1 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 114.43 1.27 . . . . 71.299999999999997 114.43 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.492 ' ND2' ' HB3' ' A' ' 79' ' ' LYS . 28.0 p-10 -79.39 -6.02 55.89 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.061 0.545 . . . . 72.329999999999998 112.429 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.34 45.99 5.99 Favored Glycine 0 CA--C 1.535 1.281 0 N-CA-C 112.108 -0.397 . . . . 64.150000000000006 112.108 -172.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.57 -177.9 39.79 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 122.932 0.301 . . . . 61.329999999999998 112.961 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -65.16 123.32 19.22 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 119.277 -0.392 . . . . 75.129999999999995 110.177 173.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 12.2 ttm180 -51.95 111.08 0.55 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.216 0.606 . . . . 72.25 111.6 173.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 49' ' ' HIS . 21.6 t -88.54 102.76 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 115.532 -0.758 . . . . 63.32 110.248 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -97.89 143.01 28.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.703 0.801 . . . . 75.430000000000007 110.43 -177.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.7 m170 56.96 33.92 24.07 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.763 0.825 . . . . 35.210000000000001 111.871 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.573 ' HB2' HG12 ' A' ' 46' ' ' VAL . 85.7 t60 -62.95 132.67 52.83 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.409 1.084 . . . . 61.130000000000003 111.85 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -154.99 152.31 29.53 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 114.562 -1.199 . . . . 72.129999999999995 109.492 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.6 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 72.7 m95 -106.36 126.17 51.91 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.254 -1.529 . . . . 72.439999999999998 112.35 4.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.3 m -113.89 133.67 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.377 1.071 . . . . 63.229999999999997 108.625 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.6 pt -97.12 157.6 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-O 120.85 0.357 . . . . 71.540000000000006 110.675 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -54.57 -36.59 64.55 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.606 0.762 . . . . 72.109999999999999 112.922 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -70.76 -14.34 62.4 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.142 0.577 . . . . 72.120000000000005 112.211 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -94.69 -19.66 20.21 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.246 1.018 . . . . 75.120000000000005 111.268 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.5 mt -89.07 137.32 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.583 0.753 . . . . 74.409999999999997 109.968 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.551 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 36.8 ttpt -76.67 -45.29 30.34 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.039 0.536 . . . . 61.109999999999999 111.496 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.467 ' HB3' HG12 ' A' ' 71' ' ' VAL . 5.9 t70 -68.51 -9.54 49.78 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.686 0.794 . . . . 62.32 112.625 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.582 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -42.21 -65.23 0.48 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.781 1.4 . . . . 64.420000000000002 114.781 176.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.47 13.53 58.57 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 114.894 0.718 . . . . 40.439999999999998 114.894 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.71 13.89 7.76 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.197 1.399 . . . . 61.530000000000001 112.779 -172.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -98.96 155.18 17.54 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.768 0.827 . . . . 72.299999999999997 110.48 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.9 m -72.65 109.21 6.12 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.389 0.276 . . . . 70.120000000000005 111.009 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.418 HD11 ' HA ' ' A' ' 60' ' ' ALA . 62.9 mt -86.63 146.23 26.41 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.361 0.665 . . . . 71.420000000000002 109.242 173.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -139.28 169.06 13.22 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 124.01 0.924 . . . . 64.510000000000005 110.741 -171.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 1.4 Cg_endo -44.1 109.6 0.16 Allowed 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 123.331 2.687 . . . . 63.439999999999998 114.459 172.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.91 -17.27 13.12 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.262 0.865 . . . . 40.530000000000001 115.262 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.99 120.94 14.02 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 118.413 1.106 . . . . 75.319999999999993 111.526 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -89.72 119.34 30.04 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.289 -0.634 . . . . 61.210000000000001 109.289 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' A' ' 59' ' ' ASP . 32.0 m -124.07 168.01 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.644 0.777 . . . . 72.549999999999997 111.76 -172.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.8 mm -118.74 137.91 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 123.409 0.684 . . . . 45.240000000000002 110.083 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.5 mt -92.4 109.34 20.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.821 0.848 . . . . 72.510000000000005 110.638 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.551 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 67.9 mm-40 -83.11 -9.93 58.95 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.55 0.945 . . . . 52.109999999999999 113.55 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.2 170.55 8.38 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.403 0.62 . . . . 63.219999999999999 111.065 174.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 81' ' ' MET . 31.1 t -143.81 125.42 14.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.403 -0.817 . . . . 73.510000000000005 109.173 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -103.72 -4.74 23.3 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.626 0.77 . . . . 73.450000000000003 110.465 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -165.88 -176.07 3.67 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.691 0.796 . . . . 72.420000000000002 111.386 -168.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HB3' ' ND2' ' A' ' 41' ' ' ASN . 5.5 mptp? -59.35 114.36 2.63 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 112.803 0.668 . . . . 72.0 112.803 177.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.82 27.36 67.1 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.807 1.083 . . . . 74.519999999999996 115.807 169.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.47 ' HB3' ' HA ' ' A' ' 76' ' ' SER . 27.2 ttt -83.58 -42.18 17.06 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 118.025 0.913 . . . . 54.329999999999998 111.809 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.29 130.89 44.98 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 120.693 0.282 . . . . 73.230000000000004 111.612 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.12 80.77 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.102 -0.499 . . . . 53.5 113.054 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.58 139.68 42.23 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.096 0.558 . . . . 62.399999999999999 111.982 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.9 m -84.01 120.05 25.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.228 -0.896 . . . . 71.150000000000006 108.889 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.453 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -117.46 162.92 17.18 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.971 0.908 . . . . 55.229999999999997 110.06 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -127.72 134.08 49.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.632 -0.507 . . . . 73.340000000000003 109.632 172.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.456 HD13 HG12 ' A' ' 35' ' ' VAL . 28.5 mm -66.93 104.21 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 N-CA-C 109.378 -0.601 . . . . 73.319999999999993 109.378 174.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.25 -40.74 77.67 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.377 1.071 . . . . 64.109999999999999 110.419 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.8 m -154.77 149.02 26.02 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.731 0.813 . . . . 63.399999999999999 110.599 -176.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.0 130.76 53.14 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.898 0.879 . . . . 64.129999999999995 108.89 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -140.88 115.47 9.51 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 121.132 0.491 . . . . 70.239999999999995 112.281 -168.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.04 94.2 9.86 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.365 0.666 . . . . 54.409999999999997 109.56 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 t -137.96 154.17 49.4 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.493 0.717 . . . . 64.129999999999995 110.068 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.7 m -84.21 128.26 34.45 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.889 -0.412 . . . . 72.209999999999994 109.889 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 m -111.61 134.55 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.612 0.765 . . . . 63.140000000000001 109.539 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.05 140.22 49.49 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.423 0.689 . . . . 71.329999999999998 112.314 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.3 ttp -89.69 112.44 23.71 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.881 -1.054 . . . . 54.210000000000001 108.28 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.68 145.85 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 112.826 0.676 . . . . 72.230000000000004 112.826 -170.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.84 115.68 30.93 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.488 -0.93 . . . . 73.519999999999996 108.488 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -127.97 158.82 36.83 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.218 0.463 . . . . 74.519999999999996 111.758 -173.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.7 m -104.25 104.16 14.02 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.425 -0.583 . . . . 74.049999999999997 109.425 172.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 108' ' ' GLU . 36.0 t -59.61 109.24 0.86 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.862 0.865 . . . . 74.420000000000002 111.546 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.2 p -62.26 -14.21 36.21 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.824 1.25 . . . . 72.129999999999995 113.297 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 78.8 m -58.79 -57.28 13.71 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.68 0.792 . . . . 64.319999999999993 112.498 174.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.5 p -126.32 -2.06 6.92 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.214 0.606 . . . . 50.530000000000001 112.574 -172.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.97 84.91 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 120.063 -0.298 . . . . 63.32 113.404 -170.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 103' ' ' SER . 38.1 tt0 -59.35 113.26 2.08 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.517 1.127 . . . . 65.310000000000002 112.003 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -88.7 125.63 34.94 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.681 0.753 . . . . 73.540000000000006 109.184 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -119.14 132.28 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.39 1.076 . . . . 74.230000000000004 109.12 -170.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 133.51 50.74 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 120.775 0.322 . . . . 73.040000000000006 110.297 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.6 m120 55.28 54.78 8.24 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 125.079 1.352 . . . . 73.510000000000005 113.857 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -63.91 141.92 58.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.416 0.686 . . . . 61.329999999999998 111.598 170.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 98.9 mttt -137.67 127.42 25.38 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.742 0.817 . . . . 72.239999999999995 111.053 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.6 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 85.7 m95 -120.55 165.46 14.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.198 -1.564 . . . . 71.540000000000006 112.258 -12.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.418 HG21 HD21 ' A' ' 121' ' ' LEU . 20.2 m -124.05 168.32 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 113.786 -1.552 . . . . 54.240000000000002 107.72 162.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 40.3 p -117.61 169.84 9.24 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.827 0.739 . . . . 64.219999999999999 112.282 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -53.2 -40.86 64.76 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.13 0.972 . . . . 75.540000000000006 111.279 172.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.66 -29.45 70.68 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.385 1.074 . . . . 53.119999999999997 111.774 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.495 ' HG2' ' HB ' ' A' ' 11' ' ' THR . 56.8 mt-10 -94.0 0.19 55.86 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.891 0.876 . . . . 63.439999999999998 112.078 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.418 HD21 HG21 ' A' ' 116' ' ' VAL . 83.6 mt -117.87 152.65 34.96 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.805 0.842 . . . . 63.100000000000001 110.244 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.5 m -146.84 122.94 10.8 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.099 -1.075 . . . . 73.299999999999997 108.099 173.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -59.77 105.6 0.39 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 118.28 0.491 . . . . 75.519999999999996 110.975 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.512 ' H ' ' HA ' ' A' ' 7' ' ' VAL . 56.2 tptt . . . . . 0 CA--C 1.569 1.682 0 C-N-CA 124.992 1.317 . . . . 75.349999999999994 113.251 -167.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.319 -0.252 . . . . 74.349999999999994 110.319 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.4 160.73 18.1 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.295 0.638 . . . . 71.549999999999997 111.849 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.18 131.6 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.461 0.704 . . . . 65.349999999999994 111.704 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.18 -10.28 43.38 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 115.818 -0.628 . . . . 61.32 112.782 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.4 t -81.13 145.14 31.21 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.236 0.614 . . . . 72.340000000000003 112.186 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -94.92 116.5 28.78 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.84 0.856 . . . . 73.200000000000003 109.058 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.23 153.43 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.131 0.972 . . . . 75.109999999999999 110.678 -174.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 mm -100.15 134.68 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 109.292 -0.633 . . . . 55.420000000000002 109.292 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.441 HG21 ' HG2' ' A' ' 17' ' ' MET . 63.3 mt -78.42 104.07 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.946 -0.472 . . . . 74.420000000000002 109.732 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -78.35 -32.8 49.22 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.188 0.595 . . . . 63.409999999999997 111.367 -168.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 t -144.47 164.97 29.28 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.205 0.602 . . . . 63.009999999999998 110.061 168.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 98.8 p -157.18 167.07 31.45 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.379 0.609 . . . . 62.43 112.431 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -91.4 -37.49 13.17 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.091 -0.959 . . . . 61.43 109.884 168.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.5 mpt? -85.49 132.85 34.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.835 0.854 . . . . 71.030000000000001 110.748 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -58.97 -38.45 79.13 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.553 0.741 . . . . 54.340000000000003 112.494 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.22 -6.65 87.76 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 114.545 0.578 . . . . 71.299999999999997 114.545 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.441 ' HG2' HG21 ' A' ' 9' ' ' ILE . 41.8 ttp -94.85 -28.66 15.12 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 117.821 0.811 . . . . 71.450000000000003 112.13 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.19 128.6 37.15 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.13 0.49 . . . . 71.549999999999997 111.85 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.47 0.27 88.89 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-N 115.563 -0.744 . . . . 64.150000000000006 113.958 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.55 149.46 29.95 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.357 0.663 . . . . 44.200000000000003 110.851 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -90.95 106.53 18.59 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.919 0.39 . . . . 63.420000000000002 110.267 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.545 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -88.55 169.84 11.38 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.681 0.792 . . . . 72.109999999999999 111.767 175.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.7 m -136.89 134.54 36.95 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.165 -0.68 . . . . 52.539999999999999 109.165 171.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.79 105.69 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 123.127 0.571 . . . . 52.219999999999999 110.856 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.4 p -92.63 -15.76 26.42 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.31 0.644 . . . . 34.520000000000003 111.738 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.51 146.3 13.66 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.4 -0.28 . . . . 72.299999999999997 112.4 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.17 125.35 31.01 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.868 0.867 . . . . 41.210000000000001 109.544 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.601 ' HB2' HG23 ' A' ' 96' ' ' VAL . 58.1 m-85 -128.46 130.64 47.85 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.584 0.754 . . . . 72.439999999999998 110.816 -171.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -107.31 79.49 1.31 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 122.153 0.978 . . . . 70.010000000000005 110.073 174.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 t -133.43 162.61 31.4 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.186 -0.915 . . . . 64.010000000000005 110.425 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.8 m -65.89 119.9 12.12 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.833 0.453 . . . . 71.099999999999994 110.577 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.41 153.48 23.94 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.011 0.924 . . . . 71.319999999999993 109.846 -176.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -133.95 147.42 51.05 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.902 0.858 . . . . 64.5 112.078 -170.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.95 115.0 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 106.804 -1.554 . . . . 72.030000000000001 106.804 167.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.457 HG12 HD13 ' A' ' 88' ' ' ILE . 31.6 m -122.13 154.75 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-O 121.492 0.663 . . . . 71.349999999999994 112.751 -173.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 61.7 p -121.22 124.52 44.86 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.248 1.019 . . . . 75.040000000000006 109.667 173.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -142.64 154.59 44.51 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.308 0.643 . . . . 73.109999999999999 110.682 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.0 m -102.89 107.22 54.06 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.902 -1.147 . . . . 71.310000000000002 107.902 171.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.32 133.9 45.8 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.304 2.002 . . . . 74.030000000000001 111.326 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 72.8 p -68.66 -2.27 8.78 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.502 0.927 . . . . 73.120000000000005 113.502 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -64.24 -21.47 66.59 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.298 0.639 . . . . 75.140000000000001 111.087 165.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.57 29.73 38.72 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 114.981 0.752 . . . . 72.319999999999993 114.981 169.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.35 -109.03 1.55 Allowed Glycine 0 CA--C 1.537 1.439 0 CA-C-N 117.519 0.66 . . . . 64.329999999999998 112.9 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -109.6 141.33 42.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.943 0.897 . . . . 73.120000000000005 110.172 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -63.11 124.42 21.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.283 0.633 . . . . 74.340000000000003 111.182 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.645 HG21 ' SD ' ' A' ' 78' ' ' MET . 48.5 t -90.28 114.01 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.362 0.665 . . . . 73.420000000000002 109.985 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -105.96 151.52 24.5 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.017 0.527 . . . . 74.349999999999994 110.97 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.9 m80 55.72 29.99 14.8 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.213 1.005 . . . . 63.100000000000001 113.166 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.437 ' HB2' HG12 ' A' ' 46' ' ' VAL . 60.0 t60 -72.3 118.72 15.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.992 0.917 . . . . 72.409999999999997 110.43 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 59.2 pttt -133.06 146.8 52.01 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 115.929 -0.578 . . . . 75.040000000000006 111.629 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 92.7 m95 -110.83 152.46 26.64 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.446 -1.409 . . . . 75.120000000000005 112.209 0.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.16 136.41 60.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.1 -1.409 . . . . 52.32 107.747 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.456 HG21 HG21 ' A' ' 96' ' ' VAL . 39.9 pt -101.55 166.37 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.637 -0.664 . . . . 74.310000000000002 112.143 -172.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.86 -33.74 67.13 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.841 0.856 . . . . 72.510000000000005 111.88 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -71.94 -21.23 61.64 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.064 0.546 . . . . 72.150000000000006 112.422 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -83.08 -33.83 26.3 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.938 0.895 . . . . 74.150000000000006 110.948 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.0 mt -86.85 132.19 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.079 0.552 . . . . 74.450000000000003 110.984 -171.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.524 ' HB2' ' HG3' ' A' ' 74' ' ' GLU . 59.0 tttm -60.43 -43.67 96.54 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.998 0.919 . . . . 74.349999999999994 112.167 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.36 -7.63 50.63 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 123.775 0.83 . . . . 73.420000000000002 113.154 -174.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.511 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -33.98 -67.02 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.96 1.467 . . . . 40.329999999999998 114.96 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.81 25.7 70.71 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 114.956 0.742 . . . . 65.400000000000006 114.956 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 64.32 9.43 4.87 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.527 1.131 . . . . 63.409999999999997 113.231 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 24.8 pttm -109.66 167.59 10.04 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.457 0.703 . . . . 65.430000000000007 111.357 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 m -91.89 119.54 31.75 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.286 0.634 . . . . 73.239999999999995 110.225 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.61 HD13 HG11 ' A' ' 71' ' ' VAL . 44.6 mt -79.64 127.92 32.76 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.362 0.665 . . . . 61.520000000000003 110.8 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -89.46 153.37 48.24 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.671 0.788 . . . . 63.039999999999999 111.283 -173.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.27 115.39 2.26 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.423 2.082 . . . . 74.420000000000002 113.277 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.33 -19.39 14.86 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.534 -0.757 . . . . 74.329999999999998 113.608 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.04 130.82 47.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.381 0.673 . . . . 65.049999999999997 112.189 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -90.84 120.43 31.86 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.504 -0.771 . . . . 64.519999999999996 109.312 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.61 HG11 HD13 ' A' ' 65' ' ' LEU . 32.4 m -134.43 174.68 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 C-N-CA 124.367 1.067 . . . . 73.200000000000003 111.321 -171.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.31 141.95 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.895 0.878 . . . . 63.229999999999997 109.861 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 mt -96.96 131.04 44.16 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.641 0.777 . . . . 62.009999999999998 111.596 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.524 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 36.2 mt-10 -101.0 9.44 42.24 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 113.464 0.913 . . . . 75.25 113.464 175.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.38 165.85 17.64 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.379 0.672 . . . . 63.210000000000001 110.055 169.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.4 t -139.57 123.56 17.72 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.954 -0.567 . . . . 60.140000000000001 110.517 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -99.09 -5.43 30.25 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.912 0.885 . . . . 74.319999999999993 110.173 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.645 ' SD ' HG21 ' A' ' 46' ' ' VAL . 26.0 ptp -159.07 147.45 18.07 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.539 1.135 . . . . 63.310000000000002 109.682 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -53.77 121.74 8.51 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.117 0.567 . . . . 74.25 112.296 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.9 -15.91 54.94 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 119.361 -0.688 . . . . 53.539999999999999 114.572 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.0 ttt -64.01 -46.02 86.35 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.559 0.744 . . . . 63.020000000000003 112.781 -175.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -67.53 118.5 10.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.95 -0.389 . . . . 74.230000000000004 109.95 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 3.16 74.41 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 116.383 -0.371 . . . . 73.239999999999995 113.49 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.22 145.63 32.13 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.222 0.511 . . . . 42.039999999999999 110.341 172.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m -80.32 114.56 19.31 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 109.443 -0.577 . . . . 73.349999999999994 109.443 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.51 145.63 32.87 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.598 0.759 . . . . 74.329999999999998 111.257 -173.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -123.15 117.07 24.53 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.378 1.071 . . . . 65.329999999999998 109.135 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.457 HD13 HG12 ' A' ' 35' ' ' VAL . 28.2 mm -61.55 115.07 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.188 0.595 . . . . 72.439999999999998 111.028 -178.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -83.35 -36.46 24.36 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.821 0.449 . . . . 72.349999999999994 110.967 173.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.9 t -157.83 150.65 22.89 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.24 0.616 . . . . 72.209999999999994 111.745 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.81 131.64 56.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.19 0.996 . . . . 74.030000000000001 109.37 173.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -146.68 128.9 15.71 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.942 0.497 . . . . 72.25 111.739 -171.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -91.62 95.35 9.87 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.253 -0.647 . . . . 71.340000000000003 109.253 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.3 t -136.87 155.39 49.83 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.444 1.098 . . . . 60.409999999999997 110.202 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.4 m -80.94 120.0 24.19 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.887 -0.412 . . . . 75.439999999999998 109.887 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.601 HG23 ' HB2' ' A' ' 28' ' ' TYR . 9.0 m -104.68 132.45 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.317 0.647 . . . . 72.219999999999999 109.535 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.56 135.02 51.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.36 1.064 . . . . 74.109999999999999 111.118 -176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.6 ttp -94.1 120.98 35.12 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.924 -1.139 . . . . 71.340000000000003 107.924 166.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.545 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 24.2 m -124.85 169.6 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 112.779 0.659 . . . . 73.030000000000001 112.779 -169.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -137.06 133.14 35.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.282 0.633 . . . . 72.340000000000003 110.909 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -143.32 177.61 8.31 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.853 0.861 . . . . 60.229999999999997 111.299 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.6 m -119.96 119.18 32.69 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 108.248 -1.019 . . . . 74.310000000000002 108.248 169.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.9 m -61.22 134.71 57.29 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.363 0.665 . . . . 60.32 112.396 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -65.18 -47.96 75.11 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.293 1.037 . . . . 72.209999999999994 112.176 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.4 p -75.67 -50.8 14.36 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.447 0.699 . . . . 53.420000000000002 112.052 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.8 m -75.38 -33.57 61.03 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.495 0.718 . . . . 75.209999999999994 112.677 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.37 11.92 79.88 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-N 116.543 -0.298 . . . . 71.430000000000007 113.498 -172.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -100.21 140.11 34.92 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.59 0.756 . . . . 71.299999999999997 111.239 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -81.1 115.57 20.6 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.634 0.773 . . . . 75.439999999999998 110.998 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.9 t -104.85 122.34 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.874 0.87 . . . . 63.420000000000002 109.534 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.77 160.7 17.07 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.014 0.526 . . . . 74.109999999999999 111.289 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.0 m120 56.5 28.89 14.45 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.133 0.973 . . . . 65.019999999999996 112.897 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -64.75 137.73 57.97 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.537 0.735 . . . . 63.420000000000002 111.888 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 8.0 ptpp? -155.56 148.42 24.33 Favored 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 123.513 0.725 . . . . 74.209999999999994 111.941 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 98.9 m95 -112.15 144.51 41.41 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.461 1.505 . . . . 73.010000000000005 112.536 -8.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.81 154.34 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.2 1.4 . . . . 65.239999999999995 109.048 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.3 p -117.33 177.7 4.64 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.812 0.445 . . . . 74.219999999999999 110.911 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -66.12 -14.28 61.52 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.469 0.708 . . . . 54.350000000000001 111.888 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.54 -35.4 65.52 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 122.971 0.508 . . . . 71.239999999999995 110.863 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -94.84 -5.08 45.88 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.021 0.528 . . . . 71.319999999999993 111.643 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 66.0 mt -108.24 134.41 51.12 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.851 0.834 . . . . 71.420000000000002 110.962 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.4 t -101.57 156.72 17.31 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.399 1.48 . . . . 75.519999999999996 108.925 170.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.68 160.73 15.48 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.637 0.375 . . . . 51.399999999999999 110.301 175.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.543 ' HA ' ' HE3' ' A' ' 124' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 110.081 -0.34 . . . . 75.150000000000006 110.081 174.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 120.814 0.34 . . . . 72.230000000000004 111.865 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -120.46 174.37 6.58 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.639 0.776 . . . . 53.240000000000002 112.481 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.75 136.01 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 C-N-CA 123.844 0.858 . . . . 61.149999999999999 111.718 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.38 -9.76 75.48 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 115.825 -0.625 . . . . 64.200000000000003 113.702 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.8 t -83.65 142.14 31.0 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.149 0.579 . . . . 74.040000000000006 111.707 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -90.48 122.15 33.07 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.637 0.775 . . . . 64.340000000000003 110.318 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . 33.2 m -122.29 153.44 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.638 0.775 . . . . 71.329999999999998 111.886 -176.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.4 mm -104.56 123.79 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.333 1.053 . . . . 64.409999999999997 108.472 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.4 mt -77.21 125.25 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 120.967 0.413 . . . . 72.5 111.06 -172.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -89.19 -68.4 0.78 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.697 0.799 . . . . 54.009999999999998 109.725 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.0 m -98.8 144.64 27.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.941 0.897 . . . . 73.340000000000003 110.25 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 18' ' ' LYS . 84.8 p -159.28 152.7 22.56 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.704 0.631 . . . . 73.040000000000006 112.704 -172.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -85.82 -37.53 19.13 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.469 0.708 . . . . 64.439999999999998 110.309 168.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.462 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.4 mpt? -83.32 129.1 34.98 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.262 0.625 . . . . 73.430000000000007 110.259 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -30.8 71.05 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.611 0.967 . . . . 74.450000000000003 113.611 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.14 -9.1 70.9 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 114.023 0.369 . . . . 54.109999999999999 114.023 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 55.2 ttp -82.72 -28.65 30.36 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.901 0.481 . . . . 74.019999999999996 110.197 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 3.4 ttmp? -67.77 118.68 11.34 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.711 0.404 . . . . 62.32 111.134 173.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.95 2.07 86.45 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 116.134 -0.485 . . . . 65.109999999999999 113.553 -177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.97 152.17 29.64 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.108 0.563 . . . . 74.420000000000002 112.035 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -86.39 131.94 34.08 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.134 0.974 . . . . 75.519999999999996 110.359 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.55 173.86 11.08 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.728 0.811 . . . . 62.100000000000001 112.22 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.7 m -137.99 146.52 43.22 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.441 1.097 . . . . 74.140000000000001 108.754 170.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.5 t -79.75 117.95 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 122.756 0.423 . . . . 63.240000000000002 110.556 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.3 p -94.86 -18.3 21.3 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.51 0.724 . . . . 65.109999999999999 111.58 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.44 145.18 11.52 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 120.201 -0.222 . . . . 72.510000000000005 112.701 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.54 119.61 19.73 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.665 0.786 . . . . 74.150000000000006 110.725 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -130.18 149.67 51.78 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.315 1.046 . . . . 61.509999999999998 110.42 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -125.82 90.97 3.3 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.158 0.98 . . . . 63.240000000000002 109.965 167.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.0 t -135.19 177.46 7.79 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.282 -0.872 . . . . 72.329999999999998 111.144 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -73.35 110.26 7.5 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.528 0.68 . . . . 63.530000000000001 110.454 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.09 161.02 13.9 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.375 1.47 . . . . 51.119999999999997 109.918 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -138.59 144.64 39.9 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.567 0.747 . . . . 74.5 111.606 -172.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.9 110.96 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 107.048 -1.464 . . . . 72.450000000000003 107.048 164.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.547 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 21.1 m -112.16 144.09 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.378 0.609 . . . . 73.010000000000005 112.231 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 p -116.65 128.24 55.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.204 1.002 . . . . 62.32 109.634 173.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -151.17 158.29 43.77 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.94 0.496 . . . . 71.420000000000002 111.386 -169.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.2 m -108.15 117.06 55.8 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 109.008 -0.738 . . . . 74.430000000000007 109.008 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -60.77 124.04 14.19 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.656 2.237 . . . . 74.120000000000005 111.887 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -63.05 -14.45 48.26 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.575 1.324 . . . . 71.120000000000005 114.575 -168.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.463 HD22 ' N ' ' A' ' 41' ' ' ASN . 0.8 OUTLIER -85.73 11.35 11.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.532 0.733 . . . . 45.109999999999999 112.718 -176.69 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.46 53.15 3.93 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 120.977 0.209 . . . . 62.25 112.9 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.34 168.91 13.91 Favored Glycine 0 N--CA 1.476 1.312 0 C-N-CA 122.96 0.314 . . . . 64.209999999999994 112.854 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -58.75 135.36 57.43 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.33 0.652 . . . . 75.030000000000001 111.331 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -56.59 136.5 54.55 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-O 121.186 0.517 . . . . 71.310000000000002 111.065 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.478 HG21 ' SD ' ' A' ' 78' ' ' MET . 57.8 t -86.72 103.13 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.246 0.618 . . . . 41.240000000000002 109.709 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.69 108.7 14.56 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.902 0.881 . . . . 54.219999999999999 110.828 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.2 m170 57.7 79.11 0.21 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.152 0.981 . . . . 73.439999999999998 112.992 176.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -94.29 109.67 21.48 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.125 0.97 . . . . 73.019999999999996 109.671 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 22.2 pttp -121.01 140.16 52.3 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.286 0.235 . . . . 52.32 111.551 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 79.6 m95 -117.83 158.33 25.01 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.054 1.342 . . . . 74.319999999999993 112.478 2.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.49 143.67 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 113.183 -1.826 . . . . 72.409999999999997 107.18 167.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.505 HG13 ' H ' ' A' ' 55' ' ' GLU . 29.8 pt -106.93 179.56 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.678 -0.639 . . . . 72.299999999999997 109.676 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -48.71 -33.9 11.0 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.205 1.002 . . . . 64.510000000000005 113.093 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.505 ' H ' HG13 ' A' ' 53' ' ' ILE . 28.5 tt0 -69.78 -23.96 63.43 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.072 0.949 . . . . 74.140000000000001 113.493 -175.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.2 -10.78 59.56 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.553 0.575 . . . . 73.310000000000002 112.553 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.1 mt -113.18 134.22 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 123.433 0.693 . . . . 63.0 111.808 -169.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.432 ' HB2' ' HG3' ' A' ' 74' ' ' GLU . 40.8 ttmt -67.82 -46.37 72.06 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.025 0.93 . . . . 73.549999999999997 111.999 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -62.84 -22.28 66.56 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.802 0.841 . . . . 74.299999999999997 112.675 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -35.79 -57.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.292 1.59 . . . . 50.340000000000003 115.292 -171.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.85 19.48 67.55 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 115.984 1.154 . . . . 75.109999999999999 115.984 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 t70 61.84 15.77 7.38 Favored 'General case' 0 CA--C 1.572 1.806 0 C-N-CA 124.959 1.304 . . . . 75.340000000000003 112.212 -172.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 22.9 pttm -107.59 160.15 15.9 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.787 0.835 . . . . 53.409999999999997 109.771 175.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 p -76.88 128.16 34.05 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 110.034 -0.358 . . . . 62.439999999999998 110.034 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.572 HD13 HG11 ' A' ' 71' ' ' VAL . 38.7 mt -87.95 136.51 32.93 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.696 -0.483 . . . . 65.200000000000003 109.696 170.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -105.89 153.49 40.05 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.58 0.752 . . . . 72.420000000000002 110.593 -173.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.83 130.37 40.02 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 122.538 2.159 . . . . 75.319999999999993 112.427 171.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.86 -22.61 29.6 Favored Glycine 0 N--CA 1.479 1.507 0 N-CA-C 113.992 0.357 . . . . 43.229999999999997 113.992 -175.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -73.14 157.18 37.72 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.255 0.527 . . . . 65.430000000000007 112.226 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -125.7 135.48 52.14 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.576 -0.738 . . . . 70.230000000000004 109.737 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.572 HG11 HD13 ' A' ' 65' ' ' LEU . 36.0 m -138.79 -178.36 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 125.41 1.484 . . . . 75.019999999999996 110.355 -167.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.3 mt -128.22 140.94 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.315 0.646 . . . . 71.310000000000002 110.252 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.2 mt -90.33 130.22 36.46 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.275 1.03 . . . . 72.409999999999997 111.622 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 43.0 mt-10 -91.31 -12.97 33.47 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.218 0.607 . . . . 70.519999999999996 112.192 169.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.93 160.66 14.23 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.271 0.628 . . . . 72.510000000000005 111.193 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.818 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 10.4 t -140.2 125.9 19.29 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.691 0.396 . . . . 64.150000000000006 110.324 178.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -113.41 0.74 14.85 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.466 0.706 . . . . 74.040000000000006 110.723 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.478 ' SD ' HG21 ' A' ' 46' ' ' VAL . 23.7 ptp -157.57 167.38 30.33 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.814 0.845 . . . . 74.430000000000007 111.515 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -63.89 101.61 0.39 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.073 0.949 . . . . 64.209999999999994 111.901 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.77 23.92 9.63 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-O 119.733 -0.482 . . . . 40.520000000000003 114.101 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.4 ttt -93.23 -39.46 10.99 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 117.664 0.732 . . . . 74.319999999999993 111.689 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.818 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 60.7 tttm -67.76 119.73 12.95 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.443 0.297 . . . . 64.319999999999993 110.389 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.33 -8.44 75.16 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 123.462 0.476 . . . . 54.5 113.149 -176.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.54 146.97 36.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.055 0.542 . . . . 65.319999999999993 111.612 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.0 m -86.31 119.72 26.88 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.734 -0.666 . . . . 71.239999999999995 110.069 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.547 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -112.62 149.3 33.01 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.89 0.876 . . . . 72.25 110.653 -177.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -118.43 126.47 52.13 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.939 0.496 . . . . 74.239999999999995 110.261 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.409 HD13 HG12 ' A' ' 35' ' ' VAL . 25.8 mm -68.36 102.56 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 123.456 0.702 . . . . 64.140000000000001 110.276 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -71.79 -39.35 69.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.187 0.595 . . . . 55.329999999999998 110.166 173.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 t -154.98 147.93 24.62 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.05 -0.977 . . . . 61.439999999999998 111.286 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.78 132.96 42.82 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.0 0.92 . . . . 61.539999999999999 109.924 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -148.38 142.25 25.76 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.303 0.641 . . . . 72.519999999999996 110.803 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.03 94.6 9.7 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.427 -1.323 . . . . 71.109999999999999 107.427 172.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.3 t -134.81 156.81 48.23 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.927 0.891 . . . . 54.549999999999997 111.103 -171.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 93.5 m -79.95 120.24 23.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.934 0.494 . . . . 75.409999999999997 110.614 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.86 134.49 58.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.037 0.935 . . . . 72.530000000000001 110.239 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.48 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 98.2 m-85 -110.32 135.83 50.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.041 0.936 . . . . 73.319999999999993 112.004 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 52.8 ttp -90.26 121.07 31.94 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 107.844 -1.169 . . . . 63.329999999999998 107.844 167.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.14 145.63 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 113.17 0.804 . . . . 60.520000000000003 113.17 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -106.77 120.47 42.09 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.732 0.813 . . . . 72.319999999999993 109.747 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -127.44 165.56 19.59 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.374 0.607 . . . . 75.019999999999996 112.077 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.8 m -104.02 108.64 20.08 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.768 -0.827 . . . . 73.439999999999998 108.768 171.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.1 t -62.21 107.44 0.89 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.286 0.634 . . . . 62.340000000000003 110.682 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.7 p -59.24 -31.8 69.4 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.148 0.979 . . . . 73.219999999999999 113.142 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 t -76.49 -13.17 60.12 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.035 0.934 . . . . 72.120000000000005 112.958 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 t -123.82 -43.96 2.1 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.4 0.68 . . . . 75.420000000000002 112.663 -172.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.8 -18.47 57.19 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 116.5 -0.318 . . . . 54.119999999999997 112.436 -166.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.41 137.15 44.46 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.22 1.008 . . . . 73.420000000000002 111.493 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -91.31 118.2 30.3 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 121.322 0.582 . . . . 72.209999999999994 110.263 174.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.8 t -104.37 119.09 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.946 0.898 . . . . 64.540000000000006 108.616 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -103.63 153.29 20.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.559 0.344 . . . . 74.299999999999997 111.68 -169.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 53.73 42.42 31.81 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.541 1.137 . . . . 75.430000000000007 114.03 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -58.91 134.36 56.86 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.245 1.018 . . . . 72.299999999999997 111.903 175.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 62.1 mttp -132.3 132.12 42.67 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.093 0.957 . . . . 62.299999999999997 111.167 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 99.8 m95 -119.19 153.9 34.2 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.258 -1.526 . . . . 73.230000000000004 111.603 -15.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.36 158.15 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 114.524 -1.216 . . . . 61.109999999999999 108.831 168.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.9 p -105.84 175.51 5.47 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.251 0.548 . . . . 74.129999999999995 111.712 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.48 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 34.8 tt0 -67.54 -26.6 66.39 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.924 -0.58 . . . . 75.230000000000004 110.727 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.13 -29.13 70.55 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 123.982 0.913 . . . . 73.040000000000006 111.418 171.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -98.39 3.61 48.49 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.077 0.951 . . . . 65.120000000000005 112.715 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.93 142.55 51.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.351 0.66 . . . . 74.409999999999997 111.367 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.5 p -130.09 119.64 23.38 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.32 1.048 . . . . 75.200000000000003 108.297 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -85.69 105.02 15.94 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.919 0.782 . . . . 63.450000000000003 112.495 -167.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.5 tptm . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 116.229 1.937 . . . . 75.209999999999994 116.229 172.297 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.1 tpp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.08 -0.341 . . . . 74.230000000000004 110.08 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -78.51 155.92 29.54 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.511 0.672 . . . . 71.239999999999995 112.693 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.07 122.87 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-N 115.331 -0.85 . . . . 65.340000000000003 109.593 165.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.71 41.85 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-N 115.869 -0.605 . . . . 50.420000000000002 113.583 -175.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.9 m -74.85 136.43 41.54 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.091 0.556 . . . . 55.149999999999999 111.721 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -94.12 125.16 38.59 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.931 0.893 . . . . 44.109999999999999 109.63 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.28 153.43 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.393 0.677 . . . . 41.229999999999997 112.635 -168.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.3 mm -98.37 125.44 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 124.679 1.192 . . . . 65.540000000000006 109.931 172.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 22' ' ' ALA . 41.4 mt -87.28 125.4 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.19 0.596 . . . . 70.5 111.223 -176.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -98.66 -59.02 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.381 0.672 . . . . 74.349999999999994 111.063 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.6 m -94.44 144.57 25.45 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.692 0.797 . . . . 33.420000000000002 109.448 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 17' ' ' MET . 77.2 p -149.88 144.46 25.94 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.112 0.482 . . . . 71.510000000000005 111.574 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -92.42 -24.43 18.86 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.809 0.844 . . . . 74.010000000000005 110.465 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.415 ' H ' ' HE2' ' A' ' 17' ' ' MET . 23.2 mmt -95.97 134.47 38.94 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.688 0.795 . . . . 71.400000000000006 109.316 169.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.438 ' HG2' HG21 ' A' ' 105' ' ' THR . 62.5 tttp -59.01 -44.25 91.65 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.732 0.813 . . . . 71.340000000000003 112.728 -175.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.98 -0.26 64.43 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 114.889 0.715 . . . . 63.020000000000003 114.889 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.513 ' HB3' ' HB2' ' A' ' 12' ' ' SER . 41.1 ttp -91.47 -24.84 19.55 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.725 0.763 . . . . 71.019999999999996 111.235 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -67.02 121.83 16.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.916 0.487 . . . . 73.109999999999999 111.282 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.58 1.71 90.54 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 115.837 -0.62 . . . . 60.109999999999999 114.297 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.34 146.46 36.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.043 0.537 . . . . 72.530000000000001 111.206 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -95.75 99.59 11.4 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.36 -0.607 . . . . 65.420000000000002 109.36 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -91.15 175.98 6.75 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.717 0.807 . . . . 51.539999999999999 112.724 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.9 m -136.13 138.67 42.26 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.118 -1.067 . . . . 72.319999999999993 108.118 169.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.4 t -83.45 126.88 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.213 0.605 . . . . 70.219999999999999 110.398 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.6 p -113.44 -2.07 14.02 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.406 0.682 . . . . 61.5 112.102 170.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.5 136.03 4.67 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 118.365 0.53 . . . . 75.340000000000003 113.004 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.01 107.68 13.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.848 0.859 . . . . 62.229999999999997 109.768 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -108.95 120.33 42.21 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.678 0.791 . . . . 73.420000000000002 110.669 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.94 87.01 3.18 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 108.644 -0.872 . . . . 71.540000000000006 108.644 174.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -137.24 174.95 10.06 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 112.858 0.688 . . . . 63.229999999999997 112.858 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.3 m -82.87 124.98 30.84 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.743 0.817 . . . . 74.209999999999994 110.306 172.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.02 120.4 37.11 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.187 0.995 . . . . 71.510000000000005 110.297 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -92.22 149.75 21.28 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.765 0.826 . . . . 74.319999999999993 112.538 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.96 111.61 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 107.764 -1.199 . . . . 65.430000000000007 107.764 170.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.52 HG12 HD13 ' A' ' 88' ' ' ILE . 27.1 m -114.3 165.72 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 112.869 0.692 . . . . 63.109999999999999 112.869 -172.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -135.68 123.88 23.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.829 0.852 . . . . 70.319999999999993 109.438 173.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -150.52 154.36 37.46 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 122.116 -0.365 . . . . 73.030000000000001 111.61 -170.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.3 m -104.52 115.32 63.02 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 107.856 -1.164 . . . . 63.340000000000003 107.856 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.95 133.22 56.53 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.628 2.218 . . . . 74.010000000000005 112.471 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.4 p -63.22 -14.64 51.5 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.27 1.028 . . . . 64.140000000000001 112.459 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -62.64 -17.69 60.89 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 124.333 1.053 . . . . 54.140000000000001 112.598 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.26 60.09 2.3 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 112.453 -0.259 . . . . 73.209999999999994 112.453 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 -152.31 8.04 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 115.626 -0.287 . . . . 74.219999999999999 113.695 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -81.2 126.92 32.1 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.222 0.609 . . . . 74.329999999999998 109.98 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.83 112.57 1.2 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.069 0.461 . . . . 64.230000000000004 110.452 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.431 HG21 ' SD ' ' A' ' 78' ' ' MET . 15.1 t -80.84 104.15 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.65 -0.704 . . . . 74.120000000000005 109.64 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -101.12 150.72 22.64 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.988 0.515 . . . . 53.409999999999997 109.942 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.1 m80 56.54 29.23 15.13 Favored 'General case' 0 CA--C 1.559 1.317 0 O-C-N 124.089 0.868 . . . . 70.209999999999994 111.754 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -61.99 127.46 31.5 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.948 0.899 . . . . 73.319999999999993 111.739 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 97.8 mttt -132.61 141.68 48.79 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.386 1.074 . . . . 65.420000000000002 109.947 -178.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 93.8 m95 -113.02 134.53 54.47 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 120.418 -1.426 . . . . 75.219999999999999 111.273 -7.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.75 148.36 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.456 -0.942 . . . . 72.299999999999997 108.456 169.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.8 pt -111.51 166.74 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 120.806 0.336 . . . . 64.5 110.983 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -53.15 -34.71 58.01 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.131 0.972 . . . . 73.109999999999999 113.405 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.6 -18.66 60.53 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 123.634 0.774 . . . . 73.219999999999999 112.382 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -90.5 1.31 56.8 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.255 0.622 . . . . 75.230000000000004 111.899 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.473 ' HB ' ' HB2' ' A' ' 60' ' ' ALA . 55.0 mt -121.62 125.37 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 124.059 0.944 . . . . 74.109999999999999 109.751 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -68.62 -54.48 16.2 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 118.193 0.451 . . . . 65.530000000000001 112.024 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.19 -4.33 17.17 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.183 0.809 . . . . 62.399999999999999 113.183 -177.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.475 ' HA ' HD11 ' A' ' 65' ' ' LEU . . . -54.78 -30.4 56.67 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.995 0.739 . . . . 63.32 112.995 172.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.14 14.84 66.73 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 114.828 0.691 . . . . 74.349999999999994 114.828 170.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 59.31 23.14 11.55 Favored 'General case' 0 CA--C 1.566 1.565 0 C-N-CA 124.51 1.124 . . . . 75.230000000000004 112.016 -172.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 65.1 pttt -120.56 171.54 8.49 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.362 1.065 . . . . 74.040000000000006 111.341 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.3 m -77.36 109.35 11.2 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.273 0.629 . . . . 64.400000000000006 110.078 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.494 ' HB3' HG13 ' A' ' 88' ' ' ILE . 86.9 mt -78.34 121.28 24.26 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.949 0.5 . . . . 75.200000000000003 110.784 174.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -88.97 150.7 45.91 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.891 0.876 . . . . 72.319999999999993 109.94 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 88.0 Cg_exo -50.49 121.98 8.75 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.341 2.028 . . . . 71.25 113.239 173.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.93 -21.03 12.63 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-O 119.457 -0.635 . . . . 52.420000000000002 114.151 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -69.19 133.17 47.64 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.227 1.014 . . . . 53.200000000000003 111.936 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -100.37 121.43 41.5 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.388 0.675 . . . . 75.430000000000007 109.564 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.94 165.33 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.8 1.24 . . . . 64.030000000000001 110.982 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.93 137.95 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.897 -0.502 . . . . 62.149999999999999 111.186 175.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.8 mt -85.44 122.05 29.03 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.208 1.003 . . . . 61.140000000000001 111.203 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -87.54 -17.61 31.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.382 0.512 . . . . 60.520000000000003 112.382 171.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -88.51 162.67 16.3 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.333 0.587 . . . . 44.299999999999997 111.108 170.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -142.49 124.89 15.62 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.686 -0.688 . . . . 63.140000000000001 110.085 173.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -104.14 -4.19 23.48 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 123.789 0.836 . . . . 72.450000000000003 110.841 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.431 ' SD ' HG21 ' A' ' 46' ' ' VAL . 24.4 ptp -154.69 -179.16 7.74 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.3 0.64 . . . . 73.530000000000001 112.433 -173.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.69 108.97 0.71 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.817 0.847 . . . . 75.040000000000006 112.438 174.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.65 24.38 67.67 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 115.026 0.77 . . . . 61.520000000000003 115.026 172.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -75.91 -42.31 49.3 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.801 0.8 . . . . 62.539999999999999 111.551 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.33 123.74 21.2 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 120.506 0.193 . . . . 73.209999999999994 110.69 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.5 -18.34 57.12 Favored Glycine 0 N--CA 1.471 0.97 0 CA-C-N 116.206 -0.452 . . . . 62.520000000000003 113.12 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.12 137.23 56.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.243 0.617 . . . . 71.340000000000003 111.743 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.7 m -73.48 111.09 8.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.378 0.671 . . . . 73.230000000000004 110.519 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.26 147.61 27.29 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.165 0.986 . . . . 62.399999999999999 110.419 -175.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -130.35 129.18 42.82 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 108.79 -0.819 . . . . 75.140000000000001 108.79 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.52 HD13 HG12 ' A' ' 35' ' ' VAL . 47.1 mm -74.1 112.72 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.865 0.866 . . . . 73.140000000000001 111.54 -170.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.58 -41.42 27.19 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.068 0.947 . . . . 74.400000000000006 110.582 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.5 t -163.27 172.24 15.0 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 115.681 -0.69 . . . . 74.439999999999998 111.345 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.42 132.16 24.1 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.078 0.951 . . . . 51.5 110.609 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -125.97 141.52 51.93 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.583 0.753 . . . . 73.0 112.329 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -100.5 95.35 6.66 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.452 -1.314 . . . . 70.219999999999999 107.452 163.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.9 t -136.42 154.8 50.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.072 0.949 . . . . 72.230000000000004 110.6 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.9 p -78.33 124.05 27.67 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.532 -0.544 . . . . 70.340000000000003 109.532 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.83 133.01 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.87 0.868 . . . . 60.140000000000001 108.734 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -115.1 152.83 31.84 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.723 0.773 . . . . 73.400000000000006 112.487 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.459 ' SD ' ' HE3' ' A' ' 114' ' ' LYS . 59.1 ttp -100.57 112.4 24.77 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.496 -1.229 . . . . 63.43 108.134 171.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.429 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 29.7 m -120.89 151.82 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 112.543 0.571 . . . . 74.239999999999995 112.543 -172.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.67 117.09 28.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.283 1.033 . . . . 74.540000000000006 108.97 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -136.87 175.66 9.41 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.247 0.619 . . . . 71.120000000000005 111.385 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.3 m -107.63 126.08 52.13 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.728 -0.842 . . . . 74.340000000000003 108.728 169.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.8 t -60.87 108.06 0.8 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.919 0.488 . . . . 64.319999999999993 110.526 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.0 p -58.88 -24.31 62.07 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.367 1.067 . . . . 72.230000000000004 112.887 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.438 HG21 ' HG2' ' A' ' 15' ' ' LYS . 71.1 p -87.96 -60.04 2.08 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 123.325 0.65 . . . . 70.230000000000004 112.151 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.8 p -84.57 -37.17 21.51 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.421 0.526 . . . . 65.519999999999996 112.421 -173.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.08 -2.16 51.33 Favored Glycine 0 N--CA 1.48 1.604 0 CA-C-N 116.453 -0.339 . . . . 63.240000000000002 113.151 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.73 128.28 35.89 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.461 0.704 . . . . 64.239999999999995 111.895 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -75.52 96.84 3.58 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.045 -0.724 . . . . 62.5 109.045 174.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.72 114.49 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.191 0.597 . . . . 70.099999999999994 109.799 -175.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.558 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -112.02 144.77 40.83 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 120.986 0.422 . . . . 73.209999999999994 111.376 -175.89 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 56.3 36.92 28.29 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.794 1.238 . . . . 64.019999999999996 113.152 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -64.54 137.95 58.13 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.505 0.722 . . . . 65.340000000000003 112.265 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 99.7 mttt -138.88 144.19 39.05 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 124.487 1.115 . . . . 73.420000000000002 110.638 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 98.5 m95 -110.2 142.62 41.49 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.539 1.536 . . . . 73.519999999999996 112.263 -11.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.57 154.41 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.225 1.01 . . . . 63.399999999999999 109.147 166.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.4 p -100.82 177.5 4.96 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.289 0.495 . . . . 71.030000000000001 112.26 173.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -69.3 -43.13 74.43 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.049 0.54 . . . . 63.240000000000002 111.197 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.33 -14.95 62.8 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.556 0.742 . . . . 64.219999999999999 111.466 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.08 -21.84 56.28 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.228 1.011 . . . . 72.439999999999998 110.149 176.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.0 mt -117.18 178.49 4.34 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.968 1.307 . . . . 63.399999999999999 109.92 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.3 m -155.31 150.37 26.79 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.019 1.328 . . . . 52.109999999999999 107.81 166.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.98 164.02 26.37 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.535 0.607 . . . . 74.329999999999998 112.586 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.5 tptt . . . . . 0 CA--C 1.56 1.331 0 C-N-CA 123.5 0.72 . . . . 55.030000000000001 111.416 176.391 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.432 -0.581 . . . . 74.450000000000003 109.432 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -73.54 133.51 43.59 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.22 0.608 . . . . 72.450000000000003 112.152 -174.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.0 124.2 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 115.925 -0.579 . . . . 71.239999999999995 110.177 169.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.3 1.69 38.23 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.895 -0.593 . . . . 62.340000000000003 113.195 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.0 t -78.87 136.21 37.23 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.39 0.676 . . . . 73.120000000000005 111.591 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -87.71 110.74 20.66 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.005 -0.739 . . . . 64.230000000000004 109.005 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.21 160.0 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-O 121.63 0.728 . . . . 71.510000000000005 112.464 -168.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.59 137.53 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.12 0.968 . . . . 64.109999999999999 109.047 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' A' ' 20' ' ' ALA . 60.9 mt -79.46 118.87 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 109.684 -0.487 . . . . 73.409999999999997 109.684 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -77.66 -42.5 34.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.786 0.834 . . . . 74.030000000000001 110.48 -176.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.8 m -142.34 147.74 36.81 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.466 1.106 . . . . 61.420000000000002 110.142 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.444 ' HB2' ' HE2' ' A' ' 17' ' ' MET . 76.7 p -155.14 157.47 37.48 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.119 0.485 . . . . 75.140000000000001 111.599 173.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -84.15 -17.79 38.88 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.007 -0.997 . . . . 74.510000000000005 110.705 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.468 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.4 mpt? -86.88 168.22 13.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.765 0.826 . . . . 64.409999999999997 110.131 169.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -87.8 -50.08 6.7 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.112 0.482 . . . . 62.039999999999999 110.685 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.21 -13.2 79.7 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 115.086 0.794 . . . . 74.219999999999999 115.086 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.444 ' HE2' ' HB2' ' A' ' 12' ' ' SER . 47.4 ttp -89.01 -29.32 19.57 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.135 0.467 . . . . 72.140000000000001 111.315 -176.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -69.09 122.04 17.94 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.61 0.364 . . . . 60.109999999999999 111.331 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.43 1.6 89.27 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.981 -0.554 . . . . 63.109999999999999 113.501 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.47 ' HB3' HD12 ' A' ' 9' ' ' ILE . . . -72.73 146.84 46.14 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.626 0.602 . . . . 50.119999999999997 112.626 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.84 98.84 4.97 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.363 0.665 . . . . 74.430000000000007 110.152 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -103.11 169.48 8.53 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.782 0.833 . . . . 63.439999999999998 112.307 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.5 m -141.05 134.59 30.0 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.57 -0.741 . . . . 71.510000000000005 109.195 168.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.23 114.05 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.914 0.486 . . . . 74.400000000000006 110.077 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.3 p -106.51 -4.12 20.1 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.063 0.545 . . . . 73.409999999999997 112.403 175.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.14 150.43 18.77 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-O 120.148 -0.251 . . . . 53.140000000000001 112.805 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.73 113.08 14.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.124 0.969 . . . . 71.010000000000005 110.336 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -114.17 115.76 28.0 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.793 0.837 . . . . 72.450000000000003 110.522 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -99.71 88.0 3.7 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 109.057 -0.72 . . . . 65.340000000000003 109.057 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.401 HG21 HD12 ' A' ' 53' ' ' ILE . 6.0 t -136.45 168.19 19.93 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.641 1.176 . . . . 64.219999999999999 111.133 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.7 m -75.31 129.93 38.22 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.886 -0.412 . . . . 63.020000000000003 109.886 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.7 154.93 20.76 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.751 0.821 . . . . 64.230000000000004 109.629 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -134.96 147.18 49.69 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.95 0.881 . . . . 72.319999999999993 112.129 -173.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.72 111.39 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 113.804 -1.544 . . . . 71.329999999999998 107.784 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.533 HG12 HD13 ' A' ' 88' ' ' ILE . 29.0 m -116.11 147.36 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.363 0.601 . . . . 75.510000000000005 112.214 -175.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -121.96 125.69 46.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.335 1.054 . . . . 71.519999999999996 110.057 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -147.1 158.49 43.95 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.431 0.692 . . . . 71.430000000000007 110.878 -172.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.6 m -109.87 111.46 58.66 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 108.824 -0.806 . . . . 72.329999999999998 108.824 174.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -46.82 118.29 2.6 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.719 2.946 . . . . 74.510000000000005 114.304 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.0 p -59.29 -24.68 63.48 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.903 1.281 . . . . 75.25 113.411 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -79.91 11.21 3.46 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 123.329 0.652 . . . . 73.230000000000004 112.107 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.03 51.61 3.72 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 121.97 -0.456 . . . . 73.25 112.729 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.53 163.89 12.39 Favored Glycine 0 C--N 1.344 0.991 0 N-CA-C 113.623 0.209 . . . . 42.140000000000001 113.623 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -60.19 132.91 55.4 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.398 0.679 . . . . 72.540000000000006 111.135 174.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.05 116.65 3.12 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.753 0.821 . . . . 74.319999999999993 111.626 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.46 HG21 ' SD ' ' A' ' 78' ' ' MET . 39.9 t -87.4 111.62 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 123.77 0.828 . . . . 74.349999999999994 109.657 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -104.32 138.78 40.25 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.682 0.793 . . . . 72.010000000000005 110.253 -173.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 54.42 40.48 31.81 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.151 0.98 . . . . 51.549999999999997 113.178 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.432 ' HB2' HG12 ' A' ' 46' ' ' VAL . 42.7 t60 -66.62 129.2 39.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.683 0.793 . . . . 62.520000000000003 111.118 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 47.4 mtmt -135.48 151.42 50.36 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 123.793 0.837 . . . . 73.340000000000003 110.482 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 84.7 m95 -111.86 137.39 49.88 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.446 1.499 . . . . 71.439999999999998 112.293 -4.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.06 138.48 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.872 1.269 . . . . 73.329999999999998 108.002 169.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.401 HD12 HG21 ' A' ' 30' ' ' THR . 34.0 pt -106.59 170.84 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.705 -0.622 . . . . 51.210000000000001 111.617 -176.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -57.27 -35.17 69.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.744 0.818 . . . . 65.239999999999995 112.721 178.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -71.14 -25.07 62.41 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 123.35 0.66 . . . . 65.140000000000001 111.691 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -86.72 -12.2 48.94 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 124.034 0.933 . . . . 74.409999999999997 112.102 -172.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.7 mt -107.88 137.96 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 124.062 0.945 . . . . 73.109999999999999 110.906 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -72.27 -54.01 10.82 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.301 0.64 . . . . 62.109999999999999 112.353 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.59 -10.2 17.26 Favored 'General case' 0 CA--C 1.568 1.667 0 C-N-CA 123.961 0.904 . . . . 62.0 113.156 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -52.56 -65.89 0.48 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.714 0.806 . . . . 44.32 112.608 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.51 28.66 72.78 Favored Glycine 0 N--CA 1.478 1.485 0 N-CA-C 114.998 0.759 . . . . 71.25 114.998 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.38 13.66 6.22 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 124.191 0.996 . . . . 54.229999999999997 112.895 -171.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 60' ' ' ALA . 5.8 ttpm? -94.27 143.59 26.26 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.897 1.279 . . . . 75.010000000000005 110.218 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.6 m -71.48 109.27 5.34 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.139 0.576 . . . . 74.450000000000003 110.009 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.626 HD13 HG11 ' A' ' 71' ' ' VAL . 53.1 mt -78.74 128.58 33.61 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.438 0.695 . . . . 71.109999999999999 110.009 178.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -119.26 157.29 51.51 Favored Pre-proline 0 N--CA 1.487 1.376 0 C-N-CA 123.714 0.806 . . . . 71.420000000000002 110.315 -167.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -49.72 118.87 4.11 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.219 2.612 . . . . 43.399999999999999 114.308 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.95 -22.3 25.82 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 123.161 0.41 . . . . 75.450000000000003 113.875 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.55 138.62 51.12 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.529 0.664 . . . . 63.310000000000002 111.712 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -102.11 122.19 43.65 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.333 0.653 . . . . 72.120000000000005 110.569 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.626 HG11 HD13 ' A' ' 65' ' ' LEU . 30.2 m -120.98 166.74 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.059 0.944 . . . . 63.200000000000003 112.244 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mm -110.97 135.47 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.845 0.858 . . . . 71.439999999999998 110.107 173.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.7 mt -96.07 114.55 26.27 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.963 0.905 . . . . 75.120000000000005 111.118 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -78.33 -34.68 48.39 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.306 0.642 . . . . 72.040000000000006 111.425 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.66 165.13 18.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.312 0.645 . . . . 54.520000000000003 111.712 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 51.0 p -143.59 125.91 15.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.231 -0.895 . . . . 61.219999999999999 110.779 173.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -99.67 1.13 43.2 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.988 0.915 . . . . 72.430000000000007 109.694 167.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.46 ' SD ' HG21 ' A' ' 46' ' ' VAL . 23.5 ptp -156.02 166.24 34.04 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.332 1.053 . . . . 73.409999999999997 111.353 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -54.14 -32.15 54.43 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 115.456 1.65 . . . . 51.149999999999999 115.456 -169.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.29 26.64 6.31 Favored Glycine 0 N--CA 1.484 1.853 0 CA-C-N 118.054 0.388 . . . . 54.210000000000001 114.01 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.7 ttt -89.82 -41.62 11.73 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 117.185 0.492 . . . . 72.129999999999995 112.071 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 88.4 tttt -67.52 120.68 14.37 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 122.354 -0.216 . . . . 63.439999999999998 110.634 173.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.1 76.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.232 -0.44 . . . . 75.319999999999993 112.504 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.0 145.6 35.87 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-O 121.428 0.632 . . . . 74.25 111.696 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.5 m -88.27 122.5 31.87 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.779 -1.101 . . . . 70.129999999999995 109.0 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -118.74 162.89 17.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.893 0.877 . . . . 64.540000000000006 110.773 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -131.91 128.25 38.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.779 0.832 . . . . 54.140000000000001 109.815 175.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.546 HG13 ' HB3' ' A' ' 65' ' ' LEU . 31.3 mm -66.48 116.42 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.646 0.779 . . . . 74.340000000000003 110.491 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -82.08 -36.75 27.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.487 0.715 . . . . 72.230000000000004 111.201 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.9 t -161.9 151.75 16.61 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.567 -0.742 . . . . 74.409999999999997 111.258 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.89 130.69 56.94 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.919 0.888 . . . . 61.240000000000002 109.353 172.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -134.68 119.97 18.94 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.211 0.604 . . . . 71.400000000000006 110.295 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.462 ' H ' ' HD2' ' A' ' 93' ' ' LYS . 6.8 mptt -90.31 93.79 9.48 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.173 -1.047 . . . . 74.219999999999999 108.173 -177.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.3 t -136.99 154.03 50.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.337 0.655 . . . . 74.530000000000001 110.945 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.8 m -80.77 128.11 33.28 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.146 -0.687 . . . . 63.439999999999998 109.146 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 m -120.53 135.71 59.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.572 1.149 . . . . 74.239999999999995 108.801 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.592 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 82.7 m-85 -109.72 157.27 19.29 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.108 0.956 . . . . 74.329999999999998 112.738 -171.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.526 ' SD ' ' HE3' ' A' ' 114' ' ' LYS . 35.7 ttp -100.28 117.59 34.81 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.071 -1.422 . . . . 73.420000000000002 107.699 165.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.7 m -125.07 148.25 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-O 121.37 0.605 . . . . 71.329999999999998 111.784 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.62 116.05 31.25 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.294 -1.002 . . . . 63.32 108.294 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -127.05 170.34 12.43 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.325 0.583 . . . . 75.430000000000007 111.978 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 m -112.07 111.2 21.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.205 -0.907 . . . . 75.400000000000006 109.071 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.8 m -57.21 96.82 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.209 -0.663 . . . . 45.409999999999997 109.209 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 52.0 p -56.83 -47.1 81.1 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.044 1.127 . . . . 74.129999999999995 114.044 -166.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.3 t -72.72 -32.23 65.56 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.392 0.515 . . . . 74.530000000000001 112.392 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.4 m -87.14 -26.93 23.37 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.545 0.738 . . . . 64.239999999999995 112.256 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.33 -22.2 10.98 Favored Glycine 0 CA--C 1.545 1.951 0 CA-C-N 116.004 -0.544 . . . . 73.230000000000004 114.313 -172.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -71.22 136.64 48.13 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.622 0.769 . . . . 52.439999999999998 112.094 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.33 131.63 44.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.629 0.771 . . . . 71.530000000000001 110.673 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.5 t -115.01 128.21 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.339 1.056 . . . . 53.240000000000002 109.302 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -107.19 143.44 35.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.006 0.522 . . . . 72.040000000000006 111.09 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.6 m120 58.78 39.5 24.09 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.281 1.432 . . . . 73.519999999999996 113.431 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -69.21 133.58 48.13 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.629 -0.714 . . . . 73.299999999999997 111.733 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.526 ' HE3' ' SD ' ' A' ' 98' ' ' MET . 96.7 mttt -142.47 145.77 34.07 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.565 1.146 . . . . 73.430000000000007 110.497 -175.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 87.5 m95 -106.98 122.32 46.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.703 1.601 . . . . 73.109999999999999 110.884 -9.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.7 m -99.37 154.81 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 109.208 -0.664 . . . . 71.109999999999999 109.208 170.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 31.7 m -113.81 158.16 21.37 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.827 0.451 . . . . 65.219999999999999 110.868 -175.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.592 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 67.0 tt0 -59.42 -35.83 74.72 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.189 0.519 . . . . 74.209999999999994 111.67 175.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -52.39 -32.96 41.32 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.816 1.247 . . . . 72.219999999999999 112.129 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -101.43 7.16 42.67 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.572 1.149 . . . . 65.329999999999998 112.5 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.2 mt -125.17 158.92 32.77 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.54 0.736 . . . . 74.230000000000004 110.871 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.2 t -148.05 140.89 24.73 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.026 0.93 . . . . 71.0 109.939 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.69 130.25 38.4 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.628 0.371 . . . . 73.150000000000006 110.902 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.4 tttm . . . . . 0 CA--C 1.556 1.204 0 CA-C-O 121.183 0.516 . . . . 74.319999999999993 110.661 179.472 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 110.288 -0.264 . . . . 74.019999999999996 110.288 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -86.44 143.24 27.88 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.443 0.697 . . . . 74.310000000000002 111.633 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.5 t -66.58 126.58 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 C-N-CA 122.82 0.448 . . . . 71.530000000000001 110.215 170.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.97 -12.53 62.34 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 116.239 -0.437 . . . . 54.0 113.156 -171.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.3 t -88.66 161.04 17.09 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.259 0.623 . . . . 42.549999999999997 111.027 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -121.98 138.7 54.32 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.123 0.569 . . . . 55.409999999999997 111.207 -176.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.17 170.84 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 124.966 1.307 . . . . 73.329999999999998 111.118 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.5 mm -105.09 141.93 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.124 0.97 . . . . 61.229999999999997 109.814 171.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.663 HG21 ' HG2' ' A' ' 17' ' ' MET . 27.1 mm -65.04 129.31 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.5 0 C-N-CA 123.445 0.698 . . . . 73.239999999999995 111.263 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -108.07 -13.98 14.83 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.37 0.668 . . . . 65.340000000000003 111.604 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.9 m -145.49 139.17 26.62 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.241 0.616 . . . . 75.340000000000003 110.511 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.42 ' HA ' ' SD ' ' A' ' 17' ' ' MET . 58.8 p -113.49 118.5 34.66 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.301 0.64 . . . . 71.109999999999999 112.109 -173.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -89.58 -36.23 15.43 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.744 0.817 . . . . 74.109999999999999 109.441 169.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.488 ' H ' ' HE3' ' A' ' 17' ' ' MET . 41.0 tpp -96.21 144.7 26.18 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.482 1.113 . . . . 74.409999999999997 108.901 175.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -23.72 66.74 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.331 0.863 . . . . 63.25 113.331 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.507 ' HA2' HG22 ' A' ' 105' ' ' THR . . . -89.84 -2.26 75.55 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 113.815 0.286 . . . . 73.519999999999996 113.815 174.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.663 ' HG2' HG21 ' A' ' 9' ' ' ILE . 49.8 ttm -81.39 -29.34 34.0 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.2 0.5 . . . . 75.049999999999997 110.942 -172.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.16 119.75 8.45 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.488 0.715 . . . . 73.329999999999998 112.144 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.96 1.27 87.29 Favored Glycine 0 N--CA 1.476 1.308 0 N-CA-C 114.519 0.567 . . . . 72.409999999999997 114.519 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.87 149.48 39.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.043 0.537 . . . . 72.019999999999996 111.661 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -92.72 102.87 15.28 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 122.984 0.514 . . . . 62.140000000000001 110.552 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.579 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -86.02 150.66 24.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.932 0.893 . . . . 50.43 111.766 -175.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.1 m -123.48 115.62 21.86 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.204 0.602 . . . . 71.409999999999997 109.763 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.47 96.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.272 0.629 . . . . 72.409999999999997 110.352 -174.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.8 p -98.59 -4.36 34.22 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.416 0.686 . . . . 60.43 111.448 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.92 139.46 6.61 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 111.984 -0.446 . . . . 53.119999999999997 111.984 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.61 108.69 12.31 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.808 0.843 . . . . 75.049999999999997 109.688 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -111.96 112.1 23.5 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.802 0.841 . . . . 71.0 110.338 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -94.98 82.76 3.85 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.494 0.664 . . . . 71.129999999999995 109.312 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.6 t -134.94 177.27 7.94 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.86 0.864 . . . . 54.409999999999997 111.72 -173.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.7 m -85.74 125.9 33.58 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 122.823 0.449 . . . . 75.200000000000003 110.192 173.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -103.53 154.45 19.46 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.648 1.179 . . . . 44.43 110.524 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.545 ' HB2' HG23 ' A' ' 52' ' ' VAL . 92.0 m-85 -137.61 146.03 43.47 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.715 0.769 . . . . 73.409999999999997 111.583 -174.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.85 121.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 106.939 -1.504 . . . . 63.210000000000001 106.939 167.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.8 m -123.02 162.18 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.479 0.657 . . . . 63.43 112.761 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 71.5 p -131.01 122.12 26.25 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.295 -0.866 . . . . 71.209999999999994 109.732 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -148.01 151.24 35.41 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.344 0.498 . . . . 74.239999999999995 112.344 -170.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.2 m -96.37 109.15 46.19 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 107.814 -1.18 . . . . 73.340000000000003 107.814 170.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.32 148.64 40.77 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.371 2.047 . . . . 61.119999999999997 112.901 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.8 p -64.27 -17.21 63.4 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.176 0.99 . . . . 62.329999999999998 113.029 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -70.54 -19.51 62.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.76 0.424 . . . . 74.540000000000006 111.197 172.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.26 24.75 65.22 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 114.898 0.719 . . . . 74.439999999999998 114.898 168.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.18 -96.49 0.35 Allowed Glycine 0 CA--C 1.537 1.428 0 CA-C-N 117.03 0.415 . . . . 45.100000000000001 112.746 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -116.83 142.19 47.25 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.707 0.803 . . . . 70.209999999999994 110.539 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -69.71 115.3 8.8 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.675 0.39 . . . . 73.299999999999997 110.501 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.1 t -84.43 85.54 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-O 121.766 0.793 . . . . 62.109999999999999 109.837 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.0 p-10 -67.26 158.21 31.99 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.961 1.097 . . . . 64.129999999999995 113.961 163.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 42.3 m80 56.33 29.17 14.58 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 113.829 -1.532 . . . . 72.340000000000003 113.654 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -64.87 128.83 37.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.048 0.539 . . . . 74.430000000000007 111.167 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 98.3 mttt -129.66 133.75 47.29 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.801 0.84 . . . . 71.510000000000005 111.273 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.636 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 84.6 m95 -120.07 160.91 21.9 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.436 1.494 . . . . 60.219999999999999 111.159 -9.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.545 HG23 ' HB2' ' A' ' 33' ' ' TYR . 19.3 m -127.83 141.88 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.334 1.054 . . . . 63.229999999999997 109.301 170.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.6 pt -106.97 167.63 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 122.129 -0.357 . . . . 71.310000000000002 111.632 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.489 ' HG2' ' HB1' ' A' ' 60' ' ' ALA . 53.6 tt0 -47.75 -57.35 5.69 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.847 1.054 . . . . 74.409999999999997 113.847 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -82.09 7.02 14.51 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 112.866 0.691 . . . . 70.030000000000001 112.866 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -91.59 -11.39 37.34 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.386 1.074 . . . . 64.409999999999997 110.506 172.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.8 mt -116.88 140.01 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 125.031 1.332 . . . . 72.340000000000003 109.382 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HB3' ' HG2' ' A' ' 74' ' ' GLU . 16.0 ptmt -71.99 -36.21 69.7 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.758 0.651 . . . . 73.099999999999994 112.758 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -72.9 -8.99 58.16 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.756 0.822 . . . . 71.439999999999998 112.627 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.489 ' HB1' ' HG2' ' A' ' 54' ' ' GLN . . . -33.69 -63.3 0.26 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.228 1.411 . . . . 63.140000000000001 114.69 176.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.7 19.98 65.69 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 115.269 0.868 . . . . 74.329999999999998 115.269 169.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.1 t70 71.81 -3.08 2.28 Favored 'General case' 0 CA--C 1.573 1.853 0 C-N-CA 125.336 1.454 . . . . 74.230000000000004 112.843 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.68 168.15 10.11 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.68 0.792 . . . . 74.340000000000003 111.72 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.0 m -90.91 119.37 31.05 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.296 0.639 . . . . 55.240000000000002 110.409 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.5 HD13 HG11 ' A' ' 71' ' ' VAL . 49.6 mt -73.69 118.16 16.32 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.194 0.598 . . . . 73.230000000000004 110.21 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -101.27 144.55 28.79 Favored Pre-proline 0 N--CA 1.489 1.52 0 C-N-CA 123.614 0.765 . . . . 72.420000000000002 112.172 -165.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.39 124.95 16.22 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 123.082 2.521 . . . . 54.030000000000001 114.324 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.2 -19.22 29.93 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 123.841 0.734 . . . . 73.25 113.393 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -74.35 148.49 41.24 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.546 0.739 . . . . 74.129999999999995 112.291 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -113.07 123.24 49.82 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.726 0.81 . . . . 62.020000000000003 111.216 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.5 HG11 HD13 ' A' ' 65' ' ' LEU . 26.9 m -121.42 177.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 125.392 1.477 . . . . 50.310000000000002 111.496 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 85' ' ' THR . 38.5 mm -120.52 137.0 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 123.935 0.894 . . . . 72.019999999999996 109.821 170.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.4 mt -90.43 121.54 32.5 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.097 0.959 . . . . 51.310000000000002 111.818 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.468 ' HG2' ' HB3' ' A' ' 58' ' ' LYS . 33.8 mm-40 -89.66 -4.06 57.95 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.447 0.536 . . . . 53.420000000000002 112.447 174.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.48 167.62 12.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.255 0.55 . . . . 54.030000000000001 111.056 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 t -141.96 125.01 16.23 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.503 -0.771 . . . . 65.200000000000003 111.683 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -98.73 -11.81 21.57 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.89 0.876 . . . . 63.25 111.527 170.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 20.4 ptp -144.14 -175.6 4.68 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.545 0.738 . . . . 63.43 111.951 -172.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -70.05 100.81 1.68 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.793 0.664 . . . . 73.109999999999999 112.793 -178.017 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.35 38.97 8.62 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.387 -0.824 . . . . 62.109999999999999 114.426 172.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.6 ttt -86.49 -28.98 23.1 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 117.402 0.601 . . . . 64.329999999999998 111.765 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -64.59 129.24 39.08 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 120.908 0.385 . . . . 72.409999999999997 111.848 172.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.23 -4.15 84.34 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.924 -0.58 . . . . 74.329999999999998 113.143 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.78 146.93 32.04 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.463 0.705 . . . . 71.209999999999994 111.588 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.449 ' HA ' HD13 ' A' ' 72' ' ' ILE . 57.9 m -84.11 117.06 23.21 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.989 -0.55 . . . . 64.040000000000006 109.699 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -106.5 152.81 23.18 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.529 0.732 . . . . 72.209999999999994 110.36 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -123.1 121.47 36.08 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.555 -0.906 . . . . 75.209999999999994 108.555 174.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.34 106.38 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.537 0.735 . . . . 73.420000000000002 110.133 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -76.59 -37.71 56.05 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.512 0.725 . . . . 74.510000000000005 109.735 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.0 t -159.77 158.62 31.53 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.671 -0.695 . . . . 72.150000000000006 111.286 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -135.17 139.33 44.49 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.957 0.903 . . . . 62.009999999999998 109.905 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -151.44 142.98 23.58 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.763 0.425 . . . . 65.019999999999996 110.751 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.578 ' HD2' ' H ' ' A' ' 93' ' ' LYS . 1.3 mptt -96.78 92.52 6.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 107.986 -1.116 . . . . 65.310000000000002 107.986 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.3 t -138.11 153.17 49.28 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.532 0.733 . . . . 74.049999999999997 111.337 -172.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.2 m -77.69 122.99 26.09 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.926 -0.398 . . . . 74.420000000000002 109.926 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.524 HG12 HG22 ' A' ' 117' ' ' THR . 24.0 m -109.31 134.2 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.728 0.811 . . . . 71.299999999999997 108.976 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -110.96 144.11 40.57 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.366 0.666 . . . . 73.430000000000007 111.684 -174.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.9 ttp -93.58 111.17 22.79 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.671 -1.233 . . . . 73.329999999999998 107.671 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.579 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 27.4 m -124.42 146.76 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 112.822 0.675 . . . . 72.530000000000001 112.822 -168.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.55 116.18 29.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.945 0.898 . . . . 74.129999999999995 109.827 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -130.96 175.5 9.03 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.188 0.595 . . . . 74.5 111.524 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.8 m -117.56 119.98 36.66 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.878 -0.786 . . . . 72.140000000000001 108.878 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 106' ' ' SER . 72.9 p -60.95 126.09 26.1 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.336 0.654 . . . . 74.209999999999994 111.558 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.5 p -70.71 -48.42 54.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.451 0.7 . . . . 52.149999999999999 112.87 -172.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.507 HG22 ' HA2' ' A' ' 16' ' ' GLY . 11.6 t -86.03 -4.2 59.11 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.304 0.853 . . . . 44.43 113.304 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.434 ' HB2' ' OG ' ' A' ' 103' ' ' SER . 16.5 m -119.12 -49.16 2.41 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.945 0.498 . . . . 75.230000000000004 111.4 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.5 -6.52 55.43 Favored Glycine 0 N--CA 1.481 1.635 0 CA-C-N 116.219 -0.446 . . . . 74.310000000000002 113.618 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.53 130.64 39.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.463 0.705 . . . . 73.420000000000002 110.894 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.474 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -81.3 100.61 9.27 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.837 -0.801 . . . . 74.329999999999998 108.837 178.69 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 113' ' ' HIS . 46.9 t -88.0 108.67 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.052 0.941 . . . . 73.439999999999998 110.004 -172.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.609 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -102.73 139.93 37.67 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.105 0.562 . . . . 51.109999999999999 111.777 -169.805 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 51.67 36.99 18.86 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.509 1.123 . . . . 60.340000000000003 113.249 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.442 ' HB2' HG12 ' A' ' 110' ' ' VAL . 64.8 t60 -64.75 132.52 49.82 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.884 -0.598 . . . . 64.129999999999995 110.819 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HB2' ' CE3' ' A' ' 115' ' ' TRP . 21.1 pttp -158.39 146.96 18.77 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 115.188 -0.915 . . . . 73.099999999999994 111.019 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.636 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 87.9 m95 -106.87 136.6 46.43 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.08 1.352 . . . . 72.150000000000006 112.735 4.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.4 m -122.16 141.58 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 124.881 1.272 . . . . 61.020000000000003 108.313 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.524 HG22 HG12 ' A' ' 96' ' ' VAL . 30.7 p -96.37 178.01 5.51 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.781 -0.574 . . . . 72.439999999999998 112.202 -174.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -59.65 -52.92 63.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.021 0.928 . . . . 74.430000000000007 112.868 -176.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.52 -21.15 66.6 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.942 0.897 . . . . 70.420000000000002 112.223 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -88.53 3.06 51.65 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.646 0.778 . . . . 74.219999999999999 111.521 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.6 mt -121.95 166.65 14.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.63 1.172 . . . . 63.539999999999999 109.289 171.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.3 t -151.13 130.78 13.09 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.439 0.696 . . . . 73.349999999999994 110.16 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.3 143.72 50.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.832 0.453 . . . . 43.299999999999997 111.524 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.3 tptt . . . . . 0 CA--C 1.556 1.199 0 C-N-CA 123.16 0.584 . . . . 73.439999999999998 111.039 178.774 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mmt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.952 -0.388 . . . . 62.43 109.952 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -100.8 154.24 18.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.38 0.672 . . . . 72.430000000000007 111.219 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.24 122.74 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 121.084 0.468 . . . . 62.0 110.397 173.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.7 -7.77 42.55 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 115.53 -0.759 . . . . 42.200000000000003 112.689 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -80.9 151.22 28.71 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.412 0.685 . . . . 71.230000000000004 112.349 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -93.06 136.96 32.84 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.163 0.985 . . . . 73.409999999999997 109.136 170.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.95 153.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.7 0.8 . . . . 63.439999999999998 110.308 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.8 mm -104.95 121.53 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.889 0.876 . . . . 72.5 109.828 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 22' ' ' ALA . 35.3 mt -82.01 120.41 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 122.938 0.495 . . . . 62.310000000000002 109.886 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -96.86 -56.08 2.68 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.865 0.466 . . . . 70.349999999999994 110.833 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.454 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 84.3 m -95.3 140.03 30.77 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.85 -1.167 . . . . 75.019999999999996 107.85 174.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 17' ' ' MET . 79.6 p -154.71 141.28 18.86 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.976 0.732 . . . . 74.219999999999999 112.976 -164.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -75.18 -43.63 51.07 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.157 0.983 . . . . 75.340000000000003 109.6 174.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.485 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 25.3 mmt -96.34 140.42 31.03 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.377 -0.829 . . . . 74.319999999999993 110.535 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -60.96 -35.19 76.11 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.763 0.825 . . . . 71.129999999999995 111.468 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.46 -4.54 24.91 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 115.118 0.807 . . . . 73.129999999999995 115.118 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.531 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 48.6 mtm -99.52 -25.38 14.45 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 117.401 0.6 . . . . 65.25 111.678 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -68.34 116.93 9.48 Favored 'General case' 0 CA--C 1.556 1.178 0 CA-C-N 118.475 0.579 . . . . 72.409999999999997 110.375 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.81 2.0 89.81 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 115.383 -0.826 . . . . 44.130000000000003 113.689 -174.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.9 148.29 27.03 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.205 0.602 . . . . 42.119999999999997 111.797 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -95.18 104.26 16.14 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.643 0.777 . . . . 71.019999999999996 109.635 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.535 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -90.61 161.12 15.56 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.828 0.851 . . . . 64.219999999999999 112.189 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.4 m -124.11 121.77 36.05 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.363 -0.976 . . . . 63.32 108.363 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.07 100.4 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 122.8 0.44 . . . . 51.119999999999997 109.906 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.5 p -91.98 -8.1 47.11 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.167 0.587 . . . . 73.120000000000005 111.32 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.26 148.96 15.42 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.369 -0.378 . . . . 72.219999999999999 112.386 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.78 114.53 14.22 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.821 0.848 . . . . 52.310000000000002 109.915 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.453 ' HB2' HG23 ' A' ' 96' ' ' VAL . 5.9 m-85 -116.06 130.54 56.86 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.173 0.989 . . . . 72.329999999999998 111.155 -171.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -103.83 81.65 1.9 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.938 0.895 . . . . 75.239999999999995 110.319 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -133.88 166.15 23.34 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.088 0.555 . . . . 60.43 111.307 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.412 ' HB ' ' HG2' ' A' ' 54' ' ' GLN . 4.0 m -76.83 121.93 24.07 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.372 -0.603 . . . . 62.200000000000003 109.372 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.89 151.62 26.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.452 0.701 . . . . 74.239999999999995 109.635 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -136.42 149.18 48.14 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.934 0.873 . . . . 64.340000000000003 112.25 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.52 111.58 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 113.892 -1.503 . . . . 73.040000000000006 107.149 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.541 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 26.7 m -119.92 149.49 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.321 0.648 . . . . 74.409999999999997 112.165 -176.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.1 t -117.41 132.21 56.61 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.655 0.782 . . . . 71.400000000000006 109.908 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -150.71 156.1 40.64 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.09 0.472 . . . . 74.430000000000007 111.968 -173.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 m -109.3 111.66 59.79 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.332 -0.988 . . . . 44.039999999999999 108.332 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.79 117.2 3.11 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.376 2.718 . . . . 72.109999999999999 114.125 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.466 HG23 ' HA ' ' A' ' 84' ' ' ALA . 25.6 p -59.49 -24.4 63.57 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.741 1.216 . . . . 70.040000000000006 113.892 -173.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -79.38 14.69 1.47 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.483 0.713 . . . . 74.239999999999995 112.858 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.95 43.7 6.63 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 113.774 0.27 . . . . 44.539999999999999 113.774 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.93 163.61 12.94 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 122.708 0.194 . . . . 71.140000000000001 113.024 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -66.28 135.12 53.98 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.372 0.669 . . . . 52.509999999999998 111.099 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -58.19 116.83 3.82 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.584 0.754 . . . . 72.129999999999995 112.376 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.55 HG12 ' HB2' ' A' ' 49' ' ' HIS . 30.7 t -84.82 104.94 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.202 -0.908 . . . . 72.430000000000007 109.198 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -99.41 135.5 40.72 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.414 0.686 . . . . 75.519999999999996 110.668 -172.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.8 m170 57.45 39.06 28.36 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.233 1.013 . . . . 71.549999999999997 112.446 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.55 ' HB2' HG12 ' A' ' 46' ' ' VAL . 46.0 t60 -66.25 135.29 54.25 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.908 0.883 . . . . 70.510000000000005 110.701 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -150.81 153.61 35.75 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.889 -0.596 . . . . 71.310000000000002 110.46 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.559 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 98.0 m95 -106.43 139.61 40.63 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.39 1.476 . . . . 65.239999999999995 111.824 -2.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.5 137.43 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.333 1.053 . . . . 41.409999999999997 108.377 169.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.2 pt -113.74 174.1 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.965 0.506 . . . . 62.130000000000003 111.722 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.412 ' HG2' ' HB ' ' A' ' 31' ' ' THR . 14.1 mm100 -48.85 -49.16 40.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.57 1.322 . . . . 73.420000000000002 114.57 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.46 -1.22 40.66 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 122.856 0.462 . . . . 63.509999999999998 112.163 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.45 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 0.9 OUTLIER -83.81 -22.06 31.92 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.826 0.85 . . . . 71.519999999999996 110.27 175.105 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.4 mt -117.34 136.14 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 124.715 1.206 . . . . 72.349999999999994 111.079 -168.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.485 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 38.4 ttpt -72.01 -57.41 4.31 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.489 0.716 . . . . 62.020000000000003 111.539 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.09 -4.61 14.12 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.581 1.152 . . . . 74.209999999999994 113.685 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.728 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -54.55 -55.74 26.12 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.45 0.7 . . . . 75.219999999999999 112.006 171.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.91 19.79 65.93 Favored Glycine 0 N--CA 1.479 1.565 0 N-CA-C 114.676 0.63 . . . . 53.140000000000001 114.676 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 62.79 20.14 11.93 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.06 1.344 . . . . 73.150000000000006 113.813 -172.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 16.6 pttp -98.32 160.18 14.46 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 122.914 0.486 . . . . 64.510000000000005 109.91 173.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.8 m -76.46 110.81 11.31 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.891 -0.411 . . . . 73.409999999999997 109.891 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 60' ' ' ALA . 61.1 mt -74.68 114.07 12.68 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.267 0.627 . . . . 74.439999999999998 110.458 177.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -81.23 147.81 61.73 Favored Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 123.561 0.744 . . . . 42.219999999999999 111.731 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.42 114.63 1.65 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.836 2.358 . . . . 75.150000000000006 113.339 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.81 -14.21 24.39 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-N 115.826 -0.625 . . . . 61.229999999999997 113.96 -174.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -75.24 141.84 43.47 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.423 0.689 . . . . 75.340000000000003 111.03 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -111.38 133.22 53.84 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.536 0.684 . . . . 74.349999999999994 110.975 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.9 m -140.09 156.39 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 125.389 1.476 . . . . 63.039999999999999 110.634 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -103.46 136.13 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 122.853 0.461 . . . . 73.409999999999997 109.769 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.3 mt -87.44 120.88 29.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.167 0.987 . . . . 74.430000000000007 111.44 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.485 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 8.2 mm-40 -81.73 -36.97 28.01 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.317 0.647 . . . . 75.219999999999999 112.43 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.45 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -83.73 164.99 19.26 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.058 0.456 . . . . 71.5 111.214 176.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 96.5 p -143.74 124.81 14.44 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.737 -0.468 . . . . 63.210000000000001 109.737 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -91.66 -4.28 55.37 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.777 0.831 . . . . 71.450000000000003 110.602 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -164.33 175.78 9.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.304 1.042 . . . . 74.140000000000001 111.141 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -80.4 116.38 20.43 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.352 0.661 . . . . 74.310000000000002 111.387 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.31 27.34 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 123.019 0.342 . . . . 75.329999999999998 113.821 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.9 ttt -82.53 -50.52 8.73 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.587 0.755 . . . . 73.340000000000003 112.906 -173.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -63.31 128.78 37.39 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.834 0.453 . . . . 64.040000000000006 111.893 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.2 -10.3 67.58 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.562 -0.29 . . . . 50.109999999999999 113.227 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.466 ' HA ' HG23 ' A' ' 40' ' ' THR . . . -76.63 145.9 38.55 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.018 0.527 . . . . 73.340000000000003 111.775 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.0 m -84.17 117.25 23.37 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.693 -0.685 . . . . 62.329999999999998 109.554 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.541 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -110.95 149.27 30.9 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.758 1.223 . . . . 71.310000000000002 109.94 -175.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.47 132.24 52.71 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 109.483 -0.562 . . . . 63.340000000000003 109.483 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.525 HD13 HG12 ' A' ' 35' ' ' VAL . 30.4 mm -67.42 109.4 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.607 0.763 . . . . 73.030000000000001 110.354 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -78.06 -38.36 44.61 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.217 0.607 . . . . 74.120000000000005 109.743 172.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.2 t -154.92 141.15 18.55 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.458 -0.792 . . . . 71.549999999999997 111.301 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.16 131.89 52.07 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.907 0.883 . . . . 75.129999999999995 108.955 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -132.5 139.29 47.87 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.788 0.662 . . . . 74.519999999999996 112.788 -168.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -111.22 95.39 5.5 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.06 0.944 . . . . 63.340000000000003 109.414 169.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -137.56 157.25 46.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.116 0.966 . . . . 45.32 110.841 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.6 m -85.38 119.37 25.66 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.307 -0.997 . . . . 72.129999999999995 108.307 171.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.453 HG23 ' HB2' ' A' ' 28' ' ' TYR . 13.7 m -106.51 132.76 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.398 0.618 . . . . 63.140000000000001 109.624 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.402 ' HB2' HG23 ' A' ' 116' ' ' VAL . 89.7 m-85 -111.97 140.43 46.65 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.935 0.894 . . . . 62.329999999999998 111.231 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.8 ttp -94.21 119.88 33.65 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.268 -1.382 . . . . 51.140000000000001 107.268 167.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.535 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 23.5 m -128.03 156.56 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 113.789 1.033 . . . . 71.099999999999994 113.789 -171.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -110.29 118.28 35.91 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.124 1.37 . . . . 63.229999999999997 109.087 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -133.72 166.86 21.64 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.174 0.511 . . . . 71.209999999999994 110.947 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.4 m -105.61 119.14 38.37 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 108.791 -0.818 . . . . 75.329999999999998 108.791 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.8 m -56.84 95.98 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.754 0.821 . . . . 71.140000000000001 110.834 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.4 p -58.3 -26.0 62.51 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.351 1.06 . . . . 64.310000000000002 113.709 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 m -62.6 -38.3 89.63 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 123.734 0.813 . . . . 73.209999999999994 112.421 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.9 p -113.94 -50.76 2.81 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 123.357 0.663 . . . . 70.120000000000005 112.068 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.21 15.85 7.52 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.158 0.885 . . . . 71.349999999999994 111.945 -172.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -86.49 141.54 29.02 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.727 0.811 . . . . 43.299999999999997 111.547 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -85.01 117.71 24.15 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.752 1.221 . . . . 73.040000000000006 111.093 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -120.53 132.6 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 124.03 0.932 . . . . 71.219999999999999 110.591 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.453 ' HD3' ' H ' ' A' ' 111' ' ' LYS . 0.4 OUTLIER -115.8 168.7 9.82 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.263 0.625 . . . . 63.329999999999998 111.365 178.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.7 p30 44.79 37.58 2.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 126.516 1.926 . . . . 74.420000000000002 115.221 176.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -61.53 133.0 55.2 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.483 0.713 . . . . 71.25 111.642 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 90.5 mttt -137.11 132.61 34.31 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.025 0.93 . . . . 74.230000000000004 110.951 -175.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.559 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.7 m95 -116.37 154.35 30.4 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.824 1.65 . . . . 74.150000000000006 111.564 -11.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.402 HG23 ' HB2' ' A' ' 97' ' ' TYR . 15.4 m -124.51 142.47 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.865 0.866 . . . . 61.030000000000001 109.637 172.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.1 p -109.98 168.26 9.56 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.52 0.563 . . . . 72.140000000000001 112.52 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -57.2 -35.23 69.37 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.678 0.791 . . . . 71.310000000000002 111.686 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.49 -43.01 93.4 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.34 1.056 . . . . 64.439999999999998 111.799 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.454 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 52.2 mt-10 -85.73 -2.79 58.56 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.903 0.881 . . . . 72.030000000000001 112.892 -172.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.07 150.49 40.49 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.636 0.731 . . . . 72.349999999999994 111.578 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 m -122.77 147.7 46.2 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.312 -1.366 . . . . 74.150000000000006 107.312 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.17 151.85 33.03 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.95 0.795 . . . . 33.240000000000002 111.692 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -65.62 -46.01 80.9 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.075 0.55 . . . . 72.099999999999994 110.766 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.5 tt -70.54 -64.94 0.8 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.697 0.799 . . . . 61.32 109.42 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.12 74.08 10.32 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.509 0.671 . . . . 41.200000000000003 110.298 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -76.44 145.61 39.17 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 115.551 -0.75 . . . . 72.420000000000002 110.013 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.9 m80 75.49 -21.65 0.3 Allowed 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 125.321 1.448 . . . . 61.229999999999997 112.741 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -70.37 105.02 2.88 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.731 0.812 . . . . 71.310000000000002 111.274 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -111.98 148.13 34.46 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.308 -0.86 . . . . 70.230000000000004 110.248 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -104.25 124.06 48.46 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.975 -0.75 . . . . 74.109999999999999 108.975 171.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 . . . . . 0 CA--C 1.566 1.573 0 CA-C-O 118.11 -0.948 . . . . 71.219999999999999 109.774 176.491 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.529 ' HG2' HG11 ' A' ' 7' ' ' VAL . 1.8 mpt? . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.431 0.158 . . . . 52.219999999999999 110.95 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -109.13 164.13 12.71 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.613 0.765 . . . . 74.540000000000006 110.392 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.2 123.06 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-O 121.132 0.492 . . . . 75.409999999999997 110.532 172.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.57 -4.37 50.61 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 115.797 -0.638 . . . . 64.200000000000003 113.572 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -83.41 142.86 30.68 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.222 0.609 . . . . 54.409999999999997 111.455 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -109.13 135.73 49.79 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.42 0.629 . . . . 64.439999999999998 111.005 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 123' ' ' ALA . 23.7 m -139.81 155.29 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.967 1.307 . . . . 64.549999999999997 110.475 -170.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.1 mm -98.56 132.53 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.173 0.589 . . . . 73.129999999999995 109.714 170.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.687 HG21 ' HG2' ' A' ' 17' ' ' MET . 39.8 mt -81.71 123.34 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 122.387 0.275 . . . . 72.519999999999996 110.357 -175.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -95.11 -60.06 1.76 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.433 0.693 . . . . 73.439999999999998 110.247 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.627 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 79.7 m -98.24 140.03 33.14 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.073 -1.084 . . . . 73.540000000000006 108.073 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.437 ' HB3' ' HB3' ' A' ' 17' ' ' MET . 74.1 m -140.16 139.88 35.82 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.991 1.108 . . . . 64.299999999999997 113.991 -167.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -91.31 -15.92 28.34 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 113.994 -1.457 . . . . 71.420000000000002 110.417 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 26.5 mmt -126.56 155.43 42.44 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.646 1.179 . . . . 62.439999999999998 110.226 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -67.05 -36.9 83.06 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.095 0.558 . . . . 73.219999999999999 112.193 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.43 -9.98 86.58 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 114.046 0.379 . . . . 75.120000000000005 114.046 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.687 ' HG2' HG21 ' A' ' 9' ' ' ILE . 44.0 ttm -80.69 -32.1 36.01 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 122.69 0.396 . . . . 62.020000000000003 111.718 -172.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -68.87 122.34 18.42 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.13 0.572 . . . . 64.450000000000003 112.201 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.61 -8.48 79.05 Favored Glycine 0 CA--C 1.537 1.469 0 CA-C-N 115.729 -0.669 . . . . 71.120000000000005 114.147 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.18 149.68 42.73 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.169 0.588 . . . . 52.229999999999997 112.131 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -87.94 101.93 14.23 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.623 0.369 . . . . 73.549999999999997 110.04 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . . . -86.56 156.96 19.85 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.604 0.762 . . . . 73.120000000000005 111.374 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.0 m -131.25 127.51 37.95 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.454 -0.943 . . . . 73.150000000000006 108.454 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.95 113.83 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 123.207 0.603 . . . . 73.140000000000001 111.017 -173.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.4 p -89.9 -21.04 22.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.102 0.561 . . . . 74.340000000000003 110.53 173.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.6 142.57 8.52 Favored Glycine 0 C--N 1.354 1.547 0 C-N-CA 122.741 0.21 . . . . 54.299999999999997 112.612 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.98 107.55 9.7 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.66 0.784 . . . . 51.420000000000002 110.067 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -111.58 132.91 54.21 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.801 0.84 . . . . 75.439999999999998 110.674 -175.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.4 82.71 1.77 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.77 0.795 . . . . 52.32 109.97 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -134.96 -179.51 5.66 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.816 0.846 . . . . 75.530000000000001 111.321 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 m -83.91 128.26 34.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.918 -0.489 . . . . 74.450000000000003 110.383 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.11 140.18 48.1 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.141 0.976 . . . . 74.140000000000001 109.895 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -113.72 152.51 30.41 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 122.081 0.943 . . . . 74.319999999999993 112.6 -174.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.54 111.41 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.069 -1.423 . . . . 42.340000000000003 107.753 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.426 HG12 HD13 ' A' ' 88' ' ' ILE . 19.3 m -112.39 150.85 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.386 0.612 . . . . 75.200000000000003 112.444 -176.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -122.0 125.57 46.59 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.298 1.039 . . . . 72.239999999999995 109.263 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -152.27 159.03 43.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.564 0.745 . . . . 74.549999999999997 111.294 -174.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.9 m -105.52 116.73 59.64 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.724 -1.213 . . . . 74.530000000000001 107.724 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -58.96 133.32 52.79 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.096 1.864 . . . . 74.129999999999995 110.873 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.1 p -68.83 2.06 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.109 0.781 . . . . 61.049999999999997 113.109 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.14 -21.2 66.04 Favored 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 123.663 0.785 . . . . 65.129999999999995 111.317 165.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.19 15.13 56.46 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 115.066 0.786 . . . . 64.340000000000003 115.066 171.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.62 -131.43 7.38 Favored Glycine 0 N--CA 1.476 1.357 0 CA-C-N 117.655 0.728 . . . . 25.550000000000001 113.688 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -71.21 128.27 35.36 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.919 0.888 . . . . 73.019999999999996 111.974 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -62.24 122.3 15.28 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.587 0.755 . . . . 72.299999999999997 111.938 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.593 HG21 ' SD ' ' A' ' 78' ' ' MET . 68.0 t -84.47 110.77 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.396 0.679 . . . . 70.439999999999998 110.256 176.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -101.44 148.33 25.31 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.903 0.481 . . . . 73.219999999999999 109.958 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 34.3 m80 54.59 38.95 30.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.732 0.813 . . . . 75.030000000000001 112.779 173.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -60.46 128.35 36.21 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.857 0.863 . . . . 71.409999999999997 111.198 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 66.1 mttm -126.3 132.68 51.6 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 123.504 0.722 . . . . 71.239999999999995 110.594 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 94.4 m95 -117.86 156.14 28.92 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.154 1.382 . . . . 70.450000000000003 111.53 -11.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.55 160.4 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.96 1.304 . . . . 75.430000000000007 108.169 169.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.416 HG21 HG21 ' A' ' 96' ' ' VAL . 37.4 pt -126.7 163.65 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 118.983 0.81 . . . . 54.039999999999999 112.546 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -44.14 -51.59 7.96 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.499 1.519 . . . . 64.430000000000007 112.538 174.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -82.15 -5.92 58.81 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.787 0.835 . . . . 70.040000000000006 112.97 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -88.32 -33.67 17.92 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.686 0.795 . . . . 35.450000000000003 110.234 173.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.8 mt -78.93 130.25 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 115.754 -0.657 . . . . 74.409999999999997 110.468 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -69.34 -35.45 75.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.492 0.717 . . . . 71.230000000000004 112.351 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.24 -8.9 58.35 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.971 0.73 . . . . 73.099999999999994 112.971 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -34.17 -59.43 0.43 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 114.945 1.461 . . . . 51.43 114.945 -173.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.51 21.01 68.4 Favored Glycine 0 N--CA 1.479 1.519 0 N-CA-C 115.352 0.901 . . . . 75.540000000000006 115.352 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 68.84 -2.94 1.57 Allowed 'General case' 0 CA--C 1.573 1.85 0 C-N-CA 124.862 1.265 . . . . 64.439999999999998 112.472 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 25.0 pttm -95.68 152.78 18.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.628 -0.67 . . . . 74.349999999999994 111.022 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.6 m -84.08 112.36 20.15 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.006 -0.739 . . . . 74.129999999999995 109.006 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.534 ' HB3' HG13 ' A' ' 88' ' ' ILE . 42.3 mt -71.31 120.5 16.98 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.817 0.847 . . . . 63.399999999999999 110.763 -174.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -91.19 157.48 42.7 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 123.682 0.793 . . . . 72.219999999999999 111.292 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 87.2 Cg_exo -50.99 112.25 0.74 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.644 2.229 . . . . 72.040000000000006 113.163 172.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.64 -9.93 16.52 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 115.975 -0.557 . . . . 63.009999999999998 114.031 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.6 122.73 19.12 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 117.772 0.786 . . . . 74.5 109.495 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -100.91 118.35 36.78 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.471 -0.937 . . . . 75.150000000000006 108.471 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.423 HG11 HD13 ' A' ' 65' ' ' LEU . 33.3 m -125.29 171.92 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.607 1.163 . . . . 52.420000000000002 110.877 -166.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.3 mm -116.17 135.95 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 122.863 0.465 . . . . 62.210000000000001 110.033 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.9 mt -90.93 134.73 34.24 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.74 0.816 . . . . 63.450000000000003 110.996 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.16 -5.62 27.49 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 113.0 0.741 . . . . 75.549999999999997 113.0 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.6 156.27 16.89 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.139 0.575 . . . . 74.299999999999997 110.618 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.9 p -136.04 124.4 23.34 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.193 0.521 . . . . 65.310000000000002 110.319 171.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -100.35 -16.22 17.72 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.793 0.837 . . . . 75.140000000000001 108.991 162.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.593 ' SD ' HG21 ' A' ' 46' ' ' VAL . 43.3 mtt -128.57 173.42 10.28 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.39 1.076 . . . . 73.209999999999994 112.213 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.59 105.67 8.89 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.0 0.92 . . . . 63.329999999999998 110.836 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.1 33.58 17.34 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.23 -0.441 . . . . 72.109999999999999 113.207 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -89.59 -49.4 6.69 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.303 0.641 . . . . 71.099999999999994 109.97 173.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -69.04 120.57 15.1 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.34 0.656 . . . . 73.120000000000005 111.036 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.71 2.35 75.82 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 123.103 0.252 . . . . 70.109999999999999 113.263 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.44 158.09 19.06 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.4 0.68 . . . . 72.439999999999998 111.551 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 m -87.51 118.33 26.9 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.2 -0.909 . . . . 72.109999999999999 110.023 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -115.43 162.17 17.52 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.112 0.965 . . . . 61.530000000000001 110.114 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -130.75 130.28 43.57 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.051 0.54 . . . . 65.219999999999999 109.873 173.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 65' ' ' LEU . 36.7 mm -64.78 104.61 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.503 0.721 . . . . 73.510000000000005 110.137 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.6 -37.59 65.38 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.696 0.798 . . . . 72.319999999999993 110.601 172.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.6 t -162.66 159.04 23.95 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.287 0.635 . . . . 62.219999999999999 111.829 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.42 150.52 39.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.518 1.127 . . . . 61.509999999999998 110.645 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -154.54 134.0 12.68 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 112.02 0.378 . . . . 63.530000000000001 112.02 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -93.59 96.57 9.94 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.105 -0.702 . . . . 73.329999999999998 109.105 172.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.8 t -137.09 154.4 50.32 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.621 0.768 . . . . 64.319999999999993 111.68 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.2 m -80.11 119.21 22.6 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.055 -0.72 . . . . 72.420000000000002 109.055 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.416 HG21 HG21 ' A' ' 53' ' ' ILE . 24.8 m -108.65 136.42 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.811 0.845 . . . . 71.140000000000001 110.728 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.07 146.62 36.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.358 1.075 . . . . 72.109999999999999 112.912 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.7 ttp -108.03 118.93 38.03 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 113.466 -1.697 . . . . 73.450000000000003 106.825 165.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.2 m -127.99 173.27 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 112.699 0.629 . . . . 74.310000000000002 112.699 -170.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.69 ' HB2' ' HD3' ' A' ' 111' ' ' LYS . 4.8 p-10 -138.16 133.48 33.38 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.127 0.571 . . . . 75.319999999999993 110.441 172.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.445 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 47.7 p90 -151.18 177.23 10.42 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.165 0.586 . . . . 75.420000000000002 111.571 -174.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.2 m -111.59 112.34 23.99 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.291 -1.003 . . . . 63.310000000000002 108.291 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.5 p -59.01 116.57 3.9 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.3 0.64 . . . . 54.43 111.281 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.4 p -58.07 -32.81 68.4 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.846 1.258 . . . . 75.319999999999993 113.876 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.4 p -87.82 -45.13 10.57 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.262 0.467 . . . . 73.200000000000003 112.262 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -89.04 -31.89 17.85 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.401 0.68 . . . . 74.519999999999996 112.548 -169.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.14 -6.1 83.82 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 116.228 -0.442 . . . . 31.219999999999999 113.592 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -77.26 132.76 38.84 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.161 0.984 . . . . 75.329999999999998 112.142 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -80.27 94.15 6.03 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.476 0.71 . . . . 73.129999999999995 109.395 174.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 113' ' ' HIS . 58.5 t -77.35 104.62 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.234 -0.893 . . . . 72.420000000000002 109.713 -176.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.69 ' HD3' ' HB2' ' A' ' 100' ' ' ASP . 74.9 mmtt -99.93 133.75 43.85 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.597 0.759 . . . . 73.230000000000004 111.697 -172.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 m120 61.58 35.66 17.19 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.299 1.04 . . . . 51.009999999999998 112.21 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.447 ' HB2' HG12 ' A' ' 110' ' ' VAL . 86.3 t60 -58.78 129.52 42.5 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.98 0.912 . . . . 63.109999999999999 112.23 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 19.2 ptpt -152.49 147.45 26.25 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.899 0.88 . . . . 64.310000000000002 110.787 -176.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 97.6 m95 -109.14 138.48 45.43 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.33 1.452 . . . . 73.420000000000002 111.77 -4.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.78 172.38 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.438 1.095 . . . . 72.120000000000005 108.895 170.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 120' ' ' GLU . 30.3 p -118.58 178.22 4.54 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.362 0.665 . . . . 61.299999999999997 111.01 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -67.28 -28.18 67.8 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.455 0.302 . . . . 74.510000000000005 111.385 174.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.42 -15.27 53.25 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 122.939 0.496 . . . . 72.040000000000006 111.754 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.627 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 4.7 mm-40 -81.19 -18.82 44.89 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.199 0.523 . . . . 70.420000000000002 110.407 171.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.0 mt -115.05 159.18 21.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.024 0.93 . . . . 75.299999999999997 110.593 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.1 m -137.71 138.18 39.08 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.019 -1.104 . . . . 60.299999999999997 108.019 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.548 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -57.38 158.08 5.95 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.73 0.695 . . . . 63.439999999999998 111.454 176.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -54.01 -34.51 60.12 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.924 0.49 . . . . 64.450000000000003 112.026 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.7 tp -75.9 -49.72 17.07 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.666 0.786 . . . . 72.439999999999998 111.23 169.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -64.44 142.79 58.3 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.992 0.917 . . . . 74.409999999999997 113.202 -171.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -157.96 104.07 1.9 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.433 0.693 . . . . 75.319999999999993 110.496 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -137.83 98.12 3.59 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.61 0.764 . . . . 60.329999999999998 110.455 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -69.94 126.94 31.19 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.6 0.36 . . . . 71.209999999999994 110.747 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -147.35 -2.46 0.59 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.814 0.672 . . . . 74.230000000000004 112.814 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -166.01 167.56 16.42 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.456 1.102 . . . . 71.299999999999997 110.602 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 . . . . . 0 CA--C 1.562 1.406 0 C-N-CA 123.995 0.918 . . . . 63.539999999999999 110.493 173.609 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' HB3' HG21 ' A' ' 24' ' ' VAL . 24.9 mmt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.535 0.207 . . . . 71.439999999999998 110.93 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -70.97 157.14 38.72 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.464 1.105 . . . . 65.340000000000003 111.212 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -62.23 127.57 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 C-N-CA 122.589 0.356 . . . . 75.239999999999995 110.868 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.44 -3.62 56.52 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.246 0.45 . . . . 70.219999999999999 113.412 -175.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.8 t -73.15 127.85 33.78 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.229 0.612 . . . . 45.450000000000003 111.82 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -87.58 109.92 19.99 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.341 0.656 . . . . 74.420000000000002 110.14 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.427 HG21 HD13 ' A' ' 121' ' ' LEU . 30.4 m -125.99 157.66 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 124.011 0.924 . . . . 74.099999999999994 111.074 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.2 mm -105.54 136.99 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.344 1.057 . . . . 70.319999999999993 109.241 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 17' ' ' MET . 54.0 mt -76.76 118.43 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 CA-C-O 120.759 0.314 . . . . 74.219999999999999 110.192 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -84.54 -59.27 2.42 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.04 0.936 . . . . 71.420000000000002 110.127 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 94.0 m -91.88 139.69 30.41 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.527 -0.76 . . . . 71.340000000000003 109.767 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 14' ' ' MET . 80.6 p -130.34 122.42 27.86 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.091 0.472 . . . . 60.43 111.707 -174.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -83.12 -44.86 14.64 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.565 -0.902 . . . . 74.239999999999995 108.565 171.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.462 ' O ' ' HB2' ' A' ' 12' ' ' SER . 1.8 mpt? -94.18 130.9 40.22 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 114.164 -1.38 . . . . 63.420000000000002 107.536 166.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -63.0 -24.2 67.81 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 119.363 0.983 . . . . 65.230000000000004 113.234 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.01 -4.61 68.01 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 114.694 0.638 . . . . 53.229999999999997 114.694 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.432 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 35.0 mtp -84.97 -29.73 24.84 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.308 0.643 . . . . 73.200000000000003 110.722 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -67.94 117.73 10.2 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.571 0.348 . . . . 73.109999999999999 111.075 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.2 1.09 90.48 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 116.087 -0.506 . . . . 34.109999999999999 113.645 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.92 135.46 43.28 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.239 0.616 . . . . 72.329999999999998 111.141 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -82.29 103.94 12.24 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.641 -0.709 . . . . 73.409999999999997 110.323 -176.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.33 160.48 14.25 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.059 0.943 . . . . 70.439999999999998 113.301 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.3 m -133.14 136.36 45.73 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.841 1.257 . . . . 74.209999999999994 108.611 171.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.519 HG21 ' HB3' ' A' ' 1' ' ' MET . 61.1 t -82.66 111.19 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 122.888 0.475 . . . . 61.219999999999999 110.868 -177.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.5 p -86.32 -19.9 29.14 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.824 0.45 . . . . 72.519999999999996 111.571 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.34 166.45 39.23 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 113.843 0.297 . . . . 54.229999999999997 113.843 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.63 138.51 47.39 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.091 0.957 . . . . 73.25 110.935 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.457 ' HB2' HG23 ' A' ' 96' ' ' VAL . 42.8 m-85 -128.55 111.84 13.67 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.32 1.048 . . . . 65.019999999999996 109.756 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -97.91 79.24 2.62 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.874 0.845 . . . . 72.400000000000006 110.401 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -133.91 170.89 14.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.658 0.783 . . . . 73.019999999999996 111.624 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -73.74 121.26 20.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.977 0.511 . . . . 65.239999999999995 109.879 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.35 147.86 43.08 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.638 0.775 . . . . 63.409999999999997 110.383 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -131.96 154.56 49.17 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.163 0.982 . . . . 75.329999999999998 112.591 -167.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 90' ' ' SER . 64.6 t -105.14 133.66 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 113.729 -1.578 . . . . 70.439999999999998 107.62 167.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.43 ' HA ' ' H ' ' A' ' 89' ' ' ASP . 12.5 m -131.18 166.03 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.8 0.809 . . . . 74.549999999999997 112.788 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.2 t -132.92 127.78 35.07 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 114.38 -1.282 . . . . 71.120000000000005 108.658 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.52 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 43.8 p90 -155.87 160.27 40.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.596 0.758 . . . . 74.230000000000004 111.062 -171.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.1 m -109.28 119.48 48.31 Favored Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 108.783 -0.821 . . . . 65.209999999999994 108.783 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.27 133.17 45.0 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.127 1.885 . . . . 60.399999999999999 111.902 172.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.8 p -65.19 -7.28 12.02 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.99 0.916 . . . . 72.049999999999997 113.081 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.33 -18.0 60.29 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 124.728 1.211 . . . . 71.040000000000006 113.046 171.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.69 57.46 3.54 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 111.624 -0.59 . . . . 75.519999999999996 111.624 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.47 -155.56 8.16 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 115.007 -0.597 . . . . 72.040000000000006 113.005 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -69.48 119.05 13.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.469 0.708 . . . . 61.240000000000002 110.808 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -56.95 116.28 3.11 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 109.317 -0.623 . . . . 73.349999999999994 109.317 168.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.492 HG12 ' HB2' ' A' ' 49' ' ' HIS . 40.7 t -88.67 115.51 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 123.311 0.645 . . . . 74.430000000000007 110.154 -176.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -109.35 155.69 20.91 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.376 0.671 . . . . 50.409999999999997 110.491 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.2 m170 57.82 26.4 13.15 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.902 0.881 . . . . 70.400000000000006 112.376 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.492 ' HB2' HG12 ' A' ' 46' ' ' VAL . 84.9 t60 -71.65 136.95 47.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.811 0.844 . . . . 74.230000000000004 110.908 -178.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 65.1 pttt -158.11 148.71 20.56 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-N 116.313 -0.403 . . . . 63.439999999999998 111.508 -176.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 82.4 m95 -107.59 147.75 30.2 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.022 1.329 . . . . 72.049999999999997 111.471 -0.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.92 135.5 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.436 1.095 . . . . 74.230000000000004 108.272 172.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.5 pt -115.53 169.98 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.284 -0.885 . . . . 71.439999999999998 112.754 -168.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -50.85 -39.76 54.42 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.299 1.039 . . . . 73.310000000000002 113.791 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -72.61 -20.86 61.21 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.479 0.712 . . . . 60.299999999999997 111.882 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.531 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 27.3 tt0 -91.98 -24.76 19.14 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.59 0.756 . . . . 73.209999999999994 111.446 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.1 mt -101.22 129.36 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.867 0.867 . . . . 65.299999999999997 110.35 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -72.02 -57.09 4.58 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.581 0.705 . . . . 64.140000000000001 111.567 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.99 -2.99 6.02 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.687 1.195 . . . . 74.040000000000006 113.98 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.499 ' HA ' HD11 ' A' ' 65' ' ' LEU . . . -39.53 -58.34 1.29 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.126 1.37 . . . . 71.549999999999997 114.166 171.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.07 27.6 73.5 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 114.76 0.664 . . . . 72.040000000000006 114.76 174.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 63.17 16.56 9.48 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.686 1.194 . . . . 63.140000000000001 113.561 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 14.5 ptpt -105.6 167.94 9.43 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 122.882 0.473 . . . . 74.209999999999994 111.18 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.4 m -82.87 108.95 16.58 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.742 -0.836 . . . . 73.219999999999999 108.742 169.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.639 ' HB3' HG13 ' A' ' 88' ' ' ILE . 86.9 mt -75.91 138.37 40.99 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.47 -0.567 . . . . 70.109999999999999 109.47 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -118.19 161.39 35.1 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 123.713 0.805 . . . . 73.329999999999998 111.275 -169.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 71.3 Cg_exo -44.71 106.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.082 2.521 . . . . 73.040000000000006 113.937 171.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.48 -12.8 15.86 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 114.901 0.72 . . . . 60.210000000000001 114.901 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.95 100.46 1.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.252 1.026 . . . . 71.140000000000001 111.305 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -79.93 122.58 26.87 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 115.996 -0.547 . . . . 70.299999999999997 110.726 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.98 173.14 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 125.115 1.366 . . . . 73.239999999999995 111.68 -170.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.0 mm -115.13 139.79 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 123.845 0.858 . . . . 74.340000000000003 110.41 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.28 123.31 35.52 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.758 0.823 . . . . 63.450000000000003 111.76 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -79.98 -44.87 19.45 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.827 0.851 . . . . 60.109999999999999 112.457 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.531 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -83.56 174.17 10.8 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.27 0.557 . . . . 74.010000000000005 111.542 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 80.0 p -143.73 126.28 15.92 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.05 -0.523 . . . . 71.349999999999994 111.055 175.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.507 ' H ' ' HG2' ' A' ' 81' ' ' MET . 19.9 m-70 -91.5 -23.48 19.94 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.991 0.916 . . . . 65.340000000000003 110.868 171.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -155.96 -176.9 6.2 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.838 0.855 . . . . 74.530000000000001 110.839 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -65.74 131.63 46.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.411 0.684 . . . . 74.129999999999995 112.213 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.64 10.93 84.61 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 115.871 -0.604 . . . . 65.25 114.567 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.507 ' HG2' ' H ' ' A' ' 77' ' ' HIS . 11.6 tpt -84.97 -52.43 5.99 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.58 0.752 . . . . 75.430000000000007 110.644 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 86.9 tttt -66.54 129.0 38.38 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.387 0.675 . . . . 65.129999999999995 111.379 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.11 -9.25 73.34 Favored Glycine 0 N--CA 1.476 1.316 0 O-C-N 123.004 0.19 . . . . 54.520000000000003 113.186 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 152.84 30.58 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.386 0.675 . . . . 65.530000000000001 111.118 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.7 m -90.26 120.07 31.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.228 -0.897 . . . . 64.329999999999998 109.774 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -104.15 162.97 12.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.885 0.874 . . . . 42.439999999999998 109.428 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -137.71 126.95 24.56 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.055 -0.72 . . . . 70.219999999999999 109.055 168.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.639 HG13 ' HB3' ' A' ' 65' ' ' LEU . 26.1 mm -60.47 110.27 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.381 0.672 . . . . 54.420000000000002 110.357 -177.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.43 ' H ' ' HA ' ' A' ' 35' ' ' VAL . 22.7 t70 -77.93 -36.37 49.41 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.167 0.987 . . . . 71.400000000000006 110.284 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.526 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 47.3 t -160.1 163.27 33.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.353 1.061 . . . . 73.310000000000002 110.277 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.64 148.12 51.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.493 0.717 . . . . 75.540000000000006 111.535 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -156.05 148.27 23.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.302 0.482 . . . . 62.420000000000002 112.302 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.51 95.44 7.0 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 107.757 -1.201 . . . . 73.140000000000001 107.757 163.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 t -136.26 154.55 50.87 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.302 0.641 . . . . 73.120000000000005 110.317 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.8 m -84.99 120.48 26.57 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.383 -0.599 . . . . 35.030000000000001 109.383 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.457 HG23 ' HB2' ' A' ' 28' ' ' TYR . 13.4 m -107.67 132.68 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.875 -0.787 . . . . 72.230000000000004 108.875 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.538 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 96.3 m-85 -109.62 166.7 10.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.489 1.138 . . . . 73.200000000000003 112.648 -171.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.2 ttp -120.96 111.09 17.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 112.832 -1.986 . . . . 64.109999999999999 107.199 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.26 147.11 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 112.921 0.711 . . . . 74.019999999999996 112.921 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 111' ' ' LYS . 4.6 p30 -105.51 138.03 42.38 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.612 0.765 . . . . 55.439999999999998 110.165 172.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -156.69 178.25 10.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.642 0.777 . . . . 73.400000000000006 111.126 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.0 m -118.11 114.57 23.29 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.438 0.695 . . . . 71.439999999999998 109.242 173.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -56.85 109.3 0.61 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.679 0.792 . . . . 75.409999999999997 111.02 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.8 p -54.47 -31.17 55.2 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.669 1.188 . . . . 73.030000000000001 113.293 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.6 m -64.54 -60.77 2.75 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.392 0.677 . . . . 45.329999999999998 112.313 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 36.2 m -101.92 -12.95 17.83 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.296 0.85 . . . . 64.400000000000006 113.296 -166.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.5 12.32 83.76 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 113.723 0.249 . . . . 63.240000000000002 113.723 -172.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -71.38 125.51 27.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.709 0.804 . . . . 72.450000000000003 112.314 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -75.98 96.8 3.85 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.786 0.435 . . . . 75.310000000000002 109.94 171.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.65 107.88 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 109.458 -0.571 . . . . 74.409999999999997 109.458 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 92.5 mttt -106.78 143.84 34.29 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.647 0.379 . . . . 75.099999999999994 110.948 -174.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 54.62 39.43 31.22 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.151 0.981 . . . . 43.439999999999998 113.151 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -61.79 131.74 50.84 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.646 0.778 . . . . 75.430000000000007 111.399 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 97.5 mttt -134.76 146.61 49.54 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.301 1.04 . . . . 65.120000000000005 110.492 -175.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 85.1 m95 -109.54 127.55 54.56 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.658 1.583 . . . . 73.439999999999998 110.513 -10.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.6 m -119.63 162.09 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 C-N-CA 124.452 1.101 . . . . 53.5 109.814 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 50.0 p -117.82 171.12 8.27 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.931 0.715 . . . . 71.540000000000006 112.931 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.538 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 38.0 tt0 -67.18 -32.17 73.08 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.715 0.806 . . . . 42.240000000000002 111.891 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -70.76 -20.12 62.65 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.245 0.618 . . . . 73.430000000000007 111.948 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -91.87 4.06 53.76 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.602 0.761 . . . . 71.150000000000006 111.666 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.427 HD13 HG21 ' A' ' 7' ' ' VAL . 81.8 mt -121.11 171.92 8.34 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.861 1.265 . . . . 75.239999999999995 109.612 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.8 m -147.22 122.54 10.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.681 0.792 . . . . 62.149999999999999 109.962 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.08 111.11 4.27 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.885 0.474 . . . . 72.530000000000001 110.871 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -84.08 83.18 8.05 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 121.486 0.66 . . . . 75.450000000000003 110.899 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.1 tp -77.53 -56.96 4.09 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.661 0.784 . . . . 75.219999999999999 109.685 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.2 178.54 4.74 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.862 0.839 . . . . 72.420000000000002 112.361 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -45.94 127.25 8.11 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 125.412 1.485 . . . . 63.100000000000001 113.328 166.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -135.39 108.21 7.55 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.411 1.085 . . . . 74.430000000000007 110.283 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -110.43 104.81 13.61 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.575 0.75 . . . . 74.230000000000004 109.392 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -63.32 125.96 25.85 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.85 0.685 . . . . 74.310000000000002 112.85 -170.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -117.59 118.05 31.08 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.223 1.009 . . . . 73.010000000000005 110.192 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.8 m80 . . . . . 0 N--CA 1.494 1.761 0 C-N-CA 124.855 1.262 . . . . 73.409999999999997 112.755 179.599 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mmt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.695 0.283 . . . . 75.310000000000002 111.037 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -105.92 157.99 17.09 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.576 0.75 . . . . 74.340000000000003 109.913 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.97 122.76 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 CA-C-O 121.193 0.521 . . . . 70.140000000000001 110.118 170.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.77 -6.52 48.43 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-N 115.323 -0.853 . . . . 72.319999999999993 112.966 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.7 m -75.15 128.15 34.83 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.019 0.527 . . . . 24.140000000000001 111.559 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -85.57 117.58 24.56 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.282 -1.007 . . . . 72.140000000000001 108.282 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.09 150.84 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.287 0.635 . . . . 71.530000000000001 111.777 -174.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.1 mm -98.77 128.55 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.364 1.065 . . . . 70.219999999999999 108.406 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.3 mt -91.58 115.89 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.872 -0.418 . . . . 74.129999999999995 109.872 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -93.36 -24.44 18.09 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.065 0.546 . . . . 72.310000000000002 112.306 -171.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 m -110.62 142.57 42.3 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.401 0.68 . . . . 62.130000000000003 109.594 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 14' ' ' MET . 78.0 p -123.62 120.26 32.27 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.827 0.677 . . . . 64.219999999999999 112.827 -173.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -84.81 -41.75 15.8 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.23 1.012 . . . . 73.230000000000004 108.503 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.471 ' O ' ' HB2' ' A' ' 12' ' ' SER . 24.1 mmt -100.65 137.26 39.29 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.057 0.943 . . . . 73.319999999999993 108.698 167.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.509 ' HG3' HG21 ' A' ' 105' ' ' THR . 17.6 ptpt -60.65 -31.23 70.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.22 0.822 . . . . 74.219999999999999 113.22 -175.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.04 0.59 72.42 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 114.062 0.385 . . . . 74.299999999999997 114.062 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.6 ttp -99.04 -15.44 19.04 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.053 0.541 . . . . 63.200000000000003 110.893 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -65.96 117.0 7.69 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.171 0.588 . . . . 75.549999999999997 110.16 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.71 2.51 70.12 Favored Glycine 0 CA--C 1.542 1.772 0 N-CA-C 114.358 0.503 . . . . 54.340000000000003 114.358 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.38 146.34 43.06 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 117.575 0.687 . . . . 65.409999999999997 112.76 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -85.21 131.2 34.46 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.672 0.789 . . . . 72.329999999999998 110.219 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.6 172.1 13.15 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.314 0.857 . . . . 74.140000000000001 113.314 -170.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.7 m -140.72 138.2 34.04 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.02 0.928 . . . . 74.230000000000004 109.801 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -81.76 112.93 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.371 0.669 . . . . 73.219999999999999 109.974 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.9 p -99.55 -4.99 29.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.749 0.82 . . . . 63.399999999999999 112.297 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.85 149.6 17.07 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 120.09 -0.283 . . . . 55.310000000000002 112.56 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.75 114.46 10.52 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.525 0.73 . . . . 75.0 110.464 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -115.42 111.92 21.53 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.972 0.909 . . . . 74.219999999999999 111.233 -173.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.97 80.28 5.76 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 122.163 0.982 . . . . 62.009999999999998 109.856 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -133.61 174.63 10.22 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 115.69 -0.686 . . . . 64.219999999999999 111.987 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.1 m -82.5 119.53 24.34 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.894 0.478 . . . . 65.209999999999994 109.87 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.96 162.63 13.42 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.639 1.176 . . . . 63.409999999999997 109.286 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -139.54 149.02 43.4 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.683 0.754 . . . . 73.439999999999998 111.26 -173.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.9 121.13 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 106.677 -1.601 . . . . 71.400000000000006 106.677 168.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.404 HG12 HD13 ' A' ' 88' ' ' ILE . 17.0 m -124.3 151.35 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 118.881 0.764 . . . . 62.409999999999997 112.681 -175.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.5 p -119.52 125.45 48.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.168 0.987 . . . . 74.439999999999998 109.132 171.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.458 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 49.4 p90 -147.46 152.6 38.35 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.702 0.401 . . . . 74.400000000000006 112.057 -172.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.9 m -99.17 106.61 39.62 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 108.122 -1.066 . . . . 72.299999999999997 108.122 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.11 146.1 23.81 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.55 2.833 . . . . 53.229999999999997 113.984 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.5 p -66.09 -16.57 64.05 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.79 0.836 . . . . 71.049999999999997 112.554 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.57 -20.82 65.96 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 123.224 0.609 . . . . 64.319999999999993 111.292 170.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.06 14.72 76.48 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.682 -0.69 . . . . 40.350000000000001 114.483 172.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.53 -112.55 0.37 Allowed Glycine 0 CA--C 1.539 1.583 0 CA-C-N 117.272 0.536 . . . . 72.540000000000006 113.536 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -106.53 142.75 35.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.355 0.662 . . . . 74.25 111.259 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -66.91 133.94 51.02 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.374 0.669 . . . . 74.049999999999997 111.687 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.6 t -91.48 118.8 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 124.1 0.96 . . . . 65.030000000000001 110.099 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -102.1 138.28 39.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.324 0.65 . . . . 64.409999999999997 110.493 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 m170 57.28 41.92 25.97 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.191 0.996 . . . . 75.439999999999998 113.351 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -67.1 124.18 22.33 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 116.07 -0.514 . . . . 71.540000000000006 110.654 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 31.3 mtmm -131.49 144.59 51.25 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.86 0.864 . . . . 73.129999999999995 110.216 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 94.4 m95 -112.69 141.66 46.22 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.347 1.459 . . . . 75.510000000000005 110.624 -9.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.86 142.48 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.696 -0.853 . . . . 70.230000000000004 108.696 170.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.1 pt -110.55 167.34 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 O-C-N 121.934 -0.479 . . . . 74.310000000000002 110.862 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -53.65 -35.02 60.54 Favored 'General case' 0 CA--C 1.563 1.442 0 C-N-CA 123.976 0.91 . . . . 64.099999999999994 113.201 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -67.21 -24.95 65.89 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.415 0.686 . . . . 70.340000000000003 112.296 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -91.44 1.47 57.1 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.548 0.739 . . . . 75.310000000000002 112.096 -175.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.7 mt -108.78 131.65 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.904 0.882 . . . . 64.310000000000002 110.151 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -72.65 -42.42 64.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.056 0.942 . . . . 74.129999999999995 112.019 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -78.71 -10.4 59.75 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.701 0.8 . . . . 73.340000000000003 112.35 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -43.45 -58.33 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.872 1.064 . . . . 72.010000000000005 113.872 -173.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.94 31.31 78.03 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 116.502 1.361 . . . . 73.430000000000007 116.502 167.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.8 t70 73.76 -10.58 1.06 Allowed 'General case' 0 CA--C 1.578 2.027 0 C-N-CA 124.551 1.14 . . . . 62.350000000000001 113.06 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 24.2 pttm -90.53 153.68 20.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.497 -0.752 . . . . 70.150000000000006 110.865 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.7 m -85.87 129.82 34.72 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.183 0.593 . . . . 73.439999999999998 109.645 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.8 mt -88.79 146.21 25.13 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.508 0.723 . . . . 72.150000000000006 111.492 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -116.58 158.68 42.81 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 124.966 1.306 . . . . 71.319999999999993 109.523 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.65 114.04 1.51 Allowed 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.621 2.214 . . . . 52.229999999999997 112.991 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.02 -17.52 12.79 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 115.23 -0.895 . . . . 72.150000000000006 114.426 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.0 125.99 27.73 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 117.936 0.868 . . . . 52.340000000000003 111.131 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.55 124.95 50.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.286 0.635 . . . . 63.530000000000001 109.913 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.71 174.74 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.84 1.256 . . . . 75.540000000000006 111.307 -169.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.3 mm -111.7 142.31 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 123.364 0.666 . . . . 74.109999999999999 109.741 170.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.1 mt -89.41 126.99 35.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.469 0.708 . . . . 74.439999999999998 112.26 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -87.29 -22.89 24.88 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.833 0.853 . . . . 73.219999999999999 111.847 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.86 158.93 19.83 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.048 0.451 . . . . 60.149999999999999 111.831 174.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.678 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 25.4 t -137.86 122.86 19.05 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.278 -0.874 . . . . 51.310000000000002 108.707 169.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -107.26 -9.52 16.06 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.045 0.538 . . . . 75.239999999999995 111.048 173.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.7 mtm -138.15 -175.75 4.21 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.588 1.155 . . . . 71.510000000000005 110.31 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -72.84 131.72 42.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 122.017 -0.427 . . . . 74.0 110.898 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.22 20.28 60.49 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 114.574 0.59 . . . . 74.019999999999996 114.574 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -77.89 -43.26 30.66 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.6 0.76 . . . . 73.549999999999997 110.954 -174.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 88.8 tttt -65.36 134.85 54.43 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.975 0.51 . . . . 65.299999999999997 111.55 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.66 65.11 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.178 -0.464 . . . . 42.149999999999999 112.8 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.91 143.18 56.99 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.571 0.748 . . . . 43.219999999999999 112.243 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.0 m -77.95 105.92 9.47 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.737 -0.665 . . . . 61.43 109.931 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -103.77 150.11 24.39 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.23 1.012 . . . . 44.43 110.946 -172.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.43 128.98 44.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.319 -0.623 . . . . 75.549999999999997 109.319 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.404 HD13 HG12 ' A' ' 35' ' ' VAL . 38.0 mm -64.77 106.47 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 122.891 0.477 . . . . 74.430000000000007 110.009 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.39 -36.25 58.19 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.911 0.885 . . . . 71.099999999999994 109.991 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.1 t -158.57 147.78 19.09 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.661 0.784 . . . . 43.109999999999999 110.563 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.14 133.3 56.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.467 0.707 . . . . 72.099999999999994 110.55 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -145.07 123.76 12.55 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.734 0.814 . . . . 73.519999999999996 111.139 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.26 97.19 10.97 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.238 -0.653 . . . . 63.009999999999998 109.238 175.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.5 t -135.54 154.71 51.29 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.756 0.822 . . . . 71.530000000000001 111.108 -173.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.2 m -81.98 120.72 25.6 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.62 -0.881 . . . . 75.319999999999993 108.62 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.486 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 11.4 m -110.48 133.33 56.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.892 0.877 . . . . 74.109999999999999 108.952 -176.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.07 145.26 38.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.192 0.997 . . . . 75.030000000000001 111.511 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.7 ttm -92.51 120.87 33.4 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.31 -1.367 . . . . 60.340000000000003 107.31 166.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.69 152.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.627 0.771 . . . . 73.140000000000001 111.814 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -117.81 114.4 23.22 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.298 1.039 . . . . 65.5 109.002 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -129.0 170.48 13.41 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.48 0.657 . . . . 75.409999999999997 112.203 -174.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.0 m -114.02 127.78 56.1 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.06 -0.719 . . . . 55.329999999999998 109.06 170.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.9 t -64.7 125.52 25.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.962 0.905 . . . . 73.540000000000006 112.548 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 70.5 p -71.23 -36.67 71.9 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.937 0.895 . . . . 54.520000000000003 112.424 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.509 HG21 ' HG3' ' A' ' 15' ' ' LYS . 11.0 t -80.12 -40.0 28.34 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.946 0.721 . . . . 70.219999999999999 112.946 -175.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.6 p -113.83 -24.84 8.91 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 112.332 0.493 . . . . 73.340000000000003 112.332 -172.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.15 7.56 80.0 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-O 119.89 -0.395 . . . . 55.200000000000003 113.877 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -78.99 133.34 36.85 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 117.288 0.544 . . . . 74.430000000000007 111.323 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -83.09 109.74 17.41 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 109.206 -0.665 . . . . 72.209999999999994 109.206 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.23 127.09 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.975 0.91 . . . . 55.539999999999999 110.704 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.84 157.36 27.75 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.503 0.721 . . . . 72.329999999999998 111.548 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.66 30.67 19.22 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.428 1.091 . . . . 71.230000000000004 111.616 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -73.76 135.84 43.59 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.053 0.541 . . . . 73.019999999999996 111.179 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -164.41 154.46 14.31 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 122.964 0.505 . . . . 70.129999999999995 111.903 -172.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.486 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 81.9 m95 -106.53 137.14 45.08 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.747 1.619 . . . . 72.030000000000001 112.039 1.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 m -120.23 144.44 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.279 1.032 . . . . 61.450000000000003 109.452 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.3 p -100.31 178.41 4.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.487 -0.758 . . . . 61.399999999999999 112.014 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -56.38 -50.81 70.48 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.338 1.055 . . . . 71.0 112.336 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -66.53 -17.9 65.07 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.591 0.756 . . . . 71.319999999999993 113.02 -178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -90.37 -6.2 55.29 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.062 0.545 . . . . 72.319999999999993 111.482 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 75.2 mt -115.23 160.7 19.42 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.376 1.07 . . . . 75.519999999999996 109.47 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -146.6 120.75 9.48 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.166 -0.679 . . . . 70.209999999999994 109.166 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.99 139.87 58.81 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.029 0.531 . . . . 65.340000000000003 112.028 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -64.37 87.39 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.865 0.84 . . . . 74.150000000000006 110.65 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.7 mt -145.26 142.75 29.77 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.042 1.337 . . . . 72.329999999999998 109.744 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -77.12 -13.53 59.93 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.48 0.712 . . . . 73.129999999999995 111.186 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -52.14 -32.49 35.94 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.296 1.038 . . . . 74.25 112.178 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -119.94 102.94 8.91 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.365 0.666 . . . . 73.319999999999993 109.4 170.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.98 122.22 14.93 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.712 -0.848 . . . . 72.120000000000005 108.712 172.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -62.22 -16.56 54.16 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 112.942 0.719 . . . . 75.349999999999994 112.942 -173.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -159.66 120.29 3.1 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.895 0.878 . . . . 74.019999999999996 109.549 170.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.0 p80 . . . . . 0 CA--C 1.567 1.598 0 CA-C-O 118.747 -0.644 . . . . 71.230000000000004 111.293 -177.94 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.668 0.271 . . . . 55.240000000000002 110.627 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -101.44 142.28 33.07 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.208 1.003 . . . . 52.420000000000002 110.195 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.85 132.51 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-O 121.038 0.446 . . . . 75.319999999999993 111.077 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.45 -3.57 68.96 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 115.776 -0.647 . . . . 71.530000000000001 112.948 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.0 m -85.1 151.6 24.02 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.773 0.657 . . . . 71.439999999999998 112.773 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -92.89 122.65 35.48 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.97 -1.014 . . . . 65.340000000000003 109.808 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 121' ' ' LEU . 27.0 m -121.56 151.89 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.36 0.664 . . . . 74.120000000000005 109.72 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.7 mm -107.51 134.78 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.43 -0.952 . . . . 65.239999999999995 108.43 172.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.9 mt -75.29 105.57 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.327 0 CA-C-O 120.95 0.405 . . . . 74.099999999999994 109.927 -176.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -83.18 -34.25 26.0 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.931 0.892 . . . . 73.349999999999994 111.034 -172.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.7 m -131.47 141.13 49.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.578 1.151 . . . . 74.230000000000004 108.244 172.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 17' ' ' MET . 95.7 p -143.5 159.3 42.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.855 0.836 . . . . 60.299999999999997 112.366 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -91.29 -17.58 25.72 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 114.114 -1.403 . . . . 72.310000000000002 110.457 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.666 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 53.6 mtt -131.34 144.37 51.2 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.418 1.087 . . . . 71.209999999999994 109.788 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -54.07 -41.23 67.94 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.206 1.187 . . . . 75.030000000000001 114.206 -173.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.33 -11.98 83.63 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 114.339 0.496 . . . . 65.010000000000005 114.339 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.666 ' HG3' ' HB2' ' A' ' 14' ' ' MET . 20.6 mtm -81.24 -29.27 34.5 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.398 0.599 . . . . 73.239999999999995 109.921 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -64.11 122.81 17.48 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 122.739 0.415 . . . . 63.119999999999997 111.008 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.4 1.74 89.25 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 115.694 -0.684 . . . . 73.349999999999994 113.545 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 149.62 31.72 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.776 0.658 . . . . 33.119999999999997 112.776 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -84.66 105.64 15.61 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.17 0.588 . . . . 65.010000000000005 110.251 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.43 154.37 19.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.938 0.895 . . . . 51.109999999999999 111.532 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.5 m -120.84 122.3 39.99 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.362 0.665 . . . . 55.420000000000002 109.661 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -73.27 103.35 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.855 0.462 . . . . 74.420000000000002 109.906 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.4 p -113.94 -5.78 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.482 0.549 . . . . 64.450000000000003 112.482 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.17 123.39 1.75 Allowed Glycine 0 C--N 1.344 1.015 0 N-CA-C 111.834 -0.506 . . . . 71.25 111.834 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.98 116.59 32.22 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.384 0.674 . . . . 54.149999999999999 110.493 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.439 ' HB2' HG23 ' A' ' 96' ' ' VAL . 38.8 m-85 -127.12 119.44 26.53 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.392 0.677 . . . . 73.319999999999993 109.961 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -113.82 87.4 2.61 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.906 0.86 . . . . 74.530000000000001 109.721 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -135.95 179.93 6.05 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.792 0.837 . . . . 74.430000000000007 110.669 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -78.76 123.75 27.5 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 122.022 -0.424 . . . . 71.040000000000006 110.433 176.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.89 126.27 54.93 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.102 0.961 . . . . 74.109999999999999 110.17 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -103.34 150.32 23.9 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.971 0.891 . . . . 74.439999999999998 113.02 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 50' ' ' LYS . 21.7 t -107.49 114.1 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 114.084 -1.416 . . . . 71.319999999999993 107.915 169.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.507 HG12 HD13 ' A' ' 88' ' ' ILE . 34.1 m -125.89 146.7 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 112.908 0.707 . . . . 75.239999999999995 112.908 -170.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.1 m -110.08 131.4 55.09 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.177 0.591 . . . . 75.140000000000001 110.491 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -157.04 159.78 38.3 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.36 0.6 . . . . 72.519999999999996 112.079 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.9 m -111.95 113.78 52.06 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 107.771 -1.196 . . . . 64.109999999999999 107.771 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.83 116.8 2.99 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.003 2.469 . . . . 73.319999999999993 112.108 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 p -68.94 -7.04 31.31 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.329 1.052 . . . . 60.399999999999999 113.745 -169.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -77.8 -3.06 39.52 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 123.433 0.693 . . . . 64.129999999999995 111.585 171.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.02 34.95 8.45 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 122.198 -0.313 . . . . 60.109999999999999 112.319 -173.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.42 -173.48 44.62 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 122.911 0.291 . . . . 72.329999999999998 113.444 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.08 117.47 15.92 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.443 0.697 . . . . 61.219999999999999 110.16 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.56 117.85 2.45 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.512 0.725 . . . . 74.219999999999999 110.969 169.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.96 115.38 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.371 -0.831 . . . . 72.519999999999996 109.609 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -100.38 140.78 34.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.145 0.578 . . . . 72.319999999999993 109.482 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.8 m170 57.92 39.58 26.55 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.423 0.689 . . . . 64.340000000000003 112.396 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -61.22 131.71 51.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.352 1.061 . . . . 72.540000000000006 111.455 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HB3' HG22 ' A' ' 34' ' ' VAL . 25.2 pttm -149.13 148.49 29.73 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.288 -0.869 . . . . 64.340000000000003 109.665 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 92.1 m95 -109.95 135.88 50.1 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.456 -1.402 . . . . 64.420000000000002 111.502 0.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.01 147.15 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.782 1.233 . . . . 73.109999999999999 108.306 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.3 pt -111.47 167.17 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 122.046 -0.409 . . . . 70.409999999999997 111.669 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -53.96 -36.18 62.59 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.943 0.897 . . . . 75.510000000000005 113.265 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -70.24 -19.24 63.14 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 123.464 0.706 . . . . 62.140000000000001 112.092 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -94.54 8.28 42.77 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.589 0.756 . . . . 72.109999999999999 112.442 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.5 mt -124.23 136.64 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.692 0.797 . . . . 64.239999999999995 110.631 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -72.08 -53.72 11.96 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.796 0.839 . . . . 62.520000000000003 111.614 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.08 -3.96 11.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.705 1.202 . . . . 63.310000000000002 113.381 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -41.23 -46.75 3.22 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.534 1.309 . . . . 73.25 114.534 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.69 19.06 68.88 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.924 1.13 . . . . 71.209999999999994 115.924 165.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 66.19 11.17 7.68 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.051 1.341 . . . . 71.030000000000001 112.801 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -110.47 167.93 9.84 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.016 0.926 . . . . 71.25 110.817 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.3 m -82.93 118.17 23.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.487 -0.931 . . . . 71.239999999999995 108.487 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.606 HD13 HG11 ' A' ' 71' ' ' VAL . 76.4 mt -74.48 118.3 17.28 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.315 0.579 . . . . 42.130000000000003 110.24 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -110.91 155.25 42.72 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.426 1.091 . . . . 73.099999999999994 110.712 -169.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 76.1 Cg_exo -45.64 111.84 0.36 Allowed 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.702 2.935 . . . . 70.439999999999998 114.506 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.44 -11.54 16.43 Favored Glycine 0 N--CA 1.485 1.963 0 CA-C-N 116.182 -0.463 . . . . 73.310000000000002 113.938 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -79.88 124.04 28.3 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.386 0.593 . . . . 64.340000000000003 111.222 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -98.23 122.18 41.07 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.742 -0.836 . . . . 63.399999999999999 108.742 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.606 HG11 HD13 ' A' ' 65' ' ' LEU . 32.4 m -121.62 175.81 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.927 0.891 . . . . 74.450000000000003 112.115 -172.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mm -121.65 136.71 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.336 1.055 . . . . 70.5 109.079 170.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.5 mt -83.49 119.19 24.37 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.574 0.75 . . . . 70.299999999999997 111.411 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -81.92 -26.64 33.88 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.526 0.73 . . . . 74.109999999999999 111.473 171.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.51 153.99 25.29 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.029 0.442 . . . . 53.219999999999999 111.152 173.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 42.9 t -142.25 124.31 15.38 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.71 -0.677 . . . . 43.43 110.698 173.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -106.43 -24.86 12.11 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.331 1.053 . . . . 64.319999999999993 109.784 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.2 mtm -127.28 164.64 21.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.083 0.953 . . . . 71.420000000000002 110.867 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.598 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.37 127.92 33.63 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.877 0.471 . . . . 64.450000000000003 111.986 174.395 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.41 14.81 82.11 Favored Glycine 0 N--CA 1.476 1.315 0 N-CA-C 114.328 0.491 . . . . 64.340000000000003 114.328 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.4 ttt -84.71 -40.9 16.78 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 117.632 0.716 . . . . 63.509999999999998 110.739 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.438 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 21.0 tptm -66.53 119.57 11.91 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.209 -0.663 . . . . 54.439999999999998 109.209 166.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.55 74.66 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 116.063 -0.517 . . . . 70.129999999999995 112.914 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.31 137.63 46.81 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.753 0.776 . . . . 44.25 111.529 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 78.7 m -79.09 114.55 18.12 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.176 0.59 . . . . 72.409999999999997 109.531 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.67 157.24 21.49 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.785 0.834 . . . . 44.530000000000001 109.739 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -129.42 131.88 46.87 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.79 -0.819 . . . . 65.349999999999994 108.79 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.561 HG13 ' HB3' ' A' ' 65' ' ' LEU . 24.3 mm -74.27 107.5 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.28 0.632 . . . . 64.349999999999994 110.724 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -68.91 -39.72 79.53 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.926 0.394 . . . . 75.209999999999994 110.662 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.0 t -164.41 157.36 17.33 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.207 -0.906 . . . . 63.530000000000001 111.357 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -114.14 131.27 56.49 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.216 1.007 . . . . 61.329999999999998 109.131 171.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -126.7 135.51 51.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.007 0.523 . . . . 64.329999999999998 111.522 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -97.14 95.77 7.99 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.587 0.708 . . . . 71.140000000000001 109.657 168.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -135.85 148.3 48.6 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.929 -1.032 . . . . 72.519999999999996 109.4 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.4 m -84.24 123.61 30.32 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.221 -0.659 . . . . 53.409999999999997 109.221 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 28' ' ' TYR . 16.1 m -112.87 135.96 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.375 0.67 . . . . 73.299999999999997 109.553 -173.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.43 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 98.2 m-85 -120.03 141.54 49.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.43 0.692 . . . . 64.129999999999995 111.965 -175.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.41 ' SD ' ' HA ' ' A' ' 112' ' ' ASN . 19.4 tmm? -90.14 112.47 23.97 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.879 -1.055 . . . . 72.150000000000006 108.254 169.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.51 160.83 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 112.668 0.618 . . . . 74.319999999999993 112.668 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -119.57 116.98 27.16 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.87 0.868 . . . . 72.430000000000007 108.7 172.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -124.27 165.29 17.89 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 122.96 0.504 . . . . 75.319999999999993 111.918 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.8 m -109.21 111.67 23.41 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.3 0.64 . . . . 72.120000000000005 110.552 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.3 p -58.8 122.48 13.67 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.144 0.577 . . . . 71.519999999999996 111.87 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.7 p -70.91 -23.23 62.23 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.414 1.086 . . . . 73.329999999999998 112.767 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -87.86 -10.73 49.88 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.234 0.828 . . . . 72.010000000000005 113.234 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.4 m -134.74 -40.19 0.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.234 0.614 . . . . 74.430000000000007 111.833 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.81 -1.82 59.9 Favored Glycine 0 N--CA 1.48 1.582 0 CA-C-N 116.197 -0.456 . . . . 54.009999999999998 113.077 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -80.84 140.16 35.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.008 0.923 . . . . 63.130000000000003 111.124 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -96.37 132.81 41.51 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 121.156 0.503 . . . . 73.239999999999995 110.783 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.96 128.39 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.115 1.366 . . . . 64.409999999999997 109.723 -175.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 136.71 42.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.876 0.87 . . . . 71.219999999999999 111.105 -173.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.41 ' HA ' ' SD ' ' A' ' 98' ' ' MET . 11.8 m120 56.0 43.01 27.89 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.694 1.198 . . . . 74.439999999999998 113.84 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -62.3 132.8 53.87 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.672 0.789 . . . . 73.450000000000003 112.104 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 59.4 mttp -133.76 136.35 44.51 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.137 0.975 . . . . 70.099999999999994 111.491 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.7 m95 -114.44 146.11 41.03 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.511 1.524 . . . . 72.400000000000006 111.122 -15.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -119.67 148.23 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.022 0.929 . . . . 74.420000000000002 109.331 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.4 p -97.93 163.96 12.56 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.018 0.748 . . . . 74.239999999999995 113.018 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.43 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 44.0 tt0 -60.99 -33.91 73.98 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.489 1.116 . . . . 75.329999999999998 110.916 173.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.1 -36.84 85.56 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.701 1.2 . . . . 74.340000000000003 112.428 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.99 10.02 38.78 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.202 0.445 . . . . 62.020000000000003 112.202 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.462 HD13 HG21 ' A' ' 7' ' ' VAL . 91.2 mt -120.24 162.27 19.68 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.017 0.927 . . . . 73.400000000000006 109.215 175.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -138.83 120.67 15.4 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.074 0.549 . . . . 73.120000000000005 109.752 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.75 115.25 10.73 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.639 0.376 . . . . 64.099999999999994 110.676 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -119.75 119.18 32.88 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.905 0.482 . . . . 62.32 111.541 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 125' ' ' LEU . 2.7 pt? -98.97 178.24 5.0 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.537 0.735 . . . . 71.530000000000001 110.2 172.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -65.41 143.04 57.98 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.751 0.82 . . . . 53.109999999999999 111.562 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -74.57 158.46 33.68 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.388 0.675 . . . . 75.209999999999994 110.715 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -70.54 82.17 0.59 Allowed 'General case' 0 CA--C 1.558 1.258 0 CA-C-O 121.76 0.79 . . . . 64.409999999999997 111.378 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -133.11 -10.47 2.96 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.526 1.13 . . . . 74.540000000000006 109.563 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -72.25 161.46 30.83 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.45 0.7 . . . . 64.319999999999993 110.923 169.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -83.64 77.29 9.88 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.559 0.744 . . . . 75.230000000000004 110.992 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 . . . . . 0 CA--C 1.571 1.759 0 C-N-CA 123.762 0.825 . . . . 72.109999999999999 110.225 177.207 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.405 ' HB3' HG21 ' A' ' 24' ' ' VAL . 18.7 mmt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 109.725 -0.472 . . . . 60.509999999999998 109.725 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.581 ' HD3' ' H ' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -72.44 158.87 34.94 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 120.965 0.412 . . . . 62.439999999999998 111.824 -179.535 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.81 130.1 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 123.609 0.763 . . . . 53.140000000000001 112.262 -175.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.57 -13.03 47.1 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.268 -0.878 . . . . 55.310000000000002 113.343 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.9 m -82.67 152.9 25.64 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.387 0.675 . . . . 71.209999999999994 111.638 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -108.74 141.03 41.32 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.143 -0.688 . . . . 72.450000000000003 109.143 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 123' ' ' ALA . 33.4 m -135.9 157.63 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.047 0.939 . . . . 61.219999999999999 111.063 -172.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.1 mm -96.46 129.06 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.423 -0.954 . . . . 74.140000000000001 108.423 166.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.716 HD11 ' HB2' ' A' ' 22' ' ' ALA . 48.7 mt -82.65 127.0 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.186 0.594 . . . . 63.219999999999999 109.945 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -96.8 -63.05 1.17 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 120.951 0.405 . . . . 73.450000000000003 110.386 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.8 m -91.79 140.97 29.17 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.13 -0.692 . . . . 72.150000000000006 109.13 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.9 p -132.04 140.42 48.88 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.569 0.7 . . . . 54.009999999999998 112.24 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -85.66 -37.97 18.87 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.02 1.328 . . . . 62.549999999999997 109.326 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 52.0 mtt -99.34 130.53 45.63 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.316 1.046 . . . . 74.219999999999999 109.219 169.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -55.92 -37.98 69.66 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 113.0 0.741 . . . . 75.230000000000004 113.0 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.62 0.8 60.03 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 114.439 0.536 . . . . 75.209999999999994 114.439 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.496 ' HG2' HG21 ' A' ' 9' ' ' ILE . 52.9 ttp -93.3 -25.21 17.85 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.324 0.65 . . . . 71.200000000000003 111.13 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -67.36 123.34 20.1 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.994 0.518 . . . . 71.109999999999999 111.39 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.99 -12.18 66.89 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.658 -0.701 . . . . 75.129999999999995 113.868 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.43 155.42 40.13 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.642 0.777 . . . . 40.310000000000002 112.212 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -91.07 100.28 13.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.302 0.641 . . . . 70.0 110.946 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.716 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -89.65 158.14 17.72 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.78 -0.645 . . . . 72.400000000000006 111.137 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.4 m -131.7 126.01 33.49 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.865 -0.791 . . . . 65.209999999999994 108.865 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' A' ' 1' ' ' MET . 41.3 t -76.57 102.0 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.346 0.658 . . . . 71.150000000000006 110.281 -170.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.2 p -96.25 -10.63 27.52 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.331 0.652 . . . . 72.230000000000004 111.561 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.49 149.09 19.5 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 112.125 -0.39 . . . . 75.010000000000005 112.125 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.06 119.47 15.81 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.645 0.778 . . . . 44.210000000000001 110.694 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -121.92 117.22 25.91 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.852 0.861 . . . . 63.210000000000001 110.445 -172.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -95.49 83.82 3.88 Favored 'General case' 0 CA--C 1.565 1.519 0 CA-C-O 122.236 1.017 . . . . 72.010000000000005 110.645 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -134.39 -178.61 5.13 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.473 0.709 . . . . 73.549999999999997 111.878 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 m -90.87 128.58 36.8 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.714 -0.476 . . . . 64.439999999999998 109.714 170.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.46 157.93 19.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.716 0.806 . . . . 74.530000000000001 110.43 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.491 ' HB2' HG23 ' A' ' 52' ' ' VAL . 97.2 m-85 -135.15 149.55 49.99 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.726 0.774 . . . . 74.109999999999999 111.383 -173.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.54 109.65 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.188 -1.369 . . . . 61.130000000000003 107.439 171.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.483 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 29.6 m -121.82 148.01 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.525 0.679 . . . . 52.310000000000002 112.699 -173.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.1 t -112.3 139.24 48.02 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.915 0.886 . . . . 75.549999999999997 109.152 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -158.92 159.42 34.91 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.171 0.589 . . . . 74.209999999999994 111.777 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.5 m -107.91 108.78 61.78 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 107.29 -1.374 . . . . 52.5 107.29 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -47.59 152.82 2.47 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 123.949 3.099 . . . . 71.310000000000002 115.715 -175.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.8 p -64.92 -24.29 67.48 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.228 1.011 . . . . 43.030000000000001 112.393 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.434 ' ND2' ' H ' ' A' ' 43' ' ' GLY . 1.3 p-10 -67.55 -19.81 65.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.657 0.265 . . . . 75.239999999999995 111.213 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 19.21 71.18 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 114.812 0.685 . . . . 74.120000000000005 114.812 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' H ' ' ND2' ' A' ' 41' ' ' ASN . . . -87.0 -130.18 2.89 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 117.62 0.71 . . . . 74.519999999999996 113.085 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -69.99 129.04 38.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.282 0.633 . . . . 75.420000000000002 111.493 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -58.5 133.16 55.56 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.296 0.638 . . . . 75.209999999999994 111.5 171.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.43 108.85 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.435 0.694 . . . . 70.340000000000003 110.128 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -102.57 148.78 25.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.736 0.814 . . . . 74.140000000000001 111.04 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.3 m80 55.63 33.97 22.29 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.25 1.02 . . . . 71.400000000000006 112.86 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -62.4 122.78 16.56 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.132 0.973 . . . . 63.520000000000003 111.036 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 41.3 mtmt -121.37 143.9 48.95 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.531 0.733 . . . . 73.310000000000002 110.933 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 92.8 m95 -110.55 144.44 39.41 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.295 1.438 . . . . 75.450000000000003 109.4 -14.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 33' ' ' TYR . 25.4 m -115.65 130.06 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 107.748 -1.205 . . . . 74.310000000000002 107.748 169.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.421 HG21 HG21 ' A' ' 96' ' ' VAL . 26.0 pt -104.9 163.69 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 121.794 -0.566 . . . . 65.209999999999994 111.696 -169.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -52.56 -39.19 61.22 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.852 1.261 . . . . 71.010000000000005 113.494 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -73.71 -28.91 61.96 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 120.885 0.374 . . . . 75.510000000000005 111.703 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.515 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 28.1 tt0 -80.38 -13.42 59.17 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.378 1.071 . . . . 74.510000000000005 110.956 -174.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.37 139.9 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 124.369 1.068 . . . . 75.209999999999994 109.84 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -75.58 -55.8 5.32 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.489 0.715 . . . . 72.209999999999994 111.477 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.22 -5.38 13.6 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.161 0.985 . . . . 74.150000000000006 113.285 -175.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.607 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -51.59 -50.24 60.55 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.569 0.951 . . . . 74.239999999999995 113.569 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.51 25.44 71.46 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 114.917 0.727 . . . . 73.25 114.917 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 64.78 16.3 10.34 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 124.831 1.253 . . . . 63.409999999999997 113.434 -175.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 64.1 pttt -115.26 179.65 3.9 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.0 0.52 . . . . 72.219999999999999 111.161 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.2 m -84.75 114.9 22.39 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.691 -0.686 . . . . 62.439999999999998 109.902 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.704 HD13 HG11 ' A' ' 71' ' ' VAL . 70.5 mt -76.29 115.69 16.26 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.624 -0.51 . . . . 64.209999999999994 109.624 170.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -89.6 147.91 38.94 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.474 0.71 . . . . 74.040000000000006 111.643 -168.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.24 116.23 2.15 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.408 2.739 . . . . 73.230000000000004 114.44 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.07 -22.92 11.04 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 115.053 0.781 . . . . 43.420000000000002 115.053 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -79.35 149.1 31.8 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.083 0.942 . . . . 73.230000000000004 112.04 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -107.17 132.82 52.62 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.179 0.592 . . . . 65.430000000000007 111.552 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.704 HG11 HD13 ' A' ' 65' ' ' LEU . 26.8 m -138.73 155.55 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.361 1.065 . . . . 72.439999999999998 111.063 -174.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.07 135.33 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 123.189 0.595 . . . . 71.040000000000006 109.785 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.2 mt -88.33 118.17 27.76 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.974 0.909 . . . . 71.310000000000002 110.837 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -84.12 -3.19 57.93 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 112.808 0.67 . . . . 54.439999999999998 112.808 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.515 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -128.81 173.15 10.61 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.272 0.629 . . . . 65.120000000000005 111.015 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.418 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 66.1 p -149.32 127.77 12.27 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.435 -0.802 . . . . 65.230000000000004 110.998 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -85.27 -14.75 45.66 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.813 0.845 . . . . 72.439999999999998 110.253 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -156.85 -179.04 7.82 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.253 1.021 . . . . 71.219999999999999 111.139 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -67.19 135.88 54.16 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.786 0.662 . . . . 74.049999999999997 112.786 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.33 17.67 76.23 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 115.103 0.801 . . . . 74.129999999999995 115.103 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.7 ttt -90.95 -42.8 10.36 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 117.625 0.713 . . . . 72.450000000000003 111.273 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 4.1 ttpm? -67.79 129.25 39.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.873 0.469 . . . . 64.200000000000003 111.156 175.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.38 -15.72 62.64 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 116.48 -0.327 . . . . 71.239999999999995 112.629 -178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.73 141.99 49.79 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.224 0.61 . . . . 71.329999999999998 111.665 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.7 m -90.36 110.33 21.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.474 -0.936 . . . . 62.350000000000001 108.474 176.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.483 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -98.05 167.94 10.58 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.45 0.7 . . . . 53.130000000000003 110.972 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.22 138.34 52.41 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.969 0.908 . . . . 74.530000000000001 109.281 171.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.459 HD13 HG12 ' A' ' 35' ' ' VAL . 28.0 mm -72.14 120.58 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 123.106 0.562 . . . . 63.310000000000002 110.777 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -85.43 -42.13 14.78 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.925 0.49 . . . . 75.299999999999997 109.757 170.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.0 m -155.11 153.99 31.69 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.975 0.91 . . . . 71.329999999999998 110.841 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.29 146.99 49.79 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.681 0.792 . . . . 61.039999999999999 110.453 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -156.2 131.52 9.4 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.865 0.466 . . . . 61.119999999999997 111.493 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -88.93 96.33 10.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.482 -0.933 . . . . 74.049999999999997 108.482 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.6 t -136.63 153.74 50.84 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.534 0.734 . . . . 74.400000000000006 111.256 -171.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 48.7 m -84.52 123.94 30.83 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.81 -0.441 . . . . 70.409999999999997 109.81 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 18.0 m -113.2 138.8 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.727 0.811 . . . . 72.530000000000001 109.451 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -115.37 150.07 36.93 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.588 0.755 . . . . 61.020000000000003 112.126 -171.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 58.2 ttp -96.36 115.37 27.32 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.421 -1.326 . . . . 74.530000000000001 107.421 163.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.462 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 30.0 m -122.79 160.21 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.219 0.533 . . . . 74.230000000000004 112.413 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -121.94 116.84 25.08 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.369 1.068 . . . . 74.319999999999993 109.591 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -132.47 173.79 10.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.085 0.554 . . . . 65.030000000000001 110.508 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 31.8 m -119.28 116.76 26.91 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.588 -0.523 . . . . 75.420000000000002 109.588 173.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.8 t -54.71 121.88 9.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.456 1.102 . . . . 75.439999999999998 112.408 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p -66.62 -30.44 70.72 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.25 1.02 . . . . 73.230000000000004 112.584 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.7 t -83.17 -34.24 26.04 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.037 0.755 . . . . 71.219999999999999 113.037 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.0 p -106.78 -28.12 10.34 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.567 0.58 . . . . 75.340000000000003 112.567 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.93 9.33 85.5 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 116.611 -0.268 . . . . 44.310000000000002 113.177 -172.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -91.13 138.57 31.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.053 0.941 . . . . 72.209999999999994 110.659 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 5.7 ttpm? -84.88 120.59 26.64 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 120.984 0.421 . . . . 52.009999999999998 110.513 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.67 114.29 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 109.369 -0.604 . . . . 64.150000000000006 109.369 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.25 150.37 29.69 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.008 0.923 . . . . 50.340000000000003 111.208 -171.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 57.28 31.9 20.87 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.382 1.073 . . . . 74.400000000000006 112.243 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -64.41 124.49 21.91 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.249 0.62 . . . . 73.140000000000001 111.649 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 10.2 mtmp? -140.85 140.02 34.55 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 124.177 0.991 . . . . 73.329999999999998 110.681 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 87.8 m95 -112.51 148.53 34.26 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.875 1.67 . . . . 72.109999999999999 111.928 -4.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.8 m -131.47 142.36 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 124.347 1.059 . . . . 74.340000000000003 110.3 174.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 81.3 p -100.41 167.86 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 112.644 0.609 . . . . 44.25 112.644 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -56.12 -38.01 70.21 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.69 1.196 . . . . 73.349999999999994 111.701 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -58.39 -39.87 80.84 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.926 1.29 . . . . 75.430000000000007 112.111 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -88.39 -0.62 57.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.017 0.927 . . . . 75.340000000000003 113.367 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.53 163.86 17.32 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.438 0.695 . . . . 63.329999999999998 110.988 -177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.9 p -145.35 124.08 12.59 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.547 0.739 . . . . 74.340000000000003 110.447 174.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.562 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -66.11 133.47 50.78 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 113.268 0.84 . . . . 53.030000000000001 113.268 -172.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.612 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -95.95 102.05 13.79 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.652 0.781 . . . . 72.420000000000002 111.077 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.79 -58.32 1.9 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.445 0.698 . . . . 61.439999999999998 110.284 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.5 167.71 14.32 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.86 0.864 . . . . 75.510000000000005 111.678 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.6 m80 61.93 33.86 17.2 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.117 0.967 . . . . 75.209999999999994 112.168 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -62.7 114.99 3.92 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.664 -0.698 . . . . 64.430000000000007 110.752 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -80.57 102.28 9.68 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.259 0.623 . . . . 55.219999999999999 111.38 -170.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -64.76 121.26 14.14 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 110.024 -0.361 . . . . 54.020000000000003 110.024 172.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -60.67 136.74 58.15 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 112.511 0.56 . . . . 64.120000000000005 112.511 -176.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.7 m80 . . . . . 0 CA--C 1.56 1.346 0 C-N-CA 123.995 0.918 . . . . 73.340000000000003 109.558 174.117 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 mmt . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.415 -0.587 . . . . 73.120000000000005 109.415 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -113.59 159.32 19.74 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.131 0.572 . . . . 70.409999999999997 110.176 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.1 t -65.22 124.73 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 CA-C-O 121.376 0.608 . . . . 50.350000000000001 111.688 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.32 -2.99 43.37 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 115.559 -0.746 . . . . 62.549999999999997 113.094 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 p -81.56 145.34 30.71 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 117.343 0.571 . . . . 73.230000000000004 112.359 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -94.02 128.74 40.54 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.583 0.753 . . . . 65.549999999999997 110.276 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.529 HG21 HD13 ' A' ' 121' ' ' LEU . 29.5 m -131.35 152.88 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.639 0.776 . . . . 72.25 110.111 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.1 mm -102.76 132.6 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.521 0.728 . . . . 72.430000000000007 109.241 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.6 mt -78.85 113.02 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 C-N-CA 122.739 0.416 . . . . 72.140000000000001 109.915 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.492 HD22 ' HB2' ' A' ' 122' ' ' SER . 33.9 p30 -91.49 -31.07 16.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 122.002 -0.437 . . . . 54.109999999999999 111.672 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.2 m -125.88 141.16 52.11 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.256 1.022 . . . . 74.310000000000002 109.905 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 m -154.1 139.66 17.85 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.987 0.515 . . . . 53.119999999999997 111.198 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.414 ' CE1' ' HB2' ' A' ' 50' ' ' LYS . 73.0 m-70 -79.23 -25.61 42.6 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.345 0.658 . . . . 71.0 110.1 170.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.603 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 1.6 mpt? -97.55 125.23 42.14 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.171 0.988 . . . . 73.219999999999999 109.527 171.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.68 -28.46 68.63 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.23 0.826 . . . . 71.519999999999996 113.23 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.79 -12.8 84.1 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 114.597 0.599 . . . . 62.450000000000003 114.597 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' A' ' 14' ' ' MET . 39.3 mtp -91.47 -24.36 19.7 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.549 0.74 . . . . 73.420000000000002 111.761 -177.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.45 119.41 12.23 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.073 0.549 . . . . 72.439999999999998 111.659 -176.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.92 2.17 69.5 Favored Glycine 0 CA--C 1.541 1.677 0 CA-C-N 115.799 -0.637 . . . . 64.340000000000003 113.78 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.25 156.77 21.83 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.371 0.668 . . . . 72.209999999999994 112.792 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -83.83 114.31 21.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.352 0.661 . . . . 75.540000000000006 111.204 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . . . -107.03 150.63 26.31 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.861 0.864 . . . . 35.439999999999998 111.895 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -124.6 121.05 33.66 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.634 0.774 . . . . 71.239999999999995 108.968 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.2 t -72.75 106.29 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 122.823 0.449 . . . . 71.420000000000002 110.277 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.7 p -99.08 -11.33 21.54 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.352 0.661 . . . . 60.539999999999999 111.9 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.11 145.31 11.81 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 112.187 -0.365 . . . . 73.120000000000005 112.187 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.87 121.7 27.21 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.911 0.884 . . . . 73.129999999999995 110.503 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.485 ' HB2' HG23 ' A' ' 96' ' ' VAL . 26.3 m-85 -125.6 125.97 44.01 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.665 0.786 . . . . 71.239999999999995 111.249 -175.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.18 78.87 1.34 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.263 1.03 . . . . 75.299999999999997 110.35 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.569 HG21 HD12 ' A' ' 53' ' ' ILE . 10.2 t -134.79 174.86 10.11 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.726 -0.67 . . . . 53.299999999999997 111.867 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.5 m -78.98 125.03 28.84 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.97 0.508 . . . . 72.439999999999998 110.752 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . . . -100.27 163.54 12.35 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.478 1.111 . . . . 43.25 109.215 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -134.11 138.03 44.98 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.54 0.686 . . . . 63.149999999999999 111.208 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.0 t -99.15 107.75 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 107.711 -1.218 . . . . 74.349999999999994 107.711 172.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.514 HG12 HD13 ' A' ' 88' ' ' ILE . 34.3 m -119.88 145.16 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-O 121.314 0.578 . . . . 73.0 112.056 -173.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -115.16 132.88 56.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.817 0.847 . . . . 74.219999999999999 109.091 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -148.88 157.14 43.21 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.241 0.543 . . . . 74.420000000000002 112.361 -172.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.4 m -105.7 112.11 64.59 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 108.163 -1.051 . . . . 74.140000000000001 108.163 170.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.449 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 11.5 Cg_endo -56.26 118.74 5.59 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.344 2.029 . . . . 74.319999999999993 111.399 174.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.0 t -60.8 -14.22 20.25 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 124.361 1.064 . . . . 74.340000000000003 113.552 -170.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -82.8 10.83 6.87 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 123.789 0.836 . . . . 75.430000000000007 111.92 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.94 46.97 7.4 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 113.672 0.229 . . . . 44.119999999999997 113.672 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.23 -177.91 21.4 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 113.542 0.177 . . . . 64.299999999999997 113.542 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -65.36 122.42 17.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.924 0.49 . . . . 71.030000000000001 110.984 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -58.81 115.35 3.03 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.988 0.423 . . . . 73.540000000000006 110.593 173.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -86.57 120.46 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.713 -0.676 . . . . 62.439999999999998 110.399 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -92.84 120.69 33.46 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.334 0.653 . . . . 54.310000000000002 109.683 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 58.64 54.8 5.13 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.597 1.159 . . . . 75.019999999999996 113.147 175.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -65.04 132.07 48.24 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.063 0.945 . . . . 74.420000000000002 111.892 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 99.5 mttt -136.94 150.13 48.0 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.743 0.817 . . . . 51.109999999999999 110.652 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 96.9 m95 -107.43 130.81 54.78 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.888 1.275 . . . . 73.209999999999994 111.908 -7.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.84 142.68 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.716 1.207 . . . . 75.420000000000002 108.088 168.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.625 HG13 ' H ' ' A' ' 55' ' ' GLU . 27.8 pt -117.02 -175.37 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.075 0.55 . . . . 74.150000000000006 110.032 175.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -47.73 -33.18 6.7 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.623 1.169 . . . . 73.420000000000002 113.357 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.625 ' H ' HG13 ' A' ' 53' ' ' ILE . 7.0 tp10 -69.94 -28.86 65.92 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 113.924 1.083 . . . . 61.210000000000001 113.924 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -80.89 -10.98 59.66 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.487 -0.758 . . . . 54.109999999999999 112.589 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.9 mt -110.12 138.92 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 C-N-CA 123.543 0.737 . . . . 74.129999999999995 111.759 -172.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.592 ' HE3' ' HB ' ' A' ' 72' ' ' ILE . 27.8 ttpp -65.68 -53.22 44.13 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.312 1.045 . . . . 64.310000000000002 112.336 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.19 -3.33 39.04 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.014 -0.994 . . . . 63.25 113.138 -170.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.514 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -40.87 -58.76 1.6 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.444 1.276 . . . . 74.549999999999997 114.444 177.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.0 23.71 69.69 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 115.537 0.975 . . . . 23.23 115.537 170.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 61.53 17.35 8.43 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.621 1.168 . . . . 71.239999999999995 113.113 -173.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 12.3 ptpt -108.75 167.07 10.33 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.364 0.666 . . . . 73.439999999999998 110.54 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.5 m -87.02 112.5 21.91 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.293 -0.632 . . . . 75.140000000000001 109.293 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.546 HD13 HG11 ' A' ' 71' ' ' VAL . 54.5 mt -75.26 120.71 21.12 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.443 0.697 . . . . 62.109999999999999 109.353 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -96.77 154.1 38.47 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.913 0.885 . . . . 53.32 111.513 -167.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.486 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 84.8 Cg_exo -49.25 113.92 1.1 Allowed 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.995 2.463 . . . . 73.230000000000004 113.736 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.56 -17.91 18.01 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-N 115.975 -0.557 . . . . 73.329999999999998 114.135 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.8 133.14 47.09 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.327 0.564 . . . . 63.5 110.626 173.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -111.27 121.24 44.75 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.899 -0.778 . . . . 42.420000000000002 108.899 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.546 HG11 HD13 ' A' ' 65' ' ' LEU . 27.0 m -131.21 164.53 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.543 1.137 . . . . 74.340000000000003 111.027 -167.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.592 ' HB ' ' HE3' ' A' ' 58' ' ' LYS . 46.3 mm -110.51 141.47 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.01 0.524 . . . . 75.219999999999999 110.534 176.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.2 mt -88.71 123.64 33.34 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.806 0.843 . . . . 74.349999999999994 111.565 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -88.77 -28.74 20.28 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.239 0.615 . . . . 52.140000000000001 112.352 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.52 158.55 20.93 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.12 0.486 . . . . 64.209999999999994 110.572 171.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 21.1 t -143.58 125.02 14.74 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.728 -0.669 . . . . 74.430000000000007 109.703 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.7 m170 -95.34 -13.88 24.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.953 0.901 . . . . 70.099999999999994 111.272 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -156.3 177.35 11.54 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.617 0.767 . . . . 71.219999999999999 111.896 -173.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -63.95 104.96 0.77 Allowed 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.113 0.965 . . . . 71.129999999999995 112.566 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.56 12.94 56.46 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 115.182 0.833 . . . . 52.32 115.182 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -74.36 -42.23 59.71 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 117.481 0.641 . . . . 62.520000000000003 111.677 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.595 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 50.5 tttm -66.22 132.63 48.86 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 122.414 -0.179 . . . . 73.129999999999995 110.522 172.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.57 -9.52 75.7 Favored Glycine 0 N--CA 1.472 1.094 0 CA-C-O 120.337 -0.146 . . . . 72.310000000000002 112.89 -177.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 39' ' ' PRO . . . -71.11 141.48 50.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.47 0.708 . . . . 74.219999999999999 111.903 177.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -81.83 113.44 19.78 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.965 -0.561 . . . . 75.010000000000005 109.945 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -110.1 150.68 28.25 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.5 1.12 . . . . 75.310000000000002 110.388 -175.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -125.06 130.34 52.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.12 0.568 . . . . 65.010000000000005 109.958 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.514 HD13 HG12 ' A' ' 35' ' ' VAL . 27.4 mm -69.86 101.64 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.442 0.697 . . . . 52.439999999999998 109.639 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.61 -32.97 70.52 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.319 0.581 . . . . 73.25 110.346 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.486 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . 40.0 t -168.89 150.31 4.61 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.669 -1.151 . . . . 61.030000000000001 109.849 -175.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.84 128.49 54.31 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.536 -0.913 . . . . 74.140000000000001 108.536 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -114.07 125.77 54.35 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.708 0.803 . . . . 72.129999999999995 111.551 -169.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -93.91 95.12 8.88 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.5 -0.555 . . . . 75.019999999999996 109.5 170.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.0 t -137.06 154.39 50.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.786 0.835 . . . . 74.129999999999995 110.592 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.3 m -86.37 125.47 33.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.509 -0.552 . . . . 74.040000000000006 109.509 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.625 HG21 HG21 ' A' ' 53' ' ' ILE . 14.9 m -114.42 134.83 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.361 0.664 . . . . 52.539999999999999 110.092 -172.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.401 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 89.8 m-85 -116.21 143.03 46.04 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.434 0.694 . . . . 60.329999999999998 112.049 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.5 ttp -89.57 115.86 27.29 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.109 -1.441 . . . . 75.219999999999999 107.109 164.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.4 m -118.16 152.95 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.866 0.841 . . . . 62.130000000000003 112.135 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -121.28 121.56 37.98 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.608 1.563 . . . . 74.109999999999999 107.4 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.533 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 51.2 p90 -152.45 178.85 9.12 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.143 0.497 . . . . 74.099999999999994 112.098 -171.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.2 m -118.49 117.49 29.15 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.761 0.824 . . . . 75.310000000000002 109.631 172.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.5 t -60.95 119.25 7.91 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.449 0.7 . . . . 75.319999999999993 110.378 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.1 p -59.4 -45.18 92.23 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.815 0.846 . . . . 63.240000000000002 113.139 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.4 m -64.06 -52.86 57.35 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.108 0.563 . . . . 71.530000000000001 111.793 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.1 m -79.06 -24.08 43.78 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.137 0.575 . . . . 44.240000000000002 112.319 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.41 17.27 74.26 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 116.35 -0.386 . . . . 75.25 113.566 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -108.6 144.09 36.79 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.876 0.87 . . . . 73.439999999999998 111.661 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -77.13 105.1 8.01 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.013 0.925 . . . . 73.129999999999995 111.304 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.2 t -90.46 110.55 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 108.297 -1.001 . . . . 75.519999999999996 108.297 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -112.94 145.96 39.85 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.692 0.797 . . . . 71.349999999999994 111.76 -166.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 17.8 m120 57.45 32.41 21.76 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 124.064 0.946 . . . . 64.400000000000006 113.225 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -64.59 133.42 52.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.675 0.79 . . . . 75.099999999999994 112.573 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 99.7 mttt -135.59 134.42 39.31 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.199 1.0 . . . . 71.219999999999999 110.72 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 97.7 m95 -115.15 155.61 26.81 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.321 1.448 . . . . 63.200000000000003 112.521 -10.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.22 160.98 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.774 1.23 . . . . 73.420000000000002 109.084 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.8 p -118.2 162.76 17.71 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.735 0.414 . . . . 50.439999999999998 111.557 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.401 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 30.5 tt0 -61.36 -36.18 79.49 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.891 0.476 . . . . 73.430000000000007 111.671 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -66.28 -32.55 74.03 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.309 0.644 . . . . 74.319999999999993 110.885 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -83.33 -9.91 58.8 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.119 0.967 . . . . 72.219999999999999 111.376 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.529 HD13 HG21 ' A' ' 7' ' ' VAL . 82.6 mt -112.08 173.37 6.4 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.993 0.917 . . . . 70.109999999999999 109.857 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB2' HD22 ' A' ' 10' ' ' ASN . 47.8 t -137.28 136.68 38.25 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.657 0.783 . . . . 70.319999999999993 109.171 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.63 138.09 50.46 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 120.863 0.364 . . . . 74.049999999999997 111.522 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -86.17 67.77 10.06 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.727 0.775 . . . . 75.120000000000005 110.846 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.18 -39.1 3.1 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.713 0.805 . . . . 72.319999999999993 110.983 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -81.22 159.26 24.6 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.958 0.725 . . . . 75.430000000000007 112.958 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -74.31 86.09 1.96 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 115.413 -0.812 . . . . 74.209999999999994 109.745 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -79.99 69.71 6.42 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.228 1.011 . . . . 72.299999999999997 112.452 -174.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -91.02 5.28 49.47 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.415 0.686 . . . . 72.349999999999994 111.856 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -113.5 114.05 25.99 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.813 0.845 . . . . 72.540000000000006 109.855 175.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -81.0 121.77 26.45 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.346 -0.612 . . . . 61.25 109.346 172.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 . . . . . 0 C--O 1.257 1.499 0 CA-C-O 118.155 -0.926 . . . . 64.329999999999998 110.527 179.515 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.532 ' SD ' HG11 ' A' ' 7' ' ' VAL . 24.2 ptp . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.629 0.252 . . . . 52.329999999999998 110.574 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -99.41 161.61 13.52 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.31 0.644 . . . . 74.209999999999994 111.575 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.56 132.29 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 123.592 0.757 . . . . 64.209999999999994 111.779 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.41 -7.21 39.67 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.508 -0.769 . . . . 51.439999999999998 113.566 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 m -75.4 134.85 40.82 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.01 0.524 . . . . 64.239999999999995 111.782 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -95.81 123.64 39.47 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.317 0.647 . . . . 62.039999999999999 109.636 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.532 HG11 ' SD ' ' A' ' 1' ' ' MET . 31.8 m -130.04 154.54 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.735 0.814 . . . . 70.140000000000001 111.818 -172.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.8 mm -98.05 128.76 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.93 0.892 . . . . 60.210000000000001 109.656 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 17' ' ' MET . 49.8 mt -78.01 109.96 13.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.38 0.672 . . . . 72.209999999999994 109.968 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -87.53 -53.22 4.92 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.79 0.436 . . . . 75.340000000000003 110.76 -173.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.808 ' HB ' ' HB2' ' A' ' 120' ' ' GLU . 72.0 m -91.42 140.36 29.84 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.694 -0.854 . . . . 41.539999999999999 108.694 170.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 14' ' ' MET . 86.0 p -133.06 124.83 28.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.502 0.321 . . . . 71.010000000000005 111.825 -173.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -71.36 -33.37 69.51 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.347 0.659 . . . . 75.519999999999996 110.088 171.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.676 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 1.8 mpt? -115.58 137.48 52.03 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.518 1.127 . . . . 71.010000000000005 108.938 172.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -30.87 69.79 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.591 1.33 . . . . 74.329999999999998 114.591 -169.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.82 -3.34 87.46 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 114.599 0.6 . . . . 74.25 114.599 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.676 ' SD ' ' HB2' ' A' ' 14' ' ' MET . 61.6 mtp -86.63 -26.99 24.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.622 0.769 . . . . 73.140000000000001 111.196 -178.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -67.46 121.96 16.94 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.587 0.355 . . . . 64.310000000000002 111.05 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.69 -3.84 86.03 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 116.134 -0.485 . . . . 41.229999999999997 113.606 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.78 150.69 32.31 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 117.503 0.651 . . . . 60.030000000000001 112.651 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -90.1 100.61 13.4 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.765 0.826 . . . . 72.219999999999999 111.464 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.97 163.56 13.44 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.804 0.842 . . . . 42.210000000000001 112.297 176.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.6 m -130.79 130.94 44.34 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.108 0.963 . . . . 62.140000000000001 108.958 172.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.4 t -74.01 103.36 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.085 0.554 . . . . 74.239999999999995 109.515 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.8 p -95.79 -12.19 25.73 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.09 0.556 . . . . 73.109999999999999 111.756 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.6 139.69 6.45 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.747 -0.541 . . . . 64.310000000000002 111.747 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.74 122.08 37.14 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.298 0.639 . . . . 74.5 111.184 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -128.88 122.44 30.34 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.277 1.031 . . . . 74.010000000000005 110.688 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -103.98 79.67 1.66 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.947 0.879 . . . . 70.510000000000005 110.085 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -133.63 175.75 9.16 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.588 -0.733 . . . . 73.209999999999994 112.467 -169.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 93' ' ' LYS . 54.9 m -77.93 118.95 20.73 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.851 0.86 . . . . 73.340000000000003 110.931 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.81 111.61 24.21 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.04 0.936 . . . . 65.010000000000005 110.373 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -87.86 149.9 23.85 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.868 0.842 . . . . 75.209999999999994 111.956 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 55.8 t -106.92 118.84 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 107.907 -1.146 . . . . 71.340000000000003 107.907 170.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.438 HG12 HD13 ' A' ' 88' ' ' ILE . 30.0 m -117.59 168.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 112.492 0.552 . . . . 72.239999999999995 112.492 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 91.1 p -137.33 134.87 36.52 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.568 0.747 . . . . 61.130000000000003 109.467 170.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 43.5 p90 -151.66 157.6 42.33 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.469 0.652 . . . . 64.430000000000007 111.96 -174.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 m -101.19 110.98 62.85 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.182 -1.044 . . . . 73.049999999999997 108.182 171.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.97 123.39 13.71 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.861 2.374 . . . . 74.319999999999993 112.846 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.3 p -58.02 -25.32 60.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.525 1.306 . . . . 70.129999999999995 114.525 -171.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -72.62 -6.38 43.84 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 112.918 0.71 . . . . 74.510000000000005 112.918 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.11 38.67 5.94 Favored Glycine 0 N--CA 1.472 1.098 0 N-CA-C 111.789 -0.524 . . . . 30.210000000000001 111.789 -169.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.14 158.94 26.05 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.338 -0.431 . . . . 52.119999999999997 112.479 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -56.26 122.99 13.07 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.173 0.589 . . . . 72.239999999999995 110.961 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.89 124.19 14.67 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.152 0.981 . . . . 71.510000000000005 111.628 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.9 t -103.99 124.56 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.75 0.82 . . . . 63.420000000000002 111.298 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -117.32 148.62 41.55 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.638 0.775 . . . . 72.329999999999998 111.054 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 m170 57.62 38.02 27.64 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.434 1.093 . . . . 55.43 112.991 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -69.13 138.58 54.33 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.426 0.69 . . . . 72.140000000000001 111.477 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -153.88 153.36 31.95 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 123.75 0.82 . . . . 65.420000000000002 111.069 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -106.88 128.69 54.51 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.542 1.537 . . . . 71.299999999999997 111.693 -0.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.74 142.31 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.893 -1.151 . . . . 72.329999999999998 107.893 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.2 pt -124.13 176.88 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.556 -0.715 . . . . 74.519999999999996 112.076 -175.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -49.88 -50.45 45.79 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.172 1.175 . . . . 75.200000000000003 114.172 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -6.94 52.27 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 112.864 0.69 . . . . 71.25 112.864 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -79.16 -31.17 43.91 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.954 0.901 . . . . 73.540000000000006 110.066 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.7 mt -96.08 131.1 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 123.688 0.795 . . . . 71.319999999999993 111.02 -169.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -63.0 -47.51 82.79 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 122.092 0.949 . . . . 52.140000000000001 111.207 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.26 -2.65 22.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.912 1.285 . . . . 74.230000000000004 113.543 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -40.7 -60.84 1.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.602 1.161 . . . . 62.119999999999997 113.665 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.73 17.52 65.0 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 115.848 1.099 . . . . 53.439999999999998 115.848 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.64 12.91 7.92 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.45 1.1 . . . . 62.219999999999999 113.46 -174.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -106.26 157.24 17.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.362 0.665 . . . . 74.519999999999996 110.435 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.4 m -76.1 111.05 11.11 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.046 0.539 . . . . 71.420000000000002 110.432 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.424 HD13 HG11 ' A' ' 71' ' ' VAL . 92.9 mt -75.57 124.53 27.36 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.346 0.659 . . . . 74.340000000000003 110.679 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -120.57 157.74 53.35 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.325 1.05 . . . . 55.210000000000001 110.518 -170.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 32.8 Cg_exo -41.58 116.49 0.52 Allowed 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.032 2.488 . . . . 65.5 114.27 171.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.81 -9.73 16.15 Favored Glycine 0 N--CA 1.478 1.45 0 CA-C-N 115.137 -0.938 . . . . 75.140000000000001 113.499 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -84.37 102.38 12.69 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 117.519 0.659 . . . . 74.319999999999993 112.451 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -69.87 120.98 16.43 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.736 -0.468 . . . . 75.409999999999997 109.736 164.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.424 HG11 HD13 ' A' ' 65' ' ' LEU . 30.1 m -131.96 157.31 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.596 1.159 . . . . 64.439999999999998 110.428 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.9 mm -105.82 137.0 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.855 -0.528 . . . . 73.450000000000003 110.308 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.5 mt -87.54 128.0 35.25 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.67 0.788 . . . . 73.040000000000006 112.299 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -92.69 -31.33 15.14 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.798 0.839 . . . . 60.229999999999997 111.943 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.5 161.02 14.39 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.463 0.649 . . . . 62.149999999999999 110.29 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.1 p -147.24 128.46 14.74 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.784 -0.644 . . . . 75.120000000000005 110.623 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -88.68 6.84 36.56 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.817 0.847 . . . . 75.25 110.886 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -172.35 158.35 4.35 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.501 1.52 . . . . 64.519999999999996 109.824 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -75.99 133.46 40.42 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 122.274 -0.266 . . . . 72.409999999999997 110.987 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.63 -29.03 12.58 Favored Glycine 0 N--CA 1.482 1.711 0 CA-C-N 116.56 -0.291 . . . . 75.209999999999994 112.44 -172.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.0 ttt -68.36 -37.54 80.56 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.065 0.946 . . . . 64.140000000000001 111.253 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -65.35 119.24 10.61 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.988 0.515 . . . . 72.310000000000002 109.793 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.7 3.03 74.81 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 120.064 -0.298 . . . . 64.099999999999994 113.275 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.13 144.31 31.78 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 117.19 0.495 . . . . 64.030000000000001 111.429 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.4 m -80.84 110.67 16.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.693 -0.685 . . . . 64.019999999999996 109.174 176.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -101.2 159.73 15.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.316 1.047 . . . . 72.109999999999999 108.973 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.95 129.49 30.14 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.047 -1.094 . . . . 74.409999999999997 108.047 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.438 HD13 HG12 ' A' ' 35' ' ' VAL . 38.5 mm -63.26 100.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.562 0.745 . . . . 61.329999999999998 110.389 -176.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.19 -40.55 71.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.02 0.928 . . . . 74.420000000000002 110.519 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.408 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 68.0 m -153.96 151.41 29.37 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.987 0.915 . . . . 75.299999999999997 110.059 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.01 129.89 56.82 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.114 0.566 . . . . 63.420000000000002 109.61 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -140.61 151.83 44.96 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.724 0.81 . . . . 72.420000000000002 109.537 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -124.81 95.27 4.45 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.036 0.922 . . . . 73.349999999999994 109.156 177.22 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 t -134.9 151.89 51.27 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.288 -0.869 . . . . 53.0 110.552 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.8 m -78.39 123.69 27.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 122.613 0.365 . . . . 74.239999999999995 110.54 -173.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 15.2 m -118.33 140.06 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.193 0.997 . . . . 60.130000000000003 110.089 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.424 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 77.7 m-85 -122.53 145.85 47.95 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.702 0.801 . . . . 71.420000000000002 111.543 -172.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.5 ttp -89.9 121.38 31.97 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.974 -1.121 . . . . 62.43 107.974 163.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.2 m -120.94 153.76 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-O 121.488 0.661 . . . . 74.430000000000007 112.367 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -118.12 122.42 43.05 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.836 1.254 . . . . 51.409999999999997 107.747 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.444 ' CE2' ' HG2' ' A' ' 17' ' ' MET . 56.1 p90 -148.65 177.87 9.13 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.939 0.496 . . . . 73.230000000000004 111.681 -174.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.2 m -125.38 128.87 48.82 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.49 0.716 . . . . 64.340000000000003 109.726 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.4 t -62.48 120.7 11.6 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.662 0.785 . . . . 71.319999999999993 110.925 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.0 p -60.15 -41.13 92.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.895 0.878 . . . . 63.409999999999997 112.408 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.4 p -75.15 -57.5 3.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.143 0.577 . . . . 64.329999999999998 112.104 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.0 m -71.04 -40.35 71.76 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.272 0.629 . . . . 71.239999999999995 111.905 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.06 1.31 82.2 Favored Glycine 0 N--CA 1.479 1.528 0 CA-C-N 116.188 -0.46 . . . . 55.130000000000003 113.033 -170.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -75.11 129.89 38.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.64 1.176 . . . . 55.340000000000003 112.937 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -82.54 98.94 9.21 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.806 0.842 . . . . 74.200000000000003 109.881 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -88.39 118.26 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.012 0.525 . . . . 74.439999999999998 110.211 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -107.94 148.06 30.17 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.506 0.723 . . . . 64.340000000000003 112.18 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 m120 58.46 34.2 23.75 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.631 1.172 . . . . 64.200000000000003 113.349 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -65.35 125.4 24.98 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.622 0.769 . . . . 72.120000000000005 112.316 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 64.4 mttp -132.42 135.77 46.32 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.877 0.871 . . . . 74.109999999999999 111.096 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.476 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 97.9 m95 -116.52 160.71 20.23 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 126.018 1.727 . . . . 64.010000000000005 111.644 -12.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.33 139.72 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.047 0.939 . . . . 62.049999999999997 110.692 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.3 p -91.73 159.4 15.86 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.03 0.532 . . . . 73.409999999999997 112.028 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 36.5 tt0 -65.33 -26.42 68.04 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.115 0.483 . . . . 75.219999999999999 111.173 173.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -63.9 -34.29 77.62 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.859 0.864 . . . . 75.319999999999993 111.614 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.808 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 11.0 pt-20 -95.66 -2.51 47.95 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.881 0.697 . . . . 74.510000000000005 112.881 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.8 mt -111.78 168.69 9.38 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.551 0.741 . . . . 44.43 109.633 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.2 m -143.47 123.19 13.35 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.396 0.679 . . . . 74.25 109.812 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.485 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -63.77 144.32 57.14 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.075 0.55 . . . . 75.239999999999995 111.465 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -74.75 76.43 2.08 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 122.035 0.921 . . . . 73.140000000000001 111.213 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.4 mt -121.11 -39.52 2.69 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.158 1.383 . . . . 74.329999999999998 109.359 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -139.88 156.65 46.59 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.6 1.16 . . . . 73.310000000000002 110.007 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -159.34 96.37 1.29 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.485 0.714 . . . . 74.219999999999999 110.145 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -89.83 135.18 33.78 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.871 0.469 . . . . 73.109999999999999 111.293 172.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -71.51 -32.61 68.4 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.76 0.424 . . . . 74.349999999999994 110.506 171.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.53 102.73 14.68 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.574 0.749 . . . . 72.239999999999995 109.488 170.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -84.5 155.53 22.13 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.274 0.63 . . . . 72.120000000000005 112.472 -172.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.7 m170 . . . . . 0 N--CA 1.491 1.577 0 C-N-CA 123.606 0.762 . . . . 75.549999999999997 111.989 175.234 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 110.204 -0.295 . . . . 65.420000000000002 110.204 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -75.0 137.42 41.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.835 0.854 . . . . 71.430000000000007 111.006 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.3 t -67.3 126.06 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 CA-C-O 121.353 0.596 . . . . 70.299999999999997 110.728 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.49 -18.03 38.92 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 115.189 -0.914 . . . . 72.209999999999994 113.07 -171.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 t -85.97 161.14 19.14 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.666 0.787 . . . . 75.209999999999994 110.202 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -124.62 149.59 46.93 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.084 0.468 . . . . 74.310000000000002 111.369 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 123' ' ' ALA . 24.5 m -138.27 163.92 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.256 1.022 . . . . 75.510000000000005 111.92 -171.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 mm -98.81 132.22 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.413 1.085 . . . . 53.229999999999997 109.169 165.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.9 mt -91.73 125.5 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 N-CA-C 109.782 -0.451 . . . . 54.030000000000001 109.782 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -96.16 -58.98 1.94 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.64 1.176 . . . . 61.43 111.222 -171.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.515 ' HB ' ' HG2' ' A' ' 120' ' ' GLU . 23.7 m -91.75 140.75 29.39 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.451 -0.944 . . . . 73.530000000000001 108.451 169.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 75.5 m -148.19 136.62 21.44 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.238 0.542 . . . . 62.439999999999998 111.484 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -83.89 -22.78 31.5 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.647 -1.16 . . . . 72.349999999999994 109.46 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.1 mmt -97.7 122.04 40.31 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.498 1.119 . . . . 70.140000000000001 108.906 167.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -32.01 72.59 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.638 0.977 . . . . 75.430000000000007 113.638 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.98 -4.31 77.22 Favored Glycine 0 N--CA 1.476 1.307 0 N-CA-C 114.03 0.372 . . . . 51.310000000000002 114.03 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 54.8 ttp -100.85 -22.25 14.89 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.473 0.709 . . . . 72.120000000000005 110.562 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 58.8 tttm -68.12 120.09 13.76 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.159 0.584 . . . . 74.230000000000004 111.87 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.22 -6.01 82.79 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 115.214 -0.903 . . . . 71.409999999999997 113.99 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.91 159.97 24.82 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.27 0.841 . . . . 71.400000000000006 113.27 -171.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.75 115.76 21.81 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.091 -0.959 . . . . 73.129999999999995 110.403 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.513 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -113.41 164.13 14.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.033 0.933 . . . . 55.420000000000002 112.221 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 62.1 m -133.55 125.37 28.72 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.277 0.631 . . . . 73.120000000000005 110.987 174.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.91 104.55 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.656 0.782 . . . . 74.340000000000003 110.371 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.3 p -111.57 3.69 18.17 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.455 0.539 . . . . 72.200000000000003 112.455 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.9 146.44 14.11 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 120.002 -0.332 . . . . 74.099999999999994 112.812 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.69 108.26 6.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.626 0.77 . . . . 32.439999999999998 110.731 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -112.14 116.89 31.21 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.194 0.998 . . . . 71.209999999999994 110.378 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -99.35 88.62 3.95 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 122.086 0.946 . . . . 64.140000000000001 109.731 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -134.25 179.8 6.04 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.646 0.779 . . . . 72.310000000000002 111.041 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -83.15 123.01 29.12 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.566 -0.531 . . . . 72.420000000000002 109.566 171.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.86 155.15 20.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.096 0.558 . . . . 70.150000000000006 109.562 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -132.48 147.95 52.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.875 0.845 . . . . 72.510000000000005 111.663 -173.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.31 108.7 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.906 -1.516 . . . . 75.200000000000003 106.906 169.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.425 HG12 HD13 ' A' ' 88' ' ' ILE . 19.1 m -107.02 155.51 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.356 0.598 . . . . 73.140000000000001 111.924 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 68.5 m -134.31 122.96 23.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.894 0.877 . . . . 62.240000000000002 108.92 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -153.23 159.2 42.56 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.299 0.571 . . . . 62.109999999999999 110.81 -167.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.9 m -101.65 124.49 40.48 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.679 -1.23 . . . . 74.219999999999999 107.679 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.72 145.75 94.76 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.024 1.816 . . . . 74.329999999999998 111.922 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -62.82 -17.74 61.76 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.358 0.663 . . . . 74.230000000000004 112.527 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.488 HD21 ' HG2' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -70.25 -20.82 63.04 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.533 0.733 . . . . 72.310000000000002 111.539 172.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.12 29.57 45.48 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 115.108 0.803 . . . . 72.049999999999997 115.108 168.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.86 -127.48 5.33 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 117.912 0.856 . . . . 43.119999999999997 113.103 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.75 119.59 18.18 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.448 0.699 . . . . 74.319999999999993 110.551 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -57.29 105.67 0.25 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.764 0.826 . . . . 62.210000000000001 112.059 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.23 104.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 121.218 0.533 . . . . 72.310000000000002 109.998 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 6.8 p-10 -110.48 155.3 22.44 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.233 0.613 . . . . 74.200000000000003 109.855 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.0 m170 58.69 30.48 19.99 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.556 0.742 . . . . 63.520000000000003 112.101 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -65.07 125.58 25.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.904 0.882 . . . . 60.439999999999998 110.962 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 6.9 mtmp? -139.94 144.35 37.04 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 124.082 0.953 . . . . 73.219999999999999 111.25 -174.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 97.5 m95 -112.32 138.07 49.57 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 125.32 1.448 . . . . 74.349999999999994 111.474 -4.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.81 138.69 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.322 -0.854 . . . . 71.239999999999995 109.077 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.3 pt -99.35 162.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.089 0.471 . . . . 74.219999999999999 111.737 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.423 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 63.5 tt0 -51.36 -41.06 60.38 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.375 1.07 . . . . 74.140000000000001 113.322 175.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.74 -13.69 61.38 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.436 0.636 . . . . 70.040000000000006 112.363 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 15.4 tt0 -92.18 -16.72 25.87 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.347 1.059 . . . . 61.530000000000001 111.204 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.9 mt -102.67 132.38 48.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.904 0.882 . . . . 74.400000000000006 110.159 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.556 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 87.2 tttt -64.51 -54.88 25.36 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.761 0.824 . . . . 62.409999999999997 111.508 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -72.96 -5.88 41.61 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.046 1.128 . . . . 64.430000000000007 114.046 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 54' ' ' GLN . . . -52.91 -39.61 62.89 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.163 1.171 . . . . 51.140000000000001 114.163 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.7 28.32 73.51 Favored Glycine 0 N--CA 1.481 1.697 0 N-CA-C 116.189 1.236 . . . . 74.439999999999998 116.189 163.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 61.47 14.28 5.73 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.275 1.03 . . . . 74.400000000000006 112.999 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -119.5 170.47 9.13 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.782 0.833 . . . . 45.130000000000003 111.023 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.0 m -96.6 114.59 26.26 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.159 -0.682 . . . . 75.310000000000002 109.159 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.474 HD13 HG11 ' A' ' 71' ' ' VAL . 34.9 mt -76.68 140.38 40.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.372 0.669 . . . . 71.030000000000001 110.988 -173.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -91.0 151.85 43.67 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.109 0.563 . . . . 71.439999999999998 110.951 -174.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.1 120.24 7.95 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.361 2.041 . . . . 74.109999999999999 112.35 170.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.79 -17.45 17.87 Favored Glycine 0 CA--C 1.538 1.484 0 CA-C-O 119.515 -0.603 . . . . 63.100000000000001 114.427 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.18 154.47 41.02 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.336 1.068 . . . . 73.420000000000002 111.844 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -120.6 136.9 54.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.267 0.627 . . . . 74.430000000000007 110.812 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.474 HG11 HD13 ' A' ' 65' ' ' LEU . 35.8 m -132.89 172.38 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 124.841 1.256 . . . . 74.219999999999999 111.848 -170.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.46 138.86 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 124.231 1.012 . . . . 73.5 109.739 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.5 mt -97.94 118.2 33.98 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.669 0.788 . . . . 74.420000000000002 111.579 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.556 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 30.5 mm-40 -82.19 -22.59 35.91 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.157 0.583 . . . . 72.409999999999997 112.511 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.592 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -104.78 172.12 6.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.095 0.558 . . . . 71.049999999999997 111.464 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 29.1 t -137.26 126.22 24.25 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.149 0.579 . . . . 43.109999999999999 111.487 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.576 ' H ' ' HG2' ' A' ' 81' ' ' MET . 32.8 m170 -92.92 -20.16 20.92 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.483 0.713 . . . . 74.120000000000005 111.003 164.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.0 ptp -151.43 158.73 44.07 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.296 0.638 . . . . 54.350000000000001 111.566 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.488 ' HG2' HD21 ' A' ' 41' ' ' ASN . 38.0 ttpt -66.78 95.91 0.38 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.447 0.699 . . . . 74.450000000000003 110.143 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.13 -12.4 4.41 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 115.859 -0.61 . . . . 64.319999999999993 113.354 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.576 ' HG2' ' H ' ' A' ' 77' ' ' HIS . 9.4 tpt -75.93 -59.57 2.7 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.389 1.076 . . . . 54.43 111.865 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 58.5 tttm -67.21 131.05 45.0 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.74 0.816 . . . . 54.020000000000003 112.267 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.61 -26.33 14.6 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.397 -0.365 . . . . 65.310000000000002 113.539 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.08 156.78 38.08 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.335 0.654 . . . . 72.140000000000001 111.914 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.9 m -84.5 116.35 23.06 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.909 -0.774 . . . . 62.340000000000003 108.909 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.63 150.82 22.33 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.721 0.809 . . . . 70.129999999999995 109.354 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -118.9 118.68 32.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.15 0.58 . . . . 71.310000000000002 109.472 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.425 HD13 HG12 ' A' ' 35' ' ' VAL . 36.9 mm -60.1 98.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.092 0.557 . . . . 74.239999999999995 109.869 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.11 -39.84 82.69 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.768 0.827 . . . . 62.409999999999997 109.254 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.6 t -163.44 163.25 24.97 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.064 -0.971 . . . . 71.209999999999994 110.473 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.6 139.27 52.85 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.661 0.785 . . . . 73.239999999999995 110.403 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -139.23 124.55 19.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.223 0.609 . . . . 74.549999999999997 111.102 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -86.81 94.11 9.46 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.088 -1.078 . . . . 71.150000000000006 108.088 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 t -136.79 155.04 50.34 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.8 0.84 . . . . 74.450000000000003 111.706 -170.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.4 m -87.46 125.06 34.07 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.794 -0.817 . . . . 55.549999999999997 108.794 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.5 134.16 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.012 0.925 . . . . 74.349999999999994 109.703 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.499 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 93.9 m-85 -112.63 154.98 25.2 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.764 0.792 . . . . 74.439999999999998 112.71 -169.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.3 ttp -102.55 112.49 25.25 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.546 -1.206 . . . . 70.120000000000005 108.734 173.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.513 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 23.6 m -121.5 148.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 112.909 0.707 . . . . 61.119999999999997 112.909 -172.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.3 122.86 48.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.839 0.856 . . . . 74.239999999999995 109.455 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -138.88 167.72 21.39 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.593 0.711 . . . . 63.229999999999997 112.591 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.1 m -106.84 118.64 37.22 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.102 -1.073 . . . . 72.310000000000002 108.102 168.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.6 p -64.96 124.64 22.59 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.421 0.288 . . . . 61.420000000000002 111.072 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.3 p -69.85 -41.42 74.9 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.119 0.968 . . . . 63.530000000000001 112.596 -176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.3 p -78.6 -48.48 15.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.041 0.537 . . . . 53.420000000000002 111.785 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.3 t -81.2 -36.38 30.18 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.405 0.682 . . . . 63.130000000000003 112.577 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.8 2.58 89.72 Favored Glycine 0 N--CA 1.483 1.768 0 CA-C-O 120.877 0.154 . . . . 52.43 113.478 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -82.08 137.79 34.95 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.91 0.884 . . . . 63.219999999999999 111.208 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.28 111.14 19.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.677 0.791 . . . . 73.329999999999998 109.138 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -110.8 120.17 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.181 0.592 . . . . 60.219999999999999 109.502 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -113.59 152.16 30.7 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.654 0.382 . . . . 72.420000000000002 110.412 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.4 m120 53.74 34.8 19.83 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 124.494 1.118 . . . . 71.310000000000002 113.224 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -58.27 135.99 57.25 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.645 1.178 . . . . 70.200000000000003 112.256 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 61.8 mttp -137.37 137.4 38.82 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.425 1.09 . . . . 74.450000000000003 110.45 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.4 m95 -115.17 156.94 24.36 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.64 1.576 . . . . 71.310000000000002 112.031 -9.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.5 m -128.02 154.12 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.637 1.175 . . . . 71.209999999999994 109.245 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 75.2 p -103.66 160.75 14.49 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 122.075 -0.391 . . . . 60.329999999999998 110.905 174.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.499 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 40.3 tt0 -63.07 -27.41 69.38 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.444 0.698 . . . . 64.349999999999994 111.552 178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -63.62 -25.42 68.22 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.168 0.987 . . . . 75.239999999999995 112.227 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.515 ' HG2' ' HB ' ' A' ' 11' ' ' THR . 40.2 mt-10 -91.86 0.03 57.5 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.914 0.885 . . . . 74.209999999999994 111.818 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 117' ' ' THR . 68.8 mt -119.95 140.48 50.84 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.344 0.52 . . . . 64.209999999999994 110.351 -172.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -131.56 122.94 26.93 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.848 0.859 . . . . 73.099999999999994 109.087 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.551 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -56.35 117.78 4.13 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.38 0.672 . . . . 45.439999999999998 111.728 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -81.13 86.98 6.09 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-O 121.616 0.722 . . . . 72.230000000000004 111.821 -172.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.7 mp -82.63 169.04 16.71 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.146 -0.933 . . . . 44.409999999999997 110.108 168.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.94 -24.32 67.68 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.097 0.559 . . . . 73.310000000000002 112.113 176.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -65.95 104.44 1.11 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.594 0.758 . . . . 73.040000000000006 110.562 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -86.64 116.45 24.76 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.316 0.647 . . . . 70.340000000000003 110.553 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -65.97 -31.29 72.11 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.36 0.664 . . . . 65.239999999999995 112.491 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -155.05 115.16 3.79 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.593 0.757 . . . . 72.019999999999996 109.266 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -79.05 177.76 8.55 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.284 0.634 . . . . 73.450000000000003 112.171 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 . . . . . 0 CA--C 1.568 1.672 0 CA-C-O 118.88 -0.581 . . . . 75.150000000000006 110.984 175.17 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.018 -0.364 . . . . 71.040000000000006 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.01 147.22 48.83 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.838 0.455 . . . . 65.209999999999994 110.326 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.66 132.39 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 CA-C-O 121.209 0.528 . . . . 75.200000000000003 111.133 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.32 -5.55 49.08 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.338 -0.847 . . . . 72.400000000000006 113.757 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.2 m -68.08 136.1 53.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.988 0.736 . . . . 70.409999999999997 112.988 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -84.63 113.69 21.45 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.007 -0.738 . . . . 63.020000000000003 109.007 167.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 123' ' ' ALA . 29.8 m -123.76 174.03 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.555 0.742 . . . . 71.200000000000003 111.29 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 21' ' ' GLU . 9.7 mt -130.64 134.72 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.141 0.976 . . . . 65.230000000000004 109.341 170.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.5 mt -86.39 108.12 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.008 0.923 . . . . 73.030000000000001 110.144 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -89.18 -48.21 7.54 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.251 0.62 . . . . 72.420000000000002 111.133 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 28.0 m -102.14 143.07 32.42 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 107.987 -1.116 . . . . 64.329999999999998 107.987 173.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 17' ' ' MET . 31.1 t -157.45 155.62 30.74 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.472 0.916 . . . . 62.130000000000003 113.472 -172.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -83.86 -42.71 16.09 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.147 -1.388 . . . . 61.32 109.111 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.7 mmt -90.67 128.6 36.69 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.185 0.994 . . . . 52.439999999999998 109.557 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HE2' HG21 ' A' ' 105' ' ' THR . 0.0 OUTLIER -66.88 -17.86 65.1 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.558 0.577 . . . . 71.400000000000006 112.558 -177.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.52 -11.08 62.8 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 113.937 0.335 . . . . 52.009999999999998 113.937 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.457 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 53.4 ttp -88.06 -23.05 23.85 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.31 0.555 . . . . 71.319999999999993 111.51 -177.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 141.97 57.77 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 121.025 0.44 . . . . 60.0 111.348 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.68 -8.65 41.05 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-N 116.003 -0.544 . . . . 73.400000000000006 114.116 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.41 148.25 32.03 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.498 0.719 . . . . 71.230000000000004 111.529 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HA ' HG12 ' A' ' 8' ' ' ILE . 8.8 pt-20 -96.17 110.55 22.81 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 121.272 0.558 . . . . 65.329999999999998 109.976 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.518 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -101.86 172.28 7.03 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.209 1.004 . . . . 75.510000000000005 113.303 -174.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.2 m -125.79 123.89 39.77 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.028 0.931 . . . . 73.319999999999993 109.806 172.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.41 122.21 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.053 0.541 . . . . 61.030000000000001 110.08 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 p -126.72 -6.33 6.27 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.543 0.737 . . . . 61.299999999999997 112.591 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.38 145.71 13.38 Favored Glycine 0 N--CA 1.476 1.314 0 CA-C-O 119.648 -0.529 . . . . 71.430000000000007 112.019 173.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.29 123.48 12.95 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.618 0.767 . . . . 73.439999999999998 110.689 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -133.1 130.24 39.04 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.663 0.785 . . . . 75.310000000000002 111.926 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -104.24 87.47 2.75 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.617 0.767 . . . . 74.299999999999997 109.165 169.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -134.53 170.98 14.96 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.847 0.859 . . . . 51.32 110.921 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.5 m -75.47 107.71 7.78 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.492 -0.558 . . . . 61.399999999999999 109.492 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.01 110.5 23.1 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.601 0.76 . . . . 70.140000000000001 109.004 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.458 ' HE2' ' HA ' ' A' ' 54' ' ' GLN . 95.7 m-85 -89.33 151.86 21.85 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.873 0.844 . . . . 71.219999999999999 112.158 -172.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.0 t -99.68 120.41 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.255 -1.387 . . . . 74.120000000000005 107.255 164.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -125.72 148.55 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.514 0.673 . . . . 73.319999999999993 112.671 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.6 p -115.81 124.99 52.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.241 1.017 . . . . 54.450000000000003 109.14 170.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.425 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 47.2 p90 -152.11 156.19 39.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.767 0.427 . . . . 74.239999999999995 110.678 -174.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.423 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 15.1 m -113.31 110.85 50.3 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 109.123 -0.695 . . . . 72.049999999999997 109.123 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 38' ' ' THR . 9.2 Cg_endo -53.01 118.44 4.8 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.248 2.632 . . . . 64.239999999999995 112.791 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.3 p -64.71 -17.19 63.88 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.723 1.209 . . . . 75.200000000000003 113.596 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -67.47 -10.21 49.32 Favored 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 123.669 0.788 . . . . 74.420000000000002 112.466 174.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.77 51.38 2.14 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 122.255 -0.278 . . . . 64.140000000000001 112.717 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.57 -151.05 21.12 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 120.903 0.168 . . . . 45.130000000000003 113.421 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -106.14 133.86 50.19 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.725 0.81 . . . . 72.310000000000002 109.636 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -59.5 118.6 6.23 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.915 0.486 . . . . 73.150000000000006 111.208 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.7 t -84.01 110.57 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.316 0.646 . . . . 60.310000000000002 110.638 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -95.72 130.65 42.57 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.934 0.894 . . . . 72.299999999999997 110.777 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 m170 54.01 57.93 5.51 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.065 0.946 . . . . 74.420000000000002 112.547 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.465 ' HD2' HG13 ' A' ' 52' ' ' VAL . 63.9 t60 -73.14 126.31 29.73 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.092 0.557 . . . . 72.109999999999999 111.446 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 66.4 mttm -131.21 139.36 49.69 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.44 1.096 . . . . 72.25 109.732 173.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.622 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 85.9 m95 -114.12 133.32 55.64 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.424 1.49 . . . . 74.319999999999993 111.474 -5.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.465 HG13 ' HD2' ' A' ' 49' ' ' HIS . 14.2 m -110.74 142.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 108.477 -0.935 . . . . 62.439999999999998 108.477 167.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.81 161.92 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-O 120.817 0.341 . . . . 52.409999999999997 111.241 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.458 ' HA ' ' HE2' ' A' ' 33' ' ' TYR . 63.3 tt0 -52.01 -47.98 64.71 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.189 0.996 . . . . 73.340000000000003 113.487 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -74.94 -8.1 55.51 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.509 0.723 . . . . 73.510000000000005 112.124 -174.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 35.7 tt0 -90.7 -8.84 48.81 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 124.842 1.257 . . . . 52.100000000000001 110.931 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.64 142.16 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 C-N-CA 124.506 1.123 . . . . 73.239999999999995 110.311 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -63.56 -50.37 69.77 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.228 1.011 . . . . 70.400000000000006 112.968 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.36 -6.58 57.1 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.225 0.824 . . . . 72.209999999999994 113.225 -170.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -33.19 -56.22 0.4 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.761 1.763 . . . . 55.32 115.761 -170.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.39 15.18 63.24 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 115.119 0.807 . . . . 41.119999999999997 115.119 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.37 3.52 1.87 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.2 1.4 . . . . 73.510000000000005 113.146 -170.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -100.54 160.37 14.4 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.931 0.892 . . . . 61.149999999999999 110.942 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.1 m -83.25 109.54 17.32 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.423 -0.584 . . . . 61.049999999999997 109.423 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.511 HD13 HG11 ' A' ' 71' ' ' VAL . 63.7 mt -72.02 122.13 20.35 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.724 -0.843 . . . . 65.549999999999997 108.724 175.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -97.55 149.09 35.35 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.212 0.605 . . . . 65.400000000000006 112.324 -164.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -46.25 115.65 1.22 Allowed 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.806 3.004 . . . . 74.349999999999994 114.623 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.77 -16.96 15.98 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 115.887 -0.597 . . . . 63.530000000000001 114.053 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.53 154.66 32.23 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 117.811 0.805 . . . . 74.299999999999997 111.714 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -126.07 137.29 53.61 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.344 0.658 . . . . 61.229999999999997 110.448 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.511 HG11 HD13 ' A' ' 65' ' ' LEU . 16.9 m -141.29 -179.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.621 1.169 . . . . 74.209999999999994 110.908 -168.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.53 146.44 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.494 0.718 . . . . 60.210000000000001 110.398 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.1 mt -96.09 123.92 39.89 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.673 0.789 . . . . 73.409999999999997 111.193 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -86.75 -6.03 58.94 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.525 0.565 . . . . 73.409999999999997 112.525 173.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -122.95 170.62 9.95 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.554 0.693 . . . . 72.549999999999997 110.525 170.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.448 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 66.1 p -146.99 127.72 14.3 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.281 -0.872 . . . . 71.230000000000004 110.458 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -82.82 -31.27 28.22 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.553 0.741 . . . . 71.109999999999999 109.524 168.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 66.6 mtm -125.77 177.61 6.18 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.971 0.908 . . . . 74.030000000000001 112.086 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -81.84 128.82 34.42 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.682 0.793 . . . . 73.129999999999995 111.394 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.67 11.48 83.96 Favored Glycine 0 N--CA 1.477 1.416 0 C-N-CA 123.179 0.418 . . . . 64.530000000000001 113.73 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.7 ttt -86.32 -44.0 12.44 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.882 0.873 . . . . 73.120000000000005 111.447 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 88.1 tttt -67.69 127.53 33.09 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.728 0.411 . . . . 74.340000000000003 111.209 174.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.15 -16.6 60.62 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 116.537 -0.301 . . . . 50.039999999999999 112.817 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.77 152.39 42.76 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.405 0.682 . . . . 74.200000000000003 111.116 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.8 m -84.18 114.0 21.48 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.971 -0.559 . . . . 65.519999999999996 109.914 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -100.44 130.14 46.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.863 0.865 . . . . 73.239999999999995 109.752 -177.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -99.87 117.58 34.48 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.343 -0.984 . . . . 73.200000000000003 108.343 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.3 mm -64.35 94.46 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 109.486 -0.561 . . . . 75.510000000000005 109.486 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.59 -33.17 68.82 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.884 0.873 . . . . 65.319999999999993 109.832 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.9 t -167.08 166.2 15.27 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.187 0.995 . . . . 62.439999999999998 110.506 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.03 131.48 42.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.978 0.911 . . . . 72.340000000000003 109.538 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -130.42 140.01 50.58 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.832 0.453 . . . . 72.349999999999994 111.168 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -94.12 96.71 9.81 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.518 0.727 . . . . 72.5 109.091 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.1 t -137.39 157.1 47.33 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.631 0.773 . . . . 74.530000000000001 111.116 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.9 m -86.43 125.84 33.97 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.764 -0.458 . . . . 45.009999999999998 109.764 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 8.6 m -117.34 138.23 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.735 0.814 . . . . 74.150000000000006 110.321 -176.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -122.11 164.0 18.52 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.314 1.045 . . . . 71.329999999999998 112.613 -169.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 ttp -119.35 116.92 27.18 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.95 -1.477 . . . . 70.310000000000002 107.984 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.518 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 24.5 m -125.72 149.67 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 123.544 0.737 . . . . 52.149999999999999 112.667 -172.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -115.88 116.77 28.56 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.018 0.927 . . . . 64.540000000000006 109.9 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -136.68 177.7 7.65 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.53 0.681 . . . . 75.319999999999993 111.781 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.5 m -123.78 125.01 43.95 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.326 1.051 . . . . 72.409999999999997 108.803 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.3 t -61.19 127.77 33.14 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.413 0.685 . . . . 72.310000000000002 112.216 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.6 p -69.33 -44.52 71.52 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.892 0.877 . . . . 64.200000000000003 111.441 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.409 HG21 ' HE2' ' A' ' 15' ' ' LYS . 38.0 m -81.07 -57.46 3.51 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.693 -0.685 . . . . 71.140000000000001 111.775 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.2 m -86.49 -21.13 27.17 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.185 0.809 . . . . 71.030000000000001 113.185 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.98 -17.96 38.5 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 115.121 0.809 . . . . 62.329999999999998 115.121 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.51 124.76 22.17 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.5 0.72 . . . . 73.310000000000002 112.258 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -81.57 101.97 10.32 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.414 0.686 . . . . 75.25 109.275 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.0 t -98.74 119.21 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.69 0.796 . . . . 72.219999999999999 110.396 -170.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.716 ' H ' ' HD3' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -105.3 137.53 42.95 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.645 0.778 . . . . 74.430000000000007 111.276 -174.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.8 m120 56.53 40.09 29.62 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.737 1.215 . . . . 63.039999999999999 113.174 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -64.72 132.83 50.71 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.936 0.894 . . . . 73.340000000000003 111.233 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -152.06 151.76 31.53 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.101 0.56 . . . . 65.319999999999993 111.37 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.622 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 92.3 m95 -105.88 144.54 32.47 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 125.984 1.713 . . . . 74.209999999999994 110.777 -4.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.7 148.92 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 123.903 0.881 . . . . 63.130000000000003 110.888 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.6 p -94.37 168.57 10.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.682 -0.636 . . . . 53.130000000000003 112.17 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -71.22 -25.56 62.55 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.001 0.52 . . . . 63.310000000000002 111.07 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -60.46 -20.02 58.49 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 124.275 1.03 . . . . 72.140000000000001 111.295 170.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.405 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 41.4 mt-10 -100.74 -2.67 31.85 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.344 1.058 . . . . 75.530000000000001 112.881 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.5 mt -119.45 157.5 28.12 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.51 0.724 . . . . 52.119999999999997 110.907 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.9 t -144.97 122.8 11.93 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.324 0.65 . . . . 74.310000000000002 110.292 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -68.28 117.67 10.38 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 122.784 0.434 . . . . 62.420000000000002 111.619 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -105.83 133.56 50.35 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.625 0.77 . . . . 62.450000000000003 111.995 -170.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.6 tp -118.9 137.78 53.22 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.658 0.783 . . . . 72.439999999999998 110.406 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -129.06 132.32 47.43 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.088 0.955 . . . . 71.510000000000005 110.285 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -85.03 128.97 34.86 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.771 0.828 . . . . 64.099999999999994 109.719 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -56.26 -70.52 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.494 0.718 . . . . 70.200000000000003 112.453 -172.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -86.68 72.92 10.13 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.954 0.883 . . . . 74.150000000000006 109.754 174.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -83.86 -33.61 24.79 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 114.992 -1.004 . . . . 73.510000000000005 111.85 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -73.13 118.24 15.84 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.176 0.59 . . . . 54.100000000000001 111.405 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.1 m80 . . . . . 0 CA--C 1.564 1.51 0 C-N-CA 123.55 0.74 . . . . 52.340000000000003 109.836 173.898 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.563 ' SD ' HG11 ' A' ' 7' ' ' VAL . 17.9 ptp . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 110.784 -0.08 . . . . 63.219999999999999 110.784 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.0 158.87 16.45 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.045 0.538 . . . . 71.030000000000001 111.798 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.92 123.48 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 CA-C-O 121.017 0.437 . . . . 54.310000000000002 110.691 173.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.22 -4.42 38.16 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.694 -0.685 . . . . 62.530000000000001 113.02 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.5 m -76.8 140.65 40.78 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.501 0.556 . . . . 65.530000000000001 112.501 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -91.02 114.78 27.39 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.964 -1.125 . . . . 72.439999999999998 107.964 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.563 HG11 ' SD ' ' A' ' 1' ' ' MET . 27.3 m -128.33 153.62 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.571 0.748 . . . . 74.239999999999995 111.329 -170.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -100.59 121.91 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.599 0.76 . . . . 62.119999999999997 110.164 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.663 HD11 ' HB2' ' A' ' 22' ' ' ALA . 46.0 mt -80.18 120.79 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.632 0.373 . . . . 75.319999999999993 110.459 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -92.49 1.0 57.5 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 123.426 0.69 . . . . 64.049999999999997 111.977 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.426 HG21 ' HG2' ' A' ' 120' ' ' GLU . 21.7 m -142.61 154.51 44.45 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.226 0.61 . . . . 72.329999999999998 111.686 -171.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.766 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 33.0 p -117.84 116.58 27.26 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.579 0.704 . . . . 73.239999999999995 112.042 173.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.529 ' H ' ' HE2' ' A' ' 17' ' ' MET . 38.2 m-70 -96.36 -33.06 12.07 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 107.616 -1.253 . . . . 72.140000000000001 107.616 160.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 26.6 mmt -107.87 149.49 28.21 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.786 1.234 . . . . 51.240000000000002 109.283 167.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HG3' HG21 ' A' ' 105' ' ' THR . 17.4 tppt? -58.33 -45.19 88.55 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.853 0.861 . . . . 52.229999999999997 113.102 -172.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.96 2.27 87.77 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 115.172 0.829 . . . . 35.210000000000001 115.172 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.537 ' HG2' HG21 ' A' ' 9' ' ' ILE . 47.8 ttp -87.76 -26.65 22.78 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.539 0.669 . . . . 75.400000000000006 111.991 -170.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.766 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 28.0 ttpp -66.28 119.28 11.25 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.546 0.338 . . . . 71.420000000000002 110.646 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.93 0.62 88.86 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 115.793 -0.64 . . . . 22.34 114.494 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.06 151.08 35.66 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.997 0.519 . . . . 73.120000000000005 111.214 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -95.43 113.02 24.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.525 0.33 . . . . 73.230000000000004 110.775 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.663 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -96.1 168.5 10.57 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.713 0.768 . . . . 63.310000000000002 113.058 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.4 m -126.26 123.61 38.5 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.096 -1.446 . . . . 73.120000000000005 107.096 166.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.08 110.29 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.871 0.468 . . . . 42.329999999999998 110.203 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.6 p -95.4 -14.02 24.17 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.116 0.567 . . . . 71.340000000000003 111.799 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.95 154.41 25.35 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 113.44 0.136 . . . . 42.310000000000002 113.44 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.39 110.45 11.05 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.942 0.897 . . . . 71.150000000000006 110.725 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -115.1 123.19 48.34 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.847 0.859 . . . . 74.200000000000003 110.683 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.9 86.25 2.35 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 122.408 1.099 . . . . 71.519999999999996 109.757 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -134.57 173.02 12.12 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.122 -0.945 . . . . 72.239999999999995 111.045 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.1 m -78.6 123.74 27.42 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.683 -0.488 . . . . 63.149999999999999 109.683 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.08 144.87 31.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.91 0.884 . . . . 54.130000000000003 109.818 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -128.79 149.54 50.68 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.891 0.853 . . . . 74.230000000000004 111.888 -170.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.3 t -105.75 127.11 60.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 114.144 -1.389 . . . . 74.510000000000005 108.069 172.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.458 HG12 HD13 ' A' ' 88' ' ' ILE . 15.8 m -127.78 161.39 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 112.781 0.659 . . . . 45.539999999999999 112.781 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.0 t -128.99 125.25 36.99 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.13 0.972 . . . . 74.239999999999995 109.408 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -153.79 158.42 40.87 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.463 0.705 . . . . 74.120000000000005 110.87 -172.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.4 m -109.65 112.31 58.66 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 108.566 -0.902 . . . . 74.239999999999995 108.566 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.32 128.69 28.48 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.183 2.589 . . . . 71.150000000000006 113.593 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.9 p -62.6 -18.39 62.08 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.968 1.307 . . . . 70.420000000000002 113.408 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -64.82 -10.05 25.25 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 123.938 0.895 . . . . 65.030000000000001 112.526 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.71 53.51 2.71 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-O 121.117 0.287 . . . . 45.109999999999999 112.467 -175.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.68 171.16 14.31 Favored Glycine 0 N--CA 1.471 1.005 0 CA-C-N 115.352 -0.424 . . . . 74.209999999999994 113.408 -175.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -62.91 134.94 56.98 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.556 0.742 . . . . 74.219999999999999 111.512 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -58.99 123.92 18.19 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.379 0.672 . . . . 72.409999999999997 112.223 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.5 t -87.2 108.76 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.515 0.726 . . . . 63.43 109.723 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -101.78 139.21 37.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.681 0.793 . . . . 62.409999999999997 110.526 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.5 m170 57.82 37.41 27.03 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.089 0.956 . . . . 64.420000000000002 112.746 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -60.77 129.69 42.76 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.168 0.987 . . . . 75.349999999999994 111.408 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 61.1 mttp -130.2 137.24 49.97 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.936 0.895 . . . . 63.140000000000001 110.862 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 79.8 m95 -118.03 145.78 44.53 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 125.468 1.507 . . . . 74.230000000000004 111.242 -11.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -114.09 132.4 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 107.99 -1.115 . . . . 70.310000000000002 107.99 169.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.0 pt -102.02 167.27 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 121.598 -0.689 . . . . 74.439999999999998 109.909 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -47.6 -33.61 6.82 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.68 1.192 . . . . 72.010000000000005 113.393 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.51 -13.09 60.64 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.707 1.003 . . . . 64.019999999999996 113.707 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.548 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 0.5 OUTLIER -89.51 -12.91 38.66 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.623 0.601 . . . . 65.299999999999997 112.623 -179.283 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 mp -98.57 132.79 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 122.961 0.504 . . . . 73.329999999999998 111.293 -169.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -60.83 -44.16 97.3 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.81 1.244 . . . . 74.310000000000002 112.854 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -78.97 -16.32 57.1 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 118.189 -0.91 . . . . 73.409999999999997 112.813 -175.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -30.42 -62.19 0.16 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.813 1.412 . . . . 74.430000000000007 114.813 -160.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.19 23.2 65.98 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 114.602 0.601 . . . . 64.200000000000003 114.602 169.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 t70 72.54 -2.63 2.58 Favored 'General case' 0 CA--C 1.577 1.984 0 C-N-CA 125.304 1.442 . . . . 71.299999999999997 112.401 -176.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.452 ' HE3' HD23 ' A' ' 65' ' ' LEU . 53.0 pttt -79.65 153.71 29.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.376 -0.828 . . . . 62.009999999999998 110.954 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.4 m -84.48 118.73 24.48 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.142 -0.688 . . . . 75.329999999999998 109.142 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.531 ' HB3' HG13 ' A' ' 88' ' ' ILE . 41.6 mt -73.09 124.37 25.41 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.755 0.822 . . . . 70.420000000000002 110.598 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -109.02 155.94 40.01 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 123.584 0.754 . . . . 74.340000000000003 111.358 -171.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 84.5 Cg_exo -45.89 111.53 0.35 Allowed 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.123 2.549 . . . . 61.409999999999997 114.172 174.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.64 -16.39 14.11 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 114.611 0.604 . . . . 41.149999999999999 114.611 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.48 130.97 45.19 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 117.932 0.866 . . . . 75.319999999999993 112.33 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -87.8 122.06 30.99 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.827 -0.805 . . . . 70.340000000000003 108.827 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.14 146.74 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.596 0.758 . . . . 70.409999999999997 110.763 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -101.23 135.75 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 109.449 -0.574 . . . . 62.039999999999999 109.449 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.3 mt -91.19 109.15 20.4 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.98 0.512 . . . . 71.420000000000002 111.152 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.11 -40.04 65.28 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.63 0.772 . . . . 53.119999999999997 111.243 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.548 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -89.39 173.78 8.18 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.95 0.5 . . . . 51.130000000000003 111.044 174.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.658 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 29.4 t -149.17 125.44 10.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.866 -0.606 . . . . 43.32 109.804 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -86.73 -18.4 31.26 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.456 0.702 . . . . 63.310000000000002 110.976 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -155.14 147.61 24.06 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.31 1.044 . . . . 74.030000000000001 109.811 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.4 ' HB3' ' NZ ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -51.1 124.11 10.81 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.105 0.962 . . . . 60.520000000000003 113.593 -174.178 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.2 -15.6 56.25 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 115.891 -0.595 . . . . 74.439999999999998 114.201 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.2 ttt -68.91 -39.02 79.91 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.539 0.736 . . . . 73.420000000000002 112.518 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 87.7 tttt -66.39 134.94 53.56 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.689 0.396 . . . . 60.5 111.66 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.79 -7.08 79.65 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.134 -0.485 . . . . 32.049999999999997 112.901 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.42 143.15 37.02 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.103 0.561 . . . . 64.510000000000005 111.58 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.1 m -87.01 116.74 25.27 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.705 -0.85 . . . . 75.219999999999999 108.705 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -112.34 156.99 21.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.819 0.848 . . . . 53.420000000000002 110.136 -173.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -120.07 125.97 49.61 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.293 -0.632 . . . . 73.400000000000006 109.293 174.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.531 HG13 ' HB3' ' A' ' 65' ' ' LEU . 34.6 mm -63.08 105.29 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 N-CA-C 109.691 -0.485 . . . . 55.420000000000002 109.691 175.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -75.94 -37.86 58.22 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.987 0.915 . . . . 64.329999999999998 109.889 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.4 t -157.42 152.0 25.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.674 0.79 . . . . 50.32 111.111 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.08 132.17 54.35 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.885 0.874 . . . . 74.319999999999993 109.949 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -142.16 140.68 32.48 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.099 0.476 . . . . 64.439999999999998 112.171 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -96.66 95.6 8.05 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.126 -0.488 . . . . 73.209999999999994 109.703 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.2 t -136.88 149.91 47.94 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.455 0.702 . . . . 74.120000000000005 110.764 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.0 m -82.49 124.88 30.5 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.459 -0.571 . . . . 64.200000000000003 109.459 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.637 HG12 HG22 ' A' ' 117' ' ' THR . 16.5 m -112.03 132.97 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.455 0.702 . . . . 44.210000000000001 109.464 -173.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.422 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 96.4 m-85 -109.63 139.0 45.18 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.937 0.875 . . . . 71.329999999999998 112.048 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.434 ' HG2' ' HA ' ' A' ' 112' ' ' ASN . 60.9 ttp -91.27 120.3 32.05 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 107.493 -1.299 . . . . 64.209999999999994 107.493 170.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.425 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 27.6 m -130.65 163.31 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 113.826 1.047 . . . . 70.420000000000002 113.826 -171.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -125.69 118.32 25.36 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.292 1.037 . . . . 64.230000000000004 110.61 174.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -131.87 178.47 6.75 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.067 0.947 . . . . 75.340000000000003 110.76 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.1 m -114.73 114.31 25.44 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.081 -0.711 . . . . 72.099999999999994 109.081 170.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.3 t -55.54 103.48 0.1 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.97 0.908 . . . . 53.5 110.684 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.2 p -65.53 -17.93 64.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.511 1.125 . . . . 74.310000000000002 113.578 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.406 HG21 ' HG3' ' A' ' 15' ' ' LYS . 65.1 p -92.9 -24.21 18.51 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.357 0.503 . . . . 74.129999999999995 112.357 177.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.3 m -112.26 -22.57 10.85 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.133 0.79 . . . . 73.209999999999994 113.133 -170.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.15 -12.5 49.85 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 113.717 0.247 . . . . 64.109999999999999 113.717 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -72.82 129.29 37.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.202 1.001 . . . . 61.509999999999998 112.202 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -84.45 111.63 19.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.05 0.54 . . . . 71.329999999999998 110.177 170.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.0 t -101.06 117.99 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.898 0.879 . . . . 73.049999999999997 110.145 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.529 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -113.67 148.89 35.53 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.293 0.637 . . . . 62.119999999999997 111.677 -175.075 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.434 ' HA ' ' HG2' ' A' ' 98' ' ' MET . 81.5 m-20 55.74 36.74 27.82 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 124.143 0.977 . . . . 75.209999999999994 112.416 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -62.11 134.91 57.2 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.198 0.999 . . . . 74.230000000000004 111.911 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 98.3 mttt -140.02 136.03 33.28 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.887 0.875 . . . . 60.43 111.381 -175.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 91.9 m95 -114.46 142.96 45.7 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.114 1.366 . . . . 71.400000000000006 112.961 -12.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.5 146.48 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 114.016 -1.447 . . . . 75.209999999999994 108.19 166.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.637 HG22 HG12 ' A' ' 96' ' ' VAL . 18.8 p -103.55 173.46 6.29 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.948 -0.47 . . . . 63.530000000000001 111.289 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.422 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 13.4 tp10 -58.23 -29.93 66.13 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.791 0.836 . . . . 71.129999999999995 111.258 170.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.53 -35.11 79.43 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.831 0.853 . . . . 70.209999999999994 111.72 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.426 ' HG2' HG21 ' A' ' 11' ' ' THR . 1.3 mt-10 -92.56 -3.18 55.47 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.133 0.573 . . . . 74.030000000000001 112.463 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.4 mt -118.78 143.77 46.71 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.662 0.785 . . . . 70.109999999999999 110.283 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 57.5 m -122.29 149.52 43.61 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.427 -0.953 . . . . 74.219999999999999 108.427 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.03 170.86 7.64 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.49 0.316 . . . . 42.009999999999998 111.268 173.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -61.16 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.713 0.768 . . . . 71.219999999999999 110.474 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.82 -175.41 3.83 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.284 1.434 . . . . 75.049999999999997 109.479 -178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.37 142.38 58.41 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.283 0.633 . . . . 73.120000000000005 112.217 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -154.92 61.2 0.66 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 112.253 0.464 . . . . 64.549999999999997 112.253 -175.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -65.43 -42.01 92.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 122.119 -0.363 . . . . 73.329999999999998 111.86 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -167.83 105.25 0.5 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.732 0.813 . . . . 74.150000000000006 109.653 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -141.73 152.77 44.12 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.745 0.818 . . . . 72.120000000000005 111.757 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -151.27 -178.92 6.93 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.247 1.019 . . . . 74.439999999999998 109.663 173.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 CA--C 1.559 1.29 0 CA-C-O 118.968 -0.539 . . . . 73.030000000000001 110.096 175.189 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' SD ' HG11 ' A' ' 7' ' ' VAL . 58.3 mtt . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.446 0.165 . . . . 64.349999999999994 111.167 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -90.79 137.9 32.0 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.404 0.682 . . . . 62.130000000000003 112.756 -171.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.28 136.49 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 C-N-CA 123.597 0.759 . . . . 73.140000000000001 110.975 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.67 -12.6 68.95 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 116.007 -0.542 . . . . 61.539999999999999 113.129 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.9 t -87.1 159.12 19.03 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.426 0.69 . . . . 61.009999999999998 110.802 175.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -101.25 147.51 26.2 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.919 0.487 . . . . 62.25 109.756 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' A' ' 123' ' ' ALA . 16.6 m -130.89 151.25 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.733 0.813 . . . . 61.340000000000003 110.399 176.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.2 mm -98.76 124.99 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.792 0.837 . . . . 74.5 109.743 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 22' ' ' ALA . 30.1 mt -78.31 107.41 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 109.14 -0.689 . . . . 74.310000000000002 109.14 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -87.22 -34.28 19.03 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.061 0.458 . . . . 54.25 111.946 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.9 m -133.33 141.31 47.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.678 1.191 . . . . 44.100000000000001 108.223 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.8 p -162.64 173.16 14.27 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.602 0.715 . . . . 63.100000000000001 111.555 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -86.29 -6.95 58.85 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 114.964 -1.016 . . . . 70.5 111.353 -175.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.6 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 51.5 mtt -133.2 144.66 49.96 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.371 1.068 . . . . 75.450000000000003 110.367 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -60.27 -38.2 82.82 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.232 0.613 . . . . 71.409999999999997 111.343 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.68 -24.07 63.81 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 114.766 0.666 . . . . 65.140000000000001 114.766 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.6 ' HG3' ' HB2' ' A' ' 14' ' ' MET . 27.0 mtm -94.14 -26.74 16.57 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.637 0.375 . . . . 71.329999999999998 110.968 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -67.71 121.04 15.08 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.025 0.53 . . . . 73.25 111.431 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.44 0.96 88.13 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 115.671 -0.695 . . . . 64.319999999999993 114.117 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.79 158.87 19.88 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.195 0.598 . . . . 61.5 112.491 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -89.69 123.51 33.78 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.751 -0.659 . . . . 74.109999999999999 109.641 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -114.83 168.7 9.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.244 1.018 . . . . 65.239999999999995 110.905 171.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 m -133.9 128.35 34.39 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.663 0.785 . . . . 73.329999999999998 109.24 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.24 105.21 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 109.692 -0.484 . . . . 55.25 109.692 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.2 p -103.87 -4.73 23.12 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.957 0.503 . . . . 64.409999999999997 111.085 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.81 133.06 3.27 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 111.21 -0.756 . . . . 61.509999999999998 111.21 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.01 107.02 12.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.62 0.768 . . . . 63.409999999999997 109.532 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -110.12 133.2 53.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.847 0.859 . . . . 74.310000000000002 109.745 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -122.24 86.38 2.57 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.993 0.901 . . . . 61.32 110.142 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -135.43 -178.54 5.16 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.751 0.82 . . . . 63.32 111.206 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.2 m -75.27 119.54 19.53 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.748 0.419 . . . . 64.219999999999999 110.136 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.03 150.19 25.17 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.582 0.753 . . . . 74.5 109.613 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HB2' HG23 ' A' ' 52' ' ' VAL . 90.0 m-85 -128.61 142.91 50.89 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.784 0.802 . . . . 54.509999999999998 111.75 -173.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.18 109.65 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 114.146 -1.388 . . . . 62.130000000000003 107.29 171.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.9 148.31 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 113.816 1.043 . . . . 61.219999999999999 113.816 -170.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.4 t -116.7 125.03 51.12 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.112 0.965 . . . . 71.439999999999998 110.542 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -150.9 156.3 40.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 122.143 -0.348 . . . . 72.150000000000006 111.649 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 m -105.36 119.48 52.73 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.139 0.576 . . . . 73.25 109.826 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.34 124.4 15.97 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.801 2.334 . . . . 62.020000000000003 112.391 169.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.4 p -63.48 -10.32 17.02 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.013 1.486 . . . . 74.299999999999997 115.013 -167.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -90.95 10.1 27.88 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 122.845 0.458 . . . . 71.0 112.074 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.59 47.19 5.76 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.923 -0.471 . . . . 71.329999999999998 111.923 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.51 160.65 18.98 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 123.039 0.352 . . . . 61.020000000000003 112.514 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -62.89 130.1 43.31 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.017 0.527 . . . . 71.340000000000003 110.709 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -64.48 123.87 20.35 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.026 0.441 . . . . 74.239999999999995 111.453 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.6 t -86.87 113.25 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.542 -0.754 . . . . 71.030000000000001 109.51 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -97.95 143.44 28.52 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.984 0.914 . . . . 70.329999999999998 110.115 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.6 m80 55.92 35.3 25.23 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.642 0.777 . . . . 74.5 112.801 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.415 ' HD2' HG13 ' A' ' 52' ' ' VAL . 66.7 t60 -57.86 118.3 5.19 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.826 0.85 . . . . 74.239999999999995 111.597 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 97.9 mttt -118.32 131.37 56.33 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.837 0.855 . . . . 65.5 110.414 176.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.672 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 94.4 m95 -118.84 154.83 32.25 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.642 -1.286 . . . . 71.329999999999998 111.499 -10.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 33' ' ' TYR . 18.4 m -122.38 148.3 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 114.443 -1.253 . . . . 73.439999999999998 107.979 166.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.9 pt -103.01 170.4 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.606 0.717 . . . . 73.209999999999994 112.186 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -54.4 -34.35 61.11 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.206 1.002 . . . . 64.430000000000007 113.243 172.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.46 -1.04 49.03 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.493 0.717 . . . . 61.409999999999997 112.373 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -80.12 -17.96 51.14 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.202 1.001 . . . . 63.340000000000003 111.156 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 71' ' ' VAL . 82.2 mt -122.2 140.29 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.725 1.21 . . . . 74.200000000000003 111.076 -165.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -75.42 -49.86 17.63 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.265 0.626 . . . . 71.329999999999998 112.027 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -68.14 -5.2 16.66 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.606 0.965 . . . . 75.010000000000005 113.606 -174.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.486 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -61.01 -58.6 7.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 122.854 0.462 . . . . 35.130000000000003 111.626 169.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.85 32.76 83.8 Favored Glycine 0 N--CA 1.48 1.577 0 O-C-N 121.967 -0.458 . . . . 74.329999999999998 112.441 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.4 p30 44.6 28.28 0.31 Allowed 'General case' 0 CA--C 1.57 1.733 0 C-N-CA 126.236 1.814 . . . . 72.129999999999995 114.268 -166.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 42.4 pttt -100.22 166.23 11.09 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.537 -0.542 . . . . 52.240000000000002 109.537 174.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 m -80.97 108.98 15.12 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.621 0.368 . . . . 71.310000000000002 110.537 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.561 HD13 HG11 ' A' ' 71' ' ' VAL . 50.9 mt -78.85 129.16 34.27 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.45 0.7 . . . . 72.430000000000007 110.63 175.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -98.32 145.27 29.55 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.601 0.76 . . . . 63.240000000000002 111.29 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.461 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 97.9 Cg_exo -47.07 130.12 15.99 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.536 2.824 . . . . 52.140000000000001 114.327 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.16 -12.68 48.69 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 123.17 0.414 . . . . 53.020000000000003 113.221 -174.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.1 143.77 41.08 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.604 0.762 . . . . 60.399999999999999 112.561 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -107.03 130.33 54.67 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.956 0.902 . . . . 73.340000000000003 110.428 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 65' ' ' LEU . 28.0 m -133.36 175.77 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 124.159 0.984 . . . . 73.230000000000004 111.493 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -117.61 136.02 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.571 0.748 . . . . 73.099999999999994 109.864 171.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.5 mt -88.72 120.7 30.36 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.818 0.847 . . . . 73.120000000000005 110.791 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.04 1.32 56.23 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.09 0.556 . . . . 70.230000000000004 112.457 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.91 157.83 18.85 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.448 0.699 . . . . 53.130000000000003 112.108 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.9 p -118.03 128.95 55.26 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.924 -0.769 . . . . 24.219999999999999 108.924 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -141.5 -42.85 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.524 -1.288 . . . . 71.340000000000003 107.524 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -157.21 -176.17 5.82 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 114.058 -1.428 . . . . 61.049999999999997 110.596 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -60.74 124.15 19.59 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.595 0.758 . . . . 61.32 112.493 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.9 14.36 82.42 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 114.718 0.647 . . . . 33.439999999999998 114.718 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.5 tpt -69.71 -59.51 2.9 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.36 0.58 . . . . 72.450000000000003 111.174 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -67.55 129.29 39.45 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 115.998 -0.547 . . . . 75.030000000000001 111.453 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.86 -9.48 61.89 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 116.473 -0.33 . . . . 52.530000000000001 113.553 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.67 148.62 31.53 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.261 0.624 . . . . 74.329999999999998 111.852 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.3 m -89.7 122.32 32.7 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.196 0.598 . . . . 62.140000000000001 109.629 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.84 141.71 36.79 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.461 0.704 . . . . 41.340000000000003 111.359 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -98.79 115.62 29.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.318 1.447 . . . . 73.450000000000003 108.78 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.7 mm -69.09 96.23 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 109.03 -0.73 . . . . 50.299999999999997 109.03 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -71.65 -36.87 70.84 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.778 0.431 . . . . 73.430000000000007 110.154 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.461 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . 26.5 t -166.65 162.69 16.58 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.5 -0.773 . . . . 74.0 111.37 -177.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.14 135.76 49.29 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.253 1.021 . . . . 74.209999999999994 110.355 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -138.51 135.2 34.86 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.378 0.671 . . . . 72.120000000000005 111.399 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -90.0 94.87 9.97 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.463 -0.94 . . . . 74.310000000000002 108.463 171.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -136.08 154.99 50.85 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.427 0.691 . . . . 61.549999999999997 110.803 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 m -87.78 116.59 26.03 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.151 -0.685 . . . . 72.510000000000005 109.151 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.2 m -111.47 134.99 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.189 0.996 . . . . 44.439999999999998 109.529 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.92 148.61 36.52 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.989 0.9 . . . . 70.439999999999998 112.871 -169.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.7 ttp -103.11 111.35 23.68 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.966 -1.47 . . . . 74.5 107.312 167.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.8 m -123.84 147.62 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 112.891 0.7 . . . . 74.239999999999995 112.891 -170.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -105.24 117.65 34.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.926 0.89 . . . . 73.109999999999999 108.835 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -130.56 169.13 15.99 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.617 0.723 . . . . 74.140000000000001 111.692 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.2 m -116.82 133.3 56.18 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 108.931 -0.766 . . . . 64.439999999999998 108.931 167.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.2 t -72.82 129.31 37.89 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.78 0.432 . . . . 72.030000000000001 111.671 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.6 p -66.04 -41.54 90.75 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.066 0.946 . . . . 75.420000000000002 112.094 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.0 p -85.63 -50.05 7.52 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.31 0.644 . . . . 72.209999999999994 112.282 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.0 m -88.81 -24.02 22.69 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.0 0.741 . . . . 75.530000000000001 113.0 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 4.34 79.26 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 114.334 0.494 . . . . 53.299999999999997 114.334 -177.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -68.36 131.59 45.58 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.359 0.874 . . . . 64.319999999999993 113.359 -176.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -84.72 86.21 7.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.793 0.837 . . . . 63.030000000000001 109.405 174.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.91 125.61 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 115.866 -0.607 . . . . 61.140000000000001 109.726 -172.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.93 153.61 33.31 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.093 0.473 . . . . 73.409999999999997 111.471 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 60.5 28.45 18.12 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 114.522 -1.217 . . . . 73.109999999999999 112.563 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -66.78 130.1 42.05 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.525 0.73 . . . . 75.340000000000003 110.807 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -162.3 154.79 19.46 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 115.672 -0.695 . . . . 72.200000000000003 111.465 -169.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.672 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 96.6 m95 -103.23 133.04 48.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.473 -1.392 . . . . 72.400000000000006 111.862 0.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -126.88 139.72 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.604 1.162 . . . . 65.230000000000004 109.051 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.3 p -94.72 173.48 7.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.826 -0.546 . . . . 74.439999999999998 112.055 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.43 -19.99 65.88 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.367 0.667 . . . . 72.150000000000006 111.24 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.65 -33.98 71.56 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.953 0.901 . . . . 73.400000000000006 110.807 173.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.95 -2.64 58.47 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.166 0.586 . . . . 64.439999999999998 111.742 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.16 160.86 28.16 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.032 0.92 . . . . 74.209999999999994 111.018 -173.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.3 m -140.63 146.98 38.64 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 107.206 -1.405 . . . . 75.019999999999996 107.206 168.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.494 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -58.76 162.14 4.25 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 119.177 0.899 . . . . 42.0 111.567 176.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -54.79 98.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.454 0.645 . . . . 72.129999999999995 111.33 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 14.9 tp -120.72 175.48 6.0 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.278 1.031 . . . . 73.439999999999998 110.845 -164.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.27 154.2 41.82 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 123.123 0.569 . . . . 73.310000000000002 111.4 173.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -63.97 -11.18 26.23 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.778 1.231 . . . . 65.049999999999997 113.872 -175.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 48.05 113.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 126.242 1.817 . . . . 65.040000000000006 114.48 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -75.54 19.83 0.18 Allowed 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 115.388 1.625 . . . . 73.049999999999997 115.388 -166.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -163.53 106.74 0.99 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.368 0.531 . . . . 73.329999999999998 110.795 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -164.47 151.95 11.81 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.284 0.634 . . . . 72.109999999999999 111.758 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 64.9 m80 . . . . . 0 CA--C 1.568 1.649 0 C-N-CA 123.916 0.886 . . . . 75.430000000000007 109.794 172.198 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.464 ' SD ' HG11 ' A' ' 7' ' ' VAL . 64.2 mtt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 110.274 -0.269 . . . . 65.420000000000002 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.17 161.86 14.09 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.398 0.679 . . . . 64.510000000000005 111.128 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.4 t -65.96 125.36 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 121.116 0.484 . . . . 73.239999999999995 111.315 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.02 -1.68 35.49 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.532 0.587 . . . . 25.140000000000001 112.993 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.3 m -73.58 129.77 38.65 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.319 0.647 . . . . 53.049999999999997 111.897 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -99.24 117.27 33.33 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.367 0.667 . . . . 73.349999999999994 109.639 174.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.464 HG11 ' SD ' ' A' ' 1' ' ' MET . 30.5 m -134.38 153.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 124.114 0.966 . . . . 61.5 110.917 -168.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.56 126.29 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 123.301 0.64 . . . . 73.099999999999994 110.059 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 22' ' ' ALA . 25.7 mt -83.88 131.56 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 122.013 -0.429 . . . . 70.349999999999994 110.849 -171.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -96.08 -51.24 4.51 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 118.116 0.416 . . . . 71.409999999999997 111.724 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m -93.21 140.69 29.25 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.049 0.54 . . . . 71.439999999999998 109.56 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 14' ' ' MET . 93.0 p -128.44 125.45 38.54 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.758 0.651 . . . . 64.310000000000002 112.758 -171.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -84.05 -41.35 17.29 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.755 0.822 . . . . 72.239999999999995 108.841 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' SER . 25.1 mmt -101.56 153.22 19.92 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.34 1.056 . . . . 65.340000000000003 109.478 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -63.71 -35.52 80.84 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.209 0.818 . . . . 73.25 113.209 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.62 -1.26 89.2 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 114.347 0.499 . . . . 63.420000000000002 114.347 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.492 ' HG2' HG21 ' A' ' 9' ' ' ILE . 52.7 ttm -75.2 -30.12 60.53 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 122.979 0.512 . . . . 62.219999999999999 110.05 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -63.21 119.25 9.22 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.896 0.878 . . . . 74.450000000000003 111.79 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.42 2.25 78.96 Favored Glycine 0 CA--C 1.539 1.548 0 N-CA-C 114.667 0.627 . . . . 51.350000000000001 114.667 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.76 149.12 38.06 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.22 0.608 . . . . 63.229999999999997 111.93 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -85.14 102.32 13.18 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.652 -0.499 . . . . 65.140000000000001 109.652 174.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.609 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -85.24 147.07 26.76 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.559 0.744 . . . . 53.210000000000001 111.552 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.0 m -119.3 116.5 26.36 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.1 -1.074 . . . . 72.430000000000007 108.1 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.37 100.49 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 N-CA-C 109.607 -0.516 . . . . 71.400000000000006 109.607 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.1 p -91.72 -9.18 44.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.158 0.583 . . . . 42.439999999999998 110.927 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.05 137.32 4.73 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.833 -0.507 . . . . 31.43 111.833 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.87 106.93 13.5 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.888 0.875 . . . . 65.239999999999995 109.297 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -112.48 128.18 56.26 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.808 0.843 . . . . 72.040000000000006 110.298 -172.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -114.36 93.13 4.21 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.382 -0.599 . . . . 60.420000000000002 109.382 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.515 HG21 HD12 ' A' ' 53' ' ' ILE . 8.2 t -137.09 -179.53 5.77 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.853 0.861 . . . . 41.200000000000003 111.356 -176.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.8 m -75.8 116.94 17.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.976 0.511 . . . . 75.430000000000007 110.305 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.05 151.0 22.32 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.411 0.684 . . . . 44.420000000000002 110.191 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -130.6 146.11 52.04 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.485 0.659 . . . . 73.319999999999993 111.373 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.82 118.8 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.665 -1.235 . . . . 62.439999999999998 107.665 168.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.475 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 27.0 m -123.79 144.71 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.331 0.493 . . . . 74.530000000000001 112.331 -175.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.7 m -114.5 132.65 56.22 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.73 0.812 . . . . 74.430000000000007 110.303 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.419 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 46.1 p90 -160.5 160.52 32.07 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.08 0.552 . . . . 64.439999999999998 111.276 -174.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.9 m -113.99 114.96 46.08 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 108.501 -0.926 . . . . 61.310000000000002 108.501 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.31 127.18 24.92 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.972 2.448 . . . . 72.209999999999994 113.025 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.6 p -64.44 -17.34 63.72 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.462 1.105 . . . . 51.229999999999997 113.833 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -82.93 11.11 6.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.251 0.62 . . . . 74.530000000000001 112.335 176.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.66 51.24 5.62 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 122.735 0.207 . . . . 71.209999999999994 113.306 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.97 -171.61 26.33 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 122.559 0.123 . . . . 63.539999999999999 113.072 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.74 124.78 28.19 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.12 -1.067 . . . . 62.43 108.12 174.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -50.35 114.01 1.02 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.798 0.839 . . . . 73.420000000000002 112.469 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.9 t -75.17 96.86 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.468 -0.787 . . . . 54.009999999999998 109.825 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -85.46 117.96 24.69 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.498 -0.774 . . . . 70.349999999999994 109.915 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 58.22 59.88 2.87 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.129 0.972 . . . . 74.420000000000002 112.136 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -59.8 121.47 11.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.011 0.925 . . . . 73.040000000000006 111.562 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 98.5 mttt -126.66 136.17 52.14 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.854 0.861 . . . . 62.439999999999998 110.234 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 89.1 m95 -115.46 146.56 41.53 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.906 1.282 . . . . 73.430000000000007 111.698 -10.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.02 151.83 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 113.813 -1.539 . . . . 70.319999999999993 108.205 166.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 96' ' ' VAL . 33.0 pt -118.93 -177.07 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 120.96 0.409 . . . . 65.120000000000005 110.948 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.453 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 30.5 tt0 -49.73 -33.13 15.2 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.734 1.214 . . . . 63.43 113.822 175.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.486 ' H ' HG13 ' A' ' 53' ' ' ILE . 7.5 tp10 -62.59 -26.43 68.59 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 113.117 0.784 . . . . 65.219999999999999 113.117 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.44 -13.62 54.38 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 112.654 0.613 . . . . 71.420000000000002 112.654 -173.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.41 137.37 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.285 0.634 . . . . 73.030000000000001 110.958 -171.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.527 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 27.1 ttpt -78.28 -37.08 45.76 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.455 1.102 . . . . 71.510000000000005 112.434 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.07 -14.7 59.78 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.093 0.957 . . . . 74.329999999999998 112.821 -173.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -49.86 -63.35 1.14 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.881 1.067 . . . . 74.120000000000005 113.881 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.67 33.85 88.35 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 115.234 0.853 . . . . 70.129999999999995 115.234 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 67.07 16.81 10.37 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.607 1.163 . . . . 65.230000000000004 113.24 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 12.0 ptpt -106.47 176.43 5.17 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.256 0.551 . . . . 63.240000000000002 111.073 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.3 m -96.48 113.82 25.43 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.031 0.933 . . . . 75.200000000000003 109.156 168.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.0 mt -77.03 136.93 38.7 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.25 0.62 . . . . 53.219999999999999 110.168 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -95.55 152.59 39.31 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 123.522 0.729 . . . . 71.439999999999998 111.489 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 82.7 Cg_exo -50.86 119.88 5.87 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.124 2.549 . . . . 73.239999999999995 113.395 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.85 -13.98 26.84 Favored Glycine 0 N--CA 1.48 1.609 0 CA-C-O 119.959 -0.356 . . . . 54.43 113.815 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.55 120.63 14.89 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.736 0.768 . . . . 70.340000000000003 112.123 176.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -89.1 120.68 30.71 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.6 -0.727 . . . . 74.510000000000005 109.839 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.88 166.43 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.695 1.198 . . . . 73.299999999999997 110.906 -172.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.9 mm -112.11 135.81 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.612 0.765 . . . . 71.409999999999997 110.116 171.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.7 mt -83.29 122.82 28.95 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.064 0.545 . . . . 70.319999999999993 111.291 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 45.5 mm-40 -93.29 13.19 22.09 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 123.173 0.589 . . . . 54.109999999999999 112.043 173.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.14 156.44 32.32 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.358 0.663 . . . . 73.150000000000006 110.138 169.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.4 t -139.83 126.65 20.69 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.929 -0.578 . . . . 75.409999999999997 110.149 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -110.37 2.01 18.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.852 0.861 . . . . 71.439999999999998 109.859 171.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -173.44 161.03 4.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.737 1.215 . . . . 63.109999999999999 110.336 -174.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -68.22 124.28 23.04 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 120.728 0.299 . . . . 60.100000000000001 110.65 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.92 41.42 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.575 -0.569 . . . . 72.129999999999995 113.897 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.6 ttt -98.69 -58.42 1.96 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 117.469 0.635 . . . . 73.450000000000003 110.172 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -66.96 131.2 45.38 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.333 0.253 . . . . 74.140000000000001 110.522 171.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.69 -15.91 59.34 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 116.587 -0.279 . . . . 75.430000000000007 113.218 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.38 151.82 30.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.289 0.636 . . . . 35.310000000000002 111.687 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.1 m -87.55 118.82 27.27 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.478 -0.783 . . . . 75.030000000000001 110.165 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.475 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -116.98 149.5 40.12 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.195 0.998 . . . . 74.319999999999993 110.112 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -115.03 129.23 56.66 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.968 -0.382 . . . . 73.420000000000002 109.968 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 67' ' ' PRO . 32.0 mm -66.21 108.7 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 N-CA-C 109.415 -0.587 . . . . 71.319999999999993 109.415 174.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -75.16 -38.91 60.76 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.184 0.516 . . . . 65.310000000000002 109.951 170.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.8 t -161.73 152.7 18.07 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.22 -0.9 . . . . 71.430000000000007 111.388 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -128.55 132.74 48.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.946 0.899 . . . . 72.409999999999997 110.076 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -134.57 143.83 47.6 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.413 0.685 . . . . 63.520000000000003 111.415 -171.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -98.27 94.16 6.62 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.69 -0.856 . . . . 71.239999999999995 108.69 170.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -136.56 155.9 49.32 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.522 0.729 . . . . 74.209999999999994 110.992 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.2 m -84.11 119.54 25.1 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.15 -0.685 . . . . 54.210000000000001 109.15 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 53' ' ' ILE . 15.8 m -107.24 135.33 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.853 0.861 . . . . 60.130000000000003 109.049 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.462 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 86.3 m-85 -109.82 135.88 50.01 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.451 0.643 . . . . 72.519999999999996 111.475 -174.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.3 ttp -90.18 111.74 23.01 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.319 -1.363 . . . . 74.140000000000001 107.319 167.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.49 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 27.3 m -124.08 144.91 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 113.435 0.902 . . . . 61.130000000000003 113.435 -170.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -109.61 118.22 36.01 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.942 1.297 . . . . 55.100000000000001 108.315 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.45 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 55.0 p90 -139.6 166.66 24.0 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.265 0.839 . . . . 53.240000000000002 113.265 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.2 m -100.39 109.34 21.5 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.963 -1.017 . . . . 55.439999999999998 109.333 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.2 m -57.54 106.06 0.3 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.3 0.64 . . . . 65.329999999999998 111.181 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.7 p -61.4 -23.05 65.53 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.0 0.92 . . . . 75.040000000000006 113.295 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.8 t -65.88 -25.99 67.43 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.428 0.899 . . . . 73.230000000000004 113.428 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.2 t -142.63 -42.55 0.32 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.636 0.606 . . . . 74.040000000000006 112.636 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.01 -8.89 18.6 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 123.259 0.457 . . . . 71.120000000000005 113.141 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.21 139.54 54.53 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.86 0.864 . . . . 64.219999999999999 111.955 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -85.0 114.74 22.39 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.4 0.68 . . . . 74.120000000000005 111.151 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.1 t -88.84 104.9 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 108.075 -1.083 . . . . 73.120000000000005 108.075 171.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -93.84 131.8 38.89 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.396 -0.82 . . . . 74.219999999999999 110.721 -168.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.5 p30 45.48 52.9 8.8 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 125.29 1.436 . . . . 74.420000000000002 114.286 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -57.83 139.7 53.48 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.542 1.137 . . . . 75.450000000000003 112.876 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 68.1 mttm -131.67 128.39 38.92 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 124.249 1.02 . . . . 71.120000000000005 111.063 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 94.3 m95 -120.81 160.97 22.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.918 1.687 . . . . 65.239999999999995 111.203 -13.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.73 166.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 124.31 1.044 . . . . 74.140000000000001 109.806 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 53.2 p -117.18 167.4 11.23 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.098 0.559 . . . . 62.219999999999999 111.214 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.462 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 36.0 tt0 -67.24 -24.57 65.83 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.782 0.433 . . . . 73.519999999999996 111.601 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.2 -30.91 71.94 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.442 0.697 . . . . 70.219999999999999 111.441 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -93.65 -3.11 53.06 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.15 0.98 . . . . 70.0 111.942 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.6 mt -117.1 123.46 46.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.808 0.843 . . . . 61.240000000000002 109.639 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.43 ' O ' ' HB ' ' A' ' 7' ' ' VAL . 58.0 m -104.0 150.63 24.07 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.682 -0.858 . . . . 74.200000000000003 108.682 172.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.17 169.8 9.7 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.205 0.457 . . . . 74.040000000000006 111.38 174.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -54.39 99.88 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.011 0.525 . . . . 65.329999999999998 111.285 177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 48.8 tp -137.23 137.77 39.44 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.635 0.774 . . . . 75.209999999999994 110.933 -172.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.13 11.24 8.19 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.327 1.051 . . . . 72.230000000000004 111.712 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -74.42 103.11 4.66 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.854 0.862 . . . . 73.030000000000001 110.778 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -135.08 151.07 50.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.351 1.06 . . . . 71.519999999999996 110.572 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -113.25 157.78 21.33 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.627 0.771 . . . . 73.120000000000005 111.765 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -94.2 -176.52 4.0 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.18 0.992 . . . . 72.109999999999999 110.799 174.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -74.66 90.12 2.28 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.031 0.532 . . . . 75.040000000000006 111.102 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 C--O 1.255 1.38 0 C-N-CA 123.546 0.738 . . . . 63.030000000000001 109.8 170.335 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HB3' HG21 ' A' ' 24' ' ' VAL . 23.7 mmt . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 110.934 -0.025 . . . . 44.399999999999999 110.934 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.532 ' H ' ' HD2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -110.36 149.19 30.59 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.35 0.66 . . . . 65.420000000000002 110.669 178.009 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.37 130.04 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 123.333 0.653 . . . . 73.430000000000007 111.414 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.73 -8.75 56.56 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 115.42 -0.809 . . . . 72.519999999999996 113.081 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.1 t -85.4 151.51 23.95 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.577 0.584 . . . . 74.109999999999999 112.577 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -100.59 117.46 34.77 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.153 0.981 . . . . 74.109999999999999 110.266 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.48 154.88 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.947 0.899 . . . . 55.140000000000001 111.293 -176.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.8 mm -100.61 133.51 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.23 1.012 . . . . 74.430000000000007 110.511 172.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 17' ' ' MET . 33.0 mt -84.63 123.91 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 122.162 -0.336 . . . . 74.400000000000006 110.325 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -100.66 -46.55 5.14 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.274 0.63 . . . . 62.509999999999998 112.46 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 79.0 m -109.14 140.83 42.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.717 0.807 . . . . 62.539999999999999 109.293 -176.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 17' ' ' MET . 13.7 m -160.46 163.46 32.97 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.631 0.604 . . . . 41.25 112.631 -169.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -95.79 -40.34 9.4 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.414 -0.812 . . . . 75.019999999999996 109.053 164.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.6 mpt? -84.02 142.06 30.73 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.998 0.919 . . . . 45.420000000000002 111.028 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 12.2 mptt -72.18 -26.71 62.18 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.299 0.64 . . . . 70.140000000000001 112.016 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.62 -4.77 81.89 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 114.999 0.76 . . . . 33.450000000000003 114.999 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.43 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 63.4 mtt -87.87 -26.29 22.85 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 117.558 0.679 . . . . 52.240000000000002 112.364 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 25.6 pttm -61.75 118.84 7.67 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.154 0.502 . . . . 72.420000000000002 111.522 -175.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.1 1.94 70.5 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 113.939 0.336 . . . . 64.400000000000006 113.939 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.12 138.38 47.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.292 0.637 . . . . 73.329999999999998 112.279 -177.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -78.87 97.61 6.04 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.521 0.728 . . . . 71.140000000000001 110.11 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.56 157.31 16.04 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.23 1.012 . . . . 72.25 111.601 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.3 m -126.73 124.27 39.37 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.992 -0.744 . . . . 65.129999999999995 108.992 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.423 ' HA ' HG12 ' A' ' 99' ' ' VAL . 46.6 t -72.75 102.17 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.241 0.616 . . . . 55.530000000000001 110.001 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.9 p -99.92 -2.76 33.91 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.334 0.654 . . . . 71.140000000000001 112.718 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.07 151.81 20.95 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 112.283 -0.327 . . . . 72.299999999999997 112.283 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.93 108.82 7.59 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.756 0.822 . . . . 74.409999999999997 110.558 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.407 ' HB2' HG23 ' A' ' 96' ' ' VAL . 4.6 m-85 -108.87 122.63 47.59 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.959 0.904 . . . . 71.310000000000002 110.597 -174.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -100.01 83.24 2.67 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 122.058 0.932 . . . . 64.019999999999996 109.74 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.3 t -133.95 170.4 15.68 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 115.506 -0.77 . . . . 54.020000000000003 111.443 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.2 m -87.51 122.66 31.51 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.97 0.508 . . . . 50.350000000000001 109.96 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.1 154.77 27.18 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.16 0.984 . . . . 44.119999999999997 109.989 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.429 ' HB2' HG23 ' A' ' 52' ' ' VAL . 91.5 m-85 -130.28 149.4 51.99 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.916 0.865 . . . . 75.129999999999995 113.099 -169.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -102.25 111.17 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 113.941 -1.482 . . . . 74.109999999999999 108.055 171.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.494 HG12 HD13 ' A' ' 88' ' ' ILE . 22.2 m -125.12 146.99 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 113.203 0.816 . . . . 54.409999999999997 113.203 -172.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 66.6 p -117.73 129.98 56.04 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.374 1.07 . . . . 74.329999999999998 110.775 176.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.642 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 37.9 p90 -159.09 160.35 35.61 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.569 0.7 . . . . 75.209999999999994 111.639 -171.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.0 m -113.55 116.76 45.69 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 107.511 -1.292 . . . . 54.310000000000002 107.511 173.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.43 147.17 17.37 Favored 'Trans proline' 0 CA--C 1.564 2.013 0 C-N-CA 123.228 2.618 . . . . 73.129999999999995 113.271 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.5 p -63.55 -18.79 64.23 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.697 0.799 . . . . 75.329999999999998 111.998 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.76 -21.4 66.51 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.957 0.903 . . . . 70.299999999999997 111.984 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 33.35 70.63 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 114.782 0.673 . . . . 75.129999999999995 114.782 172.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.09 -113.62 2.68 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-N 117.16 0.48 . . . . 60.530000000000001 111.961 174.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -70.65 175.36 4.96 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.684 0.794 . . . . 72.420000000000002 112.934 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -116.78 129.29 56.01 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.165 -0.925 . . . . 73.329999999999998 108.64 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.29 102.62 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 122.969 0.508 . . . . 71.099999999999994 109.952 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.7 p-10 -109.97 153.91 23.9 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.698 0.799 . . . . 65.109999999999999 111.218 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 34.5 m80 55.63 33.78 21.92 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.21 1.004 . . . . 63.039999999999999 112.303 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -70.91 134.74 47.49 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.912 1.285 . . . . 70.530000000000001 111.59 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 18.0 ptpt -139.7 139.38 36.56 Favored 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.68 0.792 . . . . 73.200000000000003 110.723 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 92.3 m95 -115.97 149.28 39.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 119.86 -1.775 . . . . 73.450000000000003 112.419 -3.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.429 HG23 ' HB2' ' A' ' 33' ' ' TYR . 15.8 m -127.36 132.84 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 114.519 -1.219 . . . . 73.510000000000005 109.131 170.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.2 pt -104.31 176.17 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.9 -0.5 . . . . 74.200000000000003 112.324 -171.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.457 ' NE2' ' HB1' ' A' ' 60' ' ' ALA . 16.1 mm100 -45.07 -52.55 8.9 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.544 1.138 . . . . 64.040000000000006 113.773 171.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.01 -16.26 63.14 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.59 0.756 . . . . 74.519999999999996 111.976 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.607 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 7.9 tt0 -93.53 -17.03 23.84 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.418 1.087 . . . . 70.239999999999995 111.423 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.2 mt -111.94 127.4 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.208 1.003 . . . . 74.150000000000006 110.838 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -61.82 -56.16 22.31 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.685 0.794 . . . . 71.150000000000006 112.057 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.27 -17.43 62.49 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.633 0.975 . . . . 74.219999999999999 113.633 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.623 ' HA ' HD11 ' A' ' 65' ' ' LEU . . . -38.12 -47.03 1.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.869 1.433 . . . . 60.350000000000001 114.869 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.65 18.04 67.63 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 114.871 0.708 . . . . 74.239999999999995 114.871 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 63.65 17.86 10.71 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.945 1.298 . . . . 73.200000000000003 112.719 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.2 171.54 7.45 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.84 0.856 . . . . 72.439999999999998 110.466 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.1 m -89.97 112.68 24.15 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.306 -0.628 . . . . 71.230000000000004 109.306 173.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.623 HD11 ' HA ' ' A' ' 60' ' ' ALA . 49.5 mt -74.45 130.23 39.24 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.617 0.767 . . . . 73.019999999999996 110.618 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -100.43 152.91 37.97 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 123.634 0.773 . . . . 75.239999999999995 111.269 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -54.24 114.42 1.81 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.971 2.447 . . . . 44.509999999999998 113.685 177.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.95 -10.34 18.2 Favored Glycine 0 N--CA 1.481 1.655 0 CA-C-N 115.845 -0.616 . . . . 42.109999999999999 114.13 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -77.56 133.49 38.48 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.626 0.713 . . . . 74.310000000000002 112.353 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -98.31 120.36 38.6 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.2 -0.909 . . . . 45.140000000000001 109.184 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.568 HG11 HD13 ' A' ' 65' ' ' LEU . 19.4 m -124.7 169.98 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.574 0.75 . . . . 65.140000000000001 112.355 -171.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mm -117.37 141.15 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.936 0.894 . . . . 75.409999999999997 109.938 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.29 124.2 40.2 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.56 0.744 . . . . 64.519999999999996 111.363 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.01 -36.39 19.79 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 122.936 0.494 . . . . 74.439999999999998 112.322 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.607 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -86.82 169.52 12.51 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.07 0.462 . . . . 61.409999999999997 111.305 175.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.759 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 8.7 t -142.62 126.1 16.75 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.308 -0.405 . . . . 70.439999999999998 111.122 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -95.73 -28.05 14.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.588 0.755 . . . . 74.0 111.024 169.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 60.1 mtm -133.75 177.04 8.02 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.669 0.788 . . . . 74.510000000000005 111.86 -170.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -68.07 106.23 2.31 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-O 121.586 0.707 . . . . 65.530000000000001 112.043 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.14 22.98 36.2 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 116.023 -0.535 . . . . 75.129999999999995 114.293 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -85.06 -38.66 18.89 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 117.495 0.647 . . . . 65.200000000000003 111.04 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.759 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 59.3 tttp -67.04 124.83 24.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.038 0.535 . . . . 55.219999999999999 110.845 170.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.74 0.24 87.79 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-O 120.196 -0.224 . . . . 61.409999999999997 113.013 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.55 151.51 25.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.181 0.592 . . . . 75.109999999999999 111.358 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 51.2 m -92.08 117.74 30.13 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.332 -0.849 . . . . 75.540000000000006 109.888 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.642 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -105.69 150.79 25.15 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.557 0.743 . . . . 73.450000000000003 110.902 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -114.86 121.08 42.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.296 1.038 . . . . 73.099999999999994 110.153 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.494 HD13 HG12 ' A' ' 35' ' ' VAL . 36.9 mm -68.87 109.26 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 122.346 0.258 . . . . 61.210000000000001 110.753 -178.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -82.58 -37.13 25.51 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.262 0.625 . . . . 74.030000000000001 110.713 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.9 t -162.79 153.92 17.37 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.23 0.612 . . . . 73.510000000000005 111.727 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.89 132.57 56.66 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.25 1.02 . . . . 61.409999999999997 110.442 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -129.26 130.91 46.82 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.382 0.673 . . . . 70.430000000000007 112.222 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -92.91 93.26 8.29 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 108.248 -1.019 . . . . 73.420000000000002 108.248 167.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.8 t -138.25 154.22 49.07 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.275 0.63 . . . . 62.350000000000001 111.627 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.0 m -88.26 124.54 33.97 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.52 -0.548 . . . . 71.430000000000007 109.52 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.407 HG23 ' HB2' ' A' ' 28' ' ' TYR . 16.5 m -110.02 131.95 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 108.921 -0.77 . . . . 72.109999999999999 108.921 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.73 141.69 36.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.212 1.005 . . . . 70.109999999999999 111.423 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.6 ttp -93.65 115.76 28.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 108.367 -0.975 . . . . 74.340000000000003 108.367 171.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 24' ' ' VAL . 35.5 m -126.21 166.88 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 112.482 0.549 . . . . 60.240000000000002 112.482 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -133.74 129.12 36.25 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.781 0.432 . . . . 62.100000000000001 111.767 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -138.29 176.04 9.05 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.883 0.873 . . . . 62.539999999999999 111.541 -173.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.5 m -114.41 134.57 54.89 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.652 0.781 . . . . 72.530000000000001 109.496 171.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.3 t -68.25 119.53 12.95 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.319 0.648 . . . . 71.120000000000005 111.589 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.5 p -71.0 -26.11 62.98 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.862 0.865 . . . . 70.450000000000003 112.651 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.3 p -81.55 -56.64 3.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.82 0.448 . . . . 64.439999999999998 111.417 175.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.7 t -92.25 -51.06 5.34 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.72 0.808 . . . . 40.520000000000003 112.789 -172.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.44 -15.96 19.78 Favored Glycine 0 N--CA 1.478 1.492 0 CA-C-N 116.03 -0.532 . . . . 20.120000000000001 112.7 -168.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -51.29 113.48 0.96 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.854 1.262 . . . . 53.399999999999999 112.467 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -80.48 120.65 24.76 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.265 -0.643 . . . . 44.329999999999998 109.265 173.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.0 t -111.11 123.22 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.646 0.778 . . . . 72.239999999999995 109.111 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -113.4 153.76 28.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.943 0.497 . . . . 63.240000000000002 111.606 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 56.4 29.12 14.64 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.448 1.099 . . . . 62.439999999999998 113.211 177.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -59.31 139.68 56.77 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.033 0.933 . . . . 74.230000000000004 113.27 -174.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 66.6 mttm -142.11 135.07 28.72 Favored 'General case' 0 CA--C 1.572 1.804 0 C-N-CA 125.361 1.464 . . . . 62.450000000000003 110.088 -175.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 80.7 m95 -114.4 143.51 44.81 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.36 1.891 . . . . 72.310000000000002 111.5 -11.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.57 141.86 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 124.435 1.094 . . . . 72.439999999999998 108.944 170.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 69.3 p -100.6 -177.93 3.63 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.67 0.748 . . . . 74.540000000000006 112.264 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -55.95 -28.47 57.11 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 124.821 1.249 . . . . 64.409999999999997 111.776 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.07 -28.48 60.37 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.902 0.881 . . . . 74.239999999999995 112.095 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.452 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 1.5 mp0 -87.77 -9.23 54.56 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.6 0.36 . . . . 73.319999999999993 111.881 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.4 mt -121.45 127.26 50.93 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.171 0.589 . . . . 73.010000000000005 110.815 -172.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.5 m -118.91 133.12 56.04 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.162 0.985 . . . . 61.509999999999998 109.289 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.35 155.77 31.28 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.64 0.376 . . . . 61.329999999999998 111.896 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -62.47 93.31 0.05 Allowed 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.066 0.46 . . . . 70.519999999999996 110.482 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.2 tp -130.35 133.44 46.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.175 0.99 . . . . 62.409999999999997 110.143 -174.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -79.57 102.3 8.78 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.766 0.426 . . . . 72.129999999999995 111.803 -174.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.2 m170 -133.86 160.47 37.54 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.342 1.057 . . . . 70.420000000000002 109.916 170.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -70.19 163.67 25.89 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 116.052 -0.522 . . . . 62.299999999999997 111.095 170.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -57.0 110.83 0.88 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.306 0.642 . . . . 74.239999999999995 112.067 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -69.12 131.65 45.32 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.89 0.876 . . . . 72.329999999999998 111.739 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -129.73 160.6 32.89 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.31 0.644 . . . . 74.439999999999998 110.569 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.1 p80 . . . . . 0 CA--C 1.573 1.854 0 C-N-CA 123.892 0.877 . . . . 73.409999999999997 111.859 174.667 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HG2' HG21 ' A' ' 24' ' ' VAL . 49.4 tpp . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 110.102 -0.333 . . . . 71.340000000000003 110.102 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -92.96 155.99 17.2 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.291 0.567 . . . . 71.010000000000005 112.343 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.8 t -68.12 136.12 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 123.859 0.863 . . . . 75.040000000000006 110.821 173.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.22 -12.04 66.96 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 116.077 -0.51 . . . . 74.129999999999995 113.399 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.1 t -76.38 141.05 41.59 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 117.417 0.608 . . . . 33.340000000000003 111.738 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -99.25 121.46 41.08 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.236 0.615 . . . . 74.340000000000003 110.218 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.512 ' HA ' ' H ' ' A' ' 124' ' ' LYS . 32.7 m -125.24 156.16 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.091 0.956 . . . . 70.430000000000007 111.571 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.518 HD13 ' HA ' ' A' ' 21' ' ' GLU . 35.9 mm -103.96 135.71 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.493 -0.929 . . . . 73.129999999999995 108.493 165.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.3 mt -88.59 119.86 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 109.268 -0.641 . . . . 71.219999999999999 109.268 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.66 -28.82 17.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 122.089 -0.382 . . . . 72.230000000000004 111.814 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.495 ' HB ' ' HG2' ' A' ' 120' ' ' GLU . 66.4 m -136.28 141.95 43.9 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.043 0.937 . . . . 72.340000000000003 109.416 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -169.4 174.0 6.24 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.41 0.624 . . . . 72.120000000000005 112.148 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -98.41 2.19 47.6 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.238 -0.892 . . . . 74.430000000000007 112.425 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 23.3 mmt -115.4 127.34 55.3 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.508 0.723 . . . . 73.25 109.278 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' HD3' ' H ' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -52.98 -41.87 65.0 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.393 1.077 . . . . 61.100000000000001 112.877 179.322 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.35 -8.23 85.46 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.371 0.509 . . . . 74.510000000000005 114.371 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 42.7 ttp -96.14 -28.93 14.34 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 117.285 0.542 . . . . 74.340000000000003 110.334 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -69.26 119.64 13.84 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.152 0.581 . . . . 74.209999999999994 109.627 173.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.6 2.5 89.97 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 115.399 -0.819 . . . . 44.329999999999998 114.358 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.88 161.89 18.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 113.55 0.945 . . . . 73.430000000000007 113.55 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.518 ' HA ' HD13 ' A' ' 8' ' ' ILE . 10.9 tp10 -76.99 138.73 39.79 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.89 -1.05 . . . . 74.439999999999998 110.439 172.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.77 166.67 30.66 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.436 0.636 . . . . 62.350000000000001 112.672 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.5 m -138.53 129.22 26.42 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.702 0.801 . . . . 53.130000000000003 110.408 173.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.417 HG21 ' HG2' ' A' ' 1' ' ' MET . 80.8 t -77.71 104.73 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.513 0.725 . . . . 54.350000000000001 109.741 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.7 p -103.02 -2.42 27.59 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.567 0.747 . . . . 62.109999999999999 112.394 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.47 142.44 9.05 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-O 120.076 -0.291 . . . . 54.420000000000002 112.494 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.97 111.36 14.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.421 0.688 . . . . 70.310000000000002 111.231 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -118.08 110.11 17.24 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.303 1.041 . . . . 74.109999999999999 110.203 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.21 76.3 3.02 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 122.159 0.981 . . . . 70.349999999999994 108.99 174.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -133.06 168.95 17.57 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.736 -0.665 . . . . 43.5 112.258 -169.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 m -70.55 119.77 15.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.122 0.569 . . . . 72.349999999999994 111.116 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.36 146.51 28.72 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.6 0.76 . . . . 65.400000000000006 109.421 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -127.98 148.04 50.51 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.985 0.898 . . . . 64.230000000000004 111.713 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.0 t -102.61 109.7 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 114.156 -1.383 . . . . 74.040000000000006 107.707 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.456 HG12 HD13 ' A' ' 88' ' ' ILE . 30.6 m -111.63 167.43 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 118.533 0.606 . . . . 64.219999999999999 112.301 -175.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.3 p -141.59 126.58 18.3 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.192 0.597 . . . . 43.32 110.588 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -161.99 128.29 3.67 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 112.772 0.656 . . . . 73.209999999999994 112.772 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 73.3 m -71.07 117.76 59.38 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-O 119.083 -0.484 . . . . 73.200000000000003 110.099 159.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.57 140.6 94.62 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.143 2.562 . . . . 70.439999999999998 113.235 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.7 p -64.61 -16.05 62.1 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 114.43 1.27 . . . . 71.299999999999997 114.43 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.492 ' ND2' ' HB3' ' A' ' 79' ' ' LYS . 28.0 p-10 -79.39 -6.02 55.89 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.061 0.545 . . . . 72.329999999999998 112.429 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.34 45.99 5.99 Favored Glycine 0 CA--C 1.535 1.281 0 N-CA-C 112.108 -0.397 . . . . 64.150000000000006 112.108 -172.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.57 -177.9 39.79 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 122.932 0.301 . . . . 61.329999999999998 112.961 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -65.16 123.32 19.22 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 119.277 -0.392 . . . . 75.129999999999995 110.177 173.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 12.2 ttm180 -51.95 111.08 0.55 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.216 0.606 . . . . 72.25 111.6 173.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 49' ' ' HIS . 21.6 t -88.54 102.76 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 115.532 -0.758 . . . . 63.32 110.248 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -97.89 143.01 28.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.703 0.801 . . . . 75.430000000000007 110.43 -177.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.7 m170 56.96 33.92 24.07 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.763 0.825 . . . . 35.210000000000001 111.871 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.573 ' HB2' HG12 ' A' ' 46' ' ' VAL . 85.7 t60 -62.95 132.67 52.83 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.409 1.084 . . . . 61.130000000000003 111.85 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -154.99 152.31 29.53 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 114.562 -1.199 . . . . 72.129999999999995 109.492 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.6 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 72.7 m95 -106.36 126.17 51.91 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.254 -1.529 . . . . 72.439999999999998 112.35 4.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.3 m -113.89 133.67 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.377 1.071 . . . . 63.229999999999997 108.625 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.6 pt -97.12 157.6 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-O 120.85 0.357 . . . . 71.540000000000006 110.675 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -54.57 -36.59 64.55 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.606 0.762 . . . . 72.109999999999999 112.922 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -70.76 -14.34 62.4 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.142 0.577 . . . . 72.120000000000005 112.211 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -94.69 -19.66 20.21 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.246 1.018 . . . . 75.120000000000005 111.268 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.5 mt -89.07 137.32 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.583 0.753 . . . . 74.409999999999997 109.968 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.551 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 36.8 ttpt -76.67 -45.29 30.34 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.039 0.536 . . . . 61.109999999999999 111.496 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.467 ' HB3' HG12 ' A' ' 71' ' ' VAL . 5.9 t70 -68.51 -9.54 49.78 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.686 0.794 . . . . 62.32 112.625 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.582 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -42.21 -65.23 0.48 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.781 1.4 . . . . 64.420000000000002 114.781 176.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.47 13.53 58.57 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 114.894 0.718 . . . . 40.439999999999998 114.894 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.71 13.89 7.76 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.197 1.399 . . . . 61.530000000000001 112.779 -172.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -98.96 155.18 17.54 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.768 0.827 . . . . 72.299999999999997 110.48 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.9 m -72.65 109.21 6.12 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.389 0.276 . . . . 70.120000000000005 111.009 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.418 HD11 ' HA ' ' A' ' 60' ' ' ALA . 62.9 mt -86.63 146.23 26.41 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.361 0.665 . . . . 71.420000000000002 109.242 173.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -139.28 169.06 13.22 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 124.01 0.924 . . . . 64.510000000000005 110.741 -171.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 1.4 Cg_endo -44.1 109.6 0.16 Allowed 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 123.331 2.687 . . . . 63.439999999999998 114.459 172.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.91 -17.27 13.12 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.262 0.865 . . . . 40.530000000000001 115.262 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.99 120.94 14.02 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 118.413 1.106 . . . . 75.319999999999993 111.526 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -89.72 119.34 30.04 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.289 -0.634 . . . . 61.210000000000001 109.289 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' A' ' 59' ' ' ASP . 32.0 m -124.07 168.01 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.644 0.777 . . . . 72.549999999999997 111.76 -172.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.8 mm -118.74 137.91 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 123.409 0.684 . . . . 45.240000000000002 110.083 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.5 mt -92.4 109.34 20.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.821 0.848 . . . . 72.510000000000005 110.638 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.551 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 67.9 mm-40 -83.11 -9.93 58.95 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.55 0.945 . . . . 52.109999999999999 113.55 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.2 170.55 8.38 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.403 0.62 . . . . 63.219999999999999 111.065 174.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 81' ' ' MET . 31.1 t -143.81 125.42 14.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.403 -0.817 . . . . 73.510000000000005 109.173 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -103.72 -4.74 23.3 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.626 0.77 . . . . 73.450000000000003 110.465 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -165.88 -176.07 3.67 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.691 0.796 . . . . 72.420000000000002 111.386 -168.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HB3' ' ND2' ' A' ' 41' ' ' ASN . 5.5 mptp? -59.35 114.36 2.63 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 112.803 0.668 . . . . 72.0 112.803 177.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.82 27.36 67.1 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.807 1.083 . . . . 74.519999999999996 115.807 169.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.47 ' HB3' ' HA ' ' A' ' 76' ' ' SER . 27.2 ttt -83.58 -42.18 17.06 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 118.025 0.913 . . . . 54.329999999999998 111.809 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.29 130.89 44.98 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 120.693 0.282 . . . . 73.230000000000004 111.612 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.12 80.77 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.102 -0.499 . . . . 53.5 113.054 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.58 139.68 42.23 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.096 0.558 . . . . 62.399999999999999 111.982 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.9 m -84.01 120.05 25.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.228 -0.896 . . . . 71.150000000000006 108.889 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.453 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -117.46 162.92 17.18 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.971 0.908 . . . . 55.229999999999997 110.06 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -127.72 134.08 49.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.632 -0.507 . . . . 73.340000000000003 109.632 172.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.456 HD13 HG12 ' A' ' 35' ' ' VAL . 28.5 mm -66.93 104.21 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 N-CA-C 109.378 -0.601 . . . . 73.319999999999993 109.378 174.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.25 -40.74 77.67 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.377 1.071 . . . . 64.109999999999999 110.419 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.8 m -154.77 149.02 26.02 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.731 0.813 . . . . 63.399999999999999 110.599 -176.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.0 130.76 53.14 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.898 0.879 . . . . 64.129999999999995 108.89 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -140.88 115.47 9.51 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 121.132 0.491 . . . . 70.239999999999995 112.281 -168.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.04 94.2 9.86 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.365 0.666 . . . . 54.409999999999997 109.56 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 t -137.96 154.17 49.4 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.493 0.717 . . . . 64.129999999999995 110.068 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.7 m -84.21 128.26 34.45 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.889 -0.412 . . . . 72.209999999999994 109.889 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 m -111.61 134.55 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.612 0.765 . . . . 63.140000000000001 109.539 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.05 140.22 49.49 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.423 0.689 . . . . 71.329999999999998 112.314 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.3 ttp -89.69 112.44 23.71 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.881 -1.054 . . . . 54.210000000000001 108.28 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.68 145.85 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 112.826 0.676 . . . . 72.230000000000004 112.826 -170.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.84 115.68 30.93 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.488 -0.93 . . . . 73.519999999999996 108.488 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -127.97 158.82 36.83 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.218 0.463 . . . . 74.519999999999996 111.758 -173.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.7 m -104.25 104.16 14.02 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.425 -0.583 . . . . 74.049999999999997 109.425 172.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 108' ' ' GLU . 36.0 t -59.61 109.24 0.86 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.862 0.865 . . . . 74.420000000000002 111.546 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.2 p -62.26 -14.21 36.21 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.824 1.25 . . . . 72.129999999999995 113.297 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 78.8 m -58.79 -57.28 13.71 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.68 0.792 . . . . 64.319999999999993 112.498 174.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.5 p -126.32 -2.06 6.92 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.214 0.606 . . . . 50.530000000000001 112.574 -172.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.97 84.91 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 120.063 -0.298 . . . . 63.32 113.404 -170.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 103' ' ' SER . 38.1 tt0 -59.35 113.26 2.08 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.517 1.127 . . . . 65.310000000000002 112.003 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -88.7 125.63 34.94 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.681 0.753 . . . . 73.540000000000006 109.184 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -119.14 132.28 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.39 1.076 . . . . 74.230000000000004 109.12 -170.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 133.51 50.74 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 120.775 0.322 . . . . 73.040000000000006 110.297 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.6 m120 55.28 54.78 8.24 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 125.079 1.352 . . . . 73.510000000000005 113.857 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -63.91 141.92 58.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.416 0.686 . . . . 61.329999999999998 111.598 170.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 98.9 mttt -137.67 127.42 25.38 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.742 0.817 . . . . 72.239999999999995 111.053 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.6 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 85.7 m95 -120.55 165.46 14.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.198 -1.564 . . . . 71.540000000000006 112.258 -12.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.418 HG21 HD21 ' A' ' 121' ' ' LEU . 20.2 m -124.05 168.32 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 113.786 -1.552 . . . . 54.240000000000002 107.72 162.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 40.3 p -117.61 169.84 9.24 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.827 0.739 . . . . 64.219999999999999 112.282 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -53.2 -40.86 64.76 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.13 0.972 . . . . 75.540000000000006 111.279 172.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.66 -29.45 70.68 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.385 1.074 . . . . 53.119999999999997 111.774 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.495 ' HG2' ' HB ' ' A' ' 11' ' ' THR . 56.8 mt-10 -94.0 0.19 55.86 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.891 0.876 . . . . 63.439999999999998 112.078 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.418 HD21 HG21 ' A' ' 116' ' ' VAL . 83.6 mt -117.87 152.65 34.96 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.805 0.842 . . . . 63.100000000000001 110.244 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.557 ' HB2' ' HB2' ' A' ' 125' ' ' LEU . 50.5 m -146.84 122.94 10.8 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.099 -1.075 . . . . 73.299999999999997 108.099 173.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -59.77 105.6 0.39 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 118.28 0.491 . . . . 75.519999999999996 110.975 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.512 ' H ' ' HA ' ' A' ' 7' ' ' VAL . 56.2 tptt 33.94 74.4 0.06 Allowed 'General case' 0 CA--C 1.569 1.682 0 C-N-CA 124.992 1.317 . . . . 75.349999999999994 113.251 -167.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 122' ' ' SER . 30.2 tp -66.71 123.46 20.17 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.388 0.675 . . . . 51.020000000000003 110.152 173.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 123.54 17.56 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-O 121.025 0.441 . . . . 65.120000000000005 111.53 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -53.55 123.63 12.68 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.784 1.234 . . . . 72.209999999999994 113.247 -172.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -154.95 122.55 5.7 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.61 0.364 . . . . 64.310000000000002 110.948 177.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -144.24 177.09 8.85 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.979 0.912 . . . . 73.409999999999997 110.779 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -159.29 170.13 22.55 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.478 0.711 . . . . 74.409999999999997 112.4 -175.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -65.97 97.58 0.37 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.639 0.775 . . . . 63.240000000000002 111.84 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 84.7 t60 . . . . . 0 CA--C 1.564 1.486 0 C-N-CA 124.664 1.186 . . . . 75.219999999999999 110.03 -177.049 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.319 -0.252 . . . . 74.349999999999994 110.319 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.4 160.73 18.1 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.295 0.638 . . . . 71.549999999999997 111.849 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.18 131.6 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.461 0.704 . . . . 65.349999999999994 111.704 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.18 -10.28 43.38 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 115.818 -0.628 . . . . 61.32 112.782 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.4 t -81.13 145.14 31.21 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.236 0.614 . . . . 72.340000000000003 112.186 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -94.92 116.5 28.78 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.84 0.856 . . . . 73.200000000000003 109.058 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.23 153.43 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.131 0.972 . . . . 75.109999999999999 110.678 -174.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 mm -100.15 134.68 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 109.292 -0.633 . . . . 55.420000000000002 109.292 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.441 HG21 ' HG2' ' A' ' 17' ' ' MET . 63.3 mt -78.42 104.07 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.946 -0.472 . . . . 74.420000000000002 109.732 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -78.35 -32.8 49.22 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.188 0.595 . . . . 63.409999999999997 111.367 -168.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 t -144.47 164.97 29.28 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.205 0.602 . . . . 63.009999999999998 110.061 168.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 98.8 p -157.18 167.07 31.45 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.379 0.609 . . . . 62.43 112.431 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -91.4 -37.49 13.17 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.091 -0.959 . . . . 61.43 109.884 168.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.5 mpt? -85.49 132.85 34.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.835 0.854 . . . . 71.030000000000001 110.748 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -58.97 -38.45 79.13 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.553 0.741 . . . . 54.340000000000003 112.494 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.22 -6.65 87.76 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 114.545 0.578 . . . . 71.299999999999997 114.545 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.441 ' HG2' HG21 ' A' ' 9' ' ' ILE . 41.8 ttp -94.85 -28.66 15.12 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 117.821 0.811 . . . . 71.450000000000003 112.13 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.19 128.6 37.15 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.13 0.49 . . . . 71.549999999999997 111.85 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.47 0.27 88.89 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-N 115.563 -0.744 . . . . 64.150000000000006 113.958 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.55 149.46 29.95 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.357 0.663 . . . . 44.200000000000003 110.851 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -90.95 106.53 18.59 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.919 0.39 . . . . 63.420000000000002 110.267 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.545 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -88.55 169.84 11.38 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.681 0.792 . . . . 72.109999999999999 111.767 175.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.7 m -136.89 134.54 36.95 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.165 -0.68 . . . . 52.539999999999999 109.165 171.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.79 105.69 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 123.127 0.571 . . . . 52.219999999999999 110.856 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.4 p -92.63 -15.76 26.42 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.31 0.644 . . . . 34.520000000000003 111.738 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.51 146.3 13.66 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.4 -0.28 . . . . 72.299999999999997 112.4 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.17 125.35 31.01 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.868 0.867 . . . . 41.210000000000001 109.544 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.601 ' HB2' HG23 ' A' ' 96' ' ' VAL . 58.1 m-85 -128.46 130.64 47.85 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.584 0.754 . . . . 72.439999999999998 110.816 -171.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -107.31 79.49 1.31 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 122.153 0.978 . . . . 70.010000000000005 110.073 174.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 t -133.43 162.61 31.4 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.186 -0.915 . . . . 64.010000000000005 110.425 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.8 m -65.89 119.9 12.12 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.833 0.453 . . . . 71.099999999999994 110.577 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.41 153.48 23.94 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.011 0.924 . . . . 71.319999999999993 109.846 -176.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -133.95 147.42 51.05 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.902 0.858 . . . . 64.5 112.078 -170.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.95 115.0 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 106.804 -1.554 . . . . 72.030000000000001 106.804 167.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.457 HG12 HD13 ' A' ' 88' ' ' ILE . 31.6 m -122.13 154.75 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-O 121.492 0.663 . . . . 71.349999999999994 112.751 -173.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 61.7 p -121.22 124.52 44.86 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.248 1.019 . . . . 75.040000000000006 109.667 173.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -142.64 154.59 44.51 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.308 0.643 . . . . 73.109999999999999 110.682 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.0 m -102.89 107.22 54.06 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.902 -1.147 . . . . 71.310000000000002 107.902 171.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.32 133.9 45.8 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.304 2.002 . . . . 74.030000000000001 111.326 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 72.8 p -68.66 -2.27 8.78 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.502 0.927 . . . . 73.120000000000005 113.502 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -64.24 -21.47 66.59 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.298 0.639 . . . . 75.140000000000001 111.087 165.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.57 29.73 38.72 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 114.981 0.752 . . . . 72.319999999999993 114.981 169.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.35 -109.03 1.55 Allowed Glycine 0 CA--C 1.537 1.439 0 CA-C-N 117.519 0.66 . . . . 64.329999999999998 112.9 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -109.6 141.33 42.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.943 0.897 . . . . 73.120000000000005 110.172 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -63.11 124.42 21.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.283 0.633 . . . . 74.340000000000003 111.182 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.645 HG21 ' SD ' ' A' ' 78' ' ' MET . 48.5 t -90.28 114.01 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.362 0.665 . . . . 73.420000000000002 109.985 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -105.96 151.52 24.5 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.017 0.527 . . . . 74.349999999999994 110.97 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.9 m80 55.72 29.99 14.8 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.213 1.005 . . . . 63.100000000000001 113.166 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.437 ' HB2' HG12 ' A' ' 46' ' ' VAL . 60.0 t60 -72.3 118.72 15.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.992 0.917 . . . . 72.409999999999997 110.43 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 59.2 pttt -133.06 146.8 52.01 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 115.929 -0.578 . . . . 75.040000000000006 111.629 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 92.7 m95 -110.83 152.46 26.64 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.446 -1.409 . . . . 75.120000000000005 112.209 0.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.16 136.41 60.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.1 -1.409 . . . . 52.32 107.747 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.456 HG21 HG21 ' A' ' 96' ' ' VAL . 39.9 pt -101.55 166.37 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.637 -0.664 . . . . 74.310000000000002 112.143 -172.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.86 -33.74 67.13 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.841 0.856 . . . . 72.510000000000005 111.88 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -71.94 -21.23 61.64 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.064 0.546 . . . . 72.150000000000006 112.422 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -83.08 -33.83 26.3 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.938 0.895 . . . . 74.150000000000006 110.948 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.0 mt -86.85 132.19 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.079 0.552 . . . . 74.450000000000003 110.984 -171.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.524 ' HB2' ' HG3' ' A' ' 74' ' ' GLU . 59.0 tttm -60.43 -43.67 96.54 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.998 0.919 . . . . 74.349999999999994 112.167 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.36 -7.63 50.63 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 123.775 0.83 . . . . 73.420000000000002 113.154 -174.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.511 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -33.98 -67.02 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.96 1.467 . . . . 40.329999999999998 114.96 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.81 25.7 70.71 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 114.956 0.742 . . . . 65.400000000000006 114.956 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 64.32 9.43 4.87 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.527 1.131 . . . . 63.409999999999997 113.231 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 24.8 pttm -109.66 167.59 10.04 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.457 0.703 . . . . 65.430000000000007 111.357 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 m -91.89 119.54 31.75 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.286 0.634 . . . . 73.239999999999995 110.225 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.61 HD13 HG11 ' A' ' 71' ' ' VAL . 44.6 mt -79.64 127.92 32.76 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.362 0.665 . . . . 61.520000000000003 110.8 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -89.46 153.37 48.24 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.671 0.788 . . . . 63.039999999999999 111.283 -173.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.27 115.39 2.26 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.423 2.082 . . . . 74.420000000000002 113.277 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.33 -19.39 14.86 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.534 -0.757 . . . . 74.329999999999998 113.608 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.04 130.82 47.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.381 0.673 . . . . 65.049999999999997 112.189 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -90.84 120.43 31.86 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.504 -0.771 . . . . 64.519999999999996 109.312 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.61 HG11 HD13 ' A' ' 65' ' ' LEU . 32.4 m -134.43 174.68 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 C-N-CA 124.367 1.067 . . . . 73.200000000000003 111.321 -171.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.31 141.95 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.895 0.878 . . . . 63.229999999999997 109.861 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 mt -96.96 131.04 44.16 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.641 0.777 . . . . 62.009999999999998 111.596 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.524 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 36.2 mt-10 -101.0 9.44 42.24 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 113.464 0.913 . . . . 75.25 113.464 175.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.38 165.85 17.64 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.379 0.672 . . . . 63.210000000000001 110.055 169.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.4 t -139.57 123.56 17.72 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.954 -0.567 . . . . 60.140000000000001 110.517 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -99.09 -5.43 30.25 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.912 0.885 . . . . 74.319999999999993 110.173 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.645 ' SD ' HG21 ' A' ' 46' ' ' VAL . 26.0 ptp -159.07 147.45 18.07 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.539 1.135 . . . . 63.310000000000002 109.682 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -53.77 121.74 8.51 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.117 0.567 . . . . 74.25 112.296 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.9 -15.91 54.94 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 119.361 -0.688 . . . . 53.539999999999999 114.572 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.0 ttt -64.01 -46.02 86.35 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.559 0.744 . . . . 63.020000000000003 112.781 -175.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -67.53 118.5 10.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.95 -0.389 . . . . 74.230000000000004 109.95 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 3.16 74.41 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 116.383 -0.371 . . . . 73.239999999999995 113.49 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.22 145.63 32.13 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.222 0.511 . . . . 42.039999999999999 110.341 172.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m -80.32 114.56 19.31 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 109.443 -0.577 . . . . 73.349999999999994 109.443 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.51 145.63 32.87 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.598 0.759 . . . . 74.329999999999998 111.257 -173.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -123.15 117.07 24.53 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.378 1.071 . . . . 65.329999999999998 109.135 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.457 HD13 HG12 ' A' ' 35' ' ' VAL . 28.2 mm -61.55 115.07 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.188 0.595 . . . . 72.439999999999998 111.028 -178.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -83.35 -36.46 24.36 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.821 0.449 . . . . 72.349999999999994 110.967 173.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.9 t -157.83 150.65 22.89 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.24 0.616 . . . . 72.209999999999994 111.745 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.81 131.64 56.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.19 0.996 . . . . 74.030000000000001 109.37 173.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -146.68 128.9 15.71 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.942 0.497 . . . . 72.25 111.739 -171.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -91.62 95.35 9.87 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.253 -0.647 . . . . 71.340000000000003 109.253 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.3 t -136.87 155.39 49.83 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.444 1.098 . . . . 60.409999999999997 110.202 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.4 m -80.94 120.0 24.19 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.887 -0.412 . . . . 75.439999999999998 109.887 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.601 HG23 ' HB2' ' A' ' 28' ' ' TYR . 9.0 m -104.68 132.45 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.317 0.647 . . . . 72.219999999999999 109.535 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.56 135.02 51.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.36 1.064 . . . . 74.109999999999999 111.118 -176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.6 ttp -94.1 120.98 35.12 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.924 -1.139 . . . . 71.340000000000003 107.924 166.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.545 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 24.2 m -124.85 169.6 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 112.779 0.659 . . . . 73.030000000000001 112.779 -169.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -137.06 133.14 35.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.282 0.633 . . . . 72.340000000000003 110.909 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -143.32 177.61 8.31 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.853 0.861 . . . . 60.229999999999997 111.299 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.6 m -119.96 119.18 32.69 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 108.248 -1.019 . . . . 74.310000000000002 108.248 169.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.9 m -61.22 134.71 57.29 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.363 0.665 . . . . 60.32 112.396 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -65.18 -47.96 75.11 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.293 1.037 . . . . 72.209999999999994 112.176 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.4 p -75.67 -50.8 14.36 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.447 0.699 . . . . 53.420000000000002 112.052 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.8 m -75.38 -33.57 61.03 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.495 0.718 . . . . 75.209999999999994 112.677 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.37 11.92 79.88 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-N 116.543 -0.298 . . . . 71.430000000000007 113.498 -172.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -100.21 140.11 34.92 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.59 0.756 . . . . 71.299999999999997 111.239 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -81.1 115.57 20.6 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.634 0.773 . . . . 75.439999999999998 110.998 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.9 t -104.85 122.34 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.874 0.87 . . . . 63.420000000000002 109.534 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.77 160.7 17.07 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.014 0.526 . . . . 74.109999999999999 111.289 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.0 m120 56.5 28.89 14.45 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.133 0.973 . . . . 65.019999999999996 112.897 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -64.75 137.73 57.97 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.537 0.735 . . . . 63.420000000000002 111.888 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 8.0 ptpp? -155.56 148.42 24.33 Favored 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 123.513 0.725 . . . . 74.209999999999994 111.941 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 98.9 m95 -112.15 144.51 41.41 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.461 1.505 . . . . 73.010000000000005 112.536 -8.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.81 154.34 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.2 1.4 . . . . 65.239999999999995 109.048 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.3 p -117.33 177.7 4.64 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.812 0.445 . . . . 74.219999999999999 110.911 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -66.12 -14.28 61.52 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.469 0.708 . . . . 54.350000000000001 111.888 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.54 -35.4 65.52 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 122.971 0.508 . . . . 71.239999999999995 110.863 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -94.84 -5.08 45.88 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.021 0.528 . . . . 71.319999999999993 111.643 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 66.0 mt -108.24 134.41 51.12 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.851 0.834 . . . . 71.420000000000002 110.962 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.4 t -101.57 156.72 17.31 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.399 1.48 . . . . 75.519999999999996 108.925 170.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.68 160.73 15.48 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.637 0.375 . . . . 51.399999999999999 110.301 175.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.543 ' HA ' ' HE3' ' A' ' 124' ' ' LYS . 0.8 OUTLIER -111.7 159.33 18.33 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 110.081 -0.34 . . . . 75.150000000000006 110.081 174.385 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.3 mp 69.99 10.25 7.36 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 124.505 1.122 . . . . 63.439999999999998 112.086 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -82.51 169.35 16.45 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.652 0.781 . . . . 72.409999999999997 111.2 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -131.67 4.01 4.2 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.02 0.528 . . . . 73.519999999999996 112.377 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -84.42 71.63 10.68 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.402 1.096 . . . . 72.219999999999999 111.139 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -87.26 6.19 34.49 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.03 -0.986 . . . . 64.319999999999993 112.803 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -69.98 126.79 30.71 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 122.219 -0.3 . . . . 75.239999999999995 110.891 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 64.9 8.78 4.86 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.465 1.106 . . . . 71.239999999999995 111.585 -175.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 . . . . . 0 CA--C 1.566 1.565 0 C-N-CA 123.315 0.646 . . . . 63.520000000000003 111.747 -164.37 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 120.814 0.34 . . . . 72.230000000000004 111.865 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -120.46 174.37 6.58 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.639 0.776 . . . . 53.240000000000002 112.481 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.75 136.01 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 C-N-CA 123.844 0.858 . . . . 61.149999999999999 111.718 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.38 -9.76 75.48 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 115.825 -0.625 . . . . 64.200000000000003 113.702 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.8 t -83.65 142.14 31.0 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.149 0.579 . . . . 74.040000000000006 111.707 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -90.48 122.15 33.07 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.637 0.775 . . . . 64.340000000000003 110.318 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . 33.2 m -122.29 153.44 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.638 0.775 . . . . 71.329999999999998 111.886 -176.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.4 mm -104.56 123.79 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.333 1.053 . . . . 64.409999999999997 108.472 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.4 mt -77.21 125.25 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 120.967 0.413 . . . . 72.5 111.06 -172.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -89.19 -68.4 0.78 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.697 0.799 . . . . 54.009999999999998 109.725 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.0 m -98.8 144.64 27.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.941 0.897 . . . . 73.340000000000003 110.25 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 18' ' ' LYS . 84.8 p -159.28 152.7 22.56 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.704 0.631 . . . . 73.040000000000006 112.704 -172.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -85.82 -37.53 19.13 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.469 0.708 . . . . 64.439999999999998 110.309 168.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.462 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.4 mpt? -83.32 129.1 34.98 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.262 0.625 . . . . 73.430000000000007 110.259 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -30.8 71.05 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.611 0.967 . . . . 74.450000000000003 113.611 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.14 -9.1 70.9 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 114.023 0.369 . . . . 54.109999999999999 114.023 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 55.2 ttp -82.72 -28.65 30.36 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.901 0.481 . . . . 74.019999999999996 110.197 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 3.4 ttmp? -67.77 118.68 11.34 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.711 0.404 . . . . 62.32 111.134 173.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.95 2.07 86.45 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 116.134 -0.485 . . . . 65.109999999999999 113.553 -177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.97 152.17 29.64 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.108 0.563 . . . . 74.420000000000002 112.035 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -86.39 131.94 34.08 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.134 0.974 . . . . 75.519999999999996 110.359 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.55 173.86 11.08 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.728 0.811 . . . . 62.100000000000001 112.22 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.7 m -137.99 146.52 43.22 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.441 1.097 . . . . 74.140000000000001 108.754 170.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.5 t -79.75 117.95 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 122.756 0.423 . . . . 63.240000000000002 110.556 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.3 p -94.86 -18.3 21.3 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.51 0.724 . . . . 65.109999999999999 111.58 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.44 145.18 11.52 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 120.201 -0.222 . . . . 72.510000000000005 112.701 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.54 119.61 19.73 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.665 0.786 . . . . 74.150000000000006 110.725 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -130.18 149.67 51.78 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.315 1.046 . . . . 61.509999999999998 110.42 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -125.82 90.97 3.3 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.158 0.98 . . . . 63.240000000000002 109.965 167.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.0 t -135.19 177.46 7.79 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.282 -0.872 . . . . 72.329999999999998 111.144 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -73.35 110.26 7.5 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.528 0.68 . . . . 63.530000000000001 110.454 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.09 161.02 13.9 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.375 1.47 . . . . 51.119999999999997 109.918 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -138.59 144.64 39.9 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.567 0.747 . . . . 74.5 111.606 -172.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.9 110.96 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 107.048 -1.464 . . . . 72.450000000000003 107.048 164.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.547 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 21.1 m -112.16 144.09 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.378 0.609 . . . . 73.010000000000005 112.231 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 p -116.65 128.24 55.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.204 1.002 . . . . 62.32 109.634 173.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -151.17 158.29 43.77 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.94 0.496 . . . . 71.420000000000002 111.386 -169.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.2 m -108.15 117.06 55.8 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 109.008 -0.738 . . . . 74.430000000000007 109.008 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -60.77 124.04 14.19 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.656 2.237 . . . . 74.120000000000005 111.887 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -63.05 -14.45 48.26 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.575 1.324 . . . . 71.120000000000005 114.575 -168.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.463 HD22 ' N ' ' A' ' 41' ' ' ASN . 0.8 OUTLIER -85.73 11.35 11.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.532 0.733 . . . . 45.109999999999999 112.718 -176.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.46 53.15 3.93 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 120.977 0.209 . . . . 62.25 112.9 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.34 168.91 13.91 Favored Glycine 0 N--CA 1.476 1.312 0 C-N-CA 122.96 0.314 . . . . 64.209999999999994 112.854 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -58.75 135.36 57.43 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.33 0.652 . . . . 75.030000000000001 111.331 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -56.59 136.5 54.55 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-O 121.186 0.517 . . . . 71.310000000000002 111.065 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.478 HG21 ' SD ' ' A' ' 78' ' ' MET . 57.8 t -86.72 103.13 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.246 0.618 . . . . 41.240000000000002 109.709 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.69 108.7 14.56 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.902 0.881 . . . . 54.219999999999999 110.828 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.2 m170 57.7 79.11 0.21 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.152 0.981 . . . . 73.439999999999998 112.992 176.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -94.29 109.67 21.48 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.125 0.97 . . . . 73.019999999999996 109.671 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 22.2 pttp -121.01 140.16 52.3 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.286 0.235 . . . . 52.32 111.551 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 79.6 m95 -117.83 158.33 25.01 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.054 1.342 . . . . 74.319999999999993 112.478 2.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.49 143.67 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 113.183 -1.826 . . . . 72.409999999999997 107.18 167.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.505 HG13 ' H ' ' A' ' 55' ' ' GLU . 29.8 pt -106.93 179.56 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.678 -0.639 . . . . 72.299999999999997 109.676 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -48.71 -33.9 11.0 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.205 1.002 . . . . 64.510000000000005 113.093 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.505 ' H ' HG13 ' A' ' 53' ' ' ILE . 28.5 tt0 -69.78 -23.96 63.43 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.072 0.949 . . . . 74.140000000000001 113.493 -175.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.2 -10.78 59.56 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.553 0.575 . . . . 73.310000000000002 112.553 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.1 mt -113.18 134.22 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 123.433 0.693 . . . . 63.0 111.808 -169.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.432 ' HB2' ' HG3' ' A' ' 74' ' ' GLU . 40.8 ttmt -67.82 -46.37 72.06 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.025 0.93 . . . . 73.549999999999997 111.999 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -62.84 -22.28 66.56 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.802 0.841 . . . . 74.299999999999997 112.675 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -35.79 -57.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.292 1.59 . . . . 50.340000000000003 115.292 -171.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.85 19.48 67.55 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 115.984 1.154 . . . . 75.109999999999999 115.984 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 t70 61.84 15.77 7.38 Favored 'General case' 0 CA--C 1.572 1.806 0 C-N-CA 124.959 1.304 . . . . 75.340000000000003 112.212 -172.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 22.9 pttm -107.59 160.15 15.9 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.787 0.835 . . . . 53.409999999999997 109.771 175.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 p -76.88 128.16 34.05 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 110.034 -0.358 . . . . 62.439999999999998 110.034 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.572 HD13 HG11 ' A' ' 71' ' ' VAL . 38.7 mt -87.95 136.51 32.93 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.696 -0.483 . . . . 65.200000000000003 109.696 170.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -105.89 153.49 40.05 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.58 0.752 . . . . 72.420000000000002 110.593 -173.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.83 130.37 40.02 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 122.538 2.159 . . . . 75.319999999999993 112.427 171.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.86 -22.61 29.6 Favored Glycine 0 N--CA 1.479 1.507 0 N-CA-C 113.992 0.357 . . . . 43.229999999999997 113.992 -175.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -73.14 157.18 37.72 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.255 0.527 . . . . 65.430000000000007 112.226 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -125.7 135.48 52.14 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.576 -0.738 . . . . 70.230000000000004 109.737 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.572 HG11 HD13 ' A' ' 65' ' ' LEU . 36.0 m -138.79 -178.36 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 125.41 1.484 . . . . 75.019999999999996 110.355 -167.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.3 mt -128.22 140.94 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.315 0.646 . . . . 71.310000000000002 110.252 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.2 mt -90.33 130.22 36.46 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.275 1.03 . . . . 72.409999999999997 111.622 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 43.0 mt-10 -91.31 -12.97 33.47 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.218 0.607 . . . . 70.519999999999996 112.192 169.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.93 160.66 14.23 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.271 0.628 . . . . 72.510000000000005 111.193 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.818 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 10.4 t -140.2 125.9 19.29 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.691 0.396 . . . . 64.150000000000006 110.324 178.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -113.41 0.74 14.85 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.466 0.706 . . . . 74.040000000000006 110.723 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.478 ' SD ' HG21 ' A' ' 46' ' ' VAL . 23.7 ptp -157.57 167.38 30.33 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.814 0.845 . . . . 74.430000000000007 111.515 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -63.89 101.61 0.39 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.073 0.949 . . . . 64.209999999999994 111.901 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.77 23.92 9.63 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-O 119.733 -0.482 . . . . 40.520000000000003 114.101 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.4 ttt -93.23 -39.46 10.99 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 117.664 0.732 . . . . 74.319999999999993 111.689 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.818 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 60.7 tttm -67.76 119.73 12.95 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.443 0.297 . . . . 64.319999999999993 110.389 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.33 -8.44 75.16 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 123.462 0.476 . . . . 54.5 113.149 -176.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.54 146.97 36.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.055 0.542 . . . . 65.319999999999993 111.612 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.0 m -86.31 119.72 26.88 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.734 -0.666 . . . . 71.239999999999995 110.069 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.547 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -112.62 149.3 33.01 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.89 0.876 . . . . 72.25 110.653 -177.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -118.43 126.47 52.13 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.939 0.496 . . . . 74.239999999999995 110.261 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.409 HD13 HG12 ' A' ' 35' ' ' VAL . 25.8 mm -68.36 102.56 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 123.456 0.702 . . . . 64.140000000000001 110.276 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -71.79 -39.35 69.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.187 0.595 . . . . 55.329999999999998 110.166 173.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 t -154.98 147.93 24.62 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.05 -0.977 . . . . 61.439999999999998 111.286 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.78 132.96 42.82 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.0 0.92 . . . . 61.539999999999999 109.924 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -148.38 142.25 25.76 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.303 0.641 . . . . 72.519999999999996 110.803 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.03 94.6 9.7 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.427 -1.323 . . . . 71.109999999999999 107.427 172.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.3 t -134.81 156.81 48.23 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.927 0.891 . . . . 54.549999999999997 111.103 -171.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 93.5 m -79.95 120.24 23.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.934 0.494 . . . . 75.409999999999997 110.614 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.86 134.49 58.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.037 0.935 . . . . 72.530000000000001 110.239 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.48 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 98.2 m-85 -110.32 135.83 50.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.041 0.936 . . . . 73.319999999999993 112.004 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 52.8 ttp -90.26 121.07 31.94 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 107.844 -1.169 . . . . 63.329999999999998 107.844 167.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.14 145.63 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 113.17 0.804 . . . . 60.520000000000003 113.17 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -106.77 120.47 42.09 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.732 0.813 . . . . 72.319999999999993 109.747 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -127.44 165.56 19.59 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.374 0.607 . . . . 75.019999999999996 112.077 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.8 m -104.02 108.64 20.08 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.768 -0.827 . . . . 73.439999999999998 108.768 171.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.1 t -62.21 107.44 0.89 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.286 0.634 . . . . 62.340000000000003 110.682 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.7 p -59.24 -31.8 69.4 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.148 0.979 . . . . 73.219999999999999 113.142 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 t -76.49 -13.17 60.12 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.035 0.934 . . . . 72.120000000000005 112.958 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 t -123.82 -43.96 2.1 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.4 0.68 . . . . 75.420000000000002 112.663 -172.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.8 -18.47 57.19 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 116.5 -0.318 . . . . 54.119999999999997 112.436 -166.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.41 137.15 44.46 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.22 1.008 . . . . 73.420000000000002 111.493 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -91.31 118.2 30.3 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 121.322 0.582 . . . . 72.209999999999994 110.263 174.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.8 t -104.37 119.09 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.946 0.898 . . . . 64.540000000000006 108.616 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -103.63 153.29 20.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.559 0.344 . . . . 74.299999999999997 111.68 -169.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 53.73 42.42 31.81 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.541 1.137 . . . . 75.430000000000007 114.03 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -58.91 134.36 56.86 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.245 1.018 . . . . 72.299999999999997 111.903 175.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 62.1 mttp -132.3 132.12 42.67 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.093 0.957 . . . . 62.299999999999997 111.167 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 99.8 m95 -119.19 153.9 34.2 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.258 -1.526 . . . . 73.230000000000004 111.603 -15.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.36 158.15 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 114.524 -1.216 . . . . 61.109999999999999 108.831 168.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.9 p -105.84 175.51 5.47 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.251 0.548 . . . . 74.129999999999995 111.712 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.48 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 34.8 tt0 -67.54 -26.6 66.39 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.924 -0.58 . . . . 75.230000000000004 110.727 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.13 -29.13 70.55 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 123.982 0.913 . . . . 73.040000000000006 111.418 171.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -98.39 3.61 48.49 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.077 0.951 . . . . 65.120000000000005 112.715 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.93 142.55 51.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.351 0.66 . . . . 74.409999999999997 111.367 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.5 p -130.09 119.64 23.38 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.32 1.048 . . . . 75.200000000000003 108.297 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -85.69 105.02 15.94 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.919 0.782 . . . . 63.450000000000003 112.495 -167.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.5 tptm 64.62 -59.49 0.23 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.229 1.937 . . . . 75.209999999999994 116.229 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -55.01 144.2 24.14 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.294 1.037 . . . . 71.120000000000005 113.674 -169.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 129' ' ' HIS . 25.5 mm-40 57.61 26.37 12.77 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 124.64 1.176 . . . . 73.409999999999997 113.877 175.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -51.6 150.52 3.75 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.666 0.786 . . . . 74.120000000000005 112.537 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 80.94 4.44 1.55 Allowed 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 125.514 1.526 . . . . 72.230000000000004 110.778 -163.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.427 ' HB2' ' O ' ' A' ' 126' ' ' GLU . 27.8 t-80 -66.09 95.74 0.29 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.315 1.046 . . . . 73.450000000000003 110.095 174.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -65.78 144.82 56.63 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.951 0.5 . . . . 65.140000000000001 111.879 -177.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -157.29 153.98 28.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.348 0.659 . . . . 70.510000000000005 111.166 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.5 m80 . . . . . 0 CA--C 1.562 1.427 0 C-N-CA 123.774 0.83 . . . . 72.319999999999993 111.94 -174.921 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.1 tpp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.08 -0.341 . . . . 74.230000000000004 110.08 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -78.51 155.92 29.54 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.511 0.672 . . . . 71.239999999999995 112.693 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.07 122.87 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-N 115.331 -0.85 . . . . 65.340000000000003 109.593 165.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.71 41.85 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-N 115.869 -0.605 . . . . 50.420000000000002 113.583 -175.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.9 m -74.85 136.43 41.54 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.091 0.556 . . . . 55.149999999999999 111.721 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -94.12 125.16 38.59 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.931 0.893 . . . . 44.109999999999999 109.63 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.28 153.43 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.393 0.677 . . . . 41.229999999999997 112.635 -168.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.3 mm -98.37 125.44 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 124.679 1.192 . . . . 65.540000000000006 109.931 172.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 22' ' ' ALA . 41.4 mt -87.28 125.4 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.19 0.596 . . . . 70.5 111.223 -176.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -98.66 -59.02 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.381 0.672 . . . . 74.349999999999994 111.063 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.6 m -94.44 144.57 25.45 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.692 0.797 . . . . 33.420000000000002 109.448 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 17' ' ' MET . 77.2 p -149.88 144.46 25.94 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.112 0.482 . . . . 71.510000000000005 111.574 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -92.42 -24.43 18.86 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.809 0.844 . . . . 74.010000000000005 110.465 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.415 ' H ' ' HE2' ' A' ' 17' ' ' MET . 23.2 mmt -95.97 134.47 38.94 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.688 0.795 . . . . 71.400000000000006 109.316 169.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.438 ' HG2' HG21 ' A' ' 105' ' ' THR . 62.5 tttp -59.01 -44.25 91.65 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.732 0.813 . . . . 71.340000000000003 112.728 -175.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.98 -0.26 64.43 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 114.889 0.715 . . . . 63.020000000000003 114.889 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.513 ' HB3' ' HB2' ' A' ' 12' ' ' SER . 41.1 ttp -91.47 -24.84 19.55 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.725 0.763 . . . . 71.019999999999996 111.235 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -67.02 121.83 16.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.916 0.487 . . . . 73.109999999999999 111.282 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.58 1.71 90.54 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 115.837 -0.62 . . . . 60.109999999999999 114.297 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.34 146.46 36.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.043 0.537 . . . . 72.530000000000001 111.206 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -95.75 99.59 11.4 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.36 -0.607 . . . . 65.420000000000002 109.36 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -91.15 175.98 6.75 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.717 0.807 . . . . 51.539999999999999 112.724 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.9 m -136.13 138.67 42.26 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.118 -1.067 . . . . 72.319999999999993 108.118 169.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.4 t -83.45 126.88 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.213 0.605 . . . . 70.219999999999999 110.398 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.6 p -113.44 -2.07 14.02 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.406 0.682 . . . . 61.5 112.102 170.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.5 136.03 4.67 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 118.365 0.53 . . . . 75.340000000000003 113.004 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.01 107.68 13.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.848 0.859 . . . . 62.229999999999997 109.768 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -108.95 120.33 42.21 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.678 0.791 . . . . 73.420000000000002 110.669 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.94 87.01 3.18 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 108.644 -0.872 . . . . 71.540000000000006 108.644 174.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -137.24 174.95 10.06 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 112.858 0.688 . . . . 63.229999999999997 112.858 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.3 m -82.87 124.98 30.84 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.743 0.817 . . . . 74.209999999999994 110.306 172.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.02 120.4 37.11 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.187 0.995 . . . . 71.510000000000005 110.297 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -92.22 149.75 21.28 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.765 0.826 . . . . 74.319999999999993 112.538 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.96 111.61 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 107.764 -1.199 . . . . 65.430000000000007 107.764 170.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.52 HG12 HD13 ' A' ' 88' ' ' ILE . 27.1 m -114.3 165.72 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 112.869 0.692 . . . . 63.109999999999999 112.869 -172.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -135.68 123.88 23.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.829 0.852 . . . . 70.319999999999993 109.438 173.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -150.52 154.36 37.46 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 122.116 -0.365 . . . . 73.030000000000001 111.61 -170.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.3 m -104.52 115.32 63.02 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 107.856 -1.164 . . . . 63.340000000000003 107.856 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.95 133.22 56.53 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.628 2.218 . . . . 74.010000000000005 112.471 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.4 p -63.22 -14.64 51.5 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.27 1.028 . . . . 64.140000000000001 112.459 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -62.64 -17.69 60.89 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 124.333 1.053 . . . . 54.140000000000001 112.598 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.26 60.09 2.3 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 112.453 -0.259 . . . . 73.209999999999994 112.453 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 -152.31 8.04 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 115.626 -0.287 . . . . 74.219999999999999 113.695 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -81.2 126.92 32.1 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.222 0.609 . . . . 74.329999999999998 109.98 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.83 112.57 1.2 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.069 0.461 . . . . 64.230000000000004 110.452 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.431 HG21 ' SD ' ' A' ' 78' ' ' MET . 15.1 t -80.84 104.15 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.65 -0.704 . . . . 74.120000000000005 109.64 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -101.12 150.72 22.64 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.988 0.515 . . . . 53.409999999999997 109.942 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.1 m80 56.54 29.23 15.13 Favored 'General case' 0 CA--C 1.559 1.317 0 O-C-N 124.089 0.868 . . . . 70.209999999999994 111.754 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -61.99 127.46 31.5 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.948 0.899 . . . . 73.319999999999993 111.739 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 97.8 mttt -132.61 141.68 48.79 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.386 1.074 . . . . 65.420000000000002 109.947 -178.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 93.8 m95 -113.02 134.53 54.47 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 120.418 -1.426 . . . . 75.219999999999999 111.273 -7.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.75 148.36 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.456 -0.942 . . . . 72.299999999999997 108.456 169.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.8 pt -111.51 166.74 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 120.806 0.336 . . . . 64.5 110.983 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -53.15 -34.71 58.01 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.131 0.972 . . . . 73.109999999999999 113.405 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.6 -18.66 60.53 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 123.634 0.774 . . . . 73.219999999999999 112.382 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -90.5 1.31 56.8 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.255 0.622 . . . . 75.230000000000004 111.899 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.473 ' HB ' ' HB2' ' A' ' 60' ' ' ALA . 55.0 mt -121.62 125.37 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 124.059 0.944 . . . . 74.109999999999999 109.751 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -68.62 -54.48 16.2 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 118.193 0.451 . . . . 65.530000000000001 112.024 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.19 -4.33 17.17 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.183 0.809 . . . . 62.399999999999999 113.183 -177.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.475 ' HA ' HD11 ' A' ' 65' ' ' LEU . . . -54.78 -30.4 56.67 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.995 0.739 . . . . 63.32 112.995 172.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.14 14.84 66.73 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 114.828 0.691 . . . . 74.349999999999994 114.828 170.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 59.31 23.14 11.55 Favored 'General case' 0 CA--C 1.566 1.565 0 C-N-CA 124.51 1.124 . . . . 75.230000000000004 112.016 -172.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 65.1 pttt -120.56 171.54 8.49 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.362 1.065 . . . . 74.040000000000006 111.341 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.3 m -77.36 109.35 11.2 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.273 0.629 . . . . 64.400000000000006 110.078 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.494 ' HB3' HG13 ' A' ' 88' ' ' ILE . 86.9 mt -78.34 121.28 24.26 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.949 0.5 . . . . 75.200000000000003 110.784 174.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -88.97 150.7 45.91 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.891 0.876 . . . . 72.319999999999993 109.94 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 88.0 Cg_exo -50.49 121.98 8.75 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.341 2.028 . . . . 71.25 113.239 173.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.93 -21.03 12.63 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-O 119.457 -0.635 . . . . 52.420000000000002 114.151 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -69.19 133.17 47.64 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.227 1.014 . . . . 53.200000000000003 111.936 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -100.37 121.43 41.5 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.388 0.675 . . . . 75.430000000000007 109.564 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.94 165.33 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.8 1.24 . . . . 64.030000000000001 110.982 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.93 137.95 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.897 -0.502 . . . . 62.149999999999999 111.186 175.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.8 mt -85.44 122.05 29.03 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.208 1.003 . . . . 61.140000000000001 111.203 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -87.54 -17.61 31.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.382 0.512 . . . . 60.520000000000003 112.382 171.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -88.51 162.67 16.3 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.333 0.587 . . . . 44.299999999999997 111.108 170.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -142.49 124.89 15.62 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.686 -0.688 . . . . 63.140000000000001 110.085 173.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -104.14 -4.19 23.48 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 123.789 0.836 . . . . 72.450000000000003 110.841 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.431 ' SD ' HG21 ' A' ' 46' ' ' VAL . 24.4 ptp -154.69 -179.16 7.74 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.3 0.64 . . . . 73.530000000000001 112.433 -173.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.69 108.97 0.71 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.817 0.847 . . . . 75.040000000000006 112.438 174.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.65 24.38 67.67 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 115.026 0.77 . . . . 61.520000000000003 115.026 172.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -75.91 -42.31 49.3 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.801 0.8 . . . . 62.539999999999999 111.551 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.33 123.74 21.2 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 120.506 0.193 . . . . 73.209999999999994 110.69 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.5 -18.34 57.12 Favored Glycine 0 N--CA 1.471 0.97 0 CA-C-N 116.206 -0.452 . . . . 62.520000000000003 113.12 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.12 137.23 56.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.243 0.617 . . . . 71.340000000000003 111.743 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.7 m -73.48 111.09 8.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.378 0.671 . . . . 73.230000000000004 110.519 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.26 147.61 27.29 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.165 0.986 . . . . 62.399999999999999 110.419 -175.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -130.35 129.18 42.82 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 108.79 -0.819 . . . . 75.140000000000001 108.79 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.52 HD13 HG12 ' A' ' 35' ' ' VAL . 47.1 mm -74.1 112.72 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.865 0.866 . . . . 73.140000000000001 111.54 -170.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.58 -41.42 27.19 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.068 0.947 . . . . 74.400000000000006 110.582 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.5 t -163.27 172.24 15.0 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 115.681 -0.69 . . . . 74.439999999999998 111.345 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.42 132.16 24.1 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.078 0.951 . . . . 51.5 110.609 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -125.97 141.52 51.93 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.583 0.753 . . . . 73.0 112.329 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -100.5 95.35 6.66 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.452 -1.314 . . . . 70.219999999999999 107.452 163.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.9 t -136.42 154.8 50.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.072 0.949 . . . . 72.230000000000004 110.6 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.9 p -78.33 124.05 27.67 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.532 -0.544 . . . . 70.340000000000003 109.532 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.83 133.01 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.87 0.868 . . . . 60.140000000000001 108.734 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -115.1 152.83 31.84 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.723 0.773 . . . . 73.400000000000006 112.487 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.459 ' SD ' ' HE3' ' A' ' 114' ' ' LYS . 59.1 ttp -100.57 112.4 24.77 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.496 -1.229 . . . . 63.43 108.134 171.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.429 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 29.7 m -120.89 151.82 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 112.543 0.571 . . . . 74.239999999999995 112.543 -172.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.67 117.09 28.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.283 1.033 . . . . 74.540000000000006 108.97 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -136.87 175.66 9.41 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.247 0.619 . . . . 71.120000000000005 111.385 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.3 m -107.63 126.08 52.13 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.728 -0.842 . . . . 74.340000000000003 108.728 169.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.8 t -60.87 108.06 0.8 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.919 0.488 . . . . 64.319999999999993 110.526 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.0 p -58.88 -24.31 62.07 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.367 1.067 . . . . 72.230000000000004 112.887 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.438 HG21 ' HG2' ' A' ' 15' ' ' LYS . 71.1 p -87.96 -60.04 2.08 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 123.325 0.65 . . . . 70.230000000000004 112.151 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.8 p -84.57 -37.17 21.51 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.421 0.526 . . . . 65.519999999999996 112.421 -173.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.08 -2.16 51.33 Favored Glycine 0 N--CA 1.48 1.604 0 CA-C-N 116.453 -0.339 . . . . 63.240000000000002 113.151 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.73 128.28 35.89 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.461 0.704 . . . . 64.239999999999995 111.895 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -75.52 96.84 3.58 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.045 -0.724 . . . . 62.5 109.045 174.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.72 114.49 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.191 0.597 . . . . 70.099999999999994 109.799 -175.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.558 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -112.02 144.77 40.83 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 120.986 0.422 . . . . 73.209999999999994 111.376 -175.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 56.3 36.92 28.29 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.794 1.238 . . . . 64.019999999999996 113.152 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -64.54 137.95 58.13 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.505 0.722 . . . . 65.340000000000003 112.265 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 99.7 mttt -138.88 144.19 39.05 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 124.487 1.115 . . . . 73.420000000000002 110.638 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 98.5 m95 -110.2 142.62 41.49 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.539 1.536 . . . . 73.519999999999996 112.263 -11.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.57 154.41 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.225 1.01 . . . . 63.399999999999999 109.147 166.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.4 p -100.82 177.5 4.96 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.289 0.495 . . . . 71.030000000000001 112.26 173.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -69.3 -43.13 74.43 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.049 0.54 . . . . 63.240000000000002 111.197 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.33 -14.95 62.8 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.556 0.742 . . . . 64.219999999999999 111.466 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.08 -21.84 56.28 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.228 1.011 . . . . 72.439999999999998 110.149 176.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.0 mt -117.18 178.49 4.34 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.968 1.307 . . . . 63.399999999999999 109.92 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.3 m -155.31 150.37 26.79 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.019 1.328 . . . . 52.109999999999999 107.81 166.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.98 164.02 26.37 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.535 0.607 . . . . 74.329999999999998 112.586 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.578 ' HG3' ' HG ' ' A' ' 125' ' ' LEU . 56.5 tptt -68.85 142.82 54.73 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.5 0.72 . . . . 55.030000000000001 111.416 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.578 ' HG ' ' HG3' ' A' ' 124' ' ' LYS . 96.3 mt 65.58 28.3 11.35 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 124.601 1.16 . . . . 65.530000000000001 113.216 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.7 -177.76 3.89 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.576 0.954 . . . . 60.310000000000002 113.576 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -61.66 143.72 55.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.295 1.038 . . . . 71.239999999999995 111.588 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -98.16 88.8 4.3 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.009 0.524 . . . . 73.140000000000001 111.054 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -107.76 94.49 5.11 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.413 0.685 . . . . 71.129999999999995 110.997 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -69.96 132.95 46.74 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.019 0.928 . . . . 73.219999999999999 112.8 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -144.62 142.6 30.25 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.869 1.267 . . . . 74.200000000000003 109.414 174.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 112.45 0.537 . . . . 53.140000000000001 112.45 -176.81 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.432 -0.581 . . . . 74.450000000000003 109.432 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -73.54 133.51 43.59 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.22 0.608 . . . . 72.450000000000003 112.152 -174.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.0 124.2 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 115.925 -0.579 . . . . 71.239999999999995 110.177 169.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.3 1.69 38.23 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.895 -0.593 . . . . 62.340000000000003 113.195 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.0 t -78.87 136.21 37.23 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.39 0.676 . . . . 73.120000000000005 111.591 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -87.71 110.74 20.66 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.005 -0.739 . . . . 64.230000000000004 109.005 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.21 160.0 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-O 121.63 0.728 . . . . 71.510000000000005 112.464 -168.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.59 137.53 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.12 0.968 . . . . 64.109999999999999 109.047 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' A' ' 20' ' ' ALA . 60.9 mt -79.46 118.87 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 109.684 -0.487 . . . . 73.409999999999997 109.684 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -77.66 -42.5 34.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.786 0.834 . . . . 74.030000000000001 110.48 -176.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.8 m -142.34 147.74 36.81 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.466 1.106 . . . . 61.420000000000002 110.142 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.444 ' HB2' ' HE2' ' A' ' 17' ' ' MET . 76.7 p -155.14 157.47 37.48 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.119 0.485 . . . . 75.140000000000001 111.599 173.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -84.15 -17.79 38.88 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.007 -0.997 . . . . 74.510000000000005 110.705 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.468 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.4 mpt? -86.88 168.22 13.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.765 0.826 . . . . 64.409999999999997 110.131 169.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -87.8 -50.08 6.7 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.112 0.482 . . . . 62.039999999999999 110.685 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.21 -13.2 79.7 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 115.086 0.794 . . . . 74.219999999999999 115.086 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.444 ' HE2' ' HB2' ' A' ' 12' ' ' SER . 47.4 ttp -89.01 -29.32 19.57 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.135 0.467 . . . . 72.140000000000001 111.315 -176.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -69.09 122.04 17.94 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.61 0.364 . . . . 60.109999999999999 111.331 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.43 1.6 89.27 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.981 -0.554 . . . . 63.109999999999999 113.501 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.47 ' HB3' HD12 ' A' ' 9' ' ' ILE . . . -72.73 146.84 46.14 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.626 0.602 . . . . 50.119999999999997 112.626 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.84 98.84 4.97 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.363 0.665 . . . . 74.430000000000007 110.152 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -103.11 169.48 8.53 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.782 0.833 . . . . 63.439999999999998 112.307 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.5 m -141.05 134.59 30.0 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.57 -0.741 . . . . 71.510000000000005 109.195 168.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.23 114.05 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.914 0.486 . . . . 74.400000000000006 110.077 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.3 p -106.51 -4.12 20.1 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.063 0.545 . . . . 73.409999999999997 112.403 175.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.14 150.43 18.77 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-O 120.148 -0.251 . . . . 53.140000000000001 112.805 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.73 113.08 14.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.124 0.969 . . . . 71.010000000000005 110.336 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -114.17 115.76 28.0 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.793 0.837 . . . . 72.450000000000003 110.522 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -99.71 88.0 3.7 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 109.057 -0.72 . . . . 65.340000000000003 109.057 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.401 HG21 HD12 ' A' ' 53' ' ' ILE . 6.0 t -136.45 168.19 19.93 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.641 1.176 . . . . 64.219999999999999 111.133 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.7 m -75.31 129.93 38.22 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.886 -0.412 . . . . 63.020000000000003 109.886 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.7 154.93 20.76 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.751 0.821 . . . . 64.230000000000004 109.629 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -134.96 147.18 49.69 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.95 0.881 . . . . 72.319999999999993 112.129 -173.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.72 111.39 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 113.804 -1.544 . . . . 71.329999999999998 107.784 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.533 HG12 HD13 ' A' ' 88' ' ' ILE . 29.0 m -116.11 147.36 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.363 0.601 . . . . 75.510000000000005 112.214 -175.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -121.96 125.69 46.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.335 1.054 . . . . 71.519999999999996 110.057 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -147.1 158.49 43.95 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.431 0.692 . . . . 71.430000000000007 110.878 -172.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.6 m -109.87 111.46 58.66 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 108.824 -0.806 . . . . 72.329999999999998 108.824 174.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -46.82 118.29 2.6 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.719 2.946 . . . . 74.510000000000005 114.304 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.0 p -59.29 -24.68 63.48 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.903 1.281 . . . . 75.25 113.411 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -79.91 11.21 3.46 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 123.329 0.652 . . . . 73.230000000000004 112.107 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.03 51.61 3.72 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 121.97 -0.456 . . . . 73.25 112.729 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.53 163.89 12.39 Favored Glycine 0 C--N 1.344 0.991 0 N-CA-C 113.623 0.209 . . . . 42.140000000000001 113.623 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -60.19 132.91 55.4 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.398 0.679 . . . . 72.540000000000006 111.135 174.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.05 116.65 3.12 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.753 0.821 . . . . 74.319999999999993 111.626 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.46 HG21 ' SD ' ' A' ' 78' ' ' MET . 39.9 t -87.4 111.62 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 123.77 0.828 . . . . 74.349999999999994 109.657 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -104.32 138.78 40.25 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.682 0.793 . . . . 72.010000000000005 110.253 -173.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 54.42 40.48 31.81 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.151 0.98 . . . . 51.549999999999997 113.178 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.432 ' HB2' HG12 ' A' ' 46' ' ' VAL . 42.7 t60 -66.62 129.2 39.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.683 0.793 . . . . 62.520000000000003 111.118 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 47.4 mtmt -135.48 151.42 50.36 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 123.793 0.837 . . . . 73.340000000000003 110.482 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 84.7 m95 -111.86 137.39 49.88 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.446 1.499 . . . . 71.439999999999998 112.293 -4.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.06 138.48 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.872 1.269 . . . . 73.329999999999998 108.002 169.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.401 HD12 HG21 ' A' ' 30' ' ' THR . 34.0 pt -106.59 170.84 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.705 -0.622 . . . . 51.210000000000001 111.617 -176.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -57.27 -35.17 69.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.744 0.818 . . . . 65.239999999999995 112.721 178.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -71.14 -25.07 62.41 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 123.35 0.66 . . . . 65.140000000000001 111.691 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -86.72 -12.2 48.94 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 124.034 0.933 . . . . 74.409999999999997 112.102 -172.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.7 mt -107.88 137.96 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 124.062 0.945 . . . . 73.109999999999999 110.906 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -72.27 -54.01 10.82 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.301 0.64 . . . . 62.109999999999999 112.353 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.59 -10.2 17.26 Favored 'General case' 0 CA--C 1.568 1.667 0 C-N-CA 123.961 0.904 . . . . 62.0 113.156 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -52.56 -65.89 0.48 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.714 0.806 . . . . 44.32 112.608 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.51 28.66 72.78 Favored Glycine 0 N--CA 1.478 1.485 0 N-CA-C 114.998 0.759 . . . . 71.25 114.998 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.38 13.66 6.22 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 124.191 0.996 . . . . 54.229999999999997 112.895 -171.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 60' ' ' ALA . 5.8 ttpm? -94.27 143.59 26.26 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.897 1.279 . . . . 75.010000000000005 110.218 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.6 m -71.48 109.27 5.34 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.139 0.576 . . . . 74.450000000000003 110.009 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.626 HD13 HG11 ' A' ' 71' ' ' VAL . 53.1 mt -78.74 128.58 33.61 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.438 0.695 . . . . 71.109999999999999 110.009 178.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -119.26 157.29 51.51 Favored Pre-proline 0 N--CA 1.487 1.376 0 C-N-CA 123.714 0.806 . . . . 71.420000000000002 110.315 -167.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -49.72 118.87 4.11 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.219 2.612 . . . . 43.399999999999999 114.308 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.95 -22.3 25.82 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 123.161 0.41 . . . . 75.450000000000003 113.875 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.55 138.62 51.12 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.529 0.664 . . . . 63.310000000000002 111.712 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -102.11 122.19 43.65 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.333 0.653 . . . . 72.120000000000005 110.569 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.626 HG11 HD13 ' A' ' 65' ' ' LEU . 30.2 m -120.98 166.74 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.059 0.944 . . . . 63.200000000000003 112.244 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mm -110.97 135.47 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.845 0.858 . . . . 71.439999999999998 110.107 173.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.7 mt -96.07 114.55 26.27 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.963 0.905 . . . . 75.120000000000005 111.118 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -78.33 -34.68 48.39 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.306 0.642 . . . . 72.040000000000006 111.425 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.66 165.13 18.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.312 0.645 . . . . 54.520000000000003 111.712 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 51.0 p -143.59 125.91 15.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.231 -0.895 . . . . 61.219999999999999 110.779 173.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -99.67 1.13 43.2 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.988 0.915 . . . . 72.430000000000007 109.694 167.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.46 ' SD ' HG21 ' A' ' 46' ' ' VAL . 23.5 ptp -156.02 166.24 34.04 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.332 1.053 . . . . 73.409999999999997 111.353 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -54.14 -32.15 54.43 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 115.456 1.65 . . . . 51.149999999999999 115.456 -169.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.29 26.64 6.31 Favored Glycine 0 N--CA 1.484 1.853 0 CA-C-N 118.054 0.388 . . . . 54.210000000000001 114.01 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.7 ttt -89.82 -41.62 11.73 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 117.185 0.492 . . . . 72.129999999999995 112.071 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 88.4 tttt -67.52 120.68 14.37 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 122.354 -0.216 . . . . 63.439999999999998 110.634 173.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.1 76.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.232 -0.44 . . . . 75.319999999999993 112.504 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.0 145.6 35.87 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-O 121.428 0.632 . . . . 74.25 111.696 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.5 m -88.27 122.5 31.87 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.779 -1.101 . . . . 70.129999999999995 109.0 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -118.74 162.89 17.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.893 0.877 . . . . 64.540000000000006 110.773 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -131.91 128.25 38.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.779 0.832 . . . . 54.140000000000001 109.815 175.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.546 HG13 ' HB3' ' A' ' 65' ' ' LEU . 31.3 mm -66.48 116.42 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.646 0.779 . . . . 74.340000000000003 110.491 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -82.08 -36.75 27.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.487 0.715 . . . . 72.230000000000004 111.201 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.9 t -161.9 151.75 16.61 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.567 -0.742 . . . . 74.409999999999997 111.258 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.89 130.69 56.94 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.919 0.888 . . . . 61.240000000000002 109.353 172.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -134.68 119.97 18.94 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.211 0.604 . . . . 71.400000000000006 110.295 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.462 ' H ' ' HD2' ' A' ' 93' ' ' LYS . 6.8 mptt -90.31 93.79 9.48 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.173 -1.047 . . . . 74.219999999999999 108.173 -177.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.3 t -136.99 154.03 50.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.337 0.655 . . . . 74.530000000000001 110.945 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.8 m -80.77 128.11 33.28 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.146 -0.687 . . . . 63.439999999999998 109.146 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 m -120.53 135.71 59.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.572 1.149 . . . . 74.239999999999995 108.801 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.592 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 82.7 m-85 -109.72 157.27 19.29 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.108 0.956 . . . . 74.329999999999998 112.738 -171.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.526 ' SD ' ' HE3' ' A' ' 114' ' ' LYS . 35.7 ttp -100.28 117.59 34.81 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.071 -1.422 . . . . 73.420000000000002 107.699 165.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.7 m -125.07 148.25 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-O 121.37 0.605 . . . . 71.329999999999998 111.784 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.62 116.05 31.25 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.294 -1.002 . . . . 63.32 108.294 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -127.05 170.34 12.43 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.325 0.583 . . . . 75.430000000000007 111.978 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 m -112.07 111.2 21.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.205 -0.907 . . . . 75.400000000000006 109.071 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.8 m -57.21 96.82 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.209 -0.663 . . . . 45.409999999999997 109.209 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 52.0 p -56.83 -47.1 81.1 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.044 1.127 . . . . 74.129999999999995 114.044 -166.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.3 t -72.72 -32.23 65.56 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.392 0.515 . . . . 74.530000000000001 112.392 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.4 m -87.14 -26.93 23.37 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.545 0.738 . . . . 64.239999999999995 112.256 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.33 -22.2 10.98 Favored Glycine 0 CA--C 1.545 1.951 0 CA-C-N 116.004 -0.544 . . . . 73.230000000000004 114.313 -172.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -71.22 136.64 48.13 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.622 0.769 . . . . 52.439999999999998 112.094 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.33 131.63 44.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.629 0.771 . . . . 71.530000000000001 110.673 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.5 t -115.01 128.21 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.339 1.056 . . . . 53.240000000000002 109.302 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -107.19 143.44 35.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.006 0.522 . . . . 72.040000000000006 111.09 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.6 m120 58.78 39.5 24.09 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.281 1.432 . . . . 73.519999999999996 113.431 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -69.21 133.58 48.13 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.629 -0.714 . . . . 73.299999999999997 111.733 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.526 ' HE3' ' SD ' ' A' ' 98' ' ' MET . 96.7 mttt -142.47 145.77 34.07 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.565 1.146 . . . . 73.430000000000007 110.497 -175.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 87.5 m95 -106.98 122.32 46.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.703 1.601 . . . . 73.109999999999999 110.884 -9.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.7 m -99.37 154.81 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 109.208 -0.664 . . . . 71.109999999999999 109.208 170.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 31.7 m -113.81 158.16 21.37 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.827 0.451 . . . . 65.219999999999999 110.868 -175.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.592 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 67.0 tt0 -59.42 -35.83 74.72 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.189 0.519 . . . . 74.209999999999994 111.67 175.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -52.39 -32.96 41.32 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.816 1.247 . . . . 72.219999999999999 112.129 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -101.43 7.16 42.67 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.572 1.149 . . . . 65.329999999999998 112.5 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.2 mt -125.17 158.92 32.77 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.54 0.736 . . . . 74.230000000000004 110.871 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.2 t -148.05 140.89 24.73 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.026 0.93 . . . . 71.0 109.939 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.69 130.25 38.4 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.628 0.371 . . . . 73.150000000000006 110.902 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -73.05 90.49 1.52 Allowed 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.183 0.516 . . . . 74.319999999999993 110.661 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.5 mt -112.56 -65.54 1.17 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.683 0.793 . . . . 72.319999999999993 110.548 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -92.52 159.04 15.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.928 0.891 . . . . 71.329999999999998 111.6 -178.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -81.7 72.35 8.74 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.434 0.694 . . . . 73.319999999999993 109.866 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -148.77 114.6 5.71 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.518 1.127 . . . . 74.319999999999993 109.841 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -87.78 -56.75 3.21 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.991 0.916 . . . . 74.209999999999994 109.663 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -167.99 145.13 4.2 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.353 1.061 . . . . 75.510000000000005 110.225 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.36 -164.6 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.591 0.757 . . . . 73.010000000000005 111.971 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.2 p80 . . . . . 0 CA--C 1.57 1.724 0 C-N-CA 122.938 0.495 . . . . 64.239999999999995 112.266 173.772 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 110.288 -0.264 . . . . 74.019999999999996 110.288 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -86.44 143.24 27.88 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.443 0.697 . . . . 74.310000000000002 111.633 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.5 t -66.58 126.58 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 C-N-CA 122.82 0.448 . . . . 71.530000000000001 110.215 170.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.97 -12.53 62.34 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 116.239 -0.437 . . . . 54.0 113.156 -171.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.3 t -88.66 161.04 17.09 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.259 0.623 . . . . 42.549999999999997 111.027 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -121.98 138.7 54.32 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.123 0.569 . . . . 55.409999999999997 111.207 -176.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.17 170.84 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 124.966 1.307 . . . . 73.329999999999998 111.118 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.5 mm -105.09 141.93 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.124 0.97 . . . . 61.229999999999997 109.814 171.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.663 HG21 ' HG2' ' A' ' 17' ' ' MET . 27.1 mm -65.04 129.31 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.5 0 C-N-CA 123.445 0.698 . . . . 73.239999999999995 111.263 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -108.07 -13.98 14.83 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.37 0.668 . . . . 65.340000000000003 111.604 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.9 m -145.49 139.17 26.62 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.241 0.616 . . . . 75.340000000000003 110.511 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.42 ' HA ' ' SD ' ' A' ' 17' ' ' MET . 58.8 p -113.49 118.5 34.66 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.301 0.64 . . . . 71.109999999999999 112.109 -173.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -89.58 -36.23 15.43 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.744 0.817 . . . . 74.109999999999999 109.441 169.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.488 ' H ' ' HE3' ' A' ' 17' ' ' MET . 41.0 tpp -96.21 144.7 26.18 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.482 1.113 . . . . 74.409999999999997 108.901 175.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -23.72 66.74 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.331 0.863 . . . . 63.25 113.331 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.507 ' HA2' HG22 ' A' ' 105' ' ' THR . . . -89.84 -2.26 75.55 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 113.815 0.286 . . . . 73.519999999999996 113.815 174.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.663 ' HG2' HG21 ' A' ' 9' ' ' ILE . 49.8 ttm -81.39 -29.34 34.0 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.2 0.5 . . . . 75.049999999999997 110.942 -172.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.16 119.75 8.45 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.488 0.715 . . . . 73.329999999999998 112.144 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.96 1.27 87.29 Favored Glycine 0 N--CA 1.476 1.308 0 N-CA-C 114.519 0.567 . . . . 72.409999999999997 114.519 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.87 149.48 39.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.043 0.537 . . . . 72.019999999999996 111.661 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -92.72 102.87 15.28 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 122.984 0.514 . . . . 62.140000000000001 110.552 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.579 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -86.02 150.66 24.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.932 0.893 . . . . 50.43 111.766 -175.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.1 m -123.48 115.62 21.86 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.204 0.602 . . . . 71.409999999999997 109.763 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.47 96.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.272 0.629 . . . . 72.409999999999997 110.352 -174.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.8 p -98.59 -4.36 34.22 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.416 0.686 . . . . 60.43 111.448 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.92 139.46 6.61 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 111.984 -0.446 . . . . 53.119999999999997 111.984 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.61 108.69 12.31 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.808 0.843 . . . . 75.049999999999997 109.688 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -111.96 112.1 23.5 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.802 0.841 . . . . 71.0 110.338 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -94.98 82.76 3.85 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.494 0.664 . . . . 71.129999999999995 109.312 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.6 t -134.94 177.27 7.94 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.86 0.864 . . . . 54.409999999999997 111.72 -173.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.7 m -85.74 125.9 33.58 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 122.823 0.449 . . . . 75.200000000000003 110.192 173.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -103.53 154.45 19.46 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.648 1.179 . . . . 44.43 110.524 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.545 ' HB2' HG23 ' A' ' 52' ' ' VAL . 92.0 m-85 -137.61 146.03 43.47 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.715 0.769 . . . . 73.409999999999997 111.583 -174.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.85 121.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 106.939 -1.504 . . . . 63.210000000000001 106.939 167.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.8 m -123.02 162.18 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.479 0.657 . . . . 63.43 112.761 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 71.5 p -131.01 122.12 26.25 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.295 -0.866 . . . . 71.209999999999994 109.732 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -148.01 151.24 35.41 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.344 0.498 . . . . 74.239999999999995 112.344 -170.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.2 m -96.37 109.15 46.19 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 107.814 -1.18 . . . . 73.340000000000003 107.814 170.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.32 148.64 40.77 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.371 2.047 . . . . 61.119999999999997 112.901 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.8 p -64.27 -17.21 63.4 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.176 0.99 . . . . 62.329999999999998 113.029 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -70.54 -19.51 62.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.76 0.424 . . . . 74.540000000000006 111.197 172.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.26 24.75 65.22 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 114.898 0.719 . . . . 74.439999999999998 114.898 168.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.18 -96.49 0.35 Allowed Glycine 0 CA--C 1.537 1.428 0 CA-C-N 117.03 0.415 . . . . 45.100000000000001 112.746 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -116.83 142.19 47.25 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.707 0.803 . . . . 70.209999999999994 110.539 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -69.71 115.3 8.8 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.675 0.39 . . . . 73.299999999999997 110.501 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.1 t -84.43 85.54 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-O 121.766 0.793 . . . . 62.109999999999999 109.837 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.0 p-10 -67.26 158.21 31.99 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.961 1.097 . . . . 64.129999999999995 113.961 163.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 42.3 m80 56.33 29.17 14.58 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 113.829 -1.532 . . . . 72.340000000000003 113.654 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -64.87 128.83 37.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.048 0.539 . . . . 74.430000000000007 111.167 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 98.3 mttt -129.66 133.75 47.29 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.801 0.84 . . . . 71.510000000000005 111.273 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.636 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 84.6 m95 -120.07 160.91 21.9 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.436 1.494 . . . . 60.219999999999999 111.159 -9.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.545 HG23 ' HB2' ' A' ' 33' ' ' TYR . 19.3 m -127.83 141.88 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.334 1.054 . . . . 63.229999999999997 109.301 170.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.6 pt -106.97 167.63 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 122.129 -0.357 . . . . 71.310000000000002 111.632 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.489 ' HG2' ' HB1' ' A' ' 60' ' ' ALA . 53.6 tt0 -47.75 -57.35 5.69 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.847 1.054 . . . . 74.409999999999997 113.847 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -82.09 7.02 14.51 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 112.866 0.691 . . . . 70.030000000000001 112.866 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -91.59 -11.39 37.34 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.386 1.074 . . . . 64.409999999999997 110.506 172.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.8 mt -116.88 140.01 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 125.031 1.332 . . . . 72.340000000000003 109.382 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HB3' ' HG2' ' A' ' 74' ' ' GLU . 16.0 ptmt -71.99 -36.21 69.7 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.758 0.651 . . . . 73.099999999999994 112.758 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -72.9 -8.99 58.16 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.756 0.822 . . . . 71.439999999999998 112.627 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.489 ' HB1' ' HG2' ' A' ' 54' ' ' GLN . . . -33.69 -63.3 0.26 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.228 1.411 . . . . 63.140000000000001 114.69 176.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.7 19.98 65.69 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 115.269 0.868 . . . . 74.329999999999998 115.269 169.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.1 t70 71.81 -3.08 2.28 Favored 'General case' 0 CA--C 1.573 1.853 0 C-N-CA 125.336 1.454 . . . . 74.230000000000004 112.843 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.68 168.15 10.11 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.68 0.792 . . . . 74.340000000000003 111.72 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.0 m -90.91 119.37 31.05 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.296 0.639 . . . . 55.240000000000002 110.409 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.5 HD13 HG11 ' A' ' 71' ' ' VAL . 49.6 mt -73.69 118.16 16.32 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.194 0.598 . . . . 73.230000000000004 110.21 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -101.27 144.55 28.79 Favored Pre-proline 0 N--CA 1.489 1.52 0 C-N-CA 123.614 0.765 . . . . 72.420000000000002 112.172 -165.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.39 124.95 16.22 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 123.082 2.521 . . . . 54.030000000000001 114.324 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.2 -19.22 29.93 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 123.841 0.734 . . . . 73.25 113.393 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -74.35 148.49 41.24 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.546 0.739 . . . . 74.129999999999995 112.291 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -113.07 123.24 49.82 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.726 0.81 . . . . 62.020000000000003 111.216 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.5 HG11 HD13 ' A' ' 65' ' ' LEU . 26.9 m -121.42 177.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 125.392 1.477 . . . . 50.310000000000002 111.496 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 85' ' ' THR . 38.5 mm -120.52 137.0 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 123.935 0.894 . . . . 72.019999999999996 109.821 170.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.4 mt -90.43 121.54 32.5 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.097 0.959 . . . . 51.310000000000002 111.818 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.468 ' HG2' ' HB3' ' A' ' 58' ' ' LYS . 33.8 mm-40 -89.66 -4.06 57.95 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.447 0.536 . . . . 53.420000000000002 112.447 174.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.48 167.62 12.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.255 0.55 . . . . 54.030000000000001 111.056 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 t -141.96 125.01 16.23 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.503 -0.771 . . . . 65.200000000000003 111.683 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -98.73 -11.81 21.57 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.89 0.876 . . . . 63.25 111.527 170.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 20.4 ptp -144.14 -175.6 4.68 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.545 0.738 . . . . 63.43 111.951 -172.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -70.05 100.81 1.68 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.793 0.664 . . . . 73.109999999999999 112.793 -178.017 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.35 38.97 8.62 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.387 -0.824 . . . . 62.109999999999999 114.426 172.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.6 ttt -86.49 -28.98 23.1 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 117.402 0.601 . . . . 64.329999999999998 111.765 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -64.59 129.24 39.08 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 120.908 0.385 . . . . 72.409999999999997 111.848 172.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.23 -4.15 84.34 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.924 -0.58 . . . . 74.329999999999998 113.143 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.78 146.93 32.04 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.463 0.705 . . . . 71.209999999999994 111.588 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.449 ' HA ' HD13 ' A' ' 72' ' ' ILE . 57.9 m -84.11 117.06 23.21 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.989 -0.55 . . . . 64.040000000000006 109.699 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -106.5 152.81 23.18 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.529 0.732 . . . . 72.209999999999994 110.36 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -123.1 121.47 36.08 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.555 -0.906 . . . . 75.209999999999994 108.555 174.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.34 106.38 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.537 0.735 . . . . 73.420000000000002 110.133 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -76.59 -37.71 56.05 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.512 0.725 . . . . 74.510000000000005 109.735 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.0 t -159.77 158.62 31.53 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.671 -0.695 . . . . 72.150000000000006 111.286 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -135.17 139.33 44.49 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.957 0.903 . . . . 62.009999999999998 109.905 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -151.44 142.98 23.58 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.763 0.425 . . . . 65.019999999999996 110.751 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.578 ' HD2' ' H ' ' A' ' 93' ' ' LYS . 1.3 mptt -96.78 92.52 6.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 107.986 -1.116 . . . . 65.310000000000002 107.986 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.3 t -138.11 153.17 49.28 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.532 0.733 . . . . 74.049999999999997 111.337 -172.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.2 m -77.69 122.99 26.09 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.926 -0.398 . . . . 74.420000000000002 109.926 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.524 HG12 HG22 ' A' ' 117' ' ' THR . 24.0 m -109.31 134.2 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.728 0.811 . . . . 71.299999999999997 108.976 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -110.96 144.11 40.57 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.366 0.666 . . . . 73.430000000000007 111.684 -174.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.9 ttp -93.58 111.17 22.79 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.671 -1.233 . . . . 73.329999999999998 107.671 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.579 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 27.4 m -124.42 146.76 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 112.822 0.675 . . . . 72.530000000000001 112.822 -168.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.55 116.18 29.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.945 0.898 . . . . 74.129999999999995 109.827 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -130.96 175.5 9.03 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.188 0.595 . . . . 74.5 111.524 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.8 m -117.56 119.98 36.66 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.878 -0.786 . . . . 72.140000000000001 108.878 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 106' ' ' SER . 72.9 p -60.95 126.09 26.1 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.336 0.654 . . . . 74.209999999999994 111.558 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.5 p -70.71 -48.42 54.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.451 0.7 . . . . 52.149999999999999 112.87 -172.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.507 HG22 ' HA2' ' A' ' 16' ' ' GLY . 11.6 t -86.03 -4.2 59.11 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.304 0.853 . . . . 44.43 113.304 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.434 ' HB2' ' OG ' ' A' ' 103' ' ' SER . 16.5 m -119.12 -49.16 2.41 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.945 0.498 . . . . 75.230000000000004 111.4 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.5 -6.52 55.43 Favored Glycine 0 N--CA 1.481 1.635 0 CA-C-N 116.219 -0.446 . . . . 74.310000000000002 113.618 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.53 130.64 39.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.463 0.705 . . . . 73.420000000000002 110.894 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.474 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -81.3 100.61 9.27 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.837 -0.801 . . . . 74.329999999999998 108.837 178.69 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 113' ' ' HIS . 46.9 t -88.0 108.67 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.052 0.941 . . . . 73.439999999999998 110.004 -172.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.609 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -102.73 139.93 37.67 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.105 0.562 . . . . 51.109999999999999 111.777 -169.805 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 51.67 36.99 18.86 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.509 1.123 . . . . 60.340000000000003 113.249 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.442 ' HB2' HG12 ' A' ' 110' ' ' VAL . 64.8 t60 -64.75 132.52 49.82 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.884 -0.598 . . . . 64.129999999999995 110.819 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HB2' ' CE3' ' A' ' 115' ' ' TRP . 21.1 pttp -158.39 146.96 18.77 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 115.188 -0.915 . . . . 73.099999999999994 111.019 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.636 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 87.9 m95 -106.87 136.6 46.43 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.08 1.352 . . . . 72.150000000000006 112.735 4.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.4 m -122.16 141.58 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 124.881 1.272 . . . . 61.020000000000003 108.313 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.524 HG22 HG12 ' A' ' 96' ' ' VAL . 30.7 p -96.37 178.01 5.51 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.781 -0.574 . . . . 72.439999999999998 112.202 -174.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -59.65 -52.92 63.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.021 0.928 . . . . 74.430000000000007 112.868 -176.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.52 -21.15 66.6 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.942 0.897 . . . . 70.420000000000002 112.223 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -88.53 3.06 51.65 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.646 0.778 . . . . 74.219999999999999 111.521 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.6 mt -121.95 166.65 14.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.63 1.172 . . . . 63.539999999999999 109.289 171.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.3 t -151.13 130.78 13.09 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.439 0.696 . . . . 73.349999999999994 110.16 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.3 143.72 50.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.832 0.453 . . . . 43.299999999999997 111.524 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -83.09 113.68 20.78 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.16 0.584 . . . . 73.439999999999998 111.039 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.29 139.43 41.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.419 0.688 . . . . 72.439999999999998 110.657 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.51 19.82 12.76 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.845 0.858 . . . . 73.010000000000005 112.25 -174.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -60.47 142.68 54.85 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.706 0.802 . . . . 71.140000000000001 113.072 -173.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -74.18 130.44 39.76 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.313 0.645 . . . . 72.340000000000003 111.009 -176.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -107.4 74.1 0.95 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.578 0.704 . . . . 73.420000000000002 111.978 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -136.31 76.37 1.6 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.85 0.86 . . . . 75.420000000000002 109.559 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -130.65 157.62 42.26 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.443 0.697 . . . . 75.540000000000006 111.827 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 . . . . . 0 CA--C 1.572 1.806 0 C-N-CA 123.149 0.58 . . . . 72.019999999999996 112.385 179.403 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mmt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.952 -0.388 . . . . 62.43 109.952 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -100.8 154.24 18.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.38 0.672 . . . . 72.43 111.219 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.24 122.74 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 121.084 0.468 . . . . 62.0 110.397 173.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.7 -7.77 42.55 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 115.53 -0.759 . . . . 42.2 112.689 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -80.9 151.22 28.71 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.412 0.685 . . . . 71.23 112.349 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -93.06 136.96 32.84 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.163 0.985 . . . . 73.41 109.136 170.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.95 153.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.7 0.8 . . . . 63.44 110.308 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.8 mm -104.95 121.53 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.889 0.876 . . . . 72.5 109.828 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 22' ' ' ALA . 35.3 mt -82.01 120.41 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 122.938 0.495 . . . . 62.31 109.886 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -96.86 -56.08 2.68 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.865 0.466 . . . . 70.35 110.833 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.454 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 84.3 m -95.3 140.03 30.77 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.85 -1.167 . . . . 75.02 107.85 174.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 17' ' ' MET . 79.6 p -154.71 141.28 18.86 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.976 0.732 . . . . 74.22 112.976 -164.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -75.18 -43.63 51.07 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.157 0.983 . . . . 75.34 109.6 174.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.485 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 25.3 mmt -96.34 140.42 31.03 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.377 -0.829 . . . . 74.32 110.535 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -60.96 -35.19 76.11 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.763 0.825 . . . . 71.13 111.468 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.46 -4.54 24.91 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 115.118 0.807 . . . . 73.13 115.118 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.531 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 48.6 mtm -99.52 -25.38 14.45 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 117.401 0.6 . . . . 65.25 111.678 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -68.34 116.93 9.48 Favored 'General case' 0 CA--C 1.556 1.178 0 CA-C-N 118.475 0.579 . . . . 72.41 110.375 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.81 2.0 89.81 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 115.383 -0.826 . . . . 44.13 113.689 -174.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.9 148.29 27.03 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.205 0.602 . . . . 42.12 111.797 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -95.18 104.26 16.14 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.643 0.777 . . . . 71.02 109.635 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.535 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -90.61 161.12 15.56 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.828 0.851 . . . . 64.22 112.189 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.4 m -124.11 121.77 36.05 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.363 -0.976 . . . . 63.32 108.363 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.07 100.4 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 122.8 0.44 . . . . 51.12 109.906 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.5 p -91.98 -8.1 47.11 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.167 0.587 . . . . 73.12 111.32 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.26 148.96 15.42 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.369 -0.378 . . . . 72.22 112.386 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.78 114.53 14.22 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.821 0.848 . . . . 52.31 109.915 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.453 ' HB2' HG23 ' A' ' 96' ' ' VAL . 5.9 m-85 -116.06 130.54 56.86 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.173 0.989 . . . . 72.33 111.155 -171.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -103.83 81.65 1.9 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.938 0.895 . . . . 75.24 110.319 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -133.88 166.15 23.34 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.088 0.555 . . . . 60.43 111.307 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.412 ' HB ' ' HG2' ' A' ' 54' ' ' GLN . 4.0 m -76.83 121.93 24.07 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.372 -0.603 . . . . 62.2 109.372 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.89 151.62 26.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.452 0.701 . . . . 74.24 109.635 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -136.42 149.18 48.14 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.934 0.873 . . . . 64.34 112.25 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.52 111.58 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 113.892 -1.503 . . . . 73.04 107.149 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.541 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 26.7 m -119.92 149.49 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.321 0.648 . . . . 74.41 112.165 -176.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.1 t -117.41 132.21 56.61 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.655 0.782 . . . . 71.4 109.908 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -150.71 156.1 40.64 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.09 0.472 . . . . 74.43 111.968 -173.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 m -109.3 111.66 59.79 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.332 -0.988 . . . . 44.04 108.332 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.79 117.2 3.11 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.376 2.718 . . . . 72.11 114.125 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.466 HG23 ' HA ' ' A' ' 84' ' ' ALA . 25.6 p -59.49 -24.4 63.57 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.741 1.216 . . . . 70.04 113.892 -173.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -79.38 14.69 1.47 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.483 0.713 . . . . 74.24 112.858 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.95 43.7 6.63 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 113.774 0.27 . . . . 44.54 113.774 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.93 163.61 12.94 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 122.708 0.194 . . . . 71.14 113.024 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -66.28 135.12 53.98 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.372 0.669 . . . . 52.51 111.099 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -58.19 116.83 3.82 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.584 0.754 . . . . 72.13 112.376 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.55 HG12 ' HB2' ' A' ' 49' ' ' HIS . 30.7 t -84.82 104.94 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.202 -0.908 . . . . 72.43 109.198 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -99.41 135.5 40.72 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.414 0.686 . . . . 75.52 110.668 -172.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.8 m170 57.45 39.06 28.36 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.233 1.013 . . . . 71.55 112.446 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.55 ' HB2' HG12 ' A' ' 46' ' ' VAL . 46.0 t60 -66.25 135.29 54.25 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.908 0.883 . . . . 70.51 110.701 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -150.81 153.61 35.75 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.889 -0.596 . . . . 71.31 110.46 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.559 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 98.0 m95 -106.43 139.61 40.63 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.39 1.476 . . . . 65.24 111.824 -2.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.5 137.43 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.333 1.053 . . . . 41.41 108.377 169.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.2 pt -113.74 174.1 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.965 0.506 . . . . 62.13 111.722 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.412 ' HG2' ' HB ' ' A' ' 31' ' ' THR . 14.1 mm100 -48.85 -49.16 40.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.57 1.322 . . . . 73.42 114.57 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.46 -1.22 40.66 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 122.856 0.462 . . . . 63.51 112.163 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.45 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 0.9 OUTLIER -83.81 -22.06 31.92 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.826 0.85 . . . . 71.52 110.27 175.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.4 mt -117.34 136.14 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 124.715 1.206 . . . . 72.35 111.079 -168.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.485 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 38.4 ttpt -72.01 -57.41 4.31 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.489 0.716 . . . . 62.02 111.539 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.09 -4.61 14.12 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.581 1.152 . . . . 74.21 113.685 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.728 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -54.55 -55.74 26.12 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.45 0.7 . . . . 75.22 112.006 171.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.91 19.79 65.93 Favored Glycine 0 N--CA 1.479 1.565 0 N-CA-C 114.676 0.63 . . . . 53.14 114.676 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 62.79 20.14 11.93 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.06 1.344 . . . . 73.15 113.813 -172.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 16.6 pttp -98.32 160.18 14.46 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 122.914 0.486 . . . . 64.51 109.91 173.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.8 m -76.46 110.81 11.31 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.891 -0.411 . . . . 73.41 109.891 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 60' ' ' ALA . 61.1 mt -74.68 114.07 12.68 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.267 0.627 . . . . 74.44 110.458 177.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -81.23 147.81 61.73 Favored Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 123.561 0.744 . . . . 42.22 111.731 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.42 114.63 1.65 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.836 2.358 . . . . 75.15 113.339 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.81 -14.21 24.39 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-N 115.826 -0.625 . . . . 61.23 113.96 -174.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -75.24 141.84 43.47 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.423 0.689 . . . . 75.34 111.03 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -111.38 133.22 53.84 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.536 0.684 . . . . 74.35 110.975 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.9 m -140.09 156.39 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 125.389 1.476 . . . . 63.04 110.634 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -103.46 136.13 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 122.853 0.461 . . . . 73.41 109.769 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.3 mt -87.44 120.88 29.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.167 0.987 . . . . 74.43 111.44 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.485 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 8.2 mm-40 -81.73 -36.97 28.01 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.317 0.647 . . . . 75.22 112.43 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.45 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -83.73 164.99 19.26 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.058 0.456 . . . . 71.5 111.214 176.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 96.5 p -143.74 124.81 14.44 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.737 -0.468 . . . . 63.21 109.737 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -91.66 -4.28 55.37 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.777 0.831 . . . . 71.45 110.602 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -164.33 175.78 9.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.304 1.042 . . . . 74.14 111.141 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -80.4 116.38 20.43 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.352 0.661 . . . . 74.31 111.387 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.31 27.34 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 123.019 0.342 . . . . 75.33 113.821 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.9 ttt -82.53 -50.52 8.73 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.587 0.755 . . . . 73.34 112.906 -173.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -63.31 128.78 37.39 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.834 0.453 . . . . 64.04 111.893 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.2 -10.3 67.58 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.562 -0.29 . . . . 50.11 113.227 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.466 ' HA ' HG23 ' A' ' 40' ' ' THR . . . -76.63 145.9 38.55 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.018 0.527 . . . . 73.34 111.775 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.0 m -84.17 117.25 23.37 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.693 -0.685 . . . . 62.33 109.554 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.541 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -110.95 149.27 30.9 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.758 1.223 . . . . 71.31 109.94 -175.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.47 132.24 52.71 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 109.483 -0.562 . . . . 63.34 109.483 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.525 HD13 HG12 ' A' ' 35' ' ' VAL . 30.4 mm -67.42 109.4 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.607 0.763 . . . . 73.03 110.354 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -78.06 -38.36 44.61 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.217 0.607 . . . . 74.12 109.743 172.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.2 t -154.92 141.15 18.55 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.458 -0.792 . . . . 71.55 111.301 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.16 131.89 52.07 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.907 0.883 . . . . 75.13 108.955 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -132.5 139.29 47.87 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.788 0.662 . . . . 74.52 112.788 -168.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -111.22 95.39 5.5 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.06 0.944 . . . . 63.34 109.414 169.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -137.56 157.25 46.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.116 0.966 . . . . 45.32 110.841 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.6 m -85.38 119.37 25.66 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.307 -0.997 . . . . 72.13 108.307 171.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.453 HG23 ' HB2' ' A' ' 28' ' ' TYR . 13.7 m -106.51 132.76 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.398 0.618 . . . . 63.14 109.624 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.402 ' HB2' HG23 ' A' ' 116' ' ' VAL . 89.7 m-85 -111.97 140.43 46.65 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.935 0.894 . . . . 62.33 111.231 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.8 ttp -94.21 119.88 33.65 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.268 -1.382 . . . . 51.14 107.268 167.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.535 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 23.5 m -128.03 156.56 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 113.789 1.033 . . . . 71.1 113.789 -171.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -110.29 118.28 35.91 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.124 1.37 . . . . 63.23 109.087 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -133.72 166.86 21.64 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.174 0.511 . . . . 71.21 110.947 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.4 m -105.61 119.14 38.37 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 108.791 -0.818 . . . . 75.33 108.791 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.8 m -56.84 95.98 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.754 0.821 . . . . 71.14 110.834 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.4 p -58.3 -26.0 62.51 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.351 1.06 . . . . 64.31 113.709 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 m -62.6 -38.3 89.63 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 123.734 0.813 . . . . 73.21 112.421 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.9 p -113.94 -50.76 2.81 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 123.357 0.663 . . . . 70.12 112.068 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.21 15.85 7.52 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.158 0.885 . . . . 71.35 111.945 -172.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -86.49 141.54 29.02 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.727 0.811 . . . . 43.3 111.547 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -85.01 117.71 24.15 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.752 1.221 . . . . 73.04 111.093 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -120.53 132.6 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 124.03 0.932 . . . . 71.22 110.591 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.453 ' HD3' ' H ' ' A' ' 111' ' ' LYS . 0.4 OUTLIER -115.8 168.7 9.82 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.263 0.625 . . . . 63.33 111.365 178.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.79 37.58 2.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 126.516 1.926 . . . . 74.42 115.221 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -61.53 133.0 55.2 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.483 0.713 . . . . 71.25 111.642 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 90.5 mttt -137.11 132.61 34.31 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.025 0.93 . . . . 74.23 110.951 -175.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.559 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.7 m95 -116.37 154.35 30.4 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.824 1.65 . . . . 74.15 111.564 -11.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.402 HG23 ' HB2' ' A' ' 97' ' ' TYR . 15.4 m -124.51 142.47 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.865 0.866 . . . . 61.03 109.637 172.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.1 p -109.98 168.26 9.56 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.52 0.563 . . . . 72.14 112.52 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -57.2 -35.23 69.37 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.678 0.791 . . . . 71.31 111.686 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.49 -43.01 93.4 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.34 1.056 . . . . 64.44 111.799 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.454 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 52.2 mt-10 -85.73 -2.79 58.56 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.903 0.881 . . . . 72.03 112.892 -172.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.07 150.49 40.49 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.636 0.731 . . . . 72.35 111.578 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 m -122.77 147.7 46.2 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.312 -1.366 . . . . 74.15 107.312 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.17 151.85 33.03 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.95 0.795 . . . . 33.24 111.692 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.7 tptt . . . . . 0 N--CA 1.484 1.228 0 C-N-CA 123.075 0.55 . . . . 72.1 110.766 175.406 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.529 ' HG2' HG11 ' A' ' 7' ' ' VAL . 1.8 mpt? . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.431 0.158 . . . . 52.22 110.95 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -109.13 164.13 12.71 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.613 0.765 . . . . 74.54 110.392 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.2 123.06 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-O 121.132 0.492 . . . . 75.41 110.532 172.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.57 -4.37 50.61 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 115.797 -0.638 . . . . 64.2 113.572 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -83.41 142.86 30.68 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.222 0.609 . . . . 54.41 111.455 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -109.13 135.73 49.79 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.42 0.629 . . . . 64.44 111.005 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 123' ' ' ALA . 23.7 m -139.81 155.29 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.967 1.307 . . . . 64.55 110.475 -170.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.1 mm -98.56 132.53 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.173 0.589 . . . . 73.13 109.714 170.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.687 HG21 ' HG2' ' A' ' 17' ' ' MET . 39.8 mt -81.71 123.34 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 122.387 0.275 . . . . 72.52 110.357 -175.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -95.11 -60.06 1.76 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.433 0.693 . . . . 73.44 110.247 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.627 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 79.7 m -98.24 140.03 33.14 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.073 -1.084 . . . . 73.54 108.073 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.437 ' HB3' ' HB3' ' A' ' 17' ' ' MET . 74.1 m -140.16 139.88 35.82 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.991 1.108 . . . . 64.3 113.991 -167.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -91.31 -15.92 28.34 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 113.994 -1.457 . . . . 71.42 110.417 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 26.5 mmt -126.56 155.43 42.44 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.646 1.179 . . . . 62.44 110.226 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -67.05 -36.9 83.06 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.095 0.558 . . . . 73.22 112.193 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.43 -9.98 86.58 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 114.046 0.379 . . . . 75.12 114.046 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.687 ' HG2' HG21 ' A' ' 9' ' ' ILE . 44.0 ttm -80.69 -32.1 36.01 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 122.69 0.396 . . . . 62.02 111.718 -172.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -68.87 122.34 18.42 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.13 0.572 . . . . 64.45 112.201 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.61 -8.48 79.05 Favored Glycine 0 CA--C 1.537 1.469 0 CA-C-N 115.729 -0.669 . . . . 71.12 114.147 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.18 149.68 42.73 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.169 0.588 . . . . 52.23 112.131 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -87.94 101.93 14.23 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.623 0.369 . . . . 73.55 110.04 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . . . -86.56 156.96 19.85 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.604 0.762 . . . . 73.12 111.374 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.0 m -131.25 127.51 37.95 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.454 -0.943 . . . . 73.15 108.454 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.95 113.83 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 123.207 0.603 . . . . 73.14 111.017 -173.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.4 p -89.9 -21.04 22.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.102 0.561 . . . . 74.34 110.53 173.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.6 142.57 8.52 Favored Glycine 0 C--N 1.354 1.547 0 C-N-CA 122.741 0.21 . . . . 54.3 112.612 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.98 107.55 9.7 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.66 0.784 . . . . 51.42 110.067 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -111.58 132.91 54.21 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.801 0.84 . . . . 75.44 110.674 -175.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.4 82.71 1.77 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.77 0.795 . . . . 52.32 109.97 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -134.96 -179.51 5.66 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.816 0.846 . . . . 75.53 111.321 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 m -83.91 128.26 34.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.918 -0.489 . . . . 74.45 110.383 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.11 140.18 48.1 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.141 0.976 . . . . 74.14 109.895 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -113.72 152.51 30.41 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 122.081 0.943 . . . . 74.32 112.6 -174.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.54 111.41 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.069 -1.423 . . . . 42.34 107.753 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.426 HG12 HD13 ' A' ' 88' ' ' ILE . 19.3 m -112.39 150.85 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.386 0.612 . . . . 75.2 112.444 -176.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -122.0 125.57 46.59 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.298 1.039 . . . . 72.24 109.263 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -152.27 159.03 43.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.564 0.745 . . . . 74.55 111.294 -174.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.9 m -105.52 116.73 59.64 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.724 -1.213 . . . . 74.53 107.724 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -58.96 133.32 52.79 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.096 1.864 . . . . 74.13 110.873 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.1 p -68.83 2.06 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.109 0.781 . . . . 61.05 113.109 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.14 -21.2 66.04 Favored 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 123.663 0.785 . . . . 65.13 111.317 165.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.19 15.13 56.46 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 115.066 0.786 . . . . 64.34 115.066 171.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.62 -131.43 7.38 Favored Glycine 0 N--CA 1.476 1.357 0 CA-C-N 117.655 0.728 . . . . 25.55 113.688 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -71.21 128.27 35.36 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.919 0.888 . . . . 73.02 111.974 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -62.24 122.3 15.28 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.587 0.755 . . . . 72.3 111.938 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.593 HG21 ' SD ' ' A' ' 78' ' ' MET . 68.0 t -84.47 110.77 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.396 0.679 . . . . 70.44 110.256 176.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -101.44 148.33 25.31 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.903 0.481 . . . . 73.22 109.958 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 34.3 m80 54.59 38.95 30.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.732 0.813 . . . . 75.03 112.779 173.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -60.46 128.35 36.21 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.857 0.863 . . . . 71.41 111.198 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 66.1 mttm -126.3 132.68 51.6 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 123.504 0.722 . . . . 71.24 110.594 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 94.4 m95 -117.86 156.14 28.92 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.154 1.382 . . . . 70.45 111.53 -11.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.55 160.4 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.96 1.304 . . . . 75.43 108.169 169.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.416 HG21 HG21 ' A' ' 96' ' ' VAL . 37.4 pt -126.7 163.65 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 118.983 0.81 . . . . 54.04 112.546 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -44.14 -51.59 7.96 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.499 1.519 . . . . 64.43 112.538 174.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -82.15 -5.92 58.81 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.787 0.835 . . . . 70.04 112.97 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -88.32 -33.67 17.92 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.686 0.795 . . . . 35.45 110.234 173.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.8 mt -78.93 130.25 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 115.754 -0.657 . . . . 74.41 110.468 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -69.34 -35.45 75.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.492 0.717 . . . . 71.23 112.351 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.24 -8.9 58.35 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.971 0.73 . . . . 73.1 112.971 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -34.17 -59.43 0.43 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 114.945 1.461 . . . . 51.43 114.945 -173.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.51 21.01 68.4 Favored Glycine 0 N--CA 1.479 1.519 0 N-CA-C 115.352 0.901 . . . . 75.54 115.352 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 68.84 -2.94 1.57 Allowed 'General case' 0 CA--C 1.573 1.85 0 C-N-CA 124.862 1.265 . . . . 64.44 112.472 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 25.0 pttm -95.68 152.78 18.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.628 -0.67 . . . . 74.35 111.022 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.6 m -84.08 112.36 20.15 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.006 -0.739 . . . . 74.13 109.006 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.534 ' HB3' HG13 ' A' ' 88' ' ' ILE . 42.3 mt -71.31 120.5 16.98 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.817 0.847 . . . . 63.4 110.763 -174.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -91.19 157.48 42.7 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 123.682 0.793 . . . . 72.22 111.292 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 87.2 Cg_exo -50.99 112.25 0.74 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.644 2.229 . . . . 72.04 113.163 172.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.64 -9.93 16.52 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 115.975 -0.557 . . . . 63.01 114.031 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.6 122.73 19.12 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 117.772 0.786 . . . . 74.5 109.495 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -100.91 118.35 36.78 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.471 -0.937 . . . . 75.15 108.471 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.423 HG11 HD13 ' A' ' 65' ' ' LEU . 33.3 m -125.29 171.92 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.607 1.163 . . . . 52.42 110.877 -166.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.3 mm -116.17 135.95 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 122.863 0.465 . . . . 62.21 110.033 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.9 mt -90.93 134.73 34.24 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.74 0.816 . . . . 63.45 110.996 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.16 -5.62 27.49 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 113.0 0.741 . . . . 75.55 113.0 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.6 156.27 16.89 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.139 0.575 . . . . 74.3 110.618 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.9 p -136.04 124.4 23.34 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.193 0.521 . . . . 65.31 110.319 171.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -100.35 -16.22 17.72 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.793 0.837 . . . . 75.14 108.991 162.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.593 ' SD ' HG21 ' A' ' 46' ' ' VAL . 43.3 mtt -128.57 173.42 10.28 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.39 1.076 . . . . 73.21 112.213 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.59 105.67 8.89 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.0 0.92 . . . . 63.33 110.836 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.1 33.58 17.34 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.23 -0.441 . . . . 72.11 113.207 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -89.59 -49.4 6.69 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.303 0.641 . . . . 71.1 109.97 173.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -69.04 120.57 15.1 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.34 0.656 . . . . 73.12 111.036 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.71 2.35 75.82 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 123.103 0.252 . . . . 70.11 113.263 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.44 158.09 19.06 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.4 0.68 . . . . 72.44 111.551 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 m -87.51 118.33 26.9 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.2 -0.909 . . . . 72.11 110.023 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -115.43 162.17 17.52 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.112 0.965 . . . . 61.53 110.114 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -130.75 130.28 43.57 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.051 0.54 . . . . 65.22 109.873 173.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 65' ' ' LEU . 36.7 mm -64.78 104.61 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.503 0.721 . . . . 73.51 110.137 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.6 -37.59 65.38 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.696 0.798 . . . . 72.32 110.601 172.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.6 t -162.66 159.04 23.95 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.287 0.635 . . . . 62.22 111.829 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.42 150.52 39.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.518 1.127 . . . . 61.51 110.645 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -154.54 134.0 12.68 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 112.02 0.378 . . . . 63.53 112.02 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -93.59 96.57 9.94 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.105 -0.702 . . . . 73.33 109.105 172.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.8 t -137.09 154.4 50.32 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.621 0.768 . . . . 64.32 111.68 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.2 m -80.11 119.21 22.6 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.055 -0.72 . . . . 72.42 109.055 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.416 HG21 HG21 ' A' ' 53' ' ' ILE . 24.8 m -108.65 136.42 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.811 0.845 . . . . 71.14 110.728 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.07 146.62 36.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.358 1.075 . . . . 72.11 112.912 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.7 ttp -108.03 118.93 38.03 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 113.466 -1.697 . . . . 73.45 106.825 165.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.2 m -127.99 173.27 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 112.699 0.629 . . . . 74.31 112.699 -170.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.69 ' HB2' ' HD3' ' A' ' 111' ' ' LYS . 4.8 p-10 -138.16 133.48 33.38 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.127 0.571 . . . . 75.32 110.441 172.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.445 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 47.7 p90 -151.18 177.23 10.42 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.165 0.586 . . . . 75.42 111.571 -174.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.2 m -111.59 112.34 23.99 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.291 -1.003 . . . . 63.31 108.291 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.5 p -59.01 116.57 3.9 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.3 0.64 . . . . 54.43 111.281 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.4 p -58.07 -32.81 68.4 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.846 1.258 . . . . 75.32 113.876 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.4 p -87.82 -45.13 10.57 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.262 0.467 . . . . 73.2 112.262 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -89.04 -31.89 17.85 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.401 0.68 . . . . 74.52 112.548 -169.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.14 -6.1 83.82 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 116.228 -0.442 . . . . 31.22 113.592 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -77.26 132.76 38.84 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.161 0.984 . . . . 75.33 112.142 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -80.27 94.15 6.03 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.476 0.71 . . . . 73.13 109.395 174.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 113' ' ' HIS . 58.5 t -77.35 104.62 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.234 -0.893 . . . . 72.42 109.713 -176.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.69 ' HD3' ' HB2' ' A' ' 100' ' ' ASP . 74.9 mmtt -99.93 133.75 43.85 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.597 0.759 . . . . 73.23 111.697 -172.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 m120 61.58 35.66 17.19 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.299 1.04 . . . . 51.01 112.21 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.447 ' HB2' HG12 ' A' ' 110' ' ' VAL . 86.3 t60 -58.78 129.52 42.5 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.98 0.912 . . . . 63.11 112.23 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 19.2 ptpt -152.49 147.45 26.25 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.899 0.88 . . . . 64.31 110.787 -176.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 97.6 m95 -109.14 138.48 45.43 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.33 1.452 . . . . 73.42 111.77 -4.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.78 172.38 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.438 1.095 . . . . 72.12 108.895 170.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 120' ' ' GLU . 30.3 p -118.58 178.22 4.54 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.362 0.665 . . . . 61.3 111.01 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -67.28 -28.18 67.8 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.455 0.302 . . . . 74.51 111.385 174.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.42 -15.27 53.25 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 122.939 0.496 . . . . 72.04 111.754 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.627 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 4.7 mm-40 -81.19 -18.82 44.89 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.199 0.523 . . . . 70.42 110.407 171.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.0 mt -115.05 159.18 21.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.024 0.93 . . . . 75.3 110.593 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.1 m -137.71 138.18 39.08 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.019 -1.104 . . . . 60.3 108.019 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.548 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -57.38 158.08 5.95 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.73 0.695 . . . . 63.44 111.454 176.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.3 tptm . . . . . 0 N--CA 1.491 1.605 0 C-N-CA 122.924 0.49 . . . . 64.45 112.026 -178.219 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.519 ' HB3' HG21 ' A' ' 24' ' ' VAL . 24.9 mmt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.535 0.207 . . . . 71.44 110.93 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -70.97 157.14 38.72 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.464 1.105 . . . . 65.34 111.212 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -62.23 127.57 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 C-N-CA 122.589 0.356 . . . . 75.24 110.868 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.44 -3.62 56.52 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.246 0.45 . . . . 70.22 113.412 -175.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.8 t -73.15 127.85 33.78 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.229 0.612 . . . . 45.45 111.82 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -87.58 109.92 19.99 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.341 0.656 . . . . 74.42 110.14 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.427 HG21 HD13 ' A' ' 121' ' ' LEU . 30.4 m -125.99 157.66 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 124.011 0.924 . . . . 74.1 111.074 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.2 mm -105.54 136.99 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.344 1.057 . . . . 70.32 109.241 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 17' ' ' MET . 54.0 mt -76.76 118.43 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 CA-C-O 120.759 0.314 . . . . 74.22 110.192 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -84.54 -59.27 2.42 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.04 0.936 . . . . 71.42 110.127 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 94.0 m -91.88 139.69 30.41 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.527 -0.76 . . . . 71.34 109.767 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 14' ' ' MET . 80.6 p -130.34 122.42 27.86 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.091 0.472 . . . . 60.43 111.707 -174.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -83.12 -44.86 14.64 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.565 -0.902 . . . . 74.24 108.565 171.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.462 ' O ' ' HB2' ' A' ' 12' ' ' SER . 1.8 mpt? -94.18 130.9 40.22 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 114.164 -1.38 . . . . 63.42 107.536 166.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -63.0 -24.2 67.81 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 119.363 0.983 . . . . 65.23 113.234 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.01 -4.61 68.01 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 114.694 0.638 . . . . 53.23 114.694 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.432 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 35.0 mtp -84.97 -29.73 24.84 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.308 0.643 . . . . 73.2 110.722 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -67.94 117.73 10.2 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.571 0.348 . . . . 73.11 111.075 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.2 1.09 90.48 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 116.087 -0.506 . . . . 34.11 113.645 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.92 135.46 43.28 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.239 0.616 . . . . 72.33 111.141 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -82.29 103.94 12.24 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.641 -0.709 . . . . 73.41 110.323 -176.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.33 160.48 14.25 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.059 0.943 . . . . 70.44 113.301 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.3 m -133.14 136.36 45.73 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.841 1.257 . . . . 74.21 108.611 171.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.519 HG21 ' HB3' ' A' ' 1' ' ' MET . 61.1 t -82.66 111.19 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 122.888 0.475 . . . . 61.22 110.868 -177.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.5 p -86.32 -19.9 29.14 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.824 0.45 . . . . 72.52 111.571 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.34 166.45 39.23 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 113.843 0.297 . . . . 54.23 113.843 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.63 138.51 47.39 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.091 0.957 . . . . 73.25 110.935 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.457 ' HB2' HG23 ' A' ' 96' ' ' VAL . 42.8 m-85 -128.55 111.84 13.67 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.32 1.048 . . . . 65.02 109.756 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -97.91 79.24 2.62 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.874 0.845 . . . . 72.4 110.401 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -133.91 170.89 14.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.658 0.783 . . . . 73.02 111.624 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -73.74 121.26 20.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.977 0.511 . . . . 65.24 109.879 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.35 147.86 43.08 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.638 0.775 . . . . 63.41 110.383 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -131.96 154.56 49.17 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.163 0.982 . . . . 75.33 112.591 -167.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 90' ' ' SER . 64.6 t -105.14 133.66 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 113.729 -1.578 . . . . 70.44 107.62 167.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.43 ' HA ' ' H ' ' A' ' 89' ' ' ASP . 12.5 m -131.18 166.03 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.8 0.809 . . . . 74.55 112.788 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.2 t -132.92 127.78 35.07 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 114.38 -1.282 . . . . 71.12 108.658 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.52 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 43.8 p90 -155.87 160.27 40.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.596 0.758 . . . . 74.23 111.062 -171.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.1 m -109.28 119.48 48.31 Favored Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 108.783 -0.821 . . . . 65.21 108.783 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.27 133.17 45.0 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.127 1.885 . . . . 60.4 111.902 172.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.8 p -65.19 -7.28 12.02 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.99 0.916 . . . . 72.05 113.081 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.33 -18.0 60.29 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 124.728 1.211 . . . . 71.04 113.046 171.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.69 57.46 3.54 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 111.624 -0.59 . . . . 75.52 111.624 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.47 -155.56 8.16 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 115.007 -0.597 . . . . 72.04 113.005 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -69.48 119.05 13.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.469 0.708 . . . . 61.24 110.808 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -56.95 116.28 3.11 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 109.317 -0.623 . . . . 73.35 109.317 168.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.492 HG12 ' HB2' ' A' ' 49' ' ' HIS . 40.7 t -88.67 115.51 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 123.311 0.645 . . . . 74.43 110.154 -176.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -109.35 155.69 20.91 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.376 0.671 . . . . 50.41 110.491 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.2 m170 57.82 26.4 13.15 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.902 0.881 . . . . 70.4 112.376 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.492 ' HB2' HG12 ' A' ' 46' ' ' VAL . 84.9 t60 -71.65 136.95 47.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.811 0.844 . . . . 74.23 110.908 -178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 65.1 pttt -158.11 148.71 20.56 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-N 116.313 -0.403 . . . . 63.44 111.508 -176.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 82.4 m95 -107.59 147.75 30.2 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.022 1.329 . . . . 72.05 111.471 -0.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.92 135.5 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.436 1.095 . . . . 74.23 108.272 172.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.5 pt -115.53 169.98 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.284 -0.885 . . . . 71.44 112.754 -168.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -50.85 -39.76 54.42 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.299 1.039 . . . . 73.31 113.791 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -72.61 -20.86 61.21 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.479 0.712 . . . . 60.3 111.882 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.531 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 27.3 tt0 -91.98 -24.76 19.14 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.59 0.756 . . . . 73.21 111.446 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.1 mt -101.22 129.36 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.867 0.867 . . . . 65.3 110.35 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -72.02 -57.09 4.58 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.581 0.705 . . . . 64.14 111.567 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.99 -2.99 6.02 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.687 1.195 . . . . 74.04 113.98 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.499 ' HA ' HD11 ' A' ' 65' ' ' LEU . . . -39.53 -58.34 1.29 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.126 1.37 . . . . 71.55 114.166 171.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.07 27.6 73.5 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 114.76 0.664 . . . . 72.04 114.76 174.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 63.17 16.56 9.48 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.686 1.194 . . . . 63.14 113.561 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 14.5 ptpt -105.6 167.94 9.43 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 122.882 0.473 . . . . 74.21 111.18 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.4 m -82.87 108.95 16.58 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.742 -0.836 . . . . 73.22 108.742 169.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.639 ' HB3' HG13 ' A' ' 88' ' ' ILE . 86.9 mt -75.91 138.37 40.99 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.47 -0.567 . . . . 70.11 109.47 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -118.19 161.39 35.1 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 123.713 0.805 . . . . 73.33 111.275 -169.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 71.3 Cg_exo -44.71 106.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.082 2.521 . . . . 73.04 113.937 171.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.48 -12.8 15.86 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 114.901 0.72 . . . . 60.21 114.901 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.95 100.46 1.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.252 1.026 . . . . 71.14 111.305 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -79.93 122.58 26.87 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 115.996 -0.547 . . . . 70.3 110.726 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.98 173.14 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 125.115 1.366 . . . . 73.24 111.68 -170.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.0 mm -115.13 139.79 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 123.845 0.858 . . . . 74.34 110.41 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.28 123.31 35.52 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.758 0.823 . . . . 63.45 111.76 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -79.98 -44.87 19.45 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.827 0.851 . . . . 60.11 112.457 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.531 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -83.56 174.17 10.8 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.27 0.557 . . . . 74.01 111.542 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 80.0 p -143.73 126.28 15.92 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.05 -0.523 . . . . 71.35 111.055 175.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.507 ' H ' ' HG2' ' A' ' 81' ' ' MET . 19.9 m-70 -91.5 -23.48 19.94 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.991 0.916 . . . . 65.34 110.868 171.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -155.96 -176.9 6.2 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.838 0.855 . . . . 74.53 110.839 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -65.74 131.63 46.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.411 0.684 . . . . 74.13 112.213 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.64 10.93 84.61 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 115.871 -0.604 . . . . 65.25 114.567 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.507 ' HG2' ' H ' ' A' ' 77' ' ' HIS . 11.6 tpt -84.97 -52.43 5.99 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.58 0.752 . . . . 75.43 110.644 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 86.9 tttt -66.54 129.0 38.38 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.387 0.675 . . . . 65.13 111.379 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.11 -9.25 73.34 Favored Glycine 0 N--CA 1.476 1.316 0 O-C-N 123.004 0.19 . . . . 54.52 113.186 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 152.84 30.58 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.386 0.675 . . . . 65.53 111.118 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.7 m -90.26 120.07 31.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.228 -0.897 . . . . 64.33 109.774 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -104.15 162.97 12.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.885 0.874 . . . . 42.44 109.428 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -137.71 126.95 24.56 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.055 -0.72 . . . . 70.22 109.055 168.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.639 HG13 ' HB3' ' A' ' 65' ' ' LEU . 26.1 mm -60.47 110.27 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.381 0.672 . . . . 54.42 110.357 -177.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.43 ' H ' ' HA ' ' A' ' 35' ' ' VAL . 22.7 t70 -77.93 -36.37 49.41 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.167 0.987 . . . . 71.4 110.284 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.526 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 47.3 t -160.1 163.27 33.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.353 1.061 . . . . 73.31 110.277 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.64 148.12 51.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.493 0.717 . . . . 75.54 111.535 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -156.05 148.27 23.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.302 0.482 . . . . 62.42 112.302 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.51 95.44 7.0 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 107.757 -1.201 . . . . 73.14 107.757 163.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 t -136.26 154.55 50.87 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.302 0.641 . . . . 73.12 110.317 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.8 m -84.99 120.48 26.57 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.383 -0.599 . . . . 35.03 109.383 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.457 HG23 ' HB2' ' A' ' 28' ' ' TYR . 13.4 m -107.67 132.68 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.875 -0.787 . . . . 72.23 108.875 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.538 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 96.3 m-85 -109.62 166.7 10.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.489 1.138 . . . . 73.2 112.648 -171.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.2 ttp -120.96 111.09 17.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 112.832 -1.986 . . . . 64.11 107.199 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.26 147.11 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 112.921 0.711 . . . . 74.02 112.921 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 111' ' ' LYS . 4.6 p30 -105.51 138.03 42.38 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.612 0.765 . . . . 55.44 110.165 172.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -156.69 178.25 10.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.642 0.777 . . . . 73.4 111.126 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.0 m -118.11 114.57 23.29 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.438 0.695 . . . . 71.44 109.242 173.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -56.85 109.3 0.61 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.679 0.792 . . . . 75.41 111.02 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.8 p -54.47 -31.17 55.2 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.669 1.188 . . . . 73.03 113.293 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.6 m -64.54 -60.77 2.75 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.392 0.677 . . . . 45.33 112.313 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 36.2 m -101.92 -12.95 17.83 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.296 0.85 . . . . 64.4 113.296 -166.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.5 12.32 83.76 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 113.723 0.249 . . . . 63.24 113.723 -172.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -71.38 125.51 27.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.709 0.804 . . . . 72.45 112.314 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -75.98 96.8 3.85 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.786 0.435 . . . . 75.31 109.94 171.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.65 107.88 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 109.458 -0.571 . . . . 74.41 109.458 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 92.5 mttt -106.78 143.84 34.29 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.647 0.379 . . . . 75.1 110.948 -174.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 54.62 39.43 31.22 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.151 0.981 . . . . 43.44 113.151 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -61.79 131.74 50.84 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.646 0.778 . . . . 75.43 111.399 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 97.5 mttt -134.76 146.61 49.54 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.301 1.04 . . . . 65.12 110.492 -175.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 85.1 m95 -109.54 127.55 54.56 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.658 1.583 . . . . 73.44 110.513 -10.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.6 m -119.63 162.09 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 C-N-CA 124.452 1.101 . . . . 53.5 109.814 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 50.0 p -117.82 171.12 8.27 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.931 0.715 . . . . 71.54 112.931 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.538 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 38.0 tt0 -67.18 -32.17 73.08 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.715 0.806 . . . . 42.24 111.891 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -70.76 -20.12 62.65 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.245 0.618 . . . . 73.43 111.948 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -91.87 4.06 53.76 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.602 0.761 . . . . 71.15 111.666 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.427 HD13 HG21 ' A' ' 7' ' ' VAL . 81.8 mt -121.11 171.92 8.34 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.861 1.265 . . . . 75.24 109.612 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.8 m -147.22 122.54 10.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.681 0.792 . . . . 62.15 109.962 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.08 111.11 4.27 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.885 0.474 . . . . 72.53 110.871 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp . . . . . 0 CA--C 1.553 1.063 0 CA-C-O 121.486 0.66 . . . . 75.45 110.899 -176.872 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mmt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.695 0.283 . . . . 75.31 111.037 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -105.92 157.99 17.09 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.576 0.75 . . . . 74.34 109.913 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.97 122.76 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 CA-C-O 121.193 0.521 . . . . 70.14 110.118 170.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.77 -6.52 48.43 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-N 115.323 -0.853 . . . . 72.32 112.966 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.7 m -75.15 128.15 34.83 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.019 0.527 . . . . 24.14 111.559 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -85.57 117.58 24.56 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.282 -1.007 . . . . 72.14 108.282 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.09 150.84 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.287 0.635 . . . . 71.53 111.777 -174.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.1 mm -98.77 128.55 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.364 1.065 . . . . 70.22 108.406 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.3 mt -91.58 115.89 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.872 -0.418 . . . . 74.13 109.872 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -93.36 -24.44 18.09 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.065 0.546 . . . . 72.31 112.306 -171.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 m -110.62 142.57 42.3 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.401 0.68 . . . . 62.13 109.594 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 14' ' ' MET . 78.0 p -123.62 120.26 32.27 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.827 0.677 . . . . 64.22 112.827 -173.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -84.81 -41.75 15.8 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.23 1.012 . . . . 73.23 108.503 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.471 ' O ' ' HB2' ' A' ' 12' ' ' SER . 24.1 mmt -100.65 137.26 39.29 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.057 0.943 . . . . 73.32 108.698 167.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.509 ' HG3' HG21 ' A' ' 105' ' ' THR . 17.6 ptpt -60.65 -31.23 70.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.22 0.822 . . . . 74.22 113.22 -175.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.04 0.59 72.42 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 114.062 0.385 . . . . 74.3 114.062 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.6 ttp -99.04 -15.44 19.04 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.053 0.541 . . . . 63.2 110.893 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -65.96 117.0 7.69 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.171 0.588 . . . . 75.55 110.16 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.71 2.51 70.12 Favored Glycine 0 CA--C 1.542 1.772 0 N-CA-C 114.358 0.503 . . . . 54.34 114.358 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.38 146.34 43.06 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 117.575 0.687 . . . . 65.41 112.76 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -85.21 131.2 34.46 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.672 0.789 . . . . 72.33 110.219 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.6 172.1 13.15 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.314 0.857 . . . . 74.14 113.314 -170.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.7 m -140.72 138.2 34.04 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.02 0.928 . . . . 74.23 109.801 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -81.76 112.93 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.371 0.669 . . . . 73.22 109.974 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.9 p -99.55 -4.99 29.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.749 0.82 . . . . 63.4 112.297 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.85 149.6 17.07 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 120.09 -0.283 . . . . 55.31 112.56 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.75 114.46 10.52 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.525 0.73 . . . . 75.0 110.464 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -115.42 111.92 21.53 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.972 0.909 . . . . 74.22 111.233 -173.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.97 80.28 5.76 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 122.163 0.982 . . . . 62.01 109.856 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -133.61 174.63 10.22 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 115.69 -0.686 . . . . 64.22 111.987 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.1 m -82.5 119.53 24.34 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.894 0.478 . . . . 65.21 109.87 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.96 162.63 13.42 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.639 1.176 . . . . 63.41 109.286 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -139.54 149.02 43.4 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.683 0.754 . . . . 73.44 111.26 -173.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.9 121.13 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 106.677 -1.601 . . . . 71.4 106.677 168.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.404 HG12 HD13 ' A' ' 88' ' ' ILE . 17.0 m -124.3 151.35 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 118.881 0.764 . . . . 62.41 112.681 -175.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.5 p -119.52 125.45 48.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.168 0.987 . . . . 74.44 109.132 171.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.458 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 49.4 p90 -147.46 152.6 38.35 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.702 0.401 . . . . 74.4 112.057 -172.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.9 m -99.17 106.61 39.62 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 108.122 -1.066 . . . . 72.3 108.122 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.11 146.1 23.81 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.55 2.833 . . . . 53.23 113.984 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.5 p -66.09 -16.57 64.05 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.79 0.836 . . . . 71.05 112.554 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.57 -20.82 65.96 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 123.224 0.609 . . . . 64.32 111.292 170.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.06 14.72 76.48 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.682 -0.69 . . . . 40.35 114.483 172.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.53 -112.55 0.37 Allowed Glycine 0 CA--C 1.539 1.583 0 CA-C-N 117.272 0.536 . . . . 72.54 113.536 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -106.53 142.75 35.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.355 0.662 . . . . 74.25 111.259 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -66.91 133.94 51.02 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.374 0.669 . . . . 74.05 111.687 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.6 t -91.48 118.8 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 124.1 0.96 . . . . 65.03 110.099 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -102.1 138.28 39.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.324 0.65 . . . . 64.41 110.493 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 m170 57.28 41.92 25.97 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.191 0.996 . . . . 75.44 113.351 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -67.1 124.18 22.33 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 116.07 -0.514 . . . . 71.54 110.654 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 31.3 mtmm -131.49 144.59 51.25 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.86 0.864 . . . . 73.13 110.216 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 94.4 m95 -112.69 141.66 46.22 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.347 1.459 . . . . 75.51 110.624 -9.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.86 142.48 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.696 -0.853 . . . . 70.23 108.696 170.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.1 pt -110.55 167.34 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 O-C-N 121.934 -0.479 . . . . 74.31 110.862 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -53.65 -35.02 60.54 Favored 'General case' 0 CA--C 1.563 1.442 0 C-N-CA 123.976 0.91 . . . . 64.1 113.201 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -67.21 -24.95 65.89 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.415 0.686 . . . . 70.34 112.296 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -91.44 1.47 57.1 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.548 0.739 . . . . 75.31 112.096 -175.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.7 mt -108.78 131.65 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.904 0.882 . . . . 64.31 110.151 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -72.65 -42.42 64.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.056 0.942 . . . . 74.13 112.019 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -78.71 -10.4 59.75 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.701 0.8 . . . . 73.34 112.35 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -43.45 -58.33 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.872 1.064 . . . . 72.01 113.872 -173.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.94 31.31 78.03 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 116.502 1.361 . . . . 73.43 116.502 167.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.8 t70 73.76 -10.58 1.06 Allowed 'General case' 0 CA--C 1.578 2.027 0 C-N-CA 124.551 1.14 . . . . 62.35 113.06 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 24.2 pttm -90.53 153.68 20.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.497 -0.752 . . . . 70.15 110.865 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.7 m -85.87 129.82 34.72 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.183 0.593 . . . . 73.44 109.645 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.8 mt -88.79 146.21 25.13 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.508 0.723 . . . . 72.15 111.492 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.58 158.68 42.81 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 124.966 1.306 . . . . 71.32 109.523 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.65 114.04 1.51 Allowed 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.621 2.214 . . . . 52.23 112.991 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.02 -17.52 12.79 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 115.23 -0.895 . . . . 72.15 114.426 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.0 125.99 27.73 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 117.936 0.868 . . . . 52.34 111.131 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.55 124.95 50.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.286 0.635 . . . . 63.53 109.913 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.71 174.74 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.84 1.256 . . . . 75.54 111.307 -169.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.3 mm -111.7 142.31 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 123.364 0.666 . . . . 74.11 109.741 170.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.1 mt -89.41 126.99 35.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.469 0.708 . . . . 74.44 112.26 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -87.29 -22.89 24.88 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.833 0.853 . . . . 73.22 111.847 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.86 158.93 19.83 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.048 0.451 . . . . 60.15 111.831 174.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.678 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 25.4 t -137.86 122.86 19.05 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.278 -0.874 . . . . 51.31 108.707 169.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -107.26 -9.52 16.06 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.045 0.538 . . . . 75.24 111.048 173.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.7 mtm -138.15 -175.75 4.21 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.588 1.155 . . . . 71.51 110.31 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -72.84 131.72 42.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 122.017 -0.427 . . . . 74.0 110.898 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.22 20.28 60.49 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 114.574 0.59 . . . . 74.02 114.574 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -77.89 -43.26 30.66 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.6 0.76 . . . . 73.55 110.954 -174.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 88.8 tttt -65.36 134.85 54.43 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.975 0.51 . . . . 65.3 111.55 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.66 65.11 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.178 -0.464 . . . . 42.15 112.8 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.91 143.18 56.99 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.571 0.748 . . . . 43.22 112.243 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.0 m -77.95 105.92 9.47 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.737 -0.665 . . . . 61.43 109.931 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -103.77 150.11 24.39 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.23 1.012 . . . . 44.43 110.946 -172.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.43 128.98 44.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.319 -0.623 . . . . 75.55 109.319 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.404 HD13 HG12 ' A' ' 35' ' ' VAL . 38.0 mm -64.77 106.47 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 122.891 0.477 . . . . 74.43 110.009 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.39 -36.25 58.19 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.911 0.885 . . . . 71.1 109.991 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.1 t -158.57 147.78 19.09 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.661 0.784 . . . . 43.11 110.563 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.14 133.3 56.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.467 0.707 . . . . 72.1 110.55 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -145.07 123.76 12.55 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.734 0.814 . . . . 73.52 111.139 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.26 97.19 10.97 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.238 -0.653 . . . . 63.01 109.238 175.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.5 t -135.54 154.71 51.29 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.756 0.822 . . . . 71.53 111.108 -173.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.2 m -81.98 120.72 25.6 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.62 -0.881 . . . . 75.32 108.62 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.486 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 11.4 m -110.48 133.33 56.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.892 0.877 . . . . 74.11 108.952 -176.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.07 145.26 38.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.192 0.997 . . . . 75.03 111.511 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.7 ttm -92.51 120.87 33.4 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.31 -1.367 . . . . 60.34 107.31 166.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.69 152.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.627 0.771 . . . . 73.14 111.814 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -117.81 114.4 23.22 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.298 1.039 . . . . 65.5 109.002 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -129.0 170.48 13.41 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.48 0.657 . . . . 75.41 112.203 -174.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.0 m -114.02 127.78 56.1 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.06 -0.719 . . . . 55.33 109.06 170.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.9 t -64.7 125.52 25.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.962 0.905 . . . . 73.54 112.548 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 70.5 p -71.23 -36.67 71.9 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.937 0.895 . . . . 54.52 112.424 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.509 HG21 ' HG3' ' A' ' 15' ' ' LYS . 11.0 t -80.12 -40.0 28.34 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.946 0.721 . . . . 70.22 112.946 -175.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.6 p -113.83 -24.84 8.91 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 112.332 0.493 . . . . 73.34 112.332 -172.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.15 7.56 80.0 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-O 119.89 -0.395 . . . . 55.2 113.877 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -78.99 133.34 36.85 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 117.288 0.544 . . . . 74.43 111.323 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -83.09 109.74 17.41 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 109.206 -0.665 . . . . 72.21 109.206 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.23 127.09 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.975 0.91 . . . . 55.54 110.704 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.84 157.36 27.75 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.503 0.721 . . . . 72.33 111.548 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 57.66 30.67 19.22 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.428 1.091 . . . . 71.23 111.616 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -73.76 135.84 43.59 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.053 0.541 . . . . 73.02 111.179 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -164.41 154.46 14.31 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 122.964 0.505 . . . . 70.13 111.903 -172.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.486 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 81.9 m95 -106.53 137.14 45.08 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.747 1.619 . . . . 72.03 112.039 1.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 m -120.23 144.44 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.279 1.032 . . . . 61.45 109.452 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.3 p -100.31 178.41 4.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.487 -0.758 . . . . 61.4 112.014 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -56.38 -50.81 70.48 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.338 1.055 . . . . 71.0 112.336 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -66.53 -17.9 65.07 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.591 0.756 . . . . 71.32 113.02 -178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -90.37 -6.2 55.29 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.062 0.545 . . . . 72.32 111.482 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 75.2 mt -115.23 160.7 19.42 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.376 1.07 . . . . 75.52 109.47 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -146.6 120.75 9.48 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.166 -0.679 . . . . 70.21 109.166 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.99 139.87 58.81 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.029 0.531 . . . . 65.34 112.028 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.5 tptt . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.865 0.84 . . . . 74.15 110.65 -178.681 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.668 0.271 . . . . 55.24 110.627 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -101.44 142.28 33.07 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.208 1.003 . . . . 52.42 110.195 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.85 132.51 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-O 121.038 0.446 . . . . 75.32 111.077 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.45 -3.57 68.96 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 115.776 -0.647 . . . . 71.53 112.948 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.0 m -85.1 151.6 24.02 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.773 0.657 . . . . 71.44 112.773 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -92.89 122.65 35.48 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.97 -1.014 . . . . 65.34 109.808 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 121' ' ' LEU . 27.0 m -121.56 151.89 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.36 0.664 . . . . 74.12 109.72 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.7 mm -107.51 134.78 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.43 -0.952 . . . . 65.24 108.43 172.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.9 mt -75.29 105.57 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.327 0 CA-C-O 120.95 0.405 . . . . 74.1 109.927 -176.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -83.18 -34.25 26.0 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.931 0.892 . . . . 73.35 111.034 -172.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.7 m -131.47 141.13 49.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.578 1.151 . . . . 74.23 108.244 172.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 17' ' ' MET . 95.7 p -143.5 159.3 42.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.855 0.836 . . . . 60.3 112.366 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.491 ' HE1' ' HG3' ' A' ' 50' ' ' LYS . 7.9 m-70 -91.29 -17.58 25.72 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 114.114 -1.403 . . . . 72.31 110.457 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.666 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 53.6 mtt -131.34 144.37 51.2 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.418 1.087 . . . . 71.21 109.788 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -54.07 -41.23 67.94 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.206 1.187 . . . . 75.03 114.206 -173.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.33 -11.98 83.63 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 114.339 0.496 . . . . 65.01 114.339 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.666 ' HG3' ' HB2' ' A' ' 14' ' ' MET . 20.6 mtm -81.24 -29.27 34.5 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.398 0.599 . . . . 73.24 109.921 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -64.11 122.81 17.48 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 122.739 0.415 . . . . 63.12 111.008 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.4 1.74 89.25 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 115.694 -0.684 . . . . 73.35 113.545 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 149.62 31.72 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.776 0.658 . . . . 33.12 112.776 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -84.66 105.64 15.61 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.17 0.588 . . . . 65.01 110.251 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.43 154.37 19.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.938 0.895 . . . . 51.11 111.532 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.5 m -120.84 122.3 39.99 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.362 0.665 . . . . 55.42 109.661 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -73.27 103.35 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.855 0.462 . . . . 74.42 109.906 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.4 p -113.94 -5.78 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.482 0.549 . . . . 64.45 112.482 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.17 123.39 1.75 Allowed Glycine 0 C--N 1.344 1.015 0 N-CA-C 111.834 -0.506 . . . . 71.25 111.834 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.98 116.59 32.22 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.384 0.674 . . . . 54.15 110.493 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.439 ' HB2' HG23 ' A' ' 96' ' ' VAL . 38.8 m-85 -127.12 119.44 26.53 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.392 0.677 . . . . 73.32 109.961 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -113.82 87.4 2.61 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.906 0.86 . . . . 74.53 109.721 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -135.95 179.93 6.05 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.792 0.837 . . . . 74.43 110.669 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -78.76 123.75 27.5 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 122.022 -0.424 . . . . 71.04 110.433 176.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.89 126.27 54.93 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.102 0.961 . . . . 74.11 110.17 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -103.34 150.32 23.9 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.971 0.891 . . . . 74.44 113.02 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 50' ' ' LYS . 21.7 t -107.49 114.1 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 114.084 -1.416 . . . . 71.32 107.915 169.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.507 HG12 HD13 ' A' ' 88' ' ' ILE . 34.1 m -125.89 146.7 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 112.908 0.707 . . . . 75.24 112.908 -170.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.1 m -110.08 131.4 55.09 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.177 0.591 . . . . 75.14 110.491 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -157.04 159.78 38.3 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.36 0.6 . . . . 72.52 112.079 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.9 m -111.95 113.78 52.06 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 107.771 -1.196 . . . . 64.11 107.771 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.83 116.8 2.99 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.003 2.469 . . . . 73.32 112.108 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 p -68.94 -7.04 31.31 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.329 1.052 . . . . 60.4 113.745 -169.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -77.8 -3.06 39.52 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 123.433 0.693 . . . . 64.13 111.585 171.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.02 34.95 8.45 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 122.198 -0.313 . . . . 60.11 112.319 -173.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.42 -173.48 44.62 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 122.911 0.291 . . . . 72.33 113.444 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.08 117.47 15.92 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.443 0.697 . . . . 61.22 110.16 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.56 117.85 2.45 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.512 0.725 . . . . 74.22 110.969 169.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.96 115.38 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.371 -0.831 . . . . 72.52 109.609 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -100.38 140.78 34.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.145 0.578 . . . . 72.32 109.482 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.8 m170 57.92 39.58 26.55 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.423 0.689 . . . . 64.34 112.396 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -61.22 131.71 51.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.352 1.061 . . . . 72.54 111.455 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.491 ' HG3' ' HE1' ' A' ' 13' ' ' HIS . 25.2 pttm -149.13 148.49 29.73 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.288 -0.869 . . . . 64.34 109.665 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 92.1 m95 -109.95 135.88 50.1 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.456 -1.402 . . . . 64.42 111.502 0.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.01 147.15 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.782 1.233 . . . . 73.11 108.306 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.3 pt -111.47 167.17 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 122.046 -0.409 . . . . 70.41 111.669 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -53.96 -36.18 62.59 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.943 0.897 . . . . 75.51 113.265 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -70.24 -19.24 63.14 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 123.464 0.706 . . . . 62.14 112.092 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -94.54 8.28 42.77 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.589 0.756 . . . . 72.11 112.442 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.5 mt -124.23 136.64 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.692 0.797 . . . . 64.24 110.631 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -72.08 -53.72 11.96 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.796 0.839 . . . . 62.52 111.614 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.08 -3.96 11.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.705 1.202 . . . . 63.31 113.381 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -41.23 -46.75 3.22 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.534 1.309 . . . . 73.25 114.534 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.69 19.06 68.88 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.924 1.13 . . . . 71.21 115.924 165.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 66.19 11.17 7.68 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.051 1.341 . . . . 71.03 112.801 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -110.47 167.93 9.84 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.016 0.926 . . . . 71.25 110.817 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.3 m -82.93 118.17 23.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.487 -0.931 . . . . 71.24 108.487 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.606 HD13 HG11 ' A' ' 71' ' ' VAL . 76.4 mt -74.48 118.3 17.28 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.315 0.579 . . . . 42.13 110.24 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -110.91 155.25 42.72 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.426 1.091 . . . . 73.1 110.712 -169.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 76.1 Cg_exo -45.64 111.84 0.36 Allowed 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.702 2.935 . . . . 70.44 114.506 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.44 -11.54 16.43 Favored Glycine 0 N--CA 1.485 1.963 0 CA-C-N 116.182 -0.463 . . . . 73.31 113.938 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -79.88 124.04 28.3 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.386 0.593 . . . . 64.34 111.222 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -98.23 122.18 41.07 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.742 -0.836 . . . . 63.4 108.742 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.606 HG11 HD13 ' A' ' 65' ' ' LEU . 32.4 m -121.62 175.81 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.927 0.891 . . . . 74.45 112.115 -172.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mm -121.65 136.71 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.336 1.055 . . . . 70.5 109.079 170.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.5 mt -83.49 119.19 24.37 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.574 0.75 . . . . 70.3 111.411 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -81.92 -26.64 33.88 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.526 0.73 . . . . 74.11 111.473 171.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.51 153.99 25.29 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.029 0.442 . . . . 53.22 111.152 173.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 42.9 t -142.25 124.31 15.38 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.71 -0.677 . . . . 43.43 110.698 173.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -106.43 -24.86 12.11 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.331 1.053 . . . . 64.32 109.784 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.2 mtm -127.28 164.64 21.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.083 0.953 . . . . 71.42 110.867 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.598 ' HD2' ' H ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.37 127.92 33.63 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.877 0.471 . . . . 64.45 111.986 174.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.41 14.81 82.11 Favored Glycine 0 N--CA 1.476 1.315 0 N-CA-C 114.328 0.491 . . . . 64.34 114.328 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.4 ttt -84.71 -40.9 16.78 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 117.632 0.716 . . . . 63.51 110.739 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.438 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 21.0 tptm -66.53 119.57 11.91 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.209 -0.663 . . . . 54.44 109.209 166.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.55 74.66 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 116.063 -0.517 . . . . 70.13 112.914 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.31 137.63 46.81 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.753 0.776 . . . . 44.25 111.529 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 78.7 m -79.09 114.55 18.12 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.176 0.59 . . . . 72.41 109.531 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.67 157.24 21.49 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.785 0.834 . . . . 44.53 109.739 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -129.42 131.88 46.87 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.79 -0.819 . . . . 65.35 108.79 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.561 HG13 ' HB3' ' A' ' 65' ' ' LEU . 24.3 mm -74.27 107.5 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.28 0.632 . . . . 64.35 110.724 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -68.91 -39.72 79.53 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.926 0.394 . . . . 75.21 110.662 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.0 t -164.41 157.36 17.33 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.207 -0.906 . . . . 63.53 111.357 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -114.14 131.27 56.49 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.216 1.007 . . . . 61.33 109.131 171.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -126.7 135.51 51.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.007 0.523 . . . . 64.33 111.522 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -97.14 95.77 7.99 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.587 0.708 . . . . 71.14 109.657 168.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -135.85 148.3 48.6 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.929 -1.032 . . . . 72.52 109.4 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.4 m -84.24 123.61 30.32 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.221 -0.659 . . . . 53.41 109.221 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 28' ' ' TYR . 16.1 m -112.87 135.96 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.375 0.67 . . . . 73.3 109.553 -173.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.43 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 98.2 m-85 -120.03 141.54 49.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.43 0.692 . . . . 64.13 111.965 -175.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.41 ' SD ' ' HA ' ' A' ' 112' ' ' ASN . 19.4 tmm? -90.14 112.47 23.97 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.879 -1.055 . . . . 72.15 108.254 169.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.51 160.83 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 112.668 0.618 . . . . 74.32 112.668 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -119.57 116.98 27.16 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.87 0.868 . . . . 72.43 108.7 172.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -124.27 165.29 17.89 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 122.96 0.504 . . . . 75.32 111.918 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.8 m -109.21 111.67 23.41 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.3 0.64 . . . . 72.12 110.552 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.3 p -58.8 122.48 13.67 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.144 0.577 . . . . 71.52 111.87 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.7 p -70.91 -23.23 62.23 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.414 1.086 . . . . 73.33 112.767 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -87.86 -10.73 49.88 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.234 0.828 . . . . 72.01 113.234 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.4 m -134.74 -40.19 0.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.234 0.614 . . . . 74.43 111.833 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.81 -1.82 59.9 Favored Glycine 0 N--CA 1.48 1.582 0 CA-C-N 116.197 -0.456 . . . . 54.01 113.077 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -80.84 140.16 35.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.008 0.923 . . . . 63.13 111.124 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -96.37 132.81 41.51 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 121.156 0.503 . . . . 73.24 110.783 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.96 128.39 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.115 1.366 . . . . 64.41 109.723 -175.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 136.71 42.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.876 0.87 . . . . 71.22 111.105 -173.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.41 ' HA ' ' SD ' ' A' ' 98' ' ' MET . 11.8 m120 56.0 43.01 27.89 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.694 1.198 . . . . 74.44 113.84 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -62.3 132.8 53.87 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.672 0.789 . . . . 73.45 112.104 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 59.4 mttp -133.76 136.35 44.51 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.137 0.975 . . . . 70.1 111.491 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.7 m95 -114.44 146.11 41.03 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.511 1.524 . . . . 72.4 111.122 -15.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -119.67 148.23 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.022 0.929 . . . . 74.42 109.331 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.4 p -97.93 163.96 12.56 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.018 0.748 . . . . 74.24 113.018 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.43 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 44.0 tt0 -60.99 -33.91 73.98 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.489 1.116 . . . . 75.33 110.916 173.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.1 -36.84 85.56 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.701 1.2 . . . . 74.34 112.428 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.99 10.02 38.78 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.202 0.445 . . . . 62.02 112.202 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.462 HD13 HG21 ' A' ' 7' ' ' VAL . 91.2 mt -120.24 162.27 19.68 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.017 0.927 . . . . 73.4 109.215 175.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -138.83 120.67 15.4 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.074 0.549 . . . . 73.12 109.752 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.75 115.25 10.73 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.639 0.376 . . . . 64.1 110.676 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt . . . . . 0 N--CA 1.478 0.959 0 C-N-CA 122.905 0.482 . . . . 62.32 111.541 -177.348 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.405 ' HB3' HG21 ' A' ' 24' ' ' VAL . 18.7 mmt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 109.725 -0.472 . . . . 60.51 109.725 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.581 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -72.44 158.87 34.94 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 120.965 0.412 . . . . 62.44 111.824 -179.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.81 130.1 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 123.609 0.763 . . . . 53.14 112.262 -175.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.57 -13.03 47.1 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.268 -0.878 . . . . 55.31 113.343 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.9 m -82.67 152.9 25.64 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.387 0.675 . . . . 71.21 111.638 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -108.74 141.03 41.32 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.143 -0.688 . . . . 72.45 109.143 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 123' ' ' ALA . 33.4 m -135.9 157.63 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.047 0.939 . . . . 61.22 111.063 -172.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.1 mm -96.46 129.06 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.423 -0.954 . . . . 74.14 108.423 166.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.716 HD11 ' HB2' ' A' ' 22' ' ' ALA . 48.7 mt -82.65 127.0 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.186 0.594 . . . . 63.22 109.945 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.575 HD21 ' HB3' ' A' ' 122' ' ' SER . 62.6 m-20 -96.8 -63.05 1.17 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 120.951 0.405 . . . . 73.45 110.386 -177.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.8 m -91.79 140.97 29.17 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.13 -0.692 . . . . 72.15 109.13 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.9 p -132.04 140.42 48.88 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.569 0.7 . . . . 54.01 112.24 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -85.66 -37.97 18.87 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.02 1.328 . . . . 62.55 109.326 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 52.0 mtt -99.34 130.53 45.63 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.316 1.046 . . . . 74.22 109.219 169.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.513 ' H ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -55.92 -37.98 69.66 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 113.0 0.741 . . . . 75.23 113.0 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.62 0.8 60.03 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 114.439 0.536 . . . . 75.21 114.439 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.496 ' HG2' HG21 ' A' ' 9' ' ' ILE . 52.9 ttp -93.3 -25.21 17.85 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.324 0.65 . . . . 71.2 111.13 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -67.36 123.34 20.1 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.994 0.518 . . . . 71.11 111.39 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.99 -12.18 66.89 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.658 -0.701 . . . . 75.13 113.868 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.43 155.42 40.13 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.642 0.777 . . . . 40.31 112.212 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -91.07 100.28 13.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.302 0.641 . . . . 70.0 110.946 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.716 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -89.65 158.14 17.72 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.78 -0.645 . . . . 72.4 111.137 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.4 m -131.7 126.01 33.49 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.865 -0.791 . . . . 65.21 108.865 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' A' ' 1' ' ' MET . 41.3 t -76.57 102.0 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.346 0.658 . . . . 71.15 110.281 -170.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.2 p -96.25 -10.63 27.52 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.331 0.652 . . . . 72.23 111.561 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.49 149.09 19.5 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 112.125 -0.39 . . . . 75.01 112.125 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.06 119.47 15.81 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.645 0.778 . . . . 44.21 110.694 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -121.92 117.22 25.91 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.852 0.861 . . . . 63.21 110.445 -172.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -95.49 83.82 3.88 Favored 'General case' 0 CA--C 1.565 1.519 0 CA-C-O 122.236 1.017 . . . . 72.01 110.645 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -134.39 -178.61 5.13 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.473 0.709 . . . . 73.55 111.878 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 m -90.87 128.58 36.8 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.714 -0.476 . . . . 64.44 109.714 170.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.46 157.93 19.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.716 0.806 . . . . 74.53 110.43 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.491 ' HB2' HG23 ' A' ' 52' ' ' VAL . 97.2 m-85 -135.15 149.55 49.99 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.726 0.774 . . . . 74.11 111.383 -173.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.54 109.65 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.188 -1.369 . . . . 61.13 107.439 171.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.483 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 29.6 m -121.82 148.01 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.525 0.679 . . . . 52.31 112.699 -173.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.1 t -112.3 139.24 48.02 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.915 0.886 . . . . 75.55 109.152 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -158.92 159.42 34.91 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.171 0.589 . . . . 74.21 111.777 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.5 m -107.91 108.78 61.78 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 107.29 -1.374 . . . . 52.5 107.29 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -47.59 152.82 2.47 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 123.949 3.099 . . . . 71.31 115.715 -175.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.8 p -64.92 -24.29 67.48 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.228 1.011 . . . . 43.03 112.393 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.577 HD22 ' HA3' ' A' ' 80' ' ' GLY . 10.9 p30 -67.55 -19.81 65.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.657 0.265 . . . . 75.24 111.213 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 19.21 71.18 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 114.812 0.685 . . . . 74.12 114.812 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.0 -130.18 2.89 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 117.62 0.71 . . . . 74.52 113.085 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -69.99 129.04 38.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.282 0.633 . . . . 75.42 111.493 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -58.5 133.16 55.56 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.296 0.638 . . . . 75.21 111.5 171.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.43 108.85 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.435 0.694 . . . . 70.34 110.128 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -102.57 148.78 25.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.736 0.814 . . . . 74.14 111.04 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.3 m80 55.63 33.97 22.29 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.25 1.02 . . . . 71.4 112.86 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -62.4 122.78 16.56 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.132 0.973 . . . . 63.52 111.036 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 41.3 mtmt -121.37 143.9 48.95 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.531 0.733 . . . . 73.31 110.933 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 92.8 m95 -110.55 144.44 39.41 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.295 1.438 . . . . 75.45 109.4 -14.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 33' ' ' TYR . 25.4 m -115.65 130.06 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 107.748 -1.205 . . . . 74.31 107.748 169.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.421 HG21 HG21 ' A' ' 96' ' ' VAL . 26.0 pt -104.9 163.69 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 121.794 -0.566 . . . . 65.21 111.696 -169.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -52.56 -39.19 61.22 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.852 1.261 . . . . 71.01 113.494 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -73.71 -28.91 61.96 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 120.885 0.374 . . . . 75.51 111.703 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.515 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 28.1 tt0 -80.38 -13.42 59.17 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.378 1.071 . . . . 74.51 110.956 -174.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.37 139.9 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 124.369 1.068 . . . . 75.21 109.84 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -75.58 -55.8 5.32 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.489 0.715 . . . . 72.21 111.477 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.22 -5.38 13.6 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.161 0.985 . . . . 74.15 113.285 -175.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.607 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -51.59 -50.24 60.55 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.569 0.951 . . . . 74.24 113.569 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.51 25.44 71.46 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 114.917 0.727 . . . . 73.25 114.917 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 64.78 16.3 10.34 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 124.831 1.253 . . . . 63.41 113.434 -175.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 64.1 pttt -115.26 179.65 3.9 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.0 0.52 . . . . 72.22 111.161 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.2 m -84.75 114.9 22.39 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.691 -0.686 . . . . 62.44 109.902 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.704 HD13 HG11 ' A' ' 71' ' ' VAL . 70.5 mt -76.29 115.69 16.26 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.624 -0.51 . . . . 64.21 109.624 170.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -89.6 147.91 38.94 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.474 0.71 . . . . 74.04 111.643 -168.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.24 116.23 2.15 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.408 2.739 . . . . 73.23 114.44 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.07 -22.92 11.04 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 115.053 0.781 . . . . 43.42 115.053 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -79.35 149.1 31.8 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.083 0.942 . . . . 73.23 112.04 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -107.17 132.82 52.62 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.179 0.592 . . . . 65.43 111.552 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.704 HG11 HD13 ' A' ' 65' ' ' LEU . 26.8 m -138.73 155.55 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.361 1.065 . . . . 72.44 111.063 -174.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.07 135.33 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 123.189 0.595 . . . . 71.04 109.785 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.2 mt -88.33 118.17 27.76 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.974 0.909 . . . . 71.31 110.837 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -84.12 -3.19 57.93 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 112.808 0.67 . . . . 54.44 112.808 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.515 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -128.81 173.15 10.61 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.272 0.629 . . . . 65.12 111.015 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.418 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 66.1 p -149.32 127.77 12.27 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.435 -0.802 . . . . 65.23 110.998 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -85.27 -14.75 45.66 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.813 0.845 . . . . 72.44 110.253 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -156.85 -179.04 7.82 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.253 1.021 . . . . 71.22 111.139 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -67.19 135.88 54.16 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.786 0.662 . . . . 74.05 112.786 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.577 ' HA3' HD22 ' A' ' 41' ' ' ASN . . . 71.33 17.67 76.23 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 115.103 0.801 . . . . 74.13 115.103 175.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.7 ttt -90.95 -42.8 10.36 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 117.625 0.713 . . . . 72.45 111.273 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 4.1 ttpm? -67.79 129.25 39.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.873 0.469 . . . . 64.2 111.156 175.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.38 -15.72 62.64 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 116.48 -0.327 . . . . 71.24 112.629 -178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.73 141.99 49.79 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.224 0.61 . . . . 71.33 111.665 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.7 m -90.36 110.33 21.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.474 -0.936 . . . . 62.35 108.474 176.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.483 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -98.05 167.94 10.58 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.45 0.7 . . . . 53.13 110.972 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.22 138.34 52.41 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.969 0.908 . . . . 74.53 109.281 171.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.459 HD13 HG12 ' A' ' 35' ' ' VAL . 28.0 mm -72.14 120.58 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 123.106 0.562 . . . . 63.31 110.777 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -85.43 -42.13 14.78 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.925 0.49 . . . . 75.3 109.757 170.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.0 m -155.11 153.99 31.69 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.975 0.91 . . . . 71.33 110.841 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.29 146.99 49.79 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.681 0.792 . . . . 61.04 110.453 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -156.2 131.52 9.4 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.865 0.466 . . . . 61.12 111.493 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -88.93 96.33 10.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.482 -0.933 . . . . 74.05 108.482 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.6 t -136.63 153.74 50.84 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.534 0.734 . . . . 74.4 111.256 -171.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 48.7 m -84.52 123.94 30.83 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.81 -0.441 . . . . 70.41 109.81 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 18.0 m -113.2 138.8 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.727 0.811 . . . . 72.53 109.451 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -115.37 150.07 36.93 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.588 0.755 . . . . 61.02 112.126 -171.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 58.2 ttp -96.36 115.37 27.32 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.421 -1.326 . . . . 74.53 107.421 163.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.462 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 30.0 m -122.79 160.21 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.219 0.533 . . . . 74.23 112.413 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -121.94 116.84 25.08 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.369 1.068 . . . . 74.32 109.591 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -132.47 173.79 10.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.085 0.554 . . . . 65.03 110.508 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 31.8 m -119.28 116.76 26.91 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.588 -0.523 . . . . 75.42 109.588 173.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.8 t -54.71 121.88 9.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.456 1.102 . . . . 75.44 112.408 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p -66.62 -30.44 70.72 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.25 1.02 . . . . 73.23 112.584 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.7 t -83.17 -34.24 26.04 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.037 0.755 . . . . 71.22 113.037 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.0 p -106.78 -28.12 10.34 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.567 0.58 . . . . 75.34 112.567 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.93 9.33 85.5 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 116.611 -0.268 . . . . 44.31 113.177 -172.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -91.13 138.57 31.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.053 0.941 . . . . 72.21 110.659 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 5.7 ttpm? -84.88 120.59 26.64 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 120.984 0.421 . . . . 52.01 110.513 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.67 114.29 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 109.369 -0.604 . . . . 64.15 109.369 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.25 150.37 29.69 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.008 0.923 . . . . 50.34 111.208 -171.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 57.28 31.9 20.87 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.382 1.073 . . . . 74.4 112.243 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -64.41 124.49 21.91 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.249 0.62 . . . . 73.14 111.649 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 10.2 mtmp? -140.85 140.02 34.55 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 124.177 0.991 . . . . 73.33 110.681 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 87.8 m95 -112.51 148.53 34.26 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.875 1.67 . . . . 72.11 111.928 -4.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.8 m -131.47 142.36 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 124.347 1.059 . . . . 74.34 110.3 174.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 81.3 p -100.41 167.86 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 112.644 0.609 . . . . 44.25 112.644 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -56.12 -38.01 70.21 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.69 1.196 . . . . 73.35 111.701 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -58.39 -39.87 80.84 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.926 1.29 . . . . 75.43 112.111 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -88.39 -0.62 57.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.017 0.927 . . . . 75.34 113.367 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.53 163.86 17.32 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.438 0.695 . . . . 63.33 110.988 -177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.575 ' HB3' HD21 ' A' ' 10' ' ' ASN . 80.9 p -145.35 124.08 12.59 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.547 0.739 . . . . 74.34 110.447 174.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.562 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -66.11 133.47 50.78 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 113.268 0.84 . . . . 53.03 113.268 -172.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.612 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 C-N-CA 123.652 0.781 . . . . 72.42 111.077 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 mmt . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.415 -0.587 . . . . 73.12 109.415 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -113.59 159.32 19.74 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.131 0.572 . . . . 70.41 110.176 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.1 t -65.22 124.73 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 CA-C-O 121.376 0.608 . . . . 50.35 111.688 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.32 -2.99 43.37 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 115.559 -0.746 . . . . 62.55 113.094 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 p -81.56 145.34 30.71 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 117.343 0.571 . . . . 73.23 112.359 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -94.02 128.74 40.54 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.583 0.753 . . . . 65.55 110.276 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.529 HG21 HD13 ' A' ' 121' ' ' LEU . 29.5 m -131.35 152.88 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.639 0.776 . . . . 72.25 110.111 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.1 mm -102.76 132.6 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.521 0.728 . . . . 72.43 109.241 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.6 mt -78.85 113.02 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 C-N-CA 122.739 0.416 . . . . 72.14 109.915 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.492 HD22 ' HB2' ' A' ' 122' ' ' SER . 33.9 p30 -91.49 -31.07 16.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 122.002 -0.437 . . . . 54.11 111.672 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.2 m -125.88 141.16 52.11 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.256 1.022 . . . . 74.31 109.905 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 m -154.1 139.66 17.85 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.987 0.515 . . . . 53.12 111.198 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.414 ' CE1' ' HB2' ' A' ' 50' ' ' LYS . 73.0 m-70 -79.23 -25.61 42.6 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.345 0.658 . . . . 71.0 110.1 170.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.603 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 1.6 mpt? -97.55 125.23 42.14 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.171 0.988 . . . . 73.22 109.527 171.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.68 -28.46 68.63 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.23 0.826 . . . . 71.52 113.23 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.79 -12.8 84.1 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 114.597 0.599 . . . . 62.45 114.597 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' A' ' 14' ' ' MET . 39.3 mtp -91.47 -24.36 19.7 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.549 0.74 . . . . 73.42 111.761 -177.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.45 119.41 12.23 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.073 0.549 . . . . 72.44 111.659 -176.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.92 2.17 69.5 Favored Glycine 0 CA--C 1.541 1.677 0 CA-C-N 115.799 -0.637 . . . . 64.34 113.78 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.25 156.77 21.83 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.371 0.668 . . . . 72.21 112.792 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -83.83 114.31 21.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.352 0.661 . . . . 75.54 111.204 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . . . -107.03 150.63 26.31 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.861 0.864 . . . . 35.44 111.895 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -124.6 121.05 33.66 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.634 0.774 . . . . 71.24 108.968 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.2 t -72.75 106.29 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 122.823 0.449 . . . . 71.42 110.277 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.7 p -99.08 -11.33 21.54 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.352 0.661 . . . . 60.54 111.9 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.11 145.31 11.81 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 112.187 -0.365 . . . . 73.12 112.187 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.87 121.7 27.21 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.911 0.884 . . . . 73.13 110.503 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.485 ' HB2' HG23 ' A' ' 96' ' ' VAL . 26.3 m-85 -125.6 125.97 44.01 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.665 0.786 . . . . 71.24 111.249 -175.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.18 78.87 1.34 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.263 1.03 . . . . 75.3 110.35 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.569 HG21 HD12 ' A' ' 53' ' ' ILE . 10.2 t -134.79 174.86 10.11 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.726 -0.67 . . . . 53.3 111.867 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.5 m -78.98 125.03 28.84 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.97 0.508 . . . . 72.44 110.752 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . . . -100.27 163.54 12.35 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.478 1.111 . . . . 43.25 109.215 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -134.11 138.03 44.98 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.54 0.686 . . . . 63.15 111.208 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.0 t -99.15 107.75 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 107.711 -1.218 . . . . 74.35 107.711 172.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.514 HG12 HD13 ' A' ' 88' ' ' ILE . 34.3 m -119.88 145.16 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-O 121.314 0.578 . . . . 73.0 112.056 -173.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -115.16 132.88 56.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.817 0.847 . . . . 74.22 109.091 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -148.88 157.14 43.21 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.241 0.543 . . . . 74.42 112.361 -172.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.4 m -105.7 112.11 64.59 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 108.163 -1.051 . . . . 74.14 108.163 170.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.449 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 11.5 Cg_endo -56.26 118.74 5.59 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.344 2.029 . . . . 74.32 111.399 174.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.0 t -60.8 -14.22 20.25 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 124.361 1.064 . . . . 74.34 113.552 -170.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -82.8 10.83 6.87 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 123.789 0.836 . . . . 75.43 111.92 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.94 46.97 7.4 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 113.672 0.229 . . . . 44.12 113.672 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.23 -177.91 21.4 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 113.542 0.177 . . . . 64.3 113.542 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -65.36 122.42 17.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.924 0.49 . . . . 71.03 110.984 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -58.81 115.35 3.03 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.988 0.423 . . . . 73.54 110.593 173.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -86.57 120.46 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.713 -0.676 . . . . 62.44 110.399 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -92.84 120.69 33.46 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.334 0.653 . . . . 54.31 109.683 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.6 m170 58.64 54.8 5.13 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.597 1.159 . . . . 75.02 113.147 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -65.04 132.07 48.24 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.063 0.945 . . . . 74.42 111.892 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 99.5 mttt -136.94 150.13 48.0 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.743 0.817 . . . . 51.11 110.652 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 96.9 m95 -107.43 130.81 54.78 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.888 1.275 . . . . 73.21 111.908 -7.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.84 142.68 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.716 1.207 . . . . 75.42 108.088 168.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.625 HG21 HG21 ' A' ' 96' ' ' VAL . 27.8 pt -117.02 -175.37 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.075 0.55 . . . . 74.15 110.032 175.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -47.73 -33.18 6.7 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.623 1.169 . . . . 73.42 113.357 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.625 ' H ' HG13 ' A' ' 53' ' ' ILE . 7.0 tp10 -69.94 -28.86 65.92 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 113.924 1.083 . . . . 61.21 113.924 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -80.89 -10.98 59.66 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.487 -0.758 . . . . 54.11 112.589 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.9 mt -110.12 138.92 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 C-N-CA 123.543 0.737 . . . . 74.13 111.759 -172.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.592 ' HE3' ' HB ' ' A' ' 72' ' ' ILE . 27.8 ttpp -65.68 -53.22 44.13 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.312 1.045 . . . . 64.31 112.336 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.19 -3.33 39.04 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.014 -0.994 . . . . 63.25 113.138 -170.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.514 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -40.87 -58.76 1.6 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.444 1.276 . . . . 74.55 114.444 177.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.0 23.71 69.69 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 115.537 0.975 . . . . 23.23 115.537 170.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 61.53 17.35 8.43 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.621 1.168 . . . . 71.24 113.113 -173.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 12.3 ptpt -108.75 167.07 10.33 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.364 0.666 . . . . 73.44 110.54 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.5 m -87.02 112.5 21.91 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.293 -0.632 . . . . 75.14 109.293 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.546 HD13 HG11 ' A' ' 71' ' ' VAL . 54.5 mt -75.26 120.71 21.12 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.443 0.697 . . . . 62.11 109.353 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -96.77 154.1 38.47 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.913 0.885 . . . . 53.32 111.513 -167.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.486 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 84.8 Cg_exo -49.25 113.92 1.1 Allowed 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.995 2.463 . . . . 73.23 113.736 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.56 -17.91 18.01 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-N 115.975 -0.557 . . . . 73.33 114.135 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.8 133.14 47.09 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.327 0.564 . . . . 63.5 110.626 173.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -111.27 121.24 44.75 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.899 -0.778 . . . . 42.42 108.899 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.546 HG11 HD13 ' A' ' 65' ' ' LEU . 27.0 m -131.21 164.53 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.543 1.137 . . . . 74.34 111.027 -167.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.592 ' HB ' ' HE3' ' A' ' 58' ' ' LYS . 46.3 mm -110.51 141.47 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.01 0.524 . . . . 75.22 110.534 176.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.2 mt -88.71 123.64 33.34 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.806 0.843 . . . . 74.35 111.565 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -88.77 -28.74 20.28 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.239 0.615 . . . . 52.14 112.352 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.52 158.55 20.93 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.12 0.486 . . . . 64.21 110.572 171.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 21.1 t -143.58 125.02 14.74 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.728 -0.669 . . . . 74.43 109.703 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.7 m170 -95.34 -13.88 24.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.953 0.901 . . . . 70.1 111.272 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -156.3 177.35 11.54 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.617 0.767 . . . . 71.22 111.896 -173.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -63.95 104.96 0.77 Allowed 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.113 0.965 . . . . 71.13 112.566 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.56 12.94 56.46 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 115.182 0.833 . . . . 52.32 115.182 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -74.36 -42.23 59.71 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 117.481 0.641 . . . . 62.52 111.677 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.595 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 50.5 tttm -66.22 132.63 48.86 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 122.414 -0.179 . . . . 73.13 110.522 172.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.57 -9.52 75.7 Favored Glycine 0 N--CA 1.472 1.094 0 CA-C-O 120.337 -0.146 . . . . 72.31 112.89 -177.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 39' ' ' PRO . . . -71.11 141.48 50.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.47 0.708 . . . . 74.22 111.903 177.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -81.83 113.44 19.78 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.965 -0.561 . . . . 75.01 109.945 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -110.1 150.68 28.25 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.5 1.12 . . . . 75.31 110.388 -175.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -125.06 130.34 52.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.12 0.568 . . . . 65.01 109.958 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.514 HD13 HG12 ' A' ' 35' ' ' VAL . 27.4 mm -69.86 101.64 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.442 0.697 . . . . 52.44 109.639 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.61 -32.97 70.52 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.319 0.581 . . . . 73.25 110.346 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.486 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . 40.0 t -168.89 150.31 4.61 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.669 -1.151 . . . . 61.03 109.849 -175.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.84 128.49 54.31 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.536 -0.913 . . . . 74.14 108.536 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -114.07 125.77 54.35 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.708 0.803 . . . . 72.13 111.551 -169.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -93.91 95.12 8.88 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.5 -0.555 . . . . 75.02 109.5 170.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.0 t -137.06 154.39 50.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.786 0.835 . . . . 74.13 110.592 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.3 m -86.37 125.47 33.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.509 -0.552 . . . . 74.04 109.509 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.625 HG21 HG21 ' A' ' 53' ' ' ILE . 14.9 m -114.42 134.83 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.361 0.664 . . . . 52.54 110.092 -172.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.401 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 89.8 m-85 -116.21 143.03 46.04 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.434 0.694 . . . . 60.33 112.049 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.5 ttp -89.57 115.86 27.29 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.109 -1.441 . . . . 75.22 107.109 164.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.4 m -118.16 152.95 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.866 0.841 . . . . 62.13 112.135 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -121.28 121.56 37.98 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.608 1.563 . . . . 74.11 107.4 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.533 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 51.2 p90 -152.45 178.85 9.12 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.143 0.497 . . . . 74.1 112.098 -171.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.2 m -118.49 117.49 29.15 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.761 0.824 . . . . 75.31 109.631 172.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.5 t -60.95 119.25 7.91 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.449 0.7 . . . . 75.32 110.378 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.1 p -59.4 -45.18 92.23 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.815 0.846 . . . . 63.24 113.139 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.4 m -64.06 -52.86 57.35 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.108 0.563 . . . . 71.53 111.793 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.1 m -79.06 -24.08 43.78 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.137 0.575 . . . . 44.24 112.319 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.41 17.27 74.26 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 116.35 -0.386 . . . . 75.25 113.566 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -108.6 144.09 36.79 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.876 0.87 . . . . 73.44 111.661 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -77.13 105.1 8.01 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.013 0.925 . . . . 73.13 111.304 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.2 t -90.46 110.55 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 108.297 -1.001 . . . . 75.52 108.297 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -112.94 145.96 39.85 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.692 0.797 . . . . 71.35 111.76 -166.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 17.8 m120 57.45 32.41 21.76 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 124.064 0.946 . . . . 64.4 113.225 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -64.59 133.42 52.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.675 0.79 . . . . 75.1 112.573 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 99.7 mttt -135.59 134.42 39.31 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.199 1.0 . . . . 71.22 110.72 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 97.7 m95 -115.15 155.61 26.81 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.321 1.448 . . . . 63.2 112.521 -10.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.22 160.98 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.774 1.23 . . . . 73.42 109.084 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.8 p -118.2 162.76 17.71 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.735 0.414 . . . . 50.44 111.557 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.401 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 30.5 tt0 -61.36 -36.18 79.49 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.891 0.476 . . . . 73.43 111.671 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -66.28 -32.55 74.03 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.309 0.644 . . . . 74.32 110.885 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -83.33 -9.91 58.8 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.119 0.967 . . . . 72.22 111.376 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.529 HD13 HG21 ' A' ' 7' ' ' VAL . 82.6 mt -112.08 173.37 6.4 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.993 0.917 . . . . 70.11 109.857 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB2' HD22 ' A' ' 10' ' ' ASN . 47.8 t -137.28 136.68 38.25 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.657 0.783 . . . . 70.32 109.171 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.63 138.09 50.46 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 120.863 0.364 . . . . 74.05 111.522 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.0 tttt . . . . . 0 CA--C 1.558 1.263 0 CA-C-O 121.727 0.775 . . . . 75.12 110.846 -176.455 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.532 ' SD ' HG11 ' A' ' 7' ' ' VAL . 24.2 ptp . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.629 0.252 . . . . 52.33 110.574 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -99.41 161.61 13.52 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.31 0.644 . . . . 74.21 111.575 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.56 132.29 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 123.592 0.757 . . . . 64.21 111.779 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.41 -7.21 39.67 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.508 -0.769 . . . . 51.44 113.566 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 m -75.4 134.85 40.82 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.01 0.524 . . . . 64.24 111.782 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -95.81 123.64 39.47 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.317 0.647 . . . . 62.04 109.636 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.532 HG11 ' SD ' ' A' ' 1' ' ' MET . 31.8 m -130.04 154.54 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.735 0.814 . . . . 70.14 111.818 -172.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.8 mm -98.05 128.76 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.93 0.892 . . . . 60.21 109.656 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 17' ' ' MET . 49.8 mt -78.01 109.96 13.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.38 0.672 . . . . 72.21 109.968 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -87.53 -53.22 4.92 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.79 0.436 . . . . 75.34 110.76 -173.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.808 ' HB ' ' HB2' ' A' ' 120' ' ' GLU . 72.0 m -91.42 140.36 29.84 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.694 -0.854 . . . . 41.54 108.694 170.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 14' ' ' MET . 86.0 p -133.06 124.83 28.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.502 0.321 . . . . 71.01 111.825 -173.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -71.36 -33.37 69.51 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.347 0.659 . . . . 75.52 110.088 171.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.676 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 1.8 mpt? -115.58 137.48 52.03 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.518 1.127 . . . . 71.01 108.938 172.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -30.87 69.79 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.591 1.33 . . . . 74.33 114.591 -169.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.82 -3.34 87.46 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 114.599 0.6 . . . . 74.25 114.599 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.676 ' SD ' ' HB2' ' A' ' 14' ' ' MET . 61.6 mtp -86.63 -26.99 24.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.622 0.769 . . . . 73.14 111.196 -178.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -67.46 121.96 16.94 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.587 0.355 . . . . 64.31 111.05 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.69 -3.84 86.03 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 116.134 -0.485 . . . . 41.23 113.606 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.78 150.69 32.31 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 117.503 0.651 . . . . 60.03 112.651 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -90.1 100.61 13.4 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.765 0.826 . . . . 72.22 111.464 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.97 163.56 13.44 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.804 0.842 . . . . 42.21 112.297 176.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.6 m -130.79 130.94 44.34 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.108 0.963 . . . . 62.14 108.958 172.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.4 t -74.01 103.36 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.085 0.554 . . . . 74.24 109.515 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.8 p -95.79 -12.19 25.73 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.09 0.556 . . . . 73.11 111.756 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.6 139.69 6.45 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.747 -0.541 . . . . 64.31 111.747 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.74 122.08 37.14 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.298 0.639 . . . . 74.5 111.184 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -128.88 122.44 30.34 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.277 1.031 . . . . 74.01 110.688 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -103.98 79.67 1.66 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.947 0.879 . . . . 70.51 110.085 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -133.63 175.75 9.16 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.588 -0.733 . . . . 73.21 112.467 -169.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 93' ' ' LYS . 54.9 m -77.93 118.95 20.73 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.851 0.86 . . . . 73.34 110.931 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.81 111.61 24.21 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.04 0.936 . . . . 65.01 110.373 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -87.86 149.9 23.85 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.868 0.842 . . . . 75.21 111.956 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 55.8 t -106.92 118.84 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 107.907 -1.146 . . . . 71.34 107.907 170.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.438 HG12 HD13 ' A' ' 88' ' ' ILE . 30.0 m -117.59 168.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 112.492 0.552 . . . . 72.24 112.492 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 91.1 p -137.33 134.87 36.52 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.568 0.747 . . . . 61.13 109.467 170.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 43.5 p90 -151.66 157.6 42.33 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.469 0.652 . . . . 64.43 111.96 -174.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 m -101.19 110.98 62.85 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.182 -1.044 . . . . 73.05 108.182 171.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.97 123.39 13.71 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.861 2.374 . . . . 74.32 112.846 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.3 p -58.02 -25.32 60.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.525 1.306 . . . . 70.13 114.525 -171.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -72.62 -6.38 43.84 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 112.918 0.71 . . . . 74.51 112.918 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.11 38.67 5.94 Favored Glycine 0 N--CA 1.472 1.098 0 N-CA-C 111.789 -0.524 . . . . 30.21 111.789 -169.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.14 158.94 26.05 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.338 -0.431 . . . . 52.12 112.479 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -56.26 122.99 13.07 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.173 0.589 . . . . 72.24 110.961 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.89 124.19 14.67 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.152 0.981 . . . . 71.51 111.628 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.9 t -103.99 124.56 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.75 0.82 . . . . 63.42 111.298 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -117.32 148.62 41.55 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.638 0.775 . . . . 72.33 111.054 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 m170 57.62 38.02 27.64 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.434 1.093 . . . . 55.43 112.991 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -69.13 138.58 54.33 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.426 0.69 . . . . 72.14 111.477 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -153.88 153.36 31.95 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 123.75 0.82 . . . . 65.42 111.069 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -106.88 128.69 54.51 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.542 1.537 . . . . 71.3 111.693 -0.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.74 142.31 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.893 -1.151 . . . . 72.33 107.893 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.2 pt -124.13 176.88 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.556 -0.715 . . . . 74.52 112.076 -175.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -49.88 -50.45 45.79 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.172 1.175 . . . . 75.2 114.172 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -6.94 52.27 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 112.864 0.69 . . . . 71.25 112.864 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -79.16 -31.17 43.91 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.954 0.901 . . . . 73.54 110.066 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.7 mt -96.08 131.1 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 123.688 0.795 . . . . 71.32 111.02 -169.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -63.0 -47.51 82.79 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 122.092 0.949 . . . . 52.14 111.207 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.26 -2.65 22.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.912 1.285 . . . . 74.23 113.543 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -40.7 -60.84 1.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.602 1.161 . . . . 62.12 113.665 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.73 17.52 65.0 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 115.848 1.099 . . . . 53.44 115.848 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.64 12.91 7.92 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.45 1.1 . . . . 62.22 113.46 -174.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -106.26 157.24 17.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.362 0.665 . . . . 74.52 110.435 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.4 m -76.1 111.05 11.11 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.046 0.539 . . . . 71.42 110.432 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.424 HD13 HG11 ' A' ' 71' ' ' VAL . 92.9 mt -75.57 124.53 27.36 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.346 0.659 . . . . 74.34 110.679 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -120.57 157.74 53.35 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.325 1.05 . . . . 55.21 110.518 -170.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 32.8 Cg_exo -41.58 116.49 0.52 Allowed 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.032 2.488 . . . . 65.5 114.27 171.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.81 -9.73 16.15 Favored Glycine 0 N--CA 1.478 1.45 0 CA-C-N 115.137 -0.938 . . . . 75.14 113.499 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -84.37 102.38 12.69 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 117.519 0.659 . . . . 74.32 112.451 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -69.87 120.98 16.43 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.736 -0.468 . . . . 75.41 109.736 164.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.424 HG11 HD13 ' A' ' 65' ' ' LEU . 30.1 m -131.96 157.31 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.596 1.159 . . . . 64.44 110.428 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.9 mm -105.82 137.0 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.855 -0.528 . . . . 73.45 110.308 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.5 mt -87.54 128.0 35.25 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.67 0.788 . . . . 73.04 112.299 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -92.69 -31.33 15.14 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.798 0.839 . . . . 60.23 111.943 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.5 161.02 14.39 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.463 0.649 . . . . 62.15 110.29 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.1 p -147.24 128.46 14.74 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.784 -0.644 . . . . 75.12 110.623 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -88.68 6.84 36.56 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.817 0.847 . . . . 75.25 110.886 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -172.35 158.35 4.35 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.501 1.52 . . . . 64.52 109.824 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -75.99 133.46 40.42 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 122.274 -0.266 . . . . 72.41 110.987 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.63 -29.03 12.58 Favored Glycine 0 N--CA 1.482 1.711 0 CA-C-N 116.56 -0.291 . . . . 75.21 112.44 -172.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.0 ttt -68.36 -37.54 80.56 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.065 0.946 . . . . 64.14 111.253 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -65.35 119.24 10.61 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.988 0.515 . . . . 72.31 109.793 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.7 3.03 74.81 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 120.064 -0.298 . . . . 64.1 113.275 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.13 144.31 31.78 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 117.19 0.495 . . . . 64.03 111.429 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.4 m -80.84 110.67 16.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.693 -0.685 . . . . 64.02 109.174 176.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -101.2 159.73 15.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.316 1.047 . . . . 72.11 108.973 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.95 129.49 30.14 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.047 -1.094 . . . . 74.41 108.047 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.438 HD13 HG12 ' A' ' 35' ' ' VAL . 38.5 mm -63.26 100.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.562 0.745 . . . . 61.33 110.389 -176.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.19 -40.55 71.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.02 0.928 . . . . 74.42 110.519 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.408 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 68.0 m -153.96 151.41 29.37 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.987 0.915 . . . . 75.3 110.059 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.01 129.89 56.82 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.114 0.566 . . . . 63.42 109.61 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -140.61 151.83 44.96 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.724 0.81 . . . . 72.42 109.537 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -124.81 95.27 4.45 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.036 0.922 . . . . 73.35 109.156 177.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 t -134.9 151.89 51.27 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.288 -0.869 . . . . 53.0 110.552 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.8 m -78.39 123.69 27.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 122.613 0.365 . . . . 74.24 110.54 -173.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 15.2 m -118.33 140.06 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.193 0.997 . . . . 60.13 110.089 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.424 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 77.7 m-85 -122.53 145.85 47.95 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.702 0.801 . . . . 71.42 111.543 -172.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.5 ttp -89.9 121.38 31.97 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.974 -1.121 . . . . 62.43 107.974 163.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.2 m -120.94 153.76 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-O 121.488 0.661 . . . . 74.43 112.367 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -118.12 122.42 43.05 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.836 1.254 . . . . 51.41 107.747 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.444 ' CE2' ' HG2' ' A' ' 17' ' ' MET . 56.1 p90 -148.65 177.87 9.13 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.939 0.496 . . . . 73.23 111.681 -174.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.2 m -125.38 128.87 48.82 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.49 0.716 . . . . 64.34 109.726 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.4 t -62.48 120.7 11.6 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.662 0.785 . . . . 71.32 110.925 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.0 p -60.15 -41.13 92.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.895 0.878 . . . . 63.41 112.408 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.4 p -75.15 -57.5 3.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.143 0.577 . . . . 64.33 112.104 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.0 m -71.04 -40.35 71.76 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.272 0.629 . . . . 71.24 111.905 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.06 1.31 82.2 Favored Glycine 0 N--CA 1.479 1.528 0 CA-C-N 116.188 -0.46 . . . . 55.13 113.033 -170.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -75.11 129.89 38.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.64 1.176 . . . . 55.34 112.937 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -82.54 98.94 9.21 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.806 0.842 . . . . 74.2 109.881 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -88.39 118.26 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.012 0.525 . . . . 74.44 110.211 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -107.94 148.06 30.17 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.506 0.723 . . . . 64.34 112.18 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 m120 58.46 34.2 23.75 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.631 1.172 . . . . 64.2 113.349 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -65.35 125.4 24.98 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.622 0.769 . . . . 72.12 112.316 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 64.4 mttp -132.42 135.77 46.32 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.877 0.871 . . . . 74.11 111.096 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.476 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 97.9 m95 -116.52 160.71 20.23 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 126.018 1.727 . . . . 64.01 111.644 -12.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.33 139.72 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.047 0.939 . . . . 62.05 110.692 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.3 p -91.73 159.4 15.86 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.03 0.532 . . . . 73.41 112.028 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 36.5 tt0 -65.33 -26.42 68.04 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.115 0.483 . . . . 75.22 111.173 173.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -63.9 -34.29 77.62 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.859 0.864 . . . . 75.32 111.614 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.808 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 11.0 pt-20 -95.66 -2.51 47.95 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.881 0.697 . . . . 74.51 112.881 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.8 mt -111.78 168.69 9.38 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.551 0.741 . . . . 44.43 109.633 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.2 m -143.47 123.19 13.35 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.396 0.679 . . . . 74.25 109.812 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.485 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -63.77 144.32 57.14 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.075 0.55 . . . . 75.24 111.465 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.6 tptm . . . . . 0 CA--C 1.558 1.265 0 CA-C-O 122.035 0.921 . . . . 73.14 111.213 -177.134 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 110.204 -0.295 . . . . 65.42 110.204 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -75.0 137.42 41.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.835 0.854 . . . . 71.43 111.006 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.3 t -67.3 126.06 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 CA-C-O 121.353 0.596 . . . . 70.3 110.728 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.49 -18.03 38.92 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 115.189 -0.914 . . . . 72.21 113.07 -171.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 t -85.97 161.14 19.14 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.666 0.787 . . . . 75.21 110.202 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -124.62 149.59 46.93 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.084 0.468 . . . . 74.31 111.369 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 123' ' ' ALA . 24.5 m -138.27 163.92 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.256 1.022 . . . . 75.51 111.92 -171.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 mm -98.81 132.22 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.413 1.085 . . . . 53.23 109.169 165.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.9 mt -91.73 125.5 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 N-CA-C 109.782 -0.451 . . . . 54.03 109.782 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -96.16 -58.98 1.94 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.64 1.176 . . . . 61.43 111.222 -171.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.515 ' HB ' ' HG2' ' A' ' 120' ' ' GLU . 23.7 m -91.75 140.75 29.39 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.451 -0.944 . . . . 73.53 108.451 169.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 75.5 m -148.19 136.62 21.44 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.238 0.542 . . . . 62.44 111.484 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -83.89 -22.78 31.5 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.647 -1.16 . . . . 72.35 109.46 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.1 mmt -97.7 122.04 40.31 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.498 1.119 . . . . 70.14 108.906 167.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -32.01 72.59 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.638 0.977 . . . . 75.43 113.638 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.98 -4.31 77.22 Favored Glycine 0 N--CA 1.476 1.307 0 N-CA-C 114.03 0.372 . . . . 51.31 114.03 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 54.8 ttp -100.85 -22.25 14.89 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.473 0.709 . . . . 72.12 110.562 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 58.8 tttm -68.12 120.09 13.76 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.159 0.584 . . . . 74.23 111.87 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.22 -6.01 82.79 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 115.214 -0.903 . . . . 71.41 113.99 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.91 159.97 24.82 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.27 0.841 . . . . 71.4 113.27 -171.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.75 115.76 21.81 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.091 -0.959 . . . . 73.13 110.403 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.513 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -113.41 164.13 14.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.033 0.933 . . . . 55.42 112.221 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 62.1 m -133.55 125.37 28.72 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.277 0.631 . . . . 73.12 110.987 174.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.91 104.55 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.656 0.782 . . . . 74.34 110.371 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.3 p -111.57 3.69 18.17 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.455 0.539 . . . . 72.2 112.455 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.9 146.44 14.11 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 120.002 -0.332 . . . . 74.1 112.812 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.69 108.26 6.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.626 0.77 . . . . 32.44 110.731 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -112.14 116.89 31.21 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.194 0.998 . . . . 71.21 110.378 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -99.35 88.62 3.95 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 122.086 0.946 . . . . 64.14 109.731 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -134.25 179.8 6.04 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.646 0.779 . . . . 72.31 111.041 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -83.15 123.01 29.12 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.566 -0.531 . . . . 72.42 109.566 171.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.86 155.15 20.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.096 0.558 . . . . 70.15 109.562 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -132.48 147.95 52.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.875 0.845 . . . . 72.51 111.663 -173.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.31 108.7 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.906 -1.516 . . . . 75.2 106.906 169.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.425 HG12 HD13 ' A' ' 88' ' ' ILE . 19.1 m -107.02 155.51 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.356 0.598 . . . . 73.14 111.924 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 68.5 m -134.31 122.96 23.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.894 0.877 . . . . 62.24 108.92 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -153.23 159.2 42.56 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.299 0.571 . . . . 62.11 110.81 -167.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.9 m -101.65 124.49 40.48 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.679 -1.23 . . . . 74.22 107.679 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.72 145.75 94.76 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.024 1.816 . . . . 74.33 111.922 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -62.82 -17.74 61.76 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.358 0.663 . . . . 74.23 112.527 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.488 HD21 ' HG2' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -70.25 -20.82 63.04 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.533 0.733 . . . . 72.31 111.539 172.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.12 29.57 45.48 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 115.108 0.803 . . . . 72.05 115.108 168.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.86 -127.48 5.33 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 117.912 0.856 . . . . 43.12 113.103 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.75 119.59 18.18 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.448 0.699 . . . . 74.32 110.551 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -57.29 105.67 0.25 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.764 0.826 . . . . 62.21 112.059 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.23 104.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 121.218 0.533 . . . . 72.31 109.998 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 6.8 p-10 -110.48 155.3 22.44 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.233 0.613 . . . . 74.2 109.855 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.0 m170 58.69 30.48 19.99 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.556 0.742 . . . . 63.52 112.101 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -65.07 125.58 25.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.904 0.882 . . . . 60.44 110.962 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 6.9 mtmp? -139.94 144.35 37.04 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 124.082 0.953 . . . . 73.22 111.25 -174.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 97.5 m95 -112.32 138.07 49.57 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 125.32 1.448 . . . . 74.35 111.474 -4.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.81 138.69 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.322 -0.854 . . . . 71.24 109.077 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.3 pt -99.35 162.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.089 0.471 . . . . 74.22 111.737 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.423 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 63.5 tt0 -51.36 -41.06 60.38 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.375 1.07 . . . . 74.14 113.322 175.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.74 -13.69 61.38 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.436 0.636 . . . . 70.04 112.363 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 15.4 tt0 -92.18 -16.72 25.87 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.347 1.059 . . . . 61.53 111.204 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.9 mt -102.67 132.38 48.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.904 0.882 . . . . 74.4 110.159 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.556 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 87.2 tttt -64.51 -54.88 25.36 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.761 0.824 . . . . 62.41 111.508 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -72.96 -5.88 41.61 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.046 1.128 . . . . 64.43 114.046 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 54' ' ' GLN . . . -52.91 -39.61 62.89 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.163 1.171 . . . . 51.14 114.163 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.7 28.32 73.51 Favored Glycine 0 N--CA 1.481 1.697 0 N-CA-C 116.189 1.236 . . . . 74.44 116.189 163.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 61.47 14.28 5.73 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.275 1.03 . . . . 74.4 112.999 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -119.5 170.47 9.13 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.782 0.833 . . . . 45.13 111.023 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.0 m -96.6 114.59 26.26 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.159 -0.682 . . . . 75.31 109.159 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.474 HD13 HG11 ' A' ' 71' ' ' VAL . 34.9 mt -76.68 140.38 40.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.372 0.669 . . . . 71.03 110.988 -173.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -91.0 151.85 43.67 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.109 0.563 . . . . 71.44 110.951 -174.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.1 120.24 7.95 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.361 2.041 . . . . 74.11 112.35 170.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.79 -17.45 17.87 Favored Glycine 0 CA--C 1.538 1.484 0 CA-C-O 119.515 -0.603 . . . . 63.1 114.427 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.18 154.47 41.02 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.336 1.068 . . . . 73.42 111.844 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -120.6 136.9 54.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.267 0.627 . . . . 74.43 110.812 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.474 HG11 HD13 ' A' ' 65' ' ' LEU . 35.8 m -132.89 172.38 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 124.841 1.256 . . . . 74.22 111.848 -170.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.46 138.86 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 124.231 1.012 . . . . 73.5 109.739 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.5 mt -97.94 118.2 33.98 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.669 0.788 . . . . 74.42 111.579 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.556 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 30.5 mm-40 -82.19 -22.59 35.91 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.157 0.583 . . . . 72.41 112.511 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.592 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -104.78 172.12 6.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.095 0.558 . . . . 71.05 111.464 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 29.1 t -137.26 126.22 24.25 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.149 0.579 . . . . 43.11 111.487 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.576 ' H ' ' HG2' ' A' ' 81' ' ' MET . 32.8 m170 -92.92 -20.16 20.92 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.483 0.713 . . . . 74.12 111.003 164.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.0 ptp -151.43 158.73 44.07 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.296 0.638 . . . . 54.35 111.566 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.488 ' HG2' HD21 ' A' ' 41' ' ' ASN . 38.0 ttpt -66.78 95.91 0.38 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.447 0.699 . . . . 74.45 110.143 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.13 -12.4 4.41 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 115.859 -0.61 . . . . 64.32 113.354 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.576 ' HG2' ' H ' ' A' ' 77' ' ' HIS . 9.4 tpt -75.93 -59.57 2.7 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.389 1.076 . . . . 54.43 111.865 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 58.5 tttm -67.21 131.05 45.0 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.74 0.816 . . . . 54.02 112.267 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.61 -26.33 14.6 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.397 -0.365 . . . . 65.31 113.539 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.08 156.78 38.08 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.335 0.654 . . . . 72.14 111.914 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.9 m -84.5 116.35 23.06 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.909 -0.774 . . . . 62.34 108.909 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.63 150.82 22.33 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.721 0.809 . . . . 70.13 109.354 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -118.9 118.68 32.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.15 0.58 . . . . 71.31 109.472 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.425 HD13 HG12 ' A' ' 35' ' ' VAL . 36.9 mm -60.1 98.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.092 0.557 . . . . 74.24 109.869 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.11 -39.84 82.69 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.768 0.827 . . . . 62.41 109.254 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.6 t -163.44 163.25 24.97 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.064 -0.971 . . . . 71.21 110.473 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.6 139.27 52.85 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.661 0.785 . . . . 73.24 110.403 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -139.23 124.55 19.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.223 0.609 . . . . 74.55 111.102 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -86.81 94.11 9.46 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.088 -1.078 . . . . 71.15 108.088 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 t -136.79 155.04 50.34 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.8 0.84 . . . . 74.45 111.706 -170.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.4 m -87.46 125.06 34.07 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.794 -0.817 . . . . 55.55 108.794 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.5 134.16 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.012 0.925 . . . . 74.35 109.703 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.499 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 93.9 m-85 -112.63 154.98 25.2 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.764 0.792 . . . . 74.44 112.71 -169.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.3 ttp -102.55 112.49 25.25 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.546 -1.206 . . . . 70.12 108.734 173.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.513 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 23.6 m -121.5 148.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 112.909 0.707 . . . . 61.12 112.909 -172.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.3 122.86 48.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.839 0.856 . . . . 74.24 109.455 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -138.88 167.72 21.39 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.593 0.711 . . . . 63.23 112.591 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.1 m -106.84 118.64 37.22 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.102 -1.073 . . . . 72.31 108.102 168.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.6 p -64.96 124.64 22.59 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.421 0.288 . . . . 61.42 111.072 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.3 p -69.85 -41.42 74.9 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.119 0.968 . . . . 63.53 112.596 -176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.3 p -78.6 -48.48 15.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.041 0.537 . . . . 53.42 111.785 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.3 t -81.2 -36.38 30.18 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.405 0.682 . . . . 63.13 112.577 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.8 2.58 89.72 Favored Glycine 0 N--CA 1.483 1.768 0 CA-C-O 120.877 0.154 . . . . 52.43 113.478 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -82.08 137.79 34.95 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.91 0.884 . . . . 63.22 111.208 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.28 111.14 19.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.677 0.791 . . . . 73.33 109.138 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -110.8 120.17 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.181 0.592 . . . . 60.22 109.502 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -113.59 152.16 30.7 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.654 0.382 . . . . 72.42 110.412 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.4 m120 53.74 34.8 19.83 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 124.494 1.118 . . . . 71.31 113.224 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -58.27 135.99 57.25 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.645 1.178 . . . . 70.2 112.256 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 61.8 mttp -137.37 137.4 38.82 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.425 1.09 . . . . 74.45 110.45 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.4 m95 -115.17 156.94 24.36 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.64 1.576 . . . . 71.31 112.031 -9.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.5 m -128.02 154.12 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.637 1.175 . . . . 71.21 109.245 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 75.2 p -103.66 160.75 14.49 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 122.075 -0.391 . . . . 60.33 110.905 174.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.499 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 40.3 tt0 -63.07 -27.41 69.38 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.444 0.698 . . . . 64.35 111.552 178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -63.62 -25.42 68.22 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.168 0.987 . . . . 75.24 112.227 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.515 ' HG2' ' HB ' ' A' ' 11' ' ' THR . 40.2 mt-10 -91.86 0.03 57.5 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.914 0.885 . . . . 74.21 111.818 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 117' ' ' THR . 68.8 mt -119.95 140.48 50.84 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.344 0.52 . . . . 64.21 110.351 -172.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -131.56 122.94 26.93 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.848 0.859 . . . . 73.1 109.087 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.551 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -56.35 117.78 4.13 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.38 0.672 . . . . 45.44 111.728 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 64.8 tttm . . . . . 0 CA--C 1.55 0.96 0 CA-C-O 121.616 0.722 . . . . 72.23 111.821 -172.114 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.018 -0.364 . . . . 71.04 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.01 147.22 48.83 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.838 0.455 . . . . 65.21 110.326 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.66 132.39 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 CA-C-O 121.209 0.528 . . . . 75.2 111.133 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.32 -5.55 49.08 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.338 -0.847 . . . . 72.4 113.757 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.2 m -68.08 136.1 53.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.988 0.736 . . . . 70.41 112.988 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -84.63 113.69 21.45 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.007 -0.738 . . . . 63.02 109.007 167.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 123' ' ' ALA . 29.8 m -123.76 174.03 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.555 0.742 . . . . 71.2 111.29 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 21' ' ' GLU . 9.7 mt -130.64 134.72 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.141 0.976 . . . . 65.23 109.341 170.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.5 mt -86.39 108.12 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.008 0.923 . . . . 73.03 110.144 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -89.18 -48.21 7.54 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.251 0.62 . . . . 72.42 111.133 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 28.0 m -102.14 143.07 32.42 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 107.987 -1.116 . . . . 64.33 107.987 173.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 17' ' ' MET . 31.1 t -157.45 155.62 30.74 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.472 0.916 . . . . 62.13 113.472 -172.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -83.86 -42.71 16.09 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.147 -1.388 . . . . 61.32 109.111 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.7 mmt -90.67 128.6 36.69 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.185 0.994 . . . . 52.44 109.557 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HE2' HG21 ' A' ' 105' ' ' THR . 0.0 OUTLIER -66.88 -17.86 65.1 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.558 0.577 . . . . 71.4 112.558 -177.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.52 -11.08 62.8 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 113.937 0.335 . . . . 52.01 113.937 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.457 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 53.4 ttp -88.06 -23.05 23.85 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.31 0.555 . . . . 71.32 111.51 -177.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 141.97 57.77 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 121.025 0.44 . . . . 60.0 111.348 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.68 -8.65 41.05 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-N 116.003 -0.544 . . . . 73.4 114.116 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.41 148.25 32.03 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.498 0.719 . . . . 71.23 111.529 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HA ' HG12 ' A' ' 8' ' ' ILE . 8.8 pt-20 -96.17 110.55 22.81 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 121.272 0.558 . . . . 65.33 109.976 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.518 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -101.86 172.28 7.03 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.209 1.004 . . . . 75.51 113.303 -174.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.2 m -125.79 123.89 39.77 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.028 0.931 . . . . 73.32 109.806 172.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.41 122.21 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.053 0.541 . . . . 61.03 110.08 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 p -126.72 -6.33 6.27 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.543 0.737 . . . . 61.3 112.591 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.38 145.71 13.38 Favored Glycine 0 N--CA 1.476 1.314 0 CA-C-O 119.648 -0.529 . . . . 71.43 112.019 173.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.29 123.48 12.95 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.618 0.767 . . . . 73.44 110.689 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -133.1 130.24 39.04 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.663 0.785 . . . . 75.31 111.926 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -104.24 87.47 2.75 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.617 0.767 . . . . 74.3 109.165 169.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -134.53 170.98 14.96 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.847 0.859 . . . . 51.32 110.921 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.5 m -75.47 107.71 7.78 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.492 -0.558 . . . . 61.4 109.492 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.01 110.5 23.1 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.601 0.76 . . . . 70.14 109.004 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.458 ' HE2' ' HA ' ' A' ' 54' ' ' GLN . 95.7 m-85 -89.33 151.86 21.85 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.873 0.844 . . . . 71.22 112.158 -172.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.0 t -99.68 120.41 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.255 -1.387 . . . . 74.12 107.255 164.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -125.72 148.55 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.514 0.673 . . . . 73.32 112.671 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.6 p -115.81 124.99 52.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.241 1.017 . . . . 54.45 109.14 170.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.425 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 47.2 p90 -152.11 156.19 39.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.767 0.427 . . . . 74.24 110.678 -174.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.423 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 15.1 m -113.31 110.85 50.3 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 109.123 -0.695 . . . . 72.05 109.123 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 38' ' ' THR . 9.2 Cg_endo -53.01 118.44 4.8 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.248 2.632 . . . . 64.24 112.791 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.3 p -64.71 -17.19 63.88 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.723 1.209 . . . . 75.2 113.596 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -67.47 -10.21 49.32 Favored 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 123.669 0.788 . . . . 74.42 112.466 174.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.77 51.38 2.14 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 122.255 -0.278 . . . . 64.14 112.717 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.57 -151.05 21.12 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 120.903 0.168 . . . . 45.13 113.421 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -106.14 133.86 50.19 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.725 0.81 . . . . 72.31 109.636 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -59.5 118.6 6.23 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.915 0.486 . . . . 73.15 111.208 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.7 t -84.01 110.57 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.316 0.646 . . . . 60.31 110.638 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -95.72 130.65 42.57 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.934 0.894 . . . . 72.3 110.777 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 m170 54.01 57.93 5.51 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.065 0.946 . . . . 74.42 112.547 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.465 ' HD2' HG13 ' A' ' 52' ' ' VAL . 63.9 t60 -73.14 126.31 29.73 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.092 0.557 . . . . 72.11 111.446 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 66.4 mttm -131.21 139.36 49.69 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.44 1.096 . . . . 72.25 109.732 173.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.622 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 85.9 m95 -114.12 133.32 55.64 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.424 1.49 . . . . 74.32 111.474 -5.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.465 HG13 ' HD2' ' A' ' 49' ' ' HIS . 14.2 m -110.74 142.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 108.477 -0.935 . . . . 62.44 108.477 167.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.81 161.92 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-O 120.817 0.341 . . . . 52.41 111.241 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.458 ' HA ' ' HE2' ' A' ' 33' ' ' TYR . 63.3 tt0 -52.01 -47.98 64.71 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.189 0.996 . . . . 73.34 113.487 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -74.94 -8.1 55.51 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.509 0.723 . . . . 73.51 112.124 -174.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 35.7 tt0 -90.7 -8.84 48.81 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 124.842 1.257 . . . . 52.1 110.931 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.64 142.16 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 C-N-CA 124.506 1.123 . . . . 73.24 110.311 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -63.56 -50.37 69.77 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.228 1.011 . . . . 70.4 112.968 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.36 -6.58 57.1 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.225 0.824 . . . . 72.21 113.225 -170.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -33.19 -56.22 0.4 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.761 1.763 . . . . 55.32 115.761 -170.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.39 15.18 63.24 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 115.119 0.807 . . . . 41.12 115.119 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.37 3.52 1.87 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.2 1.4 . . . . 73.51 113.146 -170.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -100.54 160.37 14.4 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.931 0.892 . . . . 61.15 110.942 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.1 m -83.25 109.54 17.32 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.423 -0.584 . . . . 61.05 109.423 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.511 HD13 HG11 ' A' ' 71' ' ' VAL . 63.7 mt -72.02 122.13 20.35 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.724 -0.843 . . . . 65.55 108.724 175.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -97.55 149.09 35.35 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.212 0.605 . . . . 65.4 112.324 -164.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -46.25 115.65 1.22 Allowed 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.806 3.004 . . . . 74.35 114.623 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.77 -16.96 15.98 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 115.887 -0.597 . . . . 63.53 114.053 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.53 154.66 32.23 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 117.811 0.805 . . . . 74.3 111.714 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -126.07 137.29 53.61 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.344 0.658 . . . . 61.23 110.448 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.511 HG11 HD13 ' A' ' 65' ' ' LEU . 16.9 m -141.29 -179.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.621 1.169 . . . . 74.21 110.908 -168.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.53 146.44 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.494 0.718 . . . . 60.21 110.398 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.1 mt -96.09 123.92 39.89 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.673 0.789 . . . . 73.41 111.193 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -86.75 -6.03 58.94 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.525 0.565 . . . . 73.41 112.525 173.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -122.95 170.62 9.95 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.554 0.693 . . . . 72.55 110.525 170.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.448 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 66.1 p -146.99 127.72 14.3 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.281 -0.872 . . . . 71.23 110.458 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -82.82 -31.27 28.22 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.553 0.741 . . . . 71.11 109.524 168.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 66.6 mtm -125.77 177.61 6.18 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.971 0.908 . . . . 74.03 112.086 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -81.84 128.82 34.42 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.682 0.793 . . . . 73.13 111.394 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.67 11.48 83.96 Favored Glycine 0 N--CA 1.477 1.416 0 C-N-CA 123.179 0.418 . . . . 64.53 113.73 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.7 ttt -86.32 -44.0 12.44 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.882 0.873 . . . . 73.12 111.447 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 88.1 tttt -67.69 127.53 33.09 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.728 0.411 . . . . 74.34 111.209 174.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.15 -16.6 60.62 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 116.537 -0.301 . . . . 50.04 112.817 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.77 152.39 42.76 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.405 0.682 . . . . 74.2 111.116 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.8 m -84.18 114.0 21.48 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.971 -0.559 . . . . 65.52 109.914 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -100.44 130.14 46.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.863 0.865 . . . . 73.24 109.752 -177.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -99.87 117.58 34.48 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.343 -0.984 . . . . 73.2 108.343 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.3 mm -64.35 94.46 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 109.486 -0.561 . . . . 75.51 109.486 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.59 -33.17 68.82 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.884 0.873 . . . . 65.32 109.832 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.9 t -167.08 166.2 15.27 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.187 0.995 . . . . 62.44 110.506 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.03 131.48 42.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.978 0.911 . . . . 72.34 109.538 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -130.42 140.01 50.58 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.832 0.453 . . . . 72.35 111.168 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -94.12 96.71 9.81 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.518 0.727 . . . . 72.5 109.091 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.1 t -137.39 157.1 47.33 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.631 0.773 . . . . 74.53 111.116 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.9 m -86.43 125.84 33.97 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.764 -0.458 . . . . 45.01 109.764 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 8.6 m -117.34 138.23 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.735 0.814 . . . . 74.15 110.321 -176.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -122.11 164.0 18.52 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.314 1.045 . . . . 71.33 112.613 -169.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 ttp -119.35 116.92 27.18 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.95 -1.477 . . . . 70.31 107.984 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.518 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 24.5 m -125.72 149.67 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 123.544 0.737 . . . . 52.15 112.667 -172.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -115.88 116.77 28.56 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.018 0.927 . . . . 64.54 109.9 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -136.68 177.7 7.65 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.53 0.681 . . . . 75.32 111.781 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.5 m -123.78 125.01 43.95 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.326 1.051 . . . . 72.41 108.803 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.3 t -61.19 127.77 33.14 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.413 0.685 . . . . 72.31 112.216 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.6 p -69.33 -44.52 71.52 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.892 0.877 . . . . 64.2 111.441 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.409 HG21 ' HE2' ' A' ' 15' ' ' LYS . 38.0 m -81.07 -57.46 3.51 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.693 -0.685 . . . . 71.14 111.775 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.2 m -86.49 -21.13 27.17 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.185 0.809 . . . . 71.03 113.185 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.98 -17.96 38.5 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 115.121 0.809 . . . . 62.33 115.121 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.51 124.76 22.17 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.5 0.72 . . . . 73.31 112.258 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -81.57 101.97 10.32 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.414 0.686 . . . . 75.25 109.275 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.0 t -98.74 119.21 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.69 0.796 . . . . 72.22 110.396 -170.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.716 ' HD3' ' H ' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -105.3 137.53 42.95 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.645 0.778 . . . . 74.43 111.276 -174.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.8 m120 56.53 40.09 29.62 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.737 1.215 . . . . 63.04 113.174 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -64.72 132.83 50.71 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.936 0.894 . . . . 73.34 111.233 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -152.06 151.76 31.53 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.101 0.56 . . . . 65.32 111.37 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.622 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 92.3 m95 -105.88 144.54 32.47 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 125.984 1.713 . . . . 74.21 110.777 -4.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.7 148.92 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 123.903 0.881 . . . . 63.13 110.888 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.6 p -94.37 168.57 10.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.682 -0.636 . . . . 53.13 112.17 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -71.22 -25.56 62.55 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.001 0.52 . . . . 63.31 111.07 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -60.46 -20.02 58.49 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 124.275 1.03 . . . . 72.14 111.295 170.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.405 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 41.4 mt-10 -100.74 -2.67 31.85 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.344 1.058 . . . . 75.53 112.881 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.5 mt -119.45 157.5 28.12 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.51 0.724 . . . . 52.12 110.907 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.9 t -144.97 122.8 11.93 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.324 0.65 . . . . 74.31 110.292 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -68.28 117.67 10.38 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 122.784 0.434 . . . . 62.42 111.619 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt . . . . . 0 CA--C 1.553 1.072 0 C-N-CA 123.625 0.77 . . . . 62.45 111.995 -170.241 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.563 ' SD ' HG11 ' A' ' 7' ' ' VAL . 17.9 ptp . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 110.784 -0.08 . . . . 63.22 110.784 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.0 158.87 16.45 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.045 0.538 . . . . 71.03 111.798 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.92 123.48 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 CA-C-O 121.017 0.437 . . . . 54.31 110.691 173.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.22 -4.42 38.16 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.694 -0.685 . . . . 62.53 113.02 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.5 m -76.8 140.65 40.78 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.501 0.556 . . . . 65.53 112.501 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -91.02 114.78 27.39 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.964 -1.125 . . . . 72.44 107.964 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.563 HG11 ' SD ' ' A' ' 1' ' ' MET . 27.3 m -128.33 153.62 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.571 0.748 . . . . 74.24 111.329 -170.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -100.59 121.91 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.599 0.76 . . . . 62.12 110.164 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.663 HD11 ' HB2' ' A' ' 22' ' ' ALA . 46.0 mt -80.18 120.79 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.632 0.373 . . . . 75.32 110.459 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -92.49 1.0 57.5 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 123.426 0.69 . . . . 64.05 111.977 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.426 HG21 ' HG2' ' A' ' 120' ' ' GLU . 21.7 m -142.61 154.51 44.45 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.226 0.61 . . . . 72.33 111.686 -171.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.766 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 33.0 p -117.84 116.58 27.26 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.579 0.704 . . . . 73.24 112.042 173.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.529 ' H ' ' HE2' ' A' ' 17' ' ' MET . 38.2 m-70 -96.36 -33.06 12.07 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 107.616 -1.253 . . . . 72.14 107.616 160.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 26.6 mmt -107.87 149.49 28.21 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.786 1.234 . . . . 51.24 109.283 167.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HG3' HG21 ' A' ' 105' ' ' THR . 17.4 tppt? -58.33 -45.19 88.55 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.853 0.861 . . . . 52.23 113.102 -172.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.96 2.27 87.77 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 115.172 0.829 . . . . 35.21 115.172 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.537 ' HG2' HG21 ' A' ' 9' ' ' ILE . 47.8 ttp -87.76 -26.65 22.78 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.539 0.669 . . . . 75.4 111.991 -170.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.766 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 28.0 ttpp -66.28 119.28 11.25 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.546 0.338 . . . . 71.42 110.646 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.93 0.62 88.86 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 115.793 -0.64 . . . . 22.34 114.494 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.06 151.08 35.66 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.997 0.519 . . . . 73.12 111.214 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -95.43 113.02 24.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.525 0.33 . . . . 73.23 110.775 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.663 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -96.1 168.5 10.57 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.713 0.768 . . . . 63.31 113.058 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.4 m -126.26 123.61 38.5 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.096 -1.446 . . . . 73.12 107.096 166.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.08 110.29 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.871 0.468 . . . . 42.33 110.203 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.6 p -95.4 -14.02 24.17 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.116 0.567 . . . . 71.34 111.799 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.95 154.41 25.35 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 113.44 0.136 . . . . 42.31 113.44 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.39 110.45 11.05 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.942 0.897 . . . . 71.15 110.725 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -115.1 123.19 48.34 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.847 0.859 . . . . 74.2 110.683 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.9 86.25 2.35 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 122.408 1.099 . . . . 71.52 109.757 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -134.57 173.02 12.12 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.122 -0.945 . . . . 72.24 111.045 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.1 m -78.6 123.74 27.42 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.683 -0.488 . . . . 63.15 109.683 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.08 144.87 31.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.91 0.884 . . . . 54.13 109.818 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -128.79 149.54 50.68 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.891 0.853 . . . . 74.23 111.888 -170.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.3 t -105.75 127.11 60.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 114.144 -1.389 . . . . 74.51 108.069 172.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.458 HG12 HD13 ' A' ' 88' ' ' ILE . 15.8 m -127.78 161.39 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 112.781 0.659 . . . . 45.54 112.781 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.0 t -128.99 125.25 36.99 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.13 0.972 . . . . 74.24 109.408 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -153.79 158.42 40.87 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.463 0.705 . . . . 74.12 110.87 -172.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.4 m -109.65 112.31 58.66 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 108.566 -0.902 . . . . 74.24 108.566 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.32 128.69 28.48 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.183 2.589 . . . . 71.15 113.593 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.9 p -62.6 -18.39 62.08 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.968 1.307 . . . . 70.42 113.408 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -64.82 -10.05 25.25 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 123.938 0.895 . . . . 65.03 112.526 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.71 53.51 2.71 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-O 121.117 0.287 . . . . 45.11 112.467 -175.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.68 171.16 14.31 Favored Glycine 0 N--CA 1.471 1.005 0 CA-C-N 115.352 -0.424 . . . . 74.21 113.408 -175.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -62.91 134.94 56.98 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.556 0.742 . . . . 74.22 111.512 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -58.99 123.92 18.19 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.379 0.672 . . . . 72.41 112.223 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.5 t -87.2 108.76 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.515 0.726 . . . . 63.43 109.723 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -101.78 139.21 37.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.681 0.793 . . . . 62.41 110.526 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.5 m170 57.82 37.41 27.03 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.089 0.956 . . . . 64.42 112.746 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -60.77 129.69 42.76 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.168 0.987 . . . . 75.35 111.408 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 61.1 mttp -130.2 137.24 49.97 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.936 0.895 . . . . 63.14 110.862 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 79.8 m95 -118.03 145.78 44.53 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 125.468 1.507 . . . . 74.23 111.242 -11.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -114.09 132.4 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 107.99 -1.115 . . . . 70.31 107.99 169.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.0 pt -102.02 167.27 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 121.598 -0.689 . . . . 74.44 109.909 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -47.6 -33.61 6.82 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.68 1.192 . . . . 72.01 113.393 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.51 -13.09 60.64 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.707 1.003 . . . . 64.02 113.707 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.548 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 0.5 OUTLIER -89.51 -12.91 38.66 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.623 0.601 . . . . 65.3 112.623 -179.283 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 mp -98.57 132.79 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 122.961 0.504 . . . . 73.33 111.293 -169.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -60.83 -44.16 97.3 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.81 1.244 . . . . 74.31 112.854 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -78.97 -16.32 57.1 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 118.189 -0.91 . . . . 73.41 112.813 -175.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -30.42 -62.19 0.16 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.813 1.412 . . . . 74.43 114.813 -160.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.19 23.2 65.98 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 114.602 0.601 . . . . 64.2 114.602 169.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 t70 72.54 -2.63 2.58 Favored 'General case' 0 CA--C 1.577 1.984 0 C-N-CA 125.304 1.442 . . . . 71.3 112.401 -176.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.452 ' HE3' HD23 ' A' ' 65' ' ' LEU . 53.0 pttt -79.65 153.71 29.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.376 -0.828 . . . . 62.01 110.954 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.4 m -84.48 118.73 24.48 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.142 -0.688 . . . . 75.33 109.142 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.531 ' HB3' HG13 ' A' ' 88' ' ' ILE . 41.6 mt -73.09 124.37 25.41 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.755 0.822 . . . . 70.42 110.598 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -109.02 155.94 40.01 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 123.584 0.754 . . . . 74.34 111.358 -171.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 84.5 Cg_exo -45.89 111.53 0.35 Allowed 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.123 2.549 . . . . 61.41 114.172 174.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.64 -16.39 14.11 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 114.611 0.604 . . . . 41.15 114.611 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.48 130.97 45.19 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 117.932 0.866 . . . . 75.32 112.33 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.448 HE22 ' HB2' ' A' ' 87' ' ' GLU . 31.9 mm-40 -87.8 122.06 30.99 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.827 -0.805 . . . . 70.34 108.827 171.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.14 146.74 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.596 0.758 . . . . 70.41 110.763 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -101.23 135.75 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 109.449 -0.574 . . . . 62.04 109.449 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.3 mt -91.19 109.15 20.4 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.98 0.512 . . . . 71.42 111.152 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.11 -40.04 65.28 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.63 0.772 . . . . 53.12 111.243 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.548 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -89.39 173.78 8.18 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.95 0.5 . . . . 51.13 111.044 174.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.658 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 29.4 t -149.17 125.44 10.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.866 -0.606 . . . . 43.32 109.804 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -86.73 -18.4 31.26 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.456 0.702 . . . . 63.31 110.976 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -155.14 147.61 24.06 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.31 1.044 . . . . 74.03 109.811 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.4 ' HB3' ' NZ ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -51.1 124.11 10.81 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.105 0.962 . . . . 60.52 113.593 -174.178 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.2 -15.6 56.25 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 115.891 -0.595 . . . . 74.44 114.201 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.2 ttt -68.91 -39.02 79.91 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.539 0.736 . . . . 73.42 112.518 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 87.7 tttt -66.39 134.94 53.56 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.689 0.396 . . . . 60.5 111.66 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.79 -7.08 79.65 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.134 -0.485 . . . . 32.05 112.901 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.42 143.15 37.02 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.103 0.561 . . . . 64.51 111.58 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.1 m -87.01 116.74 25.27 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.705 -0.85 . . . . 75.22 108.705 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -112.34 156.99 21.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.819 0.848 . . . . 53.42 110.136 -173.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.448 ' HB2' HE22 ' A' ' 70' ' ' GLN . 35.4 tt0 -120.07 125.97 49.61 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.293 -0.632 . . . . 73.4 109.293 174.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.531 HG13 ' HB3' ' A' ' 65' ' ' LEU . 34.6 mm -63.08 105.29 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 N-CA-C 109.691 -0.485 . . . . 55.42 109.691 175.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -75.94 -37.86 58.22 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.987 0.915 . . . . 64.33 109.889 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.4 t -157.42 152.0 25.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.674 0.79 . . . . 50.32 111.111 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.08 132.17 54.35 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.885 0.874 . . . . 74.32 109.949 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -142.16 140.68 32.48 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.099 0.476 . . . . 64.44 112.171 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -96.66 95.6 8.05 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.126 -0.488 . . . . 73.21 109.703 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.2 t -136.88 149.91 47.94 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.455 0.702 . . . . 74.12 110.764 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.0 m -82.49 124.88 30.5 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.459 -0.571 . . . . 64.2 109.459 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.637 HG12 HG22 ' A' ' 117' ' ' THR . 16.5 m -112.03 132.97 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.455 0.702 . . . . 44.21 109.464 -173.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.422 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 96.4 m-85 -109.63 139.0 45.18 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.937 0.875 . . . . 71.33 112.048 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.434 ' HG2' ' HA ' ' A' ' 112' ' ' ASN . 60.9 ttp -91.27 120.3 32.05 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 107.493 -1.299 . . . . 64.21 107.493 170.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.425 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 27.6 m -130.65 163.31 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 113.826 1.047 . . . . 70.42 113.826 -171.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -125.69 118.32 25.36 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.292 1.037 . . . . 64.23 110.61 174.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -131.87 178.47 6.75 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.067 0.947 . . . . 75.34 110.76 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.1 m -114.73 114.31 25.44 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.081 -0.711 . . . . 72.1 109.081 170.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.3 t -55.54 103.48 0.1 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.97 0.908 . . . . 53.5 110.684 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.2 p -65.53 -17.93 64.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.511 1.125 . . . . 74.31 113.578 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.406 HG21 ' HG3' ' A' ' 15' ' ' LYS . 65.1 p -92.9 -24.21 18.51 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.357 0.503 . . . . 74.13 112.357 177.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.3 m -112.26 -22.57 10.85 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.133 0.79 . . . . 73.21 113.133 -170.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.15 -12.5 49.85 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 113.717 0.247 . . . . 64.11 113.717 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -72.82 129.29 37.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.202 1.001 . . . . 61.51 112.202 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -84.45 111.63 19.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.05 0.54 . . . . 71.33 110.177 170.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.0 t -101.06 117.99 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.898 0.879 . . . . 73.05 110.145 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.529 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -113.67 148.89 35.53 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.293 0.637 . . . . 62.12 111.677 -175.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.434 ' HA ' ' HG2' ' A' ' 98' ' ' MET . 81.5 m-20 55.74 36.74 27.82 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 124.143 0.977 . . . . 75.21 112.416 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -62.11 134.91 57.2 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.198 0.999 . . . . 74.23 111.911 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 98.3 mttt -140.02 136.03 33.28 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.887 0.875 . . . . 60.43 111.381 -175.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 91.9 m95 -114.46 142.96 45.7 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.114 1.366 . . . . 71.4 112.961 -12.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.5 146.48 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 114.016 -1.447 . . . . 75.21 108.19 166.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.637 HG22 HG12 ' A' ' 96' ' ' VAL . 18.8 p -103.55 173.46 6.29 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.948 -0.47 . . . . 63.53 111.289 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.422 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 13.4 tp10 -58.23 -29.93 66.13 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.791 0.836 . . . . 71.13 111.258 170.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.53 -35.11 79.43 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.831 0.853 . . . . 70.21 111.72 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.426 ' HG2' HG21 ' A' ' 11' ' ' THR . 1.3 mt-10 -92.56 -3.18 55.47 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.133 0.573 . . . . 74.03 112.463 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.4 mt -118.78 143.77 46.71 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.662 0.785 . . . . 70.11 110.283 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 57.5 m -122.29 149.52 43.61 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.427 -0.953 . . . . 74.22 108.427 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.03 170.86 7.64 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.49 0.316 . . . . 42.01 111.268 173.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 tptt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.713 0.768 . . . . 71.22 110.474 174.458 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.417 ' SD ' HG11 ' A' ' 7' ' ' VAL . 58.3 mtt . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.446 0.165 . . . . 64.35 111.167 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -90.79 137.9 32.0 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.404 0.682 . . . . 62.13 112.756 -171.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.28 136.49 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 C-N-CA 123.597 0.759 . . . . 73.14 110.975 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.67 -12.6 68.95 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 116.007 -0.542 . . . . 61.54 113.129 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.9 t -87.1 159.12 19.03 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.426 0.69 . . . . 61.01 110.802 175.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -101.25 147.51 26.2 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.919 0.487 . . . . 62.25 109.756 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' A' ' 123' ' ' ALA . 16.6 m -130.89 151.25 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.733 0.813 . . . . 61.34 110.399 176.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.2 mm -98.76 124.99 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.792 0.837 . . . . 74.5 109.743 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 22' ' ' ALA . 30.1 mt -78.31 107.41 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 109.14 -0.689 . . . . 74.31 109.14 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -87.22 -34.28 19.03 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.061 0.458 . . . . 54.25 111.946 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.9 m -133.33 141.31 47.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.678 1.191 . . . . 44.1 108.223 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.8 p -162.64 173.16 14.27 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.602 0.715 . . . . 63.1 111.555 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -86.29 -6.95 58.85 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 114.964 -1.016 . . . . 70.5 111.353 -175.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.6 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 51.5 mtt -133.2 144.66 49.96 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.371 1.068 . . . . 75.45 110.367 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -60.27 -38.2 82.82 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.232 0.613 . . . . 71.41 111.343 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.68 -24.07 63.81 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 114.766 0.666 . . . . 65.14 114.766 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.6 ' HG3' ' HB2' ' A' ' 14' ' ' MET . 27.0 mtm -94.14 -26.74 16.57 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.637 0.375 . . . . 71.33 110.968 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -67.71 121.04 15.08 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.025 0.53 . . . . 73.25 111.431 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.44 0.96 88.13 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 115.671 -0.695 . . . . 64.32 114.117 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.79 158.87 19.88 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.195 0.598 . . . . 61.5 112.491 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -89.69 123.51 33.78 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.751 -0.659 . . . . 74.11 109.641 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -114.83 168.7 9.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.244 1.018 . . . . 65.24 110.905 171.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 m -133.9 128.35 34.39 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.663 0.785 . . . . 73.33 109.24 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.24 105.21 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 109.692 -0.484 . . . . 55.25 109.692 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.2 p -103.87 -4.73 23.12 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.957 0.503 . . . . 64.41 111.085 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.81 133.06 3.27 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 111.21 -0.756 . . . . 61.51 111.21 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.01 107.02 12.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.62 0.768 . . . . 63.41 109.532 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -110.12 133.2 53.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.847 0.859 . . . . 74.31 109.745 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -122.24 86.38 2.57 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.993 0.901 . . . . 61.32 110.142 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -135.43 -178.54 5.16 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.751 0.82 . . . . 63.32 111.206 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.2 m -75.27 119.54 19.53 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.748 0.419 . . . . 64.22 110.136 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.03 150.19 25.17 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.582 0.753 . . . . 74.5 109.613 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HB2' HG23 ' A' ' 52' ' ' VAL . 90.0 m-85 -128.61 142.91 50.89 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.784 0.802 . . . . 54.51 111.75 -173.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.18 109.65 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 114.146 -1.388 . . . . 62.13 107.29 171.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.9 148.31 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 113.816 1.043 . . . . 61.22 113.816 -170.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.4 t -116.7 125.03 51.12 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.112 0.965 . . . . 71.44 110.542 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -150.9 156.3 40.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 122.143 -0.348 . . . . 72.15 111.649 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 m -105.36 119.48 52.73 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.139 0.576 . . . . 73.25 109.826 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.34 124.4 15.97 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.801 2.334 . . . . 62.02 112.391 169.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.4 p -63.48 -10.32 17.02 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.013 1.486 . . . . 74.3 115.013 -167.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.439 HD22 ' HB3' ' A' ' 79' ' ' LYS . 55.7 m-20 -90.95 10.1 27.88 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 122.845 0.458 . . . . 71.0 112.074 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.59 47.19 5.76 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.923 -0.471 . . . . 71.33 111.923 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.51 160.65 18.98 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 123.039 0.352 . . . . 61.02 112.514 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -62.89 130.1 43.31 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.017 0.527 . . . . 71.34 110.709 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -64.48 123.87 20.35 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.026 0.441 . . . . 74.24 111.453 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.6 t -86.87 113.25 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.542 -0.754 . . . . 71.03 109.51 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -97.95 143.44 28.52 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.984 0.914 . . . . 70.33 110.115 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.6 m80 55.92 35.3 25.23 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.642 0.777 . . . . 74.5 112.801 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.415 ' HD2' HG13 ' A' ' 52' ' ' VAL . 66.7 t60 -57.86 118.3 5.19 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.826 0.85 . . . . 74.24 111.597 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 97.9 mttt -118.32 131.37 56.33 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.837 0.855 . . . . 65.5 110.414 176.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.672 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 94.4 m95 -118.84 154.83 32.25 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.642 -1.286 . . . . 71.33 111.499 -10.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 33' ' ' TYR . 18.4 m -122.38 148.3 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 114.443 -1.253 . . . . 73.44 107.979 166.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.9 pt -103.01 170.4 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.606 0.717 . . . . 73.21 112.186 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -54.4 -34.35 61.11 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.206 1.002 . . . . 64.43 113.243 172.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.46 -1.04 49.03 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.493 0.717 . . . . 61.41 112.373 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -80.12 -17.96 51.14 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.202 1.001 . . . . 63.34 111.156 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 71' ' ' VAL . 82.2 mt -122.2 140.29 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.725 1.21 . . . . 74.2 111.076 -165.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -75.42 -49.86 17.63 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.265 0.626 . . . . 71.33 112.027 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -68.14 -5.2 16.66 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.606 0.965 . . . . 75.01 113.606 -174.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.486 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -61.01 -58.6 7.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 122.854 0.462 . . . . 35.13 111.626 169.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.85 32.76 83.8 Favored Glycine 0 N--CA 1.48 1.577 0 O-C-N 121.967 -0.458 . . . . 74.33 112.441 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.4 p30 44.6 28.28 0.31 Allowed 'General case' 0 CA--C 1.57 1.733 0 C-N-CA 126.236 1.814 . . . . 72.13 114.268 -166.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 42.4 pttt -100.22 166.23 11.09 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.537 -0.542 . . . . 52.24 109.537 174.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 m -80.97 108.98 15.12 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.621 0.368 . . . . 71.31 110.537 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.561 HD13 HG11 ' A' ' 71' ' ' VAL . 50.9 mt -78.85 129.16 34.27 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.45 0.7 . . . . 72.43 110.63 175.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -98.32 145.27 29.55 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.601 0.76 . . . . 63.24 111.29 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.461 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 97.9 Cg_exo -47.07 130.12 15.99 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.536 2.824 . . . . 52.14 114.327 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.16 -12.68 48.69 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 123.17 0.414 . . . . 53.02 113.221 -174.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.1 143.77 41.08 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.604 0.762 . . . . 60.4 112.561 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -107.03 130.33 54.67 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.956 0.902 . . . . 73.34 110.428 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 65' ' ' LEU . 28.0 m -133.36 175.77 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 124.159 0.984 . . . . 73.23 111.493 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -117.61 136.02 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.571 0.748 . . . . 73.1 109.864 171.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.5 mt -88.72 120.7 30.36 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.818 0.847 . . . . 73.12 110.791 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.04 1.32 56.23 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.09 0.556 . . . . 70.23 112.457 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.91 157.83 18.85 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.448 0.699 . . . . 53.13 112.108 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.9 p -118.03 128.95 55.26 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.924 -0.769 . . . . 24.22 108.924 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -141.5 -42.85 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.524 -1.288 . . . . 71.34 107.524 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -157.21 -176.17 5.82 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 114.058 -1.428 . . . . 61.05 110.596 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.439 ' HB3' HD22 ' A' ' 41' ' ' ASN . 34.9 mmtp -60.74 124.15 19.59 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.595 0.758 . . . . 61.32 112.493 178.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.9 14.36 82.42 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 114.718 0.647 . . . . 33.44 114.718 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.5 tpt -69.71 -59.51 2.9 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.36 0.58 . . . . 72.45 111.174 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -67.55 129.29 39.45 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 115.998 -0.547 . . . . 75.03 111.453 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.86 -9.48 61.89 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 116.473 -0.33 . . . . 52.53 113.553 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.67 148.62 31.53 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.261 0.624 . . . . 74.33 111.852 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.3 m -89.7 122.32 32.7 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.196 0.598 . . . . 62.14 109.629 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.84 141.71 36.79 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.461 0.704 . . . . 41.34 111.359 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -98.79 115.62 29.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.318 1.447 . . . . 73.45 108.78 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.7 mm -69.09 96.23 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 109.03 -0.73 . . . . 50.3 109.03 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -71.65 -36.87 70.84 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.778 0.431 . . . . 73.43 110.154 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.461 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . 26.5 t -166.65 162.69 16.58 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.5 -0.773 . . . . 74.0 111.37 -177.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.14 135.76 49.29 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.253 1.021 . . . . 74.21 110.355 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -138.51 135.2 34.86 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.378 0.671 . . . . 72.12 111.399 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -90.0 94.87 9.97 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.463 -0.94 . . . . 74.31 108.463 171.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -136.08 154.99 50.85 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.427 0.691 . . . . 61.55 110.803 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 m -87.78 116.59 26.03 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.151 -0.685 . . . . 72.51 109.151 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.2 m -111.47 134.99 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.189 0.996 . . . . 44.44 109.529 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.92 148.61 36.52 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.989 0.9 . . . . 70.44 112.871 -169.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.7 ttp -103.11 111.35 23.68 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.966 -1.47 . . . . 74.5 107.312 167.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.8 m -123.84 147.62 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 112.891 0.7 . . . . 74.24 112.891 -170.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -105.24 117.65 34.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.926 0.89 . . . . 73.11 108.835 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -130.56 169.13 15.99 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.617 0.723 . . . . 74.14 111.692 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.2 m -116.82 133.3 56.18 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 108.931 -0.766 . . . . 64.44 108.931 167.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.2 t -72.82 129.31 37.89 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.78 0.432 . . . . 72.03 111.671 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.6 p -66.04 -41.54 90.75 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.066 0.946 . . . . 75.42 112.094 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.0 p -85.63 -50.05 7.52 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.31 0.644 . . . . 72.21 112.282 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.0 m -88.81 -24.02 22.69 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.0 0.741 . . . . 75.53 113.0 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 4.34 79.26 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 114.334 0.494 . . . . 53.3 114.334 -177.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -68.36 131.59 45.58 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.359 0.874 . . . . 64.32 113.359 -176.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -84.72 86.21 7.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.793 0.837 . . . . 63.03 109.405 174.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.91 125.61 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 115.866 -0.607 . . . . 61.14 109.726 -172.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.93 153.61 33.31 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.093 0.473 . . . . 73.41 111.471 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.454 HD22 ' N ' ' A' ' 112' ' ' ASN . 0.8 OUTLIER 60.5 28.45 18.12 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 114.522 -1.217 . . . . 73.11 112.563 177.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -66.78 130.1 42.05 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.525 0.73 . . . . 75.34 110.807 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -162.3 154.79 19.46 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 115.672 -0.695 . . . . 72.2 111.465 -169.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.672 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 96.6 m95 -103.23 133.04 48.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.473 -1.392 . . . . 72.4 111.862 0.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -126.88 139.72 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.604 1.162 . . . . 65.23 109.051 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.3 p -94.72 173.48 7.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.826 -0.546 . . . . 74.44 112.055 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.43 -19.99 65.88 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.367 0.667 . . . . 72.15 111.24 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.65 -33.98 71.56 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.953 0.901 . . . . 73.4 110.807 173.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.95 -2.64 58.47 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.166 0.586 . . . . 64.44 111.742 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.16 160.86 28.16 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.032 0.92 . . . . 74.21 111.018 -173.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.3 m -140.63 146.98 38.64 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 107.206 -1.405 . . . . 75.02 107.206 168.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.494 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -58.76 162.14 4.25 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 119.177 0.899 . . . . 42.0 111.567 176.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 tptm . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.454 0.645 . . . . 72.13 111.33 -176.749 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.464 ' SD ' HG11 ' A' ' 7' ' ' VAL . 64.2 mtt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 110.274 -0.269 . . . . 65.42 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.17 161.86 14.09 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.398 0.679 . . . . 64.51 111.128 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.4 t -65.96 125.36 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 121.116 0.484 . . . . 73.24 111.315 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.02 -1.68 35.49 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.532 0.587 . . . . 25.14 112.993 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.3 m -73.58 129.77 38.65 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.319 0.647 . . . . 53.05 111.897 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -99.24 117.27 33.33 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.367 0.667 . . . . 73.35 109.639 174.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.464 HG11 ' SD ' ' A' ' 1' ' ' MET . 30.5 m -134.38 153.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 124.114 0.966 . . . . 61.5 110.917 -168.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.56 126.29 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 123.301 0.64 . . . . 73.1 110.059 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 22' ' ' ALA . 25.7 mt -83.88 131.56 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 122.013 -0.429 . . . . 70.35 110.849 -171.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -96.08 -51.24 4.51 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 118.116 0.416 . . . . 71.41 111.724 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m -93.21 140.69 29.25 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.049 0.54 . . . . 71.44 109.56 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 14' ' ' MET . 93.0 p -128.44 125.45 38.54 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.758 0.651 . . . . 64.31 112.758 -171.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -84.05 -41.35 17.29 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.755 0.822 . . . . 72.24 108.841 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' SER . 25.1 mmt -101.56 153.22 19.92 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.34 1.056 . . . . 65.34 109.478 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -63.71 -35.52 80.84 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.209 0.818 . . . . 73.25 113.209 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.62 -1.26 89.2 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 114.347 0.499 . . . . 63.42 114.347 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.492 ' HG2' HG21 ' A' ' 9' ' ' ILE . 52.7 ttm -75.2 -30.12 60.53 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 122.979 0.512 . . . . 62.22 110.05 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -63.21 119.25 9.22 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.896 0.878 . . . . 74.45 111.79 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.42 2.25 78.96 Favored Glycine 0 CA--C 1.539 1.548 0 N-CA-C 114.667 0.627 . . . . 51.35 114.667 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.76 149.12 38.06 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.22 0.608 . . . . 63.23 111.93 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -85.14 102.32 13.18 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.652 -0.499 . . . . 65.14 109.652 174.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.609 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -85.24 147.07 26.76 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.559 0.744 . . . . 53.21 111.552 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.0 m -119.3 116.5 26.36 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.1 -1.074 . . . . 72.43 108.1 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.37 100.49 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 N-CA-C 109.607 -0.516 . . . . 71.4 109.607 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.1 p -91.72 -9.18 44.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.158 0.583 . . . . 42.44 110.927 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.05 137.32 4.73 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.833 -0.507 . . . . 31.43 111.833 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.87 106.93 13.5 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.888 0.875 . . . . 65.24 109.297 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -112.48 128.18 56.26 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.808 0.843 . . . . 72.04 110.298 -172.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -114.36 93.13 4.21 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.382 -0.599 . . . . 60.42 109.382 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.515 HG21 HD12 ' A' ' 53' ' ' ILE . 8.2 t -137.09 -179.53 5.77 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.853 0.861 . . . . 41.2 111.356 -176.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.8 m -75.8 116.94 17.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.976 0.511 . . . . 75.43 110.305 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.05 151.0 22.32 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.411 0.684 . . . . 44.42 110.191 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -130.6 146.11 52.04 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.485 0.659 . . . . 73.32 111.373 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.82 118.8 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.665 -1.235 . . . . 62.44 107.665 168.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.475 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 27.0 m -123.79 144.71 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.331 0.493 . . . . 74.53 112.331 -175.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.7 m -114.5 132.65 56.22 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.73 0.812 . . . . 74.43 110.303 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.419 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 46.1 p90 -160.5 160.52 32.07 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.08 0.552 . . . . 64.44 111.276 -174.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.9 m -113.99 114.96 46.08 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 108.501 -0.926 . . . . 61.31 108.501 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.31 127.18 24.92 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.972 2.448 . . . . 72.21 113.025 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.6 p -64.44 -17.34 63.72 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.462 1.105 . . . . 51.23 113.833 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -82.93 11.11 6.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.251 0.62 . . . . 74.53 112.335 176.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.66 51.24 5.62 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 122.735 0.207 . . . . 71.21 113.306 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.97 -171.61 26.33 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 122.559 0.123 . . . . 63.54 113.072 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.74 124.78 28.19 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.12 -1.067 . . . . 62.43 108.12 174.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -50.35 114.01 1.02 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.798 0.839 . . . . 73.42 112.469 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.9 t -75.17 96.86 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.468 -0.787 . . . . 54.01 109.825 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -85.46 117.96 24.69 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.498 -0.774 . . . . 70.35 109.915 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.8 m170 58.22 59.88 2.87 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.129 0.972 . . . . 74.42 112.136 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -59.8 121.47 11.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.011 0.925 . . . . 73.04 111.562 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 98.5 mttt -126.66 136.17 52.14 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.854 0.861 . . . . 62.44 110.234 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 89.1 m95 -115.46 146.56 41.53 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.906 1.282 . . . . 73.43 111.698 -10.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.02 151.83 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 113.813 -1.539 . . . . 70.32 108.205 166.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 96' ' ' VAL . 33.0 pt -118.93 -177.07 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 120.96 0.409 . . . . 65.12 110.948 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.453 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 30.5 tt0 -49.73 -33.13 15.2 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.734 1.214 . . . . 63.43 113.822 175.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.486 ' H ' HG13 ' A' ' 53' ' ' ILE . 7.5 tp10 -62.59 -26.43 68.59 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 113.117 0.784 . . . . 65.22 113.117 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.44 -13.62 54.38 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 112.654 0.613 . . . . 71.42 112.654 -173.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.41 137.37 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.285 0.634 . . . . 73.03 110.958 -171.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.527 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 27.1 ttpt -78.28 -37.08 45.76 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.455 1.102 . . . . 71.51 112.434 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.07 -14.7 59.78 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.093 0.957 . . . . 74.33 112.821 -173.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -49.86 -63.35 1.14 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.881 1.067 . . . . 74.12 113.881 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.67 33.85 88.35 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 115.234 0.853 . . . . 70.13 115.234 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 67.07 16.81 10.37 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.607 1.163 . . . . 65.23 113.24 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 12.0 ptpt -106.47 176.43 5.17 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.256 0.551 . . . . 63.24 111.073 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.3 m -96.48 113.82 25.43 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.031 0.933 . . . . 75.2 109.156 168.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.0 mt -77.03 136.93 38.7 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.25 0.62 . . . . 53.22 110.168 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -95.55 152.59 39.31 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 123.522 0.729 . . . . 71.44 111.489 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 82.7 Cg_exo -50.86 119.88 5.87 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.124 2.549 . . . . 73.24 113.395 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.85 -13.98 26.84 Favored Glycine 0 N--CA 1.48 1.609 0 CA-C-O 119.959 -0.356 . . . . 54.43 113.815 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.55 120.63 14.89 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.736 0.768 . . . . 70.34 112.123 176.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -89.1 120.68 30.71 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.6 -0.727 . . . . 74.51 109.839 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.88 166.43 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.695 1.198 . . . . 73.3 110.906 -172.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.9 mm -112.11 135.81 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.612 0.765 . . . . 71.41 110.116 171.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.7 mt -83.29 122.82 28.95 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.064 0.545 . . . . 70.32 111.291 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 45.5 mm-40 -93.29 13.19 22.09 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 123.173 0.589 . . . . 54.11 112.043 173.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.14 156.44 32.32 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.358 0.663 . . . . 73.15 110.138 169.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.4 t -139.83 126.65 20.69 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.929 -0.578 . . . . 75.41 110.149 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -110.37 2.01 18.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.852 0.861 . . . . 71.44 109.859 171.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -173.44 161.03 4.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.737 1.215 . . . . 63.11 110.336 -174.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -68.22 124.28 23.04 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 120.728 0.299 . . . . 60.1 110.65 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.92 41.42 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.575 -0.569 . . . . 72.13 113.897 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.6 ttt -98.69 -58.42 1.96 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 117.469 0.635 . . . . 73.45 110.172 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -66.96 131.2 45.38 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.333 0.253 . . . . 74.14 110.522 171.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.69 -15.91 59.34 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 116.587 -0.279 . . . . 75.43 113.218 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.38 151.82 30.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.289 0.636 . . . . 35.31 111.687 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.1 m -87.55 118.82 27.27 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.478 -0.783 . . . . 75.03 110.165 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.475 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -116.98 149.5 40.12 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.195 0.998 . . . . 74.32 110.112 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -115.03 129.23 56.66 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.968 -0.382 . . . . 73.42 109.968 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 67' ' ' PRO . 32.0 mm -66.21 108.7 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 N-CA-C 109.415 -0.587 . . . . 71.32 109.415 174.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -75.16 -38.91 60.76 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.184 0.516 . . . . 65.31 109.951 170.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.8 t -161.73 152.7 18.07 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.22 -0.9 . . . . 71.43 111.388 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -128.55 132.74 48.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.946 0.899 . . . . 72.41 110.076 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -134.57 143.83 47.6 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.413 0.685 . . . . 63.52 111.415 -171.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -98.27 94.16 6.62 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.69 -0.856 . . . . 71.24 108.69 170.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -136.56 155.9 49.32 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.522 0.729 . . . . 74.21 110.992 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.2 m -84.11 119.54 25.1 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.15 -0.685 . . . . 54.21 109.15 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 53' ' ' ILE . 15.8 m -107.24 135.33 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.853 0.861 . . . . 60.13 109.049 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.462 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 86.3 m-85 -109.82 135.88 50.01 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.451 0.643 . . . . 72.52 111.475 -174.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.3 ttp -90.18 111.74 23.01 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.319 -1.363 . . . . 74.14 107.319 167.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.49 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 27.3 m -124.08 144.91 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 113.435 0.902 . . . . 61.13 113.435 -170.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -109.61 118.22 36.01 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.942 1.297 . . . . 55.1 108.315 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.45 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 55.0 p90 -139.6 166.66 24.0 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.265 0.839 . . . . 53.24 113.265 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.2 m -100.39 109.34 21.5 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.963 -1.017 . . . . 55.44 109.333 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.2 m -57.54 106.06 0.3 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.3 0.64 . . . . 65.33 111.181 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.7 p -61.4 -23.05 65.53 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.0 0.92 . . . . 75.04 113.295 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.8 t -65.88 -25.99 67.43 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.428 0.899 . . . . 73.23 113.428 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.2 t -142.63 -42.55 0.32 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.636 0.606 . . . . 74.04 112.636 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.01 -8.89 18.6 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 123.259 0.457 . . . . 71.12 113.141 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.21 139.54 54.53 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.86 0.864 . . . . 64.22 111.955 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -85.0 114.74 22.39 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.4 0.68 . . . . 74.12 111.151 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.1 t -88.84 104.9 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 108.075 -1.083 . . . . 73.12 108.075 171.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -93.84 131.8 38.89 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.396 -0.82 . . . . 74.22 110.721 -168.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.5 p30 45.48 52.9 8.8 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 125.29 1.436 . . . . 74.42 114.286 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -57.83 139.7 53.48 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.542 1.137 . . . . 75.45 112.876 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 68.1 mttm -131.67 128.39 38.92 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 124.249 1.02 . . . . 71.12 111.063 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 94.3 m95 -120.81 160.97 22.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.918 1.687 . . . . 65.24 111.203 -13.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.73 166.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 124.31 1.044 . . . . 74.14 109.806 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 53.2 p -117.18 167.4 11.23 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.098 0.559 . . . . 62.22 111.214 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.462 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 36.0 tt0 -67.24 -24.57 65.83 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.782 0.433 . . . . 73.52 111.601 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.2 -30.91 71.94 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.442 0.697 . . . . 70.22 111.441 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -93.65 -3.11 53.06 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.15 0.98 . . . . 70.0 111.942 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.6 mt -117.1 123.46 46.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.808 0.843 . . . . 61.24 109.639 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.43 ' O ' ' HB ' ' A' ' 7' ' ' VAL . 58.0 m -104.0 150.63 24.07 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.682 -0.858 . . . . 74.2 108.682 172.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.17 169.8 9.7 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.205 0.457 . . . . 74.04 111.38 174.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.5 tptp . . . . . 0 CA--C 1.564 1.487 0 C-N-CA 123.011 0.525 . . . . 65.33 111.285 177.802 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.404 ' HB3' HG21 ' A' ' 24' ' ' VAL . 23.7 mmt . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 110.934 -0.025 . . . . 44.4 110.934 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.532 ' HD2' ' H ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -110.36 149.19 30.59 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.35 0.66 . . . . 65.42 110.669 178.009 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.37 130.04 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 123.333 0.653 . . . . 73.43 111.414 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.73 -8.75 56.56 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 115.42 -0.809 . . . . 72.52 113.081 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.1 t -85.4 151.51 23.95 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.577 0.584 . . . . 74.11 112.577 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -100.59 117.46 34.77 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.153 0.981 . . . . 74.11 110.266 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.48 154.88 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.947 0.899 . . . . 55.14 111.293 -176.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.8 mm -100.61 133.51 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.23 1.012 . . . . 74.43 110.511 172.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 17' ' ' MET . 33.0 mt -84.63 123.91 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 122.162 -0.336 . . . . 74.4 110.325 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -100.66 -46.55 5.14 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.274 0.63 . . . . 62.51 112.46 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 79.0 m -109.14 140.83 42.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.717 0.807 . . . . 62.54 109.293 -176.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 17' ' ' MET . 13.7 m -160.46 163.46 32.97 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.631 0.604 . . . . 41.25 112.631 -169.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -95.79 -40.34 9.4 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.414 -0.812 . . . . 75.02 109.053 164.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.6 mpt? -84.02 142.06 30.73 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.998 0.919 . . . . 45.42 111.028 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 12.2 mptt -72.18 -26.71 62.18 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.299 0.64 . . . . 70.14 112.016 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.62 -4.77 81.89 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 114.999 0.76 . . . . 33.45 114.999 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.43 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 63.4 mtt -87.87 -26.29 22.85 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 117.558 0.679 . . . . 52.24 112.364 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 25.6 pttm -61.75 118.84 7.67 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.154 0.502 . . . . 72.42 111.522 -175.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.1 1.94 70.5 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 113.939 0.336 . . . . 64.4 113.939 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.12 138.38 47.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.292 0.637 . . . . 73.33 112.279 -177.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -78.87 97.61 6.04 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.521 0.728 . . . . 71.14 110.11 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.56 157.31 16.04 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.23 1.012 . . . . 72.25 111.601 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.3 m -126.73 124.27 39.37 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.992 -0.744 . . . . 65.13 108.992 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.423 ' HA ' HG12 ' A' ' 99' ' ' VAL . 46.6 t -72.75 102.17 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.241 0.616 . . . . 55.53 110.001 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.9 p -99.92 -2.76 33.91 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.334 0.654 . . . . 71.14 112.718 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.07 151.81 20.95 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 112.283 -0.327 . . . . 72.3 112.283 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.93 108.82 7.59 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.756 0.822 . . . . 74.41 110.558 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.407 ' HB2' HG23 ' A' ' 96' ' ' VAL . 4.6 m-85 -108.87 122.63 47.59 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.959 0.904 . . . . 71.31 110.597 -174.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -100.01 83.24 2.67 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 122.058 0.932 . . . . 64.02 109.74 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.3 t -133.95 170.4 15.68 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 115.506 -0.77 . . . . 54.02 111.443 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.2 m -87.51 122.66 31.51 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.97 0.508 . . . . 50.35 109.96 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.1 154.77 27.18 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.16 0.984 . . . . 44.12 109.989 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.429 ' HB2' HG23 ' A' ' 52' ' ' VAL . 91.5 m-85 -130.28 149.4 51.99 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.916 0.865 . . . . 75.13 113.099 -169.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -102.25 111.17 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 113.941 -1.482 . . . . 74.11 108.055 171.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.494 HG12 HD13 ' A' ' 88' ' ' ILE . 22.2 m -125.12 146.99 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 113.203 0.816 . . . . 54.41 113.203 -172.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 66.6 p -117.73 129.98 56.04 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.374 1.07 . . . . 74.33 110.775 176.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.642 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 37.9 p90 -159.09 160.35 35.61 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.569 0.7 . . . . 75.21 111.639 -171.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.0 m -113.55 116.76 45.69 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 107.511 -1.292 . . . . 54.31 107.511 173.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.43 147.17 17.37 Favored 'Trans proline' 0 CA--C 1.564 2.013 0 C-N-CA 123.228 2.618 . . . . 73.13 113.271 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.5 p -63.55 -18.79 64.23 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.697 0.799 . . . . 75.33 111.998 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.76 -21.4 66.51 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.957 0.903 . . . . 70.3 111.984 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 33.35 70.63 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 114.782 0.673 . . . . 75.13 114.782 172.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.09 -113.62 2.68 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-N 117.16 0.48 . . . . 60.53 111.961 174.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -70.65 175.36 4.96 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.684 0.794 . . . . 72.42 112.934 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -116.78 129.29 56.01 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.165 -0.925 . . . . 73.33 108.64 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.29 102.62 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 122.969 0.508 . . . . 71.1 109.952 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.7 p-10 -109.97 153.91 23.9 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.698 0.799 . . . . 65.11 111.218 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 34.5 m80 55.63 33.78 21.92 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.21 1.004 . . . . 63.04 112.303 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -70.91 134.74 47.49 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.912 1.285 . . . . 70.53 111.59 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 18.0 ptpt -139.7 139.38 36.56 Favored 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.68 0.792 . . . . 73.2 110.723 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 92.3 m95 -115.97 149.28 39.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 119.86 -1.775 . . . . 73.45 112.419 -3.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.429 HG23 ' HB2' ' A' ' 33' ' ' TYR . 15.8 m -127.36 132.84 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 114.519 -1.219 . . . . 73.51 109.131 170.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.2 pt -104.31 176.17 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.9 -0.5 . . . . 74.2 112.324 -171.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -45.07 -52.55 8.9 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.544 1.138 . . . . 64.04 113.773 171.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.01 -16.26 63.14 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.59 0.756 . . . . 74.52 111.976 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.607 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 7.9 tt0 -93.53 -17.03 23.84 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.418 1.087 . . . . 70.24 111.423 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.2 mt -111.94 127.4 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.208 1.003 . . . . 74.15 110.838 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -61.82 -56.16 22.31 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.685 0.794 . . . . 71.15 112.057 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.27 -17.43 62.49 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.633 0.975 . . . . 74.22 113.633 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.623 ' HA ' HD11 ' A' ' 65' ' ' LEU . . . -38.12 -47.03 1.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.869 1.433 . . . . 60.35 114.869 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.65 18.04 67.63 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 114.871 0.708 . . . . 74.24 114.871 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 63.65 17.86 10.71 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.945 1.298 . . . . 73.2 112.719 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.2 171.54 7.45 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.84 0.856 . . . . 72.44 110.466 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.1 m -89.97 112.68 24.15 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.306 -0.628 . . . . 71.23 109.306 173.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.623 HD11 ' HA ' ' A' ' 60' ' ' ALA . 49.5 mt -74.45 130.23 39.24 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.617 0.767 . . . . 73.02 110.618 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -100.43 152.91 37.97 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 123.634 0.773 . . . . 75.24 111.269 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -54.24 114.42 1.81 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.971 2.447 . . . . 44.51 113.685 177.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.95 -10.34 18.2 Favored Glycine 0 N--CA 1.481 1.655 0 CA-C-N 115.845 -0.616 . . . . 42.11 114.13 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -77.56 133.49 38.48 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.626 0.713 . . . . 74.31 112.353 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -98.31 120.36 38.6 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.2 -0.909 . . . . 45.14 109.184 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.568 HG11 HD13 ' A' ' 65' ' ' LEU . 19.4 m -124.7 169.98 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.574 0.75 . . . . 65.14 112.355 -171.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mm -117.37 141.15 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.936 0.894 . . . . 75.41 109.938 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.29 124.2 40.2 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.56 0.744 . . . . 64.52 111.363 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.01 -36.39 19.79 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 122.936 0.494 . . . . 74.44 112.322 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.607 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -86.82 169.52 12.51 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.07 0.462 . . . . 61.41 111.305 175.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.759 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 8.7 t -142.62 126.1 16.75 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.308 -0.405 . . . . 70.44 111.122 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -95.73 -28.05 14.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.588 0.755 . . . . 74.0 111.024 169.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 60.1 mtm -133.75 177.04 8.02 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.669 0.788 . . . . 74.51 111.86 -170.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -68.07 106.23 2.31 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-O 121.586 0.707 . . . . 65.53 112.043 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.14 22.98 36.2 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 116.023 -0.535 . . . . 75.13 114.293 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -85.06 -38.66 18.89 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 117.495 0.647 . . . . 65.2 111.04 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.759 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 59.3 tttp -67.04 124.83 24.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.038 0.535 . . . . 55.22 110.845 170.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.74 0.24 87.79 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-O 120.196 -0.224 . . . . 61.41 113.013 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.55 151.51 25.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.181 0.592 . . . . 75.11 111.358 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 51.2 m -92.08 117.74 30.13 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.332 -0.849 . . . . 75.54 109.888 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.642 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -105.69 150.79 25.15 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.557 0.743 . . . . 73.45 110.902 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -114.86 121.08 42.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.296 1.038 . . . . 73.1 110.153 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.494 HD13 HG12 ' A' ' 35' ' ' VAL . 36.9 mm -68.87 109.26 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 122.346 0.258 . . . . 61.21 110.753 -178.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -82.58 -37.13 25.51 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.262 0.625 . . . . 74.03 110.713 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.9 t -162.79 153.92 17.37 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.23 0.612 . . . . 73.51 111.727 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.89 132.57 56.66 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.25 1.02 . . . . 61.41 110.442 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -129.26 130.91 46.82 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.382 0.673 . . . . 70.43 112.222 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -92.91 93.26 8.29 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 108.248 -1.019 . . . . 73.42 108.248 167.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.8 t -138.25 154.22 49.07 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.275 0.63 . . . . 62.35 111.627 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.0 m -88.26 124.54 33.97 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.52 -0.548 . . . . 71.43 109.52 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.407 HG23 ' HB2' ' A' ' 28' ' ' TYR . 16.5 m -110.02 131.95 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 108.921 -0.77 . . . . 72.11 108.921 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.73 141.69 36.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.212 1.005 . . . . 70.11 111.423 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.6 ttp -93.65 115.76 28.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 108.367 -0.975 . . . . 74.34 108.367 171.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 24' ' ' VAL . 35.5 m -126.21 166.88 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 112.482 0.549 . . . . 60.24 112.482 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -133.74 129.12 36.25 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.781 0.432 . . . . 62.1 111.767 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -138.29 176.04 9.05 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.883 0.873 . . . . 62.54 111.541 -173.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.5 m -114.41 134.57 54.89 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.652 0.781 . . . . 72.53 109.496 171.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.3 t -68.25 119.53 12.95 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.319 0.648 . . . . 71.12 111.589 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.5 p -71.0 -26.11 62.98 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.862 0.865 . . . . 70.45 112.651 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.3 p -81.55 -56.64 3.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.82 0.448 . . . . 64.44 111.417 175.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.7 t -92.25 -51.06 5.34 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.72 0.808 . . . . 40.52 112.789 -172.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.44 -15.96 19.78 Favored Glycine 0 N--CA 1.478 1.492 0 CA-C-N 116.03 -0.532 . . . . 20.12 112.7 -168.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -51.29 113.48 0.96 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.854 1.262 . . . . 53.4 112.467 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -80.48 120.65 24.76 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.265 -0.643 . . . . 44.33 109.265 173.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.0 t -111.11 123.22 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.646 0.778 . . . . 72.24 109.111 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -113.4 153.76 28.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.943 0.497 . . . . 63.24 111.606 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 56.4 29.12 14.64 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.448 1.099 . . . . 62.44 113.211 177.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -59.31 139.68 56.77 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.033 0.933 . . . . 74.23 113.27 -174.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 66.6 mttm -142.11 135.07 28.72 Favored 'General case' 0 CA--C 1.572 1.804 0 C-N-CA 125.361 1.464 . . . . 62.45 110.088 -175.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 80.7 m95 -114.4 143.51 44.81 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.36 1.891 . . . . 72.31 111.5 -11.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.57 141.86 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 124.435 1.094 . . . . 72.44 108.944 170.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 69.3 p -100.6 -177.93 3.63 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.67 0.748 . . . . 74.54 112.264 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -55.95 -28.47 57.11 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 124.821 1.249 . . . . 64.41 111.776 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.07 -28.48 60.37 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.902 0.881 . . . . 74.24 112.095 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.452 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 1.5 mp0 -87.77 -9.23 54.56 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.6 0.36 . . . . 73.32 111.881 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.4 mt -121.45 127.26 50.93 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.171 0.589 . . . . 73.01 110.815 -172.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.5 m -118.91 133.12 56.04 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.162 0.985 . . . . 61.51 109.289 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.35 155.77 31.28 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.64 0.376 . . . . 61.33 111.896 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.5 tptp . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 121.066 0.46 . . . . 70.52 110.482 178.731 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.417 ' HG2' HG21 ' A' ' 24' ' ' VAL . 49.4 tpp . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 110.102 -0.333 . . . . 71.34 110.102 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -92.96 155.99 17.2 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.291 0.567 . . . . 71.01 112.343 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.8 t -68.12 136.12 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 123.859 0.863 . . . . 75.04 110.821 173.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.22 -12.04 66.96 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 116.077 -0.51 . . . . 74.13 113.399 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.1 t -76.38 141.05 41.59 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 117.417 0.608 . . . . 33.34 111.738 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -99.25 121.46 41.08 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.236 0.615 . . . . 74.34 110.218 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.512 ' HA ' ' H ' ' A' ' 124' ' ' LYS . 32.7 m -125.24 156.16 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.091 0.956 . . . . 70.43 111.571 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.518 HD13 ' HA ' ' A' ' 21' ' ' GLU . 35.9 mm -103.96 135.71 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.493 -0.929 . . . . 73.13 108.493 165.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.3 mt -88.59 119.86 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 109.268 -0.641 . . . . 71.22 109.268 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.66 -28.82 17.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 122.089 -0.382 . . . . 72.23 111.814 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.495 ' HB ' ' HG2' ' A' ' 120' ' ' GLU . 66.4 m -136.28 141.95 43.9 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.043 0.937 . . . . 72.34 109.416 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -169.4 174.0 6.24 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.41 0.624 . . . . 72.12 112.148 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -98.41 2.19 47.6 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.238 -0.892 . . . . 74.43 112.425 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 23.3 mmt -115.4 127.34 55.3 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.508 0.723 . . . . 73.25 109.278 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' H ' ' HD3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -52.98 -41.87 65.0 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.393 1.077 . . . . 61.1 112.877 179.322 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.35 -8.23 85.46 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.371 0.509 . . . . 74.51 114.371 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 42.7 ttp -96.14 -28.93 14.34 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 117.285 0.542 . . . . 74.34 110.334 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -69.26 119.64 13.84 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.152 0.581 . . . . 74.21 109.627 173.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.6 2.5 89.97 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 115.399 -0.819 . . . . 44.33 114.358 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.88 161.89 18.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 113.55 0.945 . . . . 73.43 113.55 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.518 ' HA ' HD13 ' A' ' 8' ' ' ILE . 10.9 tp10 -76.99 138.73 39.79 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.89 -1.05 . . . . 74.44 110.439 172.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.77 166.67 30.66 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.436 0.636 . . . . 62.35 112.672 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.5 m -138.53 129.22 26.42 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.702 0.801 . . . . 53.13 110.408 173.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.417 HG21 ' HG2' ' A' ' 1' ' ' MET . 80.8 t -77.71 104.73 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.513 0.725 . . . . 54.35 109.741 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.7 p -103.02 -2.42 27.59 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.567 0.747 . . . . 62.11 112.394 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.47 142.44 9.05 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-O 120.076 -0.291 . . . . 54.42 112.494 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.97 111.36 14.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.421 0.688 . . . . 70.31 111.231 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -118.08 110.11 17.24 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.303 1.041 . . . . 74.11 110.203 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.21 76.3 3.02 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 122.159 0.981 . . . . 70.35 108.99 174.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -133.06 168.95 17.57 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.736 -0.665 . . . . 43.5 112.258 -169.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 m -70.55 119.77 15.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.122 0.569 . . . . 72.35 111.116 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.36 146.51 28.72 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.6 0.76 . . . . 65.4 109.421 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -127.98 148.04 50.51 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.985 0.898 . . . . 64.23 111.713 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.0 t -102.61 109.7 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 114.156 -1.383 . . . . 74.04 107.707 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.456 HG12 HD13 ' A' ' 88' ' ' ILE . 30.6 m -111.63 167.43 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 118.533 0.606 . . . . 64.22 112.301 -175.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.3 p -141.59 126.58 18.3 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.192 0.597 . . . . 43.32 110.588 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -161.99 128.29 3.67 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 112.772 0.656 . . . . 73.21 112.772 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 73.3 m -71.07 117.76 59.38 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-O 119.083 -0.484 . . . . 73.2 110.099 159.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.57 140.6 94.62 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.143 2.562 . . . . 70.44 113.235 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.7 p -64.61 -16.05 62.1 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 114.43 1.27 . . . . 71.3 114.43 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.492 ' ND2' ' HB3' ' A' ' 79' ' ' LYS . 28.0 p-10 -79.39 -6.02 55.89 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.061 0.545 . . . . 72.33 112.429 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.34 45.99 5.99 Favored Glycine 0 CA--C 1.535 1.281 0 N-CA-C 112.108 -0.397 . . . . 64.15 112.108 -172.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.57 -177.9 39.79 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 122.932 0.301 . . . . 61.33 112.961 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -65.16 123.32 19.22 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 119.277 -0.392 . . . . 75.13 110.177 173.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 12.2 ttm180 -51.95 111.08 0.55 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.216 0.606 . . . . 72.25 111.6 173.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 49' ' ' HIS . 21.6 t -88.54 102.76 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 115.532 -0.758 . . . . 63.32 110.248 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -97.89 143.01 28.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.703 0.801 . . . . 75.43 110.43 -177.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.7 m170 56.96 33.92 24.07 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.763 0.825 . . . . 35.21 111.871 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.573 ' HB2' HG12 ' A' ' 46' ' ' VAL . 85.7 t60 -62.95 132.67 52.83 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.409 1.084 . . . . 61.13 111.85 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -154.99 152.31 29.53 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 114.562 -1.199 . . . . 72.13 109.492 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.6 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 72.7 m95 -106.36 126.17 51.91 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.254 -1.529 . . . . 72.44 112.35 4.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.3 m -113.89 133.67 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.377 1.071 . . . . 63.23 108.625 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.6 pt -97.12 157.6 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-O 120.85 0.357 . . . . 71.54 110.675 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -54.57 -36.59 64.55 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.606 0.762 . . . . 72.11 112.922 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -70.76 -14.34 62.4 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.142 0.577 . . . . 72.12 112.211 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -94.69 -19.66 20.21 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.246 1.018 . . . . 75.12 111.268 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.5 mt -89.07 137.32 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.583 0.753 . . . . 74.41 109.968 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.551 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 36.8 ttpt -76.67 -45.29 30.34 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.039 0.536 . . . . 61.11 111.496 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.467 ' HB3' HG12 ' A' ' 71' ' ' VAL . 5.9 t70 -68.51 -9.54 49.78 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.686 0.794 . . . . 62.32 112.625 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.582 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -42.21 -65.23 0.48 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.781 1.4 . . . . 64.42 114.781 176.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.47 13.53 58.57 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 114.894 0.718 . . . . 40.44 114.894 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.71 13.89 7.76 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.197 1.399 . . . . 61.53 112.779 -172.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -98.96 155.18 17.54 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.768 0.827 . . . . 72.3 110.48 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.9 m -72.65 109.21 6.12 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.389 0.276 . . . . 70.12 111.009 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.418 HD11 ' HA ' ' A' ' 60' ' ' ALA . 62.9 mt -86.63 146.23 26.41 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.361 0.665 . . . . 71.42 109.242 173.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -139.28 169.06 13.22 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 124.01 0.924 . . . . 64.51 110.741 -171.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 1.4 Cg_endo -44.1 109.6 0.16 Allowed 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 123.331 2.687 . . . . 63.44 114.459 172.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.91 -17.27 13.12 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.262 0.865 . . . . 40.53 115.262 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.99 120.94 14.02 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 118.413 1.106 . . . . 75.32 111.526 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -89.72 119.34 30.04 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.289 -0.634 . . . . 61.21 109.289 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' A' ' 59' ' ' ASP . 32.0 m -124.07 168.01 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.644 0.777 . . . . 72.55 111.76 -172.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.8 mm -118.74 137.91 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 123.409 0.684 . . . . 45.24 110.083 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.5 mt -92.4 109.34 20.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.821 0.848 . . . . 72.51 110.638 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.551 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 67.9 mm-40 -83.11 -9.93 58.95 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.55 0.945 . . . . 52.11 113.55 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.2 170.55 8.38 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.403 0.62 . . . . 63.22 111.065 174.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 81' ' ' MET . 31.1 t -143.81 125.42 14.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.403 -0.817 . . . . 73.51 109.173 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -103.72 -4.74 23.3 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.626 0.77 . . . . 73.45 110.465 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -165.88 -176.07 3.67 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.691 0.796 . . . . 72.42 111.386 -168.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HB3' ' ND2' ' A' ' 41' ' ' ASN . 5.5 mptp? -59.35 114.36 2.63 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 112.803 0.668 . . . . 72.0 112.803 177.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.82 27.36 67.1 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.807 1.083 . . . . 74.52 115.807 169.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.47 ' HB3' ' HA ' ' A' ' 76' ' ' SER . 27.2 ttt -83.58 -42.18 17.06 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 118.025 0.913 . . . . 54.33 111.809 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.29 130.89 44.98 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 120.693 0.282 . . . . 73.23 111.612 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.12 80.77 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.102 -0.499 . . . . 53.5 113.054 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.58 139.68 42.23 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.096 0.558 . . . . 62.4 111.982 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.9 m -84.01 120.05 25.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.228 -0.896 . . . . 71.15 108.889 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.453 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -117.46 162.92 17.18 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.971 0.908 . . . . 55.23 110.06 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -127.72 134.08 49.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.632 -0.507 . . . . 73.34 109.632 172.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.456 HD13 HG12 ' A' ' 35' ' ' VAL . 28.5 mm -66.93 104.21 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 N-CA-C 109.378 -0.601 . . . . 73.32 109.378 174.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.25 -40.74 77.67 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.377 1.071 . . . . 64.11 110.419 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.8 m -154.77 149.02 26.02 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.731 0.813 . . . . 63.4 110.599 -176.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.0 130.76 53.14 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.898 0.879 . . . . 64.13 108.89 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -140.88 115.47 9.51 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 121.132 0.491 . . . . 70.24 112.281 -168.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.04 94.2 9.86 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.365 0.666 . . . . 54.41 109.56 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 t -137.96 154.17 49.4 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.493 0.717 . . . . 64.13 110.068 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.7 m -84.21 128.26 34.45 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.889 -0.412 . . . . 72.21 109.889 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 m -111.61 134.55 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.612 0.765 . . . . 63.14 109.539 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.05 140.22 49.49 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.423 0.689 . . . . 71.33 112.314 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.3 ttp -89.69 112.44 23.71 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.881 -1.054 . . . . 54.21 108.28 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.68 145.85 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 112.826 0.676 . . . . 72.23 112.826 -170.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.84 115.68 30.93 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.488 -0.93 . . . . 73.52 108.488 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -127.97 158.82 36.83 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.218 0.463 . . . . 74.52 111.758 -173.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.7 m -104.25 104.16 14.02 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.425 -0.583 . . . . 74.05 109.425 172.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 108' ' ' GLU . 36.0 t -59.61 109.24 0.86 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.862 0.865 . . . . 74.42 111.546 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.2 p -62.26 -14.21 36.21 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.824 1.25 . . . . 72.13 113.297 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 78.8 m -58.79 -57.28 13.71 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.68 0.792 . . . . 64.32 112.498 174.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.5 p -126.32 -2.06 6.92 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.214 0.606 . . . . 50.53 112.574 -172.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.97 84.91 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 120.063 -0.298 . . . . 63.32 113.404 -170.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 103' ' ' SER . 38.1 tt0 -59.35 113.26 2.08 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.517 1.127 . . . . 65.31 112.003 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -88.7 125.63 34.94 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.681 0.753 . . . . 73.54 109.184 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -119.14 132.28 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.39 1.076 . . . . 74.23 109.12 -170.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 133.51 50.74 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 120.775 0.322 . . . . 73.04 110.297 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.6 m120 55.28 54.78 8.24 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 125.079 1.352 . . . . 73.51 113.857 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -63.91 141.92 58.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.416 0.686 . . . . 61.33 111.598 170.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 98.9 mttt -137.67 127.42 25.38 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.742 0.817 . . . . 72.24 111.053 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.6 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 85.7 m95 -120.55 165.46 14.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.198 -1.564 . . . . 71.54 112.258 -12.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.418 HG21 HD21 ' A' ' 121' ' ' LEU . 20.2 m -124.05 168.32 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 113.786 -1.552 . . . . 54.24 107.72 162.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 40.3 p -117.61 169.84 9.24 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.827 0.739 . . . . 64.22 112.282 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -53.2 -40.86 64.76 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.13 0.972 . . . . 75.54 111.279 172.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.66 -29.45 70.68 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.385 1.074 . . . . 53.12 111.774 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.495 ' HG2' ' HB ' ' A' ' 11' ' ' THR . 56.8 mt-10 -94.0 0.19 55.86 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.891 0.876 . . . . 63.44 112.078 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.418 HD21 HG21 ' A' ' 116' ' ' VAL . 83.6 mt -117.87 152.65 34.96 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.805 0.842 . . . . 63.1 110.244 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.5 m -146.84 122.94 10.8 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.099 -1.075 . . . . 73.3 108.099 173.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -59.77 105.6 0.39 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 118.28 0.491 . . . . 75.52 110.975 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.512 ' H ' ' HA ' ' A' ' 7' ' ' VAL . 56.2 tptt . . . . . 0 CA--C 1.569 1.682 0 C-N-CA 124.992 1.317 . . . . 75.35 113.251 -167.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.319 -0.252 . . . . 74.35 110.319 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.4 160.73 18.1 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.295 0.638 . . . . 71.55 111.849 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.18 131.6 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.461 0.704 . . . . 65.35 111.704 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.18 -10.28 43.38 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 115.818 -0.628 . . . . 61.32 112.782 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.4 t -81.13 145.14 31.21 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.236 0.614 . . . . 72.34 112.186 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -94.92 116.5 28.78 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.84 0.856 . . . . 73.2 109.058 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.23 153.43 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.131 0.972 . . . . 75.11 110.678 -174.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 mm -100.15 134.68 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 109.292 -0.633 . . . . 55.42 109.292 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.441 HG21 ' HG2' ' A' ' 17' ' ' MET . 63.3 mt -78.42 104.07 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.946 -0.472 . . . . 74.42 109.732 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -78.35 -32.8 49.22 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.188 0.595 . . . . 63.41 111.367 -168.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 t -144.47 164.97 29.28 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.205 0.602 . . . . 63.01 110.061 168.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 98.8 p -157.18 167.07 31.45 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.379 0.609 . . . . 62.43 112.431 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -91.4 -37.49 13.17 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.091 -0.959 . . . . 61.43 109.884 168.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.5 mpt? -85.49 132.85 34.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.835 0.854 . . . . 71.03 110.748 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -58.97 -38.45 79.13 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.553 0.741 . . . . 54.34 112.494 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.22 -6.65 87.76 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 114.545 0.578 . . . . 71.3 114.545 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.441 ' HG2' HG21 ' A' ' 9' ' ' ILE . 41.8 ttp -94.85 -28.66 15.12 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 117.821 0.811 . . . . 71.45 112.13 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.19 128.6 37.15 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.13 0.49 . . . . 71.55 111.85 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.47 0.27 88.89 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-N 115.563 -0.744 . . . . 64.15 113.958 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.55 149.46 29.95 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.357 0.663 . . . . 44.2 110.851 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -90.95 106.53 18.59 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.919 0.39 . . . . 63.42 110.267 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.545 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -88.55 169.84 11.38 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.681 0.792 . . . . 72.11 111.767 175.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.7 m -136.89 134.54 36.95 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.165 -0.68 . . . . 52.54 109.165 171.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.79 105.69 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 123.127 0.571 . . . . 52.22 110.856 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.4 p -92.63 -15.76 26.42 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.31 0.644 . . . . 34.52 111.738 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.51 146.3 13.66 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.4 -0.28 . . . . 72.3 112.4 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.17 125.35 31.01 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.868 0.867 . . . . 41.21 109.544 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.601 ' HB2' HG23 ' A' ' 96' ' ' VAL . 58.1 m-85 -128.46 130.64 47.85 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.584 0.754 . . . . 72.44 110.816 -171.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -107.31 79.49 1.31 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 122.153 0.978 . . . . 70.01 110.073 174.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 t -133.43 162.61 31.4 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.186 -0.915 . . . . 64.01 110.425 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.8 m -65.89 119.9 12.12 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.833 0.453 . . . . 71.1 110.577 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.41 153.48 23.94 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.011 0.924 . . . . 71.32 109.846 -176.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -133.95 147.42 51.05 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.902 0.858 . . . . 64.5 112.078 -170.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.95 115.0 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 106.804 -1.554 . . . . 72.03 106.804 167.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.457 HG12 HD13 ' A' ' 88' ' ' ILE . 31.6 m -122.13 154.75 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-O 121.492 0.663 . . . . 71.35 112.751 -173.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 61.7 p -121.22 124.52 44.86 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.248 1.019 . . . . 75.04 109.667 173.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -142.64 154.59 44.51 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.308 0.643 . . . . 73.11 110.682 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.0 m -102.89 107.22 54.06 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.902 -1.147 . . . . 71.31 107.902 171.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.32 133.9 45.8 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.304 2.002 . . . . 74.03 111.326 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 72.8 p -68.66 -2.27 8.78 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.502 0.927 . . . . 73.12 113.502 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -64.24 -21.47 66.59 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.298 0.639 . . . . 75.14 111.087 165.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.57 29.73 38.72 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 114.981 0.752 . . . . 72.32 114.981 169.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.35 -109.03 1.55 Allowed Glycine 0 CA--C 1.537 1.439 0 CA-C-N 117.519 0.66 . . . . 64.33 112.9 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -109.6 141.33 42.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.943 0.897 . . . . 73.12 110.172 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -63.11 124.42 21.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.283 0.633 . . . . 74.34 111.182 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.645 HG21 ' SD ' ' A' ' 78' ' ' MET . 48.5 t -90.28 114.01 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.362 0.665 . . . . 73.42 109.985 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -105.96 151.52 24.5 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.017 0.527 . . . . 74.35 110.97 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.9 m80 55.72 29.99 14.8 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.213 1.005 . . . . 63.1 113.166 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.437 ' HB2' HG12 ' A' ' 46' ' ' VAL . 60.0 t60 -72.3 118.72 15.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.992 0.917 . . . . 72.41 110.43 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 59.2 pttt -133.06 146.8 52.01 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 115.929 -0.578 . . . . 75.04 111.629 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 92.7 m95 -110.83 152.46 26.64 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.446 -1.409 . . . . 75.12 112.209 0.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.16 136.41 60.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.1 -1.409 . . . . 52.32 107.747 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.456 HG21 HG21 ' A' ' 96' ' ' VAL . 39.9 pt -101.55 166.37 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.637 -0.664 . . . . 74.31 112.143 -172.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.86 -33.74 67.13 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.841 0.856 . . . . 72.51 111.88 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -71.94 -21.23 61.64 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.064 0.546 . . . . 72.15 112.422 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -83.08 -33.83 26.3 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.938 0.895 . . . . 74.15 110.948 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.0 mt -86.85 132.19 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.079 0.552 . . . . 74.45 110.984 -171.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.524 ' HB2' ' HG3' ' A' ' 74' ' ' GLU . 59.0 tttm -60.43 -43.67 96.54 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.998 0.919 . . . . 74.35 112.167 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.36 -7.63 50.63 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 123.775 0.83 . . . . 73.42 113.154 -174.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.511 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -33.98 -67.02 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.96 1.467 . . . . 40.33 114.96 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.81 25.7 70.71 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 114.956 0.742 . . . . 65.4 114.956 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 64.32 9.43 4.87 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.527 1.131 . . . . 63.41 113.231 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 24.8 pttm -109.66 167.59 10.04 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.457 0.703 . . . . 65.43 111.357 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 m -91.89 119.54 31.75 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.286 0.634 . . . . 73.24 110.225 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.61 HD13 HG11 ' A' ' 71' ' ' VAL . 44.6 mt -79.64 127.92 32.76 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.362 0.665 . . . . 61.52 110.8 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -89.46 153.37 48.24 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.671 0.788 . . . . 63.04 111.283 -173.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.27 115.39 2.26 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.423 2.082 . . . . 74.42 113.277 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.33 -19.39 14.86 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.534 -0.757 . . . . 74.33 113.608 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.04 130.82 47.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.381 0.673 . . . . 65.05 112.189 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -90.84 120.43 31.86 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.504 -0.771 . . . . 64.52 109.312 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.61 HG11 HD13 ' A' ' 65' ' ' LEU . 32.4 m -134.43 174.68 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 C-N-CA 124.367 1.067 . . . . 73.2 111.321 -171.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.31 141.95 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.895 0.878 . . . . 63.23 109.861 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 mt -96.96 131.04 44.16 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.641 0.777 . . . . 62.01 111.596 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.524 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 36.2 mt-10 -101.0 9.44 42.24 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 113.464 0.913 . . . . 75.25 113.464 175.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.38 165.85 17.64 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.379 0.672 . . . . 63.21 110.055 169.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.4 t -139.57 123.56 17.72 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.954 -0.567 . . . . 60.14 110.517 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -99.09 -5.43 30.25 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.912 0.885 . . . . 74.32 110.173 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.645 ' SD ' HG21 ' A' ' 46' ' ' VAL . 26.0 ptp -159.07 147.45 18.07 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.539 1.135 . . . . 63.31 109.682 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -53.77 121.74 8.51 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.117 0.567 . . . . 74.25 112.296 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.9 -15.91 54.94 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 119.361 -0.688 . . . . 53.54 114.572 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.0 ttt -64.01 -46.02 86.35 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.559 0.744 . . . . 63.02 112.781 -175.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -67.53 118.5 10.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.95 -0.389 . . . . 74.23 109.95 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 3.16 74.41 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 116.383 -0.371 . . . . 73.24 113.49 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.22 145.63 32.13 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.222 0.511 . . . . 42.04 110.341 172.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m -80.32 114.56 19.31 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 109.443 -0.577 . . . . 73.35 109.443 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.51 145.63 32.87 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.598 0.759 . . . . 74.33 111.257 -173.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -123.15 117.07 24.53 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.378 1.071 . . . . 65.33 109.135 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.457 HD13 HG12 ' A' ' 35' ' ' VAL . 28.2 mm -61.55 115.07 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.188 0.595 . . . . 72.44 111.028 -178.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -83.35 -36.46 24.36 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.821 0.449 . . . . 72.35 110.967 173.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.9 t -157.83 150.65 22.89 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.24 0.616 . . . . 72.21 111.745 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.81 131.64 56.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.19 0.996 . . . . 74.03 109.37 173.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -146.68 128.9 15.71 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.942 0.497 . . . . 72.25 111.739 -171.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -91.62 95.35 9.87 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.253 -0.647 . . . . 71.34 109.253 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.3 t -136.87 155.39 49.83 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.444 1.098 . . . . 60.41 110.202 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.4 m -80.94 120.0 24.19 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.887 -0.412 . . . . 75.44 109.887 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.601 HG23 ' HB2' ' A' ' 28' ' ' TYR . 9.0 m -104.68 132.45 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.317 0.647 . . . . 72.22 109.535 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.56 135.02 51.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.36 1.064 . . . . 74.11 111.118 -176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.6 ttp -94.1 120.98 35.12 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.924 -1.139 . . . . 71.34 107.924 166.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.545 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 24.2 m -124.85 169.6 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 112.779 0.659 . . . . 73.03 112.779 -169.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -137.06 133.14 35.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.282 0.633 . . . . 72.34 110.909 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -143.32 177.61 8.31 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.853 0.861 . . . . 60.23 111.299 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.6 m -119.96 119.18 32.69 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 108.248 -1.019 . . . . 74.31 108.248 169.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.9 m -61.22 134.71 57.29 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.363 0.665 . . . . 60.32 112.396 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -65.18 -47.96 75.11 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.293 1.037 . . . . 72.21 112.176 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.4 p -75.67 -50.8 14.36 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.447 0.699 . . . . 53.42 112.052 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.8 m -75.38 -33.57 61.03 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.495 0.718 . . . . 75.21 112.677 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.37 11.92 79.88 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-N 116.543 -0.298 . . . . 71.43 113.498 -172.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -100.21 140.11 34.92 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.59 0.756 . . . . 71.3 111.239 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -81.1 115.57 20.6 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.634 0.773 . . . . 75.44 110.998 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.9 t -104.85 122.34 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.874 0.87 . . . . 63.42 109.534 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.77 160.7 17.07 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.014 0.526 . . . . 74.11 111.289 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.0 m120 56.5 28.89 14.45 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.133 0.973 . . . . 65.02 112.897 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -64.75 137.73 57.97 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.537 0.735 . . . . 63.42 111.888 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 8.0 ptpp? -155.56 148.42 24.33 Favored 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 123.513 0.725 . . . . 74.21 111.941 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 98.9 m95 -112.15 144.51 41.41 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.461 1.505 . . . . 73.01 112.536 -8.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.81 154.34 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.2 1.4 . . . . 65.24 109.048 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.3 p -117.33 177.7 4.64 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.812 0.445 . . . . 74.22 110.911 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -66.12 -14.28 61.52 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.469 0.708 . . . . 54.35 111.888 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.54 -35.4 65.52 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 122.971 0.508 . . . . 71.24 110.863 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -94.84 -5.08 45.88 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.021 0.528 . . . . 71.32 111.643 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 66.0 mt -108.24 134.41 51.12 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.851 0.834 . . . . 71.42 110.962 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.4 t -101.57 156.72 17.31 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.399 1.48 . . . . 75.52 108.925 170.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.68 160.73 15.48 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.637 0.375 . . . . 51.4 110.301 175.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.543 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 110.081 -0.34 . . . . 75.15 110.081 174.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 120.814 0.34 . . . . 72.23 111.865 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -120.46 174.37 6.58 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.639 0.776 . . . . 53.24 112.481 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.75 136.01 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 C-N-CA 123.844 0.858 . . . . 61.15 111.718 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.38 -9.76 75.48 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 115.825 -0.625 . . . . 64.2 113.702 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.8 t -83.65 142.14 31.0 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.149 0.579 . . . . 74.04 111.707 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -90.48 122.15 33.07 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.637 0.775 . . . . 64.34 110.318 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . 33.2 m -122.29 153.44 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.638 0.775 . . . . 71.33 111.886 -176.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.4 mm -104.56 123.79 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.333 1.053 . . . . 64.41 108.472 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.4 mt -77.21 125.25 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 120.967 0.413 . . . . 72.5 111.06 -172.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -89.19 -68.4 0.78 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.697 0.799 . . . . 54.01 109.725 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.0 m -98.8 144.64 27.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.941 0.897 . . . . 73.34 110.25 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 18' ' ' LYS . 84.8 p -159.28 152.7 22.56 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.704 0.631 . . . . 73.04 112.704 -172.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -85.82 -37.53 19.13 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.469 0.708 . . . . 64.44 110.309 168.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.462 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.4 mpt? -83.32 129.1 34.98 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.262 0.625 . . . . 73.43 110.259 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -30.8 71.05 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.611 0.967 . . . . 74.45 113.611 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.14 -9.1 70.9 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 114.023 0.369 . . . . 54.11 114.023 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 55.2 ttp -82.72 -28.65 30.36 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.901 0.481 . . . . 74.02 110.197 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 3.4 ttmp? -67.77 118.68 11.34 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.711 0.404 . . . . 62.32 111.134 173.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.95 2.07 86.45 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 116.134 -0.485 . . . . 65.11 113.553 -177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.97 152.17 29.64 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.108 0.563 . . . . 74.42 112.035 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -86.39 131.94 34.08 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.134 0.974 . . . . 75.52 110.359 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.55 173.86 11.08 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.728 0.811 . . . . 62.1 112.22 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.7 m -137.99 146.52 43.22 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.441 1.097 . . . . 74.14 108.754 170.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.5 t -79.75 117.95 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 122.756 0.423 . . . . 63.24 110.556 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.3 p -94.86 -18.3 21.3 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.51 0.724 . . . . 65.11 111.58 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.44 145.18 11.52 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 120.201 -0.222 . . . . 72.51 112.701 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.54 119.61 19.73 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.665 0.786 . . . . 74.15 110.725 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -130.18 149.67 51.78 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.315 1.046 . . . . 61.51 110.42 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -125.82 90.97 3.3 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.158 0.98 . . . . 63.24 109.965 167.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.0 t -135.19 177.46 7.79 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.282 -0.872 . . . . 72.33 111.144 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -73.35 110.26 7.5 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.528 0.68 . . . . 63.53 110.454 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.09 161.02 13.9 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.375 1.47 . . . . 51.12 109.918 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -138.59 144.64 39.9 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.567 0.747 . . . . 74.5 111.606 -172.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.9 110.96 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 107.048 -1.464 . . . . 72.45 107.048 164.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.547 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 21.1 m -112.16 144.09 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.378 0.609 . . . . 73.01 112.231 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 p -116.65 128.24 55.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.204 1.002 . . . . 62.32 109.634 173.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -151.17 158.29 43.77 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.94 0.496 . . . . 71.42 111.386 -169.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.2 m -108.15 117.06 55.8 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 109.008 -0.738 . . . . 74.43 109.008 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -60.77 124.04 14.19 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.656 2.237 . . . . 74.12 111.887 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -63.05 -14.45 48.26 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.575 1.324 . . . . 71.12 114.575 -168.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.463 HD22 ' N ' ' A' ' 41' ' ' ASN . 0.8 OUTLIER -85.73 11.35 11.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.532 0.733 . . . . 45.11 112.718 -176.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.46 53.15 3.93 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 120.977 0.209 . . . . 62.25 112.9 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.34 168.91 13.91 Favored Glycine 0 N--CA 1.476 1.312 0 C-N-CA 122.96 0.314 . . . . 64.21 112.854 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -58.75 135.36 57.43 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.33 0.652 . . . . 75.03 111.331 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -56.59 136.5 54.55 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-O 121.186 0.517 . . . . 71.31 111.065 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.478 HG21 ' SD ' ' A' ' 78' ' ' MET . 57.8 t -86.72 103.13 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.246 0.618 . . . . 41.24 109.709 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.69 108.7 14.56 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.902 0.881 . . . . 54.22 110.828 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.2 m170 57.7 79.11 0.21 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.152 0.981 . . . . 73.44 112.992 176.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -94.29 109.67 21.48 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.125 0.97 . . . . 73.02 109.671 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 22.2 pttp -121.01 140.16 52.3 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.286 0.235 . . . . 52.32 111.551 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 79.6 m95 -117.83 158.33 25.01 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.054 1.342 . . . . 74.32 112.478 2.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.49 143.67 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 113.183 -1.826 . . . . 72.41 107.18 167.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.505 HG13 ' H ' ' A' ' 55' ' ' GLU . 29.8 pt -106.93 179.56 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.678 -0.639 . . . . 72.3 109.676 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -48.71 -33.9 11.0 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.205 1.002 . . . . 64.51 113.093 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.505 ' H ' HG13 ' A' ' 53' ' ' ILE . 28.5 tt0 -69.78 -23.96 63.43 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.072 0.949 . . . . 74.14 113.493 -175.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.2 -10.78 59.56 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.553 0.575 . . . . 73.31 112.553 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.1 mt -113.18 134.22 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 123.433 0.693 . . . . 63.0 111.808 -169.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.432 ' HB2' ' HG3' ' A' ' 74' ' ' GLU . 40.8 ttmt -67.82 -46.37 72.06 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.025 0.93 . . . . 73.55 111.999 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -62.84 -22.28 66.56 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.802 0.841 . . . . 74.3 112.675 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -35.79 -57.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.292 1.59 . . . . 50.34 115.292 -171.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.85 19.48 67.55 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 115.984 1.154 . . . . 75.11 115.984 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 t70 61.84 15.77 7.38 Favored 'General case' 0 CA--C 1.572 1.806 0 C-N-CA 124.959 1.304 . . . . 75.34 112.212 -172.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 22.9 pttm -107.59 160.15 15.9 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.787 0.835 . . . . 53.41 109.771 175.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 p -76.88 128.16 34.05 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 110.034 -0.358 . . . . 62.44 110.034 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.572 HD13 HG11 ' A' ' 71' ' ' VAL . 38.7 mt -87.95 136.51 32.93 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.696 -0.483 . . . . 65.2 109.696 170.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -105.89 153.49 40.05 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.58 0.752 . . . . 72.42 110.593 -173.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.83 130.37 40.02 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 122.538 2.159 . . . . 75.32 112.427 171.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.86 -22.61 29.6 Favored Glycine 0 N--CA 1.479 1.507 0 N-CA-C 113.992 0.357 . . . . 43.23 113.992 -175.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -73.14 157.18 37.72 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.255 0.527 . . . . 65.43 112.226 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -125.7 135.48 52.14 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.576 -0.738 . . . . 70.23 109.737 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.572 HG11 HD13 ' A' ' 65' ' ' LEU . 36.0 m -138.79 -178.36 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 125.41 1.484 . . . . 75.02 110.355 -167.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.3 mt -128.22 140.94 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.315 0.646 . . . . 71.31 110.252 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.2 mt -90.33 130.22 36.46 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.275 1.03 . . . . 72.41 111.622 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 43.0 mt-10 -91.31 -12.97 33.47 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.218 0.607 . . . . 70.52 112.192 169.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.93 160.66 14.23 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.271 0.628 . . . . 72.51 111.193 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.818 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 10.4 t -140.2 125.9 19.29 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.691 0.396 . . . . 64.15 110.324 178.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -113.41 0.74 14.85 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.466 0.706 . . . . 74.04 110.723 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.478 ' SD ' HG21 ' A' ' 46' ' ' VAL . 23.7 ptp -157.57 167.38 30.33 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.814 0.845 . . . . 74.43 111.515 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -63.89 101.61 0.39 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.073 0.949 . . . . 64.21 111.901 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.77 23.92 9.63 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-O 119.733 -0.482 . . . . 40.52 114.101 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.4 ttt -93.23 -39.46 10.99 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 117.664 0.732 . . . . 74.32 111.689 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.818 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 60.7 tttm -67.76 119.73 12.95 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.443 0.297 . . . . 64.32 110.389 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.33 -8.44 75.16 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 123.462 0.476 . . . . 54.5 113.149 -176.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.54 146.97 36.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.055 0.542 . . . . 65.32 111.612 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.0 m -86.31 119.72 26.88 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.734 -0.666 . . . . 71.24 110.069 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.547 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -112.62 149.3 33.01 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.89 0.876 . . . . 72.25 110.653 -177.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -118.43 126.47 52.13 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.939 0.496 . . . . 74.24 110.261 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.409 HD13 HG12 ' A' ' 35' ' ' VAL . 25.8 mm -68.36 102.56 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 123.456 0.702 . . . . 64.14 110.276 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -71.79 -39.35 69.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.187 0.595 . . . . 55.33 110.166 173.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 t -154.98 147.93 24.62 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.05 -0.977 . . . . 61.44 111.286 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.78 132.96 42.82 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.0 0.92 . . . . 61.54 109.924 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -148.38 142.25 25.76 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.303 0.641 . . . . 72.52 110.803 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.03 94.6 9.7 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.427 -1.323 . . . . 71.11 107.427 172.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.3 t -134.81 156.81 48.23 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.927 0.891 . . . . 54.55 111.103 -171.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 93.5 m -79.95 120.24 23.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.934 0.494 . . . . 75.41 110.614 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.86 134.49 58.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.037 0.935 . . . . 72.53 110.239 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.48 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 98.2 m-85 -110.32 135.83 50.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.041 0.936 . . . . 73.32 112.004 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 52.8 ttp -90.26 121.07 31.94 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 107.844 -1.169 . . . . 63.33 107.844 167.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.14 145.63 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 113.17 0.804 . . . . 60.52 113.17 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -106.77 120.47 42.09 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.732 0.813 . . . . 72.32 109.747 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -127.44 165.56 19.59 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.374 0.607 . . . . 75.02 112.077 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.8 m -104.02 108.64 20.08 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.768 -0.827 . . . . 73.44 108.768 171.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.1 t -62.21 107.44 0.89 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.286 0.634 . . . . 62.34 110.682 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.7 p -59.24 -31.8 69.4 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.148 0.979 . . . . 73.22 113.142 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 t -76.49 -13.17 60.12 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.035 0.934 . . . . 72.12 112.958 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 t -123.82 -43.96 2.1 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.4 0.68 . . . . 75.42 112.663 -172.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.8 -18.47 57.19 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 116.5 -0.318 . . . . 54.12 112.436 -166.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.41 137.15 44.46 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.22 1.008 . . . . 73.42 111.493 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -91.31 118.2 30.3 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 121.322 0.582 . . . . 72.21 110.263 174.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.8 t -104.37 119.09 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.946 0.898 . . . . 64.54 108.616 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -103.63 153.29 20.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.559 0.344 . . . . 74.3 111.68 -169.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 53.73 42.42 31.81 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.541 1.137 . . . . 75.43 114.03 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -58.91 134.36 56.86 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.245 1.018 . . . . 72.3 111.903 175.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 62.1 mttp -132.3 132.12 42.67 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.093 0.957 . . . . 62.3 111.167 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 99.8 m95 -119.19 153.9 34.2 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.258 -1.526 . . . . 73.23 111.603 -15.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.36 158.15 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 114.524 -1.216 . . . . 61.11 108.831 168.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.9 p -105.84 175.51 5.47 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.251 0.548 . . . . 74.13 111.712 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.48 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 34.8 tt0 -67.54 -26.6 66.39 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.924 -0.58 . . . . 75.23 110.727 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.13 -29.13 70.55 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 123.982 0.913 . . . . 73.04 111.418 171.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -98.39 3.61 48.49 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.077 0.951 . . . . 65.12 112.715 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.93 142.55 51.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.351 0.66 . . . . 74.41 111.367 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.5 p -130.09 119.64 23.38 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.32 1.048 . . . . 75.2 108.297 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -85.69 105.02 15.94 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.919 0.782 . . . . 63.45 112.495 -167.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.5 tptm . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 116.229 1.937 . . . . 75.21 116.229 172.297 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.1 tpp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.08 -0.341 . . . . 74.23 110.08 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -78.51 155.92 29.54 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.511 0.672 . . . . 71.24 112.693 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.07 122.87 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-N 115.331 -0.85 . . . . 65.34 109.593 165.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.71 41.85 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-N 115.869 -0.605 . . . . 50.42 113.583 -175.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.9 m -74.85 136.43 41.54 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.091 0.556 . . . . 55.15 111.721 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -94.12 125.16 38.59 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.931 0.893 . . . . 44.11 109.63 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.28 153.43 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.393 0.677 . . . . 41.23 112.635 -168.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.3 mm -98.37 125.44 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 124.679 1.192 . . . . 65.54 109.931 172.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 22' ' ' ALA . 41.4 mt -87.28 125.4 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.19 0.596 . . . . 70.5 111.223 -176.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -98.66 -59.02 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.381 0.672 . . . . 74.35 111.063 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.6 m -94.44 144.57 25.45 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.692 0.797 . . . . 33.42 109.448 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 17' ' ' MET . 77.2 p -149.88 144.46 25.94 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.112 0.482 . . . . 71.51 111.574 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -92.42 -24.43 18.86 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.809 0.844 . . . . 74.01 110.465 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.415 ' H ' ' HE2' ' A' ' 17' ' ' MET . 23.2 mmt -95.97 134.47 38.94 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.688 0.795 . . . . 71.4 109.316 169.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.438 ' HG2' HG21 ' A' ' 105' ' ' THR . 62.5 tttp -59.01 -44.25 91.65 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.732 0.813 . . . . 71.34 112.728 -175.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.98 -0.26 64.43 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 114.889 0.715 . . . . 63.02 114.889 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.513 ' HB3' ' HB2' ' A' ' 12' ' ' SER . 41.1 ttp -91.47 -24.84 19.55 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.725 0.763 . . . . 71.02 111.235 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -67.02 121.83 16.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.916 0.487 . . . . 73.11 111.282 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.58 1.71 90.54 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 115.837 -0.62 . . . . 60.11 114.297 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.34 146.46 36.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.043 0.537 . . . . 72.53 111.206 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -95.75 99.59 11.4 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.36 -0.607 . . . . 65.42 109.36 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -91.15 175.98 6.75 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.717 0.807 . . . . 51.54 112.724 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.9 m -136.13 138.67 42.26 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.118 -1.067 . . . . 72.32 108.118 169.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.4 t -83.45 126.88 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.213 0.605 . . . . 70.22 110.398 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.6 p -113.44 -2.07 14.02 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.406 0.682 . . . . 61.5 112.102 170.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.5 136.03 4.67 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 118.365 0.53 . . . . 75.34 113.004 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.01 107.68 13.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.848 0.859 . . . . 62.23 109.768 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -108.95 120.33 42.21 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.678 0.791 . . . . 73.42 110.669 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.94 87.01 3.18 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 108.644 -0.872 . . . . 71.54 108.644 174.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -137.24 174.95 10.06 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 112.858 0.688 . . . . 63.23 112.858 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.3 m -82.87 124.98 30.84 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.743 0.817 . . . . 74.21 110.306 172.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.02 120.4 37.11 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.187 0.995 . . . . 71.51 110.297 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -92.22 149.75 21.28 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.765 0.826 . . . . 74.32 112.538 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.96 111.61 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 107.764 -1.199 . . . . 65.43 107.764 170.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.52 HG12 HD13 ' A' ' 88' ' ' ILE . 27.1 m -114.3 165.72 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 112.869 0.692 . . . . 63.11 112.869 -172.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -135.68 123.88 23.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.829 0.852 . . . . 70.32 109.438 173.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -150.52 154.36 37.46 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 122.116 -0.365 . . . . 73.03 111.61 -170.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.3 m -104.52 115.32 63.02 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 107.856 -1.164 . . . . 63.34 107.856 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.95 133.22 56.53 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.628 2.218 . . . . 74.01 112.471 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.4 p -63.22 -14.64 51.5 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.27 1.028 . . . . 64.14 112.459 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -62.64 -17.69 60.89 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 124.333 1.053 . . . . 54.14 112.598 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.26 60.09 2.3 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 112.453 -0.259 . . . . 73.21 112.453 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 -152.31 8.04 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 115.626 -0.287 . . . . 74.22 113.695 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -81.2 126.92 32.1 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.222 0.609 . . . . 74.33 109.98 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.83 112.57 1.2 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.069 0.461 . . . . 64.23 110.452 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.431 HG21 ' SD ' ' A' ' 78' ' ' MET . 15.1 t -80.84 104.15 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.65 -0.704 . . . . 74.12 109.64 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -101.12 150.72 22.64 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.988 0.515 . . . . 53.41 109.942 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.1 m80 56.54 29.23 15.13 Favored 'General case' 0 CA--C 1.559 1.317 0 O-C-N 124.089 0.868 . . . . 70.21 111.754 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -61.99 127.46 31.5 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.948 0.899 . . . . 73.32 111.739 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 97.8 mttt -132.61 141.68 48.79 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.386 1.074 . . . . 65.42 109.947 -178.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 93.8 m95 -113.02 134.53 54.47 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 120.418 -1.426 . . . . 75.22 111.273 -7.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.75 148.36 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.456 -0.942 . . . . 72.3 108.456 169.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.8 pt -111.51 166.74 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 120.806 0.336 . . . . 64.5 110.983 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -53.15 -34.71 58.01 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.131 0.972 . . . . 73.11 113.405 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.6 -18.66 60.53 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 123.634 0.774 . . . . 73.22 112.382 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -90.5 1.31 56.8 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.255 0.622 . . . . 75.23 111.899 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.473 ' HB ' ' HB2' ' A' ' 60' ' ' ALA . 55.0 mt -121.62 125.37 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 124.059 0.944 . . . . 74.11 109.751 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -68.62 -54.48 16.2 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 118.193 0.451 . . . . 65.53 112.024 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.19 -4.33 17.17 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.183 0.809 . . . . 62.4 113.183 -177.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.475 ' HA ' HD11 ' A' ' 65' ' ' LEU . . . -54.78 -30.4 56.67 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.995 0.739 . . . . 63.32 112.995 172.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.14 14.84 66.73 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 114.828 0.691 . . . . 74.35 114.828 170.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 59.31 23.14 11.55 Favored 'General case' 0 CA--C 1.566 1.565 0 C-N-CA 124.51 1.124 . . . . 75.23 112.016 -172.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 65.1 pttt -120.56 171.54 8.49 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.362 1.065 . . . . 74.04 111.341 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.3 m -77.36 109.35 11.2 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.273 0.629 . . . . 64.4 110.078 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.494 ' HB3' HG13 ' A' ' 88' ' ' ILE . 86.9 mt -78.34 121.28 24.26 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.949 0.5 . . . . 75.2 110.784 174.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -88.97 150.7 45.91 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.891 0.876 . . . . 72.32 109.94 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 88.0 Cg_exo -50.49 121.98 8.75 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.341 2.028 . . . . 71.25 113.239 173.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.93 -21.03 12.63 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-O 119.457 -0.635 . . . . 52.42 114.151 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -69.19 133.17 47.64 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.227 1.014 . . . . 53.2 111.936 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -100.37 121.43 41.5 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.388 0.675 . . . . 75.43 109.564 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.94 165.33 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.8 1.24 . . . . 64.03 110.982 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.93 137.95 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.897 -0.502 . . . . 62.15 111.186 175.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.8 mt -85.44 122.05 29.03 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.208 1.003 . . . . 61.14 111.203 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -87.54 -17.61 31.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.382 0.512 . . . . 60.52 112.382 171.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -88.51 162.67 16.3 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.333 0.587 . . . . 44.3 111.108 170.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -142.49 124.89 15.62 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.686 -0.688 . . . . 63.14 110.085 173.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -104.14 -4.19 23.48 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 123.789 0.836 . . . . 72.45 110.841 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.431 ' SD ' HG21 ' A' ' 46' ' ' VAL . 24.4 ptp -154.69 -179.16 7.74 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.3 0.64 . . . . 73.53 112.433 -173.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.69 108.97 0.71 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.817 0.847 . . . . 75.04 112.438 174.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.65 24.38 67.67 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 115.026 0.77 . . . . 61.52 115.026 172.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -75.91 -42.31 49.3 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.801 0.8 . . . . 62.54 111.551 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.33 123.74 21.2 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 120.506 0.193 . . . . 73.21 110.69 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.5 -18.34 57.12 Favored Glycine 0 N--CA 1.471 0.97 0 CA-C-N 116.206 -0.452 . . . . 62.52 113.12 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.12 137.23 56.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.243 0.617 . . . . 71.34 111.743 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.7 m -73.48 111.09 8.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.378 0.671 . . . . 73.23 110.519 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.26 147.61 27.29 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.165 0.986 . . . . 62.4 110.419 -175.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -130.35 129.18 42.82 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 108.79 -0.819 . . . . 75.14 108.79 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.52 HD13 HG12 ' A' ' 35' ' ' VAL . 47.1 mm -74.1 112.72 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.865 0.866 . . . . 73.14 111.54 -170.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.58 -41.42 27.19 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.068 0.947 . . . . 74.4 110.582 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.5 t -163.27 172.24 15.0 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 115.681 -0.69 . . . . 74.44 111.345 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.42 132.16 24.1 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.078 0.951 . . . . 51.5 110.609 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -125.97 141.52 51.93 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.583 0.753 . . . . 73.0 112.329 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -100.5 95.35 6.66 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.452 -1.314 . . . . 70.22 107.452 163.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.9 t -136.42 154.8 50.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.072 0.949 . . . . 72.23 110.6 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.9 p -78.33 124.05 27.67 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.532 -0.544 . . . . 70.34 109.532 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.83 133.01 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.87 0.868 . . . . 60.14 108.734 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -115.1 152.83 31.84 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.723 0.773 . . . . 73.4 112.487 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.459 ' SD ' ' HE3' ' A' ' 114' ' ' LYS . 59.1 ttp -100.57 112.4 24.77 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.496 -1.229 . . . . 63.43 108.134 171.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.429 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 29.7 m -120.89 151.82 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 112.543 0.571 . . . . 74.24 112.543 -172.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.67 117.09 28.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.283 1.033 . . . . 74.54 108.97 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -136.87 175.66 9.41 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.247 0.619 . . . . 71.12 111.385 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.3 m -107.63 126.08 52.13 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.728 -0.842 . . . . 74.34 108.728 169.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.8 t -60.87 108.06 0.8 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.919 0.488 . . . . 64.32 110.526 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.0 p -58.88 -24.31 62.07 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.367 1.067 . . . . 72.23 112.887 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.438 HG21 ' HG2' ' A' ' 15' ' ' LYS . 71.1 p -87.96 -60.04 2.08 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 123.325 0.65 . . . . 70.23 112.151 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.8 p -84.57 -37.17 21.51 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.421 0.526 . . . . 65.52 112.421 -173.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.08 -2.16 51.33 Favored Glycine 0 N--CA 1.48 1.604 0 CA-C-N 116.453 -0.339 . . . . 63.24 113.151 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.73 128.28 35.89 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.461 0.704 . . . . 64.24 111.895 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -75.52 96.84 3.58 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.045 -0.724 . . . . 62.5 109.045 174.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.72 114.49 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.191 0.597 . . . . 70.1 109.799 -175.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.558 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -112.02 144.77 40.83 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 120.986 0.422 . . . . 73.21 111.376 -175.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.0 m120 56.3 36.92 28.29 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.794 1.238 . . . . 64.02 113.152 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -64.54 137.95 58.13 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.505 0.722 . . . . 65.34 112.265 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 99.7 mttt -138.88 144.19 39.05 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 124.487 1.115 . . . . 73.42 110.638 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 98.5 m95 -110.2 142.62 41.49 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.539 1.536 . . . . 73.52 112.263 -11.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.57 154.41 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.225 1.01 . . . . 63.4 109.147 166.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.4 p -100.82 177.5 4.96 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.289 0.495 . . . . 71.03 112.26 173.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -69.3 -43.13 74.43 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.049 0.54 . . . . 63.24 111.197 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.33 -14.95 62.8 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.556 0.742 . . . . 64.22 111.466 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.08 -21.84 56.28 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.228 1.011 . . . . 72.44 110.149 176.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.0 mt -117.18 178.49 4.34 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.968 1.307 . . . . 63.4 109.92 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.3 m -155.31 150.37 26.79 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.019 1.328 . . . . 52.11 107.81 166.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.98 164.02 26.37 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.535 0.607 . . . . 74.33 112.586 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.5 tptt . . . . . 0 CA--C 1.56 1.331 0 C-N-CA 123.5 0.72 . . . . 55.03 111.416 176.391 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.432 -0.581 . . . . 74.45 109.432 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -73.54 133.51 43.59 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.22 0.608 . . . . 72.45 112.152 -174.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.0 124.2 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 115.925 -0.579 . . . . 71.24 110.177 169.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.3 1.69 38.23 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.895 -0.593 . . . . 62.34 113.195 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.0 t -78.87 136.21 37.23 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.39 0.676 . . . . 73.12 111.591 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -87.71 110.74 20.66 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.005 -0.739 . . . . 64.23 109.005 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.21 160.0 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-O 121.63 0.728 . . . . 71.51 112.464 -168.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.59 137.53 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.12 0.968 . . . . 64.11 109.047 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' A' ' 20' ' ' ALA . 60.9 mt -79.46 118.87 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 109.684 -0.487 . . . . 73.41 109.684 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -77.66 -42.5 34.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.786 0.834 . . . . 74.03 110.48 -176.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.8 m -142.34 147.74 36.81 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.466 1.106 . . . . 61.42 110.142 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.444 ' HB2' ' HE2' ' A' ' 17' ' ' MET . 76.7 p -155.14 157.47 37.48 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.119 0.485 . . . . 75.14 111.599 173.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -84.15 -17.79 38.88 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.007 -0.997 . . . . 74.51 110.705 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.468 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.4 mpt? -86.88 168.22 13.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.765 0.826 . . . . 64.41 110.131 169.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -87.8 -50.08 6.7 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.112 0.482 . . . . 62.04 110.685 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.21 -13.2 79.7 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 115.086 0.794 . . . . 74.22 115.086 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.444 ' HE2' ' HB2' ' A' ' 12' ' ' SER . 47.4 ttp -89.01 -29.32 19.57 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.135 0.467 . . . . 72.14 111.315 -176.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -69.09 122.04 17.94 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.61 0.364 . . . . 60.11 111.331 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.43 1.6 89.27 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.981 -0.554 . . . . 63.11 113.501 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.47 ' HB3' HD12 ' A' ' 9' ' ' ILE . . . -72.73 146.84 46.14 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.626 0.602 . . . . 50.12 112.626 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.84 98.84 4.97 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.363 0.665 . . . . 74.43 110.152 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -103.11 169.48 8.53 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.782 0.833 . . . . 63.44 112.307 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.5 m -141.05 134.59 30.0 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.57 -0.741 . . . . 71.51 109.195 168.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.23 114.05 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.914 0.486 . . . . 74.4 110.077 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.3 p -106.51 -4.12 20.1 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.063 0.545 . . . . 73.41 112.403 175.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.14 150.43 18.77 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-O 120.148 -0.251 . . . . 53.14 112.805 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.73 113.08 14.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.124 0.969 . . . . 71.01 110.336 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -114.17 115.76 28.0 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.793 0.837 . . . . 72.45 110.522 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -99.71 88.0 3.7 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 109.057 -0.72 . . . . 65.34 109.057 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.401 HG21 HD12 ' A' ' 53' ' ' ILE . 6.0 t -136.45 168.19 19.93 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.641 1.176 . . . . 64.22 111.133 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.7 m -75.31 129.93 38.22 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.886 -0.412 . . . . 63.02 109.886 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.7 154.93 20.76 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.751 0.821 . . . . 64.23 109.629 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -134.96 147.18 49.69 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.95 0.881 . . . . 72.32 112.129 -173.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.72 111.39 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 113.804 -1.544 . . . . 71.33 107.784 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.533 HG12 HD13 ' A' ' 88' ' ' ILE . 29.0 m -116.11 147.36 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.363 0.601 . . . . 75.51 112.214 -175.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -121.96 125.69 46.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.335 1.054 . . . . 71.52 110.057 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -147.1 158.49 43.95 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.431 0.692 . . . . 71.43 110.878 -172.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.6 m -109.87 111.46 58.66 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 108.824 -0.806 . . . . 72.33 108.824 174.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -46.82 118.29 2.6 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.719 2.946 . . . . 74.51 114.304 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.0 p -59.29 -24.68 63.48 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.903 1.281 . . . . 75.25 113.411 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -79.91 11.21 3.46 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 123.329 0.652 . . . . 73.23 112.107 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.03 51.61 3.72 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 121.97 -0.456 . . . . 73.25 112.729 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.53 163.89 12.39 Favored Glycine 0 C--N 1.344 0.991 0 N-CA-C 113.623 0.209 . . . . 42.14 113.623 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -60.19 132.91 55.4 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.398 0.679 . . . . 72.54 111.135 174.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.05 116.65 3.12 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.753 0.821 . . . . 74.32 111.626 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.46 HG21 ' SD ' ' A' ' 78' ' ' MET . 39.9 t -87.4 111.62 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 123.77 0.828 . . . . 74.35 109.657 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -104.32 138.78 40.25 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.682 0.793 . . . . 72.01 110.253 -173.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 54.42 40.48 31.81 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.151 0.98 . . . . 51.55 113.178 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.432 ' HB2' HG12 ' A' ' 46' ' ' VAL . 42.7 t60 -66.62 129.2 39.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.683 0.793 . . . . 62.52 111.118 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 47.4 mtmt -135.48 151.42 50.36 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 123.793 0.837 . . . . 73.34 110.482 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 84.7 m95 -111.86 137.39 49.88 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.446 1.499 . . . . 71.44 112.293 -4.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.06 138.48 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.872 1.269 . . . . 73.33 108.002 169.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.401 HD12 HG21 ' A' ' 30' ' ' THR . 34.0 pt -106.59 170.84 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.705 -0.622 . . . . 51.21 111.617 -176.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -57.27 -35.17 69.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.744 0.818 . . . . 65.24 112.721 178.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -71.14 -25.07 62.41 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 123.35 0.66 . . . . 65.14 111.691 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -86.72 -12.2 48.94 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 124.034 0.933 . . . . 74.41 112.102 -172.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.7 mt -107.88 137.96 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 124.062 0.945 . . . . 73.11 110.906 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -72.27 -54.01 10.82 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.301 0.64 . . . . 62.11 112.353 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.59 -10.2 17.26 Favored 'General case' 0 CA--C 1.568 1.667 0 C-N-CA 123.961 0.904 . . . . 62.0 113.156 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -52.56 -65.89 0.48 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.714 0.806 . . . . 44.32 112.608 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.51 28.66 72.78 Favored Glycine 0 N--CA 1.478 1.485 0 N-CA-C 114.998 0.759 . . . . 71.25 114.998 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.38 13.66 6.22 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 124.191 0.996 . . . . 54.23 112.895 -171.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 60' ' ' ALA . 5.8 ttpm? -94.27 143.59 26.26 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.897 1.279 . . . . 75.01 110.218 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.6 m -71.48 109.27 5.34 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.139 0.576 . . . . 74.45 110.009 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.626 HD13 HG11 ' A' ' 71' ' ' VAL . 53.1 mt -78.74 128.58 33.61 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.438 0.695 . . . . 71.11 110.009 178.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -119.26 157.29 51.51 Favored Pre-proline 0 N--CA 1.487 1.376 0 C-N-CA 123.714 0.806 . . . . 71.42 110.315 -167.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -49.72 118.87 4.11 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.219 2.612 . . . . 43.4 114.308 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.95 -22.3 25.82 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 123.161 0.41 . . . . 75.45 113.875 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.55 138.62 51.12 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.529 0.664 . . . . 63.31 111.712 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -102.11 122.19 43.65 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.333 0.653 . . . . 72.12 110.569 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.626 HG11 HD13 ' A' ' 65' ' ' LEU . 30.2 m -120.98 166.74 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.059 0.944 . . . . 63.2 112.244 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mm -110.97 135.47 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.845 0.858 . . . . 71.44 110.107 173.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.7 mt -96.07 114.55 26.27 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.963 0.905 . . . . 75.12 111.118 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -78.33 -34.68 48.39 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.306 0.642 . . . . 72.04 111.425 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.66 165.13 18.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.312 0.645 . . . . 54.52 111.712 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 51.0 p -143.59 125.91 15.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.231 -0.895 . . . . 61.22 110.779 173.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -99.67 1.13 43.2 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.988 0.915 . . . . 72.43 109.694 167.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.46 ' SD ' HG21 ' A' ' 46' ' ' VAL . 23.5 ptp -156.02 166.24 34.04 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.332 1.053 . . . . 73.41 111.353 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -54.14 -32.15 54.43 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 115.456 1.65 . . . . 51.15 115.456 -169.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.29 26.64 6.31 Favored Glycine 0 N--CA 1.484 1.853 0 CA-C-N 118.054 0.388 . . . . 54.21 114.01 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.7 ttt -89.82 -41.62 11.73 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 117.185 0.492 . . . . 72.13 112.071 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 88.4 tttt -67.52 120.68 14.37 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 122.354 -0.216 . . . . 63.44 110.634 173.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.1 76.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.232 -0.44 . . . . 75.32 112.504 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.0 145.6 35.87 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-O 121.428 0.632 . . . . 74.25 111.696 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.5 m -88.27 122.5 31.87 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.779 -1.101 . . . . 70.13 109.0 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -118.74 162.89 17.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.893 0.877 . . . . 64.54 110.773 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -131.91 128.25 38.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.779 0.832 . . . . 54.14 109.815 175.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.546 HG13 ' HB3' ' A' ' 65' ' ' LEU . 31.3 mm -66.48 116.42 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.646 0.779 . . . . 74.34 110.491 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -82.08 -36.75 27.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.487 0.715 . . . . 72.23 111.201 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.9 t -161.9 151.75 16.61 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.567 -0.742 . . . . 74.41 111.258 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.89 130.69 56.94 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.919 0.888 . . . . 61.24 109.353 172.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -134.68 119.97 18.94 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.211 0.604 . . . . 71.4 110.295 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.462 ' H ' ' HD2' ' A' ' 93' ' ' LYS . 6.8 mptt -90.31 93.79 9.48 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.173 -1.047 . . . . 74.22 108.173 -177.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.3 t -136.99 154.03 50.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.337 0.655 . . . . 74.53 110.945 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.8 m -80.77 128.11 33.28 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.146 -0.687 . . . . 63.44 109.146 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 m -120.53 135.71 59.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.572 1.149 . . . . 74.24 108.801 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.592 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 82.7 m-85 -109.72 157.27 19.29 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.108 0.956 . . . . 74.33 112.738 -171.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.526 ' SD ' ' HE3' ' A' ' 114' ' ' LYS . 35.7 ttp -100.28 117.59 34.81 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.071 -1.422 . . . . 73.42 107.699 165.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.7 m -125.07 148.25 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-O 121.37 0.605 . . . . 71.33 111.784 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.62 116.05 31.25 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.294 -1.002 . . . . 63.32 108.294 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -127.05 170.34 12.43 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.325 0.583 . . . . 75.43 111.978 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 m -112.07 111.2 21.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.205 -0.907 . . . . 75.4 109.071 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.8 m -57.21 96.82 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.209 -0.663 . . . . 45.41 109.209 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 52.0 p -56.83 -47.1 81.1 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.044 1.127 . . . . 74.13 114.044 -166.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.3 t -72.72 -32.23 65.56 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.392 0.515 . . . . 74.53 112.392 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.4 m -87.14 -26.93 23.37 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.545 0.738 . . . . 64.24 112.256 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.33 -22.2 10.98 Favored Glycine 0 CA--C 1.545 1.951 0 CA-C-N 116.004 -0.544 . . . . 73.23 114.313 -172.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -71.22 136.64 48.13 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.622 0.769 . . . . 52.44 112.094 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.33 131.63 44.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.629 0.771 . . . . 71.53 110.673 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.5 t -115.01 128.21 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.339 1.056 . . . . 53.24 109.302 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -107.19 143.44 35.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.006 0.522 . . . . 72.04 111.09 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.6 m120 58.78 39.5 24.09 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.281 1.432 . . . . 73.52 113.431 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -69.21 133.58 48.13 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.629 -0.714 . . . . 73.3 111.733 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.526 ' HE3' ' SD ' ' A' ' 98' ' ' MET . 96.7 mttt -142.47 145.77 34.07 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.565 1.146 . . . . 73.43 110.497 -175.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 87.5 m95 -106.98 122.32 46.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.703 1.601 . . . . 73.11 110.884 -9.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.7 m -99.37 154.81 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 109.208 -0.664 . . . . 71.11 109.208 170.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 31.7 m -113.81 158.16 21.37 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.827 0.451 . . . . 65.22 110.868 -175.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.592 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 67.0 tt0 -59.42 -35.83 74.72 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.189 0.519 . . . . 74.21 111.67 175.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -52.39 -32.96 41.32 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.816 1.247 . . . . 72.22 112.129 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -101.43 7.16 42.67 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.572 1.149 . . . . 65.33 112.5 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.2 mt -125.17 158.92 32.77 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.54 0.736 . . . . 74.23 110.871 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.2 t -148.05 140.89 24.73 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.026 0.93 . . . . 71.0 109.939 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.69 130.25 38.4 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.628 0.371 . . . . 73.15 110.902 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.4 tttm . . . . . 0 CA--C 1.556 1.204 0 CA-C-O 121.183 0.516 . . . . 74.32 110.661 179.472 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 110.288 -0.264 . . . . 74.02 110.288 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -86.44 143.24 27.88 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.443 0.697 . . . . 74.31 111.633 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.5 t -66.58 126.58 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 C-N-CA 122.82 0.448 . . . . 71.53 110.215 170.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.97 -12.53 62.34 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 116.239 -0.437 . . . . 54.0 113.156 -171.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.3 t -88.66 161.04 17.09 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.259 0.623 . . . . 42.55 111.027 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -121.98 138.7 54.32 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.123 0.569 . . . . 55.41 111.207 -176.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.17 170.84 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 124.966 1.307 . . . . 73.33 111.118 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.5 mm -105.09 141.93 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.124 0.97 . . . . 61.23 109.814 171.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.663 HG21 ' HG2' ' A' ' 17' ' ' MET . 27.1 mm -65.04 129.31 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.5 0 C-N-CA 123.445 0.698 . . . . 73.24 111.263 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -108.07 -13.98 14.83 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.37 0.668 . . . . 65.34 111.604 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.9 m -145.49 139.17 26.62 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.241 0.616 . . . . 75.34 110.511 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.42 ' HA ' ' SD ' ' A' ' 17' ' ' MET . 58.8 p -113.49 118.5 34.66 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.301 0.64 . . . . 71.11 112.109 -173.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -89.58 -36.23 15.43 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.744 0.817 . . . . 74.11 109.441 169.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.488 ' H ' ' HE3' ' A' ' 17' ' ' MET . 41.0 tpp -96.21 144.7 26.18 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.482 1.113 . . . . 74.41 108.901 175.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -23.72 66.74 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.331 0.863 . . . . 63.25 113.331 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.507 ' HA2' HG22 ' A' ' 105' ' ' THR . . . -89.84 -2.26 75.55 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 113.815 0.286 . . . . 73.52 113.815 174.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.663 ' HG2' HG21 ' A' ' 9' ' ' ILE . 49.8 ttm -81.39 -29.34 34.0 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.2 0.5 . . . . 75.05 110.942 -172.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.16 119.75 8.45 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.488 0.715 . . . . 73.33 112.144 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.96 1.27 87.29 Favored Glycine 0 N--CA 1.476 1.308 0 N-CA-C 114.519 0.567 . . . . 72.41 114.519 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.87 149.48 39.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.043 0.537 . . . . 72.02 111.661 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -92.72 102.87 15.28 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 122.984 0.514 . . . . 62.14 110.552 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.579 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -86.02 150.66 24.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.932 0.893 . . . . 50.43 111.766 -175.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.1 m -123.48 115.62 21.86 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.204 0.602 . . . . 71.41 109.763 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.47 96.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.272 0.629 . . . . 72.41 110.352 -174.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.8 p -98.59 -4.36 34.22 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.416 0.686 . . . . 60.43 111.448 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.92 139.46 6.61 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 111.984 -0.446 . . . . 53.12 111.984 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.61 108.69 12.31 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.808 0.843 . . . . 75.05 109.688 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -111.96 112.1 23.5 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.802 0.841 . . . . 71.0 110.338 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -94.98 82.76 3.85 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.494 0.664 . . . . 71.13 109.312 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.6 t -134.94 177.27 7.94 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.86 0.864 . . . . 54.41 111.72 -173.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.7 m -85.74 125.9 33.58 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 122.823 0.449 . . . . 75.2 110.192 173.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -103.53 154.45 19.46 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.648 1.179 . . . . 44.43 110.524 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.545 ' HB2' HG23 ' A' ' 52' ' ' VAL . 92.0 m-85 -137.61 146.03 43.47 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.715 0.769 . . . . 73.41 111.583 -174.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.85 121.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 106.939 -1.504 . . . . 63.21 106.939 167.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.8 m -123.02 162.18 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.479 0.657 . . . . 63.43 112.761 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 71.5 p -131.01 122.12 26.25 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.295 -0.866 . . . . 71.21 109.732 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -148.01 151.24 35.41 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.344 0.498 . . . . 74.24 112.344 -170.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.2 m -96.37 109.15 46.19 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 107.814 -1.18 . . . . 73.34 107.814 170.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.32 148.64 40.77 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.371 2.047 . . . . 61.12 112.901 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.8 p -64.27 -17.21 63.4 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.176 0.99 . . . . 62.33 113.029 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.464 ' N ' HD22 ' A' ' 41' ' ' ASN . 0.8 OUTLIER -70.54 -19.51 62.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.76 0.424 . . . . 74.54 111.197 172.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.26 24.75 65.22 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 114.898 0.719 . . . . 74.44 114.898 168.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.18 -96.49 0.35 Allowed Glycine 0 CA--C 1.537 1.428 0 CA-C-N 117.03 0.415 . . . . 45.1 112.746 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -116.83 142.19 47.25 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.707 0.803 . . . . 70.21 110.539 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -69.71 115.3 8.8 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.675 0.39 . . . . 73.3 110.501 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.1 t -84.43 85.54 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-O 121.766 0.793 . . . . 62.11 109.837 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.0 p-10 -67.26 158.21 31.99 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.961 1.097 . . . . 64.13 113.961 163.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 42.3 m80 56.33 29.17 14.58 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 113.829 -1.532 . . . . 72.34 113.654 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -64.87 128.83 37.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.048 0.539 . . . . 74.43 111.167 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 98.3 mttt -129.66 133.75 47.29 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.801 0.84 . . . . 71.51 111.273 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.636 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 84.6 m95 -120.07 160.91 21.9 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.436 1.494 . . . . 60.22 111.159 -9.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.545 HG23 ' HB2' ' A' ' 33' ' ' TYR . 19.3 m -127.83 141.88 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.334 1.054 . . . . 63.23 109.301 170.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.6 pt -106.97 167.63 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 122.129 -0.357 . . . . 71.31 111.632 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.489 ' HG2' ' HB1' ' A' ' 60' ' ' ALA . 53.6 tt0 -47.75 -57.35 5.69 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.847 1.054 . . . . 74.41 113.847 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -82.09 7.02 14.51 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 112.866 0.691 . . . . 70.03 112.866 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -91.59 -11.39 37.34 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.386 1.074 . . . . 64.41 110.506 172.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.8 mt -116.88 140.01 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 125.031 1.332 . . . . 72.34 109.382 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HB3' ' HG2' ' A' ' 74' ' ' GLU . 16.0 ptmt -71.99 -36.21 69.7 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.758 0.651 . . . . 73.1 112.758 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -72.9 -8.99 58.16 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.756 0.822 . . . . 71.44 112.627 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.489 ' HB1' ' HG2' ' A' ' 54' ' ' GLN . . . -33.69 -63.3 0.26 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.228 1.411 . . . . 63.14 114.69 176.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.7 19.98 65.69 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 115.269 0.868 . . . . 74.33 115.269 169.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.1 t70 71.81 -3.08 2.28 Favored 'General case' 0 CA--C 1.573 1.853 0 C-N-CA 125.336 1.454 . . . . 74.23 112.843 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.68 168.15 10.11 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.68 0.792 . . . . 74.34 111.72 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.0 m -90.91 119.37 31.05 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.296 0.639 . . . . 55.24 110.409 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.5 HD13 HG11 ' A' ' 71' ' ' VAL . 49.6 mt -73.69 118.16 16.32 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.194 0.598 . . . . 73.23 110.21 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -101.27 144.55 28.79 Favored Pre-proline 0 N--CA 1.489 1.52 0 C-N-CA 123.614 0.765 . . . . 72.42 112.172 -165.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.39 124.95 16.22 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 123.082 2.521 . . . . 54.03 114.324 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.2 -19.22 29.93 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 123.841 0.734 . . . . 73.25 113.393 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -74.35 148.49 41.24 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.546 0.739 . . . . 74.13 112.291 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -113.07 123.24 49.82 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.726 0.81 . . . . 62.02 111.216 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.5 HG11 HD13 ' A' ' 65' ' ' LEU . 26.9 m -121.42 177.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 125.392 1.477 . . . . 50.31 111.496 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 85' ' ' THR . 38.5 mm -120.52 137.0 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 123.935 0.894 . . . . 72.02 109.821 170.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.4 mt -90.43 121.54 32.5 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.097 0.959 . . . . 51.31 111.818 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.468 ' HG2' ' HB3' ' A' ' 58' ' ' LYS . 33.8 mm-40 -89.66 -4.06 57.95 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.447 0.536 . . . . 53.42 112.447 174.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.48 167.62 12.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.255 0.55 . . . . 54.03 111.056 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 t -141.96 125.01 16.23 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.503 -0.771 . . . . 65.2 111.683 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -98.73 -11.81 21.57 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.89 0.876 . . . . 63.25 111.527 170.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 20.4 ptp -144.14 -175.6 4.68 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.545 0.738 . . . . 63.43 111.951 -172.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.52 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -70.05 100.81 1.68 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.793 0.664 . . . . 73.11 112.793 -178.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.35 38.97 8.62 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.387 -0.824 . . . . 62.11 114.426 172.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.6 ttt -86.49 -28.98 23.1 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 117.402 0.601 . . . . 64.33 111.765 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -64.59 129.24 39.08 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 120.908 0.385 . . . . 72.41 111.848 172.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.23 -4.15 84.34 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.924 -0.58 . . . . 74.33 113.143 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.78 146.93 32.04 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.463 0.705 . . . . 71.21 111.588 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.449 ' HA ' HD13 ' A' ' 72' ' ' ILE . 57.9 m -84.11 117.06 23.21 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.989 -0.55 . . . . 64.04 109.699 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -106.5 152.81 23.18 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.529 0.732 . . . . 72.21 110.36 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -123.1 121.47 36.08 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.555 -0.906 . . . . 75.21 108.555 174.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.34 106.38 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.537 0.735 . . . . 73.42 110.133 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -76.59 -37.71 56.05 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.512 0.725 . . . . 74.51 109.735 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.0 t -159.77 158.62 31.53 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.671 -0.695 . . . . 72.15 111.286 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -135.17 139.33 44.49 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.957 0.903 . . . . 62.01 109.905 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -151.44 142.98 23.58 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.763 0.425 . . . . 65.02 110.751 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.578 ' HD2' ' H ' ' A' ' 93' ' ' LYS . 1.3 mptt -96.78 92.52 6.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 107.986 -1.116 . . . . 65.31 107.986 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.3 t -138.11 153.17 49.28 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.532 0.733 . . . . 74.05 111.337 -172.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.2 m -77.69 122.99 26.09 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.926 -0.398 . . . . 74.42 109.926 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.524 HG12 HG22 ' A' ' 117' ' ' THR . 24.0 m -109.31 134.2 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.728 0.811 . . . . 71.3 108.976 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -110.96 144.11 40.57 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.366 0.666 . . . . 73.43 111.684 -174.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.9 ttp -93.58 111.17 22.79 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.671 -1.233 . . . . 73.33 107.671 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.579 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 27.4 m -124.42 146.76 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 112.822 0.675 . . . . 72.53 112.822 -168.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.55 116.18 29.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.945 0.898 . . . . 74.13 109.827 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -130.96 175.5 9.03 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.188 0.595 . . . . 74.5 111.524 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.8 m -117.56 119.98 36.66 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.878 -0.786 . . . . 72.14 108.878 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 106' ' ' SER . 72.9 p -60.95 126.09 26.1 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.336 0.654 . . . . 74.21 111.558 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.5 p -70.71 -48.42 54.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.451 0.7 . . . . 52.15 112.87 -172.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.507 HG22 ' HA2' ' A' ' 16' ' ' GLY . 11.6 t -86.03 -4.2 59.11 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.304 0.853 . . . . 44.43 113.304 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.434 ' HB2' ' OG ' ' A' ' 103' ' ' SER . 16.5 m -119.12 -49.16 2.41 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.945 0.498 . . . . 75.23 111.4 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.5 -6.52 55.43 Favored Glycine 0 N--CA 1.481 1.635 0 CA-C-N 116.219 -0.446 . . . . 74.31 113.618 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.53 130.64 39.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.463 0.705 . . . . 73.42 110.894 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -81.3 100.61 9.27 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.837 -0.801 . . . . 74.33 108.837 178.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 113' ' ' HIS . 46.9 t -88.0 108.67 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.052 0.941 . . . . 73.44 110.004 -172.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.609 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -102.73 139.93 37.67 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.105 0.562 . . . . 51.11 111.777 -169.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.5 m120 51.67 36.99 18.86 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.509 1.123 . . . . 60.34 113.249 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.442 ' HB2' HG12 ' A' ' 110' ' ' VAL . 64.8 t60 -64.75 132.52 49.82 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.884 -0.598 . . . . 64.13 110.819 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HB2' ' CE3' ' A' ' 115' ' ' TRP . 21.1 pttp -158.39 146.96 18.77 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 115.188 -0.915 . . . . 73.1 111.019 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.636 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 87.9 m95 -106.87 136.6 46.43 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.08 1.352 . . . . 72.15 112.735 4.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.4 m -122.16 141.58 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 124.881 1.272 . . . . 61.02 108.313 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.524 HG22 HG12 ' A' ' 96' ' ' VAL . 30.7 p -96.37 178.01 5.51 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.781 -0.574 . . . . 72.44 112.202 -174.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -59.65 -52.92 63.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.021 0.928 . . . . 74.43 112.868 -176.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.52 -21.15 66.6 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.942 0.897 . . . . 70.42 112.223 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -88.53 3.06 51.65 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.646 0.778 . . . . 74.22 111.521 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.6 mt -121.95 166.65 14.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.63 1.172 . . . . 63.54 109.289 171.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.3 t -151.13 130.78 13.09 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.439 0.696 . . . . 73.35 110.16 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.3 143.72 50.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.832 0.453 . . . . 43.3 111.524 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.3 tptt . . . . . 0 CA--C 1.556 1.199 0 C-N-CA 123.16 0.584 . . . . 73.44 111.039 178.774 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mmt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.952 -0.388 . . . . 62.43 109.952 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -100.8 154.24 18.8 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.38 0.672 . . . . 72.43 111.219 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.24 122.74 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 121.084 0.468 . . . . 62.0 110.397 173.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.7 -7.77 42.55 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 115.53 -0.759 . . . . 42.2 112.689 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -80.9 151.22 28.71 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.412 0.685 . . . . 71.23 112.349 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -93.06 136.96 32.84 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.163 0.985 . . . . 73.41 109.136 170.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.95 153.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.7 0.8 . . . . 63.44 110.308 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.8 mm -104.95 121.53 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.889 0.876 . . . . 72.5 109.828 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 22' ' ' ALA . 35.3 mt -82.01 120.41 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 122.938 0.495 . . . . 62.31 109.886 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -96.86 -56.08 2.68 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.865 0.466 . . . . 70.35 110.833 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.454 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 84.3 m -95.3 140.03 30.77 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.85 -1.167 . . . . 75.02 107.85 174.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 17' ' ' MET . 79.6 p -154.71 141.28 18.86 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.976 0.732 . . . . 74.22 112.976 -164.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -75.18 -43.63 51.07 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.157 0.983 . . . . 75.34 109.6 174.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.485 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 25.3 mmt -96.34 140.42 31.03 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.377 -0.829 . . . . 74.32 110.535 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -60.96 -35.19 76.11 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.763 0.825 . . . . 71.13 111.468 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.46 -4.54 24.91 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 115.118 0.807 . . . . 73.13 115.118 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.531 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 48.6 mtm -99.52 -25.38 14.45 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 117.401 0.6 . . . . 65.25 111.678 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -68.34 116.93 9.48 Favored 'General case' 0 CA--C 1.556 1.178 0 CA-C-N 118.475 0.579 . . . . 72.41 110.375 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.81 2.0 89.81 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 115.383 -0.826 . . . . 44.13 113.689 -174.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.9 148.29 27.03 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.205 0.602 . . . . 42.12 111.797 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -95.18 104.26 16.14 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.643 0.777 . . . . 71.02 109.635 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.535 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -90.61 161.12 15.56 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.828 0.851 . . . . 64.22 112.189 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.4 m -124.11 121.77 36.05 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.363 -0.976 . . . . 63.32 108.363 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.07 100.4 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 122.8 0.44 . . . . 51.12 109.906 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.5 p -91.98 -8.1 47.11 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.167 0.587 . . . . 73.12 111.32 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.26 148.96 15.42 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.369 -0.378 . . . . 72.22 112.386 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.78 114.53 14.22 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.821 0.848 . . . . 52.31 109.915 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.453 ' HB2' HG23 ' A' ' 96' ' ' VAL . 5.9 m-85 -116.06 130.54 56.86 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.173 0.989 . . . . 72.33 111.155 -171.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -103.83 81.65 1.9 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.938 0.895 . . . . 75.24 110.319 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -133.88 166.15 23.34 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.088 0.555 . . . . 60.43 111.307 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.412 ' HB ' ' HG2' ' A' ' 54' ' ' GLN . 4.0 m -76.83 121.93 24.07 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.372 -0.603 . . . . 62.2 109.372 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.89 151.62 26.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.452 0.701 . . . . 74.24 109.635 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -136.42 149.18 48.14 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.934 0.873 . . . . 64.34 112.25 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.52 111.58 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 113.892 -1.503 . . . . 73.04 107.149 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.541 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 26.7 m -119.92 149.49 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.321 0.648 . . . . 74.41 112.165 -176.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.1 t -117.41 132.21 56.61 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.655 0.782 . . . . 71.4 109.908 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -150.71 156.1 40.64 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.09 0.472 . . . . 74.43 111.968 -173.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.1 m -109.3 111.66 59.79 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.332 -0.988 . . . . 44.04 108.332 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.79 117.2 3.11 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.376 2.718 . . . . 72.11 114.125 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.466 HG23 ' HA ' ' A' ' 84' ' ' ALA . 25.6 p -59.49 -24.4 63.57 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.741 1.216 . . . . 70.04 113.892 -173.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -79.38 14.69 1.47 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.483 0.713 . . . . 74.24 112.858 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.95 43.7 6.63 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 113.774 0.27 . . . . 44.54 113.774 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.93 163.61 12.94 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 122.708 0.194 . . . . 71.14 113.024 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -66.28 135.12 53.98 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.372 0.669 . . . . 52.51 111.099 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -58.19 116.83 3.82 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.584 0.754 . . . . 72.13 112.376 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.55 HG12 ' HB2' ' A' ' 49' ' ' HIS . 30.7 t -84.82 104.94 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.202 -0.908 . . . . 72.43 109.198 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -99.41 135.5 40.72 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.414 0.686 . . . . 75.52 110.668 -172.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.8 m170 57.45 39.06 28.36 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.233 1.013 . . . . 71.55 112.446 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.55 ' HB2' HG12 ' A' ' 46' ' ' VAL . 46.0 t60 -66.25 135.29 54.25 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.908 0.883 . . . . 70.51 110.701 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -150.81 153.61 35.75 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.889 -0.596 . . . . 71.31 110.46 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.559 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 98.0 m95 -106.43 139.61 40.63 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.39 1.476 . . . . 65.24 111.824 -2.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.5 137.43 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.333 1.053 . . . . 41.41 108.377 169.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.2 pt -113.74 174.1 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.965 0.506 . . . . 62.13 111.722 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.412 ' HG2' ' HB ' ' A' ' 31' ' ' THR . 14.1 mm100 -48.85 -49.16 40.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.57 1.322 . . . . 73.42 114.57 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.46 -1.22 40.66 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 122.856 0.462 . . . . 63.51 112.163 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.45 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 0.9 OUTLIER -83.81 -22.06 31.92 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.826 0.85 . . . . 71.52 110.27 175.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.4 mt -117.34 136.14 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 124.715 1.206 . . . . 72.35 111.079 -168.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.485 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 38.4 ttpt -72.01 -57.41 4.31 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.489 0.716 . . . . 62.02 111.539 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.09 -4.61 14.12 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.581 1.152 . . . . 74.21 113.685 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.728 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -54.55 -55.74 26.12 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.45 0.7 . . . . 75.22 112.006 171.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.91 19.79 65.93 Favored Glycine 0 N--CA 1.479 1.565 0 N-CA-C 114.676 0.63 . . . . 53.14 114.676 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 62.79 20.14 11.93 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.06 1.344 . . . . 73.15 113.813 -172.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 16.6 pttp -98.32 160.18 14.46 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 122.914 0.486 . . . . 64.51 109.91 173.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.8 m -76.46 110.81 11.31 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.891 -0.411 . . . . 73.41 109.891 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 60' ' ' ALA . 61.1 mt -74.68 114.07 12.68 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.267 0.627 . . . . 74.44 110.458 177.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -81.23 147.81 61.73 Favored Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 123.561 0.744 . . . . 42.22 111.731 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.42 114.63 1.65 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.836 2.358 . . . . 75.15 113.339 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.81 -14.21 24.39 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-N 115.826 -0.625 . . . . 61.23 113.96 -174.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -75.24 141.84 43.47 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.423 0.689 . . . . 75.34 111.03 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -111.38 133.22 53.84 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.536 0.684 . . . . 74.35 110.975 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.9 m -140.09 156.39 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 125.389 1.476 . . . . 63.04 110.634 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -103.46 136.13 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 122.853 0.461 . . . . 73.41 109.769 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.3 mt -87.44 120.88 29.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.167 0.987 . . . . 74.43 111.44 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.485 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 8.2 mm-40 -81.73 -36.97 28.01 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.317 0.647 . . . . 75.22 112.43 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.45 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -83.73 164.99 19.26 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.058 0.456 . . . . 71.5 111.214 176.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 96.5 p -143.74 124.81 14.44 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.737 -0.468 . . . . 63.21 109.737 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -91.66 -4.28 55.37 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.777 0.831 . . . . 71.45 110.602 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -164.33 175.78 9.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.304 1.042 . . . . 74.14 111.141 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -80.4 116.38 20.43 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.352 0.661 . . . . 74.31 111.387 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.31 27.34 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 123.019 0.342 . . . . 75.33 113.821 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.9 ttt -82.53 -50.52 8.73 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.587 0.755 . . . . 73.34 112.906 -173.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -63.31 128.78 37.39 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.834 0.453 . . . . 64.04 111.893 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.2 -10.3 67.58 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.562 -0.29 . . . . 50.11 113.227 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.466 ' HA ' HG23 ' A' ' 40' ' ' THR . . . -76.63 145.9 38.55 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.018 0.527 . . . . 73.34 111.775 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.0 m -84.17 117.25 23.37 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.693 -0.685 . . . . 62.33 109.554 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.541 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -110.95 149.27 30.9 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.758 1.223 . . . . 71.31 109.94 -175.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.47 132.24 52.71 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 109.483 -0.562 . . . . 63.34 109.483 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.525 HD13 HG12 ' A' ' 35' ' ' VAL . 30.4 mm -67.42 109.4 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.607 0.763 . . . . 73.03 110.354 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -78.06 -38.36 44.61 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.217 0.607 . . . . 74.12 109.743 172.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.2 t -154.92 141.15 18.55 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.458 -0.792 . . . . 71.55 111.301 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.16 131.89 52.07 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.907 0.883 . . . . 75.13 108.955 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -132.5 139.29 47.87 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.788 0.662 . . . . 74.52 112.788 -168.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -111.22 95.39 5.5 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.06 0.944 . . . . 63.34 109.414 169.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -137.56 157.25 46.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.116 0.966 . . . . 45.32 110.841 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.6 m -85.38 119.37 25.66 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.307 -0.997 . . . . 72.13 108.307 171.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.453 HG23 ' HB2' ' A' ' 28' ' ' TYR . 13.7 m -106.51 132.76 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.398 0.618 . . . . 63.14 109.624 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.402 ' HB2' HG23 ' A' ' 116' ' ' VAL . 89.7 m-85 -111.97 140.43 46.65 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.935 0.894 . . . . 62.33 111.231 -172.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.8 ttp -94.21 119.88 33.65 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.268 -1.382 . . . . 51.14 107.268 167.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.535 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 23.5 m -128.03 156.56 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 113.789 1.033 . . . . 71.1 113.789 -171.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -110.29 118.28 35.91 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.124 1.37 . . . . 63.23 109.087 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -133.72 166.86 21.64 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.174 0.511 . . . . 71.21 110.947 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.4 m -105.61 119.14 38.37 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 108.791 -0.818 . . . . 75.33 108.791 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.8 m -56.84 95.98 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.754 0.821 . . . . 71.14 110.834 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.4 p -58.3 -26.0 62.51 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.351 1.06 . . . . 64.31 113.709 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 m -62.6 -38.3 89.63 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 123.734 0.813 . . . . 73.21 112.421 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.9 p -113.94 -50.76 2.81 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 123.357 0.663 . . . . 70.12 112.068 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.21 15.85 7.52 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.158 0.885 . . . . 71.35 111.945 -172.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -86.49 141.54 29.02 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.727 0.811 . . . . 43.3 111.547 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -85.01 117.71 24.15 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.752 1.221 . . . . 73.04 111.093 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -120.53 132.6 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 124.03 0.932 . . . . 71.22 110.591 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.453 ' HD3' ' H ' ' A' ' 111' ' ' LYS . 0.4 OUTLIER -115.8 168.7 9.82 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.263 0.625 . . . . 63.33 111.365 178.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.79 37.58 2.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 126.516 1.926 . . . . 74.42 115.221 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -61.53 133.0 55.2 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.483 0.713 . . . . 71.25 111.642 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 90.5 mttt -137.11 132.61 34.31 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.025 0.93 . . . . 74.23 110.951 -175.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.559 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.7 m95 -116.37 154.35 30.4 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.824 1.65 . . . . 74.15 111.564 -11.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.402 HG23 ' HB2' ' A' ' 97' ' ' TYR . 15.4 m -124.51 142.47 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.865 0.866 . . . . 61.03 109.637 172.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.1 p -109.98 168.26 9.56 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.52 0.563 . . . . 72.14 112.52 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -57.2 -35.23 69.37 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.678 0.791 . . . . 71.31 111.686 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.49 -43.01 93.4 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.34 1.056 . . . . 64.44 111.799 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.454 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 52.2 mt-10 -85.73 -2.79 58.56 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.903 0.881 . . . . 72.03 112.892 -172.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.07 150.49 40.49 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.636 0.731 . . . . 72.35 111.578 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 m -122.77 147.7 46.2 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.312 -1.366 . . . . 74.15 107.312 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.17 151.85 33.03 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.95 0.795 . . . . 33.24 111.692 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -65.62 -46.01 80.9 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.075 0.55 . . . . 72.1 110.766 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.5 tt -70.54 -64.94 0.8 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.697 0.799 . . . . 61.32 109.42 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.12 74.08 10.32 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.509 0.671 . . . . 41.2 110.298 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -76.44 145.61 39.17 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 115.551 -0.75 . . . . 72.42 110.013 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.9 m80 75.49 -21.65 0.3 Allowed 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 125.321 1.448 . . . . 61.23 112.741 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -70.37 105.02 2.88 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.731 0.812 . . . . 71.31 111.274 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -111.98 148.13 34.46 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.308 -0.86 . . . . 70.23 110.248 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -104.25 124.06 48.46 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.975 -0.75 . . . . 74.11 108.975 171.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 . . . . . 0 CA--C 1.566 1.573 0 CA-C-O 118.11 -0.948 . . . . 71.22 109.774 176.491 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.529 ' HG2' HG11 ' A' ' 7' ' ' VAL . 1.8 mpt? . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.431 0.158 . . . . 52.22 110.95 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -109.13 164.13 12.71 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.613 0.765 . . . . 74.54 110.392 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.2 123.06 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-O 121.132 0.492 . . . . 75.41 110.532 172.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.57 -4.37 50.61 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 115.797 -0.638 . . . . 64.2 113.572 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -83.41 142.86 30.68 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.222 0.609 . . . . 54.41 111.455 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -109.13 135.73 49.79 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.42 0.629 . . . . 64.44 111.005 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 123' ' ' ALA . 23.7 m -139.81 155.29 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.967 1.307 . . . . 64.55 110.475 -170.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.1 mm -98.56 132.53 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.173 0.589 . . . . 73.13 109.714 170.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.687 HG21 ' HG2' ' A' ' 17' ' ' MET . 39.8 mt -81.71 123.34 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 122.387 0.275 . . . . 72.52 110.357 -175.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -95.11 -60.06 1.76 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.433 0.693 . . . . 73.44 110.247 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.627 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 79.7 m -98.24 140.03 33.14 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.073 -1.084 . . . . 73.54 108.073 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.437 ' HB3' ' HB3' ' A' ' 17' ' ' MET . 74.1 m -140.16 139.88 35.82 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.991 1.108 . . . . 64.3 113.991 -167.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -91.31 -15.92 28.34 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 113.994 -1.457 . . . . 71.42 110.417 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 26.5 mmt -126.56 155.43 42.44 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.646 1.179 . . . . 62.44 110.226 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -67.05 -36.9 83.06 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.095 0.558 . . . . 73.22 112.193 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.43 -9.98 86.58 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 114.046 0.379 . . . . 75.12 114.046 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.687 ' HG2' HG21 ' A' ' 9' ' ' ILE . 44.0 ttm -80.69 -32.1 36.01 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 122.69 0.396 . . . . 62.02 111.718 -172.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -68.87 122.34 18.42 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.13 0.572 . . . . 64.45 112.201 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.61 -8.48 79.05 Favored Glycine 0 CA--C 1.537 1.469 0 CA-C-N 115.729 -0.669 . . . . 71.12 114.147 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.18 149.68 42.73 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.169 0.588 . . . . 52.23 112.131 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -87.94 101.93 14.23 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.623 0.369 . . . . 73.55 110.04 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . . . -86.56 156.96 19.85 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.604 0.762 . . . . 73.12 111.374 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.0 m -131.25 127.51 37.95 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.454 -0.943 . . . . 73.15 108.454 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.95 113.83 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 123.207 0.603 . . . . 73.14 111.017 -173.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.4 p -89.9 -21.04 22.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.102 0.561 . . . . 74.34 110.53 173.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.6 142.57 8.52 Favored Glycine 0 C--N 1.354 1.547 0 C-N-CA 122.741 0.21 . . . . 54.3 112.612 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.98 107.55 9.7 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.66 0.784 . . . . 51.42 110.067 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -111.58 132.91 54.21 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.801 0.84 . . . . 75.44 110.674 -175.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.4 82.71 1.77 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.77 0.795 . . . . 52.32 109.97 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -134.96 -179.51 5.66 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.816 0.846 . . . . 75.53 111.321 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 m -83.91 128.26 34.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.918 -0.489 . . . . 74.45 110.383 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.11 140.18 48.1 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.141 0.976 . . . . 74.14 109.895 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -113.72 152.51 30.41 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 122.081 0.943 . . . . 74.32 112.6 -174.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.54 111.41 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.069 -1.423 . . . . 42.34 107.753 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.426 HG12 HD13 ' A' ' 88' ' ' ILE . 19.3 m -112.39 150.85 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.386 0.612 . . . . 75.2 112.444 -176.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -122.0 125.57 46.59 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.298 1.039 . . . . 72.24 109.263 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -152.27 159.03 43.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.564 0.745 . . . . 74.55 111.294 -174.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.9 m -105.52 116.73 59.64 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.724 -1.213 . . . . 74.53 107.724 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -58.96 133.32 52.79 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.096 1.864 . . . . 74.13 110.873 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.1 p -68.83 2.06 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.109 0.781 . . . . 61.05 113.109 -173.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.14 -21.2 66.04 Favored 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 123.663 0.785 . . . . 65.13 111.317 165.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.19 15.13 56.46 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 115.066 0.786 . . . . 64.34 115.066 171.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.62 -131.43 7.38 Favored Glycine 0 N--CA 1.476 1.357 0 CA-C-N 117.655 0.728 . . . . 25.55 113.688 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -71.21 128.27 35.36 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.919 0.888 . . . . 73.02 111.974 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -62.24 122.3 15.28 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.587 0.755 . . . . 72.3 111.938 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.593 HG21 ' SD ' ' A' ' 78' ' ' MET . 68.0 t -84.47 110.77 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.396 0.679 . . . . 70.44 110.256 176.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -101.44 148.33 25.31 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.903 0.481 . . . . 73.22 109.958 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 34.3 m80 54.59 38.95 30.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.732 0.813 . . . . 75.03 112.779 173.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -60.46 128.35 36.21 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.857 0.863 . . . . 71.41 111.198 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 66.1 mttm -126.3 132.68 51.6 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 123.504 0.722 . . . . 71.24 110.594 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 94.4 m95 -117.86 156.14 28.92 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.154 1.382 . . . . 70.45 111.53 -11.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.55 160.4 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.96 1.304 . . . . 75.43 108.169 169.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.416 HG21 HG21 ' A' ' 96' ' ' VAL . 37.4 pt -126.7 163.65 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 118.983 0.81 . . . . 54.04 112.546 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -44.14 -51.59 7.96 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.499 1.519 . . . . 64.43 112.538 174.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -82.15 -5.92 58.81 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.787 0.835 . . . . 70.04 112.97 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -88.32 -33.67 17.92 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.686 0.795 . . . . 35.45 110.234 173.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.8 mt -78.93 130.25 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 115.754 -0.657 . . . . 74.41 110.468 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -69.34 -35.45 75.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.492 0.717 . . . . 71.23 112.351 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -77.24 -8.9 58.35 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.971 0.73 . . . . 73.1 112.971 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -34.17 -59.43 0.43 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 114.945 1.461 . . . . 51.43 114.945 -173.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.51 21.01 68.4 Favored Glycine 0 N--CA 1.479 1.519 0 N-CA-C 115.352 0.901 . . . . 75.54 115.352 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 68.84 -2.94 1.57 Allowed 'General case' 0 CA--C 1.573 1.85 0 C-N-CA 124.862 1.265 . . . . 64.44 112.472 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 25.0 pttm -95.68 152.78 18.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.628 -0.67 . . . . 74.35 111.022 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.6 m -84.08 112.36 20.15 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.006 -0.739 . . . . 74.13 109.006 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.534 ' HB3' HG13 ' A' ' 88' ' ' ILE . 42.3 mt -71.31 120.5 16.98 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.817 0.847 . . . . 63.4 110.763 -174.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -91.19 157.48 42.7 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 123.682 0.793 . . . . 72.22 111.292 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 87.2 Cg_exo -50.99 112.25 0.74 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.644 2.229 . . . . 72.04 113.163 172.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.64 -9.93 16.52 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 115.975 -0.557 . . . . 63.01 114.031 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.6 122.73 19.12 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 117.772 0.786 . . . . 74.5 109.495 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -100.91 118.35 36.78 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.471 -0.937 . . . . 75.15 108.471 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.423 HG11 HD13 ' A' ' 65' ' ' LEU . 33.3 m -125.29 171.92 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.607 1.163 . . . . 52.42 110.877 -166.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.3 mm -116.17 135.95 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 122.863 0.465 . . . . 62.21 110.033 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.9 mt -90.93 134.73 34.24 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.74 0.816 . . . . 63.45 110.996 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.16 -5.62 27.49 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 113.0 0.741 . . . . 75.55 113.0 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.6 156.27 16.89 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.139 0.575 . . . . 74.3 110.618 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.9 p -136.04 124.4 23.34 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.193 0.521 . . . . 65.31 110.319 171.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -100.35 -16.22 17.72 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.793 0.837 . . . . 75.14 108.991 162.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.593 ' SD ' HG21 ' A' ' 46' ' ' VAL . 43.3 mtt -128.57 173.42 10.28 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.39 1.076 . . . . 73.21 112.213 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.59 105.67 8.89 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.0 0.92 . . . . 63.33 110.836 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.1 33.58 17.34 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.23 -0.441 . . . . 72.11 113.207 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -89.59 -49.4 6.69 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.303 0.641 . . . . 71.1 109.97 173.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -69.04 120.57 15.1 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.34 0.656 . . . . 73.12 111.036 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.71 2.35 75.82 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 123.103 0.252 . . . . 70.11 113.263 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.44 158.09 19.06 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.4 0.68 . . . . 72.44 111.551 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 m -87.51 118.33 26.9 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.2 -0.909 . . . . 72.11 110.023 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -115.43 162.17 17.52 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.112 0.965 . . . . 61.53 110.114 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -130.75 130.28 43.57 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.051 0.54 . . . . 65.22 109.873 173.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 65' ' ' LEU . 36.7 mm -64.78 104.61 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.503 0.721 . . . . 73.51 110.137 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.6 -37.59 65.38 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.696 0.798 . . . . 72.32 110.601 172.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.6 t -162.66 159.04 23.95 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.287 0.635 . . . . 62.22 111.829 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.42 150.52 39.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.518 1.127 . . . . 61.51 110.645 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -154.54 134.0 12.68 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 112.02 0.378 . . . . 63.53 112.02 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -93.59 96.57 9.94 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.105 -0.702 . . . . 73.33 109.105 172.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.8 t -137.09 154.4 50.32 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.621 0.768 . . . . 64.32 111.68 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.2 m -80.11 119.21 22.6 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.055 -0.72 . . . . 72.42 109.055 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.416 HG21 HG21 ' A' ' 53' ' ' ILE . 24.8 m -108.65 136.42 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.811 0.845 . . . . 71.14 110.728 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.07 146.62 36.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.358 1.075 . . . . 72.11 112.912 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.7 ttp -108.03 118.93 38.03 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 113.466 -1.697 . . . . 73.45 106.825 165.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.2 m -127.99 173.27 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 112.699 0.629 . . . . 74.31 112.699 -170.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.69 ' HB2' ' HD3' ' A' ' 111' ' ' LYS . 4.8 p-10 -138.16 133.48 33.38 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.127 0.571 . . . . 75.32 110.441 172.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.445 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 47.7 p90 -151.18 177.23 10.42 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.165 0.586 . . . . 75.42 111.571 -174.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.2 m -111.59 112.34 23.99 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.291 -1.003 . . . . 63.31 108.291 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.5 p -59.01 116.57 3.9 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.3 0.64 . . . . 54.43 111.281 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.4 p -58.07 -32.81 68.4 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.846 1.258 . . . . 75.32 113.876 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.4 p -87.82 -45.13 10.57 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.262 0.467 . . . . 73.2 112.262 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -89.04 -31.89 17.85 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.401 0.68 . . . . 74.52 112.548 -169.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.14 -6.1 83.82 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 116.228 -0.442 . . . . 31.22 113.592 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -77.26 132.76 38.84 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.161 0.984 . . . . 75.33 112.142 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -80.27 94.15 6.03 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.476 0.71 . . . . 73.13 109.395 174.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 113' ' ' HIS . 58.5 t -77.35 104.62 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.234 -0.893 . . . . 72.42 109.713 -176.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.69 ' HD3' ' HB2' ' A' ' 100' ' ' ASP . 74.9 mmtt -99.93 133.75 43.85 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.597 0.759 . . . . 73.23 111.697 -172.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 m120 61.58 35.66 17.19 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.299 1.04 . . . . 51.01 112.21 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.447 ' HB2' HG12 ' A' ' 110' ' ' VAL . 86.3 t60 -58.78 129.52 42.5 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.98 0.912 . . . . 63.11 112.23 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 19.2 ptpt -152.49 147.45 26.25 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.899 0.88 . . . . 64.31 110.787 -176.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 97.6 m95 -109.14 138.48 45.43 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.33 1.452 . . . . 73.42 111.77 -4.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.78 172.38 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.438 1.095 . . . . 72.12 108.895 170.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 120' ' ' GLU . 30.3 p -118.58 178.22 4.54 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.362 0.665 . . . . 61.3 111.01 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -67.28 -28.18 67.8 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.455 0.302 . . . . 74.51 111.385 174.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.42 -15.27 53.25 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 122.939 0.496 . . . . 72.04 111.754 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.627 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 4.7 mm-40 -81.19 -18.82 44.89 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.199 0.523 . . . . 70.42 110.407 171.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.0 mt -115.05 159.18 21.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.024 0.93 . . . . 75.3 110.593 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.1 m -137.71 138.18 39.08 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.019 -1.104 . . . . 60.3 108.019 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.548 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -57.38 158.08 5.95 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.73 0.695 . . . . 63.44 111.454 176.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -54.01 -34.51 60.12 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.924 0.49 . . . . 64.45 112.026 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.7 tp -75.9 -49.72 17.07 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.666 0.786 . . . . 72.44 111.23 169.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -64.44 142.79 58.3 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.992 0.917 . . . . 74.41 113.202 -171.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -157.96 104.07 1.9 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.433 0.693 . . . . 75.32 110.496 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -137.83 98.12 3.59 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.61 0.764 . . . . 60.33 110.455 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -69.94 126.94 31.19 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.6 0.36 . . . . 71.21 110.747 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -147.35 -2.46 0.59 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.814 0.672 . . . . 74.23 112.814 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -166.01 167.56 16.42 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.456 1.102 . . . . 71.3 110.602 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 . . . . . 0 CA--C 1.562 1.406 0 C-N-CA 123.995 0.918 . . . . 63.54 110.493 173.609 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' HB3' HG21 ' A' ' 24' ' ' VAL . 24.9 mmt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.535 0.207 . . . . 71.44 110.93 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -70.97 157.14 38.72 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.464 1.105 . . . . 65.34 111.212 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -62.23 127.57 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 C-N-CA 122.589 0.356 . . . . 75.24 110.868 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.44 -3.62 56.52 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.246 0.45 . . . . 70.22 113.412 -175.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.8 t -73.15 127.85 33.78 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.229 0.612 . . . . 45.45 111.82 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -87.58 109.92 19.99 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.341 0.656 . . . . 74.42 110.14 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.427 HG21 HD13 ' A' ' 121' ' ' LEU . 30.4 m -125.99 157.66 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 124.011 0.924 . . . . 74.1 111.074 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.2 mm -105.54 136.99 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.344 1.057 . . . . 70.32 109.241 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 17' ' ' MET . 54.0 mt -76.76 118.43 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 CA-C-O 120.759 0.314 . . . . 74.22 110.192 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -84.54 -59.27 2.42 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.04 0.936 . . . . 71.42 110.127 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 94.0 m -91.88 139.69 30.41 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.527 -0.76 . . . . 71.34 109.767 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 14' ' ' MET . 80.6 p -130.34 122.42 27.86 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.091 0.472 . . . . 60.43 111.707 -174.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -83.12 -44.86 14.64 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.565 -0.902 . . . . 74.24 108.565 171.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.462 ' O ' ' HB2' ' A' ' 12' ' ' SER . 1.8 mpt? -94.18 130.9 40.22 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 114.164 -1.38 . . . . 63.42 107.536 166.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -63.0 -24.2 67.81 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 119.363 0.983 . . . . 65.23 113.234 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.01 -4.61 68.01 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 114.694 0.638 . . . . 53.23 114.694 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.432 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 35.0 mtp -84.97 -29.73 24.84 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.308 0.643 . . . . 73.2 110.722 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -67.94 117.73 10.2 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.571 0.348 . . . . 73.11 111.075 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.2 1.09 90.48 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 116.087 -0.506 . . . . 34.11 113.645 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.92 135.46 43.28 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.239 0.616 . . . . 72.33 111.141 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -82.29 103.94 12.24 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.641 -0.709 . . . . 73.41 110.323 -176.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.33 160.48 14.25 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.059 0.943 . . . . 70.44 113.301 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.3 m -133.14 136.36 45.73 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.841 1.257 . . . . 74.21 108.611 171.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.519 HG21 ' HB3' ' A' ' 1' ' ' MET . 61.1 t -82.66 111.19 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 122.888 0.475 . . . . 61.22 110.868 -177.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.5 p -86.32 -19.9 29.14 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.824 0.45 . . . . 72.52 111.571 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.34 166.45 39.23 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 113.843 0.297 . . . . 54.23 113.843 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.63 138.51 47.39 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.091 0.957 . . . . 73.25 110.935 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.457 ' HB2' HG23 ' A' ' 96' ' ' VAL . 42.8 m-85 -128.55 111.84 13.67 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.32 1.048 . . . . 65.02 109.756 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -97.91 79.24 2.62 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.874 0.845 . . . . 72.4 110.401 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -133.91 170.89 14.95 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.658 0.783 . . . . 73.02 111.624 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -73.74 121.26 20.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.977 0.511 . . . . 65.24 109.879 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.35 147.86 43.08 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.638 0.775 . . . . 63.41 110.383 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -131.96 154.56 49.17 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.163 0.982 . . . . 75.33 112.591 -167.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 90' ' ' SER . 64.6 t -105.14 133.66 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 113.729 -1.578 . . . . 70.44 107.62 167.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.43 ' HA ' ' H ' ' A' ' 89' ' ' ASP . 12.5 m -131.18 166.03 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.8 0.809 . . . . 74.55 112.788 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.2 t -132.92 127.78 35.07 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 114.38 -1.282 . . . . 71.12 108.658 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.52 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 43.8 p90 -155.87 160.27 40.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.596 0.758 . . . . 74.23 111.062 -171.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.1 m -109.28 119.48 48.31 Favored Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 108.783 -0.821 . . . . 65.21 108.783 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.27 133.17 45.0 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.127 1.885 . . . . 60.4 111.902 172.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.8 p -65.19 -7.28 12.02 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.99 0.916 . . . . 72.05 113.081 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.33 -18.0 60.29 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 124.728 1.211 . . . . 71.04 113.046 171.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.69 57.46 3.54 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 111.624 -0.59 . . . . 75.52 111.624 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.47 -155.56 8.16 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 115.007 -0.597 . . . . 72.04 113.005 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -69.48 119.05 13.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.469 0.708 . . . . 61.24 110.808 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -56.95 116.28 3.11 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 109.317 -0.623 . . . . 73.35 109.317 168.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.492 HG12 ' HB2' ' A' ' 49' ' ' HIS . 40.7 t -88.67 115.51 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 123.311 0.645 . . . . 74.43 110.154 -176.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -109.35 155.69 20.91 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.376 0.671 . . . . 50.41 110.491 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.2 m170 57.82 26.4 13.15 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.902 0.881 . . . . 70.4 112.376 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.492 ' HB2' HG12 ' A' ' 46' ' ' VAL . 84.9 t60 -71.65 136.95 47.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.811 0.844 . . . . 74.23 110.908 -178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 65.1 pttt -158.11 148.71 20.56 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-N 116.313 -0.403 . . . . 63.44 111.508 -176.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 82.4 m95 -107.59 147.75 30.2 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.022 1.329 . . . . 72.05 111.471 -0.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.92 135.5 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.436 1.095 . . . . 74.23 108.272 172.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.5 pt -115.53 169.98 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.284 -0.885 . . . . 71.44 112.754 -168.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -50.85 -39.76 54.42 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.299 1.039 . . . . 73.31 113.791 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -72.61 -20.86 61.21 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.479 0.712 . . . . 60.3 111.882 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.531 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 27.3 tt0 -91.98 -24.76 19.14 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.59 0.756 . . . . 73.21 111.446 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.1 mt -101.22 129.36 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.867 0.867 . . . . 65.3 110.35 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -72.02 -57.09 4.58 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.581 0.705 . . . . 64.14 111.567 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.99 -2.99 6.02 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.687 1.195 . . . . 74.04 113.98 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.499 ' HA ' HD11 ' A' ' 65' ' ' LEU . . . -39.53 -58.34 1.29 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.126 1.37 . . . . 71.55 114.166 171.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.07 27.6 73.5 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 114.76 0.664 . . . . 72.04 114.76 174.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 63.17 16.56 9.48 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.686 1.194 . . . . 63.14 113.561 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 14.5 ptpt -105.6 167.94 9.43 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 122.882 0.473 . . . . 74.21 111.18 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.4 m -82.87 108.95 16.58 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.742 -0.836 . . . . 73.22 108.742 169.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.639 ' HB3' HG13 ' A' ' 88' ' ' ILE . 86.9 mt -75.91 138.37 40.99 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.47 -0.567 . . . . 70.11 109.47 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -118.19 161.39 35.1 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 123.713 0.805 . . . . 73.33 111.275 -169.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 71.3 Cg_exo -44.71 106.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.082 2.521 . . . . 73.04 113.937 171.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.48 -12.8 15.86 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 114.901 0.72 . . . . 60.21 114.901 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.95 100.46 1.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.252 1.026 . . . . 71.14 111.305 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -79.93 122.58 26.87 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 115.996 -0.547 . . . . 70.3 110.726 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.98 173.14 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 125.115 1.366 . . . . 73.24 111.68 -170.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.0 mm -115.13 139.79 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 C-N-CA 123.845 0.858 . . . . 74.34 110.41 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.28 123.31 35.52 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.758 0.823 . . . . 63.45 111.76 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -79.98 -44.87 19.45 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.827 0.851 . . . . 60.11 112.457 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.531 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -83.56 174.17 10.8 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.27 0.557 . . . . 74.01 111.542 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 80.0 p -143.73 126.28 15.92 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.05 -0.523 . . . . 71.35 111.055 175.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.507 ' H ' ' HG2' ' A' ' 81' ' ' MET . 19.9 m-70 -91.5 -23.48 19.94 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.991 0.916 . . . . 65.34 110.868 171.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -155.96 -176.9 6.2 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.838 0.855 . . . . 74.53 110.839 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -65.74 131.63 46.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.411 0.684 . . . . 74.13 112.213 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.64 10.93 84.61 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 115.871 -0.604 . . . . 65.25 114.567 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.507 ' HG2' ' H ' ' A' ' 77' ' ' HIS . 11.6 tpt -84.97 -52.43 5.99 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.58 0.752 . . . . 75.43 110.644 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 86.9 tttt -66.54 129.0 38.38 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.387 0.675 . . . . 65.13 111.379 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.11 -9.25 73.34 Favored Glycine 0 N--CA 1.476 1.316 0 O-C-N 123.004 0.19 . . . . 54.52 113.186 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 152.84 30.58 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.386 0.675 . . . . 65.53 111.118 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.7 m -90.26 120.07 31.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.228 -0.897 . . . . 64.33 109.774 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -104.15 162.97 12.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.885 0.874 . . . . 42.44 109.428 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -137.71 126.95 24.56 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.055 -0.72 . . . . 70.22 109.055 168.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.639 HG13 ' HB3' ' A' ' 65' ' ' LEU . 26.1 mm -60.47 110.27 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.381 0.672 . . . . 54.42 110.357 -177.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.43 ' H ' ' HA ' ' A' ' 35' ' ' VAL . 22.7 t70 -77.93 -36.37 49.41 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.167 0.987 . . . . 71.4 110.284 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.526 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 47.3 t -160.1 163.27 33.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.353 1.061 . . . . 73.31 110.277 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.64 148.12 51.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.493 0.717 . . . . 75.54 111.535 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -156.05 148.27 23.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.302 0.482 . . . . 62.42 112.302 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.51 95.44 7.0 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 107.757 -1.201 . . . . 73.14 107.757 163.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 t -136.26 154.55 50.87 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.302 0.641 . . . . 73.12 110.317 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.8 m -84.99 120.48 26.57 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.383 -0.599 . . . . 35.03 109.383 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.457 HG23 ' HB2' ' A' ' 28' ' ' TYR . 13.4 m -107.67 132.68 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.875 -0.787 . . . . 72.23 108.875 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.538 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 96.3 m-85 -109.62 166.7 10.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.489 1.138 . . . . 73.2 112.648 -171.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.2 ttp -120.96 111.09 17.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 112.832 -1.986 . . . . 64.11 107.199 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.26 147.11 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 112.921 0.711 . . . . 74.02 112.921 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 111' ' ' LYS . 4.6 p30 -105.51 138.03 42.38 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.612 0.765 . . . . 55.44 110.165 172.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -156.69 178.25 10.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.642 0.777 . . . . 73.4 111.126 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.0 m -118.11 114.57 23.29 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.438 0.695 . . . . 71.44 109.242 173.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -56.85 109.3 0.61 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.679 0.792 . . . . 75.41 111.02 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.8 p -54.47 -31.17 55.2 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.669 1.188 . . . . 73.03 113.293 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.6 m -64.54 -60.77 2.75 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.392 0.677 . . . . 45.33 112.313 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 36.2 m -101.92 -12.95 17.83 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.296 0.85 . . . . 64.4 113.296 -166.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.5 12.32 83.76 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 113.723 0.249 . . . . 63.24 113.723 -172.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -71.38 125.51 27.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.709 0.804 . . . . 72.45 112.314 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -75.98 96.8 3.85 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.786 0.435 . . . . 75.31 109.94 171.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.65 107.88 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 109.458 -0.571 . . . . 74.41 109.458 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 100' ' ' ASP . 92.5 mttt -106.78 143.84 34.29 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.647 0.379 . . . . 75.1 110.948 -174.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 54.62 39.43 31.22 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.151 0.981 . . . . 43.44 113.151 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -61.79 131.74 50.84 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.646 0.778 . . . . 75.43 111.399 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 97.5 mttt -134.76 146.61 49.54 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.301 1.04 . . . . 65.12 110.492 -175.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 85.1 m95 -109.54 127.55 54.56 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.658 1.583 . . . . 73.44 110.513 -10.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.6 m -119.63 162.09 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 C-N-CA 124.452 1.101 . . . . 53.5 109.814 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 50.0 p -117.82 171.12 8.27 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.931 0.715 . . . . 71.54 112.931 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.538 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 38.0 tt0 -67.18 -32.17 73.08 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.715 0.806 . . . . 42.24 111.891 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -70.76 -20.12 62.65 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.245 0.618 . . . . 73.43 111.948 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -91.87 4.06 53.76 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.602 0.761 . . . . 71.15 111.666 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.427 HD13 HG21 ' A' ' 7' ' ' VAL . 81.8 mt -121.11 171.92 8.34 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.861 1.265 . . . . 75.24 109.612 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.8 m -147.22 122.54 10.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.681 0.792 . . . . 62.15 109.962 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.08 111.11 4.27 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.885 0.474 . . . . 72.53 110.871 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -84.08 83.18 8.05 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 121.486 0.66 . . . . 75.45 110.899 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.1 tp -77.53 -56.96 4.09 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.661 0.784 . . . . 75.22 109.685 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.2 178.54 4.74 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.862 0.839 . . . . 72.42 112.361 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -45.94 127.25 8.11 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 125.412 1.485 . . . . 63.1 113.328 166.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -135.39 108.21 7.55 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.411 1.085 . . . . 74.43 110.283 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -110.43 104.81 13.61 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.575 0.75 . . . . 74.23 109.392 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -63.32 125.96 25.85 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.85 0.685 . . . . 74.31 112.85 -170.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -117.59 118.05 31.08 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.223 1.009 . . . . 73.01 110.192 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.8 m80 . . . . . 0 N--CA 1.494 1.761 0 C-N-CA 124.855 1.262 . . . . 73.41 112.755 179.599 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mmt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.695 0.283 . . . . 75.31 111.037 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -105.92 157.99 17.09 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.576 0.75 . . . . 74.34 109.913 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.6 t -66.97 122.76 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 CA-C-O 121.193 0.521 . . . . 70.14 110.118 170.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.77 -6.52 48.43 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-N 115.323 -0.853 . . . . 72.32 112.966 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.7 m -75.15 128.15 34.83 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.019 0.527 . . . . 24.14 111.559 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -85.57 117.58 24.56 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.282 -1.007 . . . . 72.14 108.282 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.09 150.84 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.287 0.635 . . . . 71.53 111.777 -174.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.1 mm -98.77 128.55 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.364 1.065 . . . . 70.22 108.406 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.3 mt -91.58 115.89 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.872 -0.418 . . . . 74.13 109.872 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -93.36 -24.44 18.09 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.065 0.546 . . . . 72.31 112.306 -171.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 m -110.62 142.57 42.3 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.401 0.68 . . . . 62.13 109.594 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 14' ' ' MET . 78.0 p -123.62 120.26 32.27 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.827 0.677 . . . . 64.22 112.827 -173.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -84.81 -41.75 15.8 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.23 1.012 . . . . 73.23 108.503 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.471 ' O ' ' HB2' ' A' ' 12' ' ' SER . 24.1 mmt -100.65 137.26 39.29 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.057 0.943 . . . . 73.32 108.698 167.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.509 ' HG3' HG21 ' A' ' 105' ' ' THR . 17.6 ptpt -60.65 -31.23 70.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.22 0.822 . . . . 74.22 113.22 -175.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.04 0.59 72.42 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 114.062 0.385 . . . . 74.3 114.062 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.6 ttp -99.04 -15.44 19.04 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.053 0.541 . . . . 63.2 110.893 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -65.96 117.0 7.69 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.171 0.588 . . . . 75.55 110.16 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.71 2.51 70.12 Favored Glycine 0 CA--C 1.542 1.772 0 N-CA-C 114.358 0.503 . . . . 54.34 114.358 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.38 146.34 43.06 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 117.575 0.687 . . . . 65.41 112.76 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -85.21 131.2 34.46 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.672 0.789 . . . . 72.33 110.219 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.6 172.1 13.15 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.314 0.857 . . . . 74.14 113.314 -170.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.7 m -140.72 138.2 34.04 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.02 0.928 . . . . 74.23 109.801 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -81.76 112.93 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.371 0.669 . . . . 73.22 109.974 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.9 p -99.55 -4.99 29.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.749 0.82 . . . . 63.4 112.297 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.85 149.6 17.07 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 120.09 -0.283 . . . . 55.31 112.56 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.75 114.46 10.52 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.525 0.73 . . . . 75.0 110.464 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -115.42 111.92 21.53 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.972 0.909 . . . . 74.22 111.233 -173.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.97 80.28 5.76 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 122.163 0.982 . . . . 62.01 109.856 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -133.61 174.63 10.22 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 115.69 -0.686 . . . . 64.22 111.987 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.1 m -82.5 119.53 24.34 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.894 0.478 . . . . 65.21 109.87 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.96 162.63 13.42 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.639 1.176 . . . . 63.41 109.286 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -139.54 149.02 43.4 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.683 0.754 . . . . 73.44 111.26 -173.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.9 121.13 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 106.677 -1.601 . . . . 71.4 106.677 168.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.404 HG12 HD13 ' A' ' 88' ' ' ILE . 17.0 m -124.3 151.35 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 118.881 0.764 . . . . 62.41 112.681 -175.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.5 p -119.52 125.45 48.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.168 0.987 . . . . 74.44 109.132 171.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.458 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 49.4 p90 -147.46 152.6 38.35 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.702 0.401 . . . . 74.4 112.057 -172.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.9 m -99.17 106.61 39.62 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 108.122 -1.066 . . . . 72.3 108.122 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.11 146.1 23.81 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.55 2.833 . . . . 53.23 113.984 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.5 p -66.09 -16.57 64.05 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.79 0.836 . . . . 71.05 112.554 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.57 -20.82 65.96 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 123.224 0.609 . . . . 64.32 111.292 170.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.06 14.72 76.48 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.682 -0.69 . . . . 40.35 114.483 172.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.53 -112.55 0.37 Allowed Glycine 0 CA--C 1.539 1.583 0 CA-C-N 117.272 0.536 . . . . 72.54 113.536 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -106.53 142.75 35.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.355 0.662 . . . . 74.25 111.259 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -66.91 133.94 51.02 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.374 0.669 . . . . 74.05 111.687 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.6 t -91.48 118.8 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 124.1 0.96 . . . . 65.03 110.099 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -102.1 138.28 39.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.324 0.65 . . . . 64.41 110.493 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 m170 57.28 41.92 25.97 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.191 0.996 . . . . 75.44 113.351 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -67.1 124.18 22.33 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 116.07 -0.514 . . . . 71.54 110.654 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 31.3 mtmm -131.49 144.59 51.25 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.86 0.864 . . . . 73.13 110.216 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 94.4 m95 -112.69 141.66 46.22 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.347 1.459 . . . . 75.51 110.624 -9.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.86 142.48 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.696 -0.853 . . . . 70.23 108.696 170.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.1 pt -110.55 167.34 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 O-C-N 121.934 -0.479 . . . . 74.31 110.862 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -53.65 -35.02 60.54 Favored 'General case' 0 CA--C 1.563 1.442 0 C-N-CA 123.976 0.91 . . . . 64.1 113.201 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -67.21 -24.95 65.89 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.415 0.686 . . . . 70.34 112.296 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -91.44 1.47 57.1 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.548 0.739 . . . . 75.31 112.096 -175.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.7 mt -108.78 131.65 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.904 0.882 . . . . 64.31 110.151 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -72.65 -42.42 64.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.056 0.942 . . . . 74.13 112.019 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -78.71 -10.4 59.75 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.701 0.8 . . . . 73.34 112.35 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -43.45 -58.33 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.872 1.064 . . . . 72.01 113.872 -173.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.94 31.31 78.03 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 116.502 1.361 . . . . 73.43 116.502 167.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.8 t70 73.76 -10.58 1.06 Allowed 'General case' 0 CA--C 1.578 2.027 0 C-N-CA 124.551 1.14 . . . . 62.35 113.06 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 24.2 pttm -90.53 153.68 20.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.497 -0.752 . . . . 70.15 110.865 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.7 m -85.87 129.82 34.72 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.183 0.593 . . . . 73.44 109.645 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.8 mt -88.79 146.21 25.13 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.508 0.723 . . . . 72.15 111.492 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.58 158.68 42.81 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 124.966 1.306 . . . . 71.32 109.523 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.65 114.04 1.51 Allowed 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.621 2.214 . . . . 52.23 112.991 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.02 -17.52 12.79 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 115.23 -0.895 . . . . 72.15 114.426 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.0 125.99 27.73 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 117.936 0.868 . . . . 52.34 111.131 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.55 124.95 50.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.286 0.635 . . . . 63.53 109.913 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.71 174.74 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.84 1.256 . . . . 75.54 111.307 -169.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.3 mm -111.7 142.31 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 123.364 0.666 . . . . 74.11 109.741 170.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.1 mt -89.41 126.99 35.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.469 0.708 . . . . 74.44 112.26 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -87.29 -22.89 24.88 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.833 0.853 . . . . 73.22 111.847 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.86 158.93 19.83 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.048 0.451 . . . . 60.15 111.831 174.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.678 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 25.4 t -137.86 122.86 19.05 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.278 -0.874 . . . . 51.31 108.707 169.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -107.26 -9.52 16.06 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.045 0.538 . . . . 75.24 111.048 173.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.7 mtm -138.15 -175.75 4.21 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.588 1.155 . . . . 71.51 110.31 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -72.84 131.72 42.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 122.017 -0.427 . . . . 74.0 110.898 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.22 20.28 60.49 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 114.574 0.59 . . . . 74.02 114.574 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -77.89 -43.26 30.66 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.6 0.76 . . . . 73.55 110.954 -174.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 88.8 tttt -65.36 134.85 54.43 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.975 0.51 . . . . 65.3 111.55 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.66 65.11 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.178 -0.464 . . . . 42.15 112.8 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.91 143.18 56.99 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.571 0.748 . . . . 43.22 112.243 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.0 m -77.95 105.92 9.47 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.737 -0.665 . . . . 61.43 109.931 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -103.77 150.11 24.39 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.23 1.012 . . . . 44.43 110.946 -172.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.43 128.98 44.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.319 -0.623 . . . . 75.55 109.319 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.404 HD13 HG12 ' A' ' 35' ' ' VAL . 38.0 mm -64.77 106.47 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 122.891 0.477 . . . . 74.43 110.009 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.39 -36.25 58.19 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.911 0.885 . . . . 71.1 109.991 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.1 t -158.57 147.78 19.09 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.661 0.784 . . . . 43.11 110.563 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.14 133.3 56.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.467 0.707 . . . . 72.1 110.55 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -145.07 123.76 12.55 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.734 0.814 . . . . 73.52 111.139 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.26 97.19 10.97 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.238 -0.653 . . . . 63.01 109.238 175.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.5 t -135.54 154.71 51.29 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.756 0.822 . . . . 71.53 111.108 -173.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.2 m -81.98 120.72 25.6 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.62 -0.881 . . . . 75.32 108.62 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.486 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 11.4 m -110.48 133.33 56.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.892 0.877 . . . . 74.11 108.952 -176.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.07 145.26 38.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.192 0.997 . . . . 75.03 111.511 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.7 ttm -92.51 120.87 33.4 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.31 -1.367 . . . . 60.34 107.31 166.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.69 152.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.627 0.771 . . . . 73.14 111.814 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -117.81 114.4 23.22 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.298 1.039 . . . . 65.5 109.002 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -129.0 170.48 13.41 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.48 0.657 . . . . 75.41 112.203 -174.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.0 m -114.02 127.78 56.1 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.06 -0.719 . . . . 55.33 109.06 170.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.9 t -64.7 125.52 25.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.962 0.905 . . . . 73.54 112.548 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 70.5 p -71.23 -36.67 71.9 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.937 0.895 . . . . 54.52 112.424 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.509 HG21 ' HG3' ' A' ' 15' ' ' LYS . 11.0 t -80.12 -40.0 28.34 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.946 0.721 . . . . 70.22 112.946 -175.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.6 p -113.83 -24.84 8.91 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 112.332 0.493 . . . . 73.34 112.332 -172.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.15 7.56 80.0 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-O 119.89 -0.395 . . . . 55.2 113.877 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -78.99 133.34 36.85 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 117.288 0.544 . . . . 74.43 111.323 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -83.09 109.74 17.41 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 109.206 -0.665 . . . . 72.21 109.206 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.23 127.09 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.975 0.91 . . . . 55.54 110.704 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.84 157.36 27.75 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.503 0.721 . . . . 72.33 111.548 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 57.66 30.67 19.22 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.428 1.091 . . . . 71.23 111.616 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -73.76 135.84 43.59 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.053 0.541 . . . . 73.02 111.179 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -164.41 154.46 14.31 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 122.964 0.505 . . . . 70.13 111.903 -172.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.486 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 81.9 m95 -106.53 137.14 45.08 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.747 1.619 . . . . 72.03 112.039 1.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 m -120.23 144.44 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.279 1.032 . . . . 61.45 109.452 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.3 p -100.31 178.41 4.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.487 -0.758 . . . . 61.4 112.014 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -56.38 -50.81 70.48 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.338 1.055 . . . . 71.0 112.336 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -66.53 -17.9 65.07 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.591 0.756 . . . . 71.32 113.02 -178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -90.37 -6.2 55.29 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.062 0.545 . . . . 72.32 111.482 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 75.2 mt -115.23 160.7 19.42 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.376 1.07 . . . . 75.52 109.47 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -146.6 120.75 9.48 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.166 -0.679 . . . . 70.21 109.166 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.99 139.87 58.81 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.029 0.531 . . . . 65.34 112.028 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -64.37 87.39 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.865 0.84 . . . . 74.15 110.65 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.7 mt -145.26 142.75 29.77 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.042 1.337 . . . . 72.33 109.744 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -77.12 -13.53 59.93 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.48 0.712 . . . . 73.13 111.186 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -52.14 -32.49 35.94 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.296 1.038 . . . . 74.25 112.178 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -119.94 102.94 8.91 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.365 0.666 . . . . 73.32 109.4 170.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.98 122.22 14.93 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.712 -0.848 . . . . 72.12 108.712 172.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -62.22 -16.56 54.16 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 112.942 0.719 . . . . 75.35 112.942 -173.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -159.66 120.29 3.1 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.895 0.878 . . . . 74.02 109.549 170.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.0 p80 . . . . . 0 CA--C 1.567 1.598 0 CA-C-O 118.747 -0.644 . . . . 71.23 111.293 -177.94 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.668 0.271 . . . . 55.24 110.627 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -101.44 142.28 33.07 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.208 1.003 . . . . 52.42 110.195 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.85 132.51 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-O 121.038 0.446 . . . . 75.32 111.077 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.45 -3.57 68.96 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 115.776 -0.647 . . . . 71.53 112.948 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.0 m -85.1 151.6 24.02 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.773 0.657 . . . . 71.44 112.773 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -92.89 122.65 35.48 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.97 -1.014 . . . . 65.34 109.808 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 121' ' ' LEU . 27.0 m -121.56 151.89 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.36 0.664 . . . . 74.12 109.72 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.7 mm -107.51 134.78 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.43 -0.952 . . . . 65.24 108.43 172.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.9 mt -75.29 105.57 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.327 0 CA-C-O 120.95 0.405 . . . . 74.1 109.927 -176.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -83.18 -34.25 26.0 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.931 0.892 . . . . 73.35 111.034 -172.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.7 m -131.47 141.13 49.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.578 1.151 . . . . 74.23 108.244 172.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 17' ' ' MET . 95.7 p -143.5 159.3 42.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.855 0.836 . . . . 60.3 112.366 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.491 ' HE1' ' HG3' ' A' ' 50' ' ' LYS . 7.9 m-70 -91.29 -17.58 25.72 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 114.114 -1.403 . . . . 72.31 110.457 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.666 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 53.6 mtt -131.34 144.37 51.2 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.418 1.087 . . . . 71.21 109.788 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -54.07 -41.23 67.94 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.206 1.187 . . . . 75.03 114.206 -173.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.33 -11.98 83.63 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 114.339 0.496 . . . . 65.01 114.339 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.666 ' HG3' ' HB2' ' A' ' 14' ' ' MET . 20.6 mtm -81.24 -29.27 34.5 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.398 0.599 . . . . 73.24 109.921 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -64.11 122.81 17.48 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 122.739 0.415 . . . . 63.12 111.008 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.4 1.74 89.25 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 115.694 -0.684 . . . . 73.35 113.545 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 149.62 31.72 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.776 0.658 . . . . 33.12 112.776 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -84.66 105.64 15.61 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.17 0.588 . . . . 65.01 110.251 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.43 154.37 19.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.938 0.895 . . . . 51.11 111.532 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.5 m -120.84 122.3 39.99 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.362 0.665 . . . . 55.42 109.661 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -73.27 103.35 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.855 0.462 . . . . 74.42 109.906 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.4 p -113.94 -5.78 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.482 0.549 . . . . 64.45 112.482 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.17 123.39 1.75 Allowed Glycine 0 C--N 1.344 1.015 0 N-CA-C 111.834 -0.506 . . . . 71.25 111.834 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.98 116.59 32.22 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.384 0.674 . . . . 54.15 110.493 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.439 ' HB2' HG23 ' A' ' 96' ' ' VAL . 38.8 m-85 -127.12 119.44 26.53 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.392 0.677 . . . . 73.32 109.961 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -113.82 87.4 2.61 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.906 0.86 . . . . 74.53 109.721 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -135.95 179.93 6.05 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.792 0.837 . . . . 74.43 110.669 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -78.76 123.75 27.5 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 122.022 -0.424 . . . . 71.04 110.433 176.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.89 126.27 54.93 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.102 0.961 . . . . 74.11 110.17 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -103.34 150.32 23.9 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.971 0.891 . . . . 74.44 113.02 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 50' ' ' LYS . 21.7 t -107.49 114.1 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 114.084 -1.416 . . . . 71.32 107.915 169.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.507 HG12 HD13 ' A' ' 88' ' ' ILE . 34.1 m -125.89 146.7 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 112.908 0.707 . . . . 75.24 112.908 -170.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.1 m -110.08 131.4 55.09 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.177 0.591 . . . . 75.14 110.491 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -157.04 159.78 38.3 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.36 0.6 . . . . 72.52 112.079 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.9 m -111.95 113.78 52.06 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 107.771 -1.196 . . . . 64.11 107.771 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.83 116.8 2.99 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.003 2.469 . . . . 73.32 112.108 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 p -68.94 -7.04 31.31 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.329 1.052 . . . . 60.4 113.745 -169.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -77.8 -3.06 39.52 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 123.433 0.693 . . . . 64.13 111.585 171.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.02 34.95 8.45 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 122.198 -0.313 . . . . 60.11 112.319 -173.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.42 -173.48 44.62 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 122.911 0.291 . . . . 72.33 113.444 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.08 117.47 15.92 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.443 0.697 . . . . 61.22 110.16 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.56 117.85 2.45 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.512 0.725 . . . . 74.22 110.969 169.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.96 115.38 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.371 -0.831 . . . . 72.52 109.609 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -100.38 140.78 34.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.145 0.578 . . . . 72.32 109.482 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.8 m170 57.92 39.58 26.55 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.423 0.689 . . . . 64.34 112.396 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -61.22 131.71 51.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.352 1.061 . . . . 72.54 111.455 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.491 ' HG3' ' HE1' ' A' ' 13' ' ' HIS . 25.2 pttm -149.13 148.49 29.73 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.288 -0.869 . . . . 64.34 109.665 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 92.1 m95 -109.95 135.88 50.1 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.456 -1.402 . . . . 64.42 111.502 0.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.01 147.15 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.782 1.233 . . . . 73.11 108.306 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.3 pt -111.47 167.17 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 122.046 -0.409 . . . . 70.41 111.669 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -53.96 -36.18 62.59 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.943 0.897 . . . . 75.51 113.265 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -70.24 -19.24 63.14 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 123.464 0.706 . . . . 62.14 112.092 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -94.54 8.28 42.77 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.589 0.756 . . . . 72.11 112.442 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.5 mt -124.23 136.64 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.692 0.797 . . . . 64.24 110.631 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -72.08 -53.72 11.96 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.796 0.839 . . . . 62.52 111.614 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.08 -3.96 11.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.705 1.202 . . . . 63.31 113.381 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -41.23 -46.75 3.22 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.534 1.309 . . . . 73.25 114.534 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.69 19.06 68.88 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.924 1.13 . . . . 71.21 115.924 165.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 66.19 11.17 7.68 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.051 1.341 . . . . 71.03 112.801 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -110.47 167.93 9.84 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.016 0.926 . . . . 71.25 110.817 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.3 m -82.93 118.17 23.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.487 -0.931 . . . . 71.24 108.487 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.606 HD13 HG11 ' A' ' 71' ' ' VAL . 76.4 mt -74.48 118.3 17.28 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.315 0.579 . . . . 42.13 110.24 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -110.91 155.25 42.72 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.426 1.091 . . . . 73.1 110.712 -169.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 76.1 Cg_exo -45.64 111.84 0.36 Allowed 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.702 2.935 . . . . 70.44 114.506 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.44 -11.54 16.43 Favored Glycine 0 N--CA 1.485 1.963 0 CA-C-N 116.182 -0.463 . . . . 73.31 113.938 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -79.88 124.04 28.3 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.386 0.593 . . . . 64.34 111.222 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -98.23 122.18 41.07 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.742 -0.836 . . . . 63.4 108.742 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.606 HG11 HD13 ' A' ' 65' ' ' LEU . 32.4 m -121.62 175.81 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.927 0.891 . . . . 74.45 112.115 -172.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mm -121.65 136.71 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.336 1.055 . . . . 70.5 109.079 170.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.5 mt -83.49 119.19 24.37 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.574 0.75 . . . . 70.3 111.411 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -81.92 -26.64 33.88 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.526 0.73 . . . . 74.11 111.473 171.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.51 153.99 25.29 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.029 0.442 . . . . 53.22 111.152 173.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 42.9 t -142.25 124.31 15.38 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.71 -0.677 . . . . 43.43 110.698 173.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -106.43 -24.86 12.11 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.331 1.053 . . . . 64.32 109.784 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.2 mtm -127.28 164.64 21.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.083 0.953 . . . . 71.42 110.867 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.598 ' HD2' ' H ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.37 127.92 33.63 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.877 0.471 . . . . 64.45 111.986 174.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.41 14.81 82.11 Favored Glycine 0 N--CA 1.476 1.315 0 N-CA-C 114.328 0.491 . . . . 64.34 114.328 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.4 ttt -84.71 -40.9 16.78 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 117.632 0.716 . . . . 63.51 110.739 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.438 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 21.0 tptm -66.53 119.57 11.91 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.209 -0.663 . . . . 54.44 109.209 166.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.55 74.66 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 116.063 -0.517 . . . . 70.13 112.914 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.31 137.63 46.81 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.753 0.776 . . . . 44.25 111.529 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 78.7 m -79.09 114.55 18.12 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.176 0.59 . . . . 72.41 109.531 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.67 157.24 21.49 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.785 0.834 . . . . 44.53 109.739 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -129.42 131.88 46.87 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.79 -0.819 . . . . 65.35 108.79 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.561 HG13 ' HB3' ' A' ' 65' ' ' LEU . 24.3 mm -74.27 107.5 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.28 0.632 . . . . 64.35 110.724 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -68.91 -39.72 79.53 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.926 0.394 . . . . 75.21 110.662 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.0 t -164.41 157.36 17.33 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.207 -0.906 . . . . 63.53 111.357 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -114.14 131.27 56.49 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.216 1.007 . . . . 61.33 109.131 171.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -126.7 135.51 51.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.007 0.523 . . . . 64.33 111.522 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -97.14 95.77 7.99 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.587 0.708 . . . . 71.14 109.657 168.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -135.85 148.3 48.6 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.929 -1.032 . . . . 72.52 109.4 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.4 m -84.24 123.61 30.32 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.221 -0.659 . . . . 53.41 109.221 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 28' ' ' TYR . 16.1 m -112.87 135.96 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.375 0.67 . . . . 73.3 109.553 -173.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.43 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 98.2 m-85 -120.03 141.54 49.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.43 0.692 . . . . 64.13 111.965 -175.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.41 ' SD ' ' HA ' ' A' ' 112' ' ' ASN . 19.4 tmm? -90.14 112.47 23.97 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.879 -1.055 . . . . 72.15 108.254 169.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.51 160.83 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 112.668 0.618 . . . . 74.32 112.668 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -119.57 116.98 27.16 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.87 0.868 . . . . 72.43 108.7 172.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -124.27 165.29 17.89 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 122.96 0.504 . . . . 75.32 111.918 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.8 m -109.21 111.67 23.41 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.3 0.64 . . . . 72.12 110.552 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.3 p -58.8 122.48 13.67 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.144 0.577 . . . . 71.52 111.87 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.7 p -70.91 -23.23 62.23 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.414 1.086 . . . . 73.33 112.767 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -87.86 -10.73 49.88 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.234 0.828 . . . . 72.01 113.234 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.4 m -134.74 -40.19 0.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.234 0.614 . . . . 74.43 111.833 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.81 -1.82 59.9 Favored Glycine 0 N--CA 1.48 1.582 0 CA-C-N 116.197 -0.456 . . . . 54.01 113.077 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -80.84 140.16 35.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.008 0.923 . . . . 63.13 111.124 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -96.37 132.81 41.51 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 121.156 0.503 . . . . 73.24 110.783 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.96 128.39 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.115 1.366 . . . . 64.41 109.723 -175.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 136.71 42.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.876 0.87 . . . . 71.22 111.105 -173.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.41 ' HA ' ' SD ' ' A' ' 98' ' ' MET . 11.8 m120 56.0 43.01 27.89 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.694 1.198 . . . . 74.44 113.84 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -62.3 132.8 53.87 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.672 0.789 . . . . 73.45 112.104 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 59.4 mttp -133.76 136.35 44.51 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.137 0.975 . . . . 70.1 111.491 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.7 m95 -114.44 146.11 41.03 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.511 1.524 . . . . 72.4 111.122 -15.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -119.67 148.23 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.022 0.929 . . . . 74.42 109.331 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.4 p -97.93 163.96 12.56 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.018 0.748 . . . . 74.24 113.018 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.43 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 44.0 tt0 -60.99 -33.91 73.98 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.489 1.116 . . . . 75.33 110.916 173.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.1 -36.84 85.56 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.701 1.2 . . . . 74.34 112.428 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.99 10.02 38.78 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.202 0.445 . . . . 62.02 112.202 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.462 HD13 HG21 ' A' ' 7' ' ' VAL . 91.2 mt -120.24 162.27 19.68 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.017 0.927 . . . . 73.4 109.215 175.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -138.83 120.67 15.4 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.074 0.549 . . . . 73.12 109.752 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.75 115.25 10.73 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.639 0.376 . . . . 64.1 110.676 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -119.75 119.18 32.88 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.905 0.482 . . . . 62.32 111.541 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 125' ' ' LEU . 2.7 pt? -98.97 178.24 5.0 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.537 0.735 . . . . 71.53 110.2 172.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -65.41 143.04 57.98 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.751 0.82 . . . . 53.11 111.562 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -74.57 158.46 33.68 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.388 0.675 . . . . 75.21 110.715 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -70.54 82.17 0.59 Allowed 'General case' 0 CA--C 1.558 1.258 0 CA-C-O 121.76 0.79 . . . . 64.41 111.378 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -133.11 -10.47 2.96 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.526 1.13 . . . . 74.54 109.563 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -72.25 161.46 30.83 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.45 0.7 . . . . 64.32 110.923 169.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -83.64 77.29 9.88 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.559 0.744 . . . . 75.23 110.992 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 . . . . . 0 CA--C 1.571 1.759 0 C-N-CA 123.762 0.825 . . . . 72.11 110.225 177.207 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.405 ' HB3' HG21 ' A' ' 24' ' ' VAL . 18.7 mmt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 109.725 -0.472 . . . . 60.51 109.725 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.581 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -72.44 158.87 34.94 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 120.965 0.412 . . . . 62.44 111.824 -179.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.81 130.1 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 123.609 0.763 . . . . 53.14 112.262 -175.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.57 -13.03 47.1 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.268 -0.878 . . . . 55.31 113.343 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.9 m -82.67 152.9 25.64 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.387 0.675 . . . . 71.21 111.638 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -108.74 141.03 41.32 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.143 -0.688 . . . . 72.45 109.143 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 123' ' ' ALA . 33.4 m -135.9 157.63 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.047 0.939 . . . . 61.22 111.063 -172.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.1 mm -96.46 129.06 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.423 -0.954 . . . . 74.14 108.423 166.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.716 HD11 ' HB2' ' A' ' 22' ' ' ALA . 48.7 mt -82.65 127.0 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.186 0.594 . . . . 63.22 109.945 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.575 HD21 ' HB3' ' A' ' 122' ' ' SER . 62.6 m-20 -96.8 -63.05 1.17 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 120.951 0.405 . . . . 73.45 110.386 -177.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.8 m -91.79 140.97 29.17 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.13 -0.692 . . . . 72.15 109.13 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.9 p -132.04 140.42 48.88 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.569 0.7 . . . . 54.01 112.24 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -85.66 -37.97 18.87 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.02 1.328 . . . . 62.55 109.326 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 52.0 mtt -99.34 130.53 45.63 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.316 1.046 . . . . 74.22 109.219 169.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.513 ' H ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -55.92 -37.98 69.66 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 113.0 0.741 . . . . 75.23 113.0 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.62 0.8 60.03 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 114.439 0.536 . . . . 75.21 114.439 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.496 ' HG2' HG21 ' A' ' 9' ' ' ILE . 52.9 ttp -93.3 -25.21 17.85 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.324 0.65 . . . . 71.2 111.13 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -67.36 123.34 20.1 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.994 0.518 . . . . 71.11 111.39 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.99 -12.18 66.89 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.658 -0.701 . . . . 75.13 113.868 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.43 155.42 40.13 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.642 0.777 . . . . 40.31 112.212 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -91.07 100.28 13.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.302 0.641 . . . . 70.0 110.946 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.716 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -89.65 158.14 17.72 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.78 -0.645 . . . . 72.4 111.137 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.4 m -131.7 126.01 33.49 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.865 -0.791 . . . . 65.21 108.865 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' A' ' 1' ' ' MET . 41.3 t -76.57 102.0 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.346 0.658 . . . . 71.15 110.281 -170.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.2 p -96.25 -10.63 27.52 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.331 0.652 . . . . 72.23 111.561 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.49 149.09 19.5 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 112.125 -0.39 . . . . 75.01 112.125 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.06 119.47 15.81 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.645 0.778 . . . . 44.21 110.694 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -121.92 117.22 25.91 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.852 0.861 . . . . 63.21 110.445 -172.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -95.49 83.82 3.88 Favored 'General case' 0 CA--C 1.565 1.519 0 CA-C-O 122.236 1.017 . . . . 72.01 110.645 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -134.39 -178.61 5.13 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.473 0.709 . . . . 73.55 111.878 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 m -90.87 128.58 36.8 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.714 -0.476 . . . . 64.44 109.714 170.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.46 157.93 19.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.716 0.806 . . . . 74.53 110.43 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.491 ' HB2' HG23 ' A' ' 52' ' ' VAL . 97.2 m-85 -135.15 149.55 49.99 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.726 0.774 . . . . 74.11 111.383 -173.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.54 109.65 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.188 -1.369 . . . . 61.13 107.439 171.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.483 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 29.6 m -121.82 148.01 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.525 0.679 . . . . 52.31 112.699 -173.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.1 t -112.3 139.24 48.02 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.915 0.886 . . . . 75.55 109.152 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -158.92 159.42 34.91 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.171 0.589 . . . . 74.21 111.777 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.5 m -107.91 108.78 61.78 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 107.29 -1.374 . . . . 52.5 107.29 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -47.59 152.82 2.47 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 123.949 3.099 . . . . 71.31 115.715 -175.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.8 p -64.92 -24.29 67.48 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.228 1.011 . . . . 43.03 112.393 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.577 HD22 ' HA3' ' A' ' 80' ' ' GLY . 10.9 p30 -67.55 -19.81 65.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.657 0.265 . . . . 75.24 111.213 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.75 19.21 71.18 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 114.812 0.685 . . . . 74.12 114.812 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.0 -130.18 2.89 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 117.62 0.71 . . . . 74.52 113.085 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -69.99 129.04 38.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.282 0.633 . . . . 75.42 111.493 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -58.5 133.16 55.56 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.296 0.638 . . . . 75.21 111.5 171.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.43 108.85 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.435 0.694 . . . . 70.34 110.128 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -102.57 148.78 25.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.736 0.814 . . . . 74.14 111.04 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.3 m80 55.63 33.97 22.29 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.25 1.02 . . . . 71.4 112.86 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -62.4 122.78 16.56 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.132 0.973 . . . . 63.52 111.036 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 41.3 mtmt -121.37 143.9 48.95 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.531 0.733 . . . . 73.31 110.933 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 92.8 m95 -110.55 144.44 39.41 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.295 1.438 . . . . 75.45 109.4 -14.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 33' ' ' TYR . 25.4 m -115.65 130.06 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 107.748 -1.205 . . . . 74.31 107.748 169.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.421 HG21 HG21 ' A' ' 96' ' ' VAL . 26.0 pt -104.9 163.69 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 121.794 -0.566 . . . . 65.21 111.696 -169.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -52.56 -39.19 61.22 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.852 1.261 . . . . 71.01 113.494 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -73.71 -28.91 61.96 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 120.885 0.374 . . . . 75.51 111.703 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.515 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 28.1 tt0 -80.38 -13.42 59.17 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.378 1.071 . . . . 74.51 110.956 -174.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.37 139.9 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 124.369 1.068 . . . . 75.21 109.84 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -75.58 -55.8 5.32 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.489 0.715 . . . . 72.21 111.477 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.22 -5.38 13.6 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.161 0.985 . . . . 74.15 113.285 -175.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.607 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -51.59 -50.24 60.55 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.569 0.951 . . . . 74.24 113.569 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.51 25.44 71.46 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 114.917 0.727 . . . . 73.25 114.917 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 64.78 16.3 10.34 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 124.831 1.253 . . . . 63.41 113.434 -175.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 64.1 pttt -115.26 179.65 3.9 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.0 0.52 . . . . 72.22 111.161 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.2 m -84.75 114.9 22.39 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.691 -0.686 . . . . 62.44 109.902 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.704 HD13 HG11 ' A' ' 71' ' ' VAL . 70.5 mt -76.29 115.69 16.26 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.624 -0.51 . . . . 64.21 109.624 170.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -89.6 147.91 38.94 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.474 0.71 . . . . 74.04 111.643 -168.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.24 116.23 2.15 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.408 2.739 . . . . 73.23 114.44 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.07 -22.92 11.04 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 115.053 0.781 . . . . 43.42 115.053 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -79.35 149.1 31.8 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.083 0.942 . . . . 73.23 112.04 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -107.17 132.82 52.62 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.179 0.592 . . . . 65.43 111.552 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.704 HG11 HD13 ' A' ' 65' ' ' LEU . 26.8 m -138.73 155.55 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.361 1.065 . . . . 72.44 111.063 -174.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.07 135.33 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 123.189 0.595 . . . . 71.04 109.785 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.2 mt -88.33 118.17 27.76 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.974 0.909 . . . . 71.31 110.837 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -84.12 -3.19 57.93 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 112.808 0.67 . . . . 54.44 112.808 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.515 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -128.81 173.15 10.61 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.272 0.629 . . . . 65.12 111.015 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.418 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 66.1 p -149.32 127.77 12.27 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.435 -0.802 . . . . 65.23 110.998 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -85.27 -14.75 45.66 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.813 0.845 . . . . 72.44 110.253 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -156.85 -179.04 7.82 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.253 1.021 . . . . 71.22 111.139 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -67.19 135.88 54.16 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.786 0.662 . . . . 74.05 112.786 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.577 ' HA3' HD22 ' A' ' 41' ' ' ASN . . . 71.33 17.67 76.23 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 115.103 0.801 . . . . 74.13 115.103 175.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.7 ttt -90.95 -42.8 10.36 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 117.625 0.713 . . . . 72.45 111.273 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 4.1 ttpm? -67.79 129.25 39.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.873 0.469 . . . . 64.2 111.156 175.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.38 -15.72 62.64 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 116.48 -0.327 . . . . 71.24 112.629 -178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.73 141.99 49.79 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.224 0.61 . . . . 71.33 111.665 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.7 m -90.36 110.33 21.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.474 -0.936 . . . . 62.35 108.474 176.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.483 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -98.05 167.94 10.58 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.45 0.7 . . . . 53.13 110.972 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.22 138.34 52.41 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.969 0.908 . . . . 74.53 109.281 171.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.459 HD13 HG12 ' A' ' 35' ' ' VAL . 28.0 mm -72.14 120.58 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 123.106 0.562 . . . . 63.31 110.777 -174.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -85.43 -42.13 14.78 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.925 0.49 . . . . 75.3 109.757 170.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.0 m -155.11 153.99 31.69 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.975 0.91 . . . . 71.33 110.841 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.29 146.99 49.79 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.681 0.792 . . . . 61.04 110.453 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -156.2 131.52 9.4 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.865 0.466 . . . . 61.12 111.493 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -88.93 96.33 10.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.482 -0.933 . . . . 74.05 108.482 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.6 t -136.63 153.74 50.84 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.534 0.734 . . . . 74.4 111.256 -171.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 48.7 m -84.52 123.94 30.83 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.81 -0.441 . . . . 70.41 109.81 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 18.0 m -113.2 138.8 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.727 0.811 . . . . 72.53 109.451 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -115.37 150.07 36.93 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.588 0.755 . . . . 61.02 112.126 -171.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 58.2 ttp -96.36 115.37 27.32 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.421 -1.326 . . . . 74.53 107.421 163.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.462 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 30.0 m -122.79 160.21 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.219 0.533 . . . . 74.23 112.413 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -121.94 116.84 25.08 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.369 1.068 . . . . 74.32 109.591 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -132.47 173.79 10.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.085 0.554 . . . . 65.03 110.508 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 109' ' ' LYS . 31.8 m -119.28 116.76 26.91 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.588 -0.523 . . . . 75.42 109.588 173.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.8 t -54.71 121.88 9.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.456 1.102 . . . . 75.44 112.408 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p -66.62 -30.44 70.72 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.25 1.02 . . . . 73.23 112.584 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.7 t -83.17 -34.24 26.04 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.037 0.755 . . . . 71.22 113.037 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.0 p -106.78 -28.12 10.34 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.567 0.58 . . . . 75.34 112.567 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.93 9.33 85.5 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 116.611 -0.268 . . . . 44.31 113.177 -172.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -91.13 138.57 31.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.053 0.941 . . . . 72.21 110.659 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 5.7 ttpm? -84.88 120.59 26.64 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 120.984 0.421 . . . . 52.01 110.513 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.67 114.29 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 109.369 -0.604 . . . . 64.15 109.369 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.25 150.37 29.69 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.008 0.923 . . . . 50.34 111.208 -171.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 57.28 31.9 20.87 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.382 1.073 . . . . 74.4 112.243 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -64.41 124.49 21.91 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.249 0.62 . . . . 73.14 111.649 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 10.2 mtmp? -140.85 140.02 34.55 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 124.177 0.991 . . . . 73.33 110.681 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 87.8 m95 -112.51 148.53 34.26 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.875 1.67 . . . . 72.11 111.928 -4.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.8 m -131.47 142.36 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 124.347 1.059 . . . . 74.34 110.3 174.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 81.3 p -100.41 167.86 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 112.644 0.609 . . . . 44.25 112.644 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -56.12 -38.01 70.21 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.69 1.196 . . . . 73.35 111.701 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -58.39 -39.87 80.84 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.926 1.29 . . . . 75.43 112.111 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -88.39 -0.62 57.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.017 0.927 . . . . 75.34 113.367 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.53 163.86 17.32 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.438 0.695 . . . . 63.33 110.988 -177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.575 ' HB3' HD21 ' A' ' 10' ' ' ASN . 80.9 p -145.35 124.08 12.59 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.547 0.739 . . . . 74.34 110.447 174.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.562 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -66.11 133.47 50.78 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 113.268 0.84 . . . . 53.03 113.268 -172.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.612 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -95.95 102.05 13.79 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.652 0.781 . . . . 72.42 111.077 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.79 -58.32 1.9 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.445 0.698 . . . . 61.44 110.284 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.5 167.71 14.32 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.86 0.864 . . . . 75.51 111.678 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.6 m80 61.93 33.86 17.2 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.117 0.967 . . . . 75.21 112.168 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -62.7 114.99 3.92 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.664 -0.698 . . . . 64.43 110.752 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -80.57 102.28 9.68 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.259 0.623 . . . . 55.22 111.38 -170.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -64.76 121.26 14.14 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 110.024 -0.361 . . . . 54.02 110.024 172.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -60.67 136.74 58.15 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 112.511 0.56 . . . . 64.12 112.511 -176.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.7 m80 . . . . . 0 CA--C 1.56 1.346 0 C-N-CA 123.995 0.918 . . . . 73.34 109.558 174.117 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 mmt . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.415 -0.587 . . . . 73.12 109.415 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -113.59 159.32 19.74 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.131 0.572 . . . . 70.41 110.176 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.1 t -65.22 124.73 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 CA-C-O 121.376 0.608 . . . . 50.35 111.688 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.32 -2.99 43.37 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 115.559 -0.746 . . . . 62.55 113.094 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 p -81.56 145.34 30.71 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 117.343 0.571 . . . . 73.23 112.359 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -94.02 128.74 40.54 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.583 0.753 . . . . 65.55 110.276 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.529 HG21 HD13 ' A' ' 121' ' ' LEU . 29.5 m -131.35 152.88 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.639 0.776 . . . . 72.25 110.111 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.1 mm -102.76 132.6 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.521 0.728 . . . . 72.43 109.241 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.6 mt -78.85 113.02 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 C-N-CA 122.739 0.416 . . . . 72.14 109.915 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.492 HD22 ' HB2' ' A' ' 122' ' ' SER . 33.9 p30 -91.49 -31.07 16.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 122.002 -0.437 . . . . 54.11 111.672 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.2 m -125.88 141.16 52.11 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.256 1.022 . . . . 74.31 109.905 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 m -154.1 139.66 17.85 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.987 0.515 . . . . 53.12 111.198 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.414 ' CE1' ' HB2' ' A' ' 50' ' ' LYS . 73.0 m-70 -79.23 -25.61 42.6 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.345 0.658 . . . . 71.0 110.1 170.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.603 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 1.6 mpt? -97.55 125.23 42.14 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.171 0.988 . . . . 73.22 109.527 171.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.68 -28.46 68.63 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.23 0.826 . . . . 71.52 113.23 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.79 -12.8 84.1 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 114.597 0.599 . . . . 62.45 114.597 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' A' ' 14' ' ' MET . 39.3 mtp -91.47 -24.36 19.7 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.549 0.74 . . . . 73.42 111.761 -177.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.45 119.41 12.23 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.073 0.549 . . . . 72.44 111.659 -176.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.92 2.17 69.5 Favored Glycine 0 CA--C 1.541 1.677 0 CA-C-N 115.799 -0.637 . . . . 64.34 113.78 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.25 156.77 21.83 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.371 0.668 . . . . 72.21 112.792 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -83.83 114.31 21.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.352 0.661 . . . . 75.54 111.204 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . . . -107.03 150.63 26.31 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.861 0.864 . . . . 35.44 111.895 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -124.6 121.05 33.66 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.634 0.774 . . . . 71.24 108.968 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.2 t -72.75 106.29 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 122.823 0.449 . . . . 71.42 110.277 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.7 p -99.08 -11.33 21.54 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.352 0.661 . . . . 60.54 111.9 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.11 145.31 11.81 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 112.187 -0.365 . . . . 73.12 112.187 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.87 121.7 27.21 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.911 0.884 . . . . 73.13 110.503 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.485 ' HB2' HG23 ' A' ' 96' ' ' VAL . 26.3 m-85 -125.6 125.97 44.01 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.665 0.786 . . . . 71.24 111.249 -175.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.18 78.87 1.34 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.263 1.03 . . . . 75.3 110.35 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.569 HG21 HD12 ' A' ' 53' ' ' ILE . 10.2 t -134.79 174.86 10.11 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.726 -0.67 . . . . 53.3 111.867 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.5 m -78.98 125.03 28.84 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.97 0.508 . . . . 72.44 110.752 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . . . -100.27 163.54 12.35 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.478 1.111 . . . . 43.25 109.215 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -134.11 138.03 44.98 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.54 0.686 . . . . 63.15 111.208 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.0 t -99.15 107.75 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 107.711 -1.218 . . . . 74.35 107.711 172.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.514 HG12 HD13 ' A' ' 88' ' ' ILE . 34.3 m -119.88 145.16 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-O 121.314 0.578 . . . . 73.0 112.056 -173.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -115.16 132.88 56.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.817 0.847 . . . . 74.22 109.091 169.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -148.88 157.14 43.21 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.241 0.543 . . . . 74.42 112.361 -172.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.4 m -105.7 112.11 64.59 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 108.163 -1.051 . . . . 74.14 108.163 170.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.449 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 11.5 Cg_endo -56.26 118.74 5.59 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.344 2.029 . . . . 74.32 111.399 174.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.0 t -60.8 -14.22 20.25 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 124.361 1.064 . . . . 74.34 113.552 -170.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -82.8 10.83 6.87 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 123.789 0.836 . . . . 75.43 111.92 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.94 46.97 7.4 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 113.672 0.229 . . . . 44.12 113.672 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.23 -177.91 21.4 Favored Glycine 0 N--CA 1.475 1.292 0 N-CA-C 113.542 0.177 . . . . 64.3 113.542 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -65.36 122.42 17.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.924 0.49 . . . . 71.03 110.984 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -58.81 115.35 3.03 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.988 0.423 . . . . 73.54 110.593 173.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -86.57 120.46 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.713 -0.676 . . . . 62.44 110.399 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -92.84 120.69 33.46 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.334 0.653 . . . . 54.31 109.683 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.6 m170 58.64 54.8 5.13 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.597 1.159 . . . . 75.02 113.147 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -65.04 132.07 48.24 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.063 0.945 . . . . 74.42 111.892 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 99.5 mttt -136.94 150.13 48.0 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.743 0.817 . . . . 51.11 110.652 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 96.9 m95 -107.43 130.81 54.78 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.888 1.275 . . . . 73.21 111.908 -7.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.84 142.68 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.716 1.207 . . . . 75.42 108.088 168.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.625 HG21 HG21 ' A' ' 96' ' ' VAL . 27.8 pt -117.02 -175.37 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.075 0.55 . . . . 74.15 110.032 175.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -47.73 -33.18 6.7 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.623 1.169 . . . . 73.42 113.357 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.625 ' H ' HG13 ' A' ' 53' ' ' ILE . 7.0 tp10 -69.94 -28.86 65.92 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 113.924 1.083 . . . . 61.21 113.924 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -80.89 -10.98 59.66 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.487 -0.758 . . . . 54.11 112.589 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.9 mt -110.12 138.92 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 C-N-CA 123.543 0.737 . . . . 74.13 111.759 -172.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.592 ' HE3' ' HB ' ' A' ' 72' ' ' ILE . 27.8 ttpp -65.68 -53.22 44.13 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.312 1.045 . . . . 64.31 112.336 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.19 -3.33 39.04 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.014 -0.994 . . . . 63.25 113.138 -170.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.514 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -40.87 -58.76 1.6 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.444 1.276 . . . . 74.55 114.444 177.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.0 23.71 69.69 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 115.537 0.975 . . . . 23.23 115.537 170.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 61.53 17.35 8.43 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.621 1.168 . . . . 71.24 113.113 -173.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 12.3 ptpt -108.75 167.07 10.33 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.364 0.666 . . . . 73.44 110.54 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.5 m -87.02 112.5 21.91 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.293 -0.632 . . . . 75.14 109.293 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.546 HD13 HG11 ' A' ' 71' ' ' VAL . 54.5 mt -75.26 120.71 21.12 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.443 0.697 . . . . 62.11 109.353 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -96.77 154.1 38.47 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.913 0.885 . . . . 53.32 111.513 -167.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.486 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 84.8 Cg_exo -49.25 113.92 1.1 Allowed 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.995 2.463 . . . . 73.23 113.736 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.56 -17.91 18.01 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-N 115.975 -0.557 . . . . 73.33 114.135 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.8 133.14 47.09 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.327 0.564 . . . . 63.5 110.626 173.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -111.27 121.24 44.75 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.899 -0.778 . . . . 42.42 108.899 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.546 HG11 HD13 ' A' ' 65' ' ' LEU . 27.0 m -131.21 164.53 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.543 1.137 . . . . 74.34 111.027 -167.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.592 ' HB ' ' HE3' ' A' ' 58' ' ' LYS . 46.3 mm -110.51 141.47 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.01 0.524 . . . . 75.22 110.534 176.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.2 mt -88.71 123.64 33.34 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.806 0.843 . . . . 74.35 111.565 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -88.77 -28.74 20.28 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.239 0.615 . . . . 52.14 112.352 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.52 158.55 20.93 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.12 0.486 . . . . 64.21 110.572 171.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 21.1 t -143.58 125.02 14.74 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.728 -0.669 . . . . 74.43 109.703 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.7 m170 -95.34 -13.88 24.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.953 0.901 . . . . 70.1 111.272 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -156.3 177.35 11.54 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.617 0.767 . . . . 71.22 111.896 -173.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -63.95 104.96 0.77 Allowed 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.113 0.965 . . . . 71.13 112.566 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.56 12.94 56.46 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 115.182 0.833 . . . . 52.32 115.182 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -74.36 -42.23 59.71 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 117.481 0.641 . . . . 62.52 111.677 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.595 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 50.5 tttm -66.22 132.63 48.86 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 122.414 -0.179 . . . . 73.13 110.522 172.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.57 -9.52 75.7 Favored Glycine 0 N--CA 1.472 1.094 0 CA-C-O 120.337 -0.146 . . . . 72.31 112.89 -177.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 39' ' ' PRO . . . -71.11 141.48 50.8 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.47 0.708 . . . . 74.22 111.903 177.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -81.83 113.44 19.78 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.965 -0.561 . . . . 75.01 109.945 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -110.1 150.68 28.25 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.5 1.12 . . . . 75.31 110.388 -175.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -125.06 130.34 52.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.12 0.568 . . . . 65.01 109.958 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.514 HD13 HG12 ' A' ' 35' ' ' VAL . 27.4 mm -69.86 101.64 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.442 0.697 . . . . 52.44 109.639 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.61 -32.97 70.52 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.319 0.581 . . . . 73.25 110.346 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.486 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . 40.0 t -168.89 150.31 4.61 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.669 -1.151 . . . . 61.03 109.849 -175.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -106.84 128.49 54.31 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.536 -0.913 . . . . 74.14 108.536 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -114.07 125.77 54.35 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.708 0.803 . . . . 72.13 111.551 -169.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -93.91 95.12 8.88 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.5 -0.555 . . . . 75.02 109.5 170.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.0 t -137.06 154.39 50.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.786 0.835 . . . . 74.13 110.592 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.3 m -86.37 125.47 33.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.509 -0.552 . . . . 74.04 109.509 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.625 HG21 HG21 ' A' ' 53' ' ' ILE . 14.9 m -114.42 134.83 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.361 0.664 . . . . 52.54 110.092 -172.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.401 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 89.8 m-85 -116.21 143.03 46.04 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.434 0.694 . . . . 60.33 112.049 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.5 ttp -89.57 115.86 27.29 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.109 -1.441 . . . . 75.22 107.109 164.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.4 m -118.16 152.95 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.866 0.841 . . . . 62.13 112.135 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -121.28 121.56 37.98 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.608 1.563 . . . . 74.11 107.4 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.533 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 51.2 p90 -152.45 178.85 9.12 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.143 0.497 . . . . 74.1 112.098 -171.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.2 m -118.49 117.49 29.15 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.761 0.824 . . . . 75.31 109.631 172.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.5 t -60.95 119.25 7.91 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.449 0.7 . . . . 75.32 110.378 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.1 p -59.4 -45.18 92.23 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.815 0.846 . . . . 63.24 113.139 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.4 m -64.06 -52.86 57.35 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.108 0.563 . . . . 71.53 111.793 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.1 m -79.06 -24.08 43.78 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.137 0.575 . . . . 44.24 112.319 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.41 17.27 74.26 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 116.35 -0.386 . . . . 75.25 113.566 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -108.6 144.09 36.79 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.876 0.87 . . . . 73.44 111.661 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -77.13 105.1 8.01 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.013 0.925 . . . . 73.13 111.304 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.2 t -90.46 110.55 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 108.297 -1.001 . . . . 75.52 108.297 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -112.94 145.96 39.85 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.692 0.797 . . . . 71.35 111.76 -166.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 17.8 m120 57.45 32.41 21.76 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 124.064 0.946 . . . . 64.4 113.225 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -64.59 133.42 52.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.675 0.79 . . . . 75.1 112.573 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 99.7 mttt -135.59 134.42 39.31 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.199 1.0 . . . . 71.22 110.72 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 97.7 m95 -115.15 155.61 26.81 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.321 1.448 . . . . 63.2 112.521 -10.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.22 160.98 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.774 1.23 . . . . 73.42 109.084 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.8 p -118.2 162.76 17.71 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.735 0.414 . . . . 50.44 111.557 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.401 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 30.5 tt0 -61.36 -36.18 79.49 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.891 0.476 . . . . 73.43 111.671 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -66.28 -32.55 74.03 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.309 0.644 . . . . 74.32 110.885 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -83.33 -9.91 58.8 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.119 0.967 . . . . 72.22 111.376 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.529 HD13 HG21 ' A' ' 7' ' ' VAL . 82.6 mt -112.08 173.37 6.4 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.993 0.917 . . . . 70.11 109.857 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB2' HD22 ' A' ' 10' ' ' ASN . 47.8 t -137.28 136.68 38.25 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.657 0.783 . . . . 70.32 109.171 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.63 138.09 50.46 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 120.863 0.364 . . . . 74.05 111.522 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -86.17 67.77 10.06 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.727 0.775 . . . . 75.12 110.846 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.18 -39.1 3.1 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.713 0.805 . . . . 72.32 110.983 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -81.22 159.26 24.6 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.958 0.725 . . . . 75.43 112.958 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -74.31 86.09 1.96 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 115.413 -0.812 . . . . 74.21 109.745 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -79.99 69.71 6.42 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.228 1.011 . . . . 72.3 112.452 -174.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -91.02 5.28 49.47 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.415 0.686 . . . . 72.35 111.856 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -113.5 114.05 25.99 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.813 0.845 . . . . 72.54 109.855 175.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -81.0 121.77 26.45 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.346 -0.612 . . . . 61.25 109.346 172.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 . . . . . 0 C--O 1.257 1.499 0 CA-C-O 118.155 -0.926 . . . . 64.33 110.527 179.515 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.532 ' SD ' HG11 ' A' ' 7' ' ' VAL . 24.2 ptp . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.629 0.252 . . . . 52.33 110.574 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -99.41 161.61 13.52 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.31 0.644 . . . . 74.21 111.575 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.56 132.29 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 123.592 0.757 . . . . 64.21 111.779 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.41 -7.21 39.67 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.508 -0.769 . . . . 51.44 113.566 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 m -75.4 134.85 40.82 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.01 0.524 . . . . 64.24 111.782 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -95.81 123.64 39.47 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.317 0.647 . . . . 62.04 109.636 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.532 HG11 ' SD ' ' A' ' 1' ' ' MET . 31.8 m -130.04 154.54 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.735 0.814 . . . . 70.14 111.818 -172.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.8 mm -98.05 128.76 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.93 0.892 . . . . 60.21 109.656 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 17' ' ' MET . 49.8 mt -78.01 109.96 13.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.38 0.672 . . . . 72.21 109.968 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -87.53 -53.22 4.92 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.79 0.436 . . . . 75.34 110.76 -173.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.808 ' HB ' ' HB2' ' A' ' 120' ' ' GLU . 72.0 m -91.42 140.36 29.84 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.694 -0.854 . . . . 41.54 108.694 170.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 14' ' ' MET . 86.0 p -133.06 124.83 28.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.502 0.321 . . . . 71.01 111.825 -173.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -71.36 -33.37 69.51 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.347 0.659 . . . . 75.52 110.088 171.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.676 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 1.8 mpt? -115.58 137.48 52.03 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.518 1.127 . . . . 71.01 108.938 172.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -30.87 69.79 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.591 1.33 . . . . 74.33 114.591 -169.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.82 -3.34 87.46 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 114.599 0.6 . . . . 74.25 114.599 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.676 ' SD ' ' HB2' ' A' ' 14' ' ' MET . 61.6 mtp -86.63 -26.99 24.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.622 0.769 . . . . 73.14 111.196 -178.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -67.46 121.96 16.94 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.587 0.355 . . . . 64.31 111.05 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.69 -3.84 86.03 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 116.134 -0.485 . . . . 41.23 113.606 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.78 150.69 32.31 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 117.503 0.651 . . . . 60.03 112.651 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -90.1 100.61 13.4 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.765 0.826 . . . . 72.22 111.464 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.97 163.56 13.44 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.804 0.842 . . . . 42.21 112.297 176.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.6 m -130.79 130.94 44.34 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.108 0.963 . . . . 62.14 108.958 172.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.4 t -74.01 103.36 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.085 0.554 . . . . 74.24 109.515 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.8 p -95.79 -12.19 25.73 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.09 0.556 . . . . 73.11 111.756 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.6 139.69 6.45 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.747 -0.541 . . . . 64.31 111.747 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.74 122.08 37.14 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.298 0.639 . . . . 74.5 111.184 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -128.88 122.44 30.34 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.277 1.031 . . . . 74.01 110.688 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -103.98 79.67 1.66 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.947 0.879 . . . . 70.51 110.085 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -133.63 175.75 9.16 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.588 -0.733 . . . . 73.21 112.467 -169.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 93' ' ' LYS . 54.9 m -77.93 118.95 20.73 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.851 0.86 . . . . 73.34 110.931 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.81 111.61 24.21 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.04 0.936 . . . . 65.01 110.373 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -87.86 149.9 23.85 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.868 0.842 . . . . 75.21 111.956 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 55.8 t -106.92 118.84 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 107.907 -1.146 . . . . 71.34 107.907 170.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.438 HG12 HD13 ' A' ' 88' ' ' ILE . 30.0 m -117.59 168.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 112.492 0.552 . . . . 72.24 112.492 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 91.1 p -137.33 134.87 36.52 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.568 0.747 . . . . 61.13 109.467 170.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 43.5 p90 -151.66 157.6 42.33 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.469 0.652 . . . . 64.43 111.96 -174.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 m -101.19 110.98 62.85 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.182 -1.044 . . . . 73.05 108.182 171.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.97 123.39 13.71 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.861 2.374 . . . . 74.32 112.846 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.3 p -58.02 -25.32 60.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.525 1.306 . . . . 70.13 114.525 -171.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -72.62 -6.38 43.84 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 112.918 0.71 . . . . 74.51 112.918 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.11 38.67 5.94 Favored Glycine 0 N--CA 1.472 1.098 0 N-CA-C 111.789 -0.524 . . . . 30.21 111.789 -169.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.14 158.94 26.05 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.338 -0.431 . . . . 52.12 112.479 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -56.26 122.99 13.07 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.173 0.589 . . . . 72.24 110.961 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.89 124.19 14.67 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.152 0.981 . . . . 71.51 111.628 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.9 t -103.99 124.56 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.75 0.82 . . . . 63.42 111.298 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -117.32 148.62 41.55 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.638 0.775 . . . . 72.33 111.054 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 m170 57.62 38.02 27.64 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.434 1.093 . . . . 55.43 112.991 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -69.13 138.58 54.33 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.426 0.69 . . . . 72.14 111.477 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -153.88 153.36 31.95 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 123.75 0.82 . . . . 65.42 111.069 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -106.88 128.69 54.51 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.542 1.537 . . . . 71.3 111.693 -0.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.74 142.31 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.893 -1.151 . . . . 72.33 107.893 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.2 pt -124.13 176.88 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.556 -0.715 . . . . 74.52 112.076 -175.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -49.88 -50.45 45.79 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.172 1.175 . . . . 75.2 114.172 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -6.94 52.27 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 112.864 0.69 . . . . 71.25 112.864 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -79.16 -31.17 43.91 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.954 0.901 . . . . 73.54 110.066 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.7 mt -96.08 131.1 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 123.688 0.795 . . . . 71.32 111.02 -169.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -63.0 -47.51 82.79 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 122.092 0.949 . . . . 52.14 111.207 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.26 -2.65 22.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.912 1.285 . . . . 74.23 113.543 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -40.7 -60.84 1.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.602 1.161 . . . . 62.12 113.665 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.73 17.52 65.0 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 115.848 1.099 . . . . 53.44 115.848 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.64 12.91 7.92 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.45 1.1 . . . . 62.22 113.46 -174.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -106.26 157.24 17.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.362 0.665 . . . . 74.52 110.435 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.4 m -76.1 111.05 11.11 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.046 0.539 . . . . 71.42 110.432 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.424 HD13 HG11 ' A' ' 71' ' ' VAL . 92.9 mt -75.57 124.53 27.36 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.346 0.659 . . . . 74.34 110.679 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -120.57 157.74 53.35 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.325 1.05 . . . . 55.21 110.518 -170.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 32.8 Cg_exo -41.58 116.49 0.52 Allowed 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.032 2.488 . . . . 65.5 114.27 171.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.81 -9.73 16.15 Favored Glycine 0 N--CA 1.478 1.45 0 CA-C-N 115.137 -0.938 . . . . 75.14 113.499 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -84.37 102.38 12.69 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 117.519 0.659 . . . . 74.32 112.451 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -69.87 120.98 16.43 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.736 -0.468 . . . . 75.41 109.736 164.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.424 HG11 HD13 ' A' ' 65' ' ' LEU . 30.1 m -131.96 157.31 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.596 1.159 . . . . 64.44 110.428 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.9 mm -105.82 137.0 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.855 -0.528 . . . . 73.45 110.308 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.5 mt -87.54 128.0 35.25 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.67 0.788 . . . . 73.04 112.299 -175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -92.69 -31.33 15.14 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.798 0.839 . . . . 60.23 111.943 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.5 161.02 14.39 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.463 0.649 . . . . 62.15 110.29 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.1 p -147.24 128.46 14.74 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.784 -0.644 . . . . 75.12 110.623 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -88.68 6.84 36.56 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.817 0.847 . . . . 75.25 110.886 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -172.35 158.35 4.35 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.501 1.52 . . . . 64.52 109.824 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -75.99 133.46 40.42 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 122.274 -0.266 . . . . 72.41 110.987 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.63 -29.03 12.58 Favored Glycine 0 N--CA 1.482 1.711 0 CA-C-N 116.56 -0.291 . . . . 75.21 112.44 -172.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.0 ttt -68.36 -37.54 80.56 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.065 0.946 . . . . 64.14 111.253 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -65.35 119.24 10.61 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.988 0.515 . . . . 72.31 109.793 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.7 3.03 74.81 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 120.064 -0.298 . . . . 64.1 113.275 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.13 144.31 31.78 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 117.19 0.495 . . . . 64.03 111.429 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.4 m -80.84 110.67 16.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.693 -0.685 . . . . 64.02 109.174 176.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -101.2 159.73 15.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.316 1.047 . . . . 72.11 108.973 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.95 129.49 30.14 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.047 -1.094 . . . . 74.41 108.047 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.438 HD13 HG12 ' A' ' 35' ' ' VAL . 38.5 mm -63.26 100.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.562 0.745 . . . . 61.33 110.389 -176.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.19 -40.55 71.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.02 0.928 . . . . 74.42 110.519 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.408 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 68.0 m -153.96 151.41 29.37 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.987 0.915 . . . . 75.3 110.059 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.01 129.89 56.82 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.114 0.566 . . . . 63.42 109.61 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -140.61 151.83 44.96 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.724 0.81 . . . . 72.42 109.537 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -124.81 95.27 4.45 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.036 0.922 . . . . 73.35 109.156 177.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 t -134.9 151.89 51.27 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.288 -0.869 . . . . 53.0 110.552 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.8 m -78.39 123.69 27.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 122.613 0.365 . . . . 74.24 110.54 -173.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 15.2 m -118.33 140.06 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.193 0.997 . . . . 60.13 110.089 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.424 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 77.7 m-85 -122.53 145.85 47.95 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.702 0.801 . . . . 71.42 111.543 -172.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.5 ttp -89.9 121.38 31.97 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.974 -1.121 . . . . 62.43 107.974 163.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.2 m -120.94 153.76 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-O 121.488 0.661 . . . . 74.43 112.367 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -118.12 122.42 43.05 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.836 1.254 . . . . 51.41 107.747 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.444 ' CE2' ' HG2' ' A' ' 17' ' ' MET . 56.1 p90 -148.65 177.87 9.13 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.939 0.496 . . . . 73.23 111.681 -174.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.2 m -125.38 128.87 48.82 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.49 0.716 . . . . 64.34 109.726 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.4 t -62.48 120.7 11.6 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.662 0.785 . . . . 71.32 110.925 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.0 p -60.15 -41.13 92.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.895 0.878 . . . . 63.41 112.408 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.4 p -75.15 -57.5 3.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.143 0.577 . . . . 64.33 112.104 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.0 m -71.04 -40.35 71.76 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.272 0.629 . . . . 71.24 111.905 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.06 1.31 82.2 Favored Glycine 0 N--CA 1.479 1.528 0 CA-C-N 116.188 -0.46 . . . . 55.13 113.033 -170.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -75.11 129.89 38.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.64 1.176 . . . . 55.34 112.937 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -82.54 98.94 9.21 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.806 0.842 . . . . 74.2 109.881 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -88.39 118.26 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.012 0.525 . . . . 74.44 110.211 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -107.94 148.06 30.17 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.506 0.723 . . . . 64.34 112.18 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 m120 58.46 34.2 23.75 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.631 1.172 . . . . 64.2 113.349 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -65.35 125.4 24.98 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.622 0.769 . . . . 72.12 112.316 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 64.4 mttp -132.42 135.77 46.32 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.877 0.871 . . . . 74.11 111.096 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.476 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 97.9 m95 -116.52 160.71 20.23 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 126.018 1.727 . . . . 64.01 111.644 -12.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.33 139.72 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.047 0.939 . . . . 62.05 110.692 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.3 p -91.73 159.4 15.86 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.03 0.532 . . . . 73.41 112.028 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 36.5 tt0 -65.33 -26.42 68.04 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.115 0.483 . . . . 75.22 111.173 173.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -63.9 -34.29 77.62 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.859 0.864 . . . . 75.32 111.614 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.808 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 11.0 pt-20 -95.66 -2.51 47.95 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.881 0.697 . . . . 74.51 112.881 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.8 mt -111.78 168.69 9.38 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.551 0.741 . . . . 44.43 109.633 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.2 m -143.47 123.19 13.35 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.396 0.679 . . . . 74.25 109.812 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.485 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -63.77 144.32 57.14 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.075 0.55 . . . . 75.24 111.465 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -74.75 76.43 2.08 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 122.035 0.921 . . . . 73.14 111.213 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.4 mt -121.11 -39.52 2.69 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.158 1.383 . . . . 74.33 109.359 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -139.88 156.65 46.59 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.6 1.16 . . . . 73.31 110.007 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -159.34 96.37 1.29 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.485 0.714 . . . . 74.22 110.145 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -89.83 135.18 33.78 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.871 0.469 . . . . 73.11 111.293 172.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -71.51 -32.61 68.4 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.76 0.424 . . . . 74.35 110.506 171.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.53 102.73 14.68 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.574 0.749 . . . . 72.24 109.488 170.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -84.5 155.53 22.13 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.274 0.63 . . . . 72.12 112.472 -172.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.7 m170 . . . . . 0 N--CA 1.491 1.577 0 C-N-CA 123.606 0.762 . . . . 75.55 111.989 175.234 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 110.204 -0.295 . . . . 65.42 110.204 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -75.0 137.42 41.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.835 0.854 . . . . 71.43 111.006 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.3 t -67.3 126.06 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 CA-C-O 121.353 0.596 . . . . 70.3 110.728 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.49 -18.03 38.92 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 115.189 -0.914 . . . . 72.21 113.07 -171.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 t -85.97 161.14 19.14 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.666 0.787 . . . . 75.21 110.202 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -124.62 149.59 46.93 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.084 0.468 . . . . 74.31 111.369 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 123' ' ' ALA . 24.5 m -138.27 163.92 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.256 1.022 . . . . 75.51 111.92 -171.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 mm -98.81 132.22 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.413 1.085 . . . . 53.23 109.169 165.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.9 mt -91.73 125.5 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 N-CA-C 109.782 -0.451 . . . . 54.03 109.782 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -96.16 -58.98 1.94 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.64 1.176 . . . . 61.43 111.222 -171.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.515 ' HB ' ' HG2' ' A' ' 120' ' ' GLU . 23.7 m -91.75 140.75 29.39 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.451 -0.944 . . . . 73.53 108.451 169.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 75.5 m -148.19 136.62 21.44 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.238 0.542 . . . . 62.44 111.484 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -83.89 -22.78 31.5 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.647 -1.16 . . . . 72.35 109.46 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.1 mmt -97.7 122.04 40.31 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.498 1.119 . . . . 70.14 108.906 167.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -32.01 72.59 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.638 0.977 . . . . 75.43 113.638 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.98 -4.31 77.22 Favored Glycine 0 N--CA 1.476 1.307 0 N-CA-C 114.03 0.372 . . . . 51.31 114.03 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 54.8 ttp -100.85 -22.25 14.89 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.473 0.709 . . . . 72.12 110.562 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 58.8 tttm -68.12 120.09 13.76 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.159 0.584 . . . . 74.23 111.87 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.22 -6.01 82.79 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 115.214 -0.903 . . . . 71.41 113.99 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.91 159.97 24.82 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.27 0.841 . . . . 71.4 113.27 -171.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.75 115.76 21.81 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.091 -0.959 . . . . 73.13 110.403 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.513 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -113.41 164.13 14.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.033 0.933 . . . . 55.42 112.221 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 62.1 m -133.55 125.37 28.72 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.277 0.631 . . . . 73.12 110.987 174.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.91 104.55 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.656 0.782 . . . . 74.34 110.371 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.3 p -111.57 3.69 18.17 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.455 0.539 . . . . 72.2 112.455 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.9 146.44 14.11 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 120.002 -0.332 . . . . 74.1 112.812 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.69 108.26 6.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.626 0.77 . . . . 32.44 110.731 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -112.14 116.89 31.21 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.194 0.998 . . . . 71.21 110.378 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -99.35 88.62 3.95 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 122.086 0.946 . . . . 64.14 109.731 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -134.25 179.8 6.04 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.646 0.779 . . . . 72.31 111.041 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -83.15 123.01 29.12 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.566 -0.531 . . . . 72.42 109.566 171.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.86 155.15 20.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.096 0.558 . . . . 70.15 109.562 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -132.48 147.95 52.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.875 0.845 . . . . 72.51 111.663 -173.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.31 108.7 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.906 -1.516 . . . . 75.2 106.906 169.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.425 HG12 HD13 ' A' ' 88' ' ' ILE . 19.1 m -107.02 155.51 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.356 0.598 . . . . 73.14 111.924 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 68.5 m -134.31 122.96 23.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.894 0.877 . . . . 62.24 108.92 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -153.23 159.2 42.56 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.299 0.571 . . . . 62.11 110.81 -167.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.9 m -101.65 124.49 40.48 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.679 -1.23 . . . . 74.22 107.679 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.72 145.75 94.76 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.024 1.816 . . . . 74.33 111.922 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -62.82 -17.74 61.76 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.358 0.663 . . . . 74.23 112.527 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.488 HD21 ' HG2' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -70.25 -20.82 63.04 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.533 0.733 . . . . 72.31 111.539 172.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.12 29.57 45.48 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 115.108 0.803 . . . . 72.05 115.108 168.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.86 -127.48 5.33 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 117.912 0.856 . . . . 43.12 113.103 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.75 119.59 18.18 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.448 0.699 . . . . 74.32 110.551 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -57.29 105.67 0.25 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.764 0.826 . . . . 62.21 112.059 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.23 104.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 121.218 0.533 . . . . 72.31 109.998 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 6.8 p-10 -110.48 155.3 22.44 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.233 0.613 . . . . 74.2 109.855 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.0 m170 58.69 30.48 19.99 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.556 0.742 . . . . 63.52 112.101 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -65.07 125.58 25.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.904 0.882 . . . . 60.44 110.962 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 6.9 mtmp? -139.94 144.35 37.04 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 124.082 0.953 . . . . 73.22 111.25 -174.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 97.5 m95 -112.32 138.07 49.57 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 125.32 1.448 . . . . 74.35 111.474 -4.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.81 138.69 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.322 -0.854 . . . . 71.24 109.077 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.3 pt -99.35 162.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.089 0.471 . . . . 74.22 111.737 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.423 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 63.5 tt0 -51.36 -41.06 60.38 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.375 1.07 . . . . 74.14 113.322 175.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.74 -13.69 61.38 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.436 0.636 . . . . 70.04 112.363 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 15.4 tt0 -92.18 -16.72 25.87 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.347 1.059 . . . . 61.53 111.204 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.9 mt -102.67 132.38 48.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.904 0.882 . . . . 74.4 110.159 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.556 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 87.2 tttt -64.51 -54.88 25.36 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.761 0.824 . . . . 62.41 111.508 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -72.96 -5.88 41.61 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.046 1.128 . . . . 64.43 114.046 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 54' ' ' GLN . . . -52.91 -39.61 62.89 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.163 1.171 . . . . 51.14 114.163 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.7 28.32 73.51 Favored Glycine 0 N--CA 1.481 1.697 0 N-CA-C 116.189 1.236 . . . . 74.44 116.189 163.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 61.47 14.28 5.73 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.275 1.03 . . . . 74.4 112.999 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -119.5 170.47 9.13 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.782 0.833 . . . . 45.13 111.023 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.0 m -96.6 114.59 26.26 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.159 -0.682 . . . . 75.31 109.159 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.474 HD13 HG11 ' A' ' 71' ' ' VAL . 34.9 mt -76.68 140.38 40.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.372 0.669 . . . . 71.03 110.988 -173.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -91.0 151.85 43.67 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.109 0.563 . . . . 71.44 110.951 -174.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.1 120.24 7.95 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.361 2.041 . . . . 74.11 112.35 170.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.79 -17.45 17.87 Favored Glycine 0 CA--C 1.538 1.484 0 CA-C-O 119.515 -0.603 . . . . 63.1 114.427 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.18 154.47 41.02 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.336 1.068 . . . . 73.42 111.844 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -120.6 136.9 54.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.267 0.627 . . . . 74.43 110.812 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.474 HG11 HD13 ' A' ' 65' ' ' LEU . 35.8 m -132.89 172.38 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 124.841 1.256 . . . . 74.22 111.848 -170.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.46 138.86 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 124.231 1.012 . . . . 73.5 109.739 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.5 mt -97.94 118.2 33.98 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.669 0.788 . . . . 74.42 111.579 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.556 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 30.5 mm-40 -82.19 -22.59 35.91 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.157 0.583 . . . . 72.41 112.511 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.592 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -104.78 172.12 6.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.095 0.558 . . . . 71.05 111.464 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 29.1 t -137.26 126.22 24.25 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.149 0.579 . . . . 43.11 111.487 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.576 ' H ' ' HG2' ' A' ' 81' ' ' MET . 32.8 m170 -92.92 -20.16 20.92 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.483 0.713 . . . . 74.12 111.003 164.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.0 ptp -151.43 158.73 44.07 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.296 0.638 . . . . 54.35 111.566 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.488 ' HG2' HD21 ' A' ' 41' ' ' ASN . 38.0 ttpt -66.78 95.91 0.38 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.447 0.699 . . . . 74.45 110.143 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.13 -12.4 4.41 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 115.859 -0.61 . . . . 64.32 113.354 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.576 ' HG2' ' H ' ' A' ' 77' ' ' HIS . 9.4 tpt -75.93 -59.57 2.7 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.389 1.076 . . . . 54.43 111.865 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 58.5 tttm -67.21 131.05 45.0 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.74 0.816 . . . . 54.02 112.267 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.61 -26.33 14.6 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.397 -0.365 . . . . 65.31 113.539 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.08 156.78 38.08 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.335 0.654 . . . . 72.14 111.914 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.9 m -84.5 116.35 23.06 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.909 -0.774 . . . . 62.34 108.909 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.63 150.82 22.33 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.721 0.809 . . . . 70.13 109.354 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -118.9 118.68 32.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.15 0.58 . . . . 71.31 109.472 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.425 HD13 HG12 ' A' ' 35' ' ' VAL . 36.9 mm -60.1 98.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.092 0.557 . . . . 74.24 109.869 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.11 -39.84 82.69 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.768 0.827 . . . . 62.41 109.254 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.6 t -163.44 163.25 24.97 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.064 -0.971 . . . . 71.21 110.473 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.6 139.27 52.85 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.661 0.785 . . . . 73.24 110.403 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -139.23 124.55 19.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.223 0.609 . . . . 74.55 111.102 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -86.81 94.11 9.46 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.088 -1.078 . . . . 71.15 108.088 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 t -136.79 155.04 50.34 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.8 0.84 . . . . 74.45 111.706 -170.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.4 m -87.46 125.06 34.07 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.794 -0.817 . . . . 55.55 108.794 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.5 134.16 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.012 0.925 . . . . 74.35 109.703 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.499 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 93.9 m-85 -112.63 154.98 25.2 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.764 0.792 . . . . 74.44 112.71 -169.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.3 ttp -102.55 112.49 25.25 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.546 -1.206 . . . . 70.12 108.734 173.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.513 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 23.6 m -121.5 148.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 112.909 0.707 . . . . 61.12 112.909 -172.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.3 122.86 48.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.839 0.856 . . . . 74.24 109.455 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -138.88 167.72 21.39 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.593 0.711 . . . . 63.23 112.591 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.1 m -106.84 118.64 37.22 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.102 -1.073 . . . . 72.31 108.102 168.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.6 p -64.96 124.64 22.59 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.421 0.288 . . . . 61.42 111.072 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.3 p -69.85 -41.42 74.9 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.119 0.968 . . . . 63.53 112.596 -176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.3 p -78.6 -48.48 15.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.041 0.537 . . . . 53.42 111.785 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.3 t -81.2 -36.38 30.18 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.405 0.682 . . . . 63.13 112.577 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.8 2.58 89.72 Favored Glycine 0 N--CA 1.483 1.768 0 CA-C-O 120.877 0.154 . . . . 52.43 113.478 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -82.08 137.79 34.95 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.91 0.884 . . . . 63.22 111.208 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.28 111.14 19.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.677 0.791 . . . . 73.33 109.138 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -110.8 120.17 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.181 0.592 . . . . 60.22 109.502 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -113.59 152.16 30.7 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.654 0.382 . . . . 72.42 110.412 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.4 m120 53.74 34.8 19.83 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 124.494 1.118 . . . . 71.31 113.224 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -58.27 135.99 57.25 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.645 1.178 . . . . 70.2 112.256 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 61.8 mttp -137.37 137.4 38.82 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.425 1.09 . . . . 74.45 110.45 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 97.4 m95 -115.17 156.94 24.36 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.64 1.576 . . . . 71.31 112.031 -9.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.5 m -128.02 154.12 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.637 1.175 . . . . 71.21 109.245 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 75.2 p -103.66 160.75 14.49 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 122.075 -0.391 . . . . 60.33 110.905 174.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.499 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 40.3 tt0 -63.07 -27.41 69.38 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.444 0.698 . . . . 64.35 111.552 178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -63.62 -25.42 68.22 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.168 0.987 . . . . 75.24 112.227 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.515 ' HG2' ' HB ' ' A' ' 11' ' ' THR . 40.2 mt-10 -91.86 0.03 57.5 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.914 0.885 . . . . 74.21 111.818 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 117' ' ' THR . 68.8 mt -119.95 140.48 50.84 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.344 0.52 . . . . 64.21 110.351 -172.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -131.56 122.94 26.93 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.848 0.859 . . . . 73.1 109.087 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.551 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -56.35 117.78 4.13 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.38 0.672 . . . . 45.44 111.728 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -81.13 86.98 6.09 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-O 121.616 0.722 . . . . 72.23 111.821 -172.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.7 mp -82.63 169.04 16.71 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.146 -0.933 . . . . 44.41 110.108 168.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.94 -24.32 67.68 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.097 0.559 . . . . 73.31 112.113 176.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -65.95 104.44 1.11 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.594 0.758 . . . . 73.04 110.562 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -86.64 116.45 24.76 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.316 0.647 . . . . 70.34 110.553 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -65.97 -31.29 72.11 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.36 0.664 . . . . 65.24 112.491 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -155.05 115.16 3.79 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.593 0.757 . . . . 72.02 109.266 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -79.05 177.76 8.55 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.284 0.634 . . . . 73.45 112.171 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 . . . . . 0 CA--C 1.568 1.672 0 CA-C-O 118.88 -0.581 . . . . 75.15 110.984 175.17 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.018 -0.364 . . . . 71.04 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.01 147.22 48.83 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.838 0.455 . . . . 65.21 110.326 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.66 132.39 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 CA-C-O 121.209 0.528 . . . . 75.2 111.133 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.32 -5.55 49.08 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.338 -0.847 . . . . 72.4 113.757 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.2 m -68.08 136.1 53.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.988 0.736 . . . . 70.41 112.988 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -84.63 113.69 21.45 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.007 -0.738 . . . . 63.02 109.007 167.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 123' ' ' ALA . 29.8 m -123.76 174.03 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.555 0.742 . . . . 71.2 111.29 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 21' ' ' GLU . 9.7 mt -130.64 134.72 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.141 0.976 . . . . 65.23 109.341 170.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.5 mt -86.39 108.12 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.008 0.923 . . . . 73.03 110.144 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -89.18 -48.21 7.54 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.251 0.62 . . . . 72.42 111.133 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 28.0 m -102.14 143.07 32.42 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 107.987 -1.116 . . . . 64.33 107.987 173.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 17' ' ' MET . 31.1 t -157.45 155.62 30.74 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.472 0.916 . . . . 62.13 113.472 -172.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -83.86 -42.71 16.09 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.147 -1.388 . . . . 61.32 109.111 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.7 mmt -90.67 128.6 36.69 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.185 0.994 . . . . 52.44 109.557 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HE2' HG21 ' A' ' 105' ' ' THR . 0.0 OUTLIER -66.88 -17.86 65.1 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.558 0.577 . . . . 71.4 112.558 -177.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.52 -11.08 62.8 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 113.937 0.335 . . . . 52.01 113.937 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.457 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 53.4 ttp -88.06 -23.05 23.85 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.31 0.555 . . . . 71.32 111.51 -177.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 141.97 57.77 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 121.025 0.44 . . . . 60.0 111.348 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.68 -8.65 41.05 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-N 116.003 -0.544 . . . . 73.4 114.116 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.41 148.25 32.03 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.498 0.719 . . . . 71.23 111.529 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HA ' HG12 ' A' ' 8' ' ' ILE . 8.8 pt-20 -96.17 110.55 22.81 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 121.272 0.558 . . . . 65.33 109.976 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.518 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -101.86 172.28 7.03 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.209 1.004 . . . . 75.51 113.303 -174.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.2 m -125.79 123.89 39.77 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.028 0.931 . . . . 73.32 109.806 172.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.41 122.21 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.053 0.541 . . . . 61.03 110.08 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 p -126.72 -6.33 6.27 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.543 0.737 . . . . 61.3 112.591 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.38 145.71 13.38 Favored Glycine 0 N--CA 1.476 1.314 0 CA-C-O 119.648 -0.529 . . . . 71.43 112.019 173.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.29 123.48 12.95 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.618 0.767 . . . . 73.44 110.689 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -133.1 130.24 39.04 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.663 0.785 . . . . 75.31 111.926 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -104.24 87.47 2.75 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.617 0.767 . . . . 74.3 109.165 169.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -134.53 170.98 14.96 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.847 0.859 . . . . 51.32 110.921 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.5 m -75.47 107.71 7.78 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.492 -0.558 . . . . 61.4 109.492 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.01 110.5 23.1 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.601 0.76 . . . . 70.14 109.004 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.458 ' HE2' ' HA ' ' A' ' 54' ' ' GLN . 95.7 m-85 -89.33 151.86 21.85 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.873 0.844 . . . . 71.22 112.158 -172.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.0 t -99.68 120.41 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.255 -1.387 . . . . 74.12 107.255 164.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -125.72 148.55 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.514 0.673 . . . . 73.32 112.671 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.6 p -115.81 124.99 52.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.241 1.017 . . . . 54.45 109.14 170.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.425 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 47.2 p90 -152.11 156.19 39.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.767 0.427 . . . . 74.24 110.678 -174.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.423 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 15.1 m -113.31 110.85 50.3 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 109.123 -0.695 . . . . 72.05 109.123 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 38' ' ' THR . 9.2 Cg_endo -53.01 118.44 4.8 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.248 2.632 . . . . 64.24 112.791 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.3 p -64.71 -17.19 63.88 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.723 1.209 . . . . 75.2 113.596 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -67.47 -10.21 49.32 Favored 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 123.669 0.788 . . . . 74.42 112.466 174.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.77 51.38 2.14 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 122.255 -0.278 . . . . 64.14 112.717 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.57 -151.05 21.12 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 120.903 0.168 . . . . 45.13 113.421 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -106.14 133.86 50.19 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.725 0.81 . . . . 72.31 109.636 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -59.5 118.6 6.23 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.915 0.486 . . . . 73.15 111.208 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.7 t -84.01 110.57 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.316 0.646 . . . . 60.31 110.638 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -95.72 130.65 42.57 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.934 0.894 . . . . 72.3 110.777 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 m170 54.01 57.93 5.51 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.065 0.946 . . . . 74.42 112.547 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.465 ' HD2' HG13 ' A' ' 52' ' ' VAL . 63.9 t60 -73.14 126.31 29.73 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.092 0.557 . . . . 72.11 111.446 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 66.4 mttm -131.21 139.36 49.69 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.44 1.096 . . . . 72.25 109.732 173.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.622 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 85.9 m95 -114.12 133.32 55.64 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.424 1.49 . . . . 74.32 111.474 -5.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.465 HG13 ' HD2' ' A' ' 49' ' ' HIS . 14.2 m -110.74 142.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 108.477 -0.935 . . . . 62.44 108.477 167.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.81 161.92 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-O 120.817 0.341 . . . . 52.41 111.241 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.458 ' HA ' ' HE2' ' A' ' 33' ' ' TYR . 63.3 tt0 -52.01 -47.98 64.71 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.189 0.996 . . . . 73.34 113.487 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -74.94 -8.1 55.51 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.509 0.723 . . . . 73.51 112.124 -174.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 35.7 tt0 -90.7 -8.84 48.81 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 124.842 1.257 . . . . 52.1 110.931 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.64 142.16 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 C-N-CA 124.506 1.123 . . . . 73.24 110.311 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -63.56 -50.37 69.77 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.228 1.011 . . . . 70.4 112.968 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.36 -6.58 57.1 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.225 0.824 . . . . 72.21 113.225 -170.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -33.19 -56.22 0.4 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.761 1.763 . . . . 55.32 115.761 -170.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.39 15.18 63.24 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 115.119 0.807 . . . . 41.12 115.119 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.37 3.52 1.87 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.2 1.4 . . . . 73.51 113.146 -170.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -100.54 160.37 14.4 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.931 0.892 . . . . 61.15 110.942 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.1 m -83.25 109.54 17.32 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.423 -0.584 . . . . 61.05 109.423 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.511 HD13 HG11 ' A' ' 71' ' ' VAL . 63.7 mt -72.02 122.13 20.35 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.724 -0.843 . . . . 65.55 108.724 175.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -97.55 149.09 35.35 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.212 0.605 . . . . 65.4 112.324 -164.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -46.25 115.65 1.22 Allowed 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.806 3.004 . . . . 74.35 114.623 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.77 -16.96 15.98 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 115.887 -0.597 . . . . 63.53 114.053 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.53 154.66 32.23 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 117.811 0.805 . . . . 74.3 111.714 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -126.07 137.29 53.61 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.344 0.658 . . . . 61.23 110.448 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.511 HG11 HD13 ' A' ' 65' ' ' LEU . 16.9 m -141.29 -179.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 124.621 1.169 . . . . 74.21 110.908 -168.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.53 146.44 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.494 0.718 . . . . 60.21 110.398 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.1 mt -96.09 123.92 39.89 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.673 0.789 . . . . 73.41 111.193 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -86.75 -6.03 58.94 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.525 0.565 . . . . 73.41 112.525 173.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -122.95 170.62 9.95 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.554 0.693 . . . . 72.55 110.525 170.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.448 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 66.1 p -146.99 127.72 14.3 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.281 -0.872 . . . . 71.23 110.458 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -82.82 -31.27 28.22 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.553 0.741 . . . . 71.11 109.524 168.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 66.6 mtm -125.77 177.61 6.18 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.971 0.908 . . . . 74.03 112.086 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -81.84 128.82 34.42 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.682 0.793 . . . . 73.13 111.394 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.67 11.48 83.96 Favored Glycine 0 N--CA 1.477 1.416 0 C-N-CA 123.179 0.418 . . . . 64.53 113.73 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.7 ttt -86.32 -44.0 12.44 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.882 0.873 . . . . 73.12 111.447 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 88.1 tttt -67.69 127.53 33.09 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.728 0.411 . . . . 74.34 111.209 174.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.15 -16.6 60.62 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 116.537 -0.301 . . . . 50.04 112.817 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.77 152.39 42.76 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.405 0.682 . . . . 74.2 111.116 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.8 m -84.18 114.0 21.48 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.971 -0.559 . . . . 65.52 109.914 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -100.44 130.14 46.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.863 0.865 . . . . 73.24 109.752 -177.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -99.87 117.58 34.48 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.343 -0.984 . . . . 73.2 108.343 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.3 mm -64.35 94.46 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 N-CA-C 109.486 -0.561 . . . . 75.51 109.486 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.59 -33.17 68.82 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.884 0.873 . . . . 65.32 109.832 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.9 t -167.08 166.2 15.27 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.187 0.995 . . . . 62.44 110.506 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.03 131.48 42.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.978 0.911 . . . . 72.34 109.538 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -130.42 140.01 50.58 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.832 0.453 . . . . 72.35 111.168 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -94.12 96.71 9.81 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.518 0.727 . . . . 72.5 109.091 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.1 t -137.39 157.1 47.33 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.631 0.773 . . . . 74.53 111.116 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.9 m -86.43 125.84 33.97 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.764 -0.458 . . . . 45.01 109.764 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 115' ' ' TRP . 8.6 m -117.34 138.23 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.735 0.814 . . . . 74.15 110.321 -176.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -122.11 164.0 18.52 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.314 1.045 . . . . 71.33 112.613 -169.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 ttp -119.35 116.92 27.18 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.95 -1.477 . . . . 70.31 107.984 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.518 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 24.5 m -125.72 149.67 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 123.544 0.737 . . . . 52.15 112.667 -172.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -115.88 116.77 28.56 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.018 0.927 . . . . 64.54 109.9 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -136.68 177.7 7.65 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.53 0.681 . . . . 75.32 111.781 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.5 m -123.78 125.01 43.95 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.326 1.051 . . . . 72.41 108.803 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.3 t -61.19 127.77 33.14 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.413 0.685 . . . . 72.31 112.216 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.6 p -69.33 -44.52 71.52 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.892 0.877 . . . . 64.2 111.441 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.409 HG21 ' HE2' ' A' ' 15' ' ' LYS . 38.0 m -81.07 -57.46 3.51 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.693 -0.685 . . . . 71.14 111.775 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.2 m -86.49 -21.13 27.17 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.185 0.809 . . . . 71.03 113.185 -171.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.98 -17.96 38.5 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 115.121 0.809 . . . . 62.33 115.121 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.51 124.76 22.17 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.5 0.72 . . . . 73.31 112.258 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -81.57 101.97 10.32 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.414 0.686 . . . . 75.25 109.275 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.0 t -98.74 119.21 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.69 0.796 . . . . 72.22 110.396 -170.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.716 ' HD3' ' H ' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -105.3 137.53 42.95 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.645 0.778 . . . . 74.43 111.276 -174.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.8 m120 56.53 40.09 29.62 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.737 1.215 . . . . 63.04 113.174 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -64.72 132.83 50.71 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.936 0.894 . . . . 73.34 111.233 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -152.06 151.76 31.53 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.101 0.56 . . . . 65.32 111.37 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.622 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 92.3 m95 -105.88 144.54 32.47 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 125.984 1.713 . . . . 74.21 110.777 -4.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.7 148.92 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 123.903 0.881 . . . . 63.13 110.888 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.6 p -94.37 168.57 10.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.682 -0.636 . . . . 53.13 112.17 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -71.22 -25.56 62.55 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.001 0.52 . . . . 63.31 111.07 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -60.46 -20.02 58.49 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 124.275 1.03 . . . . 72.14 111.295 170.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.405 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 41.4 mt-10 -100.74 -2.67 31.85 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.344 1.058 . . . . 75.53 112.881 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.5 mt -119.45 157.5 28.12 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.51 0.724 . . . . 52.12 110.907 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.9 t -144.97 122.8 11.93 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.324 0.65 . . . . 74.31 110.292 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -68.28 117.67 10.38 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 122.784 0.434 . . . . 62.42 111.619 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -105.83 133.56 50.35 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.625 0.77 . . . . 62.45 111.995 -170.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.6 tp -118.9 137.78 53.22 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.658 0.783 . . . . 72.44 110.406 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -129.06 132.32 47.43 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.088 0.955 . . . . 71.51 110.285 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -85.03 128.97 34.86 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.771 0.828 . . . . 64.1 109.719 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -56.26 -70.52 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.494 0.718 . . . . 70.2 112.453 -172.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -86.68 72.92 10.13 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.954 0.883 . . . . 74.15 109.754 174.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -83.86 -33.61 24.79 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 114.992 -1.004 . . . . 73.51 111.85 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -73.13 118.24 15.84 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.176 0.59 . . . . 54.1 111.405 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.1 m80 . . . . . 0 CA--C 1.564 1.51 0 C-N-CA 123.55 0.74 . . . . 52.34 109.836 173.898 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.563 ' SD ' HG11 ' A' ' 7' ' ' VAL . 17.9 ptp . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 110.784 -0.08 . . . . 63.22 110.784 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.0 158.87 16.45 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.045 0.538 . . . . 71.03 111.798 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.92 123.48 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 CA-C-O 121.017 0.437 . . . . 54.31 110.691 173.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.22 -4.42 38.16 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.694 -0.685 . . . . 62.53 113.02 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.5 m -76.8 140.65 40.78 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.501 0.556 . . . . 65.53 112.501 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -91.02 114.78 27.39 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 107.964 -1.125 . . . . 72.44 107.964 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.563 HG11 ' SD ' ' A' ' 1' ' ' MET . 27.3 m -128.33 153.62 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.571 0.748 . . . . 74.24 111.329 -170.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -100.59 121.91 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.599 0.76 . . . . 62.12 110.164 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.663 HD11 ' HB2' ' A' ' 22' ' ' ALA . 46.0 mt -80.18 120.79 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.632 0.373 . . . . 75.32 110.459 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -92.49 1.0 57.5 Favored 'General case' 0 CA--C 1.569 1.689 0 C-N-CA 123.426 0.69 . . . . 64.05 111.977 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.426 HG21 ' HG2' ' A' ' 120' ' ' GLU . 21.7 m -142.61 154.51 44.45 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.226 0.61 . . . . 72.33 111.686 -171.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.766 ' HB3' ' HB2' ' A' ' 18' ' ' LYS . 33.0 p -117.84 116.58 27.26 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.579 0.704 . . . . 73.24 112.042 173.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.529 ' H ' ' HE2' ' A' ' 17' ' ' MET . 38.2 m-70 -96.36 -33.06 12.07 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 107.616 -1.253 . . . . 72.14 107.616 160.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 26.6 mmt -107.87 149.49 28.21 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.786 1.234 . . . . 51.24 109.283 167.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HG3' HG21 ' A' ' 105' ' ' THR . 17.4 tppt? -58.33 -45.19 88.55 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.853 0.861 . . . . 52.23 113.102 -172.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.96 2.27 87.77 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 115.172 0.829 . . . . 35.21 115.172 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.537 ' HG2' HG21 ' A' ' 9' ' ' ILE . 47.8 ttp -87.76 -26.65 22.78 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.539 0.669 . . . . 75.4 111.991 -170.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.766 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 28.0 ttpp -66.28 119.28 11.25 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.546 0.338 . . . . 71.42 110.646 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.93 0.62 88.86 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 115.793 -0.64 . . . . 22.34 114.494 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.06 151.08 35.66 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.997 0.519 . . . . 73.12 111.214 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -95.43 113.02 24.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.525 0.33 . . . . 73.23 110.775 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.663 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -96.1 168.5 10.57 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.713 0.768 . . . . 63.31 113.058 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.4 m -126.26 123.61 38.5 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.096 -1.446 . . . . 73.12 107.096 166.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.08 110.29 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.871 0.468 . . . . 42.33 110.203 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.6 p -95.4 -14.02 24.17 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.116 0.567 . . . . 71.34 111.799 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.95 154.41 25.35 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 113.44 0.136 . . . . 42.31 113.44 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.39 110.45 11.05 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.942 0.897 . . . . 71.15 110.725 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -115.1 123.19 48.34 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.847 0.859 . . . . 74.2 110.683 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.9 86.25 2.35 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 122.408 1.099 . . . . 71.52 109.757 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -134.57 173.02 12.12 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.122 -0.945 . . . . 72.24 111.045 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.1 m -78.6 123.74 27.42 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.683 -0.488 . . . . 63.15 109.683 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.08 144.87 31.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.91 0.884 . . . . 54.13 109.818 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -128.79 149.54 50.68 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.891 0.853 . . . . 74.23 111.888 -170.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.3 t -105.75 127.11 60.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 114.144 -1.389 . . . . 74.51 108.069 172.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.458 HG12 HD13 ' A' ' 88' ' ' ILE . 15.8 m -127.78 161.39 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 112.781 0.659 . . . . 45.54 112.781 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.0 t -128.99 125.25 36.99 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.13 0.972 . . . . 74.24 109.408 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -153.79 158.42 40.87 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.463 0.705 . . . . 74.12 110.87 -172.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.4 m -109.65 112.31 58.66 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 108.566 -0.902 . . . . 74.24 108.566 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.32 128.69 28.48 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.183 2.589 . . . . 71.15 113.593 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.9 p -62.6 -18.39 62.08 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.968 1.307 . . . . 70.42 113.408 -175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -64.82 -10.05 25.25 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 123.938 0.895 . . . . 65.03 112.526 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.71 53.51 2.71 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-O 121.117 0.287 . . . . 45.11 112.467 -175.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.68 171.16 14.31 Favored Glycine 0 N--CA 1.471 1.005 0 CA-C-N 115.352 -0.424 . . . . 74.21 113.408 -175.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -62.91 134.94 56.98 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.556 0.742 . . . . 74.22 111.512 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -58.99 123.92 18.19 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.379 0.672 . . . . 72.41 112.223 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.5 t -87.2 108.76 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.515 0.726 . . . . 63.43 109.723 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -101.78 139.21 37.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.681 0.793 . . . . 62.41 110.526 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.5 m170 57.82 37.41 27.03 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.089 0.956 . . . . 64.42 112.746 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -60.77 129.69 42.76 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.168 0.987 . . . . 75.35 111.408 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 61.1 mttp -130.2 137.24 49.97 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.936 0.895 . . . . 63.14 110.862 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 79.8 m95 -118.03 145.78 44.53 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 125.468 1.507 . . . . 74.23 111.242 -11.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -114.09 132.4 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 107.99 -1.115 . . . . 70.31 107.99 169.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.0 pt -102.02 167.27 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 121.598 -0.689 . . . . 74.44 109.909 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -47.6 -33.61 6.82 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.68 1.192 . . . . 72.01 113.393 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.51 -13.09 60.64 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.707 1.003 . . . . 64.02 113.707 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.548 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 0.5 OUTLIER -89.51 -12.91 38.66 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.623 0.601 . . . . 65.3 112.623 -179.283 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 mp -98.57 132.79 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 122.961 0.504 . . . . 73.33 111.293 -169.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -60.83 -44.16 97.3 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.81 1.244 . . . . 74.31 112.854 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -78.97 -16.32 57.1 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 118.189 -0.91 . . . . 73.41 112.813 -175.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -30.42 -62.19 0.16 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.813 1.412 . . . . 74.43 114.813 -160.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.19 23.2 65.98 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 114.602 0.601 . . . . 64.2 114.602 169.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 t70 72.54 -2.63 2.58 Favored 'General case' 0 CA--C 1.577 1.984 0 C-N-CA 125.304 1.442 . . . . 71.3 112.401 -176.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.452 ' HE3' HD23 ' A' ' 65' ' ' LEU . 53.0 pttt -79.65 153.71 29.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.376 -0.828 . . . . 62.01 110.954 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.4 m -84.48 118.73 24.48 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.142 -0.688 . . . . 75.33 109.142 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.531 ' HB3' HG13 ' A' ' 88' ' ' ILE . 41.6 mt -73.09 124.37 25.41 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.755 0.822 . . . . 70.42 110.598 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -109.02 155.94 40.01 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 123.584 0.754 . . . . 74.34 111.358 -171.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 84.5 Cg_exo -45.89 111.53 0.35 Allowed 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.123 2.549 . . . . 61.41 114.172 174.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.64 -16.39 14.11 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 114.611 0.604 . . . . 41.15 114.611 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.48 130.97 45.19 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 117.932 0.866 . . . . 75.32 112.33 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.448 HE22 ' HB2' ' A' ' 87' ' ' GLU . 31.9 mm-40 -87.8 122.06 30.99 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.827 -0.805 . . . . 70.34 108.827 171.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.14 146.74 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.596 0.758 . . . . 70.41 110.763 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -101.23 135.75 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 109.449 -0.574 . . . . 62.04 109.449 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.3 mt -91.19 109.15 20.4 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.98 0.512 . . . . 71.42 111.152 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.11 -40.04 65.28 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.63 0.772 . . . . 53.12 111.243 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.548 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -89.39 173.78 8.18 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.95 0.5 . . . . 51.13 111.044 174.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.658 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 29.4 t -149.17 125.44 10.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.866 -0.606 . . . . 43.32 109.804 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -86.73 -18.4 31.26 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.456 0.702 . . . . 63.31 110.976 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -155.14 147.61 24.06 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.31 1.044 . . . . 74.03 109.811 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.4 ' HB3' ' NZ ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -51.1 124.11 10.81 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.105 0.962 . . . . 60.52 113.593 -174.178 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.2 -15.6 56.25 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 115.891 -0.595 . . . . 74.44 114.201 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.2 ttt -68.91 -39.02 79.91 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.539 0.736 . . . . 73.42 112.518 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 87.7 tttt -66.39 134.94 53.56 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.689 0.396 . . . . 60.5 111.66 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.79 -7.08 79.65 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.134 -0.485 . . . . 32.05 112.901 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.42 143.15 37.02 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.103 0.561 . . . . 64.51 111.58 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.1 m -87.01 116.74 25.27 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.705 -0.85 . . . . 75.22 108.705 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -112.34 156.99 21.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.819 0.848 . . . . 53.42 110.136 -173.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.448 ' HB2' HE22 ' A' ' 70' ' ' GLN . 35.4 tt0 -120.07 125.97 49.61 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.293 -0.632 . . . . 73.4 109.293 174.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.531 HG13 ' HB3' ' A' ' 65' ' ' LEU . 34.6 mm -63.08 105.29 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 N-CA-C 109.691 -0.485 . . . . 55.42 109.691 175.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -75.94 -37.86 58.22 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.987 0.915 . . . . 64.33 109.889 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.4 t -157.42 152.0 25.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.674 0.79 . . . . 50.32 111.111 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.08 132.17 54.35 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.885 0.874 . . . . 74.32 109.949 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -142.16 140.68 32.48 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.099 0.476 . . . . 64.44 112.171 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -96.66 95.6 8.05 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.126 -0.488 . . . . 73.21 109.703 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.2 t -136.88 149.91 47.94 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.455 0.702 . . . . 74.12 110.764 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.0 m -82.49 124.88 30.5 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.459 -0.571 . . . . 64.2 109.459 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.637 HG12 HG22 ' A' ' 117' ' ' THR . 16.5 m -112.03 132.97 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.455 0.702 . . . . 44.21 109.464 -173.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.422 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 96.4 m-85 -109.63 139.0 45.18 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.937 0.875 . . . . 71.33 112.048 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.434 ' HG2' ' HA ' ' A' ' 112' ' ' ASN . 60.9 ttp -91.27 120.3 32.05 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 107.493 -1.299 . . . . 64.21 107.493 170.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.425 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 27.6 m -130.65 163.31 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 113.826 1.047 . . . . 70.42 113.826 -171.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -125.69 118.32 25.36 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.292 1.037 . . . . 64.23 110.61 174.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -131.87 178.47 6.75 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.067 0.947 . . . . 75.34 110.76 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.1 m -114.73 114.31 25.44 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.081 -0.711 . . . . 72.1 109.081 170.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.3 t -55.54 103.48 0.1 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.97 0.908 . . . . 53.5 110.684 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.2 p -65.53 -17.93 64.94 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.511 1.125 . . . . 74.31 113.578 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.406 HG21 ' HG3' ' A' ' 15' ' ' LYS . 65.1 p -92.9 -24.21 18.51 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.357 0.503 . . . . 74.13 112.357 177.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.3 m -112.26 -22.57 10.85 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.133 0.79 . . . . 73.21 113.133 -170.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.15 -12.5 49.85 Favored Glycine 0 CA--C 1.542 1.742 0 N-CA-C 113.717 0.247 . . . . 64.11 113.717 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -72.82 129.29 37.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.202 1.001 . . . . 61.51 112.202 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -84.45 111.63 19.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.05 0.54 . . . . 71.33 110.177 170.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.0 t -101.06 117.99 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.898 0.879 . . . . 73.05 110.145 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.529 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -113.67 148.89 35.53 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.293 0.637 . . . . 62.12 111.677 -175.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.434 ' HA ' ' HG2' ' A' ' 98' ' ' MET . 81.5 m-20 55.74 36.74 27.82 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 124.143 0.977 . . . . 75.21 112.416 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -62.11 134.91 57.2 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.198 0.999 . . . . 74.23 111.911 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 98.3 mttt -140.02 136.03 33.28 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.887 0.875 . . . . 60.43 111.381 -175.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 91.9 m95 -114.46 142.96 45.7 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.114 1.366 . . . . 71.4 112.961 -12.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.5 146.48 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 114.016 -1.447 . . . . 75.21 108.19 166.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.637 HG22 HG12 ' A' ' 96' ' ' VAL . 18.8 p -103.55 173.46 6.29 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.948 -0.47 . . . . 63.53 111.289 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.422 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 13.4 tp10 -58.23 -29.93 66.13 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.791 0.836 . . . . 71.13 111.258 170.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.53 -35.11 79.43 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.831 0.853 . . . . 70.21 111.72 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.426 ' HG2' HG21 ' A' ' 11' ' ' THR . 1.3 mt-10 -92.56 -3.18 55.47 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.133 0.573 . . . . 74.03 112.463 -176.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.4 mt -118.78 143.77 46.71 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.662 0.785 . . . . 70.11 110.283 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 57.5 m -122.29 149.52 43.61 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.427 -0.953 . . . . 74.22 108.427 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.03 170.86 7.64 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.49 0.316 . . . . 42.01 111.268 173.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -61.16 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.713 0.768 . . . . 71.22 110.474 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.82 -175.41 3.83 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.284 1.434 . . . . 75.05 109.479 -178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.37 142.38 58.41 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.283 0.633 . . . . 73.12 112.217 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -154.92 61.2 0.66 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 112.253 0.464 . . . . 64.55 112.253 -175.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -65.43 -42.01 92.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 122.119 -0.363 . . . . 73.33 111.86 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -167.83 105.25 0.5 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.732 0.813 . . . . 74.15 109.653 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -141.73 152.77 44.12 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.745 0.818 . . . . 72.12 111.757 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -151.27 -178.92 6.93 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.247 1.019 . . . . 74.44 109.663 173.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 CA--C 1.559 1.29 0 CA-C-O 118.968 -0.539 . . . . 73.03 110.096 175.189 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' SD ' HG11 ' A' ' 7' ' ' VAL . 58.3 mtt . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.446 0.165 . . . . 64.35 111.167 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -90.79 137.9 32.0 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.404 0.682 . . . . 62.13 112.756 -171.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.28 136.49 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 C-N-CA 123.597 0.759 . . . . 73.14 110.975 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.67 -12.6 68.95 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 116.007 -0.542 . . . . 61.54 113.129 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.9 t -87.1 159.12 19.03 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.426 0.69 . . . . 61.01 110.802 175.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -101.25 147.51 26.2 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.919 0.487 . . . . 62.25 109.756 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' A' ' 123' ' ' ALA . 16.6 m -130.89 151.25 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.733 0.813 . . . . 61.34 110.399 176.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.2 mm -98.76 124.99 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.792 0.837 . . . . 74.5 109.743 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 22' ' ' ALA . 30.1 mt -78.31 107.41 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 109.14 -0.689 . . . . 74.31 109.14 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -87.22 -34.28 19.03 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.061 0.458 . . . . 54.25 111.946 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.9 m -133.33 141.31 47.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.678 1.191 . . . . 44.1 108.223 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.8 p -162.64 173.16 14.27 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.602 0.715 . . . . 63.1 111.555 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -86.29 -6.95 58.85 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 114.964 -1.016 . . . . 70.5 111.353 -175.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.6 ' HB2' ' HG3' ' A' ' 17' ' ' MET . 51.5 mtt -133.2 144.66 49.96 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.371 1.068 . . . . 75.45 110.367 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -60.27 -38.2 82.82 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.232 0.613 . . . . 71.41 111.343 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.68 -24.07 63.81 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 114.766 0.666 . . . . 65.14 114.766 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.6 ' HG3' ' HB2' ' A' ' 14' ' ' MET . 27.0 mtm -94.14 -26.74 16.57 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.637 0.375 . . . . 71.33 110.968 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -67.71 121.04 15.08 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.025 0.53 . . . . 73.25 111.431 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.44 0.96 88.13 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 115.671 -0.695 . . . . 64.32 114.117 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.79 158.87 19.88 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.195 0.598 . . . . 61.5 112.491 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -89.69 123.51 33.78 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.751 -0.659 . . . . 74.11 109.641 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -114.83 168.7 9.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.244 1.018 . . . . 65.24 110.905 171.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 m -133.9 128.35 34.39 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.663 0.785 . . . . 73.33 109.24 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.24 105.21 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 109.692 -0.484 . . . . 55.25 109.692 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.2 p -103.87 -4.73 23.12 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.957 0.503 . . . . 64.41 111.085 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.81 133.06 3.27 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 111.21 -0.756 . . . . 61.51 111.21 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.01 107.02 12.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.62 0.768 . . . . 63.41 109.532 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -110.12 133.2 53.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.847 0.859 . . . . 74.31 109.745 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -122.24 86.38 2.57 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.993 0.901 . . . . 61.32 110.142 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -135.43 -178.54 5.16 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.751 0.82 . . . . 63.32 111.206 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.2 m -75.27 119.54 19.53 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.748 0.419 . . . . 64.22 110.136 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.03 150.19 25.17 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.582 0.753 . . . . 74.5 109.613 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HB2' HG23 ' A' ' 52' ' ' VAL . 90.0 m-85 -128.61 142.91 50.89 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.784 0.802 . . . . 54.51 111.75 -173.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.18 109.65 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 114.146 -1.388 . . . . 62.13 107.29 171.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.9 148.31 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 113.816 1.043 . . . . 61.22 113.816 -170.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.4 t -116.7 125.03 51.12 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.112 0.965 . . . . 71.44 110.542 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -150.9 156.3 40.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 122.143 -0.348 . . . . 72.15 111.649 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 m -105.36 119.48 52.73 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.139 0.576 . . . . 73.25 109.826 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.34 124.4 15.97 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.801 2.334 . . . . 62.02 112.391 169.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.4 p -63.48 -10.32 17.02 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.013 1.486 . . . . 74.3 115.013 -167.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.439 HD22 ' HB3' ' A' ' 79' ' ' LYS . 55.7 m-20 -90.95 10.1 27.88 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 122.845 0.458 . . . . 71.0 112.074 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.59 47.19 5.76 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.923 -0.471 . . . . 71.33 111.923 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.51 160.65 18.98 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 123.039 0.352 . . . . 61.02 112.514 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -62.89 130.1 43.31 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.017 0.527 . . . . 71.34 110.709 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -64.48 123.87 20.35 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.026 0.441 . . . . 74.24 111.453 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.6 t -86.87 113.25 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.542 -0.754 . . . . 71.03 109.51 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -97.95 143.44 28.52 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.984 0.914 . . . . 70.33 110.115 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.6 m80 55.92 35.3 25.23 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.642 0.777 . . . . 74.5 112.801 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.415 ' HD2' HG13 ' A' ' 52' ' ' VAL . 66.7 t60 -57.86 118.3 5.19 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.826 0.85 . . . . 74.24 111.597 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 97.9 mttt -118.32 131.37 56.33 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.837 0.855 . . . . 65.5 110.414 176.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.672 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 94.4 m95 -118.84 154.83 32.25 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.642 -1.286 . . . . 71.33 111.499 -10.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 33' ' ' TYR . 18.4 m -122.38 148.3 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 114.443 -1.253 . . . . 73.44 107.979 166.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.9 pt -103.01 170.4 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.606 0.717 . . . . 73.21 112.186 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -54.4 -34.35 61.11 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.206 1.002 . . . . 64.43 113.243 172.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -82.46 -1.04 49.03 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.493 0.717 . . . . 61.41 112.373 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -80.12 -17.96 51.14 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.202 1.001 . . . . 63.34 111.156 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 71' ' ' VAL . 82.2 mt -122.2 140.29 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.725 1.21 . . . . 74.2 111.076 -165.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -75.42 -49.86 17.63 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.265 0.626 . . . . 71.33 112.027 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -68.14 -5.2 16.66 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.606 0.965 . . . . 75.01 113.606 -174.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.486 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -61.01 -58.6 7.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 122.854 0.462 . . . . 35.13 111.626 169.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.85 32.76 83.8 Favored Glycine 0 N--CA 1.48 1.577 0 O-C-N 121.967 -0.458 . . . . 74.33 112.441 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.4 p30 44.6 28.28 0.31 Allowed 'General case' 0 CA--C 1.57 1.733 0 C-N-CA 126.236 1.814 . . . . 72.13 114.268 -166.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 42.4 pttt -100.22 166.23 11.09 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.537 -0.542 . . . . 52.24 109.537 174.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 m -80.97 108.98 15.12 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.621 0.368 . . . . 71.31 110.537 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.561 HD13 HG11 ' A' ' 71' ' ' VAL . 50.9 mt -78.85 129.16 34.27 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.45 0.7 . . . . 72.43 110.63 175.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -98.32 145.27 29.55 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.601 0.76 . . . . 63.24 111.29 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.461 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 97.9 Cg_exo -47.07 130.12 15.99 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.536 2.824 . . . . 52.14 114.327 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.16 -12.68 48.69 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 123.17 0.414 . . . . 53.02 113.221 -174.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.1 143.77 41.08 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.604 0.762 . . . . 60.4 112.561 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -107.03 130.33 54.67 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.956 0.902 . . . . 73.34 110.428 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 65' ' ' LEU . 28.0 m -133.36 175.77 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 124.159 0.984 . . . . 73.23 111.493 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -117.61 136.02 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.571 0.748 . . . . 73.1 109.864 171.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.5 mt -88.72 120.7 30.36 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.818 0.847 . . . . 73.12 110.791 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.04 1.32 56.23 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.09 0.556 . . . . 70.23 112.457 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -87.91 157.83 18.85 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.448 0.699 . . . . 53.13 112.108 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.9 p -118.03 128.95 55.26 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.924 -0.769 . . . . 24.22 108.924 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -141.5 -42.85 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.524 -1.288 . . . . 71.34 107.524 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -157.21 -176.17 5.82 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 114.058 -1.428 . . . . 61.05 110.596 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.439 ' HB3' HD22 ' A' ' 41' ' ' ASN . 34.9 mmtp -60.74 124.15 19.59 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.595 0.758 . . . . 61.32 112.493 178.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.9 14.36 82.42 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 114.718 0.647 . . . . 33.44 114.718 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.5 tpt -69.71 -59.51 2.9 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.36 0.58 . . . . 72.45 111.174 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -67.55 129.29 39.45 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 115.998 -0.547 . . . . 75.03 111.453 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.86 -9.48 61.89 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 116.473 -0.33 . . . . 52.53 113.553 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.67 148.62 31.53 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.261 0.624 . . . . 74.33 111.852 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.3 m -89.7 122.32 32.7 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.196 0.598 . . . . 62.14 109.629 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.84 141.71 36.79 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.461 0.704 . . . . 41.34 111.359 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -98.79 115.62 29.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.318 1.447 . . . . 73.45 108.78 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.7 mm -69.09 96.23 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 109.03 -0.73 . . . . 50.3 109.03 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -71.65 -36.87 70.84 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.778 0.431 . . . . 73.43 110.154 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.461 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . 26.5 t -166.65 162.69 16.58 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.5 -0.773 . . . . 74.0 111.37 -177.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.14 135.76 49.29 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.253 1.021 . . . . 74.21 110.355 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -138.51 135.2 34.86 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.378 0.671 . . . . 72.12 111.399 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -90.0 94.87 9.97 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.463 -0.94 . . . . 74.31 108.463 171.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -136.08 154.99 50.85 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.427 0.691 . . . . 61.55 110.803 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 m -87.78 116.59 26.03 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.151 -0.685 . . . . 72.51 109.151 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.2 m -111.47 134.99 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.189 0.996 . . . . 44.44 109.529 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.92 148.61 36.52 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.989 0.9 . . . . 70.44 112.871 -169.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.7 ttp -103.11 111.35 23.68 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.966 -1.47 . . . . 74.5 107.312 167.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.8 m -123.84 147.62 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 112.891 0.7 . . . . 74.24 112.891 -170.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -105.24 117.65 34.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.926 0.89 . . . . 73.11 108.835 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -130.56 169.13 15.99 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.617 0.723 . . . . 74.14 111.692 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.2 m -116.82 133.3 56.18 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 108.931 -0.766 . . . . 64.44 108.931 167.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.2 t -72.82 129.31 37.89 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.78 0.432 . . . . 72.03 111.671 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.6 p -66.04 -41.54 90.75 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.066 0.946 . . . . 75.42 112.094 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.0 p -85.63 -50.05 7.52 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.31 0.644 . . . . 72.21 112.282 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.0 m -88.81 -24.02 22.69 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.0 0.741 . . . . 75.53 113.0 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 4.34 79.26 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 114.334 0.494 . . . . 53.3 114.334 -177.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -68.36 131.59 45.58 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.359 0.874 . . . . 64.32 113.359 -176.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -84.72 86.21 7.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.793 0.837 . . . . 63.03 109.405 174.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.91 125.61 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 115.866 -0.607 . . . . 61.14 109.726 -172.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.93 153.61 33.31 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.093 0.473 . . . . 73.41 111.471 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.454 HD22 ' N ' ' A' ' 112' ' ' ASN . 0.8 OUTLIER 60.5 28.45 18.12 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 114.522 -1.217 . . . . 73.11 112.563 177.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -66.78 130.1 42.05 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.525 0.73 . . . . 75.34 110.807 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -162.3 154.79 19.46 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 115.672 -0.695 . . . . 72.2 111.465 -169.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.672 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 96.6 m95 -103.23 133.04 48.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.473 -1.392 . . . . 72.4 111.862 0.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -126.88 139.72 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.604 1.162 . . . . 65.23 109.051 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.3 p -94.72 173.48 7.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.826 -0.546 . . . . 74.44 112.055 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.43 -19.99 65.88 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.367 0.667 . . . . 72.15 111.24 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.65 -33.98 71.56 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.953 0.901 . . . . 73.4 110.807 173.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.95 -2.64 58.47 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.166 0.586 . . . . 64.44 111.742 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.16 160.86 28.16 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.032 0.92 . . . . 74.21 111.018 -173.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.3 m -140.63 146.98 38.64 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 107.206 -1.405 . . . . 75.02 107.206 168.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.494 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -58.76 162.14 4.25 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 119.177 0.899 . . . . 42.0 111.567 176.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -54.79 98.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.454 0.645 . . . . 72.13 111.33 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 14.9 tp -120.72 175.48 6.0 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.278 1.031 . . . . 73.44 110.845 -164.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.27 154.2 41.82 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 123.123 0.569 . . . . 73.31 111.4 173.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -63.97 -11.18 26.23 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.778 1.231 . . . . 65.05 113.872 -175.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 48.05 113.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 126.242 1.817 . . . . 65.04 114.48 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -75.54 19.83 0.18 Allowed 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 115.388 1.625 . . . . 73.05 115.388 -166.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -163.53 106.74 0.99 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.368 0.531 . . . . 73.33 110.795 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -164.47 151.95 11.81 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.284 0.634 . . . . 72.11 111.758 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 64.9 m80 . . . . . 0 CA--C 1.568 1.649 0 C-N-CA 123.916 0.886 . . . . 75.43 109.794 172.198 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.464 ' SD ' HG11 ' A' ' 7' ' ' VAL . 64.2 mtt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 110.274 -0.269 . . . . 65.42 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.17 161.86 14.09 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.398 0.679 . . . . 64.51 111.128 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.4 t -65.96 125.36 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 121.116 0.484 . . . . 73.24 111.315 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.02 -1.68 35.49 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.532 0.587 . . . . 25.14 112.993 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.3 m -73.58 129.77 38.65 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.319 0.647 . . . . 53.05 111.897 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -99.24 117.27 33.33 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.367 0.667 . . . . 73.35 109.639 174.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.464 HG11 ' SD ' ' A' ' 1' ' ' MET . 30.5 m -134.38 153.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 124.114 0.966 . . . . 61.5 110.917 -168.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.56 126.29 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 123.301 0.64 . . . . 73.1 110.059 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 22' ' ' ALA . 25.7 mt -83.88 131.56 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 122.013 -0.429 . . . . 70.35 110.849 -171.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -96.08 -51.24 4.51 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 118.116 0.416 . . . . 71.41 111.724 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m -93.21 140.69 29.25 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.049 0.54 . . . . 71.44 109.56 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 14' ' ' MET . 93.0 p -128.44 125.45 38.54 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.758 0.651 . . . . 64.31 112.758 -171.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -84.05 -41.35 17.29 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.755 0.822 . . . . 72.24 108.841 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' SER . 25.1 mmt -101.56 153.22 19.92 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.34 1.056 . . . . 65.34 109.478 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -63.71 -35.52 80.84 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.209 0.818 . . . . 73.25 113.209 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.62 -1.26 89.2 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 114.347 0.499 . . . . 63.42 114.347 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.492 ' HG2' HG21 ' A' ' 9' ' ' ILE . 52.7 ttm -75.2 -30.12 60.53 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 122.979 0.512 . . . . 62.22 110.05 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -63.21 119.25 9.22 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.896 0.878 . . . . 74.45 111.79 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.42 2.25 78.96 Favored Glycine 0 CA--C 1.539 1.548 0 N-CA-C 114.667 0.627 . . . . 51.35 114.667 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.76 149.12 38.06 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.22 0.608 . . . . 63.23 111.93 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -85.14 102.32 13.18 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.652 -0.499 . . . . 65.14 109.652 174.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.609 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -85.24 147.07 26.76 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.559 0.744 . . . . 53.21 111.552 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.0 m -119.3 116.5 26.36 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.1 -1.074 . . . . 72.43 108.1 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.37 100.49 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 N-CA-C 109.607 -0.516 . . . . 71.4 109.607 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.1 p -91.72 -9.18 44.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.158 0.583 . . . . 42.44 110.927 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.05 137.32 4.73 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.833 -0.507 . . . . 31.43 111.833 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.87 106.93 13.5 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.888 0.875 . . . . 65.24 109.297 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -112.48 128.18 56.26 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.808 0.843 . . . . 72.04 110.298 -172.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -114.36 93.13 4.21 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.382 -0.599 . . . . 60.42 109.382 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.515 HG21 HD12 ' A' ' 53' ' ' ILE . 8.2 t -137.09 -179.53 5.77 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.853 0.861 . . . . 41.2 111.356 -176.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.8 m -75.8 116.94 17.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.976 0.511 . . . . 75.43 110.305 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.05 151.0 22.32 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.411 0.684 . . . . 44.42 110.191 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -130.6 146.11 52.04 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.485 0.659 . . . . 73.32 111.373 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.82 118.8 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.665 -1.235 . . . . 62.44 107.665 168.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.475 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 27.0 m -123.79 144.71 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.331 0.493 . . . . 74.53 112.331 -175.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.7 m -114.5 132.65 56.22 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.73 0.812 . . . . 74.43 110.303 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.419 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 46.1 p90 -160.5 160.52 32.07 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.08 0.552 . . . . 64.44 111.276 -174.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.9 m -113.99 114.96 46.08 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 108.501 -0.926 . . . . 61.31 108.501 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.31 127.18 24.92 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.972 2.448 . . . . 72.21 113.025 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.6 p -64.44 -17.34 63.72 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.462 1.105 . . . . 51.23 113.833 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -82.93 11.11 6.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.251 0.62 . . . . 74.53 112.335 176.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.66 51.24 5.62 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 122.735 0.207 . . . . 71.21 113.306 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.97 -171.61 26.33 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 122.559 0.123 . . . . 63.54 113.072 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.74 124.78 28.19 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.12 -1.067 . . . . 62.43 108.12 174.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -50.35 114.01 1.02 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.798 0.839 . . . . 73.42 112.469 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.9 t -75.17 96.86 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.468 -0.787 . . . . 54.01 109.825 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -85.46 117.96 24.69 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.498 -0.774 . . . . 70.35 109.915 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.8 m170 58.22 59.88 2.87 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.129 0.972 . . . . 74.42 112.136 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -59.8 121.47 11.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.011 0.925 . . . . 73.04 111.562 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 98.5 mttt -126.66 136.17 52.14 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.854 0.861 . . . . 62.44 110.234 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 89.1 m95 -115.46 146.56 41.53 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.906 1.282 . . . . 73.43 111.698 -10.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.02 151.83 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 113.813 -1.539 . . . . 70.32 108.205 166.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 96' ' ' VAL . 33.0 pt -118.93 -177.07 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 120.96 0.409 . . . . 65.12 110.948 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.453 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 30.5 tt0 -49.73 -33.13 15.2 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.734 1.214 . . . . 63.43 113.822 175.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.486 ' H ' HG13 ' A' ' 53' ' ' ILE . 7.5 tp10 -62.59 -26.43 68.59 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 113.117 0.784 . . . . 65.22 113.117 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.44 -13.62 54.38 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 112.654 0.613 . . . . 71.42 112.654 -173.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.41 137.37 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.285 0.634 . . . . 73.03 110.958 -171.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.527 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 27.1 ttpt -78.28 -37.08 45.76 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.455 1.102 . . . . 71.51 112.434 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.07 -14.7 59.78 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.093 0.957 . . . . 74.33 112.821 -173.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -49.86 -63.35 1.14 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.881 1.067 . . . . 74.12 113.881 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.67 33.85 88.35 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 115.234 0.853 . . . . 70.13 115.234 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 67.07 16.81 10.37 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.607 1.163 . . . . 65.23 113.24 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 12.0 ptpt -106.47 176.43 5.17 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.256 0.551 . . . . 63.24 111.073 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.3 m -96.48 113.82 25.43 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.031 0.933 . . . . 75.2 109.156 168.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.0 mt -77.03 136.93 38.7 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.25 0.62 . . . . 53.22 110.168 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -95.55 152.59 39.31 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 123.522 0.729 . . . . 71.44 111.489 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 82.7 Cg_exo -50.86 119.88 5.87 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.124 2.549 . . . . 73.24 113.395 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.85 -13.98 26.84 Favored Glycine 0 N--CA 1.48 1.609 0 CA-C-O 119.959 -0.356 . . . . 54.43 113.815 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.55 120.63 14.89 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 117.736 0.768 . . . . 70.34 112.123 176.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -89.1 120.68 30.71 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.6 -0.727 . . . . 74.51 109.839 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.88 166.43 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.695 1.198 . . . . 73.3 110.906 -172.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.9 mm -112.11 135.81 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.612 0.765 . . . . 71.41 110.116 171.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.7 mt -83.29 122.82 28.95 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.064 0.545 . . . . 70.32 111.291 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 45.5 mm-40 -93.29 13.19 22.09 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 123.173 0.589 . . . . 54.11 112.043 173.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.14 156.44 32.32 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.358 0.663 . . . . 73.15 110.138 169.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.4 t -139.83 126.65 20.69 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.929 -0.578 . . . . 75.41 110.149 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -110.37 2.01 18.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.852 0.861 . . . . 71.44 109.859 171.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -173.44 161.03 4.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.737 1.215 . . . . 63.11 110.336 -174.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -68.22 124.28 23.04 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 120.728 0.299 . . . . 60.1 110.65 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.92 41.42 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.575 -0.569 . . . . 72.13 113.897 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.6 ttt -98.69 -58.42 1.96 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 117.469 0.635 . . . . 73.45 110.172 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -66.96 131.2 45.38 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.333 0.253 . . . . 74.14 110.522 171.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.69 -15.91 59.34 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 116.587 -0.279 . . . . 75.43 113.218 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.38 151.82 30.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.289 0.636 . . . . 35.31 111.687 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.1 m -87.55 118.82 27.27 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.478 -0.783 . . . . 75.03 110.165 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.475 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -116.98 149.5 40.12 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.195 0.998 . . . . 74.32 110.112 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -115.03 129.23 56.66 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.968 -0.382 . . . . 73.42 109.968 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 67' ' ' PRO . 32.0 mm -66.21 108.7 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 N-CA-C 109.415 -0.587 . . . . 71.32 109.415 174.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -75.16 -38.91 60.76 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.184 0.516 . . . . 65.31 109.951 170.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.8 t -161.73 152.7 18.07 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.22 -0.9 . . . . 71.43 111.388 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -128.55 132.74 48.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.946 0.899 . . . . 72.41 110.076 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -134.57 143.83 47.6 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.413 0.685 . . . . 63.52 111.415 -171.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -98.27 94.16 6.62 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.69 -0.856 . . . . 71.24 108.69 170.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -136.56 155.9 49.32 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.522 0.729 . . . . 74.21 110.992 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.2 m -84.11 119.54 25.1 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.15 -0.685 . . . . 54.21 109.15 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 53' ' ' ILE . 15.8 m -107.24 135.33 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.853 0.861 . . . . 60.13 109.049 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.462 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 86.3 m-85 -109.82 135.88 50.01 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.451 0.643 . . . . 72.52 111.475 -174.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.3 ttp -90.18 111.74 23.01 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.319 -1.363 . . . . 74.14 107.319 167.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.49 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 27.3 m -124.08 144.91 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 113.435 0.902 . . . . 61.13 113.435 -170.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -109.61 118.22 36.01 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.942 1.297 . . . . 55.1 108.315 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.45 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 55.0 p90 -139.6 166.66 24.0 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.265 0.839 . . . . 53.24 113.265 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.2 m -100.39 109.34 21.5 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.963 -1.017 . . . . 55.44 109.333 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.2 m -57.54 106.06 0.3 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.3 0.64 . . . . 65.33 111.181 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.7 p -61.4 -23.05 65.53 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.0 0.92 . . . . 75.04 113.295 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.8 t -65.88 -25.99 67.43 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.428 0.899 . . . . 73.23 113.428 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.2 t -142.63 -42.55 0.32 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.636 0.606 . . . . 74.04 112.636 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.01 -8.89 18.6 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 123.259 0.457 . . . . 71.12 113.141 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.21 139.54 54.53 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.86 0.864 . . . . 64.22 111.955 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -85.0 114.74 22.39 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.4 0.68 . . . . 74.12 111.151 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.1 t -88.84 104.9 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 108.075 -1.083 . . . . 73.12 108.075 171.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -93.84 131.8 38.89 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.396 -0.82 . . . . 74.22 110.721 -168.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.5 p30 45.48 52.9 8.8 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 125.29 1.436 . . . . 74.42 114.286 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -57.83 139.7 53.48 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.542 1.137 . . . . 75.45 112.876 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 68.1 mttm -131.67 128.39 38.92 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 124.249 1.02 . . . . 71.12 111.063 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 94.3 m95 -120.81 160.97 22.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.918 1.687 . . . . 65.24 111.203 -13.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.73 166.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 124.31 1.044 . . . . 74.14 109.806 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 53.2 p -117.18 167.4 11.23 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.098 0.559 . . . . 62.22 111.214 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.462 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 36.0 tt0 -67.24 -24.57 65.83 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.782 0.433 . . . . 73.52 111.601 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.2 -30.91 71.94 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.442 0.697 . . . . 70.22 111.441 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -93.65 -3.11 53.06 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.15 0.98 . . . . 70.0 111.942 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.6 mt -117.1 123.46 46.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.808 0.843 . . . . 61.24 109.639 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.43 ' O ' ' HB ' ' A' ' 7' ' ' VAL . 58.0 m -104.0 150.63 24.07 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.682 -0.858 . . . . 74.2 108.682 172.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.17 169.8 9.7 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.205 0.457 . . . . 74.04 111.38 174.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -54.39 99.88 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.011 0.525 . . . . 65.33 111.285 177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 48.8 tp -137.23 137.77 39.44 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.635 0.774 . . . . 75.21 110.933 -172.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.13 11.24 8.19 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.327 1.051 . . . . 72.23 111.712 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -74.42 103.11 4.66 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.854 0.862 . . . . 73.03 110.778 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -135.08 151.07 50.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.351 1.06 . . . . 71.52 110.572 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -113.25 157.78 21.33 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.627 0.771 . . . . 73.12 111.765 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -94.2 -176.52 4.0 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.18 0.992 . . . . 72.11 110.799 174.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -74.66 90.12 2.28 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.031 0.532 . . . . 75.04 111.102 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 C--O 1.255 1.38 0 C-N-CA 123.546 0.738 . . . . 63.03 109.8 170.335 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HB3' HG21 ' A' ' 24' ' ' VAL . 23.7 mmt . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 110.934 -0.025 . . . . 44.4 110.934 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.532 ' HD2' ' H ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -110.36 149.19 30.59 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.35 0.66 . . . . 65.42 110.669 178.009 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.37 130.04 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 123.333 0.653 . . . . 73.43 111.414 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.73 -8.75 56.56 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 115.42 -0.809 . . . . 72.52 113.081 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.1 t -85.4 151.51 23.95 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.577 0.584 . . . . 74.11 112.577 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -100.59 117.46 34.77 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.153 0.981 . . . . 74.11 110.266 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.48 154.88 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.947 0.899 . . . . 55.14 111.293 -176.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.8 mm -100.61 133.51 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.23 1.012 . . . . 74.43 110.511 172.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 17' ' ' MET . 33.0 mt -84.63 123.91 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 122.162 -0.336 . . . . 74.4 110.325 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -100.66 -46.55 5.14 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.274 0.63 . . . . 62.51 112.46 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 120' ' ' GLU . 79.0 m -109.14 140.83 42.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.717 0.807 . . . . 62.54 109.293 -176.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 17' ' ' MET . 13.7 m -160.46 163.46 32.97 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.631 0.604 . . . . 41.25 112.631 -169.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -95.79 -40.34 9.4 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.414 -0.812 . . . . 75.02 109.053 164.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.6 mpt? -84.02 142.06 30.73 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.998 0.919 . . . . 45.42 111.028 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 12.2 mptt -72.18 -26.71 62.18 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.299 0.64 . . . . 70.14 112.016 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.62 -4.77 81.89 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 114.999 0.76 . . . . 33.45 114.999 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.43 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 63.4 mtt -87.87 -26.29 22.85 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 117.558 0.679 . . . . 52.24 112.364 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 25.6 pttm -61.75 118.84 7.67 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.154 0.502 . . . . 72.42 111.522 -175.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.1 1.94 70.5 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 113.939 0.336 . . . . 64.4 113.939 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.12 138.38 47.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.292 0.637 . . . . 73.33 112.279 -177.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -78.87 97.61 6.04 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.521 0.728 . . . . 71.14 110.11 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.56 157.31 16.04 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.23 1.012 . . . . 72.25 111.601 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.3 m -126.73 124.27 39.37 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.992 -0.744 . . . . 65.13 108.992 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.423 ' HA ' HG12 ' A' ' 99' ' ' VAL . 46.6 t -72.75 102.17 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.241 0.616 . . . . 55.53 110.001 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.9 p -99.92 -2.76 33.91 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.334 0.654 . . . . 71.14 112.718 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.07 151.81 20.95 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 112.283 -0.327 . . . . 72.3 112.283 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.93 108.82 7.59 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.756 0.822 . . . . 74.41 110.558 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.407 ' HB2' HG23 ' A' ' 96' ' ' VAL . 4.6 m-85 -108.87 122.63 47.59 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.959 0.904 . . . . 71.31 110.597 -174.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -100.01 83.24 2.67 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 122.058 0.932 . . . . 64.02 109.74 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.3 t -133.95 170.4 15.68 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 115.506 -0.77 . . . . 54.02 111.443 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.2 m -87.51 122.66 31.51 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.97 0.508 . . . . 50.35 109.96 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.1 154.77 27.18 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.16 0.984 . . . . 44.12 109.989 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.429 ' HB2' HG23 ' A' ' 52' ' ' VAL . 91.5 m-85 -130.28 149.4 51.99 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.916 0.865 . . . . 75.13 113.099 -169.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -102.25 111.17 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 113.941 -1.482 . . . . 74.11 108.055 171.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.494 HG12 HD13 ' A' ' 88' ' ' ILE . 22.2 m -125.12 146.99 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 113.203 0.816 . . . . 54.41 113.203 -172.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 66.6 p -117.73 129.98 56.04 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.374 1.07 . . . . 74.33 110.775 176.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.642 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 37.9 p90 -159.09 160.35 35.61 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.569 0.7 . . . . 75.21 111.639 -171.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.0 m -113.55 116.76 45.69 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 107.511 -1.292 . . . . 54.31 107.511 173.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.43 147.17 17.37 Favored 'Trans proline' 0 CA--C 1.564 2.013 0 C-N-CA 123.228 2.618 . . . . 73.13 113.271 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.5 p -63.55 -18.79 64.23 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.697 0.799 . . . . 75.33 111.998 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.76 -21.4 66.51 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.957 0.903 . . . . 70.3 111.984 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 33.35 70.63 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 114.782 0.673 . . . . 75.13 114.782 172.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.09 -113.62 2.68 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-N 117.16 0.48 . . . . 60.53 111.961 174.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -70.65 175.36 4.96 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.684 0.794 . . . . 72.42 112.934 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -116.78 129.29 56.01 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.165 -0.925 . . . . 73.33 108.64 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.29 102.62 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 122.969 0.508 . . . . 71.1 109.952 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.7 p-10 -109.97 153.91 23.9 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.698 0.799 . . . . 65.11 111.218 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 34.5 m80 55.63 33.78 21.92 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.21 1.004 . . . . 63.04 112.303 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -70.91 134.74 47.49 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.912 1.285 . . . . 70.53 111.59 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 18.0 ptpt -139.7 139.38 36.56 Favored 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.68 0.792 . . . . 73.2 110.723 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 92.3 m95 -115.97 149.28 39.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 119.86 -1.775 . . . . 73.45 112.419 -3.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.429 HG23 ' HB2' ' A' ' 33' ' ' TYR . 15.8 m -127.36 132.84 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 114.519 -1.219 . . . . 73.51 109.131 170.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.2 pt -104.31 176.17 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.9 -0.5 . . . . 74.2 112.324 -171.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -45.07 -52.55 8.9 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.544 1.138 . . . . 64.04 113.773 171.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.01 -16.26 63.14 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.59 0.756 . . . . 74.52 111.976 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.607 ' HG3' ' HB3' ' A' ' 75' ' ' ALA . 7.9 tt0 -93.53 -17.03 23.84 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.418 1.087 . . . . 70.24 111.423 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.2 mt -111.94 127.4 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.208 1.003 . . . . 74.15 110.838 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -61.82 -56.16 22.31 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.685 0.794 . . . . 71.15 112.057 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.27 -17.43 62.49 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.633 0.975 . . . . 74.22 113.633 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.623 ' HA ' HD11 ' A' ' 65' ' ' LEU . . . -38.12 -47.03 1.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.869 1.433 . . . . 60.35 114.869 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.65 18.04 67.63 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 114.871 0.708 . . . . 74.24 114.871 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 63.65 17.86 10.71 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.945 1.298 . . . . 73.2 112.719 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.2 171.54 7.45 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.84 0.856 . . . . 72.44 110.466 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.1 m -89.97 112.68 24.15 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.306 -0.628 . . . . 71.23 109.306 173.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.623 HD11 ' HA ' ' A' ' 60' ' ' ALA . 49.5 mt -74.45 130.23 39.24 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.617 0.767 . . . . 73.02 110.618 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -100.43 152.91 37.97 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 123.634 0.773 . . . . 75.24 111.269 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -54.24 114.42 1.81 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.971 2.447 . . . . 44.51 113.685 177.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.95 -10.34 18.2 Favored Glycine 0 N--CA 1.481 1.655 0 CA-C-N 115.845 -0.616 . . . . 42.11 114.13 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -77.56 133.49 38.48 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.626 0.713 . . . . 74.31 112.353 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -98.31 120.36 38.6 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.2 -0.909 . . . . 45.14 109.184 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.568 HG11 HD13 ' A' ' 65' ' ' LEU . 19.4 m -124.7 169.98 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.574 0.75 . . . . 65.14 112.355 -171.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mm -117.37 141.15 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.936 0.894 . . . . 75.41 109.938 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.29 124.2 40.2 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.56 0.744 . . . . 64.52 111.363 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.01 -36.39 19.79 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 122.936 0.494 . . . . 74.44 112.322 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.607 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . . . -86.82 169.52 12.51 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.07 0.462 . . . . 61.41 111.305 175.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.759 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 8.7 t -142.62 126.1 16.75 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.308 -0.405 . . . . 70.44 111.122 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -95.73 -28.05 14.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.588 0.755 . . . . 74.0 111.024 169.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 60.1 mtm -133.75 177.04 8.02 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.669 0.788 . . . . 74.51 111.86 -170.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -68.07 106.23 2.31 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-O 121.586 0.707 . . . . 65.53 112.043 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.14 22.98 36.2 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 116.023 -0.535 . . . . 75.13 114.293 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -85.06 -38.66 18.89 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 117.495 0.647 . . . . 65.2 111.04 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.759 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 59.3 tttp -67.04 124.83 24.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.038 0.535 . . . . 55.22 110.845 170.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.74 0.24 87.79 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-O 120.196 -0.224 . . . . 61.41 113.013 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.55 151.51 25.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.181 0.592 . . . . 75.11 111.358 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 51.2 m -92.08 117.74 30.13 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.332 -0.849 . . . . 75.54 109.888 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.642 ' HA ' ' HB3' ' A' ' 37' ' ' TYR . . . -105.69 150.79 25.15 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.557 0.743 . . . . 73.45 110.902 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -114.86 121.08 42.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.296 1.038 . . . . 73.1 110.153 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.494 HD13 HG12 ' A' ' 35' ' ' VAL . 36.9 mm -68.87 109.26 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 122.346 0.258 . . . . 61.21 110.753 -178.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -82.58 -37.13 25.51 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.262 0.625 . . . . 74.03 110.713 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.9 t -162.79 153.92 17.37 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.23 0.612 . . . . 73.51 111.727 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.89 132.57 56.66 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.25 1.02 . . . . 61.41 110.442 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -129.26 130.91 46.82 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.382 0.673 . . . . 70.43 112.222 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -92.91 93.26 8.29 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 108.248 -1.019 . . . . 73.42 108.248 167.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.8 t -138.25 154.22 49.07 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.275 0.63 . . . . 62.35 111.627 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.0 m -88.26 124.54 33.97 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.52 -0.548 . . . . 71.43 109.52 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.407 HG23 ' HB2' ' A' ' 28' ' ' TYR . 16.5 m -110.02 131.95 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 108.921 -0.77 . . . . 72.11 108.921 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.73 141.69 36.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.212 1.005 . . . . 70.11 111.423 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.6 ttp -93.65 115.76 28.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 108.367 -0.975 . . . . 74.34 108.367 171.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 24' ' ' VAL . 35.5 m -126.21 166.88 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 112.482 0.549 . . . . 60.24 112.482 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -133.74 129.12 36.25 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.781 0.432 . . . . 62.1 111.767 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -138.29 176.04 9.05 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.883 0.873 . . . . 62.54 111.541 -173.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.5 m -114.41 134.57 54.89 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.652 0.781 . . . . 72.53 109.496 171.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.3 t -68.25 119.53 12.95 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.319 0.648 . . . . 71.12 111.589 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.5 p -71.0 -26.11 62.98 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.862 0.865 . . . . 70.45 112.651 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.3 p -81.55 -56.64 3.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.82 0.448 . . . . 64.44 111.417 175.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.7 t -92.25 -51.06 5.34 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.72 0.808 . . . . 40.52 112.789 -172.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.44 -15.96 19.78 Favored Glycine 0 N--CA 1.478 1.492 0 CA-C-N 116.03 -0.532 . . . . 20.12 112.7 -168.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -51.29 113.48 0.96 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.854 1.262 . . . . 53.4 112.467 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -80.48 120.65 24.76 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.265 -0.643 . . . . 44.33 109.265 173.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.0 t -111.11 123.22 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.646 0.778 . . . . 72.24 109.111 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -113.4 153.76 28.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.943 0.497 . . . . 63.24 111.606 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 56.4 29.12 14.64 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.448 1.099 . . . . 62.44 113.211 177.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -59.31 139.68 56.77 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.033 0.933 . . . . 74.23 113.27 -174.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 66.6 mttm -142.11 135.07 28.72 Favored 'General case' 0 CA--C 1.572 1.804 0 C-N-CA 125.361 1.464 . . . . 62.45 110.088 -175.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 80.7 m95 -114.4 143.51 44.81 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.36 1.891 . . . . 72.31 111.5 -11.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.57 141.86 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 124.435 1.094 . . . . 72.44 108.944 170.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 69.3 p -100.6 -177.93 3.63 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.67 0.748 . . . . 74.54 112.264 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -55.95 -28.47 57.11 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 124.821 1.249 . . . . 64.41 111.776 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.07 -28.48 60.37 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.902 0.881 . . . . 74.24 112.095 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.452 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 1.5 mp0 -87.77 -9.23 54.56 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.6 0.36 . . . . 73.32 111.881 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.4 mt -121.45 127.26 50.93 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.171 0.589 . . . . 73.01 110.815 -172.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.5 m -118.91 133.12 56.04 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.162 0.985 . . . . 61.51 109.289 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.35 155.77 31.28 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.64 0.376 . . . . 61.33 111.896 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -62.47 93.31 0.05 Allowed 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.066 0.46 . . . . 70.52 110.482 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.2 tp -130.35 133.44 46.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.175 0.99 . . . . 62.41 110.143 -174.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -79.57 102.3 8.78 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.766 0.426 . . . . 72.13 111.803 -174.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.2 m170 -133.86 160.47 37.54 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.342 1.057 . . . . 70.42 109.916 170.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -70.19 163.67 25.89 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 116.052 -0.522 . . . . 62.3 111.095 170.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -57.0 110.83 0.88 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.306 0.642 . . . . 74.24 112.067 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -69.12 131.65 45.32 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.89 0.876 . . . . 72.33 111.739 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -129.73 160.6 32.89 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.31 0.644 . . . . 74.44 110.569 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.1 p80 . . . . . 0 CA--C 1.573 1.854 0 C-N-CA 123.892 0.877 . . . . 73.41 111.859 174.667 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HG2' HG21 ' A' ' 24' ' ' VAL . 49.4 tpp . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 110.102 -0.333 . . . . 71.34 110.102 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -92.96 155.99 17.2 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.291 0.567 . . . . 71.01 112.343 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.8 t -68.12 136.12 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 123.859 0.863 . . . . 75.04 110.821 173.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.22 -12.04 66.96 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 116.077 -0.51 . . . . 74.13 113.399 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.1 t -76.38 141.05 41.59 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 117.417 0.608 . . . . 33.34 111.738 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -99.25 121.46 41.08 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.236 0.615 . . . . 74.34 110.218 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.512 ' HA ' ' H ' ' A' ' 124' ' ' LYS . 32.7 m -125.24 156.16 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.091 0.956 . . . . 70.43 111.571 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.518 HD13 ' HA ' ' A' ' 21' ' ' GLU . 35.9 mm -103.96 135.71 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.493 -0.929 . . . . 73.13 108.493 165.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.3 mt -88.59 119.86 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 109.268 -0.641 . . . . 71.22 109.268 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.66 -28.82 17.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 122.089 -0.382 . . . . 72.23 111.814 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.495 ' HB ' ' HG2' ' A' ' 120' ' ' GLU . 66.4 m -136.28 141.95 43.9 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.043 0.937 . . . . 72.34 109.416 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -169.4 174.0 6.24 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.41 0.624 . . . . 72.12 112.148 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -98.41 2.19 47.6 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.238 -0.892 . . . . 74.43 112.425 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 23.3 mmt -115.4 127.34 55.3 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.508 0.723 . . . . 73.25 109.278 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' H ' ' HD3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -52.98 -41.87 65.0 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.393 1.077 . . . . 61.1 112.877 179.322 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.35 -8.23 85.46 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.371 0.509 . . . . 74.51 114.371 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 42.7 ttp -96.14 -28.93 14.34 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 117.285 0.542 . . . . 74.34 110.334 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -69.26 119.64 13.84 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.152 0.581 . . . . 74.21 109.627 173.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.6 2.5 89.97 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 115.399 -0.819 . . . . 44.33 114.358 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.88 161.89 18.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 113.55 0.945 . . . . 73.43 113.55 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.518 ' HA ' HD13 ' A' ' 8' ' ' ILE . 10.9 tp10 -76.99 138.73 39.79 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.89 -1.05 . . . . 74.44 110.439 172.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.77 166.67 30.66 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.436 0.636 . . . . 62.35 112.672 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.5 m -138.53 129.22 26.42 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.702 0.801 . . . . 53.13 110.408 173.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.417 HG21 ' HG2' ' A' ' 1' ' ' MET . 80.8 t -77.71 104.73 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.513 0.725 . . . . 54.35 109.741 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.7 p -103.02 -2.42 27.59 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.567 0.747 . . . . 62.11 112.394 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.47 142.44 9.05 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-O 120.076 -0.291 . . . . 54.42 112.494 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.97 111.36 14.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.421 0.688 . . . . 70.31 111.231 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -118.08 110.11 17.24 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.303 1.041 . . . . 74.11 110.203 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.21 76.3 3.02 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 122.159 0.981 . . . . 70.35 108.99 174.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -133.06 168.95 17.57 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.736 -0.665 . . . . 43.5 112.258 -169.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 m -70.55 119.77 15.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.122 0.569 . . . . 72.35 111.116 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.36 146.51 28.72 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.6 0.76 . . . . 65.4 109.421 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -127.98 148.04 50.51 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.985 0.898 . . . . 64.23 111.713 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.0 t -102.61 109.7 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 114.156 -1.383 . . . . 74.04 107.707 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.456 HG12 HD13 ' A' ' 88' ' ' ILE . 30.6 m -111.63 167.43 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 118.533 0.606 . . . . 64.22 112.301 -175.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.3 p -141.59 126.58 18.3 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.192 0.597 . . . . 43.32 110.588 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -161.99 128.29 3.67 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 112.772 0.656 . . . . 73.21 112.772 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 73.3 m -71.07 117.76 59.38 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-O 119.083 -0.484 . . . . 73.2 110.099 159.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.57 140.6 94.62 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.143 2.562 . . . . 70.44 113.235 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.7 p -64.61 -16.05 62.1 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 114.43 1.27 . . . . 71.3 114.43 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.492 ' ND2' ' HB3' ' A' ' 79' ' ' LYS . 28.0 p-10 -79.39 -6.02 55.89 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.061 0.545 . . . . 72.33 112.429 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.34 45.99 5.99 Favored Glycine 0 CA--C 1.535 1.281 0 N-CA-C 112.108 -0.397 . . . . 64.15 112.108 -172.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.57 -177.9 39.79 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 122.932 0.301 . . . . 61.33 112.961 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -65.16 123.32 19.22 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 119.277 -0.392 . . . . 75.13 110.177 173.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 12.2 ttm180 -51.95 111.08 0.55 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.216 0.606 . . . . 72.25 111.6 173.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 49' ' ' HIS . 21.6 t -88.54 102.76 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 115.532 -0.758 . . . . 63.32 110.248 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -97.89 143.01 28.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.703 0.801 . . . . 75.43 110.43 -177.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.7 m170 56.96 33.92 24.07 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.763 0.825 . . . . 35.21 111.871 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.573 ' HB2' HG12 ' A' ' 46' ' ' VAL . 85.7 t60 -62.95 132.67 52.83 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.409 1.084 . . . . 61.13 111.85 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -154.99 152.31 29.53 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 114.562 -1.199 . . . . 72.13 109.492 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.6 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 72.7 m95 -106.36 126.17 51.91 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.254 -1.529 . . . . 72.44 112.35 4.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.3 m -113.89 133.67 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.377 1.071 . . . . 63.23 108.625 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.6 pt -97.12 157.6 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-O 120.85 0.357 . . . . 71.54 110.675 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -54.57 -36.59 64.55 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.606 0.762 . . . . 72.11 112.922 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -70.76 -14.34 62.4 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.142 0.577 . . . . 72.12 112.211 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -94.69 -19.66 20.21 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.246 1.018 . . . . 75.12 111.268 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.5 mt -89.07 137.32 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.583 0.753 . . . . 74.41 109.968 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.551 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 36.8 ttpt -76.67 -45.29 30.34 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.039 0.536 . . . . 61.11 111.496 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.467 ' HB3' HG12 ' A' ' 71' ' ' VAL . 5.9 t70 -68.51 -9.54 49.78 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.686 0.794 . . . . 62.32 112.625 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.582 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -42.21 -65.23 0.48 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.781 1.4 . . . . 64.42 114.781 176.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.47 13.53 58.57 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 114.894 0.718 . . . . 40.44 114.894 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.71 13.89 7.76 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.197 1.399 . . . . 61.53 112.779 -172.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -98.96 155.18 17.54 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.768 0.827 . . . . 72.3 110.48 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.9 m -72.65 109.21 6.12 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.389 0.276 . . . . 70.12 111.009 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.418 HD11 ' HA ' ' A' ' 60' ' ' ALA . 62.9 mt -86.63 146.23 26.41 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.361 0.665 . . . . 71.42 109.242 173.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -139.28 169.06 13.22 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 124.01 0.924 . . . . 64.51 110.741 -171.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 1.4 Cg_endo -44.1 109.6 0.16 Allowed 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 123.331 2.687 . . . . 63.44 114.459 172.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.91 -17.27 13.12 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.262 0.865 . . . . 40.53 115.262 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.99 120.94 14.02 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 118.413 1.106 . . . . 75.32 111.526 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -89.72 119.34 30.04 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.289 -0.634 . . . . 61.21 109.289 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' A' ' 59' ' ' ASP . 32.0 m -124.07 168.01 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.644 0.777 . . . . 72.55 111.76 -172.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.8 mm -118.74 137.91 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 123.409 0.684 . . . . 45.24 110.083 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.5 mt -92.4 109.34 20.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.821 0.848 . . . . 72.51 110.638 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.551 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 67.9 mm-40 -83.11 -9.93 58.95 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.55 0.945 . . . . 52.11 113.55 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.2 170.55 8.38 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.403 0.62 . . . . 63.22 111.065 174.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 81' ' ' MET . 31.1 t -143.81 125.42 14.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.403 -0.817 . . . . 73.51 109.173 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -103.72 -4.74 23.3 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.626 0.77 . . . . 73.45 110.465 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -165.88 -176.07 3.67 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.691 0.796 . . . . 72.42 111.386 -168.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HB3' ' ND2' ' A' ' 41' ' ' ASN . 5.5 mptp? -59.35 114.36 2.63 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 112.803 0.668 . . . . 72.0 112.803 177.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.82 27.36 67.1 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.807 1.083 . . . . 74.52 115.807 169.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.47 ' HB3' ' HA ' ' A' ' 76' ' ' SER . 27.2 ttt -83.58 -42.18 17.06 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 118.025 0.913 . . . . 54.33 111.809 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.29 130.89 44.98 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 120.693 0.282 . . . . 73.23 111.612 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.12 80.77 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.102 -0.499 . . . . 53.5 113.054 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.58 139.68 42.23 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.096 0.558 . . . . 62.4 111.982 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.9 m -84.01 120.05 25.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.228 -0.896 . . . . 71.15 108.889 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.453 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -117.46 162.92 17.18 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.971 0.908 . . . . 55.23 110.06 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -127.72 134.08 49.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.632 -0.507 . . . . 73.34 109.632 172.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.456 HD13 HG12 ' A' ' 35' ' ' VAL . 28.5 mm -66.93 104.21 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 N-CA-C 109.378 -0.601 . . . . 73.32 109.378 174.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.25 -40.74 77.67 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.377 1.071 . . . . 64.11 110.419 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.8 m -154.77 149.02 26.02 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.731 0.813 . . . . 63.4 110.599 -176.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.0 130.76 53.14 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.898 0.879 . . . . 64.13 108.89 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -140.88 115.47 9.51 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 121.132 0.491 . . . . 70.24 112.281 -168.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.04 94.2 9.86 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.365 0.666 . . . . 54.41 109.56 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 t -137.96 154.17 49.4 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.493 0.717 . . . . 64.13 110.068 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.7 m -84.21 128.26 34.45 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.889 -0.412 . . . . 72.21 109.889 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 m -111.61 134.55 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.612 0.765 . . . . 63.14 109.539 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -116.05 140.22 49.49 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.423 0.689 . . . . 71.33 112.314 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 65.3 ttp -89.69 112.44 23.71 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.881 -1.054 . . . . 54.21 108.28 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.68 145.85 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 112.826 0.676 . . . . 72.23 112.826 -170.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.84 115.68 30.93 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.488 -0.93 . . . . 73.52 108.488 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -127.97 158.82 36.83 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.218 0.463 . . . . 74.52 111.758 -173.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.7 m -104.25 104.16 14.02 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.425 -0.583 . . . . 74.05 109.425 172.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 108' ' ' GLU . 36.0 t -59.61 109.24 0.86 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.862 0.865 . . . . 74.42 111.546 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.2 p -62.26 -14.21 36.21 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.824 1.25 . . . . 72.13 113.297 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 78.8 m -58.79 -57.28 13.71 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.68 0.792 . . . . 64.32 112.498 174.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.5 p -126.32 -2.06 6.92 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.214 0.606 . . . . 50.53 112.574 -172.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.97 84.91 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 120.063 -0.298 . . . . 63.32 113.404 -170.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 103' ' ' SER . 38.1 tt0 -59.35 113.26 2.08 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.517 1.127 . . . . 65.31 112.003 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -88.7 125.63 34.94 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.681 0.753 . . . . 73.54 109.184 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -119.14 132.28 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.39 1.076 . . . . 74.23 109.12 -170.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 133.51 50.74 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 120.775 0.322 . . . . 73.04 110.297 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.6 m120 55.28 54.78 8.24 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 125.079 1.352 . . . . 73.51 113.857 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -63.91 141.92 58.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.416 0.686 . . . . 61.33 111.598 170.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 98.9 mttt -137.67 127.42 25.38 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.742 0.817 . . . . 72.24 111.053 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.6 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 85.7 m95 -120.55 165.46 14.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.198 -1.564 . . . . 71.54 112.258 -12.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.418 HG21 HD21 ' A' ' 121' ' ' LEU . 20.2 m -124.05 168.32 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 113.786 -1.552 . . . . 54.24 107.72 162.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 40.3 p -117.61 169.84 9.24 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.827 0.739 . . . . 64.22 112.282 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -53.2 -40.86 64.76 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.13 0.972 . . . . 75.54 111.279 172.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.66 -29.45 70.68 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.385 1.074 . . . . 53.12 111.774 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.495 ' HG2' ' HB ' ' A' ' 11' ' ' THR . 56.8 mt-10 -94.0 0.19 55.86 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.891 0.876 . . . . 63.44 112.078 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.418 HD21 HG21 ' A' ' 116' ' ' VAL . 83.6 mt -117.87 152.65 34.96 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.805 0.842 . . . . 63.1 110.244 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.557 ' HB2' ' HB2' ' A' ' 125' ' ' LEU . 50.5 m -146.84 122.94 10.8 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.099 -1.075 . . . . 73.3 108.099 173.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . -59.77 105.6 0.39 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 118.28 0.491 . . . . 75.52 110.975 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.512 ' H ' ' HA ' ' A' ' 7' ' ' VAL . 56.2 tptt 33.94 74.4 0.06 Allowed 'General case' 0 CA--C 1.569 1.682 0 C-N-CA 124.992 1.317 . . . . 75.35 113.251 -167.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 122' ' ' SER . 30.2 tp -66.71 123.46 20.17 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.388 0.675 . . . . 51.02 110.152 173.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 123.54 17.56 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-O 121.025 0.441 . . . . 65.12 111.53 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -53.55 123.63 12.68 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.784 1.234 . . . . 72.21 113.247 -172.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -154.95 122.55 5.7 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.61 0.364 . . . . 64.31 110.948 177.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -144.24 177.09 8.85 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.979 0.912 . . . . 73.41 110.779 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -159.29 170.13 22.55 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.478 0.711 . . . . 74.41 112.4 -175.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -65.97 97.58 0.37 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.639 0.775 . . . . 63.24 111.84 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 84.7 t60 . . . . . 0 CA--C 1.564 1.486 0 C-N-CA 124.664 1.186 . . . . 75.22 110.03 -177.049 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.319 -0.252 . . . . 74.35 110.319 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.4 160.73 18.1 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.295 0.638 . . . . 71.55 111.849 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.18 131.6 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.461 0.704 . . . . 65.35 111.704 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.18 -10.28 43.38 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 115.818 -0.628 . . . . 61.32 112.782 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.4 t -81.13 145.14 31.21 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.236 0.614 . . . . 72.34 112.186 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -94.92 116.5 28.78 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.84 0.856 . . . . 73.2 109.058 175.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.23 153.43 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.131 0.972 . . . . 75.11 110.678 -174.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 mm -100.15 134.68 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 109.292 -0.633 . . . . 55.42 109.292 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.441 HG21 ' HG2' ' A' ' 17' ' ' MET . 63.3 mt -78.42 104.07 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.946 -0.472 . . . . 74.42 109.732 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -78.35 -32.8 49.22 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.188 0.595 . . . . 63.41 111.367 -168.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 t -144.47 164.97 29.28 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.205 0.602 . . . . 63.01 110.061 168.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 98.8 p -157.18 167.07 31.45 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.379 0.609 . . . . 62.43 112.431 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -91.4 -37.49 13.17 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.091 -0.959 . . . . 61.43 109.884 168.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.5 mpt? -85.49 132.85 34.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.835 0.854 . . . . 71.03 110.748 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -58.97 -38.45 79.13 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.553 0.741 . . . . 54.34 112.494 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.22 -6.65 87.76 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 114.545 0.578 . . . . 71.3 114.545 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.441 ' HG2' HG21 ' A' ' 9' ' ' ILE . 41.8 ttp -94.85 -28.66 15.12 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 117.821 0.811 . . . . 71.45 112.13 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.19 128.6 37.15 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.13 0.49 . . . . 71.55 111.85 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.47 0.27 88.89 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-N 115.563 -0.744 . . . . 64.15 113.958 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.55 149.46 29.95 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.357 0.663 . . . . 44.2 110.851 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -90.95 106.53 18.59 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.919 0.39 . . . . 63.42 110.267 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.545 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -88.55 169.84 11.38 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.681 0.792 . . . . 72.11 111.767 175.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.7 m -136.89 134.54 36.95 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.165 -0.68 . . . . 52.54 109.165 171.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.79 105.69 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 123.127 0.571 . . . . 52.22 110.856 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.4 p -92.63 -15.76 26.42 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.31 0.644 . . . . 34.52 111.738 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.51 146.3 13.66 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.4 -0.28 . . . . 72.3 112.4 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.17 125.35 31.01 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.868 0.867 . . . . 41.21 109.544 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.601 ' HB2' HG23 ' A' ' 96' ' ' VAL . 58.1 m-85 -128.46 130.64 47.85 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.584 0.754 . . . . 72.44 110.816 -171.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -107.31 79.49 1.31 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 122.153 0.978 . . . . 70.01 110.073 174.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 t -133.43 162.61 31.4 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.186 -0.915 . . . . 64.01 110.425 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.8 m -65.89 119.9 12.12 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.833 0.453 . . . . 71.1 110.577 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.41 153.48 23.94 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.011 0.924 . . . . 71.32 109.846 -176.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -133.95 147.42 51.05 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.902 0.858 . . . . 64.5 112.078 -170.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.95 115.0 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 106.804 -1.554 . . . . 72.03 106.804 167.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.457 HG12 HD13 ' A' ' 88' ' ' ILE . 31.6 m -122.13 154.75 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-O 121.492 0.663 . . . . 71.35 112.751 -173.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 61.7 p -121.22 124.52 44.86 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.248 1.019 . . . . 75.04 109.667 173.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -142.64 154.59 44.51 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.308 0.643 . . . . 73.11 110.682 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.0 m -102.89 107.22 54.06 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.902 -1.147 . . . . 71.31 107.902 171.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.32 133.9 45.8 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.304 2.002 . . . . 74.03 111.326 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 72.8 p -68.66 -2.27 8.78 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.502 0.927 . . . . 73.12 113.502 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -64.24 -21.47 66.59 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.298 0.639 . . . . 75.14 111.087 165.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.57 29.73 38.72 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 114.981 0.752 . . . . 72.32 114.981 169.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.35 -109.03 1.55 Allowed Glycine 0 CA--C 1.537 1.439 0 CA-C-N 117.519 0.66 . . . . 64.33 112.9 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -109.6 141.33 42.28 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.943 0.897 . . . . 73.12 110.172 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -63.11 124.42 21.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.283 0.633 . . . . 74.34 111.182 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.645 HG21 ' SD ' ' A' ' 78' ' ' MET . 48.5 t -90.28 114.01 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.362 0.665 . . . . 73.42 109.985 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -105.96 151.52 24.5 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.017 0.527 . . . . 74.35 110.97 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.9 m80 55.72 29.99 14.8 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.213 1.005 . . . . 63.1 113.166 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.437 ' HB2' HG12 ' A' ' 46' ' ' VAL . 60.0 t60 -72.3 118.72 15.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.992 0.917 . . . . 72.41 110.43 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 59.2 pttt -133.06 146.8 52.01 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 115.929 -0.578 . . . . 75.04 111.629 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 92.7 m95 -110.83 152.46 26.64 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.446 -1.409 . . . . 75.12 112.209 0.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.16 136.41 60.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.1 -1.409 . . . . 52.32 107.747 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.456 HG21 HG21 ' A' ' 96' ' ' VAL . 39.9 pt -101.55 166.37 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.637 -0.664 . . . . 74.31 112.143 -172.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.86 -33.74 67.13 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.841 0.856 . . . . 72.51 111.88 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -71.94 -21.23 61.64 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.064 0.546 . . . . 72.15 112.422 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -83.08 -33.83 26.3 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.938 0.895 . . . . 74.15 110.948 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.0 mt -86.85 132.19 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.079 0.552 . . . . 74.45 110.984 -171.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.524 ' HB2' ' HG3' ' A' ' 74' ' ' GLU . 59.0 tttm -60.43 -43.67 96.54 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.998 0.919 . . . . 74.35 112.167 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.36 -7.63 50.63 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 123.775 0.83 . . . . 73.42 113.154 -174.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.511 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -33.98 -67.02 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.96 1.467 . . . . 40.33 114.96 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.81 25.7 70.71 Favored Glycine 0 N--CA 1.479 1.555 0 N-CA-C 114.956 0.742 . . . . 65.4 114.956 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 64.32 9.43 4.87 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.527 1.131 . . . . 63.41 113.231 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 24.8 pttm -109.66 167.59 10.04 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.457 0.703 . . . . 65.43 111.357 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 m -91.89 119.54 31.75 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.286 0.634 . . . . 73.24 110.225 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.61 HD13 HG11 ' A' ' 71' ' ' VAL . 44.6 mt -79.64 127.92 32.76 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.362 0.665 . . . . 61.52 110.8 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -89.46 153.37 48.24 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.671 0.788 . . . . 63.04 111.283 -173.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.27 115.39 2.26 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.423 2.082 . . . . 74.42 113.277 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.33 -19.39 14.86 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.534 -0.757 . . . . 74.33 113.608 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.04 130.82 47.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.381 0.673 . . . . 65.05 112.189 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -90.84 120.43 31.86 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.504 -0.771 . . . . 64.52 109.312 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.61 HG11 HD13 ' A' ' 65' ' ' LEU . 32.4 m -134.43 174.68 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 C-N-CA 124.367 1.067 . . . . 73.2 111.321 -171.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.31 141.95 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.895 0.878 . . . . 63.23 109.861 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 mt -96.96 131.04 44.16 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.641 0.777 . . . . 62.01 111.596 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.524 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 36.2 mt-10 -101.0 9.44 42.24 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 113.464 0.913 . . . . 75.25 113.464 175.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.38 165.85 17.64 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.379 0.672 . . . . 63.21 110.055 169.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.4 t -139.57 123.56 17.72 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.954 -0.567 . . . . 60.14 110.517 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -99.09 -5.43 30.25 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.912 0.885 . . . . 74.32 110.173 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.645 ' SD ' HG21 ' A' ' 46' ' ' VAL . 26.0 ptp -159.07 147.45 18.07 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.539 1.135 . . . . 63.31 109.682 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -53.77 121.74 8.51 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.117 0.567 . . . . 74.25 112.296 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.9 -15.91 54.94 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 119.361 -0.688 . . . . 53.54 114.572 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.0 ttt -64.01 -46.02 86.35 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.559 0.744 . . . . 63.02 112.781 -175.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -67.53 118.5 10.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.95 -0.389 . . . . 74.23 109.95 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 3.16 74.41 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 116.383 -0.371 . . . . 73.24 113.49 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.22 145.63 32.13 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.222 0.511 . . . . 42.04 110.341 172.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m -80.32 114.56 19.31 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 109.443 -0.577 . . . . 73.35 109.443 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.51 145.63 32.87 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.598 0.759 . . . . 74.33 111.257 -173.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -123.15 117.07 24.53 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.378 1.071 . . . . 65.33 109.135 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.457 HD13 HG12 ' A' ' 35' ' ' VAL . 28.2 mm -61.55 115.07 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.188 0.595 . . . . 72.44 111.028 -178.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -83.35 -36.46 24.36 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.821 0.449 . . . . 72.35 110.967 173.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.9 t -157.83 150.65 22.89 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.24 0.616 . . . . 72.21 111.745 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.81 131.64 56.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.19 0.996 . . . . 74.03 109.37 173.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -146.68 128.9 15.71 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.942 0.497 . . . . 72.25 111.739 -171.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -91.62 95.35 9.87 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.253 -0.647 . . . . 71.34 109.253 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.3 t -136.87 155.39 49.83 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.444 1.098 . . . . 60.41 110.202 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.4 m -80.94 120.0 24.19 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.887 -0.412 . . . . 75.44 109.887 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.601 HG23 ' HB2' ' A' ' 28' ' ' TYR . 9.0 m -104.68 132.45 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.317 0.647 . . . . 72.22 109.535 -177.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.56 135.02 51.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.36 1.064 . . . . 74.11 111.118 -176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.6 ttp -94.1 120.98 35.12 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.924 -1.139 . . . . 71.34 107.924 166.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.545 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 24.2 m -124.85 169.6 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 112.779 0.659 . . . . 73.03 112.779 -169.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -137.06 133.14 35.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.282 0.633 . . . . 72.34 110.909 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -143.32 177.61 8.31 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.853 0.861 . . . . 60.23 111.299 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.6 m -119.96 119.18 32.69 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 108.248 -1.019 . . . . 74.31 108.248 169.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.9 m -61.22 134.71 57.29 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.363 0.665 . . . . 60.32 112.396 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -65.18 -47.96 75.11 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.293 1.037 . . . . 72.21 112.176 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.4 p -75.67 -50.8 14.36 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.447 0.699 . . . . 53.42 112.052 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.8 m -75.38 -33.57 61.03 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.495 0.718 . . . . 75.21 112.677 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.37 11.92 79.88 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-N 116.543 -0.298 . . . . 71.43 113.498 -172.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -100.21 140.11 34.92 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.59 0.756 . . . . 71.3 111.239 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -81.1 115.57 20.6 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.634 0.773 . . . . 75.44 110.998 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.9 t -104.85 122.34 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.874 0.87 . . . . 63.42 109.534 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.77 160.7 17.07 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.014 0.526 . . . . 74.11 111.289 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.0 m120 56.5 28.89 14.45 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.133 0.973 . . . . 65.02 112.897 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -64.75 137.73 57.97 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.537 0.735 . . . . 63.42 111.888 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 8.0 ptpp? -155.56 148.42 24.33 Favored 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 123.513 0.725 . . . . 74.21 111.941 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 98.9 m95 -112.15 144.51 41.41 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.461 1.505 . . . . 73.01 112.536 -8.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.81 154.34 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.2 1.4 . . . . 65.24 109.048 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.3 p -117.33 177.7 4.64 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.812 0.445 . . . . 74.22 110.911 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -66.12 -14.28 61.52 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.469 0.708 . . . . 54.35 111.888 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.54 -35.4 65.52 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 122.971 0.508 . . . . 71.24 110.863 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -94.84 -5.08 45.88 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.021 0.528 . . . . 71.32 111.643 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 66.0 mt -108.24 134.41 51.12 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.851 0.834 . . . . 71.42 110.962 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.4 t -101.57 156.72 17.31 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.399 1.48 . . . . 75.52 108.925 170.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.68 160.73 15.48 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.637 0.375 . . . . 51.4 110.301 175.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.543 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 0.8 OUTLIER -111.7 159.33 18.33 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 110.081 -0.34 . . . . 75.15 110.081 174.385 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.3 mp 69.99 10.25 7.36 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 124.505 1.122 . . . . 63.44 112.086 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -82.51 169.35 16.45 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.652 0.781 . . . . 72.41 111.2 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -131.67 4.01 4.2 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.02 0.528 . . . . 73.52 112.377 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -84.42 71.63 10.68 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.402 1.096 . . . . 72.22 111.139 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -87.26 6.19 34.49 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.03 -0.986 . . . . 64.32 112.803 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -69.98 126.79 30.71 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 122.219 -0.3 . . . . 75.24 110.891 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 64.9 8.78 4.86 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.465 1.106 . . . . 71.24 111.585 -175.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 . . . . . 0 CA--C 1.566 1.565 0 C-N-CA 123.315 0.646 . . . . 63.52 111.747 -164.37 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 120.814 0.34 . . . . 72.23 111.865 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -120.46 174.37 6.58 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.639 0.776 . . . . 53.24 112.481 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.75 136.01 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 C-N-CA 123.844 0.858 . . . . 61.15 111.718 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.38 -9.76 75.48 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 115.825 -0.625 . . . . 64.2 113.702 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.8 t -83.65 142.14 31.0 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.149 0.579 . . . . 74.04 111.707 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -90.48 122.15 33.07 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.637 0.775 . . . . 64.34 110.318 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . 33.2 m -122.29 153.44 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.638 0.775 . . . . 71.33 111.886 -176.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.4 mm -104.56 123.79 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.333 1.053 . . . . 64.41 108.472 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.4 mt -77.21 125.25 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 120.967 0.413 . . . . 72.5 111.06 -172.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -89.19 -68.4 0.78 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.697 0.799 . . . . 54.01 109.725 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.0 m -98.8 144.64 27.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.941 0.897 . . . . 73.34 110.25 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 18' ' ' LYS . 84.8 p -159.28 152.7 22.56 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.704 0.631 . . . . 73.04 112.704 -172.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -85.82 -37.53 19.13 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.469 0.708 . . . . 64.44 110.309 168.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.462 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.4 mpt? -83.32 129.1 34.98 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.262 0.625 . . . . 73.43 110.259 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -30.8 71.05 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.611 0.967 . . . . 74.45 113.611 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.14 -9.1 70.9 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 114.023 0.369 . . . . 54.11 114.023 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 55.2 ttp -82.72 -28.65 30.36 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.901 0.481 . . . . 74.02 110.197 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 3.4 ttmp? -67.77 118.68 11.34 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.711 0.404 . . . . 62.32 111.134 173.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.95 2.07 86.45 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 116.134 -0.485 . . . . 65.11 113.553 -177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.97 152.17 29.64 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.108 0.563 . . . . 74.42 112.035 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -86.39 131.94 34.08 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.134 0.974 . . . . 75.52 110.359 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.55 173.86 11.08 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.728 0.811 . . . . 62.1 112.22 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.7 m -137.99 146.52 43.22 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.441 1.097 . . . . 74.14 108.754 170.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.5 t -79.75 117.95 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 122.756 0.423 . . . . 63.24 110.556 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.3 p -94.86 -18.3 21.3 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.51 0.724 . . . . 65.11 111.58 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.44 145.18 11.52 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 120.201 -0.222 . . . . 72.51 112.701 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.54 119.61 19.73 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.665 0.786 . . . . 74.15 110.725 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -130.18 149.67 51.78 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.315 1.046 . . . . 61.51 110.42 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -125.82 90.97 3.3 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.158 0.98 . . . . 63.24 109.965 167.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.0 t -135.19 177.46 7.79 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.282 -0.872 . . . . 72.33 111.144 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -73.35 110.26 7.5 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.528 0.68 . . . . 63.53 110.454 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.09 161.02 13.9 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.375 1.47 . . . . 51.12 109.918 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -138.59 144.64 39.9 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.567 0.747 . . . . 74.5 111.606 -172.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.9 110.96 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 107.048 -1.464 . . . . 72.45 107.048 164.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.547 ' HB ' ' HB1' ' A' ' 86' ' ' ALA . 21.1 m -112.16 144.09 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.378 0.609 . . . . 73.01 112.231 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 p -116.65 128.24 55.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.204 1.002 . . . . 62.32 109.634 173.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -151.17 158.29 43.77 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.94 0.496 . . . . 71.42 111.386 -169.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.2 m -108.15 117.06 55.8 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 109.008 -0.738 . . . . 74.43 109.008 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -60.77 124.04 14.19 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.656 2.237 . . . . 74.12 111.887 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -63.05 -14.45 48.26 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.575 1.324 . . . . 71.12 114.575 -168.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.463 HD22 ' N ' ' A' ' 41' ' ' ASN . 0.8 OUTLIER -85.73 11.35 11.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.532 0.733 . . . . 45.11 112.718 -176.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.46 53.15 3.93 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 120.977 0.209 . . . . 62.25 112.9 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.34 168.91 13.91 Favored Glycine 0 N--CA 1.476 1.312 0 C-N-CA 122.96 0.314 . . . . 64.21 112.854 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -58.75 135.36 57.43 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.33 0.652 . . . . 75.03 111.331 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -56.59 136.5 54.55 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-O 121.186 0.517 . . . . 71.31 111.065 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.478 HG21 ' SD ' ' A' ' 78' ' ' MET . 57.8 t -86.72 103.13 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.246 0.618 . . . . 41.24 109.709 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.69 108.7 14.56 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.902 0.881 . . . . 54.22 110.828 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.2 m170 57.7 79.11 0.21 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.152 0.981 . . . . 73.44 112.992 176.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -94.29 109.67 21.48 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.125 0.97 . . . . 73.02 109.671 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 22.2 pttp -121.01 140.16 52.3 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.286 0.235 . . . . 52.32 111.551 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 79.6 m95 -117.83 158.33 25.01 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.054 1.342 . . . . 74.32 112.478 2.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.49 143.67 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 113.183 -1.826 . . . . 72.41 107.18 167.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.505 HG13 ' H ' ' A' ' 55' ' ' GLU . 29.8 pt -106.93 179.56 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.678 -0.639 . . . . 72.3 109.676 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -48.71 -33.9 11.0 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.205 1.002 . . . . 64.51 113.093 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.505 ' H ' HG13 ' A' ' 53' ' ' ILE . 28.5 tt0 -69.78 -23.96 63.43 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.072 0.949 . . . . 74.14 113.493 -175.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.2 -10.78 59.56 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 112.553 0.575 . . . . 73.31 112.553 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.1 mt -113.18 134.22 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 123.433 0.693 . . . . 63.0 111.808 -169.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.432 ' HB2' ' HG3' ' A' ' 74' ' ' GLU . 40.8 ttmt -67.82 -46.37 72.06 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.025 0.93 . . . . 73.55 111.999 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -62.84 -22.28 66.56 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.802 0.841 . . . . 74.3 112.675 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -35.79 -57.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.292 1.59 . . . . 50.34 115.292 -171.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.85 19.48 67.55 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 115.984 1.154 . . . . 75.11 115.984 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 t70 61.84 15.77 7.38 Favored 'General case' 0 CA--C 1.572 1.806 0 C-N-CA 124.959 1.304 . . . . 75.34 112.212 -172.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 22.9 pttm -107.59 160.15 15.9 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.787 0.835 . . . . 53.41 109.771 175.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 p -76.88 128.16 34.05 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 110.034 -0.358 . . . . 62.44 110.034 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.572 HD13 HG11 ' A' ' 71' ' ' VAL . 38.7 mt -87.95 136.51 32.93 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.696 -0.483 . . . . 65.2 109.696 170.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -105.89 153.49 40.05 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.58 0.752 . . . . 72.42 110.593 -173.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.83 130.37 40.02 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 122.538 2.159 . . . . 75.32 112.427 171.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.86 -22.61 29.6 Favored Glycine 0 N--CA 1.479 1.507 0 N-CA-C 113.992 0.357 . . . . 43.23 113.992 -175.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -73.14 157.18 37.72 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.255 0.527 . . . . 65.43 112.226 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -125.7 135.48 52.14 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.576 -0.738 . . . . 70.23 109.737 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.572 HG11 HD13 ' A' ' 65' ' ' LEU . 36.0 m -138.79 -178.36 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 125.41 1.484 . . . . 75.02 110.355 -167.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.3 mt -128.22 140.94 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.315 0.646 . . . . 71.31 110.252 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.2 mt -90.33 130.22 36.46 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.275 1.03 . . . . 72.41 111.622 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 43.0 mt-10 -91.31 -12.97 33.47 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.218 0.607 . . . . 70.52 112.192 169.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.93 160.66 14.23 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.271 0.628 . . . . 72.51 111.193 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.818 ' HB2' ' HB2' ' A' ' 82' ' ' LYS . 10.4 t -140.2 125.9 19.29 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.691 0.396 . . . . 64.15 110.324 178.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -113.41 0.74 14.85 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.466 0.706 . . . . 74.04 110.723 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.478 ' SD ' HG21 ' A' ' 46' ' ' VAL . 23.7 ptp -157.57 167.38 30.33 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.814 0.845 . . . . 74.43 111.515 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -63.89 101.61 0.39 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.073 0.949 . . . . 64.21 111.901 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.77 23.92 9.63 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-O 119.733 -0.482 . . . . 40.52 114.101 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.4 ttt -93.23 -39.46 10.99 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 117.664 0.732 . . . . 74.32 111.689 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.818 ' HB2' ' HB2' ' A' ' 76' ' ' SER . 60.7 tttm -67.76 119.73 12.95 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.443 0.297 . . . . 64.32 110.389 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.33 -8.44 75.16 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 123.462 0.476 . . . . 54.5 113.149 -176.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.54 146.97 36.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.055 0.542 . . . . 65.32 111.612 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.0 m -86.31 119.72 26.88 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.734 -0.666 . . . . 71.24 110.069 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.547 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -112.62 149.3 33.01 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.89 0.876 . . . . 72.25 110.653 -177.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -118.43 126.47 52.13 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.939 0.496 . . . . 74.24 110.261 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.409 HD13 HG12 ' A' ' 35' ' ' VAL . 25.8 mm -68.36 102.56 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 123.456 0.702 . . . . 64.14 110.276 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -71.79 -39.35 69.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.187 0.595 . . . . 55.33 110.166 173.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 t -154.98 147.93 24.62 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.05 -0.977 . . . . 61.44 111.286 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.78 132.96 42.82 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.0 0.92 . . . . 61.54 109.924 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -148.38 142.25 25.76 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.303 0.641 . . . . 72.52 110.803 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.03 94.6 9.7 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.427 -1.323 . . . . 71.11 107.427 172.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.3 t -134.81 156.81 48.23 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.927 0.891 . . . . 54.55 111.103 -171.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 93.5 m -79.95 120.24 23.89 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.934 0.494 . . . . 75.41 110.614 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.86 134.49 58.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.037 0.935 . . . . 72.53 110.239 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.48 ' HE2' ' HB2' ' A' ' 118' ' ' GLU . 98.2 m-85 -110.32 135.83 50.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.041 0.936 . . . . 73.32 112.004 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 52.8 ttp -90.26 121.07 31.94 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 107.844 -1.169 . . . . 63.33 107.844 167.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.14 145.63 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 113.17 0.804 . . . . 60.52 113.17 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -106.77 120.47 42.09 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.732 0.813 . . . . 72.32 109.747 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -127.44 165.56 19.59 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.374 0.607 . . . . 75.02 112.077 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.8 m -104.02 108.64 20.08 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.768 -0.827 . . . . 73.44 108.768 171.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.1 t -62.21 107.44 0.89 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.286 0.634 . . . . 62.34 110.682 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.7 p -59.24 -31.8 69.4 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.148 0.979 . . . . 73.22 113.142 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 t -76.49 -13.17 60.12 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.035 0.934 . . . . 72.12 112.958 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 t -123.82 -43.96 2.1 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.4 0.68 . . . . 75.42 112.663 -172.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.8 -18.47 57.19 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 116.5 -0.318 . . . . 54.12 112.436 -166.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.41 137.15 44.46 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.22 1.008 . . . . 73.42 111.493 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -91.31 118.2 30.3 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 121.322 0.582 . . . . 72.21 110.263 174.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.8 t -104.37 119.09 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.946 0.898 . . . . 64.54 108.616 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -103.63 153.29 20.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.559 0.344 . . . . 74.3 111.68 -169.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 53.73 42.42 31.81 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.541 1.137 . . . . 75.43 114.03 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -58.91 134.36 56.86 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.245 1.018 . . . . 72.3 111.903 175.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 62.1 mttp -132.3 132.12 42.67 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.093 0.957 . . . . 62.3 111.167 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 99.8 m95 -119.19 153.9 34.2 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.258 -1.526 . . . . 73.23 111.603 -15.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.36 158.15 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 114.524 -1.216 . . . . 61.11 108.831 168.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.9 p -105.84 175.51 5.47 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.251 0.548 . . . . 74.13 111.712 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.48 ' HB2' ' HE2' ' A' ' 97' ' ' TYR . 34.8 tt0 -67.54 -26.6 66.39 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.924 -0.58 . . . . 75.23 110.727 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.13 -29.13 70.55 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 123.982 0.913 . . . . 73.04 111.418 171.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -98.39 3.61 48.49 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.077 0.951 . . . . 65.12 112.715 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.93 142.55 51.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.351 0.66 . . . . 74.41 111.367 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 65.5 p -130.09 119.64 23.38 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.32 1.048 . . . . 75.2 108.297 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -85.69 105.02 15.94 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.919 0.782 . . . . 63.45 112.495 -167.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.5 tptm 64.62 -59.49 0.23 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.229 1.937 . . . . 75.21 116.229 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -55.01 144.2 24.14 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.294 1.037 . . . . 71.12 113.674 -169.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 129' ' ' HIS . 25.5 mm-40 57.61 26.37 12.77 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 124.64 1.176 . . . . 73.41 113.877 175.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -51.6 150.52 3.75 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.666 0.786 . . . . 74.12 112.537 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 80.94 4.44 1.55 Allowed 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 125.514 1.526 . . . . 72.23 110.778 -163.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.427 ' HB2' ' O ' ' A' ' 126' ' ' GLU . 27.8 t-80 -66.09 95.74 0.29 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.315 1.046 . . . . 73.45 110.095 174.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -65.78 144.82 56.63 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.951 0.5 . . . . 65.14 111.879 -177.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -157.29 153.98 28.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.348 0.659 . . . . 70.51 111.166 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.5 m80 . . . . . 0 CA--C 1.562 1.427 0 C-N-CA 123.774 0.83 . . . . 72.32 111.94 -174.921 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.1 tpp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.08 -0.341 . . . . 74.23 110.08 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -78.51 155.92 29.54 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.511 0.672 . . . . 71.24 112.693 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.07 122.87 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-N 115.331 -0.85 . . . . 65.34 109.593 165.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.71 41.85 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-N 115.869 -0.605 . . . . 50.42 113.583 -175.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.9 m -74.85 136.43 41.54 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.091 0.556 . . . . 55.15 111.721 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -94.12 125.16 38.59 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.931 0.893 . . . . 44.11 109.63 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.28 153.43 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.393 0.677 . . . . 41.23 112.635 -168.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.3 mm -98.37 125.44 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 124.679 1.192 . . . . 65.54 109.931 172.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 22' ' ' ALA . 41.4 mt -87.28 125.4 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.19 0.596 . . . . 70.5 111.223 -176.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -98.66 -59.02 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.381 0.672 . . . . 74.35 111.063 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.6 m -94.44 144.57 25.45 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.692 0.797 . . . . 33.42 109.448 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 17' ' ' MET . 77.2 p -149.88 144.46 25.94 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.112 0.482 . . . . 71.51 111.574 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -92.42 -24.43 18.86 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.809 0.844 . . . . 74.01 110.465 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.415 ' H ' ' HE2' ' A' ' 17' ' ' MET . 23.2 mmt -95.97 134.47 38.94 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.688 0.795 . . . . 71.4 109.316 169.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.438 ' HG2' HG21 ' A' ' 105' ' ' THR . 62.5 tttp -59.01 -44.25 91.65 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.732 0.813 . . . . 71.34 112.728 -175.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.98 -0.26 64.43 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 114.889 0.715 . . . . 63.02 114.889 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.513 ' HB3' ' HB2' ' A' ' 12' ' ' SER . 41.1 ttp -91.47 -24.84 19.55 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.725 0.763 . . . . 71.02 111.235 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -67.02 121.83 16.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.916 0.487 . . . . 73.11 111.282 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.58 1.71 90.54 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 115.837 -0.62 . . . . 60.11 114.297 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.34 146.46 36.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.043 0.537 . . . . 72.53 111.206 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -95.75 99.59 11.4 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.36 -0.607 . . . . 65.42 109.36 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 9' ' ' ILE . . . -91.15 175.98 6.75 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.717 0.807 . . . . 51.54 112.724 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.9 m -136.13 138.67 42.26 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.118 -1.067 . . . . 72.32 108.118 169.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.4 t -83.45 126.88 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.213 0.605 . . . . 70.22 110.398 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.6 p -113.44 -2.07 14.02 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.406 0.682 . . . . 61.5 112.102 170.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.5 136.03 4.67 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 118.365 0.53 . . . . 75.34 113.004 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.01 107.68 13.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.848 0.859 . . . . 62.23 109.768 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -108.95 120.33 42.21 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.678 0.791 . . . . 73.42 110.669 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.94 87.01 3.18 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 108.644 -0.872 . . . . 71.54 108.644 174.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -137.24 174.95 10.06 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 112.858 0.688 . . . . 63.23 112.858 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.3 m -82.87 124.98 30.84 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.743 0.817 . . . . 74.21 110.306 172.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.02 120.4 37.11 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.187 0.995 . . . . 71.51 110.297 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -92.22 149.75 21.28 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.765 0.826 . . . . 74.32 112.538 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.96 111.61 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 107.764 -1.199 . . . . 65.43 107.764 170.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.52 HG12 HD13 ' A' ' 88' ' ' ILE . 27.1 m -114.3 165.72 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 112.869 0.692 . . . . 63.11 112.869 -172.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -135.68 123.88 23.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.829 0.852 . . . . 70.32 109.438 173.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -150.52 154.36 37.46 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 122.116 -0.365 . . . . 73.03 111.61 -170.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.3 m -104.52 115.32 63.02 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 107.856 -1.164 . . . . 63.34 107.856 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.95 133.22 56.53 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.628 2.218 . . . . 74.01 112.471 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.4 p -63.22 -14.64 51.5 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.27 1.028 . . . . 64.14 112.459 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -62.64 -17.69 60.89 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 124.333 1.053 . . . . 54.14 112.598 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.26 60.09 2.3 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 112.453 -0.259 . . . . 73.21 112.453 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 -152.31 8.04 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 115.626 -0.287 . . . . 74.22 113.695 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -81.2 126.92 32.1 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.222 0.609 . . . . 74.33 109.98 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.83 112.57 1.2 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.069 0.461 . . . . 64.23 110.452 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.431 HG21 ' SD ' ' A' ' 78' ' ' MET . 15.1 t -80.84 104.15 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.65 -0.704 . . . . 74.12 109.64 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -101.12 150.72 22.64 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.988 0.515 . . . . 53.41 109.942 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.1 m80 56.54 29.23 15.13 Favored 'General case' 0 CA--C 1.559 1.317 0 O-C-N 124.089 0.868 . . . . 70.21 111.754 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -61.99 127.46 31.5 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.948 0.899 . . . . 73.32 111.739 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 97.8 mttt -132.61 141.68 48.79 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.386 1.074 . . . . 65.42 109.947 -178.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 93.8 m95 -113.02 134.53 54.47 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 120.418 -1.426 . . . . 75.22 111.273 -7.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.75 148.36 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.456 -0.942 . . . . 72.3 108.456 169.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.8 pt -111.51 166.74 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 120.806 0.336 . . . . 64.5 110.983 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -53.15 -34.71 58.01 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.131 0.972 . . . . 73.11 113.405 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.6 -18.66 60.53 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 123.634 0.774 . . . . 73.22 112.382 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -90.5 1.31 56.8 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.255 0.622 . . . . 75.23 111.899 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.473 ' HB ' ' HB2' ' A' ' 60' ' ' ALA . 55.0 mt -121.62 125.37 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 124.059 0.944 . . . . 74.11 109.751 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -68.62 -54.48 16.2 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 118.193 0.451 . . . . 65.53 112.024 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.19 -4.33 17.17 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.183 0.809 . . . . 62.4 113.183 -177.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.475 ' HA ' HD11 ' A' ' 65' ' ' LEU . . . -54.78 -30.4 56.67 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.995 0.739 . . . . 63.32 112.995 172.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.14 14.84 66.73 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 114.828 0.691 . . . . 74.35 114.828 170.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 59.31 23.14 11.55 Favored 'General case' 0 CA--C 1.566 1.565 0 C-N-CA 124.51 1.124 . . . . 75.23 112.016 -172.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 65.1 pttt -120.56 171.54 8.49 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.362 1.065 . . . . 74.04 111.341 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.3 m -77.36 109.35 11.2 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.273 0.629 . . . . 64.4 110.078 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.494 ' HB3' HG13 ' A' ' 88' ' ' ILE . 86.9 mt -78.34 121.28 24.26 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.949 0.5 . . . . 75.2 110.784 174.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -88.97 150.7 45.91 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.891 0.876 . . . . 72.32 109.94 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 88.0 Cg_exo -50.49 121.98 8.75 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.341 2.028 . . . . 71.25 113.239 173.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.93 -21.03 12.63 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-O 119.457 -0.635 . . . . 52.42 114.151 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -69.19 133.17 47.64 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.227 1.014 . . . . 53.2 111.936 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -100.37 121.43 41.5 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.388 0.675 . . . . 75.43 109.564 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.94 165.33 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.8 1.24 . . . . 64.03 110.982 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.93 137.95 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.897 -0.502 . . . . 62.15 111.186 175.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.8 mt -85.44 122.05 29.03 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.208 1.003 . . . . 61.14 111.203 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -87.54 -17.61 31.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.382 0.512 . . . . 60.52 112.382 171.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -88.51 162.67 16.3 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.333 0.587 . . . . 44.3 111.108 170.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -142.49 124.89 15.62 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.686 -0.688 . . . . 63.14 110.085 173.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -104.14 -4.19 23.48 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 123.789 0.836 . . . . 72.45 110.841 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.431 ' SD ' HG21 ' A' ' 46' ' ' VAL . 24.4 ptp -154.69 -179.16 7.74 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.3 0.64 . . . . 73.53 112.433 -173.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.69 108.97 0.71 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.817 0.847 . . . . 75.04 112.438 174.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.65 24.38 67.67 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 115.026 0.77 . . . . 61.52 115.026 172.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.8 ttt -75.91 -42.31 49.3 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.801 0.8 . . . . 62.54 111.551 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.33 123.74 21.2 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 120.506 0.193 . . . . 73.21 110.69 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.5 -18.34 57.12 Favored Glycine 0 N--CA 1.471 0.97 0 CA-C-N 116.206 -0.452 . . . . 62.52 113.12 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.12 137.23 56.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.243 0.617 . . . . 71.34 111.743 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.7 m -73.48 111.09 8.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.378 0.671 . . . . 73.23 110.519 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.26 147.61 27.29 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.165 0.986 . . . . 62.4 110.419 -175.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -130.35 129.18 42.82 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 108.79 -0.819 . . . . 75.14 108.79 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.52 HD13 HG12 ' A' ' 35' ' ' VAL . 47.1 mm -74.1 112.72 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.865 0.866 . . . . 73.14 111.54 -170.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.58 -41.42 27.19 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.068 0.947 . . . . 74.4 110.582 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.5 t -163.27 172.24 15.0 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 115.681 -0.69 . . . . 74.44 111.345 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.42 132.16 24.1 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.078 0.951 . . . . 51.5 110.609 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -125.97 141.52 51.93 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.583 0.753 . . . . 73.0 112.329 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -100.5 95.35 6.66 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.452 -1.314 . . . . 70.22 107.452 163.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.9 t -136.42 154.8 50.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.072 0.949 . . . . 72.23 110.6 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.9 p -78.33 124.05 27.67 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.532 -0.544 . . . . 70.34 109.532 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.83 133.01 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.87 0.868 . . . . 60.14 108.734 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -115.1 152.83 31.84 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.723 0.773 . . . . 73.4 112.487 -170.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.459 ' SD ' ' HE3' ' A' ' 114' ' ' LYS . 59.1 ttp -100.57 112.4 24.77 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.496 -1.229 . . . . 63.43 108.134 171.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.429 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 29.7 m -120.89 151.82 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 112.543 0.571 . . . . 74.24 112.543 -172.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.67 117.09 28.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.283 1.033 . . . . 74.54 108.97 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -136.87 175.66 9.41 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.247 0.619 . . . . 71.12 111.385 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.3 m -107.63 126.08 52.13 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.728 -0.842 . . . . 74.34 108.728 169.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.8 t -60.87 108.06 0.8 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.919 0.488 . . . . 64.32 110.526 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.0 p -58.88 -24.31 62.07 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.367 1.067 . . . . 72.23 112.887 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.438 HG21 ' HG2' ' A' ' 15' ' ' LYS . 71.1 p -87.96 -60.04 2.08 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 123.325 0.65 . . . . 70.23 112.151 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.8 p -84.57 -37.17 21.51 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.421 0.526 . . . . 65.52 112.421 -173.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.08 -2.16 51.33 Favored Glycine 0 N--CA 1.48 1.604 0 CA-C-N 116.453 -0.339 . . . . 63.24 113.151 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.73 128.28 35.89 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.461 0.704 . . . . 64.24 111.895 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -75.52 96.84 3.58 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.045 -0.724 . . . . 62.5 109.045 174.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.72 114.49 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.191 0.597 . . . . 70.1 109.799 -175.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.558 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -112.02 144.77 40.83 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 120.986 0.422 . . . . 73.21 111.376 -175.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.0 m120 56.3 36.92 28.29 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.794 1.238 . . . . 64.02 113.152 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -64.54 137.95 58.13 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.505 0.722 . . . . 65.34 112.265 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 115' ' ' TRP . 99.7 mttt -138.88 144.19 39.05 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 124.487 1.115 . . . . 73.42 110.638 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 98.5 m95 -110.2 142.62 41.49 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.539 1.536 . . . . 73.52 112.263 -11.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.57 154.41 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.225 1.01 . . . . 63.4 109.147 166.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.4 p -100.82 177.5 4.96 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.289 0.495 . . . . 71.03 112.26 173.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -69.3 -43.13 74.43 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.049 0.54 . . . . 63.24 111.197 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.33 -14.95 62.8 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.556 0.742 . . . . 64.22 111.466 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.08 -21.84 56.28 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.228 1.011 . . . . 72.44 110.149 176.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.0 mt -117.18 178.49 4.34 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.968 1.307 . . . . 63.4 109.92 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.3 m -155.31 150.37 26.79 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.019 1.328 . . . . 52.11 107.81 166.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.98 164.02 26.37 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.535 0.607 . . . . 74.33 112.586 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.578 ' HG3' ' HG ' ' A' ' 125' ' ' LEU . 56.5 tptt -68.85 142.82 54.73 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.5 0.72 . . . . 55.03 111.416 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.578 ' HG ' ' HG3' ' A' ' 124' ' ' LYS . 96.3 mt 65.58 28.3 11.35 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 124.601 1.16 . . . . 65.53 113.216 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.7 -177.76 3.89 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.576 0.954 . . . . 60.31 113.576 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -61.66 143.72 55.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.295 1.038 . . . . 71.24 111.588 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -98.16 88.8 4.3 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.009 0.524 . . . . 73.14 111.054 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -107.76 94.49 5.11 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.413 0.685 . . . . 71.13 110.997 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -69.96 132.95 46.74 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.019 0.928 . . . . 73.22 112.8 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -144.62 142.6 30.25 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.869 1.267 . . . . 74.2 109.414 174.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 112.45 0.537 . . . . 53.14 112.45 -176.81 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.432 -0.581 . . . . 74.45 109.432 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -73.54 133.51 43.59 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.22 0.608 . . . . 72.45 112.152 -174.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.0 124.2 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 115.925 -0.579 . . . . 71.24 110.177 169.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.3 1.69 38.23 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.895 -0.593 . . . . 62.34 113.195 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.0 t -78.87 136.21 37.23 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.39 0.676 . . . . 73.12 111.591 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -87.71 110.74 20.66 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.005 -0.739 . . . . 64.23 109.005 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.21 160.0 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-O 121.63 0.728 . . . . 71.51 112.464 -168.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.59 137.53 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.12 0.968 . . . . 64.11 109.047 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' A' ' 20' ' ' ALA . 60.9 mt -79.46 118.87 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 109.684 -0.487 . . . . 73.41 109.684 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -77.66 -42.5 34.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.786 0.834 . . . . 74.03 110.48 -176.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.8 m -142.34 147.74 36.81 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.466 1.106 . . . . 61.42 110.142 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.444 ' HB2' ' HE2' ' A' ' 17' ' ' MET . 76.7 p -155.14 157.47 37.48 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.119 0.485 . . . . 75.14 111.599 173.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -84.15 -17.79 38.88 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.007 -0.997 . . . . 74.51 110.705 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.468 ' N ' ' SD ' ' A' ' 14' ' ' MET . 1.4 mpt? -86.88 168.22 13.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.765 0.826 . . . . 64.41 110.131 169.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -87.8 -50.08 6.7 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.112 0.482 . . . . 62.04 110.685 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.21 -13.2 79.7 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 115.086 0.794 . . . . 74.22 115.086 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.444 ' HE2' ' HB2' ' A' ' 12' ' ' SER . 47.4 ttp -89.01 -29.32 19.57 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.135 0.467 . . . . 72.14 111.315 -176.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -69.09 122.04 17.94 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.61 0.364 . . . . 60.11 111.331 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.43 1.6 89.27 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.981 -0.554 . . . . 63.11 113.501 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.47 ' HB3' HD12 ' A' ' 9' ' ' ILE . . . -72.73 146.84 46.14 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.626 0.602 . . . . 50.12 112.626 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.84 98.84 4.97 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.363 0.665 . . . . 74.43 110.152 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -103.11 169.48 8.53 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.782 0.833 . . . . 63.44 112.307 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.5 m -141.05 134.59 30.0 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.57 -0.741 . . . . 71.51 109.195 168.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.23 114.05 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.914 0.486 . . . . 74.4 110.077 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.3 p -106.51 -4.12 20.1 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.063 0.545 . . . . 73.41 112.403 175.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.14 150.43 18.77 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-O 120.148 -0.251 . . . . 53.14 112.805 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.73 113.08 14.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.124 0.969 . . . . 71.01 110.336 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -114.17 115.76 28.0 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.793 0.837 . . . . 72.45 110.522 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -99.71 88.0 3.7 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 109.057 -0.72 . . . . 65.34 109.057 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.401 HG21 HD12 ' A' ' 53' ' ' ILE . 6.0 t -136.45 168.19 19.93 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.641 1.176 . . . . 64.22 111.133 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.7 m -75.31 129.93 38.22 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.886 -0.412 . . . . 63.02 109.886 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.7 154.93 20.76 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.751 0.821 . . . . 64.23 109.629 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -134.96 147.18 49.69 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.95 0.881 . . . . 72.32 112.129 -173.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.72 111.39 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 113.804 -1.544 . . . . 71.33 107.784 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.533 HG12 HD13 ' A' ' 88' ' ' ILE . 29.0 m -116.11 147.36 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.363 0.601 . . . . 75.51 112.214 -175.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -121.96 125.69 46.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.335 1.054 . . . . 71.52 110.057 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -147.1 158.49 43.95 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.431 0.692 . . . . 71.43 110.878 -172.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.6 m -109.87 111.46 58.66 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 108.824 -0.806 . . . . 72.33 108.824 174.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -46.82 118.29 2.6 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.719 2.946 . . . . 74.51 114.304 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.0 p -59.29 -24.68 63.48 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.903 1.281 . . . . 75.25 113.411 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -79.91 11.21 3.46 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 123.329 0.652 . . . . 73.23 112.107 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.03 51.61 3.72 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 121.97 -0.456 . . . . 73.25 112.729 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.53 163.89 12.39 Favored Glycine 0 C--N 1.344 0.991 0 N-CA-C 113.623 0.209 . . . . 42.14 113.623 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -60.19 132.91 55.4 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.398 0.679 . . . . 72.54 111.135 174.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.05 116.65 3.12 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.753 0.821 . . . . 74.32 111.626 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.46 HG21 ' SD ' ' A' ' 78' ' ' MET . 39.9 t -87.4 111.62 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 C-N-CA 123.77 0.828 . . . . 74.35 109.657 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -104.32 138.78 40.25 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.682 0.793 . . . . 72.01 110.253 -173.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 54.42 40.48 31.81 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.151 0.98 . . . . 51.55 113.178 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.432 ' HB2' HG12 ' A' ' 46' ' ' VAL . 42.7 t60 -66.62 129.2 39.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.683 0.793 . . . . 62.52 111.118 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 47.4 mtmt -135.48 151.42 50.36 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 123.793 0.837 . . . . 73.34 110.482 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 84.7 m95 -111.86 137.39 49.88 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.446 1.499 . . . . 71.44 112.293 -4.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.06 138.48 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.872 1.269 . . . . 73.33 108.002 169.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.401 HD12 HG21 ' A' ' 30' ' ' THR . 34.0 pt -106.59 170.84 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.705 -0.622 . . . . 51.21 111.617 -176.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -57.27 -35.17 69.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.744 0.818 . . . . 65.24 112.721 178.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -71.14 -25.07 62.41 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 123.35 0.66 . . . . 65.14 111.691 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -86.72 -12.2 48.94 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 124.034 0.933 . . . . 74.41 112.102 -172.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.7 mt -107.88 137.96 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 124.062 0.945 . . . . 73.11 110.906 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -72.27 -54.01 10.82 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.301 0.64 . . . . 62.11 112.353 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.59 -10.2 17.26 Favored 'General case' 0 CA--C 1.568 1.667 0 C-N-CA 123.961 0.904 . . . . 62.0 113.156 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -52.56 -65.89 0.48 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.714 0.806 . . . . 44.32 112.608 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.51 28.66 72.78 Favored Glycine 0 N--CA 1.478 1.485 0 N-CA-C 114.998 0.759 . . . . 71.25 114.998 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.38 13.66 6.22 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 124.191 0.996 . . . . 54.23 112.895 -171.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 60' ' ' ALA . 5.8 ttpm? -94.27 143.59 26.26 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.897 1.279 . . . . 75.01 110.218 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.6 m -71.48 109.27 5.34 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.139 0.576 . . . . 74.45 110.009 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.626 HD13 HG11 ' A' ' 71' ' ' VAL . 53.1 mt -78.74 128.58 33.61 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.438 0.695 . . . . 71.11 110.009 178.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -119.26 157.29 51.51 Favored Pre-proline 0 N--CA 1.487 1.376 0 C-N-CA 123.714 0.806 . . . . 71.42 110.315 -167.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -49.72 118.87 4.11 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.219 2.612 . . . . 43.4 114.308 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.95 -22.3 25.82 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 123.161 0.41 . . . . 75.45 113.875 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.55 138.62 51.12 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.529 0.664 . . . . 63.31 111.712 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -102.11 122.19 43.65 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.333 0.653 . . . . 72.12 110.569 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.626 HG11 HD13 ' A' ' 65' ' ' LEU . 30.2 m -120.98 166.74 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.059 0.944 . . . . 63.2 112.244 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.3 mm -110.97 135.47 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.845 0.858 . . . . 71.44 110.107 173.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.7 mt -96.07 114.55 26.27 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.963 0.905 . . . . 75.12 111.118 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -78.33 -34.68 48.39 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.306 0.642 . . . . 72.04 111.425 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.66 165.13 18.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.312 0.645 . . . . 54.52 111.712 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 82' ' ' LYS . 51.0 p -143.59 125.91 15.66 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.231 -0.895 . . . . 61.22 110.779 173.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -99.67 1.13 43.2 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.988 0.915 . . . . 72.43 109.694 167.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.46 ' SD ' HG21 ' A' ' 46' ' ' VAL . 23.5 ptp -156.02 166.24 34.04 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.332 1.053 . . . . 73.41 111.353 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -54.14 -32.15 54.43 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 115.456 1.65 . . . . 51.15 115.456 -169.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.29 26.64 6.31 Favored Glycine 0 N--CA 1.484 1.853 0 CA-C-N 118.054 0.388 . . . . 54.21 114.01 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.7 ttt -89.82 -41.62 11.73 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 117.185 0.492 . . . . 72.13 112.071 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 88.4 tttt -67.52 120.68 14.37 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 122.354 -0.216 . . . . 63.44 110.634 173.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.1 76.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.232 -0.44 . . . . 75.32 112.504 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.0 145.6 35.87 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-O 121.428 0.632 . . . . 74.25 111.696 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.5 m -88.27 122.5 31.87 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.779 -1.101 . . . . 70.13 109.0 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -118.74 162.89 17.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.893 0.877 . . . . 64.54 110.773 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -131.91 128.25 38.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.779 0.832 . . . . 54.14 109.815 175.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.546 HG13 ' HB3' ' A' ' 65' ' ' LEU . 31.3 mm -66.48 116.42 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.646 0.779 . . . . 74.34 110.491 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -82.08 -36.75 27.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.487 0.715 . . . . 72.23 111.201 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.9 t -161.9 151.75 16.61 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.567 -0.742 . . . . 74.41 111.258 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.89 130.69 56.94 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.919 0.888 . . . . 61.24 109.353 172.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -134.68 119.97 18.94 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.211 0.604 . . . . 71.4 110.295 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.462 ' H ' ' HD2' ' A' ' 93' ' ' LYS . 6.8 mptt -90.31 93.79 9.48 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.173 -1.047 . . . . 74.22 108.173 -177.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.3 t -136.99 154.03 50.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.337 0.655 . . . . 74.53 110.945 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.8 m -80.77 128.11 33.28 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.146 -0.687 . . . . 63.44 109.146 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 m -120.53 135.71 59.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.572 1.149 . . . . 74.24 108.801 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.592 ' HE1' ' HB2' ' A' ' 118' ' ' GLU . 82.7 m-85 -109.72 157.27 19.29 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.108 0.956 . . . . 74.33 112.738 -171.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.526 ' SD ' ' HE3' ' A' ' 114' ' ' LYS . 35.7 ttp -100.28 117.59 34.81 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.071 -1.422 . . . . 73.42 107.699 165.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.7 m -125.07 148.25 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-O 121.37 0.605 . . . . 71.33 111.784 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.62 116.05 31.25 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.294 -1.002 . . . . 63.32 108.294 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -127.05 170.34 12.43 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.325 0.583 . . . . 75.43 111.978 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 m -112.07 111.2 21.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.205 -0.907 . . . . 75.4 109.071 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.8 m -57.21 96.82 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.209 -0.663 . . . . 45.41 109.209 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 52.0 p -56.83 -47.1 81.1 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.044 1.127 . . . . 74.13 114.044 -166.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.3 t -72.72 -32.23 65.56 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.392 0.515 . . . . 74.53 112.392 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.4 m -87.14 -26.93 23.37 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.545 0.738 . . . . 64.24 112.256 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.33 -22.2 10.98 Favored Glycine 0 CA--C 1.545 1.951 0 CA-C-N 116.004 -0.544 . . . . 73.23 114.313 -172.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -71.22 136.64 48.13 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.622 0.769 . . . . 52.44 112.094 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.33 131.63 44.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.629 0.771 . . . . 71.53 110.673 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.5 t -115.01 128.21 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.339 1.056 . . . . 53.24 109.302 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -107.19 143.44 35.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.006 0.522 . . . . 72.04 111.09 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.6 m120 58.78 39.5 24.09 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.281 1.432 . . . . 73.52 113.431 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -69.21 133.58 48.13 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.629 -0.714 . . . . 73.3 111.733 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.526 ' HE3' ' SD ' ' A' ' 98' ' ' MET . 96.7 mttt -142.47 145.77 34.07 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.565 1.146 . . . . 73.43 110.497 -175.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 114' ' ' LYS . 87.5 m95 -106.98 122.32 46.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.703 1.601 . . . . 73.11 110.884 -9.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.7 m -99.37 154.81 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 109.208 -0.664 . . . . 71.11 109.208 170.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 31.7 m -113.81 158.16 21.37 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.827 0.451 . . . . 65.22 110.868 -175.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.592 ' HB2' ' HE1' ' A' ' 97' ' ' TYR . 67.0 tt0 -59.42 -35.83 74.72 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.189 0.519 . . . . 74.21 111.67 175.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -52.39 -32.96 41.32 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.816 1.247 . . . . 72.22 112.129 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -101.43 7.16 42.67 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.572 1.149 . . . . 65.33 112.5 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.2 mt -125.17 158.92 32.77 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.54 0.736 . . . . 74.23 110.871 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.2 t -148.05 140.89 24.73 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.026 0.93 . . . . 71.0 109.939 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.69 130.25 38.4 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.628 0.371 . . . . 73.15 110.902 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -73.05 90.49 1.52 Allowed 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.183 0.516 . . . . 74.32 110.661 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.5 mt -112.56 -65.54 1.17 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.683 0.793 . . . . 72.32 110.548 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -92.52 159.04 15.69 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.928 0.891 . . . . 71.33 111.6 -178.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -81.7 72.35 8.74 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.434 0.694 . . . . 73.32 109.866 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -148.77 114.6 5.71 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.518 1.127 . . . . 74.32 109.841 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -87.78 -56.75 3.21 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.991 0.916 . . . . 74.21 109.663 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -167.99 145.13 4.2 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.353 1.061 . . . . 75.51 110.225 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.36 -164.6 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.591 0.757 . . . . 73.01 111.971 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.2 p80 . . . . . 0 CA--C 1.57 1.724 0 C-N-CA 122.938 0.495 . . . . 64.24 112.266 173.772 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 110.288 -0.264 . . . . 74.02 110.288 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -86.44 143.24 27.88 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.443 0.697 . . . . 74.31 111.633 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.5 t -66.58 126.58 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 C-N-CA 122.82 0.448 . . . . 71.53 110.215 170.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.97 -12.53 62.34 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 116.239 -0.437 . . . . 54.0 113.156 -171.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.3 t -88.66 161.04 17.09 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.259 0.623 . . . . 42.55 111.027 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -121.98 138.7 54.32 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.123 0.569 . . . . 55.41 111.207 -176.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.17 170.84 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 124.966 1.307 . . . . 73.33 111.118 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.5 mm -105.09 141.93 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.124 0.97 . . . . 61.23 109.814 171.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.663 HG21 ' HG2' ' A' ' 17' ' ' MET . 27.1 mm -65.04 129.31 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.5 0 C-N-CA 123.445 0.698 . . . . 73.24 111.263 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -108.07 -13.98 14.83 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.37 0.668 . . . . 65.34 111.604 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.9 m -145.49 139.17 26.62 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.241 0.616 . . . . 75.34 110.511 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.42 ' HA ' ' SD ' ' A' ' 17' ' ' MET . 58.8 p -113.49 118.5 34.66 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.301 0.64 . . . . 71.11 112.109 -173.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -89.58 -36.23 15.43 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.744 0.817 . . . . 74.11 109.441 169.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.488 ' H ' ' HE3' ' A' ' 17' ' ' MET . 41.0 tpp -96.21 144.7 26.18 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.482 1.113 . . . . 74.41 108.901 175.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -23.72 66.74 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.331 0.863 . . . . 63.25 113.331 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.507 ' HA2' HG22 ' A' ' 105' ' ' THR . . . -89.84 -2.26 75.55 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 113.815 0.286 . . . . 73.52 113.815 174.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.663 ' HG2' HG21 ' A' ' 9' ' ' ILE . 49.8 ttm -81.39 -29.34 34.0 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.2 0.5 . . . . 75.05 110.942 -172.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.16 119.75 8.45 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.488 0.715 . . . . 73.33 112.144 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.96 1.27 87.29 Favored Glycine 0 N--CA 1.476 1.308 0 N-CA-C 114.519 0.567 . . . . 72.41 114.519 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.87 149.48 39.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.043 0.537 . . . . 72.02 111.661 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -92.72 102.87 15.28 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 122.984 0.514 . . . . 62.14 110.552 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.579 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -86.02 150.66 24.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.932 0.893 . . . . 50.43 111.766 -175.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.1 m -123.48 115.62 21.86 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.204 0.602 . . . . 71.41 109.763 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.47 96.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.272 0.629 . . . . 72.41 110.352 -174.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.8 p -98.59 -4.36 34.22 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.416 0.686 . . . . 60.43 111.448 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.92 139.46 6.61 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 111.984 -0.446 . . . . 53.12 111.984 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.61 108.69 12.31 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.808 0.843 . . . . 75.05 109.688 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -111.96 112.1 23.5 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.802 0.841 . . . . 71.0 110.338 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -94.98 82.76 3.85 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.494 0.664 . . . . 71.13 109.312 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.6 t -134.94 177.27 7.94 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.86 0.864 . . . . 54.41 111.72 -173.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.7 m -85.74 125.9 33.58 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 122.823 0.449 . . . . 75.2 110.192 173.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -103.53 154.45 19.46 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.648 1.179 . . . . 44.43 110.524 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.545 ' HB2' HG23 ' A' ' 52' ' ' VAL . 92.0 m-85 -137.61 146.03 43.47 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.715 0.769 . . . . 73.41 111.583 -174.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.85 121.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 106.939 -1.504 . . . . 63.21 106.939 167.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.8 m -123.02 162.18 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.479 0.657 . . . . 63.43 112.761 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 71.5 p -131.01 122.12 26.25 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.295 -0.866 . . . . 71.21 109.732 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -148.01 151.24 35.41 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.344 0.498 . . . . 74.24 112.344 -170.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.2 m -96.37 109.15 46.19 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 107.814 -1.18 . . . . 73.34 107.814 170.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.32 148.64 40.77 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.371 2.047 . . . . 61.12 112.901 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.8 p -64.27 -17.21 63.4 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.176 0.99 . . . . 62.33 113.029 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.464 ' N ' HD22 ' A' ' 41' ' ' ASN . 0.8 OUTLIER -70.54 -19.51 62.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.76 0.424 . . . . 74.54 111.197 172.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.26 24.75 65.22 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 114.898 0.719 . . . . 74.44 114.898 168.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.18 -96.49 0.35 Allowed Glycine 0 CA--C 1.537 1.428 0 CA-C-N 117.03 0.415 . . . . 45.1 112.746 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -116.83 142.19 47.25 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.707 0.803 . . . . 70.21 110.539 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -69.71 115.3 8.8 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.675 0.39 . . . . 73.3 110.501 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.1 t -84.43 85.54 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-O 121.766 0.793 . . . . 62.11 109.837 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.0 p-10 -67.26 158.21 31.99 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.961 1.097 . . . . 64.13 113.961 163.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 42.3 m80 56.33 29.17 14.58 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 113.829 -1.532 . . . . 72.34 113.654 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -64.87 128.83 37.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.048 0.539 . . . . 74.43 111.167 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 98.3 mttt -129.66 133.75 47.29 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.801 0.84 . . . . 71.51 111.273 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.636 ' HB2' ' HB2' ' A' ' 115' ' ' TRP . 84.6 m95 -120.07 160.91 21.9 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.436 1.494 . . . . 60.22 111.159 -9.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.545 HG23 ' HB2' ' A' ' 33' ' ' TYR . 19.3 m -127.83 141.88 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.334 1.054 . . . . 63.23 109.301 170.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.6 pt -106.97 167.63 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 122.129 -0.357 . . . . 71.31 111.632 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.489 ' HG2' ' HB1' ' A' ' 60' ' ' ALA . 53.6 tt0 -47.75 -57.35 5.69 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.847 1.054 . . . . 74.41 113.847 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -82.09 7.02 14.51 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 112.866 0.691 . . . . 70.03 112.866 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -91.59 -11.39 37.34 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.386 1.074 . . . . 64.41 110.506 172.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.8 mt -116.88 140.01 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 125.031 1.332 . . . . 72.34 109.382 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HB3' ' HG2' ' A' ' 74' ' ' GLU . 16.0 ptmt -71.99 -36.21 69.7 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.758 0.651 . . . . 73.1 112.758 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -72.9 -8.99 58.16 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.756 0.822 . . . . 71.44 112.627 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.489 ' HB1' ' HG2' ' A' ' 54' ' ' GLN . . . -33.69 -63.3 0.26 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.228 1.411 . . . . 63.14 114.69 176.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.7 19.98 65.69 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 115.269 0.868 . . . . 74.33 115.269 169.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.1 t70 71.81 -3.08 2.28 Favored 'General case' 0 CA--C 1.573 1.853 0 C-N-CA 125.336 1.454 . . . . 74.23 112.843 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.68 168.15 10.11 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.68 0.792 . . . . 74.34 111.72 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.0 m -90.91 119.37 31.05 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.296 0.639 . . . . 55.24 110.409 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.5 HD13 HG11 ' A' ' 71' ' ' VAL . 49.6 mt -73.69 118.16 16.32 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.194 0.598 . . . . 73.23 110.21 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -101.27 144.55 28.79 Favored Pre-proline 0 N--CA 1.489 1.52 0 C-N-CA 123.614 0.765 . . . . 72.42 112.172 -165.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.39 124.95 16.22 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 123.082 2.521 . . . . 54.03 114.324 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.2 -19.22 29.93 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 123.841 0.734 . . . . 73.25 113.393 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -74.35 148.49 41.24 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.546 0.739 . . . . 74.13 112.291 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -113.07 123.24 49.82 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.726 0.81 . . . . 62.02 111.216 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.5 HG11 HD13 ' A' ' 65' ' ' LEU . 26.9 m -121.42 177.07 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 125.392 1.477 . . . . 50.31 111.496 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 85' ' ' THR . 38.5 mm -120.52 137.0 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 123.935 0.894 . . . . 72.02 109.821 170.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.4 mt -90.43 121.54 32.5 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.097 0.959 . . . . 51.31 111.818 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.468 ' HG2' ' HB3' ' A' ' 58' ' ' LYS . 33.8 mm-40 -89.66 -4.06 57.95 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.447 0.536 . . . . 53.42 112.447 174.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.48 167.62 12.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.255 0.55 . . . . 54.03 111.056 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 t -141.96 125.01 16.23 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.503 -0.771 . . . . 65.2 111.683 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -98.73 -11.81 21.57 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.89 0.876 . . . . 63.25 111.527 170.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 20.4 ptp -144.14 -175.6 4.68 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.545 0.738 . . . . 63.43 111.951 -172.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.52 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -70.05 100.81 1.68 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.793 0.664 . . . . 73.11 112.793 -178.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.35 38.97 8.62 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.387 -0.824 . . . . 62.11 114.426 172.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 27.6 ttt -86.49 -28.98 23.1 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 117.402 0.601 . . . . 64.33 111.765 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -64.59 129.24 39.08 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 120.908 0.385 . . . . 72.41 111.848 172.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.23 -4.15 84.34 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.924 -0.58 . . . . 74.33 113.143 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.78 146.93 32.04 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.463 0.705 . . . . 71.21 111.588 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.449 ' HA ' HD13 ' A' ' 72' ' ' ILE . 57.9 m -84.11 117.06 23.21 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.989 -0.55 . . . . 64.04 109.699 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -106.5 152.81 23.18 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.529 0.732 . . . . 72.21 110.36 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -123.1 121.47 36.08 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.555 -0.906 . . . . 75.21 108.555 174.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.5 mm -61.34 106.38 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.537 0.735 . . . . 73.42 110.133 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -76.59 -37.71 56.05 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.512 0.725 . . . . 74.51 109.735 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.0 t -159.77 158.62 31.53 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.671 -0.695 . . . . 72.15 111.286 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -135.17 139.33 44.49 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.957 0.903 . . . . 62.01 109.905 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -151.44 142.98 23.58 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.763 0.425 . . . . 65.02 110.751 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.578 ' HD2' ' H ' ' A' ' 93' ' ' LYS . 1.3 mptt -96.78 92.52 6.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 107.986 -1.116 . . . . 65.31 107.986 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.3 t -138.11 153.17 49.28 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.532 0.733 . . . . 74.05 111.337 -172.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.2 m -77.69 122.99 26.09 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.926 -0.398 . . . . 74.42 109.926 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.524 HG12 HG22 ' A' ' 117' ' ' THR . 24.0 m -109.31 134.2 52.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.728 0.811 . . . . 71.3 108.976 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -110.96 144.11 40.57 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.366 0.666 . . . . 73.43 111.684 -174.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.9 ttp -93.58 111.17 22.79 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.671 -1.233 . . . . 73.33 107.671 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.579 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 27.4 m -124.42 146.76 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 112.822 0.675 . . . . 72.53 112.822 -168.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.55 116.18 29.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.945 0.898 . . . . 74.13 109.827 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -130.96 175.5 9.03 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.188 0.595 . . . . 74.5 111.524 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.8 m -117.56 119.98 36.66 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.878 -0.786 . . . . 72.14 108.878 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 106' ' ' SER . 72.9 p -60.95 126.09 26.1 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.336 0.654 . . . . 74.21 111.558 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.5 p -70.71 -48.42 54.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.451 0.7 . . . . 52.15 112.87 -172.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.507 HG22 ' HA2' ' A' ' 16' ' ' GLY . 11.6 t -86.03 -4.2 59.11 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.304 0.853 . . . . 44.43 113.304 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.434 ' HB2' ' OG ' ' A' ' 103' ' ' SER . 16.5 m -119.12 -49.16 2.41 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.945 0.498 . . . . 75.23 111.4 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.5 -6.52 55.43 Favored Glycine 0 N--CA 1.481 1.635 0 CA-C-N 116.219 -0.446 . . . . 74.31 113.618 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.53 130.64 39.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.463 0.705 . . . . 73.42 110.894 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -81.3 100.61 9.27 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.837 -0.801 . . . . 74.33 108.837 178.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 113' ' ' HIS . 46.9 t -88.0 108.67 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.052 0.941 . . . . 73.44 110.004 -172.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.609 ' H ' ' HD2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -102.73 139.93 37.67 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.105 0.562 . . . . 51.11 111.777 -169.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.5 m120 51.67 36.99 18.86 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.509 1.123 . . . . 60.34 113.249 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.442 ' HB2' HG12 ' A' ' 110' ' ' VAL . 64.8 t60 -64.75 132.52 49.82 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.884 -0.598 . . . . 64.13 110.819 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HB2' ' CE3' ' A' ' 115' ' ' TRP . 21.1 pttp -158.39 146.96 18.77 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 115.188 -0.915 . . . . 73.1 111.019 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.636 ' HB2' ' HB2' ' A' ' 51' ' ' TRP . 87.9 m95 -106.87 136.6 46.43 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.08 1.352 . . . . 72.15 112.735 4.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.4 m -122.16 141.58 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 124.881 1.272 . . . . 61.02 108.313 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.524 HG22 HG12 ' A' ' 96' ' ' VAL . 30.7 p -96.37 178.01 5.51 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.781 -0.574 . . . . 72.44 112.202 -174.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -59.65 -52.92 63.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.021 0.928 . . . . 74.43 112.868 -176.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.52 -21.15 66.6 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.942 0.897 . . . . 70.42 112.223 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -88.53 3.06 51.65 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.646 0.778 . . . . 74.22 111.521 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.6 mt -121.95 166.65 14.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.63 1.172 . . . . 63.54 109.289 171.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.3 t -151.13 130.78 13.09 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.439 0.696 . . . . 73.35 110.16 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.3 143.72 50.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.832 0.453 . . . . 43.3 111.524 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -83.09 113.68 20.78 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.16 0.584 . . . . 73.44 111.039 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.29 139.43 41.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.419 0.688 . . . . 72.44 110.657 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.51 19.82 12.76 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.845 0.858 . . . . 73.01 112.25 -174.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -60.47 142.68 54.85 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.706 0.802 . . . . 71.14 113.072 -173.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -74.18 130.44 39.76 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.313 0.645 . . . . 72.34 111.009 -176.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -107.4 74.1 0.95 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.578 0.704 . . . . 73.42 111.978 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -136.31 76.37 1.6 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.85 0.86 . . . . 75.42 109.559 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -130.65 157.62 42.26 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.443 0.697 . . . . 75.54 111.827 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 . . . . . 0 CA--C 1.572 1.806 0 C-N-CA 123.149 0.58 . . . . 72.02 112.385 179.403 . . . . . . . . 0 0 . 1 stop_ save_